{"cells":[{"cell_type":"code","source":["# File location and type\nfile_location = \"/FileStore/tables/clinicaltrial_2021.csv/clinicaltrial_2021.csv\"\nfile_type = \"csv\"\n\n# CSV options\ninfer_schema = \"true\"\nfirst_row_is_header = \"true\"\ndelimiter = \"|\"\n\n# The applied options are for CSV files. For other file types, these will be ignored.\ndf = spark.read.format(file_type) \\\n  .option(\"inferSchema\", infer_schema) \\\n  .option(\"header\", first_row_is_header) \\\n  .option(\"sep\", delimiter) \\\n  .load(file_location)\n\ndisplay(df)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4143b278-a19a-41fb-bbde-81642b50e3a7"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"overflow":true,"datasetInfos":[],"data":[["NCT02758028","The University of Hong Kong","Recruiting","Aug 2005","Nov 2021","Interventional","Apr 2016",null,null],["NCT02751957","Duke University","Completed","Jul 2016","Jul 2020","Interventional","Apr 2016","Autistic Disorder,Autism Spectrum Disorder",null],["NCT02758483","Universidade Federal do Rio de Janeiro","Completed","Mar 2017","Jan 2018","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02759848","Istanbul Medeniyet University","Completed","Jan 2012","Dec 2014","Observational","May 2016","Tuberculosis,Lung Diseases,Pulmonary Disease",null],["NCT02758860","University of Roma La Sapienza","Active, not recruiting","Jun 2016","Sep 2020","Observational [Patient Registry]","Apr 2016","Diverticular Diseases,Diverticulum,Diverticulosis",null],["NCT02757209","Consorzio Futuro in Ricerca","Completed","Apr 2016","Jan 2018","Interventional","Apr 2016","Asthma","Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate"],["NCT02752438","Ankara University","Unknown status","May 2016","Jul 2017","Observational [Patient Registry]","Apr 2016","Hypoventilation",null],["NCT02753543","Ruijin Hospital","Unknown status","Nov 2015","Nov 2019","Interventional","Apr 2016","Lymphoma",null],["NCT02757508","Washington University School of Medicine","Completed","Mar 2016","Jul 2017","Interventional","Apr 2016",null,"Vitamins"],["NCT02753530","Orphazyme","Completed","Aug 2017","Jan 2021","Interventional","Apr 2016","Myositis",null],["NCT02754817","Novo Nordisk A/S","Completed","Apr 2016","Oct 2016","Observational","Apr 2016","Diabetes Mellitus","Liraglutide,Xultophy"],["NCT02759276","Daniel Alexandre Bottino","Completed","May 2015","Dec 2015","Observational","Apr 2016","Hypertension",null],["NCT02750956","Bulent Ecevit University","Completed","Jun 2015","Mar 2016","Observational","Apr 2016","Periodontal Diseases",null],["NCT02752113","Institut für Pharmakologie und Präventive Medizin","Completed","Apr 2016","May 2019","Interventional","Apr 2016","Diabetes Mellitus","Metformin,Empagliflozin,Linagliptin"],["NCT02752698","The Third Xiangya Hospital of Central South University","Active, not recruiting","Jan 2015","Dec 2021","Interventional","Jun 2015","Appendicitis,Stomach Ulcer,Cholecystolithiasis,Cholelithiasis,Gallstones",null],["NCT02755779","Tel Aviv Medical Center","Unknown status","Jun 2016","Jun 2017","Observational","Apr 2016",null,null],["NCT02750384","Medicines for Malaria Venture","Terminated","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02754609","James Cook University, Queensland, Australia","Completed","Sep 2016","Oct 2019","Interventional","Apr 2016","Hookworm Infections,Celiac Disease",null],["NCT02755701","Soonchunhyang University Hospital","Unknown status","Jul 2016","Dec 2018","Interventional","Apr 2016","Ascites",null],["NCT02751762","Member Companies of the Opioid PMR Consortium","Recruiting","Nov 2017","Oct 2022","Observational","Apr 2016","Chronic Pain,Substance-Related Disorders,Opioid-Related Disorders,Narcotic-Related Disorders,Behavior",null],["NCT02756299","Marmara University","Completed","Jun 2014","Apr 2015","Interventional","Apr 2016","Sleep Apnea Syndromes,Sleep Apnea",null],["NCT02750709","Cycle Pharmaceuticals Ltd.","Completed","Oct 2015","Jan 2016","Interventional","Apr 2016","Tyrosinemias","Nitisinone"],["NCT02753907","Yonsei University","Completed","Jun 2015",null,"Interventional","Apr 2016",null,null],["NCT02755467","Cutera Inc.","Completed","May 2016","Apr 2017","Interventional","Apr 2016","Hemangioma",null],["NCT02755298","University of Zurich","Completed","Oct 2016","Nov 2020","Interventional","Mar 2016","Hypertension","Acetazolamide"],["NCT02759614","Guangdong Association of Clinical Trials","Unknown status","Apr 2016","Jun 2019","Interventional","Mar 2016","Carcinoma","Bevacizumab,Erlotinib Hydrochloride"],["NCT02752815","Ruijin Hospital","Unknown status","Apr 2016","Jun 2020","Interventional","Apr 2016","Lymphoma","Prednisone,Cyclophosphamide,Rituximab,Vincristine,Epirubicin"],["NCT02757131","The Cleveland Clinic","Completed","Jul 2016","Jul 2017","Interventional","Apr 2016","Iatrogenic Disease",null],["NCT02758704","St. Justine's Hospital","Completed","Oct 2015","Jun 2021","Interventional","Apr 2016",null,null],["NCT02750501","Alcresta Therapeutics, Inc.","Completed","Jul 2016","Mar 2017","Interventional","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02759913","Iron Horse Diagnostics, Inc.","Unknown status","Jan 2015","Dec 2016","Observational","Apr 2016","Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis",null],["NCT02752724","VA Puget Sound Health Care System","Completed","Mar 2016","Apr 2018","Interventional","Mar 2016","Depressive Disorder,Depression","Ketamine,Methohexital"],["NCT02758444","University of Colorado, Denver","Completed","Nov 2015","Feb 2019","Interventional","Apr 2016",null,"Micronutrients,Trace Elements"],["NCT02758067","H. Lundbeck A/S","Withdrawn","Jun 2016",null,"Interventional","Apr 2016","Schizophrenia","Risperidone,Brexpiprazole"],["NCT02759341","Ospedale San Giovanni Bellinzona","Completed","Feb 2016","Nov 2017","Interventional","Apr 2016","Myocardial Infarction,Cardiomyopathies,Microvascular Angina,Takotsubo Cardiomyopathy,Syndrome,Infarction",null],["NCT02753803","Dong-A ST Co., Ltd.","Completed","Jul 2016","Mar 2017","Interventional","Apr 2016",null,"Pioglitazone"],["NCT02752490","The University of Texas Health Science Center, Houston","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02759562","Gilead Sciences","Terminated","Nov 2016","Jul 2017","Interventional","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02758262","Laval University","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016","Hyperphagia",null],["NCT02754258","Children's Hospital of Eastern Ontario","Unknown status","Jan 2017","Dec 2018","Interventional","Apr 2016",null,"Methylphenidate"],["NCT02755207","Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","Unknown status","Apr 2016","Dec 2020","Observational","Mar 2016","Acute Coronary Syndrome,Syndrome",null],["NCT02759900","The Skin Center Dermatology Group","Recruiting","Jan 2016","Jan 2023","Interventional","Apr 2016","Molluscum Contagiosum,Keratosis,Bowens Disease,Rosacea,Skin Diseases",null],["NCT02752581","Mert Özcan","Completed","Jan 2009","Apr 2013","Interventional","Apr 2016","Hemarthrosis",null],["NCT02759796","Instituto de Investigación Hospital Universitario La Paz","Completed","Nov 2015","Apr 2017","Interventional","Apr 2016","Necrosis,Neovascularization,Fat Necrosis",null],["NCT02754063","University Hospital, Grenoble","Active, not recruiting","Jun 2016","Apr 2022","Interventional","Apr 2016","Brain Injuries,Wounds and Injuries","3"],["NCT02750917","Foisor Orthopedics Clinical Hospital","Completed","Sep 2014","Mar 2015","Interventional","Feb 2016","Pain","Etoricoxib,Lornoxicam"],["NCT02753569","Institute of Cancer Research, United Kingdom","Completed","May 2016","May 2020","Observational","Apr 2016",null,null],["NCT02751255","VU University Medical Center","Active, not recruiting","Jul 2016","Mar 2022","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Tretinoin"],["NCT02751528","NantBioScience, Inc.","Unknown status","Dec 2016","Dec 2020","Interventional","Apr 2016","Breast Neoplasms","Vaccines"],["NCT02751619","University of Campania Luigi Vanvitelli","Completed","Jan 2013","Dec 2015","Interventional","Apr 2016","Pain","Lidocaine"],["NCT02757833","Lawson Health Research Institute","Withdrawn","Feb 2019","Feb 2019","Interventional","Apr 2016","Depression,Depressive Disorder",null],["NCT02750761","Merck Sharp & Dohme Corp.","Completed","May 2016","Dec 2018","Interventional","Apr 2016","Infections,Bacterial Infections,Gram-Positive Bacterial Infections","Tedizolid phosphate,Tedizolid,Oxazolidinones"],["NCT02752594","Sharda University","Completed","Apr 2015","Apr 2015","Interventional","Apr 2016","Dental Caries",null],["NCT02753452","Holland Bloorview Kids Rehabilitation Hospital","Unknown status","May 2015","Mar 2020","Interventional","Apr 2016",null,null],["NCT02752763","Niğde State Hospital","Completed","Oct 2015","Mar 2016","Interventional","Mar 2016","Dry Eye Syndromes,Keratoconjunctivitis Sicca","Dextrans,Povidone,Ophthalmic Solutions,Lubricant Eye Drops"],["NCT02753816","Spectrum Health Hospitals","Terminated","Apr 2016","Dec 2019","Interventional","Apr 2016","Burns","Tranexamic Acid"],["NCT02751294","GlaxoSmithKline","Completed","May 2016","Aug 2016","Interventional","Apr 2016","Malaria","Tafenoquine"],["NCT02756429","Hospices Civils de Lyon","Completed","Feb 2014","Jan 2018","Interventional","Apr 2016","Atrial Fibrillation",null],["NCT02750163","Università Politecnica delle Marche","Completed","Jul 2017","Jun 2019","Observational","Apr 2016","Shock","Acetaminophen"],["NCT02751905","Biogen","Completed","Apr 2016","May 2016","Interventional","Apr 2016","Neuralgia",null],["NCT02753153","University of Liege","Completed","May 2011","May 2015","Interventional","Apr 2016","Tooth Loss",null],["NCT02750891","Sumitomo Dainippon Pharma Co., Ltd.","Completed","Apr 2016","Jan 2020","Interventional","Apr 2016","Glioblastoma,Glioma,Diffuse Intrinsic Pontine Glioma",null],["NCT02751073","Mayo Clinic","Completed","Feb 2016","Jul 2018","Observational","Feb 2016","Infections,Communicable Diseases,Urinary Tract Infections,Prolapse,Pelvic Organ Prolapse",null],["NCT02753114","University of British Columbia","Completed","Nov 2017","May 2018","Interventional","Apr 2016","Acute Pain","Ketamine"],["NCT02752516","Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016",null,null],["NCT02752269","Medical University of Graz","Completed","Oct 2014","Jun 2019","Observational","Nov 2015","Sjogrens Syndrome,Hypertension,Vascular Diseases,Syndrome",null],["NCT02754713","Hippocration General Hospital","Recruiting","Sep 2009","Dec 2025","Observational","Apr 2016","Pericarditis",null],["NCT02759770","Beijing Anzhen Hospital","Completed","Jul 2017","Sep 2017","Observational","Apr 2016","Respiratory Distress Syndrome,Acute Lung Injury",null],["NCT02755129","Medtronic BRC","Completed","Sep 2016","Jul 2017","Interventional","Mar 2016","Frailty",null],["NCT02754674","Samsung Medical Center","Completed","May 2014","Dec 2017","Interventional","Feb 2015","Rupture",null],["NCT02757521","Washington University School of Medicine","Terminated","Mar 2016","Dec 2016","Interventional","Apr 2016","Disease,Depression,Depressive Disorder,Bipolar Disorder","Nitrous Oxide"],["NCT02750774","University of Modena and Reggio Emilia","Unknown status","Dec 2015","Dec 2016","Interventional","Apr 2016","Diabetes,Obesity,Pregnancy Complications,Fetal Macrosomia,Overweight,Birth Weight",null],["NCT02754739","Samsung Medical Center","Completed","Apr 2014","Aug 2017","Interventional","Apr 2016","Diabetes Mellitus,Prediabetic State","Pravastatin"],["NCT02758808","University of Michigan","Recruiting","Mar 2016","Oct 2023","Observational [Patient Registry]","Apr 2016","Lung Diseases,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis",null],["NCT02751840","Tel Hai College","Completed","Oct 2014","Apr 2016","Interventional","Apr 2016","Asymptomatic Diseases","Caffeine"],["NCT02752451","University of Arizona","Completed","Mar 2015","Apr 2015","Interventional","Apr 2016",null,null],["NCT02757599","Rigshospitalet, Denmark","Completed","Aug 2016","Jun 2017","Interventional","Apr 2016",null,null],["NCT02753894","Astellas Pharma Inc","Completed","Jan 2008","Jun 2008","Interventional","Mar 2016","Kidney Diseases,Renal Insufficiency,Hyperphosphatemia",null],["NCT02757638","Texas A&M University","Active, not recruiting","Oct 2015","Oct 2021","Interventional","Feb 2016","Weight Loss",null],["NCT02757378","Kevin Farrell","Completed","May 2015","Sep 2015","Interventional","Apr 2016","Back Pain,Low Back Pain",null],["NCT02751489","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02759315","Merck Sharp & Dohme Corp.","Terminated","May 2016","Nov 2017","Interventional","Apr 2016","Hepatitis A,Hepatitis C,Hepatitis","Uprifosbuvir,Ruzasvir"],["NCT02754895","Massachusetts General Hospital","Completed","Oct 2014","May 2017","Interventional","Apr 2016","Acute Coronary Syndrome,Syndrome",null],["NCT02750475","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis","Sunscreening Agents"],["NCT02755064","Adil Bharucha","Completed","Jun 2010","Nov 2013","Interventional","Apr 2016","Diabetes Mellitus","Erythromycin,Erythromycin Estolate,Erythromycin Ethylsuccinate,Erythromycin stearate,Erythromycin lactobionate"],["NCT02758002","University of California, San Diego","Withdrawn","Jan 2016","Dec 2018","Interventional","Apr 2016","Atrial Fibrillation",null],["NCT02755142","medac GmbH","Completed","Feb 2000","Jun 2001","Interventional","Apr 2016","Glioma,Brain Neoplasms","Aminolevulinic Acid"],["NCT02756364","Millennium Pharmaceuticals, Inc.","Completed","Jul 2016","Nov 2019","Interventional","Apr 2016","Breast Neoplasms","Fulvestrant"],["NCT02759484","Rush University Medical Center","Unknown status","Mar 2015","Mar 2019","Interventional","Dec 2015","Hypertension,Diabetes Mellitus,Hyperglycemia",null],["NCT02752061","Harvard School of Public Health (HSPH)","Completed","May 2016","Jul 2020","Interventional","Apr 2016",null,null],["NCT02756598","Aarhus University Hospital","Completed","Jan 2015","Jun 2018","Interventional","Dec 2015",null,"Sufentanil,Dsuvia,Propofol"],["NCT02755727","Royal Devon and Exeter NHS Foundation Trust","Completed","Mar 2016","Sep 2017","Interventional","Apr 2016","Tennis Elbow",null],["NCT02754882","Samsung Bioepis Co., Ltd.","Completed","Jul 2016","Oct 2018","Interventional","Mar 2016","Lung Neoplasms,Carcinoma","Paclitaxel,Bevacizumab,Carboplatin"],["NCT02754778","Martin-Luther-Universität Halle-Wittenberg","Completed","Apr 2016","Mar 2021","Interventional","Apr 2016","Pre-Eclampsia,HELLP Syndrome,Syndrome",null],["NCT02758171","Boehringer Ingelheim","Completed","May 2016","Aug 2016","Interventional","Apr 2016",null,"Empagliflozin,Linagliptin"],["NCT02755376","Samsung Medical Center","Completed","Jan 2014","Dec 2018","Interventional","Feb 2015",null,"Hyaluronic Acid"],["NCT02759016","Boehringer Ingelheim","Completed","Jun 2016","Jul 2019","Interventional","Apr 2016","Leukemia","BI 836826"],["NCT02758457","University of Bologna","Completed","Jan 2008","Apr 2015","Interventional","Apr 2016",null,null],["NCT02755519","Chongqing Medical University","Completed","May 2014","Oct 2016","Observational","Apr 2016","Hyperaldosteronism",null],["NCT02758782","Charite University, Berlin, Germany","Completed","Sep 2016","Jan 2021","Interventional","Apr 2016","Spondylitis","Celecoxib,Golimumab"],["NCT02756806","Cutera Inc.","Completed","Apr 2016","Sep 2016","Interventional","Apr 2016",null,null],["NCT02756156","Kahramanmaras Sutcu Imam University","Unknown status","Apr 2016","Aug 2016","Observational","Mar 2016","Humeral Fractures",null],["NCT02759458","Rush University Medical Center","Completed","Nov 2013","Jan 2017","Interventional","Apr 2016","Rotator Cuff Injuries",null],["NCT02750982","Brown, Theodore R., M.D., MPH","Completed","Jul 2016","Aug 2018","Interventional","Apr 2016","Parkinson Disease,Multiple Sclerosis,Alzheimer Disease,Brain Injuries,Spinal Cord Injuries,Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Huntington Disease,Sclerosis,Wounds and Injuries",null],["NCT02751502","NYU Langone Health","Terminated","Jan 2017","Feb 2021","Interventional","Apr 2016","Hemiplegia",null],["NCT02752087","Eli Lilly and Company","Completed","Apr 2016","May 2016","Interventional","Apr 2016",null,null],["NCT02756858","Anavex Life Sciences Corp.","Completed","Mar 2016","Nov 2020","Interventional","Mar 2016","Alzheimer Disease",null],["NCT02758249","Konkuk University Medical Center","Completed","Jan 2016","Jan 2016","Interventional","Feb 2016",null,"Propofol,Sevoflurane"],["NCT02754570","University of Colorado, Denver","Completed","Jul 2016","Feb 2018","Interventional","Apr 2016","Glaucoma,Ocular Hypertension,Hypertension","Pilocarpine"],["NCT02754102","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis","Sunscreening Agents"],["NCT02751593","Peking University People's Hospital","Unknown status","Jan 2016","Dec 2017","Interventional","Apr 2016","Thrombocytopenia,Purpura","Dexamethasone"],["NCT02757014","Bayer","Completed","Oct 2015","Oct 2015","Interventional","Apr 2016",null,null],["NCT02753062","Asan Medical Center","Recruiting","Aug 2015","Aug 2023","Interventional","Apr 2016","Lymphoma","Rituximab,Bendamustine Hydrochloride"],["NCT02752425","Hospices Civils de Lyon","Completed","May 2016","May 2018","Interventional","Apr 2016","Speech Disorders",null],["NCT02757300","Marienhospital Osnabrück","Unknown status","May 2016","Jul 2017","Interventional","Apr 2016","Pharyngitis",null],["NCT02754180","Peking Union Medical College Hospital","Unknown status","Mar 2016","Mar 2021","Interventional","Apr 2016","Adenocarcinoma,Pancreatic Neoplasms","Gemcitabine"],["NCT02752321","Northwell Health","Terminated","Aug 2016","Dec 2017","Interventional","Apr 2016",null,null],["NCT02753595","Eisai Inc.","Terminated","Jul 2016","Aug 2019","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02755246","Charite University, Berlin, Germany","Completed","Apr 2016","Sep 2016","Interventional","Apr 2016","Cognitive Dysfunction",null],["NCT02754115","Tata Memorial Centre","Recruiting","Apr 2016","Jan 2022","Observational","Mar 2016","Peritoneal Diseases",null],["NCT02756897","M.D. Anderson Cancer Center","Active, not recruiting","Jul 2016","Jul 2024","Interventional","Apr 2016","Lymphoma,Leukemia","Venetoclax"],["NCT02752334","Magrabi Eye & Ear Hospital","Completed","Sep 2015","Mar 2019","Interventional","Mar 2016",null,"Magnesium Sulfate,Bupivacaine"],["NCT02754791","Shaare Zedek Medical Center","Unknown status","May 2016","May 2017","Interventional","Apr 2016",null,null],["NCT02754128","Holland Bloorview Kids Rehabilitation Hospital","Completed","Jun 2016","Oct 2017","Interventional","Apr 2016","Cerebral Palsy",null],["NCT02751190","Umeå University","Completed","Sep 2013","Feb 2017","Observational [Patient Registry]","Apr 2016","Chronic Pain,Hernia",null],["NCT02751645","Oregon Health and Science University","Unknown status","Jun 2016","May 2020","Interventional","Apr 2016",null,null],["NCT02758184","Duke University","Terminated","Jun 2016","May 2018","Interventional","Apr 2016",null,null],["NCT02751892","University of East Anglia","Completed","Oct 2013","Sep 2014","Interventional","Apr 2016","Colorectal Neoplasms",null],["NCT02755324","Leiden University","Completed","Oct 2016","Jan 2019","Interventional","Apr 2016","Schistosomiasis",null],["NCT02758886","Washington State University","Completed","Apr 2014",null,"Interventional","Apr 2016","Stress",null],["NCT02750072","Fraser Orthopaedic Research Society","Active, not recruiting","Sep 2016","Apr 2023","Interventional","Apr 2016","Patellofemoral Pain Syndrome,Fractures,Tibial Fractures",null],["NCT02750332","Cycle Pharmaceuticals Ltd.","Completed","Nov 2015","Jan 2016","Interventional","Apr 2016","Tyrosinemias","Nitisinone"],["NCT02752529","Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","Unknown status","Mar 2016",null,"Interventional","Mar 2016","Liver Cirrhosis","Tacrolimus"],["NCT02759939","Dartmouth-Hitchcock Medical Center","Completed","Jul 2016","Jul 2017","Interventional","Feb 2016",null,null],["NCT02757157","European Respiratory Society","Terminated","Oct 2016","Jan 2020","Interventional","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02759627","Istanbul University","Completed","Nov 2014","Mar 2016","Interventional","Apr 2016","Stroke",null],["NCT02752412","Sanofi","Completed","May 2016","Oct 2018","Interventional","Apr 2016","Diabetes Mellitus","Insulin,Metformin,Insulin Glargine,Lixisenatide"],["NCT02756988","Bayer","Completed","Oct 2015","Oct 2015","Interventional","Apr 2016",null,null],["NCT02751203","Lara McKenzie","Completed","Apr 2016","Dec 2017","Interventional","Mar 2016",null,null],["NCT02753946","Nabriva Therapeutics AG","Completed","Apr 2016","May 2017","Interventional","Apr 2016","Infections,Communicable Diseases,Urinary Tract Infections,Pyelonephritis","Tazobactam,Piperacillin,Fosfomycin"],["NCT02755480","University Health Network, Toronto","Terminated","Feb 2015","Feb 2017","Interventional","Mar 2015",null,null],["NCT02753257","Valtari Bio","Unknown status","Sep 2016","Dec 2019","Observational","Apr 2016","Stroke",null],["NCT02758691","Virginia Polytechnic Institute and State University","Completed","Dec 2015","May 2017","Interventional","Apr 2016",null,"Insulin"],["NCT02755623","Centre hospitalier de Ville-Evrard, France","Unknown status","May 2015","Dec 2018","Interventional","Apr 2016","Hallucinations,Schizophrenia",null],["NCT02756234","Lancaster General Hospital","Completed","May 2016","Aug 2018","Observational","Apr 2016","Coronary Artery Disease",null],["NCT02756091","University Hospital Inselspital, Berne","Recruiting","Aug 2016","May 2022","Observational [Patient Registry]","Apr 2016","Cerebrovascular Disorders",null],["NCT02753491","Marmara University","Completed","Oct 2015","Mar 2016","Interventional","Apr 2016",null,null],["NCT02752737","Medtronic Cardiac Rhythm and Heart Failure","Recruiting","May 2016","Dec 2024","Observational [Patient Registry]","Apr 2016","Atrial Fibrillation",null],["NCT02758925","University Hospital, Caen","Unknown status","Jun 2016","Dec 2018","Interventional","Apr 2016","Lymphoma","Cytarabine,Rituximab,Bendamustine Hydrochloride"],["NCT02751723","Florian Lordick, MD","Unknown status","Sep 2014","Oct 2019","Observational","Apr 2016",null,null],["NCT02751931","Astellas Pharma Europe B.V.","Completed","Jun 2016","May 2019","Interventional","Apr 2016","Urinary Bladder","Mirabegron"],["NCT02758847","Rabih A. Chaer","Recruiting","Sep 2016","Dec 2022","Interventional","Apr 2016","Ischemia","Paclitaxel,Albumin-Bound Paclitaxel"],["NCT02757807","Eco Fusion","Unknown status","Jul 2016","Dec 2016","Interventional","Apr 2016","Erectile Dysfunction",null],["NCT02755220","Shanghai Cingularbio Co. Ltd","Completed","Jan 2016","Apr 2019","Interventional","Apr 2016",null,null],["NCT02758548","Novartis Pharmaceuticals","Completed","Mar 2016","May 2016","Interventional","Mar 2016",null,null],["NCT02756845","Amgen","Recruiting","Aug 2017","Jun 2024","Interventional","Dec 2015","Neoplasms","Talimogene laherparepvec"],["NCT02750605","Skane University Hospital","Active, not recruiting","Feb 2016","Dec 2021","Interventional","Jan 2016","Vascular Diseases,Peripheral Vascular Diseases,Peripheral Arterial Disease,Ischemia",null],["NCT02756702","Aesculap AG","Active, not recruiting","Mar 2016","Dec 2022","Observational","Apr 2016","Osteoarthritis",null],["NCT02752945","King's College London","Completed","Apr 2016","Dec 2016","Interventional","Apr 2016","Depression,Depressive Disorder,Anxiety Disorders",null],["NCT02759952","STZ eyetrial","Enrolling by invitation","Jan 2013","Dec 2025","Observational","Apr 2016","Retinitis,Retinitis Pigmentosa",null],["NCT02754661","Medtronic - MITG","Completed","Sep 2016","Aug 2018","Interventional","Apr 2016","Colorectal Neoplasms",null],["NCT02755441","Nils Hoyer","Recruiting","Apr 2016","Dec 2024","Observational","Apr 2016","Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis",null],["NCT02750098","Sheba Medical Center","Unknown status","May 2016","Mar 2018","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02753179","Hospices Civils de Lyon","Completed","May 2016","Jan 2017","Interventional","Apr 2016","Vestibular Diseases",null],["NCT02758509","Parc de Salut Mar","Completed","Jan 2010","Oct 2017","Observational","Apr 2016","Hepatitis C,Hepatitis","Interferons,Ritonavir,Ribavirin,Interferon-alpha,Interferon alpha-2,Sofosbuvir,Peginterferon alfa-2a,Ledipasvir,Simeprevir"],["NCT02751970","Universidad de Valparaiso","Unknown status","Apr 2014","Apr 2018","Interventional","Apr 2016","Dental Caries",null],["NCT02753712","Mundipharma Research Limited","Completed","Jun 2016","Aug 2017","Interventional","Apr 2016","Asthma","Fluticasone,Xhance,Formoterol Fumarate"],["NCT02751151","Inova Health Care Services","Completed","Feb 2016","May 2021","Interventional","Mar 2016","Skin Neoplasms","Aminolevulinic Acid"],["NCT02757716","Sana Klinikum Offenbach","Completed","Apr 2016","Jan 2019","Interventional","Apr 2016","Behavior",null],["NCT02758652","Tampere University Hospital","Active, not recruiting","May 2016","May 2026","Observational","Apr 2016","Ovarian Neoplasms,Carcinoma",null],["NCT02754206","Southern Methodist University","Terminated","Jan 2016","Sep 2021","Observational","Apr 2016","Post-Concussion Syndrome,Brain Concussion",null],["NCT02752243","Peter Bader","Active, not recruiting","Mar 2016","Mar 2022","Interventional","Mar 2016","Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome,Acute Disease",null],["NCT02754856","M.D. Anderson Cancer Center","Active, not recruiting","Jul 2016","Jul 2021","Interventional","Apr 2016","Colorectal Neoplasms","Durvalumab,Ipilimumab,Tremelimumab,Immunoglobulins,Antibodies,Immunoglobulin G"],["NCT02759861","University of Nebraska","Active, not recruiting","Aug 2016","Aug 2020","Interventional","Apr 2016","Hepatitis A,Hepatitis C,Hepatitis","Sofosbuvir,Ledipasvir"],["NCT02759679","Haukeland University Hospital","Unknown status","May 2016","Dec 2019","Interventional","Mar 2016","Lung Neoplasms",null],["NCT02752932","Lawson Health Research Institute","Completed","Nov 2015","Oct 2017","Interventional","Feb 2016","Carcinoma,Squamous Cell Carcinoma of Head and Neck,Neoplasms",null],["NCT02759445","RWTH Aachen University","Unknown status","Apr 2016","Oct 2016","Observational","Nov 2015",null,null],["NCT02754622","Guy's and St Thomas' NHS Foundation Trust","Completed","Jul 2016","Dec 2016","Observational","Apr 2016","Critical Illness",null],["NCT02756611","AbbVie","Active, not recruiting","Jun 2016","Sep 2022","Interventional","Apr 2016","Leukemia","Venetoclax"],["NCT02758223","Wuerzburg University Hospital","Active, not recruiting","Apr 2016","Jun 2021","Interventional","Feb 2016","Leukemia,Myelodysplastic Syndromes",null],["NCT02757079","Nobelpharma","Completed","Jun 2016","Jul 2018","Interventional","Apr 2016","Sleep Wake Disorders,Parasomnias,Disease,Neurodevelopmental Disorders","Melatonin"],["NCT02754219","Dong-A ST Co., Ltd.","Completed","Sep 2016","Jan 2018","Interventional","Apr 2016","Liver Diseases",null],["NCT02753101","Stanford University","Completed","Feb 2016","Feb 2017","Interventional","Apr 2016","Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Sciatica",null],["NCT02759003","Fondazione Salvatore Maugeri","Completed","Mar 2011","Mar 2014","Interventional","Apr 2016","Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis",null],["NCT02752659","University of British Columbia","Completed","Jun 2016","Jun 2017","Interventional","Apr 2016","Breast Neoplasms,Lymphedema",null],["NCT02758912","Burnasyan Federal Medical Biophysical Center","Completed","Nov 2016","Oct 2019","Interventional","Apr 2016","Stroke,Angina Pectoris,Infarction,Hemorrhage",null],["NCT02754388","National Taiwan University Hospital","Completed","Feb 2016","Dec 2019","Observational [Patient Registry]","Apr 2016","Lung Neoplasms",null],["NCT02759666","Atridia Pty Ltd.","Completed","Jun 2016","Apr 2019","Interventional","Apr 2016","Neoplasms",null],["NCT02750241","The University of Texas Medical Branch, Galveston","Completed","Apr 2016","Jan 2019","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02752568","Kasr El Aini Hospital","Unknown status","May 2016","Dec 2016","Interventional","Apr 2016",null,null],["NCT02758015","University of California, San Francisco","Completed","Jun 2016","Mar 2018","Interventional","Apr 2016",null,"Betaine"],["NCT02756884","Arkansas Heart Hospital","Completed","Jun 2015","Jan 2019","Interventional","Apr 2016","Peripheral Arterial Disease,Peripheral Vascular Diseases",null],["NCT02758353","JSI Research & Training Institute, Inc.","Completed","Apr 2015","Nov 2015","Interventional","Apr 2016","Malaria,Stillbirth",null],["NCT02753751","Yale University","Completed","Mar 2018","Jan 2020","Interventional","Apr 2016","Acute Kidney Injury,Wounds and Injuries",null],["NCT02757170","All India Institute of Medical Sciences, New Delhi","Unknown status","Jul 2015","Jul 2016","Interventional","Apr 2016","Liver Failure,Hepatic Insufficiency,End Stage Liver Disease,Acute-On-Chronic Liver Failure",null],["NCT02757625","Pfizer","Completed","Jul 2016","May 2017","Interventional","Apr 2016",null,"Dexmedetomidine"],["NCT02752347","Riyadh Colleges of Dentistry and Pharmacy","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016","Malocclusion",null],["NCT02756468","University of Roma La Sapienza","Unknown status","Jan 2015","Dec 2016","Observational [Patient Registry]","Apr 2016","Pancreatic Neoplasms",null],["NCT02750410","Eli Lilly and Company","Completed","Aug 2016","Jun 2018","Interventional","Apr 2016","Diabetes Mellitus","Dulaglutide"],["NCT02755389","Nova Scotia Health Authority","Completed","Sep 2016","Jun 2018","Interventional","Apr 2016","Apnea",null],["NCT02755168","Assiut University","Unknown status","May 2017","May 2018","Interventional","Apr 2016",null,null],["NCT02751567","Bayer","Withdrawn","May 2016","Jun 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02755558","Penn State University","Completed","Sep 2014","May 2015","Interventional","Apr 2016",null,null],["NCT02757547","Electrical Geodesics, Inc.","Terminated","Sep 2015","Nov 2017","Interventional","Apr 2016","Epilepsy",null],["NCT02752828","Sanofi","Completed","May 2016","Mar 2018","Interventional","Apr 2016","Diabetes Mellitus","Insulin,Insulin Glargine,Lixisenatide,Hypoglycemic Agents"],["NCT02756715","Konkuk University Medical Center","Completed","May 2016","Feb 2020","Interventional","Apr 2016","Vascular System Injuries,Ischemia","Propofol,Desflurane"],["NCT02756117","Vanderbilt University","Completed","May 2016","Oct 2016","Interventional","Apr 2016","Prediabetic State",null],["NCT02753205","Gachon University Gil Medical Center","Withdrawn","Apr 2016","Apr 2018","Interventional","Apr 2016","Intracranial Hypertension","Dexmedetomidine"],["NCT02756221","Tel Hai College","Completed","Mar 2016","Apr 2018","Interventional","Apr 2016","Respiratory Tract Infections,Gastroenteritis",null],["NCT02755675","Rigshospitalet, Denmark","Recruiting","Apr 2016","Oct 2023","Interventional","Apr 2016","Carcinoma,Lung Neoplasms,Mesothelioma",null],["NCT02754037","University of California, Davis","Recruiting","Apr 2016","Jun 2024","Observational","Apr 2016","Liver Diseases,Fatty Liver,Non-alcoholic Fatty Liver Disease,Inflammation","Fluorodeoxyglucose F18"],["NCT02750306","Merck Sharp & Dohme Corp.","Completed","May 2016","Sep 2018","Interventional","Apr 2016","Alzheimer Disease,Sleep Initiation and Maintenance Disorders","Suvorexant"],["NCT02756403","Medstar Health Research Institute","Completed","Mar 2016","Jul 2017","Interventional","Mar 2016",null,"Azithromycin,Metronidazole,Doxycycline"],["NCT02759653","Haukeland University Hospital","Completed","May 2016","Dec 2018","Observational","Apr 2016","Stroke,Ischemic Stroke,Carotid Artery Diseases,Embolic Stroke",null],["NCT02753920","Northwell Health","Completed","Mar 2016","Jul 2018","Interventional","Apr 2016","Prolapse",null],["NCT02759367","Samuel Lunenfeld Research Institute, Mount Sinai Hospital","Completed","Mar 2008","Jun 2015","Interventional","Dec 2015","Hypertension",null],["NCT02752997","Mayo Clinic","Completed","Dec 2015","Mar 2016","Interventional","Apr 2016","Heart Failure",null],["NCT02750059","South East Asia Research Collaboration with Hawaii","Completed","Jan 2015","Feb 2018","Interventional","May 2015","Infections,Communicable Diseases,HIV Infections,Acquired Immunodeficiency Syndrome","Tenofovir,Lamivudine,Efavirenz,Telmisartan"],["NCT02754505","Danube Hospital","Completed","Feb 2008","Dec 2011","Interventional","Mar 2016","Critical Illness",null],["NCT02751736","Seoul National University Hospital","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016","Rectal Neoplasms",null],["NCT02750930","GlaxoSmithKline","Terminated","Oct 2016","Mar 2017","Interventional","Apr 2016","Diabetes Mellitus","rGLP-1 protein"],["NCT02753582","Indonesia University","Unknown status","Apr 2016","Apr 2017","Interventional","Apr 2016","Frailty",null],["NCT02750722","University of Zurich","Completed","May 2016","Jan 2017","Interventional","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02756793","Lawson Health Research Institute","Active, not recruiting","Oct 2016","Jun 2026","Interventional","Apr 2016","Neoplasm Metastasis,Neoplasms",null],["NCT02750436","Montreal General Hospital","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Back Pain",null],["NCT02755922","Instituto Mexicano del Seguro Social","Completed","Apr 2010","Dec 2010","Interventional","Apr 2016","Mandibular Fractures",null],["NCT02755493","Brigham and Women's Hospital","Completed","Apr 2016","May 2018","Interventional","Apr 2016","Sleep Deprivation",null],["NCT02750397","Massachusetts General Hospital","Active, not recruiting","Aug 2016","Dec 2024","Observational","Apr 2016",null,null],["NCT02753621","Johns Hopkins University","Completed","Dec 2015","Dec 2016","Interventional","Apr 2016","Parkinson Disease",null],["NCT02754154","Bristol-Myers Squibb","Unknown status","Dec 2014","Feb 2019","Observational","Apr 2016","Atrial Fibrillation","Warfarin,Rivaroxaban,Dabigatran,Apixaban"],["NCT02753049","New York University","Unknown status","Nov 2016","Aug 2018","Interventional","Apr 2016","HIV Infections,Acquired Immunodeficiency Syndrome",null],["NCT02750813","Alcon, a Novartis Company","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016","Refractive Errors",null],["NCT02756975","Modarres Hospital","Completed","Dec 2014","Dec 2015","Interventional","Apr 2016",null,null],["NCT02759601","Queen Mary University of London","Unknown status","Jan 2013","Dec 2018","Interventional","Oct 2014","Carcinoma",null],["NCT02757326","RedHill Biopharma Limited","Terminated","Dec 2016","May 2019","Interventional","Mar 2016","Multiple Myeloma,Neoplasms",null],["NCT02758236","Ina-Respond","Active, not recruiting","Feb 2017","Dec 2021","Observational","Apr 2016","Tuberculosis",null],["NCT02754804","University Hospital, Angers","Completed","Jul 2016","Mar 2020","Observational","Apr 2016","Peripheral Arterial Disease",null],["NCT02756065","Washington University Early Recognition Center","Completed","Sep 2014","Aug 2019","Observational","Jun 2015","Schizophrenia,Bipolar Disorder",null],["NCT02756247","Memorial Sloan Kettering Cancer Center","Active, not recruiting","May 2016","May 2022","Interventional","Apr 2016","Lymphoma",null],["NCT02755857","Mayne Pharma International Pty Ltd","Completed","Jul 2016","Jan 2017","Interventional","Apr 2016","Neutropenia","Itraconazole"],["NCT02750111","Dr. Orit Hamiel","Unknown status","May 2016","May 2018","Observational","Apr 2016","Diabetes Mellitus",null],["NCT02755948","Imperial College London","Recruiting","Apr 2012","Mar 2023","Interventional","Apr 2016","Influenza,Virus Diseases,Respiratory Syncytial Virus Infections",null],["NCT02754089","Shiraz University of Medical Sciences","Completed","May 2016","Sep 2016","Interventional","Apr 2016","Body Weight",null],["NCT02756169","Universidad Iberoamericana A.C., Mexico","Completed","Jul 2016","Feb 2018","Interventional","Apr 2016","Obesity",null],["NCT02757664","Federal University of São Paulo","Completed","Feb 2017","Jun 2020","Interventional","Apr 2016","Tendinopathy",null],["NCT02757989","Groupe Francophone des Myelodysplasies","Active, not recruiting","May 2016","Jun 2024","Interventional","Mar 2016","Preleukemia,Myelodysplastic Syndromes",null],["NCT02755038","Bnai Zion Medical Center","Unknown status","Mar 2016","Mar 2017","Observational","Apr 2016",null,null],["NCT02759354","MCM Vaccines B.V.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016","Hepatitis A,Hepatitis B,Whooping Cough,Hepatitis",null],["NCT02750254","Washington University School of Medicine","Terminated","Jun 2016","Oct 2020","Interventional","Apr 2016","Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Myelodysplastic Syndromes","Plerixafor,Cyclophosphamide,Melphalan,Busulfan,Fludarabine,Azacitidine,Lenograstim,Sargramostim"],["NCT02755025","Mayo Clinic","Completed","Jul 2016","Aug 2016","Observational","Mar 2016","Sepsis",null],["NCT02757703","Kaohsiung Veterans General Hospital.","Completed","May 2010","Jan 2015","Interventional","Apr 2016","Hemorrhage","Terlipressin,Pantoprazole,Somatostatin"],["NCT02758899","Washington University School of Medicine","Terminated","Mar 2014","Aug 2016","Observational","Apr 2016","Spondylosis,Spinal Cord Diseases,Diabetes Mellitus",null],["NCT02751450","GlaxoSmithKline","Completed","Feb 2016","Jun 2016","Interventional","Apr 2016","Dentin Sensitivity,Hypersensitivity","Fluorides,Tin Fluorides,Fluorophosphate"],["NCT02759497","Tanta University","Unknown status","Mar 2016","Nov 2020","Observational","May 2016","Peritonitis",null],["NCT02750826","Alliance for Clinical Trials in Oncology","Active, not recruiting","Aug 2016",null,"Interventional","Apr 2016","Breast Neoplasms,Weight Loss",null],["NCT02750631","New York State Psychiatric Institute","Completed","Apr 2014","Jul 2017","Interventional","Apr 2016","Depression,Depressive Disorder",null],["NCT02756182","Laborie Medical Technologies Inc.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016",null,null],["NCT02754583","University of California, San Francisco","Recruiting","Dec 2015","Aug 2024","Interventional","Oct 2015","Trachoma","Azithromycin,Tetracycline"],["NCT02750020","The University of Hong Kong","Completed","Feb 2016","Sep 2016","Observational","Apr 2016",null,null],["NCT02759978","University Medical Center Groningen","Recruiting","May 2016","May 2023","Observational [Patient Registry]","Apr 2016","Endocarditis",null],["NCT02759575","Vinita Takiar","Completed","Apr 2016","Feb 2021","Interventional","Apr 2016","Carcinoma,Squamous Cell Carcinoma of Head and Neck","Pembrolizumab"],["NCT02750878","Boston Urogynecology Associates","Unknown status","Nov 2015","Jul 2020","Interventional","Apr 2016","Urinary Incontinence,Enuresis",null],["NCT02758600","Federal University of São Paulo","Unknown status","Mar 2016","Dec 2017","Interventional","Apr 2016","Myocardial Infarction,Infarction",null],["NCT02750657","University Health Network, Toronto","Active, not recruiting","Dec 2015","Dec 2021","Observational","Jan 2016","Carcinoma",null],["NCT02750007","Jiangsu Hansoh Pharmaceutical Co., Ltd.","Unknown status","Dec 2015",null,"Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02750462","University Hospital Schleswig-Holstein","Completed","Nov 2016","Sep 2019","Interventional","Apr 2016","Heart Arrest,Out-of-Hospital Cardiac Arrest",null],["NCT02755597","AbbVie","Suspended","Jul 2016","Feb 2022","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Dexamethasone,Bortezomib,Venetoclax"],["NCT02754232","Odense University Hospital","Withdrawn","Aug 2016","Aug 2016","Interventional","Apr 2016","Pulmonary Disease,Chronic Disease",null],["NCT02751515","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02758080","Seoul National University Hospital","Unknown status","Jan 2016","Jun 2019","Interventional","Apr 2016","Neoplasms,Hematologic Neoplasms",null],["NCT02756312","Beijing Tiantan Hospital","Not yet recruiting","Oct 2020","Dec 2022","Interventional","Apr 2016","Glioma","Anesthetics"],["NCT02759107","Eli Lilly and Company","Completed","May 2016","Jun 2017","Interventional","Apr 2016","Diabetes Mellitus","Dulaglutide,Tirzepatide"],["NCT02758795","University of Limerick","Completed","Feb 2016","Apr 2017","Interventional","Feb 2016","Inflammation",null],["NCT02757859","Sidney Kimmel Cancer Center at Thomas Jefferson University","Recruiting","Apr 2016","Jan 2022","Interventional","Apr 2016","Adenocarcinoma,Cholangiocarcinoma,Carcinoma,Pancreatic Intraductal Neoplasms","Pancrelipase,Pancreatin"],["NCT02750800","AbbVie","Completed","Apr 2016","Apr 2018","Observational","Apr 2016","Spondylitis,Arthritis,Crohn Disease,Colitis,Inflammatory Bowel Diseases,Psoriasis","Adalimumab"],["NCT02754167","Pieris Pharmaceuticals GmbH","Unknown status","Jun 2016","Dec 2017","Interventional","Apr 2016","Kidney Diseases,Renal Insufficiency",null],["NCT02758379","Shockwave Medical, Inc.","Completed","Jul 2014","Mar 2016","Interventional","Jan 2015","Coronary Stenosis",null],["NCT02755740","The University of Hong Kong","Completed","Jul 2015","Aug 2017","Interventional","Apr 2016",null,null],["NCT02751008","Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","Completed","Apr 2016","Jun 2018","Observational","Apr 2016","Osteoporosis",null],["NCT02756390","Dana-Farber Cancer Institute","Completed","Dec 2015","May 2018","Interventional","Apr 2016","Sleep Initiation and Maintenance Disorders",null],["NCT02753075","GlaxoSmithKline","Completed","Sep 2015","Dec 2015","Interventional","Apr 2016","Dentin Sensitivity,Hypersensitivity","Fluorides"],["NCT02753465","Fudan University","Unknown status","Apr 2016","Dec 2019","Interventional","Apr 2016","Rectal Neoplasms",null],["NCT02750852","Azienda Ospedaliera Bolognini di Seriate Bergamo","Unknown status","Apr 2016","May 2016","Observational","Apr 2016","Hemorrhage",null],["NCT02753088","Biocad","Completed","Oct 2013","Nov 2015","Interventional","Apr 2016","Multiple Sclerosis,Sclerosis","Glatiramer Acetate,Mannitol,(T"],["NCT02758626","NYU Langone Health","Completed","Nov 2016","Feb 2021","Interventional","Apr 2016","Epilepsy,Epilepsies",null],["NCT02757222","Tata Medical Center","Recruiting","Jan 2016","Dec 2022","Interventional","Mar 2016","Neoplasms,Oropharyngeal Neoplasms,Hypopharyngeal Neoplasms,Laryngeal Neoplasms,Laryngeal Diseases",null],["NCT02750150","University Hospital, Lille","Completed","Jul 2013","Jan 2016","Interventional","Apr 2016","Hemostatic Disorders,Blood Coagulation Disorders,Wounds and Injuries",null],["NCT02752776","Novartis Pharmaceuticals","Completed","Mar 2016","Mar 2018","Interventional","Feb 2016","Psoriasis",null],["NCT02752984","IRCCS Policlinico S. Matteo","Unknown status","Apr 2016","Jun 2018","Observational","Apr 2016","Thrombosis,Venous Thrombosis",null],["NCT02755272","Fox Chase Cancer Center","Recruiting","May 2016","Apr 2024","Interventional","Apr 2016","Breast Neoplasms,Triple Negative Breast Neoplasms","Gemcitabine,Carboplatin,Pembrolizumab"],["NCT02753192","Centre National de la Recherche Scientifique, France","Unknown status","Jan 2014","Jul 2017","Interventional","Apr 2016","Parkinson Disease,Dysarthria,Disease Progression",null],["NCT02750189","Konkuk University Medical Center","Completed","Sep 2015","Jan 2017","Observational","Mar 2016","Lung Diseases,Pulmonary Disease",null],["NCT02756338","Biotronik, Inc.","Completed","Jun 2016","Jul 2017","Observational","Apr 2016",null,null],["NCT02759809","The Hospital for Sick Children","Completed","Jun 2016","Jul 2018","Observational","Apr 2016","Birth Weight",null],["NCT02758431","University of Colorado, Denver","Recruiting","Feb 2016","Nov 2022","Interventional","Apr 2016","Hypogonadism","Methyltestosterone,Anastrozole,Testosterone,Testosterone undecanoate,Testosterone enanthate,Testosterone 17 beta-cypionate,Aromatase Inhibitors,Acyline,Hormone Antagonists"],["NCT02756962","Washington University School of Medicine","Recruiting","Jul 2016","Jul 2024","Interventional","Apr 2016",null,"Cytarabine"],["NCT02752919","Eli Lilly and Company","Completed","Apr 2016","Jun 2016","Interventional","Apr 2016",null,null],["NCT02759705","Hospices Civils de Lyon","Withdrawn","Sep 2017","May 2018","Observational","Apr 2016","Bladder Exstrophy",null],["NCT02753478","Catharina Ziekenhuis Eindhoven","Completed","Jun 2016","Nov 2016","Interventional","Apr 2016","Myocardial Infarction,Infarction,Hypothermia",null],["NCT02753413","GlaxoSmithKline","Completed","Apr 2016","Jun 2016","Interventional","Apr 2016","Respiratory Syncytial Virus Infections",null],["NCT02759510","RenJi Hospital","Unknown status","Jun 2016","Jun 2017","Interventional","Apr 2016","Cardiac Output","Phenylephrine,Oxymetazoline,Norepinephrine"],["NCT02756130","Jonsson Comprehensive Cancer Center","Withdrawn","Aug 2018","Feb 2021","Interventional","Apr 2016","Carcinoma,Adenocarcinoma,Ovarian Neoplasms,Cystadenocarcinoma","Carboplatin"],["NCT02750124","Karolinska Institutet","Active, not recruiting","Mar 2016","Dec 2021","Interventional","Mar 2016","Uterine Cervical Neoplasms",null],["NCT02755610","Chulalongkorn University","Unknown status","May 2016","Apr 2019","Interventional","Feb 2016","Peritonitis,Kidney Diseases,Kidney Failure",null],["NCT02759328","Ankara University","Completed","Dec 2012","Mar 2014","Interventional","Apr 2016","Stroke",null],["NCT02753608","Jena University Hospital","Completed","Jun 2016","Mar 2018","Interventional","Mar 2016","Pneumonia",null],["NCT02751944","ESM Technologies, LLC","Completed","Dec 2015","Jan 2016","Interventional","Apr 2016","Arthralgia",null],["NCT02750748","National Institute on Drug Abuse (NIDA)","Completed","Jul 2016","Sep 2016","Interventional","Apr 2016","Opioid-Related Disorders","Naltrexone"],["NCT02758405","Samuel Lunenfeld Research Institute, Mount Sinai Hospital","Completed","May 2016","Feb 2017","Interventional","Apr 2016","Labor Pain","Fentanyl,Bupivacaine"],["NCT02753829","Ágata Sofia da Silva Vieira","Completed","Sep 2013","Jul 2015","Interventional","Apr 2016","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Heart Diseases,Infarction",null],["NCT02751788","Pennington Biomedical Research Center","Completed","Apr 2016","Jun 2018","Observational","Apr 2016","Pediatric Obesity",null],["NCT02753010","Uppsala University","Completed","Mar 2011","Mar 2016","Observational","Apr 2016","Gastroparesis,Fractures,Hip Fractures",null],["NCT02750969","HaEmek Medical Center, Israel","Unknown status","Apr 2016","Feb 2019","Interventional","Mar 2016","Tinnitus","Lidocaine"],["NCT02755831","United States Naval Medical Center, San Diego","Completed","Feb 2017","Oct 2019","Interventional","Mar 2016","Apnea,Sleep Apnea Syndromes,Sleep Apnea",null],["NCT02752009","Dana-Farber Cancer Institute","Withdrawn","Apr 2016","Dec 2016","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02758990","Verifomics LLC","Terminated","Mar 2016","Nov 2016","Interventional","Apr 2016","Rhinitis,Arthralgia,Dyspnea,Sleep Deprivation,Migraine Disorders,Sleep Initiation and Maintenance Disorders,Disease,Headache,Respiratory Sounds","Vitamin D,Cholecalciferol,Vitamins,Ascorbic Acid,Vitamin E,Tocopherols,Vitamin A,Niacinamide,Niacin,Nicotinic Acids,Pyridoxine,Pyridoxal,Vitamin B 6,Caffeine"],["NCT02754193","Central Hospital, Nancy, France","Completed","Oct 2016","Nov 2019","Interventional","Apr 2016","Shock,Hypothermia",null],["NCT02758613","Eli Lilly and Company","Completed","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02751047","Seoul National University Hospital","Completed","May 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02758197","Ottawa Hospital Research Institute","Completed","Jul 2016","Oct 2020","Interventional","Apr 2016","Neuralgia,Chronic Pain",null],["NCT02753270","University of Sao Paulo","Completed","Dec 2014","Apr 2017","Interventional","Apr 2016","Varicose Veins",null],["NCT02750839","Azienda Ospedaliera Bolognini di Seriate Bergamo","Unknown status","Apr 2016","Apr 2016","Observational","Apr 2016","Osteoporosis,Fractures,Humeral Fractures",null],["NCT02750488","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02752958","GlaxoSmithKline","Completed","May 2016","Feb 2017","Interventional","Apr 2016","Dentin Sensitivity,Hypersensitivity","Fluorides,Tin Fluorides"],["NCT02753322","The Queen Elizabeth Hospital","Unknown status","Apr 2016","Mar 2018","Interventional","Apr 2016","Stroke",null],["NCT02757261","University of Nove de Julho","Unknown status","Jun 2016","Mar 2017","Interventional","Apr 2016","Bruxism,Sleep Bruxism","Salicylic Acid"],["NCT02754427","University of British Columbia","Completed","Feb 2013","Aug 2015","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02758366","Meyer Children's Hospital","Terminated","Feb 2016","Jan 2020","Interventional","Apr 2016","Glioblastoma,Glioma,Astrocytoma,Diffuse Intrinsic Pontine Glioma,Neoplasms","Doxorubicin"],["NCT02755402","Centre hospitalier de l'Université de Montréal (CHUM)","Completed","Jan 2017","May 2021","Interventional","Apr 2016","Hepatitis C",null],["NCT02754453","The Cleveland Clinic","Withdrawn","Jul 2013","Oct 2015","Interventional","Sep 2013","Body Weight,Weight Loss",null],["NCT02755103","Medical University of South Carolina","Active, not recruiting","Jun 2016","Oct 2021","Interventional","Apr 2016","Disease,Substance-Related Disorders,Stress Disorders",null],["NCT02758834","Università Politecnica delle Marche","Completed","Jan 2014","Apr 2016","Observational","Apr 2016","Liver Diseases",null],["NCT02759146","Michigan State University","Completed","May 2016","Nov 2019","Interventional","Apr 2016",null,null],["NCT02754414","Bloodworks","Unknown status","Apr 2016","Jan 2019","Interventional","Apr 2016",null,null],["NCT02759783","Royal Marsden NHS Foundation Trust","Active, not recruiting","Nov 2016","Oct 2024","Interventional","Apr 2016","Carcinoma",null],["NCT02756923","Weill Medical College of Cornell University","Suspended","Apr 2012","Dec 2025","Observational","Apr 2016","Infertility",null],["NCT02759237","Medtronic Cardiovascular","Terminated","Feb 2016","May 2017","Observational","Apr 2016","Aortic Valve Stenosis",null],["NCT02757391","M.D. Anderson Cancer Center","Terminated","Aug 2019","Oct 2020","Interventional","Apr 2016","Carcinoma,Colorectal Neoplasms,Adenocarcinoma,Stomach Neoplasms,Esophageal Neoplasms,Cholangiocarcinoma","Aldesleukin,Cyclophosphamide,Pembrolizumab,Interleukin-2,Immunologic Factors"],["NCT02750904","Fred Hutchinson Cancer Research Center","Completed","Apr 2017","May 2019","Interventional","Mar 2016","Disease,Bipolar Disorder","Nicotine"],["NCT02758418","Universitat Jaume I","Unknown status","Apr 2016","Jul 2019","Interventional","Apr 2016","Adjustment Disorders",null],["NCT02756039","AstraZeneca","Completed","May 2016","Aug 2018","Observational","Apr 2016",null,null],["NCT02755077","Massachusetts General Hospital","Completed","Jul 2014","Jan 2016","Interventional","Apr 2016",null,null],["NCT02751801","Sheffield Teaching Hospitals NHS Foundation Trust","Completed","Nov 2016","Dec 2017","Observational","Apr 2016","Hypophosphatasia",null],["NCT02751177","Institut de Cancérologie de Lorraine","Completed","Mar 2016","May 2017","Interventional","Mar 2016","Colorectal Neoplasms",null],["NCT02758574","University of Pittsburgh","Completed","May 2016","Aug 2021","Interventional","Mar 2016","Pulmonary Embolism,Embolism",null],["NCT02758587","NHS Greater Glasgow and Clyde","Recruiting","Jul 2017","Dec 2021","Interventional","Apr 2016","Mesothelioma,Carcinoma,Pancreatic Neoplasms","Pembrolizumab"],["NCT02752100","Third Military Medical University","Unknown status","Mar 2016","May 2020","Interventional","Mar 2016","Arterial Occlusive Diseases",null],["NCT02755818","University of California, Davis","Terminated","Oct 2008","Feb 2019","Observational","Mar 2016","Insulin Resistance","Heparin,Calcium heparin"],["NCT02752906","Sanofi Pasteur, a Sanofi Company","Completed","Apr 2016","Dec 2016","Interventional","Apr 2016","Meningococcal Infections,Meningitis","Vaccines"],["NCT02750371","University Hospital, Bordeaux","Active, not recruiting","Jul 2016","Oct 2021","Interventional","Apr 2016","Adenoma,Meningioma,Pituitary Neoplasms,Pituitary Diseases",null],["NCT02751125","University of Bergen","Completed","Jun 2014","Mar 2020","Interventional","Mar 2016","Atrophy",null],["NCT02754700","High Point University","Completed","Apr 2016","Feb 2019","Interventional","Apr 2016","Knee Injuries",null],["NCT02756442","Assistance Publique Hopitaux De Marseille","Unknown status","Apr 2016","Apr 2019","Interventional","Apr 2016","Respiration Disorders,Respiratory Tract Diseases,Diabetes",null],["NCT02756637","Abramson Cancer Center of the University of Pennsylvania","Completed","Apr 2016","Nov 2016","Observational","Apr 2016","Urinary Bladder Neoplasms",null],["NCT02755688","Royal Brompton & Harefield NHS Foundation Trust","Unknown status","Jun 2015","Mar 2020","Interventional","Apr 2016","Atrial Fibrillation",null],["NCT02753387","Rennes University Hospital","Completed","May 2016","Sep 2018","Interventional","Apr 2016","Bacterial Infections,Head and Neck Neoplasms","Chlorhexidine"],["NCT02758470","University of British Columbia","Completed","Nov 2016","Jun 2017","Interventional","Apr 2016","Fatigue,Hypoxia","Acetazolamide,Methazolamide"],["NCT02754375","Centre Hospitalier Universitaire de Nice","Unknown status","May 2016","May 2019","Interventional","Apr 2016","Depression,Depressive Disorder",null],["NCT02758756","University of Rochester","Completed","Jun 2016","May 2019","Interventional","Apr 2016","Fatigue",null],["NCT02750787","Abbott Nutrition","Completed","Aug 2016","Jul 2017","Interventional","Apr 2016","Malabsorption Syndromes",null],["NCT02757339","Mclean Hospital","Enrolling by invitation","Jun 2015","May 2022","Observational","Mar 2016","Disease,Stress Disorders,Dissociative Disorders,Dissociative Identity Disorder",null],["NCT02753959","Guy's and St Thomas' NHS Foundation Trust","Completed","Aug 2016","Sep 2019","Interventional","Apr 2016","Neuromuscular Diseases",null],["NCT02753426","University of California, San Francisco","Completed","Apr 2016","Jan 2018","Interventional","Apr 2016","Kidney Diseases,Renal Insufficiency,Cardio-Renal Syndrome","Doxycycline"],["NCT02757183","AnalyticsPlus, Inc.","Unknown status","Apr 2016","Mar 2017","Observational","Apr 2016",null,null],["NCT02750293","University of Tromso","Completed","Jun 2015","Sep 2017","Interventional","Apr 2016","Vitamin D Deficiency","Cholecalciferol"],["NCT02757274","European Association of Urology Research Foundation","Recruiting","Feb 2017","Jul 2027","Observational [Patient Registry]","Apr 2016","Urinary Incontinence,Enuresis",null],["NCT02756741","All India Institute of Medical Sciences, New Delhi","Completed","Apr 2014","Jul 2015","Interventional","Apr 2016","Peritonitis,Fibrosis",null],["NCT02758964","Charite University, Berlin, Germany","Completed","Sep 2016","Jan 2019","Observational","Apr 2016","Intracranial Embolism,Embolism,Aortic Valve Stenosis",null],["NCT02753439","The Baruch Padeh Medical Center, Poriya","Unknown status","Feb 2017","Feb 2019","Interventional","Mar 2016","Tooth",null],["NCT02751281","Isfahan University of Medical Sciences","Completed","Dec 2014","Apr 2016","Interventional","Apr 2016","Kidney Calculi,Nephrolithiasis",null],["NCT02756676","Ospedale Generale Di Zona Moriggia-Pelascini","Completed","Apr 2015","Dec 2016","Interventional","Apr 2016","Parkinson Disease",null],["NCT02750215","Massachusetts General Hospital","Completed","May 2016","May 2021","Interventional","Apr 2016","Lung Neoplasms",null],["NCT02755935","Cochlear","Completed","May 2016","Sep 2017","Interventional","Apr 2016","Hearing Loss",null],["NCT02759523","Penn State University","Completed","Jul 2013","Dec 2015","Observational","Apr 2016","Pediatric Obesity",null],["NCT02756533","University Hospital, Grenoble","Recruiting","Aug 2016","Aug 2021","Interventional","Mar 2016","Lung Diseases,Pulmonary Disease,Signs and Symptoms",null],["NCT02752841","Brown University","Terminated","May 2016","May 2019","Interventional","Apr 2016","Kidney Calculi,Calculi","Vitamin D"],["NCT02758392","Janssen Research & Development, LLC","Completed","Apr 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02755870","Clene Nanomedicine","Completed","Apr 2015","Oct 2016","Interventional","Apr 2016",null,null],["NCT02752464","Boston Medical Center","Completed","Sep 2016","Jun 2018","Interventional","Apr 2016",null,null],["NCT02756780","Royal Marsden NHS Foundation Trust","Unknown status","Apr 2016","Apr 2018","Interventional","Apr 2016",null,null],["NCT02753998","Assistance Publique - Hôpitaux de Paris","Active, not recruiting","Dec 2016","Sep 2021","Interventional","Apr 2016","Arteriovenous Fistula,Constriction,Fistula","Paclitaxel"],["NCT02751307","Taipei Medical University WanFang Hospital","Completed","May 2013","Jan 2015","Interventional","Apr 2016","Congenital Abnormalities,Metabolic Syndrome,Schizophrenia","Metformin,Clozapine"],["NCT02757755","Armata Pharmaceuticals, Inc.","Completed","May 2016","Aug 2016","Interventional","Apr 2016",null,null],["NCT02753972","University of New Mexico","Completed","Aug 2006","Jan 2008","Interventional","Apr 2016",null,null],["NCT02751853","University of Luebeck","Unknown status","Dec 2016","Aug 2020","Interventional","Apr 2016","Heart Failure",null],["NCT02752971","Hospital Central Dr. Luis Ortega","Completed","Feb 2015",null,"Interventional","Mar 2016","Pain","Diclofenac,Bupivacaine"],["NCT02755012","McGill University","Completed","Jun 2012","Nov 2013","Observational","Apr 2016","Infections,Mastitis,Malnutrition,Infant Nutrition Disorders,Growth Disorders,Stress",null],["NCT02751996","F-star Therapeutics, Inc.","Completed","May 2016","Feb 2020","Interventional","Apr 2016","Hepatitis A,Hepatitis B,Hepatitis","Tenofovir"],["NCT02752893","Dartmouth-Hitchcock Medical Center","Completed","Jan 2017","Apr 2019","Observational","Apr 2016","Breast Neoplasms",null],["NCT02753842","Global Protection Corp.","Completed","May 2016","Jul 2017","Interventional","Apr 2016",null,null],["NCT02757040","Peking University People's Hospital","Unknown status","Dec 2016","Dec 2018","Interventional","Apr 2016","Leukemia","Arsenic Trioxide"],["NCT02751606","Radboud University","Unknown status","Jun 2015","Nov 2019","Interventional","Nov 2014","Neoplasms,Breast Neoplasms,Rectal Neoplasms",null],["NCT02751372","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016",null,null],["NCT02753764","National Jewish Health","Completed","Jan 2017","Feb 2019","Interventional","Apr 2016","Asthma","Prednisone,AZD7624"],["NCT02758938","University of Wisconsin, Madison","Completed","Jun 2016","Sep 2018","Interventional","Dec 2015","Lower Urinary Tract Symptoms",null],["NCT02752399","Federal University of São Paulo","Unknown status","Apr 2016","Jun 2017","Observational","Apr 2016","Hypertension,Heart Defects,Eisenmenger Complex",null],["NCT02753296","University of Sheffield","Unknown status","May 2016","Jun 2018","Observational","Apr 2016",null,null],["NCT02759432","Teesside University","Completed","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02750137","KK Women's and Children's Hospital","Completed","Aug 2014","May 2015","Observational","Apr 2016","Drug-Related Side Effects and Adverse Reactions","Tetracaine"],["NCT02754466","University of Brasilia","Terminated","May 2017","Sep 2021","Interventional","Apr 2016","Dental Caries",null],["NCT02752191","Paul Finn","Recruiting","Apr 2016","Apr 2021","Interventional","Apr 2016","Heart Diseases,Heart Defects","Ferrosoferric Oxide"],["NCT02753517","University Hospital, Lille","Recruiting","Dec 2015","Nov 2023","Interventional","Apr 2016","Liver Failure,Hepatic Insufficiency",null],["NCT02758054","University of Texas Southwestern Medical Center","Active, not recruiting","Jun 2017","Mar 2023","Interventional","Apr 2016","Carcinoma",null],["NCT02757573","Tampere University Hospital","Active, not recruiting","Apr 2016","Dec 2022","Interventional","Apr 2016","Hypercapnia",null],["NCT02752789","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Jul 2014","Nov 2019","Observational","Apr 2016",null,null],["NCT02756416","University of Nottingham","Unknown status","Jul 2016","May 2017","Interventional","Mar 2016","Syndrome",null],["NCT02758106","Chung Shan Medical University","Completed","Feb 2014","Nov 2015","Interventional","Apr 2016","Respiratory Insufficiency",null],["NCT02759159","Xuanwu Hospital, Beijing","Unknown status","Jun 2016","Dec 2018","Interventional","Apr 2016","Alzheimer Disease",null],["NCT02753777","University of Pennsylvania","Recruiting","Apr 2016","Dec 2025","Observational [Patient Registry]","Apr 2016","Pemphigoid,Pemphigus",null],["NCT02754245","Baylor Research Institute","Unknown status","Nov 2016","Jul 2017","Observational","Apr 2016","Emergencies",null],["NCT02754687","Health Decisions","Unknown status","Apr 2016","Jan 2020","Interventional","Mar 2016",null,"Nandrolone Decanoate,Nandrolone,Nandrolone phenpropionate"],["NCT02755337","Dr. Soetomo General Hospital","Unknown status","Jan 2016","Dec 2016","Observational","Apr 2016","Lung Neoplasms",null],["NCT02755090","University of New Mexico","Completed","Jul 2016","May 2017","Interventional","Apr 2016",null,"Nitrous Oxide"],["NCT02751437","Liverpool Women's NHS Foundation Trust","Completed","Aug 2016","Mar 2018","Interventional","Mar 2016","Premature Birth",null],["NCT02757950","GlaxoSmithKline","Completed","Jul 2016","May 2017","Observational","Apr 2016","Diphtheria",null],["NCT02756754","University Hospital, Toulouse","Completed","Nov 2016","May 2019","Interventional","Apr 2016","Adenoma,Adrenocortical Adenoma,Hyperaldosteronism",null],["NCT02754726","HonorHealth Research Institute","Active, not recruiting","Apr 2016","Jun 2022","Interventional","Apr 2016","Adenocarcinoma","Gemcitabine,Paclitaxel,Nivolumab,Albumin-Bound Paclitaxel"],["NCT02759549","Emory University","Withdrawn","Sep 2015",null,"Interventional","Apr 2016","Breast Neoplasms",null],["NCT02755714","Haukeland University Hospital","Completed","Jun 2016","Oct 2020","Interventional","Apr 2016",null,"Bromides,Ipratropium"],["NCT02750358","Memorial Sloan Kettering Cancer Center","Active, not recruiting","May 2016","May 2022","Interventional","Apr 2016","Breast Neoplasms,Triple Negative Breast Neoplasms",null],["NCT02754921","Mohamed Sayed Mohamed Abbas","Completed","Jan 2013",null,"Interventional","Apr 2016",null,null],["NCT02755259","University of Zurich","Completed","Jan 2017","Apr 2019","Interventional","Mar 2016","Hypertension","Acetazolamide"],["NCT02759081","Dalin Tzu Chi General Hospital","Completed","Jan 2015",null,"Interventional","Apr 2016",null,null],["NCT02755155","University Hospital, Strasbourg, France","Terminated","Sep 2016","Aug 2019","Interventional","Apr 2016","Hypoalbuminemia,Syndrome,Systemic Inflammatory Response Syndrome",null],["NCT02758119","Ilumens","Completed","Jun 2016","Oct 2016","Interventional","Apr 2016","Heart Arrest,Out-of-Hospital Cardiac Arrest",null],["NCT02755415","China Medical University Hospital","Unknown status","May 2016","Dec 2017","Interventional","Apr 2016","Stroke",null],["NCT02751268","Armed Forces Hampyeong Hospital","Unknown status","Apr 2016","Mar 2017","Interventional","Apr 2016","Psychomotor Agitation,Emergence Delirium","Ropivacaine"],["NCT02756572","University of Washington","Completed","Sep 2016","Jul 2020","Interventional","Apr 2016","Leukemia,Neoplasms,Preleukemia,Myelodysplastic Syndromes,Anemia,Syndrome","Cytarabine,Cyclosporine,Mycophenolic Acid,Sirolimus,Fludarabine,Fludarabine phosphate,Melphalan,Mechlorethamine,Mitoxantrone,Nitrogen Mustard Compounds,Cladribine,2-chloro-3-deoxyadenosine,Cyclosporins,Lenograstim"],["NCT02756871","Institute of Child Health","Completed","Jul 2015","Feb 2017","Interventional","Apr 2016",null,null],["NCT02750618","Ultragenyx Pharmaceutical Inc","Completed","May 2016","Sep 2019","Interventional","Dec 2015","Familial Hypophosphatemic Rickets,Hypophosphatemia",null],["NCT02757196","Peking University People's Hospital","Unknown status","May 2016","Dec 2018","Interventional","Apr 2016","Thrombocytopenia,Purpura","Methylprednisolone,Methylprednisolone Acetate,Methylprednisolone Hemisuccinate,Prednisolone,Prednisolone acetate,Rituximab,Prednisolone hemisuccinate,Prednisolone phosphate"],["NCT02758093","University of Alabama at Birmingham","Completed","Sep 2016","Mar 2020","Interventional","Mar 2016",null,null],["NCT02750943","GlaxoSmithKline","Completed","Nov 2015","Mar 2016","Interventional","Nov 2015","Gingivitis","Fluorides,Tin Fluorides,Fluorophosphate"],["NCT02754908","The University of Hong Kong","Completed","Jan 2016","Jun 2018","Interventional","Apr 2016","Brain Neoplasms",null],["NCT02750514","Bristol-Myers Squibb","Terminated","May 2016","Jan 2020","Interventional","Apr 2016","Carcinoma","Nivolumab,Ipilimumab,Dasatinib,Linrodostat"],["NCT02755350","LVCT Health","Unknown status","Aug 2015","Apr 2017","Interventional","Nov 2015",null,"Emtricitabine"],["NCT02753374","Beijing Children's Hospital","Not yet recruiting","May 2016","Jul 2030","Observational","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02759419","Bayer","Recruiting","Jun 2016","Dec 2023","Interventional","Apr 2016","Pulmonary Arterial Hypertension,Hypertension","Riociguat"],["NCT02757612","Universidad de Murcia","Completed","Jun 2015","Jul 2016","Interventional","Apr 2016","Burning Mouth Syndrome,Syndrome,Burns",null],["NCT02754297","CHU de Quebec-Universite Laval","Recruiting","Apr 2016","Dec 2026","Interventional","Mar 2016","Neoplasms,Neuroendocrine Tumors,Carcinoid Tumor,Carcinoma","Lutetium Lu 177 dotatate"],["NCT02758665","University of Ulm","Active, not recruiting","Sep 2016","Mar 2022","Interventional","Apr 2016","Leukemia","Venetoclax,Obinutuzumab"],["NCT02755285","Fujifilm Medical Systems USA, Inc.","Completed","Aug 2016","Oct 2016","Interventional","Apr 2016",null,null],["NCT02757690","Asan Medical Center","Completed","Jan 2015","Feb 2016","Interventional","Apr 2016","Neoplasms,Brain Neoplasms",null],["NCT02753218","LEO Pharma","Terminated","Apr 2016","May 2016","Interventional","Apr 2016","Psoriasis","Midazolam"],["NCT02754986","University of Hyogo","Completed","Mar 2015",null,"Interventional","Mar 2016","Kidney Diseases,Renal Insufficiency",null],["NCT02752048","Taiho Pharmaceutical Co., Ltd.","Completed","May 2016","Oct 2017","Interventional","Apr 2016","Muscular Dystrophies,Muscular Dystrophy",null],["NCT02752256","University of Iowa","Completed","Oct 2015","Oct 2017","Observational","Apr 2016",null,"Plasminogen,Tissue Plasminogen Activator"],["NCT02756936","Genuine Research Center, Egypt","Completed","Feb 2016","Mar 2016","Interventional","Apr 2016",null,null],["NCT02756000","Clinical Hospital Center Zemun","Unknown status","Jan 2016","Jul 2018","Interventional","Apr 2016","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Infarction","Dobutamine"],["NCT02754492","Terumo BCT","Completed","Apr 2016","Feb 2017","Interventional","Apr 2016",null,null],["NCT02757677","Swiss Vision Network","Unknown status","Dec 2015","Dec 2019","Observational","Apr 2016","Glaucoma",null],["NCT02752373","Brain Sentinel","Terminated","May 2016","Feb 2017","Observational","Mar 2016","Epilepsy,Seizures",null],["NCT02752230","Kettering Health Network","Withdrawn","Nov 2016","Jun 2021","Interventional","Mar 2016","Pain",null],["NCT02756728","BioInvent International AB","Terminated","May 2016","Dec 2016","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Melphalan"],["NCT02751658","University Hospital, Montpellier","Completed","Nov 2016","Jul 2019","Interventional","Mar 2016","Otorhinolaryngologic Diseases",null],["NCT02754518","University of Chicago","Completed","Apr 2016","Apr 2019","Interventional","Apr 2016","Heart Failure","Valsartan,Sacubitril and valsartan sodium hydrate drug combination"],["NCT02759380","Sahlgrenska University Hospital, Sweden","Recruiting","Mar 2016","Oct 2022","Interventional","Apr 2016","Prostatic Neoplasms","Phytoestrogens"],["NCT02755649","Regeneron Pharmaceuticals","Completed","Jan 2016","Mar 2017","Interventional","Mar 2016","Dermatitis,Eczema",null],["NCT02751827","Institut Bergonié","Completed","Feb 2016","Nov 2019","Observational","Apr 2016",null,null],["NCT02755545","Galderma Laboratories, L.P.","Completed","May 2016","Apr 2017","Interventional","Apr 2016","Acne Vulgaris","Salicylic Acid,Adapalene,Salicylates"],["NCT02750345","Cycle Pharmaceuticals Ltd.","Completed","Mar 2016","May 2016","Interventional","Apr 2016","Tyrosinemias","Nitisinone"],["NCT02755532","Federal University of São Paulo","Completed","Jan 2014","Oct 2015","Interventional","Apr 2016",null,"Bupivacaine"],["NCT02758743","Biohit Oyj","Completed","Apr 2016","May 2017","Interventional","Apr 2016",null,null],["NCT02754947","Nationwide Children's Hospital","Completed","Feb 2015","Mar 2016","Observational","Apr 2016","Respiration Disorders,Respiratory Tract Diseases,Nervous System Diseases,Cardiovascular Diseases",null],["NCT02750280","Calvary Hospital, Bronx, NY","Completed","Jun 2015","Dec 2015","Interventional","Apr 2016","Diabetic Foot,Foot Ulcer,Ulcer",null],["NCT02756325","NYU Langone Health","Withdrawn","Jun 2016","Jan 2019","Interventional","Apr 2016","Infertility",null],["NCT02758717","Academic and Community Cancer Research United","Active, not recruiting","May 2016","May 2024","Interventional","Apr 2016","Lymphoma,Hodgkin Disease","Antineoplastic Agents,Nivolumab,Brentuximab Vedotin,Antibodies,Immunoglobulins,Immunoconjugates"],["NCT02751034","Medy-Tox","Completed","Jun 2013","Jan 2014","Interventional","Apr 2015",null,"Lidocaine"],["NCT02751476","Action Contre la Faim","Unknown status","Apr 2016","Mar 2017","Interventional","Apr 2016","Malnutrition,Severe Acute Malnutrition,Protein-Energy Malnutrition","Disinfectants"],["NCT02755454","University Health Network, Toronto","Completed","Oct 2013","Nov 2018","Interventional","Mar 2016","Lung Neoplasms",null],["NCT02752867","Dongfang Hospital Beijing University of Chinese Medicine","Unknown status","Dec 2016","Nov 2019","Interventional","Mar 2016","Cerebral Infarction,Infarction,Cognitive Dysfunction",null],["NCT02754830","Eli Lilly and Company","Completed","Apr 2016","Jul 2018","Interventional","Apr 2016","Alzheimer Disease",null],["NCT02753738","Medical University of Vienna","Unknown status","Aug 2016",null,"Interventional","Apr 2016",null,"Citalopram"],["NCT02750267","University of Virginia","Completed","May 2016","May 2016","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02754999","Prolong Pharmaceuticals","Completed","Mar 2016","May 2017","Interventional","Apr 2016","Anemia",null],["NCT02754843","Sonova AG","Completed","Oct 2015",null,"Interventional","Oct 2015","Hearing Loss",null],["NCT02759055","HealthPartners Institute","Completed","Oct 2016","Dec 2019","Interventional","Apr 2016","Prediabetic State,Glucose Intolerance",null],["NCT02753673","Memorial Sloan Kettering Cancer Center","Completed","Apr 2016","Apr 2020","Observational","Apr 2016",null,null],["NCT02754531","Indonesia University","Completed","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02750033","Seton Healthcare Family","Withdrawn","Oct 2016","Mar 2017","Observational","Apr 2016","Carcinoma",null],["NCT02759133","Centre Antoine Lacassagne","Recruiting","Jun 2016","Nov 2022","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02756650","Novartis Pharmaceuticals","Completed","Jun 2016","Jan 2019","Interventional","Mar 2016","Behcet Syndrome",null],["NCT02752152","Institut de Recherche pour le Developpement","Completed","Dec 2015","Oct 2020","Interventional","Apr 2016","Hepatitis A,Hepatitis C,Hepatitis B,Syphilis,Hepatitis",null],["NCT02751385","Boehringer Ingelheim","Terminated","May 2016","Nov 2017","Interventional","Apr 2016","Carcinoma","Nintedanib,Ethinyl estradiol,Ethinyl Estradiol-Norgestrel Combination"],["NCT02751879","Boehringer Ingelheim","Completed","Nov 2016","Sep 2017","Observational","Apr 2016","Carcinoma",null],["NCT02756663","Novartis Pharmaceuticals","Withdrawn","Dec 2016","Feb 2021","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Dexamethasone,Panobinostat"],["NCT02756273","Centre Hospitalier Universitaire, Amiens","Recruiting","May 2016","May 2022","Interventional","Apr 2016",null,null],["NCT02755974","Imperial College London","Unknown status","Jan 2009","Apr 2021","Observational","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02756507","Babes-Bolyai University","Completed","Jun 2016","Jun 2018","Interventional","Apr 2016","Disease,Depression,Anxiety Disorders,Panic Disorder",null],["NCT02750553","Jiangsu HengRui Medicine Co., Ltd.","Completed","Jan 2015",null,"Interventional","Apr 2016",null,null],["NCT02750228","Mednax Center for Research, Education, Quality and Safety","Completed","May 2016","Jun 2020","Observational","Mar 2016","Ductus Arteriosus",null],["NCT02751710","Ontario Clinical Oncology Group (OCOG)","Recruiting","Dec 2016","Dec 2022","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02753361","Suez Canal University","Completed","May 2016","Dec 2016","Interventional","Apr 2016","Lipoma",null],["NCT02753634","Lawson Health Research Institute","Completed","Apr 2015","Jun 2016","Interventional","Mar 2016","Osteoarthritis",null],["NCT02759250","argenx","Completed","Feb 2015","Jun 2018","Interventional","Apr 2016","Nasopharyngeal Carcinoma",null],["NCT02757482","Celal Bayar University","Completed","Sep 2014","Jun 2015","Interventional","Apr 2016",null,null],["NCT02757105","RedHill Biopharma Limited","Completed","May 2016","Jul 2017","Interventional","Apr 2016","Irritable Bowel Syndrome,Syndrome,Diarrhea","Ondansetron"],["NCT02756520","Fresenius Kabi","Completed","Sep 2016","Oct 2018","Observational","Apr 2016","Kidney Diseases,Renal Insufficiency",null],["NCT02753309","The University of Texas Health Science Center at San Antonio","Completed","Jun 2016","Mar 2021","Interventional","Apr 2016","Urinary Bladder Neoplasms","Sirolimus"],["NCT02756832","Takeda","Completed","Sep 2016","Apr 2018","Observational","Apr 2016","Diabetes Mellitus","Alogliptin"],["NCT02758158","University Health Network, Toronto","Completed","Jan 2016","Feb 2017","Interventional","Mar 2016","Thyroid Neoplasms,Thyroid Nodule,Thyroid Diseases",null],["NCT02752360","Beijing Friendship Hospital","Unknown status","Apr 2016","Dec 2018","Interventional","Apr 2016","Colonic Neoplasms,Crohn Disease,Diverticulum,Diverticular Diseases,Diverticulosis",null],["NCT02757794","Assistance Publique Hopitaux De Marseille","Recruiting","Nov 2016","Jun 2022","Interventional","Apr 2016","Memory Disorders",null],["NCT02751346","Washington University School of Medicine","Completed","Jan 2016","Feb 2017","Observational","Apr 2016","Pain",null],["NCT02757027","Konkuk University Medical Center","Unknown status","May 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02756689","University of Alabama at Birmingham","Completed","Mar 2016","Oct 2017","Interventional","Apr 2016",null,null],["NCT02751164","Intensive Care National Audit & Research Centre","Completed","Apr 2013","May 2016","Observational","Apr 2016","Critical Illness",null],["NCT02754765","Médecins Sans Frontières, France","Recruiting","Dec 2016","Aug 2023","Interventional","Apr 2016","Tuberculosis,Bacterial Infections","Moxifloxacin,Levofloxacin,Ofloxacin,Linezolid,Pyrazinamide,Bedaquiline,Clofazimine"],["NCT02757729","Amorepacific Corporation","Completed","Oct 2015",null,"Interventional","Apr 2016","Dermatitis,Eczema",null],["NCT02751866","University of Cincinnati","Recruiting","Jan 2016","Jul 2023","Interventional","Apr 2016","Overweight,Hyperphagia",null],["NCT02759068","Hospices Civils de Lyon","Completed","Nov 2014","May 2017","Interventional","Apr 2016","Consciousness Disorders",null],["NCT02752503","Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","Unknown status","Mar 2015",null,"Interventional","Apr 2016","Disease,Alcoholism,Alcohol Drinking,Personality Disorders,Borderline Personality Disorder","Nalmefene"],["NCT02750592","Novartis Pharmaceuticals","Completed","Mar 2016","May 2018","Interventional","Apr 2016","Spondylitis",null],["NCT02754440","Terumo BCT","Completed","Apr 2016","Jul 2017","Interventional","Apr 2016",null,null],["NCT02750670","University Health Network, Toronto","Completed","Mar 2017","Feb 2021","Interventional","Apr 2016","Lymphoma","Gemcitabine,Dexamethasone,Obinutuzumab"],["NCT02753400","Kubota Vision Inc.","Completed","May 2016","Dec 2017","Interventional","Apr 2016","Retinal Diseases,Diabetic Retinopathy",null],["NCT02754310","Ilumens","Completed","May 2016","Oct 2016","Interventional","Apr 2016",null,null],["NCT02758275","Universidad Industrial de Santander","Completed","Apr 2016","Sep 2017","Interventional","Apr 2016","Hypertension,Diabetes Mellitus",null],["NCT02757417","University Hospitals Cleveland Medical Center","Unknown status","Jul 2016","Dec 2019","Interventional","Apr 2016",null,null],["NCT02753725","University of Nairobi","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Delirium,Emergence Delirium","Fentanyl"],["NCT02752646","MDbackline, LLC","Completed","Apr 2016","Mar 2017","Interventional","Apr 2016","Cataract","Ketorolac,Nepafenac"],["NCT02750566","New York Institute of Technology","Recruiting","Nov 2015","Dec 2021","Interventional","Dec 2015","Post-Concussion Syndrome",null],["NCT02753335","University of Tromso","Recruiting","Sep 2016","Dec 2022","Interventional","Mar 2016","Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Syndrome",null],["NCT02754544","M.D. Anderson Cancer Center","Recruiting","Jul 2016","Aug 2020","Interventional","Apr 2016","Neoplasms,Brain Neoplasms",null],["NCT02751112","Imagine Institute","Terminated","Nov 2015","Aug 2017","Interventional","Apr 2016","Graft vs Host Disease",null],["NCT02751320","GlaxoSmithKline","Completed","Feb 2016","Aug 2016","Interventional","Apr 2016","Dental Caries","Citric Acid,Sodium Citrate"],["NCT02753036","Charite University, Berlin, Germany","Active, not recruiting","Jan 2016","Jun 2023","Observational","Apr 2016","Polyneuropathies,Cognition Disorders",null],["NCT02759198","Yuhan Corporation","Completed","May 2016","Sep 2017","Interventional","Apr 2016","Osteoarthritis","Celecoxib"],["NCT02752802","Osprey Medical, Inc","Completed","Apr 2016","May 2016","Interventional","Apr 2016",null,null],["NCT02757586","Peking University People's Hospital","Unknown status","Dec 2016","Dec 2019","Observational","Apr 2016","Leukemia",null],["NCT02755961","Ajou University School of Medicine","Completed","Jul 2015","Oct 2015","Interventional","Apr 2016","Kidney Diseases,Kidney Failure,Hyperphosphatemia",null],["NCT02759263","Boston Children's Hospital","Completed","Jun 2016","Oct 2018","Interventional","Apr 2016","Heart Diseases,Heart Defects",null],["NCT02754271","Toronto Rehabilitation Institute","Unknown status","Apr 2014","Mar 2017","Interventional","Apr 2016","Kidney Failure",null],["NCT02756195","Vanderbilt University","Recruiting","Nov 2016","Jan 2022","Observational [Patient Registry]","Apr 2016",null,null],["NCT02754336","Helse Stavanger HF","Completed","Oct 2014","Jun 2015","Interventional","Nov 2015",null,null],["NCT02758639","University of Texas at Austin","Completed","Sep 2015","Aug 2018","Interventional","Apr 2016",null,null],["NCT02759185","Multidisciplinary Association for Psychedelic Studies","Completed","Jan 2017","Jan 2019","Interventional","Apr 2016","Marijuana Abuse,Stress Disorders","Dronabinol,Cannabidiol"],["NCT02758145","Service de Médecine Préventive Hospitalière","Completed","Apr 2016","Apr 2018","Interventional","Apr 2016","Influenza","Vaccines"],["NCT02756455","University of Roma La Sapienza","Unknown status","Jan 2015","Dec 2016","Observational [Patient Registry]","Apr 2016","Stomach Neoplasms",null],["NCT02757118","Konkuk University Medical Center","Unknown status","May 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02756819","Takeda","Completed","Jul 2016","May 2018","Observational","Apr 2016","Hypertension,Overweight","Azilsartan medoxomil"],["NCT02754362","NYU Langone Health","Withdrawn","Nov 2016","Jun 2019","Interventional","Apr 2016","Glioblastoma","Bevacizumab,Poly ICLC,Keyhole-limpet hemocyanin,Adjuvants"],["NCT02752711","Nantes University Hospital","Completed","May 2013","Dec 2015","Observational","Apr 2016","Craniocerebral Trauma",null],["NCT02756494","Beijing Chao Yang Hospital","Unknown status","Apr 2016","Dec 2018","Observational","Apr 2016","Stroke,Ischemic Stroke,Cerebral Infarction,Ischemia",null],["NCT02753855","University of Illinois at Chicago","Completed","Apr 2016","Oct 2016","Interventional","Apr 2016",null,"Telavancin"],["NCT02756013","Case Comprehensive Cancer Center","Terminated","Apr 2016","Jan 2019","Interventional","Apr 2016","Overweight","Paclitaxel,Carboplatin"],["NCT02756949","World Bank","Completed","Oct 2015","Jun 2017","Interventional","Apr 2016","HIV Infections",null],["NCT02757885","Emory University","Recruiting","Apr 2016","Jul 2023","Interventional","Apr 2016","Anemia","Cyclophosphamide,Thiotepa,Fludarabine,Fludarabine phosphate,Hydroxyurea,Antilymphocyte Serum,Thymoglobulin"],["NCT02758340","Karachi Medical and Dental College","Completed","Apr 2016","Nov 2016","Interventional","Apr 2016","Labor Pain","Misoprostol"],["NCT02753933","Guy's and St Thomas' NHS Foundation Trust","Unknown status","Apr 2016","Dec 2018","Observational","Apr 2016","Headache Disorders,Headache",null],["NCT02756624","Nicox Ophthalmics, Inc.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016",null,"Cetirizine"],["NCT02759393","National Cheng-Kung University Hospital","Unknown status","Oct 2015","Sep 2017","Interventional","Apr 2016","Gastroesophageal Reflux,Esophagitis","Lansoprazole,Dexlansoprazole"],["NCT02757820","Assiut University","Completed","Jun 2016","Apr 2018","Interventional","Apr 2016",null,null],["NCT02754141","Bristol-Myers Squibb","Active, not recruiting","Jun 2016","Feb 2023","Interventional","Apr 2016",null,"Nivolumab"],["NCT02753985","Abramson Cancer Center of the University of Pennsylvania","Completed","Jul 2014","Apr 2016","Observational","Apr 2016",null,null],["NCT02757768","Astellas Pharma Global Development, Inc.","Completed","Jun 2016","Sep 2018","Interventional","Apr 2016","Urinary Bladder,Prostatic Hyperplasia,Hyperplasia,Lower Urinary Tract Symptoms","Tamsulosin,Mirabegron"],["NCT02753348","Henning Bundgaard","Completed","Apr 2016","Nov 2018","Observational","Apr 2016","Heart Diseases,Heart Defects",null],["NCT02759718","Asan Medical Center","Unknown status","Jun 2012","May 2017","Interventional","Apr 2016","Neuroendocrine Tumors,Endocrine Gland Neoplasms,Adenoma",null],["NCT02755181","Boehringer Ingelheim","Completed","Jul 2016","May 2018","Observational","Apr 2016","Disease,Personality Disorders,Borderline Personality Disorder,Impulsive Behavior,Disruptive",null],["NCT02759926","Universitaire Ziekenhuizen Leuven","Unknown status","Aug 2011",null,"Interventional","Apr 2016","Obesity","Quinine,Denatonium"],["NCT02756286","Think Now Incorporated","Completed","Jan 2017","Jul 2018","Observational","Nov 2015","Attention Deficit Disorder with Hyperactivity",null],["NCT02752126","Lawson Health Research Institute","Completed","Jun 2016","Sep 2020","Interventional","Apr 2016","Carcinoma",null],["NCT02752035","Astellas Pharma Global Development, Inc.","Active, not recruiting","Aug 2016","Aug 2023","Interventional","Apr 2016","Leukemia","Azacitidine"],["NCT02750865","Boston Medical Center","Recruiting","Aug 2017","Dec 2022","Interventional","Mar 2016",null,null],["NCT02752165","University of Rochester","Recruiting","Aug 2016","Feb 2023","Interventional","Mar 2016","Asthma,Emergencies",null],["NCT02755792","The Hong Kong Polytechnic University","Completed","Jul 2012","Apr 2016","Interventional","Apr 2016","Cognitive Dysfunction",null],["NCT02757898","Emory University","Recruiting","Jan 2017","Dec 2021","Interventional","Apr 2016",null,"Biotin"],["NCT02758678","Science and Technology Park, Center of Innovation Technologies for Human Health","Completed","Nov 2015","Oct 2016","Observational","Apr 2016","Lung Neoplasms",null],["NCT02751424","GlaxoSmithKline","Terminated","Jun 2016","Feb 2017","Interventional","Apr 2016","Bacterial Infections",null],["NCT02750319","Memorial Sloan Kettering Cancer Center","Active, not recruiting","Apr 2016","Apr 2022","Interventional","Apr 2016","Atrial Fibrillation","Acetylcysteine,Amiodarone,N-monoacetylcystine"],["NCT02757495","Suez Canal University","Completed","Apr 2016","May 2017","Interventional","Apr 2016","Psychomotor Agitation,Emergence Delirium,Delayed Emergence from Anesthesia","Dexmedetomidine"],["NCT02752607","Dr. Vicky Tagalakis","Terminated","May 2016","Nov 2018","Observational","Apr 2016","Thrombosis,Venous Thrombosis",null],["NCT02757911","Genethon","Active, not recruiting","Mar 2016","Jun 2024","Interventional","Apr 2016","Granuloma,Granulomatous Disease",null],["NCT02759224","Boryung Pharmaceutical Co., Ltd","Completed","Apr 2016","Dec 2016","Interventional","Apr 2016","Stomach Ulcer","Irsogladine,Lafutidine"],["NCT02756351","CytaCoat AB","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Cross Infection,Pneumonia",null],["NCT02751359","University of California, Los Angeles","Completed","Jul 2016","Apr 2020","Interventional","Apr 2016",null,"Cannabidiol"],["NCT02756585","Nova Scotia Health Authority","Unknown status","Sep 2016","Dec 2018","Interventional","Apr 2016","Brain Injuries,Craniocerebral Trauma,Wounds and Injuries",null],["NCT02751411","Aboca Spa Societa' Agricola","Completed","Apr 2016","Mar 2020","Interventional","Apr 2016","Constipation",null],["NCT02750735","University of Palermo","Completed","Jan 2001","Mar 2016","Observational","Apr 2016","Hypersensitivity",null],["NCT02753868","University of Illinois at Urbana-Champaign","Completed","Feb 2016","Feb 2017","Interventional","Feb 2016","Renal Insufficiency",null],["NCT02755844","Hospices Civils de Lyon","Active, not recruiting","Sep 2016","Apr 2022","Interventional","Apr 2016","Endometrial Neoplasms","Metformin,Cyclophosphamide,Olaparib"],["NCT02758301","Medtronic Cardiac Rhythm and Heart Failure","Completed","Jun 2016","Dec 2018","Observational","Apr 2016","Heart Failure",null],["NCT02751463","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02752633","Landspitali University Hospital","Completed","May 2013","May 2015","Interventional","Apr 2016",null,"Allopurinol,Febuxostat"],["NCT02755909","Indonesia University","Completed","Dec 2015","Mar 2016","Interventional","Apr 2016","Anxiety Disorders","Anesthetics"],["NCT02752620","Rio de Janeiro State University","Completed","May 2016","Oct 2016","Interventional","Apr 2016","Back Pain,Low Back Pain",null],["NCT02759965","Karolinska University Hospital","Completed","Sep 2014","Dec 2018","Observational","Nov 2014","Acute-Phase Reaction,Cognitive Dysfunction",null],["NCT02754752","M.D. Anderson Cancer Center","Recruiting","Sep 2016","Sep 2023","Interventional","Apr 2016","Breast Neoplasms,Chronic Pain",null],["NCT02754349","Onze Lieve Vrouw Hospital","Completed","Feb 2015","May 2016","Interventional","Mar 2016","Atrial Fibrillation",null],["NCT02754479","Cutera Inc.","Completed","Apr 2016","Mar 2017","Interventional","Apr 2016","Telangiectasis",null],["NCT02753790","New Mexico Cancer Care Alliance","Active, not recruiting","Feb 2016","Mar 2023","Interventional","Apr 2016","Neoplasm Metastasis,Neoplasms,Brain Neoplasms",null],["NCT02757248","Anne Beaven, MD","Withdrawn","Nov 2016","Nov 2016","Interventional","Mar 2016",null,"Romidepsin"],["NCT02759991","Norwegian Institute of Public Health","Completed","Oct 2017","Sep 2019","Interventional","Mar 2016","Infections,Hepatitis A,Hepatitis E,Hepatitis","Vaccines"],["NCT02758561","Ottawa Hospital Research Institute","Completed","May 2016","Nov 2017","Interventional","Dec 2015","Urinary Incontinence,Enuresis,Pelvic Floor Disorders,Prolapse",null],["NCT02753504","Chong Kun Dang Pharmaceutical","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Dyslipidemias",null],["NCT02758821","University of Oxford","Completed","Jun 2016","Sep 2017","Interventional","Mar 2016",null,null],["NCT02757430","Abbott Medical Devices","Completed","Aug 2016","Jul 2017","Observational [Patient Registry]","Apr 2016","Arrhythmias",null],["NCT02754024","Werner Anderl","Active, not recruiting","Sep 2005","Sep 2025","Observational","Apr 2016","Osteoarthritis,Necrosis",null],["NCT02757651","Institute of Cancer Research, United Kingdom","Completed","Jan 2017","Nov 2020","Interventional","Apr 2016","Breast Neoplasms","Hydrogen Peroxide"],["NCT02758769","Bristol-Myers Squibb","Active, not recruiting","Jun 2016","Oct 2023","Observational","Apr 2016","Arthritis","Abatacept"],["NCT02755896","Weill Medical College of Cornell University","Recruiting","Jul 2015","Jul 2024","Interventional","Aug 2015","Neoplasms,Breast Neoplasms,Radiation Pneumonitis",null],["NCT02753699","Debiopharm International SA","Completed","Dec 2011","May 2015","Interventional","Mar 2016","Hepatitis A,Hepatitis C,Hepatitis",null],["NCT02754323","Centre Hospitalier Universitaire de Nice","Unknown status","May 2016","Dec 2016","Interventional","Apr 2016",null,null],["NCT02753881","Yale University","Completed","Nov 2015","Dec 2019","Interventional","Mar 2016","Liver Neoplasms","Doxorubicin,Liposomal doxorubicin"],["NCT02752074","Incyte Corporation","Completed","Jun 2016","Aug 2019","Interventional","Apr 2016","Melanoma","Pembrolizumab"],["NCT02753244","Intendu Ltd.","Unknown status","Apr 2015",null,"Interventional","Apr 2016","Brain Injuries,Wounds and Injuries",null],["NCT02752672","Medical University of Graz","Completed","Mar 2016","Nov 2016","Observational","Apr 2016","Psoriasis",null],["NCT02759029","Gangnam Severance Hospital","Unknown status","Mar 2016","Feb 2018","Interventional","Apr 2016","Disease Susceptibility",null],["NCT02750202","University of Pretoria","Recruiting","Jul 2018","Jul 2023","Interventional","Apr 2016","Warts,Condylomata Acuminata,Recurrence","Vaccines"],["NCT02753686","Novartis Pharmaceuticals","Active, not recruiting","Mar 2016","Aug 2022","Observational [Patient Registry]","Apr 2016","Breast Neoplasms","Tamoxifen,Everolimus,Letrozole,Fulvestrant,Anastrozole,Exemestane"],["NCT02752217","Khon Kaen University","Unknown status","Mar 2016","Sep 2018","Interventional","Apr 2016","Hypertension",null],["NCT02755662","ResMed","Completed","May 2016","Jul 2017","Interventional","Apr 2016","Apnea,Sleep Apnea Syndromes,Sleep Apnea,Syndrome",null],["NCT02751671","St. Justine's Hospital","Completed","Aug 2016","Jun 2017","Interventional","Apr 2016",null,null],["NCT02752880","Chang Gung Memorial Hospital","Completed","Jun 2016","Feb 2018","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02751632","Orygen","Active, not recruiting","Apr 2016","May 2021","Interventional","Apr 2016","Disease,Psychotic Disorders,Mental Disorders,Personality Disorders","Fluoxetine"],["NCT02750527","Kinderkrankenhaus auf der Bult","Completed","Sep 2016","Dec 2020","Observational","Apr 2016","Hyperlipoproteinemia Type II,Diabetes Mellitus,Hypercholesterolemia",null],["NCT02751242","Vanderbilt University","Completed","Aug 2016","Jul 2017","Observational","Apr 2016","Heart Failure",null],["NCT02755363","Medical University of Warsaw","Unknown status","Apr 2016","Jul 2016","Interventional","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02751775","Pennington Biomedical Research Center","Completed","Jun 2016","Jun 2017","Observational","Apr 2016","Pediatric Obesity",null],["NCT02757976","Lawson Health Research Institute","Terminated","Mar 2018","Jun 2019","Interventional","Apr 2016","Heart Failure,Ventricular Dysfunction",null],["NCT02752386","University of Tulsa","Completed","Feb 2016","Jul 2018","Interventional","Apr 2016",null,null],["NCT02756143","University Hospital of Torrejon","Completed","Nov 2014","Feb 2017","Interventional","Apr 2016",null,null],["NCT02754648","Ain Shams University","Unknown status","Sep 2015","Sep 2016","Interventional","Mar 2016","Endometriosis",null],["NCT02751138","University of Ulm","Recruiting","Mar 2016","Sep 2024","Observational [Patient Registry]","Apr 2016","Glioblastoma",null],["NCT02753231","Universidad Santo Tomas","Completed","Jan 2017","Dec 2017","Interventional","Apr 2016","Metabolic Syndrome,Metabolic Diseases,Lipid Metabolism Disorders,Overweight",null],["NCT02759588","Genelux Corporation","Active, not recruiting","May 2016","May 2022","Interventional","Apr 2016","Ovarian Neoplasms,Carcinoma,Fallopian Tube Neoplasms,Peritoneal Neoplasms","Bevacizumab"],["NCT02757352","Eli Lilly and Company","Completed","Aug 2016","May 2019","Interventional","Apr 2016","Spondylarthritis","Ixekizumab"],["NCT02752022","St George's, University of London","Unknown status","Sep 2016","Apr 2019","Observational","Apr 2016",null,null],["NCT02754973","The University of Hong Kong","Completed","May 2015","Nov 2017","Interventional","Apr 2016",null,null],["NCT02755506","Chinese PLA General Hospital","Unknown status","Oct 2015","Oct 2016","Interventional","Apr 2016","Aneurysm",null],["NCT02751216","Moens Maarten","Completed","May 2016","Jan 2018","Interventional","Apr 2016","Syndrome,Failed Back Surgery Syndrome",null],["NCT02756559","Lixin Xie","Unknown status","Jan 2014","Dec 2017","Observational","Apr 2016",null,null],["NCT02754557","Emory University","Recruiting","Mar 2016","Dec 2021","Interventional","Apr 2016","Stress Disorders",null],["NCT02758496","Wave Neuroscience","Completed","Apr 2016","Apr 2017","Observational","Apr 2016","Autistic Disorder",null],["NCT02757066","Nobelpharma","Completed","Jun 2016","Sep 2018","Interventional","Apr 2016","Sleep Wake Disorders,Parasomnias,Disease,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders","Melatonin"],["NCT02756104","University Hospital, Montpellier","Completed","Jun 2016","May 2020","Interventional","Apr 2016",null,"Vitamin D"],["NCT02751814","Pennington Biomedical Research Center","Completed","Apr 2016","Jun 2018","Observational","Apr 2016","Pediatric Obesity",null],["NCT02751749","Örebro University, Sweden","Completed","Dec 2015","Sep 2016","Interventional","Apr 2016","Chronic Pain",null],["NCT02756052","University of Calgary","Completed","Mar 2016","Aug 2016","Interventional","Mar 2016",null,null],["NCT02753647","Ruijin Hospital","Unknown status","Apr 2016","Apr 2019","Interventional","Apr 2016","Lymphoma","Prednisone,Cyclophosphamide,Rituximab,Doxorubicin,Vincristine"],["NCT02756910","Peking Union Medical College Hospital","Completed","May 2016","Sep 2016","Observational","Apr 2016",null,null],["NCT02756208","University of Maryland, College Park","Completed","Nov 2015","Jul 2018","Interventional","Apr 2016","HIV Infections","Vaccines"],["NCT02757443","Meshalkin Research Institute of Pathology of Circulation","Completed","Jun 2016","May 2021","Interventional","Apr 2016",null,"Phosphocreatine,Anesthetics"],["NCT02759744","National Institutes of Health Clinical Center (CC)","Enrolling by invitation","Oct 2017","Jan 2026","Interventional","Apr 2016","Prostatic Neoplasms",null],["NCT02753140","Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","Unknown status","Apr 2016","Sep 2018","Interventional","Apr 2016","Carcinoma,Squamous Cell Carcinoma of Head and Neck","Docetaxel,Cetuximab"],["NCT02759536","The Third Xiangya Hospital of Central South University","Unknown status","Jul 2013",null,"Interventional","Apr 2016","Melanoma",null],["NCT02750449","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02759211","Mount Sinai Rehabilitation Hospital","Unknown status","Apr 2016","Feb 2018","Interventional","Mar 2016","Multiple Sclerosis,Sclerosis",null],["NCT02752477","Ben Lim","Active, not recruiting","Aug 2016","Sep 2020","Interventional","Mar 2016","Pain,Chronic Pain","Anesthetics"],["NCT02759835","National Cancer Institute (NCI)","Active, not recruiting","Apr 2016","Sep 2022","Interventional","Apr 2016","Lung Neoplasms,Adenocarcinoma of Lung","Osimertinib"],["NCT02754596","Glaukos Corporation","Active, not recruiting","Mar 2016","Dec 2021","Interventional","Mar 2016","Glaucoma","Timolol,Travoprost,Ophthalmic Solutions"],["NCT02757846","Chinese Academy of Sciences","Enrolling by invitation","Apr 2017","Mar 2022","Observational","Apr 2016","Carcinoma",null],["NCT02750085","Victor Blanchette","Active, not recruiting","Apr 2016","Dec 2020","Observational","Apr 2016","Hemophilia A",null],["NCT02759692","Johnson & Johnson Vision Care, Inc.","Completed","Apr 2016","Jun 2016","Interventional","Apr 2016",null,null],["NCT02752750","Medical University of Graz","Enrolling by invitation","May 2016","May 2022","Observational","Apr 2016","Alzheimer Disease",null],["NCT02757781","Avedis Donabedian Research Institute","Unknown status","Jul 2016","Dec 2018","Interventional","Apr 2016","Chronic Disease",null],["NCT02757924","Abbott Nutrition","Completed","May 2016","May 2017","Interventional","Apr 2016",null,null],["NCT02759887","St. Joseph's Hospital and Medical Center, Phoenix","Completed","Nov 2016","Dec 2018","Interventional","Apr 2016","Dementia,Down Syndrome,Alzheimer Disease,Syndrome","Fluorodeoxyglucose F18"],["NCT02758977","University of Zurich","Unknown status","May 2016",null,"Interventional","Apr 2016","Neoplasms,Neoplasm Metastasis,Liver Neoplasms,Colorectal Neoplasms,Liver Diseases",null],["NCT02751580","Sidney Kimmel Cancer Center at Thomas Jefferson University","Completed","Mar 2016","Aug 2018","Interventional","Apr 2016","Neoplasms",null],["NCT02751333","Johns Hopkins University","Withdrawn","Mar 2016","Feb 2017","Interventional","Apr 2016","Esophageal Stenosis,Esophageal Fistula,Esophageal Perforation,Fistula,Constriction",null],["NCT02759731","National Cancer Institute (NCI)","Recruiting","Nov 2016","Jun 2022","Interventional","Apr 2016","Graft vs Host Disease",null],["NCT02758288","Loma Linda University","Withdrawn","Sep 2015","Jul 2022","Observational","Mar 2016","Virus Diseases,Kidney Diseases",null],["NCT02756546","Cairo University","Completed","Sep 2014","Dec 2015","Interventional","Apr 2016","Lupus Erythematosus","Hydroxychloroquine,Hydrocortisone,Cyclophosphamide"],["NCT02759094","Implantica CE & Production Ltd","Unknown status","Dec 2016","Feb 2018","Interventional","Apr 2016","Gastroesophageal Reflux",null],["NCT02757313","Yale University","Completed","Oct 2016","May 2021","Interventional","Apr 2016","Marijuana Abuse","Dronabinol"],["NCT02754011","UNICANCER","Recruiting","Jan 2017","Dec 2021","Interventional","Feb 2016","Breast Neoplasms","Capecitabine"],["NCT02755805","University of Pittsburgh","Completed","Jul 2009","Dec 2012","Interventional","Apr 2016","Stroke",null],["NCT02755428","Chinese Academy of Sciences","Unknown status","Jan 2018","Dec 2020","Interventional","Mar 2016","Macular Degeneration",null],["NCT02752555","Benha University","Unknown status","Apr 2016",null,"Interventional","Apr 2016","Oligospermia","Antioxidants"],["NCT02751398","Yonsei University","Completed","Aug 2016","Jun 2020","Interventional","Apr 2016","Diabetes Mellitus","Dapagliflozin"],["NCT02758951","Koen Rovers","Recruiting","Jun 2017","Aug 2026","Interventional","Apr 2016","Neoplasms,Colorectal Neoplasms,Neoplasm Metastasis,Carcinoma,Peritoneal Neoplasms","Bevacizumab"],["NCT02750176","University of Southern California","Completed","Apr 2016","Jul 2018","Interventional","Apr 2016","Rotator Cuff Injuries",null],["NCT02750696","Federal University of Rio Grande do Sul","Completed","Apr 2013","Apr 2015","Interventional","Apr 2016","Abscess,Periapical Abscess","Acetaminophen,Tramadol,Codeine"],["NCT02757963","GlaxoSmithKline","Completed","May 2016","Feb 2017","Interventional","Apr 2016","Prostatic Hyperplasia,Hyperplasia",null],["NCT02756026","USDA, Western Human Nutrition Research Center","Completed","Sep 2013","Feb 2014","Interventional","Apr 2016",null,"Micronutrients,Trace Elements"],["NCT02756481","Bristol-Myers Squibb","Completed","Oct 2013","Nov 2014","Observational","Oct 2015","Atrial Fibrillation",null],["NCT02751060","Tongji Hospital","Enrolling by invitation","Apr 2016","Dec 2022","Observational [Patient Registry]","Apr 2016","Heart Diseases,Coronary Disease,Coronary Artery Disease,Myocardial Ischemia",null],["NCT02753127","Sumitomo Dainippon Pharma Oncology, Inc","Completed","Jun 2016","May 2021","Interventional","Apr 2016","Colorectal Neoplasms","Leucovorin,Bevacizumab,Fluorouracil,Irinotecan"],["NCT02755051","University of Missouri-Columbia","Completed","Jul 2016","Mar 2018","Interventional","Mar 2016","Sleep Initiation and Maintenance Disorders,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders",null],["NCT02757560","Phoenix VA Health Care System","Unknown status","Feb 2012","Dec 2020","Interventional","Aug 2015","Insulin Resistance",null],["NCT02754076","Allievex Corporation","Completed","Apr 2016","Jul 2020","Interventional","Feb 2016","Mucopolysaccharidoses,Mucopolysaccharidosis III",null],["NCT02752282","University of Washington","Unknown status","Mar 2016","Dec 2019","Interventional","Apr 2016","Uterine Hemorrhage",null],["NCT02751021","University Hospital, Caen","Completed","Jun 2016","Jun 2019","Interventional","Apr 2016","Apnea,Sleep Apnea Syndromes,Arrhythmias,Hyperaldosteronism",null],["NCT02759471","Coopervision, Inc.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016","Myopia",null],["NCT02752854","Taif University","Unknown status","Apr 2015","May 2016","Observational","Apr 2016",null,null],["NCT02759822","Leonardo Javier Arcuri","Unknown status","Apr 2016",null,"Observational","Apr 2016","Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma",null],["NCT02752139","Yi Yang","Completed","May 2016","Oct 2018","Observational [Patient Registry]","Mar 2016","Sleep Wake Disorders,Parasomnias,Sleep Disorders,Disease",null],["NCT02752295","Medical University of Vienna","Completed","May 2015","Jul 2016","Interventional","Apr 2016","Disease,Inflammation,Anxiety Disorders,Mood Disorders,Stress",null],["NCT02753023","University of Sao Paulo General Hospital","Unknown status","May 2015","May 2020","Observational [Patient Registry]","Apr 2016","Pulmonary Embolism,Pulmonary Edema,Syncope,Aneurysm,Acute Coronary Syndrome,Embolism,Aortic Aneurysm,Emergencies,Chest Pain",null],["NCT02757365","West China Hospital","Unknown status","Apr 2014","Apr 2019","Interventional","Apr 2016","Prostatic Neoplasms","Aspirin,Levofloxacin,Ofloxacin"],["NCT02757092","Chang Gung Memorial Hospital","Completed","Mar 2016","May 2017","Interventional","Apr 2016","Lung Neoplasms",null],["NCT02758327","Koffler Vision Group","Completed","Oct 2015","Mar 2016","Interventional","Apr 2016","Dry Eye Syndromes","Carboxymethylcellulose Sodium,Ophthalmic Solutions,Lubricant Eye Drops"],["NCT02757404","Medy-Tox","Completed","May 2016","Aug 2016","Interventional","Apr 2016","Muscle Spasticity","Botulinum Toxins"],["NCT02757469","Navy General Hospital, Beijing","Unknown status","May 2016","May 2021","Interventional","Apr 2016","Premature Birth,Infertility,Primary Ovarian Insufficiency,Menopause","Drospirenone,Ethinyl Estradiol,Drospirenone and ethinyl estradiol combination,Estradiol"],["NCT02759172","Michigan State University","Unknown status","Apr 2016",null,"Interventional","Apr 2016","Suicide",null],["NCT02758041","Sebacia, Inc.","Completed","Feb 2016","Feb 2017","Interventional","Apr 2016","Acne Vulgaris",null],["NCT02755116","Jaime B Hyman","Completed","Apr 2016","Sep 2019","Interventional","Apr 2016","Nausea,Vomiting,Postoperative Nausea and Vomiting","Olanzapine"],["NCT02755584","National Institute on Aging (NIA)","Completed","Jun 2016","Apr 2021","Observational","Apr 2016",null,null],["NCT02750540","Johns Hopkins University","Completed","Oct 2016","May 2019","Interventional","Apr 2016",null,"Tenofovir"],["NCT02751918","Bayer","Completed","Jun 2016","Oct 2019","Interventional","Apr 2016","Ovarian Neoplasms","Doxorubicin,Liposomal doxorubicin,Maytansine"],["NCT02751541","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis","Sunscreening Agents"],["NCT02755883","Weill Medical College of Cornell University","Completed","Apr 2016","Oct 2017","Interventional","Apr 2016","Lung Neoplasms",null],["NCT02751229","University of Ulm","Completed","May 2016","May 2017","Interventional","Mar 2016","Mental Disorders",null],["NCT02759640","Atridia Pty Ltd.","Completed","Sep 2016","May 2018","Interventional","Apr 2016","Neoplasms",null],["NCT02750683","Hopital Antoine Beclere","Completed","Oct 2014","Jan 2016","Observational","Apr 2016","Shock",null],["NCT02758132","University of Hawaii","Terminated","Mar 2016","Sep 2016","Interventional","Apr 2016","Prostatic Neoplasms,Neoplasm Metastasis","Denosumab,Prednisone"],["NCT02757001","Group of Research in Minimally Invasive Techniques","Completed","Jun 2016","Jul 2019","Observational [Patient Registry]","Apr 2016",null,null],["NCT02757235","Sahlgrenska University Hospital, Sweden","Unknown status","Mar 2016","Jun 2020","Interventional","Apr 2016","Hematoma",null],["NCT02754869","University College, London","Unknown status","Feb 2011","Aug 2018","Observational","Feb 2016","Intestinal Diseases",null],["NCT02759406","Palmaz Scientific","Completed","Sep 2013","Jun 2015","Interventional","Apr 2016","Heart Diseases,Myocardial Ischemia,Coronary Artery Disease,Ischemia",null],["NCT02758522","Hospital Universitario Dr. Jose E. Gonzalez","Completed","Oct 2013","Oct 2015","Interventional","Apr 2016","Diabetes Mellitus,Hyperglycemia","Insulin"],["NCT02750046","Second Affiliated Hospital of Soochow University","Unknown status","Mar 2016","Feb 2018","Interventional","Mar 2016","Fractures,Femoral Neck Fractures",null],["NCT02755233","University of Zurich","Completed","Jan 2014","Mar 2016","Observational","Apr 2016","Melanoma",null],["NCT02750423","Emory University","Completed","Apr 2016","Dec 2017","Interventional","Apr 2016",null,null],["NCT02754050","Tandem Technologies LTD","Unknown status","Sep 2016","Oct 2018","Interventional","Apr 2016",null,null],["NCT02754284","Chinese Academy of Sciences","Completed","Dec 2015","Jun 2020","Interventional","Apr 2016","Vocal Cord Dysfunction",null],["NCT02756078","Johnson & Johnson Vision Care, Inc.","Completed","Apr 2016","Oct 2017","Interventional","Apr 2016",null,null],["NCT02750995","Daniel El Fassi","Completed","Apr 2016","Jun 2019","Interventional","Apr 2016","Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome","Azacitidine"],["NCT02759302","Rigshospitalet, Denmark","Completed","Apr 2016","Apr 2017","Observational","Apr 2016","Muscular Dystrophies",null],["NCT02759874","Institute of Health Economics, Canada","Unknown status","Nov 2015","Nov 2018","Interventional","Apr 2016","Fetal Alcohol Spectrum Disorders,Alcoholism",null],["NCT02758535","Modarres Hospital","Completed","Mar 2015","Mar 2016","Interventional","Apr 2016",null,null],["NCT02755636","Pro-Change Behavior Systems","Unknown status","May 2016","Jul 2017","Interventional","Mar 2016",null,null],["NCT02758873","University of Sussex","Completed","Feb 2016","Jul 2019","Interventional","Apr 2016","Asthma","Salmeterol Xinafoate,Montelukast"],["NCT02753166","NYU Langone Health","Withdrawn","Jan 2017","Dec 2017","Interventional","Apr 2016",null,"Dexamethasone"],["NCT02755766","Shriners Hospitals for Children","Completed","May 2015","Jul 2019","Observational","Mar 2016","Scoliosis,Clubfoot,Talipes,Equinus Deformity",null],["NCT02751983","VA Office of Research and Development","Completed","Nov 2016","Dec 2018","Interventional","Apr 2016","Suicide",null],["NCT02754960","Shanghai Jiao Tong University School of Medicine","Withdrawn","Mar 2010","Sep 2014","Interventional","Apr 2016","Gastrointestinal Hemorrhage,Vascular Malformations,Congenital Abnormalities,Hemorrhage","Thalidomide"],["NCT02751086","International Study Group on Minimally Invasive Surgery for Gastric Cancer","Recruiting","Apr 2016","Dec 2024","Observational","Apr 2016","Stomach Neoplasms",null],["NCT02755753","YongChan Lee","Completed","Jan 2014","Apr 2016","Interventional","Sep 2015","Gastroesophageal Reflux,Esophagitis","Lansoprazole,Dexlansoprazole,Rebamipide"],["NCT02757872","Albert Einstein College of Medicine","Active, not recruiting","Apr 2016","Nov 2021","Interventional","Apr 2016","Kidney Diseases,Hypertension","Vitamin D,Ergocalciferols,Cholecalciferol,Vitamins"],["NCT02756767","Abramson Cancer Center of the University of Pennsylvania","Completed","Apr 2016","Apr 2021","Observational","Apr 2016","Neoplasms",null],["NCT02757937","Children's Hospital of Philadelphia","Completed","May 2016","Dec 2017","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02753660","Indonesia University","Completed","Aug 2014","Oct 2014","Interventional","Apr 2016",null,null],["NCT02751684","Universitätsklinikum Köln","Completed","Mar 2017","May 2017","Observational","Apr 2016",null,null],["NCT02753556","Dimagi Inc.","Completed","Sep 2015","Jun 2016","Observational","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02757287","Institut Universitari Dexeus","Withdrawn","May 2016","Dec 2018","Interventional","Apr 2016","Infertility","Desogestrel"],["NCT02752308","Isfahan University of Medical Sciences","Completed","Sep 2014","Mar 2015","Interventional","Apr 2016","Hypospadias","Atropine,Epinephrine,Fentanyl,Bupivacaine,Neostigmine"],["NCT02758314","Instituto Nacional de Cancerologia de Mexico","Unknown status","Mar 2017","Dec 2018","Observational","Apr 2016","Lung Neoplasms,Carcinoma",null],["NCT02752685","NYU Langone Health","Recruiting","Jun 2016","Dec 2021","Observational","Apr 2016","Breast Neoplasms","Paclitaxel,Pembrolizumab"],["NCT02759289","NYU Langone Health","Completed","Nov 2015","Sep 2020","Observational","Apr 2016","Atherosclerosis",null],["NCT02759120","Weill Medical College of Cornell University","Terminated","Mar 2017","Mar 2020","Interventional","Apr 2016","Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis","Doxycycline,Anti-Bacterial Agents,Trimethoprim,Anti-Infective Agents"],["NCT02754401","Renatus, Antonio Renatus, Dent., M.Sc","Completed","Jan 2014","Jul 2014","Interventional","Apr 2016","Periodontitis",null],["NCT02759757","Leandro Pires","Unknown status","May 2016","Feb 2017","Interventional","Apr 2016","Back Pain,Low Back Pain",null],["NCT02750579","Assistance Publique Hopitaux De Marseille","Completed","Sep 2016","Apr 2018","Interventional","Apr 2016","Acute Coronary Syndrome,Syndrome",null],["NCT02752204","University of Birmingham","Completed","Oct 2015","Feb 2020","Interventional","Apr 2016","Lymphoma","Rituximab"],["NCT02757053","Mosaic Life Care","Terminated","Apr 2016","Jun 2016","Interventional","Apr 2016","Brain Injuries,Brain Concussion,Diffuse Axonal Injury,Wounds and Injuries,Athletic Injuries",null],["NCT02752542","Nova Scotia Health Authority","Unknown status","Oct 2016","May 2021","Interventional","Apr 2016","Disease,Depressive Disorder,Depression",null],["NCT02753283","Susan L. Greenspan","Active, not recruiting","Jun 2016","Sep 2023","Interventional","Apr 2016","Osteoporosis,Osteoporotic Fractures","Vitamin D,Zoledronic Acid,Denosumab,Calcium"],["NCT02754934","Balgrist University Hospital","Completed","Nov 2014","Nov 2016","Observational","Apr 2016","Neck Pain",null],["NCT02755194","The Hospital for Sick Children","Terminated","Sep 2014","Sep 2019","Observational","Apr 2016",null,null],["NCT02758210","Emory University","Completed","Apr 2016","Oct 2016","Interventional","Apr 2016","Bradycardia,Tachycardia",null],["NCT02757456","Sameena Iqbal","Completed","Feb 2015","Feb 2016","Interventional","Nov 2012","Cardiovascular Diseases",null],["NCT02756377","Islamic Azad University, Tehran","Completed","May 2014","Jun 2015","Interventional","Apr 2016","Periodontal Diseases","Chlorhexidine,Chlorhexidine gluconate,Cetylpyridinium"],["NCT02751099","Centro Hospitalar de Lisboa Central","Unknown status","Nov 2015","Dec 2018","Observational","Apr 2016","Bone Diseases,Renal Insufficiency,Vascular Diseases",null],["NCT02752178","University of Cambridge","Completed","Jun 2015","Sep 2018","Observational","Mar 2016","Depressive Disorder,Depression",null],["NCT02757144","Daewoong Pharmaceutical Co. LTD.","Completed","Mar 2016","Feb 2017","Interventional","Mar 2016",null,"Esomeprazole"],["NCT02757742","Fu Wai Hospital, Beijing, China","Completed","Dec 2010","Aug 2016","Observational","Apr 2016","Cardiomyopathies",null],["NCT02750644","Joaquin de Haro, M.D.","Completed","Jan 2005","Apr 2016","Observational","Apr 2016","Carotid Artery Diseases",null],["NCT02754635","HaEmek Medical Center, Israel","Unknown status","Mar 2016","Jul 2018","Interventional","Feb 2016",null,null],["NCT02755311","Sun Yat-sen University","Unknown status","Mar 2014","Jun 2016","Interventional","Apr 2016","Carcinoma","Cisplatin,Carboplatin,Fluorouracil,Epirubicin,Ethiodized Oil,Pirarubicin,Doxorubicin,Gelatin Sponge"],["NCT00170053","Mayo Clinic","Completed","Jun 2005","Sep 2008","Interventional","Sep 2005","Kidney Diseases","Sirolimus"],["NCT00175396","University of British Columbia","Unknown status","May 2004","Jun 2014","Interventional","Sep 2005","Prostatic Neoplasms","Ascorbic Acid,Leuprolide,Methyltestosterone,Flutamide,Bicalutamide,Nilutamide,Buserelin,Androgens,Estrogens"],["NCT00179647","Celgene Corporation","Completed","Sep 2005","Apr 2009","Interventional","Sep 2005","Multiple Myeloma,Neoplasms","Dexamethasone,Lenalidomide"],["NCT00172523","National Taiwan University Hospital","Unknown status","Oct 2004","Aug 2005","Observational","Sep 2005","Polycystic Ovary Syndrome,Syndrome",null],["NCT00174785","Sanofi","Completed","Jun 2005","Mar 2008","Interventional","Sep 2005","Atrial Fibrillation,Atrial Flutter","Dronedarone"],["NCT00175058","TherOx","Completed","Aug 2005","May 2008","Interventional","Sep 2005","Myocardial Infarction,Infarction",null],["NCT00177541","University of Pittsburgh","Completed","Feb 2004","Sep 2016","Interventional","Sep 2005","Urinary Incontinence",null],["NCT00176215","Heidelberg University","Unknown status","May 2003",null,"Interventional","Sep 2005","Tooth Abrasion",null],["NCT00178529","The University of Texas Health Science Center, Houston","Completed","Jul 2001","Sep 2005","Interventional","Sep 2005","Stroke",null],["NCT00172367","National Taiwan University Hospital","Withdrawn","Jan 2006",null,"Interventional","Sep 2005","Carcinoma","Lycopene"],["NCT00173875","National Taiwan University Hospital","Completed","Mar 2005","Jul 2007","Interventional","Sep 2005","Lung Neoplasms,Carcinoma","Gefitinib"],["NCT00174668","Sanofi","Completed","Nov 2004",null,"Interventional","Sep 2005","Diabetes Mellitus","Insulin,Insulin Glargine,Insulin glulisine"],["NCT00173927","National Taiwan University Hospital","Unknown status","Mar 2004",null,"Observational","Sep 2005","Atherosclerosis",null],["NCT00179933","Ann & Robert H Lurie Children's Hospital of Chicago","Terminated","Sep 2005","Feb 2007","Interventional","Sep 2005",null,null],["NCT00176878","Masonic Cancer Center, University of Minnesota","Completed","Jun 2000","Mar 2009","Interventional","Sep 2005","Shwachman-Diamond Syndrome,Neutropenia,Bone Marrow Failure Disorders,Pancytopenia,Anemia,Syndrome","Fludarabine,Fludarabine phosphate,Busulfan,Antilymphocyte Serum"],["NCT00172653","National Taiwan University Hospital","Unknown status","Aug 2005","Jul 2006","Observational","Sep 2005",null,null],["NCT00177645","University of Pittsburgh","Completed","Mar 2002","Dec 2006","Interventional","Sep 2005","Cystic Fibrosis,Fibrosis",null],["NCT00176475","University of Medicine and Dentistry of New Jersey","Terminated","Jan 2005","Feb 2008","Interventional","Sep 2005","Lymphoma,Leukemia,Multiple Myeloma,Neoplasms,Plasmacytoma","Rituximab"],["NCT00178087","University of Pittsburgh","Completed","Aug 2005","Aug 2011","Observational","Sep 2005","Depression,Depressive Disorder",null],["NCT00178854","Vanderbilt University Medical Center","Withdrawn","May 2004","Mar 2006","Interventional","Sep 2005","Depressive Disorder","Risperidone"],["NCT00178503","The University of Texas Health Science Center, Houston","Completed","Sep 2005","May 2011","Interventional","Sep 2005","Hyperkinesis,Autistic Disorder,Attention Deficit Disorder with Hyperactivity","Methylphenidate"],["NCT00176410","University of Leipzig","Unknown status","Jan 2003","Dec 2009","Interventional","Sep 2005","Aortic Valve Stenosis,Constriction",null],["NCT00179166","Vanderbilt University","Terminated","Jun 2004","Jul 2005","Interventional","Sep 2005","Renal Insufficiency,Acute Kidney Injury",null],["NCT00171054","Novartis","Completed","Sep 2003","Oct 2007","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan,Hydrochlorothiazide"],["NCT00170300","Medtronic Bakken Research Center","Completed","Jan 2001","May 2005","Interventional","Sep 2005","Heart Failure",null],["NCT00177619","University of Pittsburgh","Completed","May 2002","Dec 2005","Interventional","Sep 2005","Prostatic Neoplasms,Osteoporosis","Alendronate"],["NCT00178139","University of Rochester","Completed","Apr 2004","Jul 2006","Interventional","Sep 2005","Respiratory Insufficiency,Pulmonary Valve Insufficiency",null],["NCT00175799","University of British Columbia","Completed","Sep 2007","Jul 2013","Observational","Sep 2005",null,null],["NCT00172874","National Taiwan University Hospital","Completed","Jan 1998","Dec 2008","Observational","Sep 2005","Feeding and Eating Disorders",null],["NCT00179985","Ann & Robert H Lurie Children's Hospital of Chicago","Completed","Dec 2004","Jul 2011","Observational","Sep 2005","Hypersensitivity",null],["NCT00176384","University of Leipzig","Completed","Mar 2003","Dec 2006","Interventional","Sep 2005","Heart Failure",null],["NCT00176644","University of Medicine and Dentistry of New Jersey","Terminated","May 2005","Dec 2008","Interventional","Sep 2005","Prostatic Neoplasms","Estradiol"],["NCT00174070","National Taiwan University Hospital","Unknown status","Aug 2005","Feb 2006","Observational","Sep 2005","Respiratory Insufficiency",null],["NCT00173472","National Taiwan University Hospital","Unknown status","Jul 2002","Jul 2005","Observational","Sep 2005","Colorectal Neoplasms",null],["NCT00172640","National Taiwan University Hospital","Unknown status","Jan 2005",null,"Observational","Sep 2005","Carcinoma",null],["NCT00174967","Takeda","Completed","Jan 2001","Jul 2001","Interventional","Sep 2005","Gout","Febuxostat"],["NCT00171028","Novartis","Completed","Dec 2003","Nov 2006","Interventional","Sep 2005","Hypertension","Valsartan"],["NCT00175344","University of British Columbia","Completed","Feb 2004","Apr 2006","Interventional","Sep 2005","Breast Neoplasms,Pain",null],["NCT00173368","National Taiwan University Hospital","Completed","Jan 2003","Mar 2005","Observational","Sep 2005","Choledocholithiasis",null],["NCT00174629","Sanofi","Completed","Jun 2001",null,"Interventional","Sep 2005","Lung Neoplasms","Gemcitabine,Docetaxel"],["NCT00179231","Vanderbilt University","Completed","May 2000","Feb 2004","Interventional","Sep 2005","Schizophrenia,Psychotic Disorders","Olanzapine,Clozapine"],["NCT00173693","National Taiwan University Hospital","Withdrawn","Jan 2006","Dec 2010","Interventional","Sep 2005","Osteoporosis,Bone Diseases",null],["NCT00171093","Novartis","Completed","Sep 2004",null,"Interventional","Sep 2005","Hypertension,Hypercholesterolemia","Valsartan,Simvastatin"],["NCT00179348","Albert Einstein College of Medicine","Completed","Feb 2001","Jul 2016","Interventional","Sep 2005","Carcinoma,Breast Neoplasms,Colorectal Neoplasms,Sleep Wake Disorders,Alopecia,Vomiting",null],["NCT00172133","Shire","Completed","Oct 2001","Apr 2005","Interventional","Sep 2005","Osteoporosis",null],["NCT00170508","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Jun 2005","Aug 2005","Interventional","Sep 2005","Influenza",null],["NCT00179543","Beth Israel Deaconess Medical Center","Completed","Aug 2001",null,"Interventional","Sep 2005","Hypertension",null],["NCT00177216","University of Pittsburgh","Completed","Feb 2002","May 2008","Interventional","Sep 2005","Sleep Initiation and Maintenance Disorders,Sleep Wake Disorders","Zolpidem,Citalopram"],["NCT00176813","University of Michigan Rogel Cancer Center","Completed","Mar 2003","Nov 2006","Interventional","Sep 2005","Pancreatic Neoplasms","Gemcitabine,Celecoxib"],["NCT00170131","Mayo Clinic","Completed","Sep 2002","Jul 2007","Observational","Sep 2005","Infections,Hepatitis C",null],["NCT00174551","Rainier Associates","Unknown status","Nov 2003","Nov 2005","Interventional","Sep 2005","Stress Disorders","Prazosin"],["NCT00170755","Novartis","Completed","Apr 2002","Jan 2005","Interventional","Sep 2005","Urinary Bladder","Darifenacin"],["NCT00174200","Pfizer","Completed","Dec 2004","May 2006","Interventional","Sep 2005","Schizophrenia,Mental Disorders,Psychotic Disorders","Risperidone"],["NCT00178698","The University of Texas Health Science Center, Houston","Unknown status","Jul 2002","Jun 2014","Interventional","Sep 2005","Lung Neoplasms,Stomach Neoplasms,Small Cell Lung Carcinoma,Carcinoma","Gemcitabine,Interferons"],["NCT00178516","University of Rochester","Completed","Jun 2004","Dec 2005","Observational","Sep 2005","Infertility",null],["NCT00172289","National Taiwan University Hospital","Unknown status","Aug 2004","Dec 2006","Observational","Sep 2005","Spinal Cord Injuries,Stroke,Wounds and Injuries",null],["NCT00172718","National Taiwan University Hospital","Unknown status","Mar 2005",null,"Observational","Sep 2005","Jaw,Mouth",null],["NCT00174239","Pfizer","Terminated","Jul 2004","Sep 2005","Interventional","Sep 2005","Parkinson Disease","Levodopa,Carbidopa,Cabergoline"],["NCT00178620","The University of Texas Health Science Center, Houston","Completed","Nov 2003","Mar 2014","Interventional","Sep 2005","Myocardial Infarction,Heart Diseases,Infarction","Reteplase"],["NCT00177112","University of Minnesota","Completed","Jun 2005","Oct 2007","Interventional","Sep 2005","Infections,Communicable Diseases,Urinary Tract Infections",null],["NCT00173108","National Taiwan University Hospital","Completed","Jan 2006","Oct 2010","Interventional","Sep 2005","Premature Birth",null],["NCT00170404","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Jun 2000","Oct 2005","Interventional","Sep 2005","Tuberculosis","Vitamins,Folic Acid,Vitamin A,Thiamine,Selenium,Micronutrients,Trace Elements"],["NCT00176280","University of Kentucky","Withdrawn","Sep 2005",null,"Interventional","Sep 2005","Carcinoma","Dexamethasone,Sargramostim"],["NCT00175123","University of Aarhus","Unknown status","May 2005","Jun 2008","Interventional","Sep 2005","Urinary Bladder,Meningomyelocele,Spina Bifida Cystica","Botulinum Toxins,abobotulinumtoxinA"],["NCT00170924","Novartis","Completed","Aug 2004","Jun 2006","Interventional","Sep 2005","Hypertension","Valsartan"],["NCT00170222","Medical Center Alkmaar","Completed","Jul 2002","Aug 2008","Interventional","Sep 2005","Lung Diseases,Pulmonary Disease","Doxycycline"],["NCT00172042","Novartis Pharmaceuticals","Completed","Mar 2005","Jun 2010","Interventional","Sep 2005","Lung Neoplasms,Carcinoma,Neoplasm Metastasis","Zoledronic Acid"],["NCT00170690","North Eastern German Society of Gynaecological Oncology","Completed","Aug 2004","Apr 2012","Interventional","Sep 2005","Ovarian Neoplasms,Carcinoma","Treosulfan,Busulfan"],["NCT00176904","Masonic Cancer Center, University of Minnesota","Completed","Jan 1995","Jun 2010","Interventional","Sep 2005","Gaucher Disease,Adrenoleukodystrophy,Pick Disease of the Brain,Gangliosidoses,Leukodystrophy,Niemann-Pick Diseases,Niemann-Pick Disease,Neuronal Ceroid-Lipofuscinoses,Tay-Sachs Disease,Gangliosidosis,Sandhoff Disease,Fucosidosis,Metabolism,Wolman Disease","Cyclophosphamide,Busulfan,Antilymphocyte Serum"],["NCT00178204","University of Rochester","Completed","Nov 2004","Dec 2011","Observational","Sep 2005","Fatigue",null],["NCT00176345","University of Leipzig","Unknown status","Jan 2001",null,"Interventional","Sep 2005","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease",null],["NCT00178711","The University of Texas Health Science Center, Houston","Terminated","Nov 2005","Dec 2009","Interventional","Sep 2005","Brain Injuries,Hypothermia,Wounds and Injuries",null],["NCT00173680","National Taiwan University Hospital","Unknown status","Aug 2005",null,"Observational","Sep 2005","Lung Neoplasms",null],["NCT00170417","NHS Greater Glasgow and Clyde","Completed","Dec 2000","May 2003","Interventional","Sep 2005","Sleep Initiation and Maintenance Disorders",null],["NCT00173485","National Taiwan University Hospital","Unknown status","Jun 2005","Jun 2009","Observational","Sep 2005","Peritonitis,Renal Insufficiency",null],["NCT00178269","University of Rochester","Completed","Jan 2005",null,"Interventional","Sep 2005","Uterine Cervical Neoplasms","Docetaxel"],["NCT00171301","Novartis Pharmaceuticals","Completed","Jun 2005","May 2008","Interventional","Sep 2005","Thalassemia,beta-Thalassemia,Iron Overload,Hemosiderosis","Deferasirox"],["NCT00171782","Novartis","Completed","Feb 2004","Dec 2004","Interventional","Sep 2005","Hypertension","Valsartan,Hydrochlorothiazide"],["NCT00176566","University of Medicine and Dentistry of New Jersey","Terminated","Sep 2003","Nov 2006","Interventional","Sep 2005","Leukoplakia",null],["NCT00170846","Novartis Pharmaceuticals","Completed","Feb 2005","Oct 2009","Interventional","Sep 2005",null,"Everolimus,Azathioprine,Calcineurin Inhibitors"],["NCT00173836","National Taiwan University Hospital","Completed","Aug 2003","Aug 2006","Observational","Sep 2005","Nasopharyngeal Carcinoma,Nasopharyngeal Neoplasms",null],["NCT00174005","National Taiwan University Hospital","Unknown status","Dec 1994",null,"Observational","Sep 2005",null,null],["NCT00176527","University of Medicine and Dentistry of New Jersey","Terminated","Nov 2002","Aug 2007","Interventional","Sep 2005","Prostatic Neoplasms","Interferons,Interferon-alpha,Interferon alpha-2,Docetaxel,Estramustine,Isotretinoin"],["NCT00171314","Novartis Pharmaceuticals","Completed","Mar 2004",null,"Interventional","Sep 2005","Breast Neoplasms","Zoledronic Acid,Letrozole"],["NCT00175409","University of British Columbia","Completed","Jan 2008","Jun 2010","Interventional","Sep 2005",null,null],["NCT00177190","University of Pittsburgh","Completed","Jun 2002","Jan 2006","Observational","Sep 2005","Mycoses,Lymphoma,Mycosis Fungoides,Sezary Syndrome",null],["NCT00179101","Vanderbilt University","Completed","Apr 2004","Nov 2005","Observational","Sep 2005","Parkinson Disease,Depression",null],["NCT00175526","University of British Columbia","Completed","Sep 2005","Dec 2010","Observational","Sep 2005","Toxemia,Sepsis",null],["NCT00176293","University of Kentucky","Terminated","Oct 2005","Feb 2007","Interventional","Sep 2005","Prostatic Neoplasms","Dexamethasone,Doxorubicin"],["NCT00178347","University of Rochester","Terminated","Dec 2004",null,"Observational","Sep 2005",null,null],["NCT00171964","Novartis Pharmaceuticals","Completed","May 2002","Dec 2008","Interventional","Sep 2005","Neoplasm Metastasis","Zoledronic Acid"],["NCT00178945","Vanderbilt University","Completed","Mar 2004","Mar 2006","Interventional","Sep 2005","Myofascial Pain Syndromes,Fibromyalgia,Dystonia,Dystonic Disorders,Syndrome,Torticollis","Botulinum Toxins,abobotulinumtoxinA"],["NCT00172965","National Taiwan University Hospital","Unknown status","Aug 2004","Jun 2005","Observational","Sep 2005","Mouth Neoplasms",null],["NCT00179764","Ann & Robert H Lurie Children's Hospital of Chicago","Completed","Mar 2000","Jan 2014","Interventional","Sep 2005","Leukemia,Melanoma,Neoplasms,Hematologic Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma","Busulfan"],["NCT00170612","University of Melbourne","Completed","Nov 2005","Aug 2008","Interventional","Sep 2005","Pneumococcal Infections","Heptavalent Pneumococcal Conjugate Vaccine"],["NCT00172627","National Taiwan University Hospital","Unknown status","Jan 2005",null,"Observational","Sep 2005","Stomach Neoplasms",null],["NCT00170872","Novartis","Completed","Nov 2004",null,"Interventional","Sep 2005","Arthritis,Osteoarthritis","Lumiracoxib"],["NCT00172770","National Taiwan University Hospital","Unknown status","Aug 2004","Jul 2006","Observational","Sep 2005","Schizophrenia",null],["NCT00173849","National Taiwan University Hospital","Unknown status","Jan 2006","Jul 2006","Observational","Sep 2005","Mouth Neoplasms",null],["NCT00175682","University of British Columbia","Completed","Dec 2004","Jul 2011","Interventional","Sep 2005","Spinal Cord Injuries,Autonomic Dysreflexia","Prazosin"],["NCT00179127","Vanderbilt University Medical Center","Completed","Aug 2004","Sep 2012","Interventional","Sep 2005","Ketosis,Acidosis,Diabetic Ketoacidosis","Insulin Glargine"],["NCT00178113","University of Pittsburgh","Completed","Jul 2003","Jul 2004","Interventional","Sep 2005","Neoplasms,Carcinoma in Situ,Prostatic Intraepithelial Neoplasia","Lycopene"],["NCT00170560","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Oct 2001",null,"Observational","Sep 2005","Infections",null],["NCT00178022","University of Pittsburgh","Completed","Feb 2005","Sep 2006","Interventional","Sep 2005","Brain Injuries,Wounds and Injuries,Depression,Anxiety Disorders",null],["NCT00178425","University of Rochester","Completed","Jan 2005","Jun 2006","Interventional","Sep 2005",null,null],["NCT00178438","University of Rochester","Withdrawn","Jun 2005","Jun 2006","Interventional","Sep 2005","Crohn Disease",null],["NCT00173173","National Taiwan University Hospital","Completed","Aug 2003","Jul 2004","Observational","Sep 2005","Disease,Feeding and Eating Disorders",null],["NCT00177294","University of Pittsburgh","Completed","Apr 2004","Aug 2009","Interventional","Sep 2005","Depression,Depressive Disorder","Citalopram"],["NCT00175461","University of British Columbia","Completed","Sep 2005","Aug 2011","Interventional","Sep 2005","Osteoarthritis",null],["NCT00179062","Vanderbilt University","Completed","Feb 2000","Jun 2007","Interventional","Sep 2005","Disease,Schizophrenia,Depressive Disorder,Bipolar Disorder,Psychotic Disorders","Olanzapine,Risperidone"],["NCT00173550","National Taiwan University Hospital","Unknown status","Aug 2004",null,"Observational","Sep 2005","Premature Birth,Menopause,Primary Ovarian Insufficiency",null],["NCT00177385","University of Pittsburgh","Completed","Jun 2003","Sep 2011","Interventional","Sep 2005",null,null],["NCT00171002","Novartis","Completed","Nov 2004","Jun 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00177125","University of Minnesota","Completed","Jan 2004","Jan 2004","Interventional","Sep 2005","Prostatic Neoplasms",null],["NCT00172861","National Taiwan University Hospital","Unknown status","Jan 2005",null,"Observational","Sep 2005","Stomach Neoplasms",null],["NCT00174798","Sanofi","Completed","May 2005","May 2006","Interventional","Sep 2005","Urinary Incontinence,Enuresis,Urinary Bladder","Tolterodine Tartrate"],["NCT00177892","National Institute on Aging (NIA)","Unknown status","Sep 2003","Aug 2008","Interventional","Sep 2005","Apnea,Sleep Apnea Syndromes,Sleep Apnea,Metabolic Syndrome,Syndrome",null],["NCT00176761","University of Michigan Rogel Cancer Center","Terminated","Mar 2000","May 2006","Interventional","Sep 2005","Colorectal Neoplasms","Interleukin-2"],["NCT00176319","University of Leipzig","Completed","May 2005",null,"Interventional","Sep 2005","Heart Failure",null],["NCT00177203","University of Pittsburgh","Completed","Jun 2003","Jan 2009","Interventional","Sep 2005","Sleep Initiation and Maintenance Disorders",null],["NCT00174993","Takeda","Completed","May 2001","Jan 2005","Interventional","Sep 2005","Diabetes Mellitus","Pioglitazone"],["NCT00177658","University of Pittsburgh","Completed","Mar 2006","Jun 2017","Observational","Sep 2005","Salmonella Infections",null],["NCT00174928","Takeda","Completed","May 2005","Aug 2005","Interventional","Sep 2005","Gastroesophageal Reflux,Esophagitis","Lansoprazole,Dexlansoprazole"],["NCT00170677","North Eastern German Society of Gynaecological Oncology","Completed","Sep 2005","Jan 2013","Interventional","Sep 2005","Ovarian Neoplasms,Carcinoma","Topotecan"],["NCT00178295","University of Rochester","Completed","Nov 1999",null,"Observational","Sep 2005","Brain Neoplasms,Trauma",null],["NCT00176449","University of Maryland, Baltimore","Completed","Apr 2001","Dec 2005","Interventional","Sep 2005","Tobacco Use Disorder","Bupropion"],["NCT00179751","Celgene Corporation","Terminated","Apr 2005","Aug 2006","Interventional","Sep 2005","Pancreatic Neoplasms","Gemcitabine,Lenalidomide"],["NCT00172744","National Taiwan University Hospital","Unknown status","Apr 2005","Jul 2006","Observational","Sep 2005",null,null],["NCT00177255","University of Pittsburgh","Terminated","Apr 2005","Dec 2008","Interventional","Sep 2005",null,"Docetaxel,Capecitabine"],["NCT00171925","Novartis Pharmaceuticals","Terminated","Aug 2000","Nov 2008","Interventional","Sep 2005","Multiple Myeloma,Neoplasms","Vitamin D,Zoledronic Acid,Calcium"],["NCT00177307","University of Pittsburgh","Completed","Jan 2005","Feb 2012","Interventional","Sep 2005","Colorectal Neoplasms","Bevacizumab,Capecitabine,Oxaliplatin"],["NCT00173862","National Taiwan University Hospital","Completed","May 2000","Jun 2006","Interventional","Jun 2005","Carcinoma","Gemcitabine,Ifosfamide"],["NCT00171990","Novartis","Completed","Jan 2003","Feb 2006","Interventional","Sep 2005","Herpes Genitalis","Famciclovir"],["NCT00177060","Hordinsky, Maria K., MD","Terminated","Oct 2003","May 2007","Interventional","Sep 2005","Wounds and Injuries","Hydromorphone"],["NCT00173043","National Taiwan University Hospital","Unknown status","Oct 2004","Aug 2005","Observational","Sep 2005","Polycystic Ovary Syndrome,Insulin Resistance,Syndrome",null],["NCT00171769","Novartis","Completed","Apr 2005",null,"Interventional","Sep 2005","Atrial Fibrillation","Certoparin"],["NCT00171951","Novartis Pharmaceuticals","Completed","Aug 2004","Jul 2013","Interventional","Sep 2005","ACTH-Secreting Pituitary Adenoma,Pituitary ACTH Hypersecretion","Pasireotide"],["NCT00174850","State University of New York - Upstate Medical University","Completed","Jul 2004","May 2005","Interventional","Sep 2005","Anxiety Disorders",null],["NCT00177970","University of Pittsburgh","Terminated","Oct 2003","Apr 2008","Interventional","Sep 2005","Diarrhea","Immunoglobulins,Antibodies,Immunoglobulin G,gamma-Globulins,Rho(D) Immune Globulin"],["NCT00171834","Novartis Pharmaceuticals","Completed","Aug 2003","Sep 2008","Interventional","Sep 2005","Lung Neoplasms,Carcinoma","Epothilones,Epothilone B"],["NCT00172601","National Taiwan University Hospital","Unknown status","Aug 2005",null,"Interventional","Sep 2005","Bursitis",null],["NCT00176254","Susanne Arnold","Completed","May 2000","Oct 2012","Interventional","Sep 2005","Carcinoma,Head and Neck Neoplasms","Paclitaxel,Carboplatin"],["NCT00176553","University of Medicine and Dentistry of New Jersey","Terminated","Mar 2003","May 2007","Interventional","Sep 2005","Neurotoxicity Syndromes","Dextromethorphan"],["NCT00171405","Novartis","Completed","Jun 2005","Feb 2006","Interventional","Aug 2005","Hypertension",null],["NCT00177814","University of Pittsburgh","Completed","Sep 2005","Jun 2017","Observational","Sep 2005","Bacterial Infections,Gram-Negative Bacterial Infections",null],["NCT00174122","National Taiwan University Hospital","Unknown status","Jul 2005","Jun 2006","Observational","Sep 2005",null,null],["NCT00179608","Celgene","Completed","Sep 2005","Jun 2007","Interventional","Sep 2005","Melanoma","Lenalidomide"],["NCT00173394","National Taiwan University Hospital","Unknown status","Aug 2005","Dec 2008","Observational","Sep 2005","Ovarian Neoplasms,Carcinoma",null],["NCT00170001","Mayo Clinic","Completed","Apr 2005","Aug 2006","Interventional","Sep 2005","Gastroesophageal Reflux","Esomeprazole"],["NCT00170963","Novartis","Completed","Oct 2004","Jun 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00170365","Hennepin Healthcare Research Institute","Completed","Jul 2004","Mar 2005","Interventional","Sep 2005",null,null],["NCT00173810","National Taiwan University Hospital","Unknown status","Aug 2005","Apr 2007","Observational","Sep 2005","Stroke",null],["NCT00179335","Albert Einstein College of Medicine","Completed","Aug 2003","Sep 2006","Observational","Sep 2005","HIV Infections",null],["NCT00178256","University of Rochester","Completed","Jun 1998","Dec 2012","Interventional","Sep 2005","Carcinoma","Paclitaxel"],["NCT00178035","University of Pittsburgh","Completed","Dec 1999","Aug 2003","Interventional","Sep 2005","Depression,Depressive Disorder","Paroxetine"],["NCT00177567","University of Pittsburgh","Completed","Jul 2001","Jan 2004","Interventional","Sep 2005","Disease,Bipolar Disorder,Mood Disorders","Lamotrigine,Valproic Acid,Olanzapine,Risperidone,Lithium Carbonate,Mirtazapine,Tranylcypromine,Bupropion,Paroxetine,Venlafaxine Hydrochloride"],["NCT00172666","National Taiwan University Hospital","Unknown status","Aug 2005","Jul 2006","Observational","Sep 2005","Arthritis,Lupus Erythematosus",null],["NCT00172731","National Taiwan University Hospital","Completed","Mar 2005","Jun 2005","Observational","Sep 2005","Schizophrenia",null],["NCT00171873","Carmen Schade-Brittinger","Completed","Sep 2001","Dec 2013","Interventional","Sep 2005","Neuroendocrine Tumors,Neoplasm Metastasis","Octreotide"],["NCT00173355","National Taiwan University Hospital","Unknown status","Jun 2005","Aug 2005","Observational","Sep 2005","Dermatofibrosarcoma,Soft Tissue Neoplasms",null],["NCT00176111","Heidelberg University","Terminated","Jan 2004","Jan 2005","Interventional","Sep 2005",null,null],["NCT00170274","Medtronic Bakken Research Center","Completed","Aug 2000","Oct 2014","Interventional","Sep 2005","Arrhythmias,Tachycardia",null],["NCT00172250","National Taiwan University Hospital","Completed","Sep 2003",null,"Observational","Sep 2005","Coronary Artery Disease",null],["NCT00174356","Pfizer","Completed","Dec 2002","Oct 2005","Interventional","Sep 2005","Carcinoma","Paclitaxel,Carboplatin"],["NCT00170989","Novartis","Completed","Sep 2004","Jul 2005","Interventional","Sep 2005","Hypertension","Valsartan,Hydrochlorothiazide"],["NCT00179569","Beth Israel Deaconess Medical Center","Completed","Aug 2005","Sep 2007","Interventional","Sep 2005",null,null],["NCT00172796","National Taiwan University Hospital","Unknown status","Apr 2005",null,"Observational","Sep 2005","Metabolic Syndrome,Prediabetic State",null],["NCT00178126","University of Pittsburgh","Completed","Mar 2004","Oct 2008","Interventional","Sep 2005","Pressure Ulcer,Ulcer",null],["NCT00172029","Novartis","Completed","Apr 2003",null,"Interventional","Sep 2005","Breast Neoplasms,Bone Diseases","Zoledronic Acid"],["NCT00176696","University of Medicine and Dentistry of New Jersey","Terminated","Aug 2005","Apr 2007","Observational","Sep 2005","Pain","Anesthetics"],["NCT00177788","University of Pittsburgh","Completed","Sep 2005","Aug 2012","Observational","Sep 2005","Mycoses,Fungemia",null],["NCT00171938","Novartis","Terminated","Apr 2004","Jun 2006","Interventional","Sep 2005","Glioblastoma","Imatinib Mesylate"],["NCT00177359","University of Pittsburgh","Completed","Nov 2005","Jun 2007","Interventional","Sep 2005","Mobility Limitation",null],["NCT00171860","Novartis Pharmaceuticals","Terminated","Sep 2002",null,"Interventional","Sep 2005","Hypereosinophilic Syndrome,Syndrome","Imatinib Mesylate"],["NCT00171717","Novartis","Completed","Feb 2004","Dec 2005","Interventional","Sep 2005","Diabetes Mellitus","Cyclosporine,Cyclosporins"],["NCT00176748","University of Michigan Rogel Cancer Center","Completed","Jul 2005","Jun 2009","Interventional","Sep 2005","Thyroid Neoplasms,Thyroid Diseases",null],["NCT00175084","Tufts University","Completed","Oct 2004","Dec 2012","Interventional","Sep 2005","Cardiovascular Diseases,Metabolic Syndrome,Hyperlipidemias",null],["NCT00178334","University of Rochester","Completed","Mar 2006","Jul 2006","Observational","Sep 2005","Urinary Incontinence,Enuresis",null],["NCT00172822","National Taiwan University Hospital","Unknown status","Jan 2003","Jun 2005","Observational","Sep 2005","Appendicitis",null],["NCT00170885","Novartis","Completed","May 2005","Jul 2007","Interventional","Sep 2005",null,"Everolimus"],["NCT00177684","University of Pittsburgh","Completed","Sep 2004","Sep 2005","Interventional","Sep 2005","Mycoses","Amphotericin B,Liposomal amphotericin B"],["NCT00178672","The University of Texas Health Science Center, Houston","Completed","Nov 2002","Aug 2007","Interventional","Sep 2005","Carotid Stenosis,Carotid Artery Diseases,Stroke,Heart Diseases",null],["NCT00171080","Novartis","Completed","Apr 2004","Mar 2006","Interventional","Sep 2005","Hypertension","Valsartan,Irbesartan"],["NCT00176891","Masonic Cancer Center, University of Minnesota","Completed","Mar 2004","Nov 2012","Interventional","Sep 2005","Mucopolysaccharidoses,Mucopolysaccharidosis I,Syndrome",null],["NCT00172107","Shire","Completed","May 1995","Mar 1997","Interventional","Sep 2005","Osteoporosis","Parathyroid Hormone"],["NCT00177827","University of Pittsburgh","Completed","Mar 2004","Mar 2006","Observational","Sep 2005","Aspergillosis",null],["NCT00177502","University of Pittsburgh","Completed","Jan 2003","Dec 2006","Interventional","Sep 2005","Body Weight,Weight Loss,Weight Gain",null],["NCT00175045","Takeda","Completed","Jun 2003","Oct 2003","Interventional","Sep 2005","Esophagitis","Lansoprazole,Dexlansoprazole"],["NCT00175981","Heidelberg University","Completed","Feb 2003","Nov 2004","Interventional","Sep 2005",null,"Sildenafil Citrate,Fluvoxamine"],["NCT00177983","University of Pittsburgh","Completed","Jan 2003","Jan 2005","Interventional","Sep 2005","Recurrence",null],["NCT00179699","Celgene Corporation","Terminated","Sep 2005","Nov 2006","Interventional","Sep 2005","Lung Neoplasms,Carcinoma","Pemetrexed,Lenalidomide"],["NCT00175383","University of British Columbia","Unknown status","Jun 2004","Dec 2013","Interventional","Sep 2005","Prostatic Neoplasms","Hormones,Prolactin Release-Inhibiting Factors"],["NCT00178230","University of Rochester","Completed","Mar 1996","Nov 2013","Observational","Sep 2005","Lung Neoplasms",null],["NCT00170859","Novartis Pharmaceuticals","Completed","Aug 2004","Dec 2006","Interventional","Sep 2005",null,"Everolimus"],["NCT00179465","Beth Israel Deaconess Medical Center","Active, not recruiting","Nov 2003","Sep 2022","Interventional","Sep 2005","Schizophrenia","Tiagabine,Antipsychotic Agents"],["NCT00173732","National Taiwan University Hospital","Unknown status","Sep 2005",null,"Observational","Sep 2005",null,null],["NCT00170976","Novartis","Completed","Apr 2004","Jun 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00173641","National Taiwan University Hospital","Unknown status","Sep 2005","Aug 2006","Observational","Sep 2005","Diabetes Mellitus",null],["NCT00173342","National Taiwan University Hospital","Unknown status","Jun 2005",null,"Observational","Sep 2005","Bundle-Branch Block,Heart Block",null],["NCT00174148","National Taiwan University Hospital","Unknown status","Jul 2005","Jul 2006","Observational","Sep 2005","Neck Pain",null],["NCT00170144","Mayo Clinic","Completed","Sep 2005","Jun 2007","Interventional","Sep 2005",null,null],["NCT00170469","PharmAthene UK Limited","Completed","Mar 2005","Feb 2007","Interventional","Sep 2005","Anthrax","Aluminum Hydroxide"],["NCT00179634","Beth Israel Deaconess Medical Center","Terminated","Mar 2005","Mar 2008","Interventional","Sep 2005","Breast Neoplasms",null],["NCT00175318","University of British Columbia","Completed","Apr 2005","Feb 2011","Interventional","Sep 2005","Dental Caries",null],["NCT00175812","University of Bergen","Completed","Nov 2004","Nov 2009","Interventional","Sep 2005","Leukemia","Tretinoin,Theophylline,Valproic Acid"],["NCT00178906","Vanderbilt University","Completed","Dec 1999","Apr 2008","Observational","Sep 2005","Depression",null],["NCT00175448","University of British Columbia","Completed","Sep 2005","Dec 2007","Interventional","Sep 2005","Arthritis",null],["NCT00173069","National Taiwan University Hospital","Unknown status","Jan 2006","Dec 2010","Observational","Sep 2005","Schizophrenia",null],["NCT00176956","Hordinsky, Maria K., MD","Terminated","Nov 2002","Jan 2007","Interventional","Sep 2005","Dermatitis,Skin Diseases",null],["NCT00173095","National Taiwan University Hospital","Unknown status","Jan 2005","Jan 2008","Observational","Sep 2005","Subarachnoid Hemorrhage,Hemorrhage",null],["NCT00177424","University of Pittsburgh","Terminated","Jul 2004","Oct 2007","Interventional","Sep 2005","Stroke,Depression,Depressive Disorder","Sertraline"],["NCT00172783","National Taiwan University Hospital","Unknown status","Jun 2005","Dec 2005","Observational","Sep 2005","Tuberculosis",null],["NCT00176917","Masonic Cancer Center, University of Minnesota","Completed","May 1999","May 2010","Interventional","Sep 2005","Mucolipidoses,Mucopolysaccharidoses,Mucopolysaccharidosis I,Mannosidase Deficiency Diseases,alpha-Mannosidosis,Mucopolysaccharidosis VI","Cyclophosphamide,Busulfan,Thymoglobulin"],["NCT00176839","Masonic Cancer Center, University of Minnesota","Terminated","Jun 2000","Feb 2012","Interventional","Sep 2005","Neoplasms,Hematologic Neoplasms,Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma","Cyclophosphamide,Melphalan,Busulfan,Antilymphocyte Serum,Lenograstim,Sargramostim"],["NCT00179322","National Institute on Deafness and Other Communication Disorders (NIDCD)","Completed","Sep 2005","Sep 2016","Observational","Sep 2005","Sleep Deprivation",null],["NCT00170664","North Eastern German Society of Gynaecological Oncology","Completed","Jan 1999","Sep 2004","Interventional","Sep 2005","Ovarian Neoplasms,Carcinoma","Paclitaxel,Carboplatin"],["NCT00172003","Novartis Pharmaceuticals","Completed","Sep 2004","Jul 2009","Interventional","Sep 2005","Neoplasm Metastasis,Neoplasms,Carcinoma","Zoledronic Acid"],["NCT00170261","Medtronic Bakken Research Center","Completed","Apr 2002","Sep 2006","Interventional","Sep 2005","Syncope",null],["NCT00179075","Vanderbilt University","Completed","Apr 2003","Apr 2008","Observational","Sep 2005","Graft vs Host Disease",null],["NCT00179777","University of Helsinki","Completed","May 2002","Sep 2017","Interventional","Sep 2005","Diabetes Mellitus",null],["NCT00174018","National Taiwan University Hospital","Completed","Sep 1993",null,"Observational","Sep 2005","Shoulder Impingement Syndrome",null],["NCT00171535","Novartis","Completed","Oct 2004","Apr 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00173914","National Taiwan University Hospital","Unknown status","Mar 2003",null,"Observational","Sep 2005",null,null],["NCT00175825","UCB Pharma","Completed","Nov 2005","Jun 2006","Interventional","Sep 2005","Epilepsy,Seizures","Brivaracetam"],["NCT00172198","National Taiwan University Hospital","Unknown status","Mar 2005","Mar 2007","Interventional","Sep 2005",null,null],["NCT00171366","Novartis","Completed","Jul 2004","Jul 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Benazepril"],["NCT00170287","Medtronic Bakken Research Center","Completed","May 2002","Aug 2011","Interventional","Sep 2005","Tachycardia",null],["NCT00170729","Novartis","Completed","Aug 2004","Feb 2005","Interventional","Sep 2005","Cataract,Capsule Opacification,Uveitis,Inflammation","Prednisolone,Methylprednisolone Acetate,Methylprednisolone,Methylprednisolone Hemisuccinate,Prednisolone acetate,Prednisolone hemisuccinate,Prednisolone phosphate"],["NCT00173225","National Taiwan University Hospital","Unknown status","Jun 2005","Jun 2005","Observational","Sep 2005","Asthma,Cough",null],["NCT00178100","University of Pittsburgh","Completed","Mar 1999","Aug 2005","Interventional","Sep 2005","Depression,Depressive Disorder","Paroxetine"],["NCT00176397","University of Leipzig","Unknown status","Aug 2003",null,"Interventional","Sep 2005","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Coronary Stenosis,Constriction",null],["NCT00177333","University of Pittsburgh","Completed","Sep 2005","May 2006","Interventional","Sep 2005","Vomiting","Doxycycline"],["NCT00175643","University of British Columbia","Completed","Feb 2005","Nov 2005","Interventional","Sep 2005","Keratosis","Imiquimod"],["NCT00172913","National Taiwan University Hospital","Unknown status","Jun 2005","Jul 2008","Observational","Sep 2005","Myopia",null],["NCT00173628","National Taiwan University Hospital","Unknown status","Jan 1990","Dec 2006","Observational","Sep 2005","Diabetes Mellitus",null],["NCT00172757","National Taiwan University Hospital","Unknown status","Jan 2002","Jun 2005","Observational","Sep 2005","Colorectal Neoplasms,Diabetes Mellitus",null],["NCT00174512","Pfizer","Completed","Mar 2005","Jun 2006","Interventional","Sep 2005","Heart Diseases,Myocardial Ischemia,Coronary Artery Disease","Moxifloxacin"],["NCT00172939","National Taiwan University Hospital","Unknown status","Jun 2005","Jan 2008","Interventional","Sep 2005","Vitiligo",null],["NCT00176995","Hordinsky, Maria K., MD","Completed","Mar 1999","Oct 2000","Interventional","Sep 2005","Hair Diseases","Eflornithine"]],"plotOptions":{"displayType":"table","customPlotOptions":{},"pivotColumns":null,"pivotAggregation":null,"xColumns":null,"yColumns":null},"columnCustomDisplayInfos":{},"aggType":"","isJsonSchema":true,"removedWidgets":[],"aggSchema":[],"schema":[{"name":"Id","type":"\"string\"","metadata":"{}"},{"name":"Sponsor","type":"\"string\"","metadata":"{}"},{"name":"Status","type":"\"string\"","metadata":"{}"},{"name":"Start","type":"\"string\"","metadata":"{}"},{"name":"Completion","type":"\"string\"","metadata":"{}"},{"name":"Type","type":"\"string\"","metadata":"{}"},{"name":"Submission","type":"\"string\"","metadata":"{}"},{"name":"Conditions","type":"\"string\"","metadata":"{}"},{"name":"Interventions","type":"\"string\"","metadata":"{}"}],"aggError":"","aggData":[],"addedWidgets":{},"metadata":{},"dbfsResultPath":null,"type":"table","aggOverflow":false,"aggSeriesLimitReached":false,"arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .table-result-container {\n    max-height: 300px;\n    overflow: auto;\n  }\n  table, th, td {\n    border: 1px solid black;\n    border-collapse: collapse;\n  }\n  th, td {\n    padding: 5px;\n  }\n  th {\n    text-align: left;\n  }\n</style><div class='table-result-container'><table class='table-result'><thead style='background-color: white'><tr><th>Id</th><th>Sponsor</th><th>Status</th><th>Start</th><th>Completion</th><th>Type</th><th>Submission</th><th>Conditions</th><th>Interventions</th></tr></thead><tbody><tr><td>NCT02758028</td><td>The University of Hong Kong</td><td>Recruiting</td><td>Aug 2005</td><td>Nov 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751957</td><td>Duke University</td><td>Completed</td><td>Jul 2016</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>Autistic Disorder,Autism Spectrum Disorder</td><td>null</td></tr><tr><td>NCT02758483</td><td>Universidade Federal do Rio de Janeiro</td><td>Completed</td><td>Mar 2017</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02759848</td><td>Istanbul Medeniyet University</td><td>Completed</td><td>Jan 2012</td><td>Dec 2014</td><td>Observational</td><td>May 2016</td><td>Tuberculosis,Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02758860</td><td>University of Roma La Sapienza</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Sep 2020</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Diverticular Diseases,Diverticulum,Diverticulosis</td><td>null</td></tr><tr><td>NCT02757209</td><td>Consorzio Futuro in Ricerca</td><td>Completed</td><td>Apr 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate</td></tr><tr><td>NCT02752438</td><td>Ankara University</td><td>Unknown status</td><td>May 2016</td><td>Jul 2017</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Hypoventilation</td><td>null</td></tr><tr><td>NCT02753543</td><td>Ruijin Hospital</td><td>Unknown status</td><td>Nov 2015</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>null</td></tr><tr><td>NCT02757508</td><td>Washington University School of Medicine</td><td>Completed</td><td>Mar 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Vitamins</td></tr><tr><td>NCT02753530</td><td>Orphazyme</td><td>Completed</td><td>Aug 2017</td><td>Jan 2021</td><td>Interventional</td><td>Apr 2016</td><td>Myositis</td><td>null</td></tr><tr><td>NCT02754817</td><td>Novo Nordisk A/S</td><td>Completed</td><td>Apr 2016</td><td>Oct 2016</td><td>Observational</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Liraglutide,Xultophy</td></tr><tr><td>NCT02759276</td><td>Daniel Alexandre Bottino</td><td>Completed</td><td>May 2015</td><td>Dec 2015</td><td>Observational</td><td>Apr 2016</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT02750956</td><td>Bulent Ecevit University</td><td>Completed</td><td>Jun 2015</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Periodontal Diseases</td><td>null</td></tr><tr><td>NCT02752113</td><td>Institut für Pharmakologie und Präventive Medizin</td><td>Completed</td><td>Apr 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Metformin,Empagliflozin,Linagliptin</td></tr><tr><td>NCT02752698</td><td>The Third Xiangya Hospital of Central South University</td><td>Active, not recruiting</td><td>Jan 2015</td><td>Dec 2021</td><td>Interventional</td><td>Jun 2015</td><td>Appendicitis,Stomach Ulcer,Cholecystolithiasis,Cholelithiasis,Gallstones</td><td>null</td></tr><tr><td>NCT02755779</td><td>Tel Aviv Medical Center</td><td>Unknown status</td><td>Jun 2016</td><td>Jun 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750384</td><td>Medicines for Malaria Venture</td><td>Terminated</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754609</td><td>James Cook University, Queensland, Australia</td><td>Completed</td><td>Sep 2016</td><td>Oct 2019</td><td>Interventional</td><td>Apr 2016</td><td>Hookworm Infections,Celiac Disease</td><td>null</td></tr><tr><td>NCT02755701</td><td>Soonchunhyang University Hospital</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Ascites</td><td>null</td></tr><tr><td>NCT02751762</td><td>Member Companies of the Opioid PMR Consortium</td><td>Recruiting</td><td>Nov 2017</td><td>Oct 2022</td><td>Observational</td><td>Apr 2016</td><td>Chronic Pain,Substance-Related Disorders,Opioid-Related Disorders,Narcotic-Related Disorders,Behavior</td><td>null</td></tr><tr><td>NCT02756299</td><td>Marmara University</td><td>Completed</td><td>Jun 2014</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Apnea Syndromes,Sleep Apnea</td><td>null</td></tr><tr><td>NCT02750709</td><td>Cycle Pharmaceuticals Ltd.</td><td>Completed</td><td>Oct 2015</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Tyrosinemias</td><td>Nitisinone</td></tr><tr><td>NCT02753907</td><td>Yonsei University</td><td>Completed</td><td>Jun 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755467</td><td>Cutera Inc.</td><td>Completed</td><td>May 2016</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hemangioma</td><td>null</td></tr><tr><td>NCT02755298</td><td>University of Zurich</td><td>Completed</td><td>Oct 2016</td><td>Nov 2020</td><td>Interventional</td><td>Mar 2016</td><td>Hypertension</td><td>Acetazolamide</td></tr><tr><td>NCT02759614</td><td>Guangdong Association of Clinical Trials</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2019</td><td>Interventional</td><td>Mar 2016</td><td>Carcinoma</td><td>Bevacizumab,Erlotinib Hydrochloride</td></tr><tr><td>NCT02752815</td><td>Ruijin Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Prednisone,Cyclophosphamide,Rituximab,Vincristine,Epirubicin</td></tr><tr><td>NCT02757131</td><td>The Cleveland Clinic</td><td>Completed</td><td>Jul 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Iatrogenic Disease</td><td>null</td></tr><tr><td>NCT02758704</td><td>St. Justine's Hospital</td><td>Completed</td><td>Oct 2015</td><td>Jun 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750501</td><td>Alcresta Therapeutics, Inc.</td><td>Completed</td><td>Jul 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02759913</td><td>Iron Horse Diagnostics, Inc.</td><td>Unknown status</td><td>Jan 2015</td><td>Dec 2016</td><td>Observational</td><td>Apr 2016</td><td>Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis</td><td>null</td></tr><tr><td>NCT02752724</td><td>VA Puget Sound Health Care System</td><td>Completed</td><td>Mar 2016</td><td>Apr 2018</td><td>Interventional</td><td>Mar 2016</td><td>Depressive Disorder,Depression</td><td>Ketamine,Methohexital</td></tr><tr><td>NCT02758444</td><td>University of Colorado, Denver</td><td>Completed</td><td>Nov 2015</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Micronutrients,Trace Elements</td></tr><tr><td>NCT02758067</td><td>H. Lundbeck A/S</td><td>Withdrawn</td><td>Jun 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Schizophrenia</td><td>Risperidone,Brexpiprazole</td></tr><tr><td>NCT02759341</td><td>Ospedale San Giovanni Bellinzona</td><td>Completed</td><td>Feb 2016</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Myocardial Infarction,Cardiomyopathies,Microvascular Angina,Takotsubo Cardiomyopathy,Syndrome,Infarction</td><td>null</td></tr><tr><td>NCT02753803</td><td>Dong-A ST Co., Ltd.</td><td>Completed</td><td>Jul 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Pioglitazone</td></tr><tr><td>NCT02752490</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759562</td><td>Gilead Sciences</td><td>Terminated</td><td>Nov 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02758262</td><td>Laval University</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hyperphagia</td><td>null</td></tr><tr><td>NCT02754258</td><td>Children's Hospital of Eastern Ontario</td><td>Unknown status</td><td>Jan 2017</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Methylphenidate</td></tr><tr><td>NCT02755207</td><td>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2020</td><td>Observational</td><td>Mar 2016</td><td>Acute Coronary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02759900</td><td>The Skin Center Dermatology Group</td><td>Recruiting</td><td>Jan 2016</td><td>Jan 2023</td><td>Interventional</td><td>Apr 2016</td><td>Molluscum Contagiosum,Keratosis,Bowens Disease,Rosacea,Skin Diseases</td><td>null</td></tr><tr><td>NCT02752581</td><td>Mert Özcan</td><td>Completed</td><td>Jan 2009</td><td>Apr 2013</td><td>Interventional</td><td>Apr 2016</td><td>Hemarthrosis</td><td>null</td></tr><tr><td>NCT02759796</td><td>Instituto de Investigación Hospital Universitario La Paz</td><td>Completed</td><td>Nov 2015</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Necrosis,Neovascularization,Fat Necrosis</td><td>null</td></tr><tr><td>NCT02754063</td><td>University Hospital, Grenoble</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Apr 2022</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Wounds and Injuries</td><td>3</td></tr><tr><td>NCT02750917</td><td>Foisor Orthopedics Clinical Hospital</td><td>Completed</td><td>Sep 2014</td><td>Mar 2015</td><td>Interventional</td><td>Feb 2016</td><td>Pain</td><td>Etoricoxib,Lornoxicam</td></tr><tr><td>NCT02753569</td><td>Institute of Cancer Research, United Kingdom</td><td>Completed</td><td>May 2016</td><td>May 2020</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751255</td><td>VU University Medical Center</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Mar 2022</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Tretinoin</td></tr><tr><td>NCT02751528</td><td>NantBioScience, Inc.</td><td>Unknown status</td><td>Dec 2016</td><td>Dec 2020</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Vaccines</td></tr><tr><td>NCT02751619</td><td>University of Campania Luigi Vanvitelli</td><td>Completed</td><td>Jan 2013</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Pain</td><td>Lidocaine</td></tr><tr><td>NCT02757833</td><td>Lawson Health Research Institute</td><td>Withdrawn</td><td>Feb 2019</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT02750761</td><td>Merck Sharp & Dohme Corp.</td><td>Completed</td><td>May 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Infections,Bacterial Infections,Gram-Positive Bacterial Infections</td><td>Tedizolid phosphate,Tedizolid,Oxazolidinones</td></tr><tr><td>NCT02752594</td><td>Sharda University</td><td>Completed</td><td>Apr 2015</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT02753452</td><td>Holland Bloorview Kids Rehabilitation Hospital</td><td>Unknown status</td><td>May 2015</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752763</td><td>Niğde State Hospital</td><td>Completed</td><td>Oct 2015</td><td>Mar 2016</td><td>Interventional</td><td>Mar 2016</td><td>Dry Eye Syndromes,Keratoconjunctivitis Sicca</td><td>Dextrans,Povidone,Ophthalmic Solutions,Lubricant Eye Drops</td></tr><tr><td>NCT02753816</td><td>Spectrum Health Hospitals</td><td>Terminated</td><td>Apr 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Burns</td><td>Tranexamic Acid</td></tr><tr><td>NCT02751294</td><td>GlaxoSmithKline</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Malaria</td><td>Tafenoquine</td></tr><tr><td>NCT02756429</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>Feb 2014</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02750163</td><td>Università Politecnica delle Marche</td><td>Completed</td><td>Jul 2017</td><td>Jun 2019</td><td>Observational</td><td>Apr 2016</td><td>Shock</td><td>Acetaminophen</td></tr><tr><td>NCT02751905</td><td>Biogen</td><td>Completed</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Neuralgia</td><td>null</td></tr><tr><td>NCT02753153</td><td>University of Liege</td><td>Completed</td><td>May 2011</td><td>May 2015</td><td>Interventional</td><td>Apr 2016</td><td>Tooth Loss</td><td>null</td></tr><tr><td>NCT02750891</td><td>Sumitomo Dainippon Pharma Co., Ltd.</td><td>Completed</td><td>Apr 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Glioblastoma,Glioma,Diffuse Intrinsic Pontine Glioma</td><td>null</td></tr><tr><td>NCT02751073</td><td>Mayo Clinic</td><td>Completed</td><td>Feb 2016</td><td>Jul 2018</td><td>Observational</td><td>Feb 2016</td><td>Infections,Communicable Diseases,Urinary Tract Infections,Prolapse,Pelvic Organ Prolapse</td><td>null</td></tr><tr><td>NCT02753114</td><td>University of British Columbia</td><td>Completed</td><td>Nov 2017</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Acute Pain</td><td>Ketamine</td></tr><tr><td>NCT02752516</td><td>Chia Tai Tianqing Pharmaceutical Group Co., Ltd.</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752269</td><td>Medical University of Graz</td><td>Completed</td><td>Oct 2014</td><td>Jun 2019</td><td>Observational</td><td>Nov 2015</td><td>Sjogrens Syndrome,Hypertension,Vascular Diseases,Syndrome</td><td>null</td></tr><tr><td>NCT02754713</td><td>Hippocration General Hospital</td><td>Recruiting</td><td>Sep 2009</td><td>Dec 2025</td><td>Observational</td><td>Apr 2016</td><td>Pericarditis</td><td>null</td></tr><tr><td>NCT02759770</td><td>Beijing Anzhen Hospital</td><td>Completed</td><td>Jul 2017</td><td>Sep 2017</td><td>Observational</td><td>Apr 2016</td><td>Respiratory Distress Syndrome,Acute Lung Injury</td><td>null</td></tr><tr><td>NCT02755129</td><td>Medtronic BRC</td><td>Completed</td><td>Sep 2016</td><td>Jul 2017</td><td>Interventional</td><td>Mar 2016</td><td>Frailty</td><td>null</td></tr><tr><td>NCT02754674</td><td>Samsung Medical Center</td><td>Completed</td><td>May 2014</td><td>Dec 2017</td><td>Interventional</td><td>Feb 2015</td><td>Rupture</td><td>null</td></tr><tr><td>NCT02757521</td><td>Washington University School of Medicine</td><td>Terminated</td><td>Mar 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Depression,Depressive Disorder,Bipolar Disorder</td><td>Nitrous Oxide</td></tr><tr><td>NCT02750774</td><td>University of Modena and Reggio Emilia</td><td>Unknown status</td><td>Dec 2015</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes,Obesity,Pregnancy Complications,Fetal Macrosomia,Overweight,Birth Weight</td><td>null</td></tr><tr><td>NCT02754739</td><td>Samsung Medical Center</td><td>Completed</td><td>Apr 2014</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus,Prediabetic State</td><td>Pravastatin</td></tr><tr><td>NCT02758808</td><td>University of Michigan</td><td>Recruiting</td><td>Mar 2016</td><td>Oct 2023</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02751840</td><td>Tel Hai College</td><td>Completed</td><td>Oct 2014</td><td>Apr 2016</td><td>Interventional</td><td>Apr 2016</td><td>Asymptomatic Diseases</td><td>Caffeine</td></tr><tr><td>NCT02752451</td><td>University of Arizona</td><td>Completed</td><td>Mar 2015</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757599</td><td>Rigshospitalet, Denmark</td><td>Completed</td><td>Aug 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753894</td><td>Astellas Pharma Inc</td><td>Completed</td><td>Jan 2008</td><td>Jun 2008</td><td>Interventional</td><td>Mar 2016</td><td>Kidney Diseases,Renal Insufficiency,Hyperphosphatemia</td><td>null</td></tr><tr><td>NCT02757638</td><td>Texas A&M University</td><td>Active, not recruiting</td><td>Oct 2015</td><td>Oct 2021</td><td>Interventional</td><td>Feb 2016</td><td>Weight Loss</td><td>null</td></tr><tr><td>NCT02757378</td><td>Kevin Farrell</td><td>Completed</td><td>May 2015</td><td>Sep 2015</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain,Low Back Pain</td><td>null</td></tr><tr><td>NCT02751489</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02759315</td><td>Merck Sharp & Dohme Corp.</td><td>Terminated</td><td>May 2016</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis</td><td>Uprifosbuvir,Ruzasvir</td></tr><tr><td>NCT02754895</td><td>Massachusetts General Hospital</td><td>Completed</td><td>Oct 2014</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Acute Coronary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02750475</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>Sunscreening Agents</td></tr><tr><td>NCT02755064</td><td>Adil Bharucha</td><td>Completed</td><td>Jun 2010</td><td>Nov 2013</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Erythromycin,Erythromycin Estolate,Erythromycin Ethylsuccinate,Erythromycin stearate,Erythromycin lactobionate</td></tr><tr><td>NCT02758002</td><td>University of California, San Diego</td><td>Withdrawn</td><td>Jan 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02755142</td><td>medac GmbH</td><td>Completed</td><td>Feb 2000</td><td>Jun 2001</td><td>Interventional</td><td>Apr 2016</td><td>Glioma,Brain Neoplasms</td><td>Aminolevulinic Acid</td></tr><tr><td>NCT02756364</td><td>Millennium Pharmaceuticals, Inc.</td><td>Completed</td><td>Jul 2016</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Fulvestrant</td></tr><tr><td>NCT02759484</td><td>Rush University Medical Center</td><td>Unknown status</td><td>Mar 2015</td><td>Mar 2019</td><td>Interventional</td><td>Dec 2015</td><td>Hypertension,Diabetes Mellitus,Hyperglycemia</td><td>null</td></tr><tr><td>NCT02752061</td><td>Harvard School of Public Health (HSPH)</td><td>Completed</td><td>May 2016</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756598</td><td>Aarhus University Hospital</td><td>Completed</td><td>Jan 2015</td><td>Jun 2018</td><td>Interventional</td><td>Dec 2015</td><td>null</td><td>Sufentanil,Dsuvia,Propofol</td></tr><tr><td>NCT02755727</td><td>Royal Devon and Exeter NHS Foundation Trust</td><td>Completed</td><td>Mar 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Tennis Elbow</td><td>null</td></tr><tr><td>NCT02754882</td><td>Samsung Bioepis Co., Ltd.</td><td>Completed</td><td>Jul 2016</td><td>Oct 2018</td><td>Interventional</td><td>Mar 2016</td><td>Lung Neoplasms,Carcinoma</td><td>Paclitaxel,Bevacizumab,Carboplatin</td></tr><tr><td>NCT02754778</td><td>Martin-Luther-Universität Halle-Wittenberg</td><td>Completed</td><td>Apr 2016</td><td>Mar 2021</td><td>Interventional</td><td>Apr 2016</td><td>Pre-Eclampsia,HELLP Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02758171</td><td>Boehringer Ingelheim</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Empagliflozin,Linagliptin</td></tr><tr><td>NCT02755376</td><td>Samsung Medical Center</td><td>Completed</td><td>Jan 2014</td><td>Dec 2018</td><td>Interventional</td><td>Feb 2015</td><td>null</td><td>Hyaluronic Acid</td></tr><tr><td>NCT02759016</td><td>Boehringer Ingelheim</td><td>Completed</td><td>Jun 2016</td><td>Jul 2019</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>BI 836826</td></tr><tr><td>NCT02758457</td><td>University of Bologna</td><td>Completed</td><td>Jan 2008</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755519</td><td>Chongqing Medical University</td><td>Completed</td><td>May 2014</td><td>Oct 2016</td><td>Observational</td><td>Apr 2016</td><td>Hyperaldosteronism</td><td>null</td></tr><tr><td>NCT02758782</td><td>Charite University, Berlin, Germany</td><td>Completed</td><td>Sep 2016</td><td>Jan 2021</td><td>Interventional</td><td>Apr 2016</td><td>Spondylitis</td><td>Celecoxib,Golimumab</td></tr><tr><td>NCT02756806</td><td>Cutera Inc.</td><td>Completed</td><td>Apr 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756156</td><td>Kahramanmaras Sutcu Imam University</td><td>Unknown status</td><td>Apr 2016</td><td>Aug 2016</td><td>Observational</td><td>Mar 2016</td><td>Humeral Fractures</td><td>null</td></tr><tr><td>NCT02759458</td><td>Rush University Medical Center</td><td>Completed</td><td>Nov 2013</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Rotator Cuff Injuries</td><td>null</td></tr><tr><td>NCT02750982</td><td>Brown, Theodore R., M.D., MPH</td><td>Completed</td><td>Jul 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease,Multiple Sclerosis,Alzheimer Disease,Brain Injuries,Spinal Cord Injuries,Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Huntington Disease,Sclerosis,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02751502</td><td>NYU Langone Health</td><td>Terminated</td><td>Jan 2017</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Hemiplegia</td><td>null</td></tr><tr><td>NCT02752087</td><td>Eli Lilly and Company</td><td>Completed</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756858</td><td>Anavex Life Sciences Corp.</td><td>Completed</td><td>Mar 2016</td><td>Nov 2020</td><td>Interventional</td><td>Mar 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02758249</td><td>Konkuk University Medical Center</td><td>Completed</td><td>Jan 2016</td><td>Jan 2016</td><td>Interventional</td><td>Feb 2016</td><td>null</td><td>Propofol,Sevoflurane</td></tr><tr><td>NCT02754570</td><td>University of Colorado, Denver</td><td>Completed</td><td>Jul 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Glaucoma,Ocular Hypertension,Hypertension</td><td>Pilocarpine</td></tr><tr><td>NCT02754102</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>Sunscreening Agents</td></tr><tr><td>NCT02751593</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>Jan 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Thrombocytopenia,Purpura</td><td>Dexamethasone</td></tr><tr><td>NCT02757014</td><td>Bayer</td><td>Completed</td><td>Oct 2015</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753062</td><td>Asan Medical Center</td><td>Recruiting</td><td>Aug 2015</td><td>Aug 2023</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Rituximab,Bendamustine Hydrochloride</td></tr><tr><td>NCT02752425</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>May 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Speech Disorders</td><td>null</td></tr><tr><td>NCT02757300</td><td>Marienhospital Osnabrück</td><td>Unknown status</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Pharyngitis</td><td>null</td></tr><tr><td>NCT02754180</td><td>Peking Union Medical College Hospital</td><td>Unknown status</td><td>Mar 2016</td><td>Mar 2021</td><td>Interventional</td><td>Apr 2016</td><td>Adenocarcinoma,Pancreatic Neoplasms</td><td>Gemcitabine</td></tr><tr><td>NCT02752321</td><td>Northwell Health</td><td>Terminated</td><td>Aug 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753595</td><td>Eisai Inc.</td><td>Terminated</td><td>Jul 2016</td><td>Aug 2019</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02755246</td><td>Charite University, Berlin, Germany</td><td>Completed</td><td>Apr 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02754115</td><td>Tata Memorial Centre</td><td>Recruiting</td><td>Apr 2016</td><td>Jan 2022</td><td>Observational</td><td>Mar 2016</td><td>Peritoneal Diseases</td><td>null</td></tr><tr><td>NCT02756897</td><td>M.D. Anderson Cancer Center</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Jul 2024</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma,Leukemia</td><td>Venetoclax</td></tr><tr><td>NCT02752334</td><td>Magrabi Eye & Ear Hospital</td><td>Completed</td><td>Sep 2015</td><td>Mar 2019</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Magnesium Sulfate,Bupivacaine</td></tr><tr><td>NCT02754791</td><td>Shaare Zedek Medical Center</td><td>Unknown status</td><td>May 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754128</td><td>Holland Bloorview Kids Rehabilitation Hospital</td><td>Completed</td><td>Jun 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cerebral Palsy</td><td>null</td></tr><tr><td>NCT02751190</td><td>Umeå University</td><td>Completed</td><td>Sep 2013</td><td>Feb 2017</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Chronic Pain,Hernia</td><td>null</td></tr><tr><td>NCT02751645</td><td>Oregon Health and Science University</td><td>Unknown status</td><td>Jun 2016</td><td>May 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758184</td><td>Duke University</td><td>Terminated</td><td>Jun 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751892</td><td>University of East Anglia</td><td>Completed</td><td>Oct 2013</td><td>Sep 2014</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT02755324</td><td>Leiden University</td><td>Completed</td><td>Oct 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Schistosomiasis</td><td>null</td></tr><tr><td>NCT02758886</td><td>Washington State University</td><td>Completed</td><td>Apr 2014</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Stress</td><td>null</td></tr><tr><td>NCT02750072</td><td>Fraser Orthopaedic Research Society</td><td>Active, not recruiting</td><td>Sep 2016</td><td>Apr 2023</td><td>Interventional</td><td>Apr 2016</td><td>Patellofemoral Pain Syndrome,Fractures,Tibial Fractures</td><td>null</td></tr><tr><td>NCT02750332</td><td>Cycle Pharmaceuticals Ltd.</td><td>Completed</td><td>Nov 2015</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Tyrosinemias</td><td>Nitisinone</td></tr><tr><td>NCT02752529</td><td>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</td><td>Unknown status</td><td>Mar 2016</td><td>null</td><td>Interventional</td><td>Mar 2016</td><td>Liver Cirrhosis</td><td>Tacrolimus</td></tr><tr><td>NCT02759939</td><td>Dartmouth-Hitchcock Medical Center</td><td>Completed</td><td>Jul 2016</td><td>Jul 2017</td><td>Interventional</td><td>Feb 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757157</td><td>European Respiratory Society</td><td>Terminated</td><td>Oct 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02759627</td><td>Istanbul University</td><td>Completed</td><td>Nov 2014</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02752412</td><td>Sanofi</td><td>Completed</td><td>May 2016</td><td>Oct 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Insulin,Metformin,Insulin Glargine,Lixisenatide</td></tr><tr><td>NCT02756988</td><td>Bayer</td><td>Completed</td><td>Oct 2015</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751203</td><td>Lara McKenzie</td><td>Completed</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753946</td><td>Nabriva Therapeutics AG</td><td>Completed</td><td>Apr 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Infections,Communicable Diseases,Urinary Tract Infections,Pyelonephritis</td><td>Tazobactam,Piperacillin,Fosfomycin</td></tr><tr><td>NCT02755480</td><td>University Health Network, Toronto</td><td>Terminated</td><td>Feb 2015</td><td>Feb 2017</td><td>Interventional</td><td>Mar 2015</td><td>null</td><td>null</td></tr><tr><td>NCT02753257</td><td>Valtari Bio</td><td>Unknown status</td><td>Sep 2016</td><td>Dec 2019</td><td>Observational</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02758691</td><td>Virginia Polytechnic Institute and State University</td><td>Completed</td><td>Dec 2015</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Insulin</td></tr><tr><td>NCT02755623</td><td>Centre hospitalier de Ville-Evrard, France</td><td>Unknown status</td><td>May 2015</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Hallucinations,Schizophrenia</td><td>null</td></tr><tr><td>NCT02756234</td><td>Lancaster General Hospital</td><td>Completed</td><td>May 2016</td><td>Aug 2018</td><td>Observational</td><td>Apr 2016</td><td>Coronary Artery Disease</td><td>null</td></tr><tr><td>NCT02756091</td><td>University Hospital Inselspital, Berne</td><td>Recruiting</td><td>Aug 2016</td><td>May 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Cerebrovascular Disorders</td><td>null</td></tr><tr><td>NCT02753491</td><td>Marmara University</td><td>Completed</td><td>Oct 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752737</td><td>Medtronic Cardiac Rhythm and Heart Failure</td><td>Recruiting</td><td>May 2016</td><td>Dec 2024</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02758925</td><td>University Hospital, Caen</td><td>Unknown status</td><td>Jun 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Cytarabine,Rituximab,Bendamustine Hydrochloride</td></tr><tr><td>NCT02751723</td><td>Florian Lordick, MD</td><td>Unknown status</td><td>Sep 2014</td><td>Oct 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751931</td><td>Astellas Pharma Europe B.V.</td><td>Completed</td><td>Jun 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Bladder</td><td>Mirabegron</td></tr><tr><td>NCT02758847</td><td>Rabih A. Chaer</td><td>Recruiting</td><td>Sep 2016</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Ischemia</td><td>Paclitaxel,Albumin-Bound Paclitaxel</td></tr><tr><td>NCT02757807</td><td>Eco Fusion</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Erectile Dysfunction</td><td>null</td></tr><tr><td>NCT02755220</td><td>Shanghai Cingularbio Co. Ltd</td><td>Completed</td><td>Jan 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758548</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>May 2016</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756845</td><td>Amgen</td><td>Recruiting</td><td>Aug 2017</td><td>Jun 2024</td><td>Interventional</td><td>Dec 2015</td><td>Neoplasms</td><td>Talimogene laherparepvec</td></tr><tr><td>NCT02750605</td><td>Skane University Hospital</td><td>Active, not recruiting</td><td>Feb 2016</td><td>Dec 2021</td><td>Interventional</td><td>Jan 2016</td><td>Vascular Diseases,Peripheral Vascular Diseases,Peripheral Arterial Disease,Ischemia</td><td>null</td></tr><tr><td>NCT02756702</td><td>Aesculap AG</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Dec 2022</td><td>Observational</td><td>Apr 2016</td><td>Osteoarthritis</td><td>null</td></tr><tr><td>NCT02752945</td><td>King's College London</td><td>Completed</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder,Anxiety Disorders</td><td>null</td></tr><tr><td>NCT02759952</td><td>STZ eyetrial</td><td>Enrolling by invitation</td><td>Jan 2013</td><td>Dec 2025</td><td>Observational</td><td>Apr 2016</td><td>Retinitis,Retinitis Pigmentosa</td><td>null</td></tr><tr><td>NCT02754661</td><td>Medtronic - MITG</td><td>Completed</td><td>Sep 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT02755441</td><td>Nils Hoyer</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2024</td><td>Observational</td><td>Apr 2016</td><td>Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02750098</td><td>Sheba Medical Center</td><td>Unknown status</td><td>May 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02753179</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Vestibular Diseases</td><td>null</td></tr><tr><td>NCT02758509</td><td>Parc de Salut Mar</td><td>Completed</td><td>Jan 2010</td><td>Oct 2017</td><td>Observational</td><td>Apr 2016</td><td>Hepatitis C,Hepatitis</td><td>Interferons,Ritonavir,Ribavirin,Interferon-alpha,Interferon alpha-2,Sofosbuvir,Peginterferon alfa-2a,Ledipasvir,Simeprevir</td></tr><tr><td>NCT02751970</td><td>Universidad de Valparaiso</td><td>Unknown status</td><td>Apr 2014</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT02753712</td><td>Mundipharma Research Limited</td><td>Completed</td><td>Jun 2016</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Fluticasone,Xhance,Formoterol Fumarate</td></tr><tr><td>NCT02751151</td><td>Inova Health Care Services</td><td>Completed</td><td>Feb 2016</td><td>May 2021</td><td>Interventional</td><td>Mar 2016</td><td>Skin Neoplasms</td><td>Aminolevulinic Acid</td></tr><tr><td>NCT02757716</td><td>Sana Klinikum Offenbach</td><td>Completed</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Behavior</td><td>null</td></tr><tr><td>NCT02758652</td><td>Tampere University Hospital</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2026</td><td>Observational</td><td>Apr 2016</td><td>Ovarian Neoplasms,Carcinoma</td><td>null</td></tr><tr><td>NCT02754206</td><td>Southern Methodist University</td><td>Terminated</td><td>Jan 2016</td><td>Sep 2021</td><td>Observational</td><td>Apr 2016</td><td>Post-Concussion Syndrome,Brain Concussion</td><td>null</td></tr><tr><td>NCT02752243</td><td>Peter Bader</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Mar 2022</td><td>Interventional</td><td>Mar 2016</td><td>Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome,Acute Disease</td><td>null</td></tr><tr><td>NCT02754856</td><td>M.D. Anderson Cancer Center</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Jul 2021</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>Durvalumab,Ipilimumab,Tremelimumab,Immunoglobulins,Antibodies,Immunoglobulin G</td></tr><tr><td>NCT02759861</td><td>University of Nebraska</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Aug 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis</td><td>Sofosbuvir,Ledipasvir</td></tr><tr><td>NCT02759679</td><td>Haukeland University Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2019</td><td>Interventional</td><td>Mar 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02752932</td><td>Lawson Health Research Institute</td><td>Completed</td><td>Nov 2015</td><td>Oct 2017</td><td>Interventional</td><td>Feb 2016</td><td>Carcinoma,Squamous Cell Carcinoma of Head and Neck,Neoplasms</td><td>null</td></tr><tr><td>NCT02759445</td><td>RWTH Aachen University</td><td>Unknown status</td><td>Apr 2016</td><td>Oct 2016</td><td>Observational</td><td>Nov 2015</td><td>null</td><td>null</td></tr><tr><td>NCT02754622</td><td>Guy's and St Thomas' NHS Foundation Trust</td><td>Completed</td><td>Jul 2016</td><td>Dec 2016</td><td>Observational</td><td>Apr 2016</td><td>Critical Illness</td><td>null</td></tr><tr><td>NCT02756611</td><td>AbbVie</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Sep 2022</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Venetoclax</td></tr><tr><td>NCT02758223</td><td>Wuerzburg University Hospital</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Jun 2021</td><td>Interventional</td><td>Feb 2016</td><td>Leukemia,Myelodysplastic Syndromes</td><td>null</td></tr><tr><td>NCT02757079</td><td>Nobelpharma</td><td>Completed</td><td>Jun 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Wake Disorders,Parasomnias,Disease,Neurodevelopmental Disorders</td><td>Melatonin</td></tr><tr><td>NCT02754219</td><td>Dong-A ST Co., Ltd.</td><td>Completed</td><td>Sep 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Liver Diseases</td><td>null</td></tr><tr><td>NCT02753101</td><td>Stanford University</td><td>Completed</td><td>Feb 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Sciatica</td><td>null</td></tr><tr><td>NCT02759003</td><td>Fondazione Salvatore Maugeri</td><td>Completed</td><td>Mar 2011</td><td>Mar 2014</td><td>Interventional</td><td>Apr 2016</td><td>Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis</td><td>null</td></tr><tr><td>NCT02752659</td><td>University of British Columbia</td><td>Completed</td><td>Jun 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Lymphedema</td><td>null</td></tr><tr><td>NCT02758912</td><td>Burnasyan Federal Medical Biophysical Center</td><td>Completed</td><td>Nov 2016</td><td>Oct 2019</td><td>Interventional</td><td>Apr 2016</td><td>Stroke,Angina Pectoris,Infarction,Hemorrhage</td><td>null</td></tr><tr><td>NCT02754388</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Feb 2016</td><td>Dec 2019</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02759666</td><td>Atridia Pty Ltd.</td><td>Completed</td><td>Jun 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02750241</td><td>The University of Texas Medical Branch, Galveston</td><td>Completed</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02752568</td><td>Kasr El Aini Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758015</td><td>University of California, San Francisco</td><td>Completed</td><td>Jun 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Betaine</td></tr><tr><td>NCT02756884</td><td>Arkansas Heart Hospital</td><td>Completed</td><td>Jun 2015</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Peripheral Arterial Disease,Peripheral Vascular Diseases</td><td>null</td></tr><tr><td>NCT02758353</td><td>JSI Research & Training Institute, Inc.</td><td>Completed</td><td>Apr 2015</td><td>Nov 2015</td><td>Interventional</td><td>Apr 2016</td><td>Malaria,Stillbirth</td><td>null</td></tr><tr><td>NCT02753751</td><td>Yale University</td><td>Completed</td><td>Mar 2018</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Acute Kidney Injury,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02757170</td><td>All India Institute of Medical Sciences, New Delhi</td><td>Unknown status</td><td>Jul 2015</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Liver Failure,Hepatic Insufficiency,End Stage Liver Disease,Acute-On-Chronic Liver Failure</td><td>null</td></tr><tr><td>NCT02757625</td><td>Pfizer</td><td>Completed</td><td>Jul 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Dexmedetomidine</td></tr><tr><td>NCT02752347</td><td>Riyadh Colleges of Dentistry and Pharmacy</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Malocclusion</td><td>null</td></tr><tr><td>NCT02756468</td><td>University of Roma La Sapienza</td><td>Unknown status</td><td>Jan 2015</td><td>Dec 2016</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Pancreatic Neoplasms</td><td>null</td></tr><tr><td>NCT02750410</td><td>Eli Lilly and Company</td><td>Completed</td><td>Aug 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Dulaglutide</td></tr><tr><td>NCT02755389</td><td>Nova Scotia Health Authority</td><td>Completed</td><td>Sep 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Apnea</td><td>null</td></tr><tr><td>NCT02755168</td><td>Assiut University</td><td>Unknown status</td><td>May 2017</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751567</td><td>Bayer</td><td>Withdrawn</td><td>May 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02755558</td><td>Penn State University</td><td>Completed</td><td>Sep 2014</td><td>May 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757547</td><td>Electrical Geodesics, Inc.</td><td>Terminated</td><td>Sep 2015</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Epilepsy</td><td>null</td></tr><tr><td>NCT02752828</td><td>Sanofi</td><td>Completed</td><td>May 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Insulin,Insulin Glargine,Lixisenatide,Hypoglycemic Agents</td></tr><tr><td>NCT02756715</td><td>Konkuk University Medical Center</td><td>Completed</td><td>May 2016</td><td>Feb 2020</td><td>Interventional</td><td>Apr 2016</td><td>Vascular System Injuries,Ischemia</td><td>Propofol,Desflurane</td></tr><tr><td>NCT02756117</td><td>Vanderbilt University</td><td>Completed</td><td>May 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Prediabetic State</td><td>null</td></tr><tr><td>NCT02753205</td><td>Gachon University Gil Medical Center</td><td>Withdrawn</td><td>Apr 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Intracranial Hypertension</td><td>Dexmedetomidine</td></tr><tr><td>NCT02756221</td><td>Tel Hai College</td><td>Completed</td><td>Mar 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Respiratory Tract Infections,Gastroenteritis</td><td>null</td></tr><tr><td>NCT02755675</td><td>Rigshospitalet, Denmark</td><td>Recruiting</td><td>Apr 2016</td><td>Oct 2023</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Lung Neoplasms,Mesothelioma</td><td>null</td></tr><tr><td>NCT02754037</td><td>University of California, Davis</td><td>Recruiting</td><td>Apr 2016</td><td>Jun 2024</td><td>Observational</td><td>Apr 2016</td><td>Liver Diseases,Fatty Liver,Non-alcoholic Fatty Liver Disease,Inflammation</td><td>Fluorodeoxyglucose F18</td></tr><tr><td>NCT02750306</td><td>Merck Sharp & Dohme Corp.</td><td>Completed</td><td>May 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Alzheimer Disease,Sleep Initiation and Maintenance Disorders</td><td>Suvorexant</td></tr><tr><td>NCT02756403</td><td>Medstar Health Research Institute</td><td>Completed</td><td>Mar 2016</td><td>Jul 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Azithromycin,Metronidazole,Doxycycline</td></tr><tr><td>NCT02759653</td><td>Haukeland University Hospital</td><td>Completed</td><td>May 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Stroke,Ischemic Stroke,Carotid Artery Diseases,Embolic Stroke</td><td>null</td></tr><tr><td>NCT02753920</td><td>Northwell Health</td><td>Completed</td><td>Mar 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Prolapse</td><td>null</td></tr><tr><td>NCT02759367</td><td>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</td><td>Completed</td><td>Mar 2008</td><td>Jun 2015</td><td>Interventional</td><td>Dec 2015</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT02752997</td><td>Mayo Clinic</td><td>Completed</td><td>Dec 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02750059</td><td>South East Asia Research Collaboration with Hawaii</td><td>Completed</td><td>Jan 2015</td><td>Feb 2018</td><td>Interventional</td><td>May 2015</td><td>Infections,Communicable Diseases,HIV Infections,Acquired Immunodeficiency Syndrome</td><td>Tenofovir,Lamivudine,Efavirenz,Telmisartan</td></tr><tr><td>NCT02754505</td><td>Danube Hospital</td><td>Completed</td><td>Feb 2008</td><td>Dec 2011</td><td>Interventional</td><td>Mar 2016</td><td>Critical Illness</td><td>null</td></tr><tr><td>NCT02751736</td><td>Seoul National University Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Rectal Neoplasms</td><td>null</td></tr><tr><td>NCT02750930</td><td>GlaxoSmithKline</td><td>Terminated</td><td>Oct 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>rGLP-1 protein</td></tr><tr><td>NCT02753582</td><td>Indonesia University</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Frailty</td><td>null</td></tr><tr><td>NCT02750722</td><td>University of Zurich</td><td>Completed</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02756793</td><td>Lawson Health Research Institute</td><td>Active, not recruiting</td><td>Oct 2016</td><td>Jun 2026</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasm Metastasis,Neoplasms</td><td>null</td></tr><tr><td>NCT02750436</td><td>Montreal General Hospital</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain</td><td>null</td></tr><tr><td>NCT02755922</td><td>Instituto Mexicano del Seguro Social</td><td>Completed</td><td>Apr 2010</td><td>Dec 2010</td><td>Interventional</td><td>Apr 2016</td><td>Mandibular Fractures</td><td>null</td></tr><tr><td>NCT02755493</td><td>Brigham and Women's Hospital</td><td>Completed</td><td>Apr 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Deprivation</td><td>null</td></tr><tr><td>NCT02750397</td><td>Massachusetts General Hospital</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Dec 2024</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753621</td><td>Johns Hopkins University</td><td>Completed</td><td>Dec 2015</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease</td><td>null</td></tr><tr><td>NCT02754154</td><td>Bristol-Myers Squibb</td><td>Unknown status</td><td>Dec 2014</td><td>Feb 2019</td><td>Observational</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>Warfarin,Rivaroxaban,Dabigatran,Apixaban</td></tr><tr><td>NCT02753049</td><td>New York University</td><td>Unknown status</td><td>Nov 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>HIV Infections,Acquired Immunodeficiency Syndrome</td><td>null</td></tr><tr><td>NCT02750813</td><td>Alcon, a Novartis Company</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Refractive Errors</td><td>null</td></tr><tr><td>NCT02756975</td><td>Modarres Hospital</td><td>Completed</td><td>Dec 2014</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759601</td><td>Queen Mary University of London</td><td>Unknown status</td><td>Jan 2013</td><td>Dec 2018</td><td>Interventional</td><td>Oct 2014</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02757326</td><td>RedHill Biopharma Limited</td><td>Terminated</td><td>Dec 2016</td><td>May 2019</td><td>Interventional</td><td>Mar 2016</td><td>Multiple Myeloma,Neoplasms</td><td>null</td></tr><tr><td>NCT02758236</td><td>Ina-Respond</td><td>Active, not recruiting</td><td>Feb 2017</td><td>Dec 2021</td><td>Observational</td><td>Apr 2016</td><td>Tuberculosis</td><td>null</td></tr><tr><td>NCT02754804</td><td>University Hospital, Angers</td><td>Completed</td><td>Jul 2016</td><td>Mar 2020</td><td>Observational</td><td>Apr 2016</td><td>Peripheral Arterial Disease</td><td>null</td></tr><tr><td>NCT02756065</td><td>Washington University Early Recognition Center</td><td>Completed</td><td>Sep 2014</td><td>Aug 2019</td><td>Observational</td><td>Jun 2015</td><td>Schizophrenia,Bipolar Disorder</td><td>null</td></tr><tr><td>NCT02756247</td><td>Memorial Sloan Kettering Cancer Center</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>null</td></tr><tr><td>NCT02755857</td><td>Mayne Pharma International Pty Ltd</td><td>Completed</td><td>Jul 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Neutropenia</td><td>Itraconazole</td></tr><tr><td>NCT02750111</td><td>Dr. Orit Hamiel</td><td>Unknown status</td><td>May 2016</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02755948</td><td>Imperial College London</td><td>Recruiting</td><td>Apr 2012</td><td>Mar 2023</td><td>Interventional</td><td>Apr 2016</td><td>Influenza,Virus Diseases,Respiratory Syncytial Virus Infections</td><td>null</td></tr><tr><td>NCT02754089</td><td>Shiraz University of Medical Sciences</td><td>Completed</td><td>May 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Body Weight</td><td>null</td></tr><tr><td>NCT02756169</td><td>Universidad Iberoamericana A.C., Mexico</td><td>Completed</td><td>Jul 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Obesity</td><td>null</td></tr><tr><td>NCT02757664</td><td>Federal University of São Paulo</td><td>Completed</td><td>Feb 2017</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Tendinopathy</td><td>null</td></tr><tr><td>NCT02757989</td><td>Groupe Francophone des Myelodysplasies</td><td>Active, not recruiting</td><td>May 2016</td><td>Jun 2024</td><td>Interventional</td><td>Mar 2016</td><td>Preleukemia,Myelodysplastic Syndromes</td><td>null</td></tr><tr><td>NCT02755038</td><td>Bnai Zion Medical Center</td><td>Unknown status</td><td>Mar 2016</td><td>Mar 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759354</td><td>MCM Vaccines B.V.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis B,Whooping Cough,Hepatitis</td><td>null</td></tr><tr><td>NCT02750254</td><td>Washington University School of Medicine</td><td>Terminated</td><td>Jun 2016</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Myelodysplastic Syndromes</td><td>Plerixafor,Cyclophosphamide,Melphalan,Busulfan,Fludarabine,Azacitidine,Lenograstim,Sargramostim</td></tr><tr><td>NCT02755025</td><td>Mayo Clinic</td><td>Completed</td><td>Jul 2016</td><td>Aug 2016</td><td>Observational</td><td>Mar 2016</td><td>Sepsis</td><td>null</td></tr><tr><td>NCT02757703</td><td>Kaohsiung Veterans General Hospital.</td><td>Completed</td><td>May 2010</td><td>Jan 2015</td><td>Interventional</td><td>Apr 2016</td><td>Hemorrhage</td><td>Terlipressin,Pantoprazole,Somatostatin</td></tr><tr><td>NCT02758899</td><td>Washington University School of Medicine</td><td>Terminated</td><td>Mar 2014</td><td>Aug 2016</td><td>Observational</td><td>Apr 2016</td><td>Spondylosis,Spinal Cord Diseases,Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02751450</td><td>GlaxoSmithKline</td><td>Completed</td><td>Feb 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dentin Sensitivity,Hypersensitivity</td><td>Fluorides,Tin Fluorides,Fluorophosphate</td></tr><tr><td>NCT02759497</td><td>Tanta University</td><td>Unknown status</td><td>Mar 2016</td><td>Nov 2020</td><td>Observational</td><td>May 2016</td><td>Peritonitis</td><td>null</td></tr><tr><td>NCT02750826</td><td>Alliance for Clinical Trials in Oncology</td><td>Active, not recruiting</td><td>Aug 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Weight Loss</td><td>null</td></tr><tr><td>NCT02750631</td><td>New York State Psychiatric Institute</td><td>Completed</td><td>Apr 2014</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT02756182</td><td>Laborie Medical Technologies Inc.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754583</td><td>University of California, San Francisco</td><td>Recruiting</td><td>Dec 2015</td><td>Aug 2024</td><td>Interventional</td><td>Oct 2015</td><td>Trachoma</td><td>Azithromycin,Tetracycline</td></tr><tr><td>NCT02750020</td><td>The University of Hong Kong</td><td>Completed</td><td>Feb 2016</td><td>Sep 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759978</td><td>University Medical Center Groningen</td><td>Recruiting</td><td>May 2016</td><td>May 2023</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Endocarditis</td><td>null</td></tr><tr><td>NCT02759575</td><td>Vinita Takiar</td><td>Completed</td><td>Apr 2016</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Squamous Cell Carcinoma of Head and Neck</td><td>Pembrolizumab</td></tr><tr><td>NCT02750878</td><td>Boston Urogynecology Associates</td><td>Unknown status</td><td>Nov 2015</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Incontinence,Enuresis</td><td>null</td></tr><tr><td>NCT02758600</td><td>Federal University of São Paulo</td><td>Unknown status</td><td>Mar 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Myocardial Infarction,Infarction</td><td>null</td></tr><tr><td>NCT02750657</td><td>University Health Network, Toronto</td><td>Active, not recruiting</td><td>Dec 2015</td><td>Dec 2021</td><td>Observational</td><td>Jan 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02750007</td><td>Jiangsu Hansoh Pharmaceutical Co., Ltd.</td><td>Unknown status</td><td>Dec 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02750462</td><td>University Hospital Schleswig-Holstein</td><td>Completed</td><td>Nov 2016</td><td>Sep 2019</td><td>Interventional</td><td>Apr 2016</td><td>Heart Arrest,Out-of-Hospital Cardiac Arrest</td><td>null</td></tr><tr><td>NCT02755597</td><td>AbbVie</td><td>Suspended</td><td>Jul 2016</td><td>Feb 2022</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Dexamethasone,Bortezomib,Venetoclax</td></tr><tr><td>NCT02754232</td><td>Odense University Hospital</td><td>Withdrawn</td><td>Aug 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Pulmonary Disease,Chronic Disease</td><td>null</td></tr><tr><td>NCT02751515</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02758080</td><td>Seoul National University Hospital</td><td>Unknown status</td><td>Jan 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Hematologic Neoplasms</td><td>null</td></tr><tr><td>NCT02756312</td><td>Beijing Tiantan Hospital</td><td>Not yet recruiting</td><td>Oct 2020</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Glioma</td><td>Anesthetics</td></tr><tr><td>NCT02759107</td><td>Eli Lilly and Company</td><td>Completed</td><td>May 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Dulaglutide,Tirzepatide</td></tr><tr><td>NCT02758795</td><td>University of Limerick</td><td>Completed</td><td>Feb 2016</td><td>Apr 2017</td><td>Interventional</td><td>Feb 2016</td><td>Inflammation</td><td>null</td></tr><tr><td>NCT02757859</td><td>Sidney Kimmel Cancer Center at Thomas Jefferson University</td><td>Recruiting</td><td>Apr 2016</td><td>Jan 2022</td><td>Interventional</td><td>Apr 2016</td><td>Adenocarcinoma,Cholangiocarcinoma,Carcinoma,Pancreatic Intraductal Neoplasms</td><td>Pancrelipase,Pancreatin</td></tr><tr><td>NCT02750800</td><td>AbbVie</td><td>Completed</td><td>Apr 2016</td><td>Apr 2018</td><td>Observational</td><td>Apr 2016</td><td>Spondylitis,Arthritis,Crohn Disease,Colitis,Inflammatory Bowel Diseases,Psoriasis</td><td>Adalimumab</td></tr><tr><td>NCT02754167</td><td>Pieris Pharmaceuticals GmbH</td><td>Unknown status</td><td>Jun 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02758379</td><td>Shockwave Medical, Inc.</td><td>Completed</td><td>Jul 2014</td><td>Mar 2016</td><td>Interventional</td><td>Jan 2015</td><td>Coronary Stenosis</td><td>null</td></tr><tr><td>NCT02755740</td><td>The University of Hong Kong</td><td>Completed</td><td>Jul 2015</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751008</td><td>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</td><td>Completed</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Osteoporosis</td><td>null</td></tr><tr><td>NCT02756390</td><td>Dana-Farber Cancer Institute</td><td>Completed</td><td>Dec 2015</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Initiation and Maintenance Disorders</td><td>null</td></tr><tr><td>NCT02753075</td><td>GlaxoSmithKline</td><td>Completed</td><td>Sep 2015</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Dentin Sensitivity,Hypersensitivity</td><td>Fluorides</td></tr><tr><td>NCT02753465</td><td>Fudan University</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Rectal Neoplasms</td><td>null</td></tr><tr><td>NCT02750852</td><td>Azienda Ospedaliera Bolognini di Seriate Bergamo</td><td>Unknown status</td><td>Apr 2016</td><td>May 2016</td><td>Observational</td><td>Apr 2016</td><td>Hemorrhage</td><td>null</td></tr><tr><td>NCT02753088</td><td>Biocad</td><td>Completed</td><td>Oct 2013</td><td>Nov 2015</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Sclerosis,Sclerosis</td><td>Glatiramer Acetate,Mannitol,(T</td></tr><tr><td>NCT02758626</td><td>NYU Langone Health</td><td>Completed</td><td>Nov 2016</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Epilepsy,Epilepsies</td><td>null</td></tr><tr><td>NCT02757222</td><td>Tata Medical Center</td><td>Recruiting</td><td>Jan 2016</td><td>Dec 2022</td><td>Interventional</td><td>Mar 2016</td><td>Neoplasms,Oropharyngeal Neoplasms,Hypopharyngeal Neoplasms,Laryngeal Neoplasms,Laryngeal Diseases</td><td>null</td></tr><tr><td>NCT02750150</td><td>University Hospital, Lille</td><td>Completed</td><td>Jul 2013</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Hemostatic Disorders,Blood Coagulation Disorders,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02752776</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>Mar 2018</td><td>Interventional</td><td>Feb 2016</td><td>Psoriasis</td><td>null</td></tr><tr><td>NCT02752984</td><td>IRCCS Policlinico S. Matteo</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Thrombosis,Venous Thrombosis</td><td>null</td></tr><tr><td>NCT02755272</td><td>Fox Chase Cancer Center</td><td>Recruiting</td><td>May 2016</td><td>Apr 2024</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Triple Negative Breast Neoplasms</td><td>Gemcitabine,Carboplatin,Pembrolizumab</td></tr><tr><td>NCT02753192</td><td>Centre National de la Recherche Scientifique, France</td><td>Unknown status</td><td>Jan 2014</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease,Dysarthria,Disease Progression</td><td>null</td></tr><tr><td>NCT02750189</td><td>Konkuk University Medical Center</td><td>Completed</td><td>Sep 2015</td><td>Jan 2017</td><td>Observational</td><td>Mar 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02756338</td><td>Biotronik, Inc.</td><td>Completed</td><td>Jun 2016</td><td>Jul 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759809</td><td>The Hospital for Sick Children</td><td>Completed</td><td>Jun 2016</td><td>Jul 2018</td><td>Observational</td><td>Apr 2016</td><td>Birth Weight</td><td>null</td></tr><tr><td>NCT02758431</td><td>University of Colorado, Denver</td><td>Recruiting</td><td>Feb 2016</td><td>Nov 2022</td><td>Interventional</td><td>Apr 2016</td><td>Hypogonadism</td><td>Methyltestosterone,Anastrozole,Testosterone,Testosterone undecanoate,Testosterone enanthate,Testosterone 17 beta-cypionate,Aromatase Inhibitors,Acyline,Hormone Antagonists</td></tr><tr><td>NCT02756962</td><td>Washington University School of Medicine</td><td>Recruiting</td><td>Jul 2016</td><td>Jul 2024</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Cytarabine</td></tr><tr><td>NCT02752919</td><td>Eli Lilly and Company</td><td>Completed</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759705</td><td>Hospices Civils de Lyon</td><td>Withdrawn</td><td>Sep 2017</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Bladder Exstrophy</td><td>null</td></tr><tr><td>NCT02753478</td><td>Catharina Ziekenhuis Eindhoven</td><td>Completed</td><td>Jun 2016</td><td>Nov 2016</td><td>Interventional</td><td>Apr 2016</td><td>Myocardial Infarction,Infarction,Hypothermia</td><td>null</td></tr><tr><td>NCT02753413</td><td>GlaxoSmithKline</td><td>Completed</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Respiratory Syncytial Virus Infections</td><td>null</td></tr><tr><td>NCT02759510</td><td>RenJi Hospital</td><td>Unknown status</td><td>Jun 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cardiac Output</td><td>Phenylephrine,Oxymetazoline,Norepinephrine</td></tr><tr><td>NCT02756130</td><td>Jonsson Comprehensive Cancer Center</td><td>Withdrawn</td><td>Aug 2018</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Adenocarcinoma,Ovarian Neoplasms,Cystadenocarcinoma</td><td>Carboplatin</td></tr><tr><td>NCT02750124</td><td>Karolinska Institutet</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Dec 2021</td><td>Interventional</td><td>Mar 2016</td><td>Uterine Cervical Neoplasms</td><td>null</td></tr><tr><td>NCT02755610</td><td>Chulalongkorn University</td><td>Unknown status</td><td>May 2016</td><td>Apr 2019</td><td>Interventional</td><td>Feb 2016</td><td>Peritonitis,Kidney Diseases,Kidney Failure</td><td>null</td></tr><tr><td>NCT02759328</td><td>Ankara University</td><td>Completed</td><td>Dec 2012</td><td>Mar 2014</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02753608</td><td>Jena University Hospital</td><td>Completed</td><td>Jun 2016</td><td>Mar 2018</td><td>Interventional</td><td>Mar 2016</td><td>Pneumonia</td><td>null</td></tr><tr><td>NCT02751944</td><td>ESM Technologies, LLC</td><td>Completed</td><td>Dec 2015</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Arthralgia</td><td>null</td></tr><tr><td>NCT02750748</td><td>National Institute on Drug Abuse (NIDA)</td><td>Completed</td><td>Jul 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Opioid-Related Disorders</td><td>Naltrexone</td></tr><tr><td>NCT02758405</td><td>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</td><td>Completed</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Labor Pain</td><td>Fentanyl,Bupivacaine</td></tr><tr><td>NCT02753829</td><td>Ágata Sofia da Silva Vieira</td><td>Completed</td><td>Sep 2013</td><td>Jul 2015</td><td>Interventional</td><td>Apr 2016</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Heart Diseases,Infarction</td><td>null</td></tr><tr><td>NCT02751788</td><td>Pennington Biomedical Research Center</td><td>Completed</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02753010</td><td>Uppsala University</td><td>Completed</td><td>Mar 2011</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Gastroparesis,Fractures,Hip Fractures</td><td>null</td></tr><tr><td>NCT02750969</td><td>HaEmek Medical Center, Israel</td><td>Unknown status</td><td>Apr 2016</td><td>Feb 2019</td><td>Interventional</td><td>Mar 2016</td><td>Tinnitus</td><td>Lidocaine</td></tr><tr><td>NCT02755831</td><td>United States Naval Medical Center, San Diego</td><td>Completed</td><td>Feb 2017</td><td>Oct 2019</td><td>Interventional</td><td>Mar 2016</td><td>Apnea,Sleep Apnea Syndromes,Sleep Apnea</td><td>null</td></tr><tr><td>NCT02752009</td><td>Dana-Farber Cancer Institute</td><td>Withdrawn</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02758990</td><td>Verifomics LLC</td><td>Terminated</td><td>Mar 2016</td><td>Nov 2016</td><td>Interventional</td><td>Apr 2016</td><td>Rhinitis,Arthralgia,Dyspnea,Sleep Deprivation,Migraine Disorders,Sleep Initiation and Maintenance Disorders,Disease,Headache,Respiratory Sounds</td><td>Vitamin D,Cholecalciferol,Vitamins,Ascorbic Acid,Vitamin E,Tocopherols,Vitamin A,Niacinamide,Niacin,Nicotinic Acids,Pyridoxine,Pyridoxal,Vitamin B 6,Caffeine</td></tr><tr><td>NCT02754193</td><td>Central Hospital, Nancy, France</td><td>Completed</td><td>Oct 2016</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>Shock,Hypothermia</td><td>null</td></tr><tr><td>NCT02758613</td><td>Eli Lilly and Company</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751047</td><td>Seoul National University Hospital</td><td>Completed</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758197</td><td>Ottawa Hospital Research Institute</td><td>Completed</td><td>Jul 2016</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Neuralgia,Chronic Pain</td><td>null</td></tr><tr><td>NCT02753270</td><td>University of Sao Paulo</td><td>Completed</td><td>Dec 2014</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Varicose Veins</td><td>null</td></tr><tr><td>NCT02750839</td><td>Azienda Ospedaliera Bolognini di Seriate Bergamo</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>Osteoporosis,Fractures,Humeral Fractures</td><td>null</td></tr><tr><td>NCT02750488</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02752958</td><td>GlaxoSmithKline</td><td>Completed</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Dentin Sensitivity,Hypersensitivity</td><td>Fluorides,Tin Fluorides</td></tr><tr><td>NCT02753322</td><td>The Queen Elizabeth Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02757261</td><td>University of Nove de Julho</td><td>Unknown status</td><td>Jun 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Bruxism,Sleep Bruxism</td><td>Salicylic Acid</td></tr><tr><td>NCT02754427</td><td>University of British Columbia</td><td>Completed</td><td>Feb 2013</td><td>Aug 2015</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02758366</td><td>Meyer Children's Hospital</td><td>Terminated</td><td>Feb 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Glioblastoma,Glioma,Astrocytoma,Diffuse Intrinsic Pontine Glioma,Neoplasms</td><td>Doxorubicin</td></tr><tr><td>NCT02755402</td><td>Centre hospitalier de l'Université de Montréal (CHUM)</td><td>Completed</td><td>Jan 2017</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis C</td><td>null</td></tr><tr><td>NCT02754453</td><td>The Cleveland Clinic</td><td>Withdrawn</td><td>Jul 2013</td><td>Oct 2015</td><td>Interventional</td><td>Sep 2013</td><td>Body Weight,Weight Loss</td><td>null</td></tr><tr><td>NCT02755103</td><td>Medical University of South Carolina</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Oct 2021</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Substance-Related Disorders,Stress Disorders</td><td>null</td></tr><tr><td>NCT02758834</td><td>Università Politecnica delle Marche</td><td>Completed</td><td>Jan 2014</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>Liver Diseases</td><td>null</td></tr><tr><td>NCT02759146</td><td>Michigan State University</td><td>Completed</td><td>May 2016</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754414</td><td>Bloodworks</td><td>Unknown status</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759783</td><td>Royal Marsden NHS Foundation Trust</td><td>Active, not recruiting</td><td>Nov 2016</td><td>Oct 2024</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02756923</td><td>Weill Medical College of Cornell University</td><td>Suspended</td><td>Apr 2012</td><td>Dec 2025</td><td>Observational</td><td>Apr 2016</td><td>Infertility</td><td>null</td></tr><tr><td>NCT02759237</td><td>Medtronic Cardiovascular</td><td>Terminated</td><td>Feb 2016</td><td>May 2017</td><td>Observational</td><td>Apr 2016</td><td>Aortic Valve Stenosis</td><td>null</td></tr><tr><td>NCT02757391</td><td>M.D. Anderson Cancer Center</td><td>Terminated</td><td>Aug 2019</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Colorectal Neoplasms,Adenocarcinoma,Stomach Neoplasms,Esophageal Neoplasms,Cholangiocarcinoma</td><td>Aldesleukin,Cyclophosphamide,Pembrolizumab,Interleukin-2,Immunologic Factors</td></tr><tr><td>NCT02750904</td><td>Fred Hutchinson Cancer Research Center</td><td>Completed</td><td>Apr 2017</td><td>May 2019</td><td>Interventional</td><td>Mar 2016</td><td>Disease,Bipolar Disorder</td><td>Nicotine</td></tr><tr><td>NCT02758418</td><td>Universitat Jaume I</td><td>Unknown status</td><td>Apr 2016</td><td>Jul 2019</td><td>Interventional</td><td>Apr 2016</td><td>Adjustment Disorders</td><td>null</td></tr><tr><td>NCT02756039</td><td>AstraZeneca</td><td>Completed</td><td>May 2016</td><td>Aug 2018</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755077</td><td>Massachusetts General Hospital</td><td>Completed</td><td>Jul 2014</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751801</td><td>Sheffield Teaching Hospitals NHS Foundation Trust</td><td>Completed</td><td>Nov 2016</td><td>Dec 2017</td><td>Observational</td><td>Apr 2016</td><td>Hypophosphatasia</td><td>null</td></tr><tr><td>NCT02751177</td><td>Institut de Cancérologie de Lorraine</td><td>Completed</td><td>Mar 2016</td><td>May 2017</td><td>Interventional</td><td>Mar 2016</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT02758574</td><td>University of Pittsburgh</td><td>Completed</td><td>May 2016</td><td>Aug 2021</td><td>Interventional</td><td>Mar 2016</td><td>Pulmonary Embolism,Embolism</td><td>null</td></tr><tr><td>NCT02758587</td><td>NHS Greater Glasgow and Clyde</td><td>Recruiting</td><td>Jul 2017</td><td>Dec 2021</td><td>Interventional</td><td>Apr 2016</td><td>Mesothelioma,Carcinoma,Pancreatic Neoplasms</td><td>Pembrolizumab</td></tr><tr><td>NCT02752100</td><td>Third Military Medical University</td><td>Unknown status</td><td>Mar 2016</td><td>May 2020</td><td>Interventional</td><td>Mar 2016</td><td>Arterial Occlusive Diseases</td><td>null</td></tr><tr><td>NCT02755818</td><td>University of California, Davis</td><td>Terminated</td><td>Oct 2008</td><td>Feb 2019</td><td>Observational</td><td>Mar 2016</td><td>Insulin Resistance</td><td>Heparin,Calcium heparin</td></tr><tr><td>NCT02752906</td><td>Sanofi Pasteur, a Sanofi Company</td><td>Completed</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Meningococcal Infections,Meningitis</td><td>Vaccines</td></tr><tr><td>NCT02750371</td><td>University Hospital, Bordeaux</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Oct 2021</td><td>Interventional</td><td>Apr 2016</td><td>Adenoma,Meningioma,Pituitary Neoplasms,Pituitary Diseases</td><td>null</td></tr><tr><td>NCT02751125</td><td>University of Bergen</td><td>Completed</td><td>Jun 2014</td><td>Mar 2020</td><td>Interventional</td><td>Mar 2016</td><td>Atrophy</td><td>null</td></tr><tr><td>NCT02754700</td><td>High Point University</td><td>Completed</td><td>Apr 2016</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>Knee Injuries</td><td>null</td></tr><tr><td>NCT02756442</td><td>Assistance Publique Hopitaux De Marseille</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Respiration Disorders,Respiratory Tract Diseases,Diabetes</td><td>null</td></tr><tr><td>NCT02756637</td><td>Abramson Cancer Center of the University of Pennsylvania</td><td>Completed</td><td>Apr 2016</td><td>Nov 2016</td><td>Observational</td><td>Apr 2016</td><td>Urinary Bladder Neoplasms</td><td>null</td></tr><tr><td>NCT02755688</td><td>Royal Brompton & Harefield NHS Foundation Trust</td><td>Unknown status</td><td>Jun 2015</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02753387</td><td>Rennes University Hospital</td><td>Completed</td><td>May 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Bacterial Infections,Head and Neck Neoplasms</td><td>Chlorhexidine</td></tr><tr><td>NCT02758470</td><td>University of British Columbia</td><td>Completed</td><td>Nov 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Fatigue,Hypoxia</td><td>Acetazolamide,Methazolamide</td></tr><tr><td>NCT02754375</td><td>Centre Hospitalier Universitaire de Nice</td><td>Unknown status</td><td>May 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT02758756</td><td>University of Rochester</td><td>Completed</td><td>Jun 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Fatigue</td><td>null</td></tr><tr><td>NCT02750787</td><td>Abbott Nutrition</td><td>Completed</td><td>Aug 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Malabsorption Syndromes</td><td>null</td></tr><tr><td>NCT02757339</td><td>Mclean Hospital</td><td>Enrolling by invitation</td><td>Jun 2015</td><td>May 2022</td><td>Observational</td><td>Mar 2016</td><td>Disease,Stress Disorders,Dissociative Disorders,Dissociative Identity Disorder</td><td>null</td></tr><tr><td>NCT02753959</td><td>Guy's and St Thomas' NHS Foundation Trust</td><td>Completed</td><td>Aug 2016</td><td>Sep 2019</td><td>Interventional</td><td>Apr 2016</td><td>Neuromuscular Diseases</td><td>null</td></tr><tr><td>NCT02753426</td><td>University of California, San Francisco</td><td>Completed</td><td>Apr 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Renal Insufficiency,Cardio-Renal Syndrome</td><td>Doxycycline</td></tr><tr><td>NCT02757183</td><td>AnalyticsPlus, Inc.</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750293</td><td>University of Tromso</td><td>Completed</td><td>Jun 2015</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Vitamin D Deficiency</td><td>Cholecalciferol</td></tr><tr><td>NCT02757274</td><td>European Association of Urology Research Foundation</td><td>Recruiting</td><td>Feb 2017</td><td>Jul 2027</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Urinary Incontinence,Enuresis</td><td>null</td></tr><tr><td>NCT02756741</td><td>All India Institute of Medical Sciences, New Delhi</td><td>Completed</td><td>Apr 2014</td><td>Jul 2015</td><td>Interventional</td><td>Apr 2016</td><td>Peritonitis,Fibrosis</td><td>null</td></tr><tr><td>NCT02758964</td><td>Charite University, Berlin, Germany</td><td>Completed</td><td>Sep 2016</td><td>Jan 2019</td><td>Observational</td><td>Apr 2016</td><td>Intracranial Embolism,Embolism,Aortic Valve Stenosis</td><td>null</td></tr><tr><td>NCT02753439</td><td>The Baruch Padeh Medical Center, Poriya</td><td>Unknown status</td><td>Feb 2017</td><td>Feb 2019</td><td>Interventional</td><td>Mar 2016</td><td>Tooth</td><td>null</td></tr><tr><td>NCT02751281</td><td>Isfahan University of Medical Sciences</td><td>Completed</td><td>Dec 2014</td><td>Apr 2016</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Calculi,Nephrolithiasis</td><td>null</td></tr><tr><td>NCT02756676</td><td>Ospedale Generale Di Zona Moriggia-Pelascini</td><td>Completed</td><td>Apr 2015</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease</td><td>null</td></tr><tr><td>NCT02750215</td><td>Massachusetts General Hospital</td><td>Completed</td><td>May 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02755935</td><td>Cochlear</td><td>Completed</td><td>May 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hearing Loss</td><td>null</td></tr><tr><td>NCT02759523</td><td>Penn State University</td><td>Completed</td><td>Jul 2013</td><td>Dec 2015</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02756533</td><td>University Hospital, Grenoble</td><td>Recruiting</td><td>Aug 2016</td><td>Aug 2021</td><td>Interventional</td><td>Mar 2016</td><td>Lung Diseases,Pulmonary Disease,Signs and Symptoms</td><td>null</td></tr><tr><td>NCT02752841</td><td>Brown University</td><td>Terminated</td><td>May 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Calculi,Calculi</td><td>Vitamin D</td></tr><tr><td>NCT02758392</td><td>Janssen Research & Development, LLC</td><td>Completed</td><td>Apr 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755870</td><td>Clene Nanomedicine</td><td>Completed</td><td>Apr 2015</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752464</td><td>Boston Medical Center</td><td>Completed</td><td>Sep 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756780</td><td>Royal Marsden NHS Foundation Trust</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753998</td><td>Assistance Publique - Hôpitaux de Paris</td><td>Active, not recruiting</td><td>Dec 2016</td><td>Sep 2021</td><td>Interventional</td><td>Apr 2016</td><td>Arteriovenous Fistula,Constriction,Fistula</td><td>Paclitaxel</td></tr><tr><td>NCT02751307</td><td>Taipei Medical University WanFang Hospital</td><td>Completed</td><td>May 2013</td><td>Jan 2015</td><td>Interventional</td><td>Apr 2016</td><td>Congenital Abnormalities,Metabolic Syndrome,Schizophrenia</td><td>Metformin,Clozapine</td></tr><tr><td>NCT02757755</td><td>Armata Pharmaceuticals, Inc.</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753972</td><td>University of New Mexico</td><td>Completed</td><td>Aug 2006</td><td>Jan 2008</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751853</td><td>University of Luebeck</td><td>Unknown status</td><td>Dec 2016</td><td>Aug 2020</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02752971</td><td>Hospital Central Dr. Luis Ortega</td><td>Completed</td><td>Feb 2015</td><td>null</td><td>Interventional</td><td>Mar 2016</td><td>Pain</td><td>Diclofenac,Bupivacaine</td></tr><tr><td>NCT02755012</td><td>McGill University</td><td>Completed</td><td>Jun 2012</td><td>Nov 2013</td><td>Observational</td><td>Apr 2016</td><td>Infections,Mastitis,Malnutrition,Infant Nutrition Disorders,Growth Disorders,Stress</td><td>null</td></tr><tr><td>NCT02751996</td><td>F-star Therapeutics, Inc.</td><td>Completed</td><td>May 2016</td><td>Feb 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis B,Hepatitis</td><td>Tenofovir</td></tr><tr><td>NCT02752893</td><td>Dartmouth-Hitchcock Medical Center</td><td>Completed</td><td>Jan 2017</td><td>Apr 2019</td><td>Observational</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02753842</td><td>Global Protection Corp.</td><td>Completed</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757040</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>Dec 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Arsenic Trioxide</td></tr><tr><td>NCT02751606</td><td>Radboud University</td><td>Unknown status</td><td>Jun 2015</td><td>Nov 2019</td><td>Interventional</td><td>Nov 2014</td><td>Neoplasms,Breast Neoplasms,Rectal Neoplasms</td><td>null</td></tr><tr><td>NCT02751372</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753764</td><td>National Jewish Health</td><td>Completed</td><td>Jan 2017</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Prednisone,AZD7624</td></tr><tr><td>NCT02758938</td><td>University of Wisconsin, Madison</td><td>Completed</td><td>Jun 2016</td><td>Sep 2018</td><td>Interventional</td><td>Dec 2015</td><td>Lower Urinary Tract Symptoms</td><td>null</td></tr><tr><td>NCT02752399</td><td>Federal University of São Paulo</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2017</td><td>Observational</td><td>Apr 2016</td><td>Hypertension,Heart Defects,Eisenmenger Complex</td><td>null</td></tr><tr><td>NCT02753296</td><td>University of Sheffield</td><td>Unknown status</td><td>May 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759432</td><td>Teesside University</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750137</td><td>KK Women's and Children's Hospital</td><td>Completed</td><td>Aug 2014</td><td>May 2015</td><td>Observational</td><td>Apr 2016</td><td>Drug-Related Side Effects and Adverse Reactions</td><td>Tetracaine</td></tr><tr><td>NCT02754466</td><td>University of Brasilia</td><td>Terminated</td><td>May 2017</td><td>Sep 2021</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT02752191</td><td>Paul Finn</td><td>Recruiting</td><td>Apr 2016</td><td>Apr 2021</td><td>Interventional</td><td>Apr 2016</td><td>Heart Diseases,Heart Defects</td><td>Ferrosoferric Oxide</td></tr><tr><td>NCT02753517</td><td>University Hospital, Lille</td><td>Recruiting</td><td>Dec 2015</td><td>Nov 2023</td><td>Interventional</td><td>Apr 2016</td><td>Liver Failure,Hepatic Insufficiency</td><td>null</td></tr><tr><td>NCT02758054</td><td>University of Texas Southwestern Medical Center</td><td>Active, not recruiting</td><td>Jun 2017</td><td>Mar 2023</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02757573</td><td>Tampere University Hospital</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Hypercapnia</td><td>null</td></tr><tr><td>NCT02752789</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Jul 2014</td><td>Nov 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756416</td><td>University of Nottingham</td><td>Unknown status</td><td>Jul 2016</td><td>May 2017</td><td>Interventional</td><td>Mar 2016</td><td>Syndrome</td><td>null</td></tr><tr><td>NCT02758106</td><td>Chung Shan Medical University</td><td>Completed</td><td>Feb 2014</td><td>Nov 2015</td><td>Interventional</td><td>Apr 2016</td><td>Respiratory Insufficiency</td><td>null</td></tr><tr><td>NCT02759159</td><td>Xuanwu Hospital, Beijing</td><td>Unknown status</td><td>Jun 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02753777</td><td>University of Pennsylvania</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2025</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Pemphigoid,Pemphigus</td><td>null</td></tr><tr><td>NCT02754245</td><td>Baylor Research Institute</td><td>Unknown status</td><td>Nov 2016</td><td>Jul 2017</td><td>Observational</td><td>Apr 2016</td><td>Emergencies</td><td>null</td></tr><tr><td>NCT02754687</td><td>Health Decisions</td><td>Unknown status</td><td>Apr 2016</td><td>Jan 2020</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Nandrolone Decanoate,Nandrolone,Nandrolone phenpropionate</td></tr><tr><td>NCT02755337</td><td>Dr. Soetomo General Hospital</td><td>Unknown status</td><td>Jan 2016</td><td>Dec 2016</td><td>Observational</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02755090</td><td>University of New Mexico</td><td>Completed</td><td>Jul 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Nitrous Oxide</td></tr><tr><td>NCT02751437</td><td>Liverpool Women's NHS Foundation Trust</td><td>Completed</td><td>Aug 2016</td><td>Mar 2018</td><td>Interventional</td><td>Mar 2016</td><td>Premature Birth</td><td>null</td></tr><tr><td>NCT02757950</td><td>GlaxoSmithKline</td><td>Completed</td><td>Jul 2016</td><td>May 2017</td><td>Observational</td><td>Apr 2016</td><td>Diphtheria</td><td>null</td></tr><tr><td>NCT02756754</td><td>University Hospital, Toulouse</td><td>Completed</td><td>Nov 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Adenoma,Adrenocortical Adenoma,Hyperaldosteronism</td><td>null</td></tr><tr><td>NCT02754726</td><td>HonorHealth Research Institute</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Jun 2022</td><td>Interventional</td><td>Apr 2016</td><td>Adenocarcinoma</td><td>Gemcitabine,Paclitaxel,Nivolumab,Albumin-Bound Paclitaxel</td></tr><tr><td>NCT02759549</td><td>Emory University</td><td>Withdrawn</td><td>Sep 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02755714</td><td>Haukeland University Hospital</td><td>Completed</td><td>Jun 2016</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Bromides,Ipratropium</td></tr><tr><td>NCT02750358</td><td>Memorial Sloan Kettering Cancer Center</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Triple Negative Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02754921</td><td>Mohamed Sayed Mohamed Abbas</td><td>Completed</td><td>Jan 2013</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755259</td><td>University of Zurich</td><td>Completed</td><td>Jan 2017</td><td>Apr 2019</td><td>Interventional</td><td>Mar 2016</td><td>Hypertension</td><td>Acetazolamide</td></tr><tr><td>NCT02759081</td><td>Dalin Tzu Chi General Hospital</td><td>Completed</td><td>Jan 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755155</td><td>University Hospital, Strasbourg, France</td><td>Terminated</td><td>Sep 2016</td><td>Aug 2019</td><td>Interventional</td><td>Apr 2016</td><td>Hypoalbuminemia,Syndrome,Systemic Inflammatory Response Syndrome</td><td>null</td></tr><tr><td>NCT02758119</td><td>Ilumens</td><td>Completed</td><td>Jun 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Heart Arrest,Out-of-Hospital Cardiac Arrest</td><td>null</td></tr><tr><td>NCT02755415</td><td>China Medical University Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02751268</td><td>Armed Forces Hampyeong Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Psychomotor Agitation,Emergence Delirium</td><td>Ropivacaine</td></tr><tr><td>NCT02756572</td><td>University of Washington</td><td>Completed</td><td>Sep 2016</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia,Neoplasms,Preleukemia,Myelodysplastic Syndromes,Anemia,Syndrome</td><td>Cytarabine,Cyclosporine,Mycophenolic Acid,Sirolimus,Fludarabine,Fludarabine phosphate,Melphalan,Mechlorethamine,Mitoxantrone,Nitrogen Mustard Compounds,Cladribine,2-chloro-3-deoxyadenosine,Cyclosporins,Lenograstim</td></tr><tr><td>NCT02756871</td><td>Institute of Child Health</td><td>Completed</td><td>Jul 2015</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750618</td><td>Ultragenyx Pharmaceutical Inc</td><td>Completed</td><td>May 2016</td><td>Sep 2019</td><td>Interventional</td><td>Dec 2015</td><td>Familial Hypophosphatemic Rickets,Hypophosphatemia</td><td>null</td></tr><tr><td>NCT02757196</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Thrombocytopenia,Purpura</td><td>Methylprednisolone,Methylprednisolone Acetate,Methylprednisolone Hemisuccinate,Prednisolone,Prednisolone acetate,Rituximab,Prednisolone hemisuccinate,Prednisolone phosphate</td></tr><tr><td>NCT02758093</td><td>University of Alabama at Birmingham</td><td>Completed</td><td>Sep 2016</td><td>Mar 2020</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750943</td><td>GlaxoSmithKline</td><td>Completed</td><td>Nov 2015</td><td>Mar 2016</td><td>Interventional</td><td>Nov 2015</td><td>Gingivitis</td><td>Fluorides,Tin Fluorides,Fluorophosphate</td></tr><tr><td>NCT02754908</td><td>The University of Hong Kong</td><td>Completed</td><td>Jan 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02750514</td><td>Bristol-Myers Squibb</td><td>Terminated</td><td>May 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>Nivolumab,Ipilimumab,Dasatinib,Linrodostat</td></tr><tr><td>NCT02755350</td><td>LVCT Health</td><td>Unknown status</td><td>Aug 2015</td><td>Apr 2017</td><td>Interventional</td><td>Nov 2015</td><td>null</td><td>Emtricitabine</td></tr><tr><td>NCT02753374</td><td>Beijing Children's Hospital</td><td>Not yet recruiting</td><td>May 2016</td><td>Jul 2030</td><td>Observational</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02759419</td><td>Bayer</td><td>Recruiting</td><td>Jun 2016</td><td>Dec 2023</td><td>Interventional</td><td>Apr 2016</td><td>Pulmonary Arterial Hypertension,Hypertension</td><td>Riociguat</td></tr><tr><td>NCT02757612</td><td>Universidad de Murcia</td><td>Completed</td><td>Jun 2015</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Burning Mouth Syndrome,Syndrome,Burns</td><td>null</td></tr><tr><td>NCT02754297</td><td>CHU de Quebec-Universite Laval</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2026</td><td>Interventional</td><td>Mar 2016</td><td>Neoplasms,Neuroendocrine Tumors,Carcinoid Tumor,Carcinoma</td><td>Lutetium Lu 177 dotatate</td></tr><tr><td>NCT02758665</td><td>University of Ulm</td><td>Active, not recruiting</td><td>Sep 2016</td><td>Mar 2022</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Venetoclax,Obinutuzumab</td></tr><tr><td>NCT02755285</td><td>Fujifilm Medical Systems USA, Inc.</td><td>Completed</td><td>Aug 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757690</td><td>Asan Medical Center</td><td>Completed</td><td>Jan 2015</td><td>Feb 2016</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02753218</td><td>LEO Pharma</td><td>Terminated</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Psoriasis</td><td>Midazolam</td></tr><tr><td>NCT02754986</td><td>University of Hyogo</td><td>Completed</td><td>Mar 2015</td><td>null</td><td>Interventional</td><td>Mar 2016</td><td>Kidney Diseases,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02752048</td><td>Taiho Pharmaceutical Co., Ltd.</td><td>Completed</td><td>May 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>Muscular Dystrophies,Muscular Dystrophy</td><td>null</td></tr><tr><td>NCT02752256</td><td>University of Iowa</td><td>Completed</td><td>Oct 2015</td><td>Oct 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>Plasminogen,Tissue Plasminogen Activator</td></tr><tr><td>NCT02756936</td><td>Genuine Research Center, Egypt</td><td>Completed</td><td>Feb 2016</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756000</td><td>Clinical Hospital Center Zemun</td><td>Unknown status</td><td>Jan 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Infarction</td><td>Dobutamine</td></tr><tr><td>NCT02754492</td><td>Terumo BCT</td><td>Completed</td><td>Apr 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757677</td><td>Swiss Vision Network</td><td>Unknown status</td><td>Dec 2015</td><td>Dec 2019</td><td>Observational</td><td>Apr 2016</td><td>Glaucoma</td><td>null</td></tr><tr><td>NCT02752373</td><td>Brain Sentinel</td><td>Terminated</td><td>May 2016</td><td>Feb 2017</td><td>Observational</td><td>Mar 2016</td><td>Epilepsy,Seizures</td><td>null</td></tr><tr><td>NCT02752230</td><td>Kettering Health Network</td><td>Withdrawn</td><td>Nov 2016</td><td>Jun 2021</td><td>Interventional</td><td>Mar 2016</td><td>Pain</td><td>null</td></tr><tr><td>NCT02756728</td><td>BioInvent International AB</td><td>Terminated</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Melphalan</td></tr><tr><td>NCT02751658</td><td>University Hospital, Montpellier</td><td>Completed</td><td>Nov 2016</td><td>Jul 2019</td><td>Interventional</td><td>Mar 2016</td><td>Otorhinolaryngologic Diseases</td><td>null</td></tr><tr><td>NCT02754518</td><td>University of Chicago</td><td>Completed</td><td>Apr 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure</td><td>Valsartan,Sacubitril and valsartan sodium hydrate drug combination</td></tr><tr><td>NCT02759380</td><td>Sahlgrenska University Hospital, Sweden</td><td>Recruiting</td><td>Mar 2016</td><td>Oct 2022</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms</td><td>Phytoestrogens</td></tr><tr><td>NCT02755649</td><td>Regeneron Pharmaceuticals</td><td>Completed</td><td>Jan 2016</td><td>Mar 2017</td><td>Interventional</td><td>Mar 2016</td><td>Dermatitis,Eczema</td><td>null</td></tr><tr><td>NCT02751827</td><td>Institut Bergonié</td><td>Completed</td><td>Feb 2016</td><td>Nov 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755545</td><td>Galderma Laboratories, L.P.</td><td>Completed</td><td>May 2016</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Acne Vulgaris</td><td>Salicylic Acid,Adapalene,Salicylates</td></tr><tr><td>NCT02750345</td><td>Cycle Pharmaceuticals Ltd.</td><td>Completed</td><td>Mar 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Tyrosinemias</td><td>Nitisinone</td></tr><tr><td>NCT02755532</td><td>Federal University of São Paulo</td><td>Completed</td><td>Jan 2014</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Bupivacaine</td></tr><tr><td>NCT02758743</td><td>Biohit Oyj</td><td>Completed</td><td>Apr 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754947</td><td>Nationwide Children's Hospital</td><td>Completed</td><td>Feb 2015</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Respiration Disorders,Respiratory Tract Diseases,Nervous System Diseases,Cardiovascular Diseases</td><td>null</td></tr><tr><td>NCT02750280</td><td>Calvary Hospital, Bronx, NY</td><td>Completed</td><td>Jun 2015</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Diabetic Foot,Foot Ulcer,Ulcer</td><td>null</td></tr><tr><td>NCT02756325</td><td>NYU Langone Health</td><td>Withdrawn</td><td>Jun 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Infertility</td><td>null</td></tr><tr><td>NCT02758717</td><td>Academic and Community Cancer Research United</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2024</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma,Hodgkin Disease</td><td>Antineoplastic Agents,Nivolumab,Brentuximab Vedotin,Antibodies,Immunoglobulins,Immunoconjugates</td></tr><tr><td>NCT02751034</td><td>Medy-Tox</td><td>Completed</td><td>Jun 2013</td><td>Jan 2014</td><td>Interventional</td><td>Apr 2015</td><td>null</td><td>Lidocaine</td></tr><tr><td>NCT02751476</td><td>Action Contre la Faim</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Malnutrition,Severe Acute Malnutrition,Protein-Energy Malnutrition</td><td>Disinfectants</td></tr><tr><td>NCT02755454</td><td>University Health Network, Toronto</td><td>Completed</td><td>Oct 2013</td><td>Nov 2018</td><td>Interventional</td><td>Mar 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02752867</td><td>Dongfang Hospital Beijing University of Chinese Medicine</td><td>Unknown status</td><td>Dec 2016</td><td>Nov 2019</td><td>Interventional</td><td>Mar 2016</td><td>Cerebral Infarction,Infarction,Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02754830</td><td>Eli Lilly and Company</td><td>Completed</td><td>Apr 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02753738</td><td>Medical University of Vienna</td><td>Unknown status</td><td>Aug 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Citalopram</td></tr><tr><td>NCT02750267</td><td>University of Virginia</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02754999</td><td>Prolong Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Anemia</td><td>null</td></tr><tr><td>NCT02754843</td><td>Sonova AG</td><td>Completed</td><td>Oct 2015</td><td>null</td><td>Interventional</td><td>Oct 2015</td><td>Hearing Loss</td><td>null</td></tr><tr><td>NCT02759055</td><td>HealthPartners Institute</td><td>Completed</td><td>Oct 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Prediabetic State,Glucose Intolerance</td><td>null</td></tr><tr><td>NCT02753673</td><td>Memorial Sloan Kettering Cancer Center</td><td>Completed</td><td>Apr 2016</td><td>Apr 2020</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754531</td><td>Indonesia University</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750033</td><td>Seton Healthcare Family</td><td>Withdrawn</td><td>Oct 2016</td><td>Mar 2017</td><td>Observational</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02759133</td><td>Centre Antoine Lacassagne</td><td>Recruiting</td><td>Jun 2016</td><td>Nov 2022</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02756650</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Jun 2016</td><td>Jan 2019</td><td>Interventional</td><td>Mar 2016</td><td>Behcet Syndrome</td><td>null</td></tr><tr><td>NCT02752152</td><td>Institut de Recherche pour le Developpement</td><td>Completed</td><td>Dec 2015</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis B,Syphilis,Hepatitis</td><td>null</td></tr><tr><td>NCT02751385</td><td>Boehringer Ingelheim</td><td>Terminated</td><td>May 2016</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>Nintedanib,Ethinyl estradiol,Ethinyl Estradiol-Norgestrel Combination</td></tr><tr><td>NCT02751879</td><td>Boehringer Ingelheim</td><td>Completed</td><td>Nov 2016</td><td>Sep 2017</td><td>Observational</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02756663</td><td>Novartis Pharmaceuticals</td><td>Withdrawn</td><td>Dec 2016</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Dexamethasone,Panobinostat</td></tr><tr><td>NCT02756273</td><td>Centre Hospitalier Universitaire, Amiens</td><td>Recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755974</td><td>Imperial College London</td><td>Unknown status</td><td>Jan 2009</td><td>Apr 2021</td><td>Observational</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02756507</td><td>Babes-Bolyai University</td><td>Completed</td><td>Jun 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Depression,Anxiety Disorders,Panic Disorder</td><td>null</td></tr><tr><td>NCT02750553</td><td>Jiangsu HengRui Medicine Co., Ltd.</td><td>Completed</td><td>Jan 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750228</td><td>Mednax Center for Research, Education, Quality and Safety</td><td>Completed</td><td>May 2016</td><td>Jun 2020</td><td>Observational</td><td>Mar 2016</td><td>Ductus Arteriosus</td><td>null</td></tr><tr><td>NCT02751710</td><td>Ontario Clinical Oncology Group (OCOG)</td><td>Recruiting</td><td>Dec 2016</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02753361</td><td>Suez Canal University</td><td>Completed</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Lipoma</td><td>null</td></tr><tr><td>NCT02753634</td><td>Lawson Health Research Institute</td><td>Completed</td><td>Apr 2015</td><td>Jun 2016</td><td>Interventional</td><td>Mar 2016</td><td>Osteoarthritis</td><td>null</td></tr><tr><td>NCT02759250</td><td>argenx</td><td>Completed</td><td>Feb 2015</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Nasopharyngeal Carcinoma</td><td>null</td></tr><tr><td>NCT02757482</td><td>Celal Bayar University</td><td>Completed</td><td>Sep 2014</td><td>Jun 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757105</td><td>RedHill Biopharma Limited</td><td>Completed</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Irritable Bowel Syndrome,Syndrome,Diarrhea</td><td>Ondansetron</td></tr><tr><td>NCT02756520</td><td>Fresenius Kabi</td><td>Completed</td><td>Sep 2016</td><td>Oct 2018</td><td>Observational</td><td>Apr 2016</td><td>Kidney Diseases,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02753309</td><td>The University of Texas Health Science Center at San Antonio</td><td>Completed</td><td>Jun 2016</td><td>Mar 2021</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Bladder Neoplasms</td><td>Sirolimus</td></tr><tr><td>NCT02756832</td><td>Takeda</td><td>Completed</td><td>Sep 2016</td><td>Apr 2018</td><td>Observational</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Alogliptin</td></tr><tr><td>NCT02758158</td><td>University Health Network, Toronto</td><td>Completed</td><td>Jan 2016</td><td>Feb 2017</td><td>Interventional</td><td>Mar 2016</td><td>Thyroid Neoplasms,Thyroid Nodule,Thyroid Diseases</td><td>null</td></tr><tr><td>NCT02752360</td><td>Beijing Friendship Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Colonic Neoplasms,Crohn Disease,Diverticulum,Diverticular Diseases,Diverticulosis</td><td>null</td></tr><tr><td>NCT02757794</td><td>Assistance Publique Hopitaux De Marseille</td><td>Recruiting</td><td>Nov 2016</td><td>Jun 2022</td><td>Interventional</td><td>Apr 2016</td><td>Memory Disorders</td><td>null</td></tr><tr><td>NCT02751346</td><td>Washington University School of Medicine</td><td>Completed</td><td>Jan 2016</td><td>Feb 2017</td><td>Observational</td><td>Apr 2016</td><td>Pain</td><td>null</td></tr><tr><td>NCT02757027</td><td>Konkuk University Medical Center</td><td>Unknown status</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756689</td><td>University of Alabama at Birmingham</td><td>Completed</td><td>Mar 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751164</td><td>Intensive Care National Audit & Research Centre</td><td>Completed</td><td>Apr 2013</td><td>May 2016</td><td>Observational</td><td>Apr 2016</td><td>Critical Illness</td><td>null</td></tr><tr><td>NCT02754765</td><td>Médecins Sans Frontières, France</td><td>Recruiting</td><td>Dec 2016</td><td>Aug 2023</td><td>Interventional</td><td>Apr 2016</td><td>Tuberculosis,Bacterial Infections</td><td>Moxifloxacin,Levofloxacin,Ofloxacin,Linezolid,Pyrazinamide,Bedaquiline,Clofazimine</td></tr><tr><td>NCT02757729</td><td>Amorepacific Corporation</td><td>Completed</td><td>Oct 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis,Eczema</td><td>null</td></tr><tr><td>NCT02751866</td><td>University of Cincinnati</td><td>Recruiting</td><td>Jan 2016</td><td>Jul 2023</td><td>Interventional</td><td>Apr 2016</td><td>Overweight,Hyperphagia</td><td>null</td></tr><tr><td>NCT02759068</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>Nov 2014</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Consciousness Disorders</td><td>null</td></tr><tr><td>NCT02752503</td><td>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</td><td>Unknown status</td><td>Mar 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Alcoholism,Alcohol Drinking,Personality Disorders,Borderline Personality Disorder</td><td>Nalmefene</td></tr><tr><td>NCT02750592</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Spondylitis</td><td>null</td></tr><tr><td>NCT02754440</td><td>Terumo BCT</td><td>Completed</td><td>Apr 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750670</td><td>University Health Network, Toronto</td><td>Completed</td><td>Mar 2017</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Gemcitabine,Dexamethasone,Obinutuzumab</td></tr><tr><td>NCT02753400</td><td>Kubota Vision Inc.</td><td>Completed</td><td>May 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Retinal Diseases,Diabetic Retinopathy</td><td>null</td></tr><tr><td>NCT02754310</td><td>Ilumens</td><td>Completed</td><td>May 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758275</td><td>Universidad Industrial de Santander</td><td>Completed</td><td>Apr 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hypertension,Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02757417</td><td>University Hospitals Cleveland Medical Center</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753725</td><td>University of Nairobi</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Delirium,Emergence Delirium</td><td>Fentanyl</td></tr><tr><td>NCT02752646</td><td>MDbackline, LLC</td><td>Completed</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cataract</td><td>Ketorolac,Nepafenac</td></tr><tr><td>NCT02750566</td><td>New York Institute of Technology</td><td>Recruiting</td><td>Nov 2015</td><td>Dec 2021</td><td>Interventional</td><td>Dec 2015</td><td>Post-Concussion Syndrome</td><td>null</td></tr><tr><td>NCT02753335</td><td>University of Tromso</td><td>Recruiting</td><td>Sep 2016</td><td>Dec 2022</td><td>Interventional</td><td>Mar 2016</td><td>Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Syndrome</td><td>null</td></tr><tr><td>NCT02754544</td><td>M.D. Anderson Cancer Center</td><td>Recruiting</td><td>Jul 2016</td><td>Aug 2020</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02751112</td><td>Imagine Institute</td><td>Terminated</td><td>Nov 2015</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>Graft vs Host Disease</td><td>null</td></tr><tr><td>NCT02751320</td><td>GlaxoSmithKline</td><td>Completed</td><td>Feb 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>Citric Acid,Sodium Citrate</td></tr><tr><td>NCT02753036</td><td>Charite University, Berlin, Germany</td><td>Active, not recruiting</td><td>Jan 2016</td><td>Jun 2023</td><td>Observational</td><td>Apr 2016</td><td>Polyneuropathies,Cognition Disorders</td><td>null</td></tr><tr><td>NCT02759198</td><td>Yuhan Corporation</td><td>Completed</td><td>May 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Osteoarthritis</td><td>Celecoxib</td></tr><tr><td>NCT02752802</td><td>Osprey Medical, Inc</td><td>Completed</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757586</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>Dec 2016</td><td>Dec 2019</td><td>Observational</td><td>Apr 2016</td><td>Leukemia</td><td>null</td></tr><tr><td>NCT02755961</td><td>Ajou University School of Medicine</td><td>Completed</td><td>Jul 2015</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Kidney Failure,Hyperphosphatemia</td><td>null</td></tr><tr><td>NCT02759263</td><td>Boston Children's Hospital</td><td>Completed</td><td>Jun 2016</td><td>Oct 2018</td><td>Interventional</td><td>Apr 2016</td><td>Heart Diseases,Heart Defects</td><td>null</td></tr><tr><td>NCT02754271</td><td>Toronto Rehabilitation Institute</td><td>Unknown status</td><td>Apr 2014</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Failure</td><td>null</td></tr><tr><td>NCT02756195</td><td>Vanderbilt University</td><td>Recruiting</td><td>Nov 2016</td><td>Jan 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754336</td><td>Helse Stavanger HF</td><td>Completed</td><td>Oct 2014</td><td>Jun 2015</td><td>Interventional</td><td>Nov 2015</td><td>null</td><td>null</td></tr><tr><td>NCT02758639</td><td>University of Texas at Austin</td><td>Completed</td><td>Sep 2015</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759185</td><td>Multidisciplinary Association for Psychedelic Studies</td><td>Completed</td><td>Jan 2017</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Marijuana Abuse,Stress Disorders</td><td>Dronabinol,Cannabidiol</td></tr><tr><td>NCT02758145</td><td>Service de Médecine Préventive Hospitalière</td><td>Completed</td><td>Apr 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Influenza</td><td>Vaccines</td></tr><tr><td>NCT02756455</td><td>University of Roma La Sapienza</td><td>Unknown status</td><td>Jan 2015</td><td>Dec 2016</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT02757118</td><td>Konkuk University Medical Center</td><td>Unknown status</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756819</td><td>Takeda</td><td>Completed</td><td>Jul 2016</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Hypertension,Overweight</td><td>Azilsartan medoxomil</td></tr><tr><td>NCT02754362</td><td>NYU Langone Health</td><td>Withdrawn</td><td>Nov 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Glioblastoma</td><td>Bevacizumab,Poly ICLC,Keyhole-limpet hemocyanin,Adjuvants</td></tr><tr><td>NCT02752711</td><td>Nantes University Hospital</td><td>Completed</td><td>May 2013</td><td>Dec 2015</td><td>Observational</td><td>Apr 2016</td><td>Craniocerebral Trauma</td><td>null</td></tr><tr><td>NCT02756494</td><td>Beijing Chao Yang Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Stroke,Ischemic Stroke,Cerebral Infarction,Ischemia</td><td>null</td></tr><tr><td>NCT02753855</td><td>University of Illinois at Chicago</td><td>Completed</td><td>Apr 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Telavancin</td></tr><tr><td>NCT02756013</td><td>Case Comprehensive Cancer Center</td><td>Terminated</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Overweight</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT02756949</td><td>World Bank</td><td>Completed</td><td>Oct 2015</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>HIV Infections</td><td>null</td></tr><tr><td>NCT02757885</td><td>Emory University</td><td>Recruiting</td><td>Apr 2016</td><td>Jul 2023</td><td>Interventional</td><td>Apr 2016</td><td>Anemia</td><td>Cyclophosphamide,Thiotepa,Fludarabine,Fludarabine phosphate,Hydroxyurea,Antilymphocyte Serum,Thymoglobulin</td></tr><tr><td>NCT02758340</td><td>Karachi Medical and Dental College</td><td>Completed</td><td>Apr 2016</td><td>Nov 2016</td><td>Interventional</td><td>Apr 2016</td><td>Labor Pain</td><td>Misoprostol</td></tr><tr><td>NCT02753933</td><td>Guy's and St Thomas' NHS Foundation Trust</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Headache Disorders,Headache</td><td>null</td></tr><tr><td>NCT02756624</td><td>Nicox Ophthalmics, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Cetirizine</td></tr><tr><td>NCT02759393</td><td>National Cheng-Kung University Hospital</td><td>Unknown status</td><td>Oct 2015</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Gastroesophageal Reflux,Esophagitis</td><td>Lansoprazole,Dexlansoprazole</td></tr><tr><td>NCT02757820</td><td>Assiut University</td><td>Completed</td><td>Jun 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754141</td><td>Bristol-Myers Squibb</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Feb 2023</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Nivolumab</td></tr><tr><td>NCT02753985</td><td>Abramson Cancer Center of the University of Pennsylvania</td><td>Completed</td><td>Jul 2014</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757768</td><td>Astellas Pharma Global Development, Inc.</td><td>Completed</td><td>Jun 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Bladder,Prostatic Hyperplasia,Hyperplasia,Lower Urinary Tract Symptoms</td><td>Tamsulosin,Mirabegron</td></tr><tr><td>NCT02753348</td><td>Henning Bundgaard</td><td>Completed</td><td>Apr 2016</td><td>Nov 2018</td><td>Observational</td><td>Apr 2016</td><td>Heart Diseases,Heart Defects</td><td>null</td></tr><tr><td>NCT02759718</td><td>Asan Medical Center</td><td>Unknown status</td><td>Jun 2012</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Neuroendocrine Tumors,Endocrine Gland Neoplasms,Adenoma</td><td>null</td></tr><tr><td>NCT02755181</td><td>Boehringer Ingelheim</td><td>Completed</td><td>Jul 2016</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Disease,Personality Disorders,Borderline Personality Disorder,Impulsive Behavior,Disruptive</td><td>null</td></tr><tr><td>NCT02759926</td><td>Universitaire Ziekenhuizen Leuven</td><td>Unknown status</td><td>Aug 2011</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Obesity</td><td>Quinine,Denatonium</td></tr><tr><td>NCT02756286</td><td>Think Now Incorporated</td><td>Completed</td><td>Jan 2017</td><td>Jul 2018</td><td>Observational</td><td>Nov 2015</td><td>Attention Deficit Disorder with Hyperactivity</td><td>null</td></tr><tr><td>NCT02752126</td><td>Lawson Health Research Institute</td><td>Completed</td><td>Jun 2016</td><td>Sep 2020</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02752035</td><td>Astellas Pharma Global Development, Inc.</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Aug 2023</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Azacitidine</td></tr><tr><td>NCT02750865</td><td>Boston Medical Center</td><td>Recruiting</td><td>Aug 2017</td><td>Dec 2022</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752165</td><td>University of Rochester</td><td>Recruiting</td><td>Aug 2016</td><td>Feb 2023</td><td>Interventional</td><td>Mar 2016</td><td>Asthma,Emergencies</td><td>null</td></tr><tr><td>NCT02755792</td><td>The Hong Kong Polytechnic University</td><td>Completed</td><td>Jul 2012</td><td>Apr 2016</td><td>Interventional</td><td>Apr 2016</td><td>Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02757898</td><td>Emory University</td><td>Recruiting</td><td>Jan 2017</td><td>Dec 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Biotin</td></tr><tr><td>NCT02758678</td><td>Science and Technology Park, Center of Innovation Technologies for Human Health</td><td>Completed</td><td>Nov 2015</td><td>Oct 2016</td><td>Observational</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02751424</td><td>GlaxoSmithKline</td><td>Terminated</td><td>Jun 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Bacterial Infections</td><td>null</td></tr><tr><td>NCT02750319</td><td>Memorial Sloan Kettering Cancer Center</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Apr 2022</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>Acetylcysteine,Amiodarone,N-monoacetylcystine</td></tr><tr><td>NCT02757495</td><td>Suez Canal University</td><td>Completed</td><td>Apr 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Psychomotor Agitation,Emergence Delirium,Delayed Emergence from Anesthesia</td><td>Dexmedetomidine</td></tr><tr><td>NCT02752607</td><td>Dr. Vicky Tagalakis</td><td>Terminated</td><td>May 2016</td><td>Nov 2018</td><td>Observational</td><td>Apr 2016</td><td>Thrombosis,Venous Thrombosis</td><td>null</td></tr><tr><td>NCT02757911</td><td>Genethon</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Jun 2024</td><td>Interventional</td><td>Apr 2016</td><td>Granuloma,Granulomatous Disease</td><td>null</td></tr><tr><td>NCT02759224</td><td>Boryung Pharmaceutical Co., Ltd</td><td>Completed</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Stomach Ulcer</td><td>Irsogladine,Lafutidine</td></tr><tr><td>NCT02756351</td><td>CytaCoat AB</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Cross Infection,Pneumonia</td><td>null</td></tr><tr><td>NCT02751359</td><td>University of California, Los Angeles</td><td>Completed</td><td>Jul 2016</td><td>Apr 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Cannabidiol</td></tr><tr><td>NCT02756585</td><td>Nova Scotia Health Authority</td><td>Unknown status</td><td>Sep 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Craniocerebral Trauma,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02751411</td><td>Aboca Spa Societa' Agricola</td><td>Completed</td><td>Apr 2016</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>Constipation</td><td>null</td></tr><tr><td>NCT02750735</td><td>University of Palermo</td><td>Completed</td><td>Jan 2001</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Hypersensitivity</td><td>null</td></tr><tr><td>NCT02753868</td><td>University of Illinois at Urbana-Champaign</td><td>Completed</td><td>Feb 2016</td><td>Feb 2017</td><td>Interventional</td><td>Feb 2016</td><td>Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02755844</td><td>Hospices Civils de Lyon</td><td>Active, not recruiting</td><td>Sep 2016</td><td>Apr 2022</td><td>Interventional</td><td>Apr 2016</td><td>Endometrial Neoplasms</td><td>Metformin,Cyclophosphamide,Olaparib</td></tr><tr><td>NCT02758301</td><td>Medtronic Cardiac Rhythm and Heart Failure</td><td>Completed</td><td>Jun 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02751463</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02752633</td><td>Landspitali University Hospital</td><td>Completed</td><td>May 2013</td><td>May 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Allopurinol,Febuxostat</td></tr><tr><td>NCT02755909</td><td>Indonesia University</td><td>Completed</td><td>Dec 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Anxiety Disorders</td><td>Anesthetics</td></tr><tr><td>NCT02752620</td><td>Rio de Janeiro State University</td><td>Completed</td><td>May 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain,Low Back Pain</td><td>null</td></tr><tr><td>NCT02759965</td><td>Karolinska University Hospital</td><td>Completed</td><td>Sep 2014</td><td>Dec 2018</td><td>Observational</td><td>Nov 2014</td><td>Acute-Phase Reaction,Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02754752</td><td>M.D. Anderson Cancer Center</td><td>Recruiting</td><td>Sep 2016</td><td>Sep 2023</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Chronic Pain</td><td>null</td></tr><tr><td>NCT02754349</td><td>Onze Lieve Vrouw Hospital</td><td>Completed</td><td>Feb 2015</td><td>May 2016</td><td>Interventional</td><td>Mar 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02754479</td><td>Cutera Inc.</td><td>Completed</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Telangiectasis</td><td>null</td></tr><tr><td>NCT02753790</td><td>New Mexico Cancer Care Alliance</td><td>Active, not recruiting</td><td>Feb 2016</td><td>Mar 2023</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasm Metastasis,Neoplasms,Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02757248</td><td>Anne Beaven, MD</td><td>Withdrawn</td><td>Nov 2016</td><td>Nov 2016</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Romidepsin</td></tr><tr><td>NCT02759991</td><td>Norwegian Institute of Public Health</td><td>Completed</td><td>Oct 2017</td><td>Sep 2019</td><td>Interventional</td><td>Mar 2016</td><td>Infections,Hepatitis A,Hepatitis E,Hepatitis</td><td>Vaccines</td></tr><tr><td>NCT02758561</td><td>Ottawa Hospital Research Institute</td><td>Completed</td><td>May 2016</td><td>Nov 2017</td><td>Interventional</td><td>Dec 2015</td><td>Urinary Incontinence,Enuresis,Pelvic Floor Disorders,Prolapse</td><td>null</td></tr><tr><td>NCT02753504</td><td>Chong Kun Dang Pharmaceutical</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dyslipidemias</td><td>null</td></tr><tr><td>NCT02758821</td><td>University of Oxford</td><td>Completed</td><td>Jun 2016</td><td>Sep 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757430</td><td>Abbott Medical Devices</td><td>Completed</td><td>Aug 2016</td><td>Jul 2017</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Arrhythmias</td><td>null</td></tr><tr><td>NCT02754024</td><td>Werner Anderl</td><td>Active, not recruiting</td><td>Sep 2005</td><td>Sep 2025</td><td>Observational</td><td>Apr 2016</td><td>Osteoarthritis,Necrosis</td><td>null</td></tr><tr><td>NCT02757651</td><td>Institute of Cancer Research, United Kingdom</td><td>Completed</td><td>Jan 2017</td><td>Nov 2020</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Hydrogen Peroxide</td></tr><tr><td>NCT02758769</td><td>Bristol-Myers Squibb</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Oct 2023</td><td>Observational</td><td>Apr 2016</td><td>Arthritis</td><td>Abatacept</td></tr><tr><td>NCT02755896</td><td>Weill Medical College of Cornell University</td><td>Recruiting</td><td>Jul 2015</td><td>Jul 2024</td><td>Interventional</td><td>Aug 2015</td><td>Neoplasms,Breast Neoplasms,Radiation Pneumonitis</td><td>null</td></tr><tr><td>NCT02753699</td><td>Debiopharm International SA</td><td>Completed</td><td>Dec 2011</td><td>May 2015</td><td>Interventional</td><td>Mar 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis</td><td>null</td></tr><tr><td>NCT02754323</td><td>Centre Hospitalier Universitaire de Nice</td><td>Unknown status</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753881</td><td>Yale University</td><td>Completed</td><td>Nov 2015</td><td>Dec 2019</td><td>Interventional</td><td>Mar 2016</td><td>Liver Neoplasms</td><td>Doxorubicin,Liposomal doxorubicin</td></tr><tr><td>NCT02752074</td><td>Incyte Corporation</td><td>Completed</td><td>Jun 2016</td><td>Aug 2019</td><td>Interventional</td><td>Apr 2016</td><td>Melanoma</td><td>Pembrolizumab</td></tr><tr><td>NCT02753244</td><td>Intendu Ltd.</td><td>Unknown status</td><td>Apr 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02752672</td><td>Medical University of Graz</td><td>Completed</td><td>Mar 2016</td><td>Nov 2016</td><td>Observational</td><td>Apr 2016</td><td>Psoriasis</td><td>null</td></tr><tr><td>NCT02759029</td><td>Gangnam Severance Hospital</td><td>Unknown status</td><td>Mar 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Disease Susceptibility</td><td>null</td></tr><tr><td>NCT02750202</td><td>University of Pretoria</td><td>Recruiting</td><td>Jul 2018</td><td>Jul 2023</td><td>Interventional</td><td>Apr 2016</td><td>Warts,Condylomata Acuminata,Recurrence</td><td>Vaccines</td></tr><tr><td>NCT02753686</td><td>Novartis Pharmaceuticals</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Aug 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Tamoxifen,Everolimus,Letrozole,Fulvestrant,Anastrozole,Exemestane</td></tr><tr><td>NCT02752217</td><td>Khon Kaen University</td><td>Unknown status</td><td>Mar 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT02755662</td><td>ResMed</td><td>Completed</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Apnea,Sleep Apnea Syndromes,Sleep Apnea,Syndrome</td><td>null</td></tr><tr><td>NCT02751671</td><td>St. Justine's Hospital</td><td>Completed</td><td>Aug 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752880</td><td>Chang Gung Memorial Hospital</td><td>Completed</td><td>Jun 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02751632</td><td>Orygen</td><td>Active, not recruiting</td><td>Apr 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Psychotic Disorders,Mental Disorders,Personality Disorders</td><td>Fluoxetine</td></tr><tr><td>NCT02750527</td><td>Kinderkrankenhaus auf der Bult</td><td>Completed</td><td>Sep 2016</td><td>Dec 2020</td><td>Observational</td><td>Apr 2016</td><td>Hyperlipoproteinemia Type II,Diabetes Mellitus,Hypercholesterolemia</td><td>null</td></tr><tr><td>NCT02751242</td><td>Vanderbilt University</td><td>Completed</td><td>Aug 2016</td><td>Jul 2017</td><td>Observational</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02755363</td><td>Medical University of Warsaw</td><td>Unknown status</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02751775</td><td>Pennington Biomedical Research Center</td><td>Completed</td><td>Jun 2016</td><td>Jun 2017</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02757976</td><td>Lawson Health Research Institute</td><td>Terminated</td><td>Mar 2018</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure,Ventricular Dysfunction</td><td>null</td></tr><tr><td>NCT02752386</td><td>University of Tulsa</td><td>Completed</td><td>Feb 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756143</td><td>University Hospital of Torrejon</td><td>Completed</td><td>Nov 2014</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754648</td><td>Ain Shams University</td><td>Unknown status</td><td>Sep 2015</td><td>Sep 2016</td><td>Interventional</td><td>Mar 2016</td><td>Endometriosis</td><td>null</td></tr><tr><td>NCT02751138</td><td>University of Ulm</td><td>Recruiting</td><td>Mar 2016</td><td>Sep 2024</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Glioblastoma</td><td>null</td></tr><tr><td>NCT02753231</td><td>Universidad Santo Tomas</td><td>Completed</td><td>Jan 2017</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Metabolic Syndrome,Metabolic Diseases,Lipid Metabolism Disorders,Overweight</td><td>null</td></tr><tr><td>NCT02759588</td><td>Genelux Corporation</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>Ovarian Neoplasms,Carcinoma,Fallopian Tube Neoplasms,Peritoneal Neoplasms</td><td>Bevacizumab</td></tr><tr><td>NCT02757352</td><td>Eli Lilly and Company</td><td>Completed</td><td>Aug 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Spondylarthritis</td><td>Ixekizumab</td></tr><tr><td>NCT02752022</td><td>St George's, University of London</td><td>Unknown status</td><td>Sep 2016</td><td>Apr 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754973</td><td>The University of Hong Kong</td><td>Completed</td><td>May 2015</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755506</td><td>Chinese PLA General Hospital</td><td>Unknown status</td><td>Oct 2015</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Aneurysm</td><td>null</td></tr><tr><td>NCT02751216</td><td>Moens Maarten</td><td>Completed</td><td>May 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Syndrome,Failed Back Surgery Syndrome</td><td>null</td></tr><tr><td>NCT02756559</td><td>Lixin Xie</td><td>Unknown status</td><td>Jan 2014</td><td>Dec 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754557</td><td>Emory University</td><td>Recruiting</td><td>Mar 2016</td><td>Dec 2021</td><td>Interventional</td><td>Apr 2016</td><td>Stress Disorders</td><td>null</td></tr><tr><td>NCT02758496</td><td>Wave Neuroscience</td><td>Completed</td><td>Apr 2016</td><td>Apr 2017</td><td>Observational</td><td>Apr 2016</td><td>Autistic Disorder</td><td>null</td></tr><tr><td>NCT02757066</td><td>Nobelpharma</td><td>Completed</td><td>Jun 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Wake Disorders,Parasomnias,Disease,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders</td><td>Melatonin</td></tr><tr><td>NCT02756104</td><td>University Hospital, Montpellier</td><td>Completed</td><td>Jun 2016</td><td>May 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Vitamin D</td></tr><tr><td>NCT02751814</td><td>Pennington Biomedical Research Center</td><td>Completed</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02751749</td><td>Örebro University, Sweden</td><td>Completed</td><td>Dec 2015</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Chronic Pain</td><td>null</td></tr><tr><td>NCT02756052</td><td>University of Calgary</td><td>Completed</td><td>Mar 2016</td><td>Aug 2016</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753647</td><td>Ruijin Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Prednisone,Cyclophosphamide,Rituximab,Doxorubicin,Vincristine</td></tr><tr><td>NCT02756910</td><td>Peking Union Medical College Hospital</td><td>Completed</td><td>May 2016</td><td>Sep 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756208</td><td>University of Maryland, College Park</td><td>Completed</td><td>Nov 2015</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>HIV Infections</td><td>Vaccines</td></tr><tr><td>NCT02757443</td><td>Meshalkin Research Institute of Pathology of Circulation</td><td>Completed</td><td>Jun 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Phosphocreatine,Anesthetics</td></tr><tr><td>NCT02759744</td><td>National Institutes of Health Clinical Center (CC)</td><td>Enrolling by invitation</td><td>Oct 2017</td><td>Jan 2026</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms</td><td>null</td></tr><tr><td>NCT02753140</td><td>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</td><td>Unknown status</td><td>Apr 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Squamous Cell Carcinoma of Head and Neck</td><td>Docetaxel,Cetuximab</td></tr><tr><td>NCT02759536</td><td>The Third Xiangya Hospital of Central South University</td><td>Unknown status</td><td>Jul 2013</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Melanoma</td><td>null</td></tr><tr><td>NCT02750449</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02759211</td><td>Mount Sinai Rehabilitation Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Feb 2018</td><td>Interventional</td><td>Mar 2016</td><td>Multiple Sclerosis,Sclerosis</td><td>null</td></tr><tr><td>NCT02752477</td><td>Ben Lim</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Sep 2020</td><td>Interventional</td><td>Mar 2016</td><td>Pain,Chronic Pain</td><td>Anesthetics</td></tr><tr><td>NCT02759835</td><td>National Cancer Institute (NCI)</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Sep 2022</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms,Adenocarcinoma of Lung</td><td>Osimertinib</td></tr><tr><td>NCT02754596</td><td>Glaukos Corporation</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Dec 2021</td><td>Interventional</td><td>Mar 2016</td><td>Glaucoma</td><td>Timolol,Travoprost,Ophthalmic Solutions</td></tr><tr><td>NCT02757846</td><td>Chinese Academy of Sciences</td><td>Enrolling by invitation</td><td>Apr 2017</td><td>Mar 2022</td><td>Observational</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02750085</td><td>Victor Blanchette</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Dec 2020</td><td>Observational</td><td>Apr 2016</td><td>Hemophilia A</td><td>null</td></tr><tr><td>NCT02759692</td><td>Johnson & Johnson Vision Care, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752750</td><td>Medical University of Graz</td><td>Enrolling by invitation</td><td>May 2016</td><td>May 2022</td><td>Observational</td><td>Apr 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02757781</td><td>Avedis Donabedian Research Institute</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Chronic Disease</td><td>null</td></tr><tr><td>NCT02757924</td><td>Abbott Nutrition</td><td>Completed</td><td>May 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759887</td><td>St. Joseph's Hospital and Medical Center, Phoenix</td><td>Completed</td><td>Nov 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Dementia,Down Syndrome,Alzheimer Disease,Syndrome</td><td>Fluorodeoxyglucose F18</td></tr><tr><td>NCT02758977</td><td>University of Zurich</td><td>Unknown status</td><td>May 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Neoplasm Metastasis,Liver Neoplasms,Colorectal Neoplasms,Liver Diseases</td><td>null</td></tr><tr><td>NCT02751580</td><td>Sidney Kimmel Cancer Center at Thomas Jefferson University</td><td>Completed</td><td>Mar 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02751333</td><td>Johns Hopkins University</td><td>Withdrawn</td><td>Mar 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Esophageal Stenosis,Esophageal Fistula,Esophageal Perforation,Fistula,Constriction</td><td>null</td></tr><tr><td>NCT02759731</td><td>National Cancer Institute (NCI)</td><td>Recruiting</td><td>Nov 2016</td><td>Jun 2022</td><td>Interventional</td><td>Apr 2016</td><td>Graft vs Host Disease</td><td>null</td></tr><tr><td>NCT02758288</td><td>Loma Linda University</td><td>Withdrawn</td><td>Sep 2015</td><td>Jul 2022</td><td>Observational</td><td>Mar 2016</td><td>Virus Diseases,Kidney Diseases</td><td>null</td></tr><tr><td>NCT02756546</td><td>Cairo University</td><td>Completed</td><td>Sep 2014</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Lupus Erythematosus</td><td>Hydroxychloroquine,Hydrocortisone,Cyclophosphamide</td></tr><tr><td>NCT02759094</td><td>Implantica CE & Production Ltd</td><td>Unknown status</td><td>Dec 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Gastroesophageal Reflux</td><td>null</td></tr><tr><td>NCT02757313</td><td>Yale University</td><td>Completed</td><td>Oct 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Marijuana Abuse</td><td>Dronabinol</td></tr><tr><td>NCT02754011</td><td>UNICANCER</td><td>Recruiting</td><td>Jan 2017</td><td>Dec 2021</td><td>Interventional</td><td>Feb 2016</td><td>Breast Neoplasms</td><td>Capecitabine</td></tr><tr><td>NCT02755805</td><td>University of Pittsburgh</td><td>Completed</td><td>Jul 2009</td><td>Dec 2012</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02755428</td><td>Chinese Academy of Sciences</td><td>Unknown status</td><td>Jan 2018</td><td>Dec 2020</td><td>Interventional</td><td>Mar 2016</td><td>Macular Degeneration</td><td>null</td></tr><tr><td>NCT02752555</td><td>Benha University</td><td>Unknown status</td><td>Apr 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Oligospermia</td><td>Antioxidants</td></tr><tr><td>NCT02751398</td><td>Yonsei University</td><td>Completed</td><td>Aug 2016</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Dapagliflozin</td></tr><tr><td>NCT02758951</td><td>Koen Rovers</td><td>Recruiting</td><td>Jun 2017</td><td>Aug 2026</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Colorectal Neoplasms,Neoplasm Metastasis,Carcinoma,Peritoneal Neoplasms</td><td>Bevacizumab</td></tr><tr><td>NCT02750176</td><td>University of Southern California</td><td>Completed</td><td>Apr 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Rotator Cuff Injuries</td><td>null</td></tr><tr><td>NCT02750696</td><td>Federal University of Rio Grande do Sul</td><td>Completed</td><td>Apr 2013</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>Abscess,Periapical Abscess</td><td>Acetaminophen,Tramadol,Codeine</td></tr><tr><td>NCT02757963</td><td>GlaxoSmithKline</td><td>Completed</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Hyperplasia,Hyperplasia</td><td>null</td></tr><tr><td>NCT02756026</td><td>USDA, Western Human Nutrition Research Center</td><td>Completed</td><td>Sep 2013</td><td>Feb 2014</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Micronutrients,Trace Elements</td></tr><tr><td>NCT02756481</td><td>Bristol-Myers Squibb</td><td>Completed</td><td>Oct 2013</td><td>Nov 2014</td><td>Observational</td><td>Oct 2015</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02751060</td><td>Tongji Hospital</td><td>Enrolling by invitation</td><td>Apr 2016</td><td>Dec 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Heart Diseases,Coronary Disease,Coronary Artery Disease,Myocardial Ischemia</td><td>null</td></tr><tr><td>NCT02753127</td><td>Sumitomo Dainippon Pharma Oncology, Inc</td><td>Completed</td><td>Jun 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>Leucovorin,Bevacizumab,Fluorouracil,Irinotecan</td></tr><tr><td>NCT02755051</td><td>University of Missouri-Columbia</td><td>Completed</td><td>Jul 2016</td><td>Mar 2018</td><td>Interventional</td><td>Mar 2016</td><td>Sleep Initiation and Maintenance Disorders,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders</td><td>null</td></tr><tr><td>NCT02757560</td><td>Phoenix VA Health Care System</td><td>Unknown status</td><td>Feb 2012</td><td>Dec 2020</td><td>Interventional</td><td>Aug 2015</td><td>Insulin Resistance</td><td>null</td></tr><tr><td>NCT02754076</td><td>Allievex Corporation</td><td>Completed</td><td>Apr 2016</td><td>Jul 2020</td><td>Interventional</td><td>Feb 2016</td><td>Mucopolysaccharidoses,Mucopolysaccharidosis III</td><td>null</td></tr><tr><td>NCT02752282</td><td>University of Washington</td><td>Unknown status</td><td>Mar 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Uterine Hemorrhage</td><td>null</td></tr><tr><td>NCT02751021</td><td>University Hospital, Caen</td><td>Completed</td><td>Jun 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Apnea,Sleep Apnea Syndromes,Arrhythmias,Hyperaldosteronism</td><td>null</td></tr><tr><td>NCT02759471</td><td>Coopervision, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Myopia</td><td>null</td></tr><tr><td>NCT02752854</td><td>Taif University</td><td>Unknown status</td><td>Apr 2015</td><td>May 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759822</td><td>Leonardo Javier Arcuri</td><td>Unknown status</td><td>Apr 2016</td><td>null</td><td>Observational</td><td>Apr 2016</td><td>Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma</td><td>null</td></tr><tr><td>NCT02752139</td><td>Yi Yang</td><td>Completed</td><td>May 2016</td><td>Oct 2018</td><td>Observational [Patient Registry]</td><td>Mar 2016</td><td>Sleep Wake Disorders,Parasomnias,Sleep Disorders,Disease</td><td>null</td></tr><tr><td>NCT02752295</td><td>Medical University of Vienna</td><td>Completed</td><td>May 2015</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Inflammation,Anxiety Disorders,Mood Disorders,Stress</td><td>null</td></tr><tr><td>NCT02753023</td><td>University of Sao Paulo General Hospital</td><td>Unknown status</td><td>May 2015</td><td>May 2020</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Pulmonary Embolism,Pulmonary Edema,Syncope,Aneurysm,Acute Coronary Syndrome,Embolism,Aortic Aneurysm,Emergencies,Chest Pain</td><td>null</td></tr><tr><td>NCT02757365</td><td>West China Hospital</td><td>Unknown status</td><td>Apr 2014</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms</td><td>Aspirin,Levofloxacin,Ofloxacin</td></tr><tr><td>NCT02757092</td><td>Chang Gung Memorial Hospital</td><td>Completed</td><td>Mar 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02758327</td><td>Koffler Vision Group</td><td>Completed</td><td>Oct 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dry Eye Syndromes</td><td>Carboxymethylcellulose Sodium,Ophthalmic Solutions,Lubricant Eye Drops</td></tr><tr><td>NCT02757404</td><td>Medy-Tox</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Muscle Spasticity</td><td>Botulinum Toxins</td></tr><tr><td>NCT02757469</td><td>Navy General Hospital, Beijing</td><td>Unknown status</td><td>May 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Premature Birth,Infertility,Primary Ovarian Insufficiency,Menopause</td><td>Drospirenone,Ethinyl Estradiol,Drospirenone and ethinyl estradiol combination,Estradiol</td></tr><tr><td>NCT02759172</td><td>Michigan State University</td><td>Unknown status</td><td>Apr 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Suicide</td><td>null</td></tr><tr><td>NCT02758041</td><td>Sebacia, Inc.</td><td>Completed</td><td>Feb 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Acne Vulgaris</td><td>null</td></tr><tr><td>NCT02755116</td><td>Jaime B Hyman</td><td>Completed</td><td>Apr 2016</td><td>Sep 2019</td><td>Interventional</td><td>Apr 2016</td><td>Nausea,Vomiting,Postoperative Nausea and Vomiting</td><td>Olanzapine</td></tr><tr><td>NCT02755584</td><td>National Institute on Aging (NIA)</td><td>Completed</td><td>Jun 2016</td><td>Apr 2021</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750540</td><td>Johns Hopkins University</td><td>Completed</td><td>Oct 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Tenofovir</td></tr><tr><td>NCT02751918</td><td>Bayer</td><td>Completed</td><td>Jun 2016</td><td>Oct 2019</td><td>Interventional</td><td>Apr 2016</td><td>Ovarian Neoplasms</td><td>Doxorubicin,Liposomal doxorubicin,Maytansine</td></tr><tr><td>NCT02751541</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>Sunscreening Agents</td></tr><tr><td>NCT02755883</td><td>Weill Medical College of Cornell University</td><td>Completed</td><td>Apr 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02751229</td><td>University of Ulm</td><td>Completed</td><td>May 2016</td><td>May 2017</td><td>Interventional</td><td>Mar 2016</td><td>Mental Disorders</td><td>null</td></tr><tr><td>NCT02759640</td><td>Atridia Pty Ltd.</td><td>Completed</td><td>Sep 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02750683</td><td>Hopital Antoine Beclere</td><td>Completed</td><td>Oct 2014</td><td>Jan 2016</td><td>Observational</td><td>Apr 2016</td><td>Shock</td><td>null</td></tr><tr><td>NCT02758132</td><td>University of Hawaii</td><td>Terminated</td><td>Mar 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms,Neoplasm Metastasis</td><td>Denosumab,Prednisone</td></tr><tr><td>NCT02757001</td><td>Group of Research in Minimally Invasive Techniques</td><td>Completed</td><td>Jun 2016</td><td>Jul 2019</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757235</td><td>Sahlgrenska University Hospital, Sweden</td><td>Unknown status</td><td>Mar 2016</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hematoma</td><td>null</td></tr><tr><td>NCT02754869</td><td>University College, London</td><td>Unknown status</td><td>Feb 2011</td><td>Aug 2018</td><td>Observational</td><td>Feb 2016</td><td>Intestinal Diseases</td><td>null</td></tr><tr><td>NCT02759406</td><td>Palmaz Scientific</td><td>Completed</td><td>Sep 2013</td><td>Jun 2015</td><td>Interventional</td><td>Apr 2016</td><td>Heart Diseases,Myocardial Ischemia,Coronary Artery Disease,Ischemia</td><td>null</td></tr><tr><td>NCT02758522</td><td>Hospital Universitario Dr. Jose E. Gonzalez</td><td>Completed</td><td>Oct 2013</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus,Hyperglycemia</td><td>Insulin</td></tr><tr><td>NCT02750046</td><td>Second Affiliated Hospital of Soochow University</td><td>Unknown status</td><td>Mar 2016</td><td>Feb 2018</td><td>Interventional</td><td>Mar 2016</td><td>Fractures,Femoral Neck Fractures</td><td>null</td></tr><tr><td>NCT02755233</td><td>University of Zurich</td><td>Completed</td><td>Jan 2014</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Melanoma</td><td>null</td></tr><tr><td>NCT02750423</td><td>Emory University</td><td>Completed</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754050</td><td>Tandem Technologies LTD</td><td>Unknown status</td><td>Sep 2016</td><td>Oct 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754284</td><td>Chinese Academy of Sciences</td><td>Completed</td><td>Dec 2015</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Vocal Cord Dysfunction</td><td>null</td></tr><tr><td>NCT02756078</td><td>Johnson & Johnson Vision Care, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750995</td><td>Daniel El Fassi</td><td>Completed</td><td>Apr 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome</td><td>Azacitidine</td></tr><tr><td>NCT02759302</td><td>Rigshospitalet, Denmark</td><td>Completed</td><td>Apr 2016</td><td>Apr 2017</td><td>Observational</td><td>Apr 2016</td><td>Muscular Dystrophies</td><td>null</td></tr><tr><td>NCT02759874</td><td>Institute of Health Economics, Canada</td><td>Unknown status</td><td>Nov 2015</td><td>Nov 2018</td><td>Interventional</td><td>Apr 2016</td><td>Fetal Alcohol Spectrum Disorders,Alcoholism</td><td>null</td></tr><tr><td>NCT02758535</td><td>Modarres Hospital</td><td>Completed</td><td>Mar 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755636</td><td>Pro-Change Behavior Systems</td><td>Unknown status</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758873</td><td>University of Sussex</td><td>Completed</td><td>Feb 2016</td><td>Jul 2019</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Salmeterol Xinafoate,Montelukast</td></tr><tr><td>NCT02753166</td><td>NYU Langone Health</td><td>Withdrawn</td><td>Jan 2017</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Dexamethasone</td></tr><tr><td>NCT02755766</td><td>Shriners Hospitals for Children</td><td>Completed</td><td>May 2015</td><td>Jul 2019</td><td>Observational</td><td>Mar 2016</td><td>Scoliosis,Clubfoot,Talipes,Equinus Deformity</td><td>null</td></tr><tr><td>NCT02751983</td><td>VA Office of Research and Development</td><td>Completed</td><td>Nov 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Suicide</td><td>null</td></tr><tr><td>NCT02754960</td><td>Shanghai Jiao Tong University School of Medicine</td><td>Withdrawn</td><td>Mar 2010</td><td>Sep 2014</td><td>Interventional</td><td>Apr 2016</td><td>Gastrointestinal Hemorrhage,Vascular Malformations,Congenital Abnormalities,Hemorrhage</td><td>Thalidomide</td></tr><tr><td>NCT02751086</td><td>International Study Group on Minimally Invasive Surgery for Gastric Cancer</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2024</td><td>Observational</td><td>Apr 2016</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT02755753</td><td>YongChan Lee</td><td>Completed</td><td>Jan 2014</td><td>Apr 2016</td><td>Interventional</td><td>Sep 2015</td><td>Gastroesophageal Reflux,Esophagitis</td><td>Lansoprazole,Dexlansoprazole,Rebamipide</td></tr><tr><td>NCT02757872</td><td>Albert Einstein College of Medicine</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Nov 2021</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Hypertension</td><td>Vitamin D,Ergocalciferols,Cholecalciferol,Vitamins</td></tr><tr><td>NCT02756767</td><td>Abramson Cancer Center of the University of Pennsylvania</td><td>Completed</td><td>Apr 2016</td><td>Apr 2021</td><td>Observational</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02757937</td><td>Children's Hospital of Philadelphia</td><td>Completed</td><td>May 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02753660</td><td>Indonesia University</td><td>Completed</td><td>Aug 2014</td><td>Oct 2014</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751684</td><td>Universitätsklinikum Köln</td><td>Completed</td><td>Mar 2017</td><td>May 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753556</td><td>Dimagi Inc.</td><td>Completed</td><td>Sep 2015</td><td>Jun 2016</td><td>Observational</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02757287</td><td>Institut Universitari Dexeus</td><td>Withdrawn</td><td>May 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Infertility</td><td>Desogestrel</td></tr><tr><td>NCT02752308</td><td>Isfahan University of Medical Sciences</td><td>Completed</td><td>Sep 2014</td><td>Mar 2015</td><td>Interventional</td><td>Apr 2016</td><td>Hypospadias</td><td>Atropine,Epinephrine,Fentanyl,Bupivacaine,Neostigmine</td></tr><tr><td>NCT02758314</td><td>Instituto Nacional de Cancerologia de Mexico</td><td>Unknown status</td><td>Mar 2017</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Lung Neoplasms,Carcinoma</td><td>null</td></tr><tr><td>NCT02752685</td><td>NYU Langone Health</td><td>Recruiting</td><td>Jun 2016</td><td>Dec 2021</td><td>Observational</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Paclitaxel,Pembrolizumab</td></tr><tr><td>NCT02759289</td><td>NYU Langone Health</td><td>Completed</td><td>Nov 2015</td><td>Sep 2020</td><td>Observational</td><td>Apr 2016</td><td>Atherosclerosis</td><td>null</td></tr><tr><td>NCT02759120</td><td>Weill Medical College of Cornell University</td><td>Terminated</td><td>Mar 2017</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis</td><td>Doxycycline,Anti-Bacterial Agents,Trimethoprim,Anti-Infective Agents</td></tr><tr><td>NCT02754401</td><td>Renatus, Antonio Renatus, Dent., M.Sc</td><td>Completed</td><td>Jan 2014</td><td>Jul 2014</td><td>Interventional</td><td>Apr 2016</td><td>Periodontitis</td><td>null</td></tr><tr><td>NCT02759757</td><td>Leandro Pires</td><td>Unknown status</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain,Low Back Pain</td><td>null</td></tr><tr><td>NCT02750579</td><td>Assistance Publique Hopitaux De Marseille</td><td>Completed</td><td>Sep 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Acute Coronary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02752204</td><td>University of Birmingham</td><td>Completed</td><td>Oct 2015</td><td>Feb 2020</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Rituximab</td></tr><tr><td>NCT02757053</td><td>Mosaic Life Care</td><td>Terminated</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Brain Concussion,Diffuse Axonal Injury,Wounds and Injuries,Athletic Injuries</td><td>null</td></tr><tr><td>NCT02752542</td><td>Nova Scotia Health Authority</td><td>Unknown status</td><td>Oct 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Depressive Disorder,Depression</td><td>null</td></tr><tr><td>NCT02753283</td><td>Susan L. Greenspan</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Sep 2023</td><td>Interventional</td><td>Apr 2016</td><td>Osteoporosis,Osteoporotic Fractures</td><td>Vitamin D,Zoledronic Acid,Denosumab,Calcium</td></tr><tr><td>NCT02754934</td><td>Balgrist University Hospital</td><td>Completed</td><td>Nov 2014</td><td>Nov 2016</td><td>Observational</td><td>Apr 2016</td><td>Neck Pain</td><td>null</td></tr><tr><td>NCT02755194</td><td>The Hospital for Sick Children</td><td>Terminated</td><td>Sep 2014</td><td>Sep 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758210</td><td>Emory University</td><td>Completed</td><td>Apr 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Bradycardia,Tachycardia</td><td>null</td></tr><tr><td>NCT02757456</td><td>Sameena Iqbal</td><td>Completed</td><td>Feb 2015</td><td>Feb 2016</td><td>Interventional</td><td>Nov 2012</td><td>Cardiovascular Diseases</td><td>null</td></tr><tr><td>NCT02756377</td><td>Islamic Azad University, Tehran</td><td>Completed</td><td>May 2014</td><td>Jun 2015</td><td>Interventional</td><td>Apr 2016</td><td>Periodontal Diseases</td><td>Chlorhexidine,Chlorhexidine gluconate,Cetylpyridinium</td></tr><tr><td>NCT02751099</td><td>Centro Hospitalar de Lisboa Central</td><td>Unknown status</td><td>Nov 2015</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Bone Diseases,Renal Insufficiency,Vascular Diseases</td><td>null</td></tr><tr><td>NCT02752178</td><td>University of Cambridge</td><td>Completed</td><td>Jun 2015</td><td>Sep 2018</td><td>Observational</td><td>Mar 2016</td><td>Depressive Disorder,Depression</td><td>null</td></tr><tr><td>NCT02757144</td><td>Daewoong Pharmaceutical Co. LTD.</td><td>Completed</td><td>Mar 2016</td><td>Feb 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Esomeprazole</td></tr><tr><td>NCT02757742</td><td>Fu Wai Hospital, Beijing, China</td><td>Completed</td><td>Dec 2010</td><td>Aug 2016</td><td>Observational</td><td>Apr 2016</td><td>Cardiomyopathies</td><td>null</td></tr><tr><td>NCT02750644</td><td>Joaquin de Haro, M.D.</td><td>Completed</td><td>Jan 2005</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>Carotid Artery Diseases</td><td>null</td></tr><tr><td>NCT02754635</td><td>HaEmek Medical Center, Israel</td><td>Unknown status</td><td>Mar 2016</td><td>Jul 2018</td><td>Interventional</td><td>Feb 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755311</td><td>Sun Yat-sen University</td><td>Unknown status</td><td>Mar 2014</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>Cisplatin,Carboplatin,Fluorouracil,Epirubicin,Ethiodized Oil,Pirarubicin,Doxorubicin,Gelatin Sponge</td></tr><tr><td>NCT00170053</td><td>Mayo Clinic</td><td>Completed</td><td>Jun 2005</td><td>Sep 2008</td><td>Interventional</td><td>Sep 2005</td><td>Kidney Diseases</td><td>Sirolimus</td></tr><tr><td>NCT00175396</td><td>University of British Columbia</td><td>Unknown status</td><td>May 2004</td><td>Jun 2014</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Ascorbic Acid,Leuprolide,Methyltestosterone,Flutamide,Bicalutamide,Nilutamide,Buserelin,Androgens,Estrogens</td></tr><tr><td>NCT00179647</td><td>Celgene Corporation</td><td>Completed</td><td>Sep 2005</td><td>Apr 2009</td><td>Interventional</td><td>Sep 2005</td><td>Multiple Myeloma,Neoplasms</td><td>Dexamethasone,Lenalidomide</td></tr><tr><td>NCT00172523</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Oct 2004</td><td>Aug 2005</td><td>Observational</td><td>Sep 2005</td><td>Polycystic Ovary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT00174785</td><td>Sanofi</td><td>Completed</td><td>Jun 2005</td><td>Mar 2008</td><td>Interventional</td><td>Sep 2005</td><td>Atrial Fibrillation,Atrial Flutter</td><td>Dronedarone</td></tr><tr><td>NCT00175058</td><td>TherOx</td><td>Completed</td><td>Aug 2005</td><td>May 2008</td><td>Interventional</td><td>Sep 2005</td><td>Myocardial Infarction,Infarction</td><td>null</td></tr><tr><td>NCT00177541</td><td>University of Pittsburgh</td><td>Completed</td><td>Feb 2004</td><td>Sep 2016</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Incontinence</td><td>null</td></tr><tr><td>NCT00176215</td><td>Heidelberg University</td><td>Unknown status</td><td>May 2003</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Tooth Abrasion</td><td>null</td></tr><tr><td>NCT00178529</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Jul 2001</td><td>Sep 2005</td><td>Interventional</td><td>Sep 2005</td><td>Stroke</td><td>null</td></tr><tr><td>NCT00172367</td><td>National Taiwan University Hospital</td><td>Withdrawn</td><td>Jan 2006</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Lycopene</td></tr><tr><td>NCT00173875</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Mar 2005</td><td>Jul 2007</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma</td><td>Gefitinib</td></tr><tr><td>NCT00174668</td><td>Sanofi</td><td>Completed</td><td>Nov 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>Insulin,Insulin Glargine,Insulin glulisine</td></tr><tr><td>NCT00173927</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2004</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Atherosclerosis</td><td>null</td></tr><tr><td>NCT00179933</td><td>Ann & Robert H Lurie Children's Hospital of Chicago</td><td>Terminated</td><td>Sep 2005</td><td>Feb 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00176878</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>Jun 2000</td><td>Mar 2009</td><td>Interventional</td><td>Sep 2005</td><td>Shwachman-Diamond Syndrome,Neutropenia,Bone Marrow Failure Disorders,Pancytopenia,Anemia,Syndrome</td><td>Fludarabine,Fludarabine phosphate,Busulfan,Antilymphocyte Serum</td></tr><tr><td>NCT00172653</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00177645</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2002</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT00176475</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Jan 2005</td><td>Feb 2008</td><td>Interventional</td><td>Sep 2005</td><td>Lymphoma,Leukemia,Multiple Myeloma,Neoplasms,Plasmacytoma</td><td>Rituximab</td></tr><tr><td>NCT00178087</td><td>University of Pittsburgh</td><td>Completed</td><td>Aug 2005</td><td>Aug 2011</td><td>Observational</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT00178854</td><td>Vanderbilt University Medical Center</td><td>Withdrawn</td><td>May 2004</td><td>Mar 2006</td><td>Interventional</td><td>Sep 2005</td><td>Depressive Disorder</td><td>Risperidone</td></tr><tr><td>NCT00178503</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Sep 2005</td><td>May 2011</td><td>Interventional</td><td>Sep 2005</td><td>Hyperkinesis,Autistic Disorder,Attention Deficit Disorder with Hyperactivity</td><td>Methylphenidate</td></tr><tr><td>NCT00176410</td><td>University of Leipzig</td><td>Unknown status</td><td>Jan 2003</td><td>Dec 2009</td><td>Interventional</td><td>Sep 2005</td><td>Aortic Valve Stenosis,Constriction</td><td>null</td></tr><tr><td>NCT00179166</td><td>Vanderbilt University</td><td>Terminated</td><td>Jun 2004</td><td>Jul 2005</td><td>Interventional</td><td>Sep 2005</td><td>Renal Insufficiency,Acute Kidney Injury</td><td>null</td></tr><tr><td>NCT00171054</td><td>Novartis</td><td>Completed</td><td>Sep 2003</td><td>Oct 2007</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan,Hydrochlorothiazide</td></tr><tr><td>NCT00170300</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>Jan 2001</td><td>May 2005</td><td>Interventional</td><td>Sep 2005</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT00177619</td><td>University of Pittsburgh</td><td>Completed</td><td>May 2002</td><td>Dec 2005</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms,Osteoporosis</td><td>Alendronate</td></tr><tr><td>NCT00178139</td><td>University of Rochester</td><td>Completed</td><td>Apr 2004</td><td>Jul 2006</td><td>Interventional</td><td>Sep 2005</td><td>Respiratory Insufficiency,Pulmonary Valve Insufficiency</td><td>null</td></tr><tr><td>NCT00175799</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2007</td><td>Jul 2013</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00172874</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Jan 1998</td><td>Dec 2008</td><td>Observational</td><td>Sep 2005</td><td>Feeding and Eating Disorders</td><td>null</td></tr><tr><td>NCT00179985</td><td>Ann & Robert H Lurie Children's Hospital of Chicago</td><td>Completed</td><td>Dec 2004</td><td>Jul 2011</td><td>Observational</td><td>Sep 2005</td><td>Hypersensitivity</td><td>null</td></tr><tr><td>NCT00176384</td><td>University of Leipzig</td><td>Completed</td><td>Mar 2003</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT00176644</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>May 2005</td><td>Dec 2008</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Estradiol</td></tr><tr><td>NCT00174070</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Feb 2006</td><td>Observational</td><td>Sep 2005</td><td>Respiratory Insufficiency</td><td>null</td></tr><tr><td>NCT00173472</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jul 2002</td><td>Jul 2005</td><td>Observational</td><td>Sep 2005</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT00172640</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT00174967</td><td>Takeda</td><td>Completed</td><td>Jan 2001</td><td>Jul 2001</td><td>Interventional</td><td>Sep 2005</td><td>Gout</td><td>Febuxostat</td></tr><tr><td>NCT00171028</td><td>Novartis</td><td>Completed</td><td>Dec 2003</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan</td></tr><tr><td>NCT00175344</td><td>University of British Columbia</td><td>Completed</td><td>Feb 2004</td><td>Apr 2006</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms,Pain</td><td>null</td></tr><tr><td>NCT00173368</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Jan 2003</td><td>Mar 2005</td><td>Observational</td><td>Sep 2005</td><td>Choledocholithiasis</td><td>null</td></tr><tr><td>NCT00174629</td><td>Sanofi</td><td>Completed</td><td>Jun 2001</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms</td><td>Gemcitabine,Docetaxel</td></tr><tr><td>NCT00179231</td><td>Vanderbilt University</td><td>Completed</td><td>May 2000</td><td>Feb 2004</td><td>Interventional</td><td>Sep 2005</td><td>Schizophrenia,Psychotic Disorders</td><td>Olanzapine,Clozapine</td></tr><tr><td>NCT00173693</td><td>National Taiwan University Hospital</td><td>Withdrawn</td><td>Jan 2006</td><td>Dec 2010</td><td>Interventional</td><td>Sep 2005</td><td>Osteoporosis,Bone Diseases</td><td>null</td></tr><tr><td>NCT00171093</td><td>Novartis</td><td>Completed</td><td>Sep 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension,Hypercholesterolemia</td><td>Valsartan,Simvastatin</td></tr><tr><td>NCT00179348</td><td>Albert Einstein College of Medicine</td><td>Completed</td><td>Feb 2001</td><td>Jul 2016</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma,Breast Neoplasms,Colorectal Neoplasms,Sleep Wake Disorders,Alopecia,Vomiting</td><td>null</td></tr><tr><td>NCT00172133</td><td>Shire</td><td>Completed</td><td>Oct 2001</td><td>Apr 2005</td><td>Interventional</td><td>Sep 2005</td><td>Osteoporosis</td><td>null</td></tr><tr><td>NCT00170508</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Jun 2005</td><td>Aug 2005</td><td>Interventional</td><td>Sep 2005</td><td>Influenza</td><td>null</td></tr><tr><td>NCT00179543</td><td>Beth Israel Deaconess Medical Center</td><td>Completed</td><td>Aug 2001</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT00177216</td><td>University of Pittsburgh</td><td>Completed</td><td>Feb 2002</td><td>May 2008</td><td>Interventional</td><td>Sep 2005</td><td>Sleep Initiation and Maintenance Disorders,Sleep Wake Disorders</td><td>Zolpidem,Citalopram</td></tr><tr><td>NCT00176813</td><td>University of Michigan Rogel Cancer Center</td><td>Completed</td><td>Mar 2003</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Pancreatic Neoplasms</td><td>Gemcitabine,Celecoxib</td></tr><tr><td>NCT00170131</td><td>Mayo Clinic</td><td>Completed</td><td>Sep 2002</td><td>Jul 2007</td><td>Observational</td><td>Sep 2005</td><td>Infections,Hepatitis C</td><td>null</td></tr><tr><td>NCT00174551</td><td>Rainier Associates</td><td>Unknown status</td><td>Nov 2003</td><td>Nov 2005</td><td>Interventional</td><td>Sep 2005</td><td>Stress Disorders</td><td>Prazosin</td></tr><tr><td>NCT00170755</td><td>Novartis</td><td>Completed</td><td>Apr 2002</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Bladder</td><td>Darifenacin</td></tr><tr><td>NCT00174200</td><td>Pfizer</td><td>Completed</td><td>Dec 2004</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Schizophrenia,Mental Disorders,Psychotic Disorders</td><td>Risperidone</td></tr><tr><td>NCT00178698</td><td>The University of Texas Health Science Center, Houston</td><td>Unknown status</td><td>Jul 2002</td><td>Jun 2014</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Stomach Neoplasms,Small Cell Lung Carcinoma,Carcinoma</td><td>Gemcitabine,Interferons</td></tr><tr><td>NCT00178516</td><td>University of Rochester</td><td>Completed</td><td>Jun 2004</td><td>Dec 2005</td><td>Observational</td><td>Sep 2005</td><td>Infertility</td><td>null</td></tr><tr><td>NCT00172289</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>Dec 2006</td><td>Observational</td><td>Sep 2005</td><td>Spinal Cord Injuries,Stroke,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT00172718</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Jaw,Mouth</td><td>null</td></tr><tr><td>NCT00174239</td><td>Pfizer</td><td>Terminated</td><td>Jul 2004</td><td>Sep 2005</td><td>Interventional</td><td>Sep 2005</td><td>Parkinson Disease</td><td>Levodopa,Carbidopa,Cabergoline</td></tr><tr><td>NCT00178620</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Nov 2003</td><td>Mar 2014</td><td>Interventional</td><td>Sep 2005</td><td>Myocardial Infarction,Heart Diseases,Infarction</td><td>Reteplase</td></tr><tr><td>NCT00177112</td><td>University of Minnesota</td><td>Completed</td><td>Jun 2005</td><td>Oct 2007</td><td>Interventional</td><td>Sep 2005</td><td>Infections,Communicable Diseases,Urinary Tract Infections</td><td>null</td></tr><tr><td>NCT00173108</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Jan 2006</td><td>Oct 2010</td><td>Interventional</td><td>Sep 2005</td><td>Premature Birth</td><td>null</td></tr><tr><td>NCT00170404</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Jun 2000</td><td>Oct 2005</td><td>Interventional</td><td>Sep 2005</td><td>Tuberculosis</td><td>Vitamins,Folic Acid,Vitamin A,Thiamine,Selenium,Micronutrients,Trace Elements</td></tr><tr><td>NCT00176280</td><td>University of Kentucky</td><td>Withdrawn</td><td>Sep 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Dexamethasone,Sargramostim</td></tr><tr><td>NCT00175123</td><td>University of Aarhus</td><td>Unknown status</td><td>May 2005</td><td>Jun 2008</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Bladder,Meningomyelocele,Spina Bifida Cystica</td><td>Botulinum Toxins,abobotulinumtoxinA</td></tr><tr><td>NCT00170924</td><td>Novartis</td><td>Completed</td><td>Aug 2004</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan</td></tr><tr><td>NCT00170222</td><td>Medical Center Alkmaar</td><td>Completed</td><td>Jul 2002</td><td>Aug 2008</td><td>Interventional</td><td>Sep 2005</td><td>Lung Diseases,Pulmonary Disease</td><td>Doxycycline</td></tr><tr><td>NCT00172042</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2005</td><td>Jun 2010</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma,Neoplasm Metastasis</td><td>Zoledronic Acid</td></tr><tr><td>NCT00170690</td><td>North Eastern German Society of Gynaecological Oncology</td><td>Completed</td><td>Aug 2004</td><td>Apr 2012</td><td>Interventional</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>Treosulfan,Busulfan</td></tr><tr><td>NCT00176904</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>Jan 1995</td><td>Jun 2010</td><td>Interventional</td><td>Sep 2005</td><td>Gaucher Disease,Adrenoleukodystrophy,Pick Disease of the Brain,Gangliosidoses,Leukodystrophy,Niemann-Pick Diseases,Niemann-Pick Disease,Neuronal Ceroid-Lipofuscinoses,Tay-Sachs Disease,Gangliosidosis,Sandhoff Disease,Fucosidosis,Metabolism,Wolman Disease</td><td>Cyclophosphamide,Busulfan,Antilymphocyte Serum</td></tr><tr><td>NCT00178204</td><td>University of Rochester</td><td>Completed</td><td>Nov 2004</td><td>Dec 2011</td><td>Observational</td><td>Sep 2005</td><td>Fatigue</td><td>null</td></tr><tr><td>NCT00176345</td><td>University of Leipzig</td><td>Unknown status</td><td>Jan 2001</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease</td><td>null</td></tr><tr><td>NCT00178711</td><td>The University of Texas Health Science Center, Houston</td><td>Terminated</td><td>Nov 2005</td><td>Dec 2009</td><td>Interventional</td><td>Sep 2005</td><td>Brain Injuries,Hypothermia,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT00173680</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT00170417</td><td>NHS Greater Glasgow and Clyde</td><td>Completed</td><td>Dec 2000</td><td>May 2003</td><td>Interventional</td><td>Sep 2005</td><td>Sleep Initiation and Maintenance Disorders</td><td>null</td></tr><tr><td>NCT00173485</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jun 2009</td><td>Observational</td><td>Sep 2005</td><td>Peritonitis,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT00178269</td><td>University of Rochester</td><td>Completed</td><td>Jan 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Uterine Cervical Neoplasms</td><td>Docetaxel</td></tr><tr><td>NCT00171301</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Jun 2005</td><td>May 2008</td><td>Interventional</td><td>Sep 2005</td><td>Thalassemia,beta-Thalassemia,Iron Overload,Hemosiderosis</td><td>Deferasirox</td></tr><tr><td>NCT00171782</td><td>Novartis</td><td>Completed</td><td>Feb 2004</td><td>Dec 2004</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan,Hydrochlorothiazide</td></tr><tr><td>NCT00176566</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Sep 2003</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Leukoplakia</td><td>null</td></tr><tr><td>NCT00170846</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Feb 2005</td><td>Oct 2009</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Everolimus,Azathioprine,Calcineurin Inhibitors</td></tr><tr><td>NCT00173836</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Aug 2003</td><td>Aug 2006</td><td>Observational</td><td>Sep 2005</td><td>Nasopharyngeal Carcinoma,Nasopharyngeal Neoplasms</td><td>null</td></tr><tr><td>NCT00174005</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Dec 1994</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00176527</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Nov 2002</td><td>Aug 2007</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Interferons,Interferon-alpha,Interferon alpha-2,Docetaxel,Estramustine,Isotretinoin</td></tr><tr><td>NCT00171314</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms</td><td>Zoledronic Acid,Letrozole</td></tr><tr><td>NCT00175409</td><td>University of British Columbia</td><td>Completed</td><td>Jan 2008</td><td>Jun 2010</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00177190</td><td>University of Pittsburgh</td><td>Completed</td><td>Jun 2002</td><td>Jan 2006</td><td>Observational</td><td>Sep 2005</td><td>Mycoses,Lymphoma,Mycosis Fungoides,Sezary Syndrome</td><td>null</td></tr><tr><td>NCT00179101</td><td>Vanderbilt University</td><td>Completed</td><td>Apr 2004</td><td>Nov 2005</td><td>Observational</td><td>Sep 2005</td><td>Parkinson Disease,Depression</td><td>null</td></tr><tr><td>NCT00175526</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2005</td><td>Dec 2010</td><td>Observational</td><td>Sep 2005</td><td>Toxemia,Sepsis</td><td>null</td></tr><tr><td>NCT00176293</td><td>University of Kentucky</td><td>Terminated</td><td>Oct 2005</td><td>Feb 2007</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Dexamethasone,Doxorubicin</td></tr><tr><td>NCT00178347</td><td>University of Rochester</td><td>Terminated</td><td>Dec 2004</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00171964</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>May 2002</td><td>Dec 2008</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasm Metastasis</td><td>Zoledronic Acid</td></tr><tr><td>NCT00178945</td><td>Vanderbilt University</td><td>Completed</td><td>Mar 2004</td><td>Mar 2006</td><td>Interventional</td><td>Sep 2005</td><td>Myofascial Pain Syndromes,Fibromyalgia,Dystonia,Dystonic Disorders,Syndrome,Torticollis</td><td>Botulinum Toxins,abobotulinumtoxinA</td></tr><tr><td>NCT00172965</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Mouth Neoplasms</td><td>null</td></tr><tr><td>NCT00179764</td><td>Ann & Robert H Lurie Children's Hospital of Chicago</td><td>Completed</td><td>Mar 2000</td><td>Jan 2014</td><td>Interventional</td><td>Sep 2005</td><td>Leukemia,Melanoma,Neoplasms,Hematologic Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma</td><td>Busulfan</td></tr><tr><td>NCT00170612</td><td>University of Melbourne</td><td>Completed</td><td>Nov 2005</td><td>Aug 2008</td><td>Interventional</td><td>Sep 2005</td><td>Pneumococcal Infections</td><td>Heptavalent Pneumococcal Conjugate Vaccine</td></tr><tr><td>NCT00172627</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT00170872</td><td>Novartis</td><td>Completed</td><td>Nov 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Arthritis,Osteoarthritis</td><td>Lumiracoxib</td></tr><tr><td>NCT00172770</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Schizophrenia</td><td>null</td></tr><tr><td>NCT00173849</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2006</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Mouth Neoplasms</td><td>null</td></tr><tr><td>NCT00175682</td><td>University of British Columbia</td><td>Completed</td><td>Dec 2004</td><td>Jul 2011</td><td>Interventional</td><td>Sep 2005</td><td>Spinal Cord Injuries,Autonomic Dysreflexia</td><td>Prazosin</td></tr><tr><td>NCT00179127</td><td>Vanderbilt University Medical Center</td><td>Completed</td><td>Aug 2004</td><td>Sep 2012</td><td>Interventional</td><td>Sep 2005</td><td>Ketosis,Acidosis,Diabetic Ketoacidosis</td><td>Insulin Glargine</td></tr><tr><td>NCT00178113</td><td>University of Pittsburgh</td><td>Completed</td><td>Jul 2003</td><td>Jul 2004</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasms,Carcinoma in Situ,Prostatic Intraepithelial Neoplasia</td><td>Lycopene</td></tr><tr><td>NCT00170560</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Oct 2001</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Infections</td><td>null</td></tr><tr><td>NCT00178022</td><td>University of Pittsburgh</td><td>Completed</td><td>Feb 2005</td><td>Sep 2006</td><td>Interventional</td><td>Sep 2005</td><td>Brain Injuries,Wounds and Injuries,Depression,Anxiety Disorders</td><td>null</td></tr><tr><td>NCT00178425</td><td>University of Rochester</td><td>Completed</td><td>Jan 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00178438</td><td>University of Rochester</td><td>Withdrawn</td><td>Jun 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Crohn Disease</td><td>null</td></tr><tr><td>NCT00173173</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Aug 2003</td><td>Jul 2004</td><td>Observational</td><td>Sep 2005</td><td>Disease,Feeding and Eating Disorders</td><td>null</td></tr><tr><td>NCT00177294</td><td>University of Pittsburgh</td><td>Completed</td><td>Apr 2004</td><td>Aug 2009</td><td>Interventional</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>Citalopram</td></tr><tr><td>NCT00175461</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2005</td><td>Aug 2011</td><td>Interventional</td><td>Sep 2005</td><td>Osteoarthritis</td><td>null</td></tr><tr><td>NCT00179062</td><td>Vanderbilt University</td><td>Completed</td><td>Feb 2000</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>Disease,Schizophrenia,Depressive Disorder,Bipolar Disorder,Psychotic Disorders</td><td>Olanzapine,Risperidone</td></tr><tr><td>NCT00173550</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Premature Birth,Menopause,Primary Ovarian Insufficiency</td><td>null</td></tr><tr><td>NCT00177385</td><td>University of Pittsburgh</td><td>Completed</td><td>Jun 2003</td><td>Sep 2011</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00171002</td><td>Novartis</td><td>Completed</td><td>Nov 2004</td><td>Jun 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00177125</td><td>University of Minnesota</td><td>Completed</td><td>Jan 2004</td><td>Jan 2004</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>null</td></tr><tr><td>NCT00172861</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT00174798</td><td>Sanofi</td><td>Completed</td><td>May 2005</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Incontinence,Enuresis,Urinary Bladder</td><td>Tolterodine Tartrate</td></tr><tr><td>NCT00177892</td><td>National Institute on Aging (NIA)</td><td>Unknown status</td><td>Sep 2003</td><td>Aug 2008</td><td>Interventional</td><td>Sep 2005</td><td>Apnea,Sleep Apnea Syndromes,Sleep Apnea,Metabolic Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT00176761</td><td>University of Michigan Rogel Cancer Center</td><td>Terminated</td><td>Mar 2000</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Colorectal Neoplasms</td><td>Interleukin-2</td></tr><tr><td>NCT00176319</td><td>University of Leipzig</td><td>Completed</td><td>May 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT00177203</td><td>University of Pittsburgh</td><td>Completed</td><td>Jun 2003</td><td>Jan 2009</td><td>Interventional</td><td>Sep 2005</td><td>Sleep Initiation and Maintenance Disorders</td><td>null</td></tr><tr><td>NCT00174993</td><td>Takeda</td><td>Completed</td><td>May 2001</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>Pioglitazone</td></tr><tr><td>NCT00177658</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2006</td><td>Jun 2017</td><td>Observational</td><td>Sep 2005</td><td>Salmonella Infections</td><td>null</td></tr><tr><td>NCT00174928</td><td>Takeda</td><td>Completed</td><td>May 2005</td><td>Aug 2005</td><td>Interventional</td><td>Sep 2005</td><td>Gastroesophageal Reflux,Esophagitis</td><td>Lansoprazole,Dexlansoprazole</td></tr><tr><td>NCT00170677</td><td>North Eastern German Society of Gynaecological Oncology</td><td>Completed</td><td>Sep 2005</td><td>Jan 2013</td><td>Interventional</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>Topotecan</td></tr><tr><td>NCT00178295</td><td>University of Rochester</td><td>Completed</td><td>Nov 1999</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Brain Neoplasms,Trauma</td><td>null</td></tr><tr><td>NCT00176449</td><td>University of Maryland, Baltimore</td><td>Completed</td><td>Apr 2001</td><td>Dec 2005</td><td>Interventional</td><td>Sep 2005</td><td>Tobacco Use Disorder</td><td>Bupropion</td></tr><tr><td>NCT00179751</td><td>Celgene Corporation</td><td>Terminated</td><td>Apr 2005</td><td>Aug 2006</td><td>Interventional</td><td>Sep 2005</td><td>Pancreatic Neoplasms</td><td>Gemcitabine,Lenalidomide</td></tr><tr><td>NCT00172744</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Apr 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00177255</td><td>University of Pittsburgh</td><td>Terminated</td><td>Apr 2005</td><td>Dec 2008</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Docetaxel,Capecitabine</td></tr><tr><td>NCT00171925</td><td>Novartis Pharmaceuticals</td><td>Terminated</td><td>Aug 2000</td><td>Nov 2008</td><td>Interventional</td><td>Sep 2005</td><td>Multiple Myeloma,Neoplasms</td><td>Vitamin D,Zoledronic Acid,Calcium</td></tr><tr><td>NCT00177307</td><td>University of Pittsburgh</td><td>Completed</td><td>Jan 2005</td><td>Feb 2012</td><td>Interventional</td><td>Sep 2005</td><td>Colorectal Neoplasms</td><td>Bevacizumab,Capecitabine,Oxaliplatin</td></tr><tr><td>NCT00173862</td><td>National Taiwan University Hospital</td><td>Completed</td><td>May 2000</td><td>Jun 2006</td><td>Interventional</td><td>Jun 2005</td><td>Carcinoma</td><td>Gemcitabine,Ifosfamide</td></tr><tr><td>NCT00171990</td><td>Novartis</td><td>Completed</td><td>Jan 2003</td><td>Feb 2006</td><td>Interventional</td><td>Sep 2005</td><td>Herpes Genitalis</td><td>Famciclovir</td></tr><tr><td>NCT00177060</td><td>Hordinsky, Maria K., MD</td><td>Terminated</td><td>Oct 2003</td><td>May 2007</td><td>Interventional</td><td>Sep 2005</td><td>Wounds and Injuries</td><td>Hydromorphone</td></tr><tr><td>NCT00173043</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Oct 2004</td><td>Aug 2005</td><td>Observational</td><td>Sep 2005</td><td>Polycystic Ovary Syndrome,Insulin Resistance,Syndrome</td><td>null</td></tr><tr><td>NCT00171769</td><td>Novartis</td><td>Completed</td><td>Apr 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Atrial Fibrillation</td><td>Certoparin</td></tr><tr><td>NCT00171951</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Aug 2004</td><td>Jul 2013</td><td>Interventional</td><td>Sep 2005</td><td>ACTH-Secreting Pituitary Adenoma,Pituitary ACTH Hypersecretion</td><td>Pasireotide</td></tr><tr><td>NCT00174850</td><td>State University of New York - Upstate Medical University</td><td>Completed</td><td>Jul 2004</td><td>May 2005</td><td>Interventional</td><td>Sep 2005</td><td>Anxiety Disorders</td><td>null</td></tr><tr><td>NCT00177970</td><td>University of Pittsburgh</td><td>Terminated</td><td>Oct 2003</td><td>Apr 2008</td><td>Interventional</td><td>Sep 2005</td><td>Diarrhea</td><td>Immunoglobulins,Antibodies,Immunoglobulin G,gamma-Globulins,Rho(D) Immune Globulin</td></tr><tr><td>NCT00171834</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Aug 2003</td><td>Sep 2008</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma</td><td>Epothilones,Epothilone B</td></tr><tr><td>NCT00172601</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Bursitis</td><td>null</td></tr><tr><td>NCT00176254</td><td>Susanne Arnold</td><td>Completed</td><td>May 2000</td><td>Oct 2012</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma,Head and Neck Neoplasms</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT00176553</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Mar 2003</td><td>May 2007</td><td>Interventional</td><td>Sep 2005</td><td>Neurotoxicity Syndromes</td><td>Dextromethorphan</td></tr><tr><td>NCT00171405</td><td>Novartis</td><td>Completed</td><td>Jun 2005</td><td>Feb 2006</td><td>Interventional</td><td>Aug 2005</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT00177814</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2005</td><td>Jun 2017</td><td>Observational</td><td>Sep 2005</td><td>Bacterial Infections,Gram-Negative Bacterial Infections</td><td>null</td></tr><tr><td>NCT00174122</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jul 2005</td><td>Jun 2006</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00179608</td><td>Celgene</td><td>Completed</td><td>Sep 2005</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>Melanoma</td><td>Lenalidomide</td></tr><tr><td>NCT00173394</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Dec 2008</td><td>Observational</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>null</td></tr><tr><td>NCT00170001</td><td>Mayo Clinic</td><td>Completed</td><td>Apr 2005</td><td>Aug 2006</td><td>Interventional</td><td>Sep 2005</td><td>Gastroesophageal Reflux</td><td>Esomeprazole</td></tr><tr><td>NCT00170963</td><td>Novartis</td><td>Completed</td><td>Oct 2004</td><td>Jun 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00170365</td><td>Hennepin Healthcare Research Institute</td><td>Completed</td><td>Jul 2004</td><td>Mar 2005</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00173810</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Apr 2007</td><td>Observational</td><td>Sep 2005</td><td>Stroke</td><td>null</td></tr><tr><td>NCT00179335</td><td>Albert Einstein College of Medicine</td><td>Completed</td><td>Aug 2003</td><td>Sep 2006</td><td>Observational</td><td>Sep 2005</td><td>HIV Infections</td><td>null</td></tr><tr><td>NCT00178256</td><td>University of Rochester</td><td>Completed</td><td>Jun 1998</td><td>Dec 2012</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Paclitaxel</td></tr><tr><td>NCT00178035</td><td>University of Pittsburgh</td><td>Completed</td><td>Dec 1999</td><td>Aug 2003</td><td>Interventional</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>Paroxetine</td></tr><tr><td>NCT00177567</td><td>University of Pittsburgh</td><td>Completed</td><td>Jul 2001</td><td>Jan 2004</td><td>Interventional</td><td>Sep 2005</td><td>Disease,Bipolar Disorder,Mood Disorders</td><td>Lamotrigine,Valproic Acid,Olanzapine,Risperidone,Lithium Carbonate,Mirtazapine,Tranylcypromine,Bupropion,Paroxetine,Venlafaxine Hydrochloride</td></tr><tr><td>NCT00172666</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Arthritis,Lupus Erythematosus</td><td>null</td></tr><tr><td>NCT00172731</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Mar 2005</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Schizophrenia</td><td>null</td></tr><tr><td>NCT00171873</td><td>Carmen Schade-Brittinger</td><td>Completed</td><td>Sep 2001</td><td>Dec 2013</td><td>Interventional</td><td>Sep 2005</td><td>Neuroendocrine Tumors,Neoplasm Metastasis</td><td>Octreotide</td></tr><tr><td>NCT00173355</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Aug 2005</td><td>Observational</td><td>Sep 2005</td><td>Dermatofibrosarcoma,Soft Tissue Neoplasms</td><td>null</td></tr><tr><td>NCT00176111</td><td>Heidelberg University</td><td>Terminated</td><td>Jan 2004</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00170274</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>Aug 2000</td><td>Oct 2014</td><td>Interventional</td><td>Sep 2005</td><td>Arrhythmias,Tachycardia</td><td>null</td></tr><tr><td>NCT00172250</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Sep 2003</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Coronary Artery Disease</td><td>null</td></tr><tr><td>NCT00174356</td><td>Pfizer</td><td>Completed</td><td>Dec 2002</td><td>Oct 2005</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT00170989</td><td>Novartis</td><td>Completed</td><td>Sep 2004</td><td>Jul 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan,Hydrochlorothiazide</td></tr><tr><td>NCT00179569</td><td>Beth Israel Deaconess Medical Center</td><td>Completed</td><td>Aug 2005</td><td>Sep 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00172796</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Apr 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Metabolic Syndrome,Prediabetic State</td><td>null</td></tr><tr><td>NCT00178126</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2004</td><td>Oct 2008</td><td>Interventional</td><td>Sep 2005</td><td>Pressure Ulcer,Ulcer</td><td>null</td></tr><tr><td>NCT00172029</td><td>Novartis</td><td>Completed</td><td>Apr 2003</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms,Bone Diseases</td><td>Zoledronic Acid</td></tr><tr><td>NCT00176696</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Aug 2005</td><td>Apr 2007</td><td>Observational</td><td>Sep 2005</td><td>Pain</td><td>Anesthetics</td></tr><tr><td>NCT00177788</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2005</td><td>Aug 2012</td><td>Observational</td><td>Sep 2005</td><td>Mycoses,Fungemia</td><td>null</td></tr><tr><td>NCT00171938</td><td>Novartis</td><td>Terminated</td><td>Apr 2004</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Glioblastoma</td><td>Imatinib Mesylate</td></tr><tr><td>NCT00177359</td><td>University of Pittsburgh</td><td>Completed</td><td>Nov 2005</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>Mobility Limitation</td><td>null</td></tr><tr><td>NCT00171860</td><td>Novartis Pharmaceuticals</td><td>Terminated</td><td>Sep 2002</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Hypereosinophilic Syndrome,Syndrome</td><td>Imatinib Mesylate</td></tr><tr><td>NCT00171717</td><td>Novartis</td><td>Completed</td><td>Feb 2004</td><td>Dec 2005</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>Cyclosporine,Cyclosporins</td></tr><tr><td>NCT00176748</td><td>University of Michigan Rogel Cancer Center</td><td>Completed</td><td>Jul 2005</td><td>Jun 2009</td><td>Interventional</td><td>Sep 2005</td><td>Thyroid Neoplasms,Thyroid Diseases</td><td>null</td></tr><tr><td>NCT00175084</td><td>Tufts University</td><td>Completed</td><td>Oct 2004</td><td>Dec 2012</td><td>Interventional</td><td>Sep 2005</td><td>Cardiovascular Diseases,Metabolic Syndrome,Hyperlipidemias</td><td>null</td></tr><tr><td>NCT00178334</td><td>University of Rochester</td><td>Completed</td><td>Mar 2006</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Urinary Incontinence,Enuresis</td><td>null</td></tr><tr><td>NCT00172822</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2003</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Appendicitis</td><td>null</td></tr><tr><td>NCT00170885</td><td>Novartis</td><td>Completed</td><td>May 2005</td><td>Jul 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Everolimus</td></tr><tr><td>NCT00177684</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2004</td><td>Sep 2005</td><td>Interventional</td><td>Sep 2005</td><td>Mycoses</td><td>Amphotericin B,Liposomal amphotericin B</td></tr><tr><td>NCT00178672</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Nov 2002</td><td>Aug 2007</td><td>Interventional</td><td>Sep 2005</td><td>Carotid Stenosis,Carotid Artery Diseases,Stroke,Heart Diseases</td><td>null</td></tr><tr><td>NCT00171080</td><td>Novartis</td><td>Completed</td><td>Apr 2004</td><td>Mar 2006</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan,Irbesartan</td></tr><tr><td>NCT00176891</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>Mar 2004</td><td>Nov 2012</td><td>Interventional</td><td>Sep 2005</td><td>Mucopolysaccharidoses,Mucopolysaccharidosis I,Syndrome</td><td>null</td></tr><tr><td>NCT00172107</td><td>Shire</td><td>Completed</td><td>May 1995</td><td>Mar 1997</td><td>Interventional</td><td>Sep 2005</td><td>Osteoporosis</td><td>Parathyroid Hormone</td></tr><tr><td>NCT00177827</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2004</td><td>Mar 2006</td><td>Observational</td><td>Sep 2005</td><td>Aspergillosis</td><td>null</td></tr><tr><td>NCT00177502</td><td>University of Pittsburgh</td><td>Completed</td><td>Jan 2003</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>Body Weight,Weight Loss,Weight Gain</td><td>null</td></tr><tr><td>NCT00175045</td><td>Takeda</td><td>Completed</td><td>Jun 2003</td><td>Oct 2003</td><td>Interventional</td><td>Sep 2005</td><td>Esophagitis</td><td>Lansoprazole,Dexlansoprazole</td></tr><tr><td>NCT00175981</td><td>Heidelberg University</td><td>Completed</td><td>Feb 2003</td><td>Nov 2004</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Sildenafil Citrate,Fluvoxamine</td></tr><tr><td>NCT00177983</td><td>University of Pittsburgh</td><td>Completed</td><td>Jan 2003</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>Recurrence</td><td>null</td></tr><tr><td>NCT00179699</td><td>Celgene Corporation</td><td>Terminated</td><td>Sep 2005</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma</td><td>Pemetrexed,Lenalidomide</td></tr><tr><td>NCT00175383</td><td>University of British Columbia</td><td>Unknown status</td><td>Jun 2004</td><td>Dec 2013</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Hormones,Prolactin Release-Inhibiting Factors</td></tr><tr><td>NCT00178230</td><td>University of Rochester</td><td>Completed</td><td>Mar 1996</td><td>Nov 2013</td><td>Observational</td><td>Sep 2005</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT00170859</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Aug 2004</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Everolimus</td></tr><tr><td>NCT00179465</td><td>Beth Israel Deaconess Medical Center</td><td>Active, not recruiting</td><td>Nov 2003</td><td>Sep 2022</td><td>Interventional</td><td>Sep 2005</td><td>Schizophrenia</td><td>Tiagabine,Antipsychotic Agents</td></tr><tr><td>NCT00173732</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Sep 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00170976</td><td>Novartis</td><td>Completed</td><td>Apr 2004</td><td>Jun 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00173641</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Sep 2005</td><td>Aug 2006</td><td>Observational</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00173342</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Bundle-Branch Block,Heart Block</td><td>null</td></tr><tr><td>NCT00174148</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jul 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Neck Pain</td><td>null</td></tr><tr><td>NCT00170144</td><td>Mayo Clinic</td><td>Completed</td><td>Sep 2005</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00170469</td><td>PharmAthene UK Limited</td><td>Completed</td><td>Mar 2005</td><td>Feb 2007</td><td>Interventional</td><td>Sep 2005</td><td>Anthrax</td><td>Aluminum Hydroxide</td></tr><tr><td>NCT00179634</td><td>Beth Israel Deaconess Medical Center</td><td>Terminated</td><td>Mar 2005</td><td>Mar 2008</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT00175318</td><td>University of British Columbia</td><td>Completed</td><td>Apr 2005</td><td>Feb 2011</td><td>Interventional</td><td>Sep 2005</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT00175812</td><td>University of Bergen</td><td>Completed</td><td>Nov 2004</td><td>Nov 2009</td><td>Interventional</td><td>Sep 2005</td><td>Leukemia</td><td>Tretinoin,Theophylline,Valproic Acid</td></tr><tr><td>NCT00178906</td><td>Vanderbilt University</td><td>Completed</td><td>Dec 1999</td><td>Apr 2008</td><td>Observational</td><td>Sep 2005</td><td>Depression</td><td>null</td></tr><tr><td>NCT00175448</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2005</td><td>Dec 2007</td><td>Interventional</td><td>Sep 2005</td><td>Arthritis</td><td>null</td></tr><tr><td>NCT00173069</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2006</td><td>Dec 2010</td><td>Observational</td><td>Sep 2005</td><td>Schizophrenia</td><td>null</td></tr><tr><td>NCT00176956</td><td>Hordinsky, Maria K., MD</td><td>Terminated</td><td>Nov 2002</td><td>Jan 2007</td><td>Interventional</td><td>Sep 2005</td><td>Dermatitis,Skin Diseases</td><td>null</td></tr><tr><td>NCT00173095</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>Jan 2008</td><td>Observational</td><td>Sep 2005</td><td>Subarachnoid Hemorrhage,Hemorrhage</td><td>null</td></tr><tr><td>NCT00177424</td><td>University of Pittsburgh</td><td>Terminated</td><td>Jul 2004</td><td>Oct 2007</td><td>Interventional</td><td>Sep 2005</td><td>Stroke,Depression,Depressive Disorder</td><td>Sertraline</td></tr><tr><td>NCT00172783</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Dec 2005</td><td>Observational</td><td>Sep 2005</td><td>Tuberculosis</td><td>null</td></tr><tr><td>NCT00176917</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>May 1999</td><td>May 2010</td><td>Interventional</td><td>Sep 2005</td><td>Mucolipidoses,Mucopolysaccharidoses,Mucopolysaccharidosis I,Mannosidase Deficiency Diseases,alpha-Mannosidosis,Mucopolysaccharidosis VI</td><td>Cyclophosphamide,Busulfan,Thymoglobulin</td></tr><tr><td>NCT00176839</td><td>Masonic Cancer Center, University of Minnesota</td><td>Terminated</td><td>Jun 2000</td><td>Feb 2012</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasms,Hematologic Neoplasms,Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma</td><td>Cyclophosphamide,Melphalan,Busulfan,Antilymphocyte Serum,Lenograstim,Sargramostim</td></tr><tr><td>NCT00179322</td><td>National Institute on Deafness and Other Communication Disorders (NIDCD)</td><td>Completed</td><td>Sep 2005</td><td>Sep 2016</td><td>Observational</td><td>Sep 2005</td><td>Sleep Deprivation</td><td>null</td></tr><tr><td>NCT00170664</td><td>North Eastern German Society of Gynaecological Oncology</td><td>Completed</td><td>Jan 1999</td><td>Sep 2004</td><td>Interventional</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT00172003</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Sep 2004</td><td>Jul 2009</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasm Metastasis,Neoplasms,Carcinoma</td><td>Zoledronic Acid</td></tr><tr><td>NCT00170261</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>Apr 2002</td><td>Sep 2006</td><td>Interventional</td><td>Sep 2005</td><td>Syncope</td><td>null</td></tr><tr><td>NCT00179075</td><td>Vanderbilt University</td><td>Completed</td><td>Apr 2003</td><td>Apr 2008</td><td>Observational</td><td>Sep 2005</td><td>Graft vs Host Disease</td><td>null</td></tr><tr><td>NCT00179777</td><td>University of Helsinki</td><td>Completed</td><td>May 2002</td><td>Sep 2017</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00174018</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Sep 1993</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Shoulder Impingement Syndrome</td><td>null</td></tr><tr><td>NCT00171535</td><td>Novartis</td><td>Completed</td><td>Oct 2004</td><td>Apr 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00173914</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2003</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00175825</td><td>UCB Pharma</td><td>Completed</td><td>Nov 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Epilepsy,Seizures</td><td>Brivaracetam</td></tr><tr><td>NCT00172198</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2005</td><td>Mar 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00171366</td><td>Novartis</td><td>Completed</td><td>Jul 2004</td><td>Jul 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Benazepril</td></tr><tr><td>NCT00170287</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>May 2002</td><td>Aug 2011</td><td>Interventional</td><td>Sep 2005</td><td>Tachycardia</td><td>null</td></tr><tr><td>NCT00170729</td><td>Novartis</td><td>Completed</td><td>Aug 2004</td><td>Feb 2005</td><td>Interventional</td><td>Sep 2005</td><td>Cataract,Capsule Opacification,Uveitis,Inflammation</td><td>Prednisolone,Methylprednisolone Acetate,Methylprednisolone,Methylprednisolone Hemisuccinate,Prednisolone acetate,Prednisolone hemisuccinate,Prednisolone phosphate</td></tr><tr><td>NCT00173225</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Asthma,Cough</td><td>null</td></tr><tr><td>NCT00178100</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 1999</td><td>Aug 2005</td><td>Interventional</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>Paroxetine</td></tr><tr><td>NCT00176397</td><td>University of Leipzig</td><td>Unknown status</td><td>Aug 2003</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Coronary Stenosis,Constriction</td><td>null</td></tr><tr><td>NCT00177333</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2005</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Vomiting</td><td>Doxycycline</td></tr><tr><td>NCT00175643</td><td>University of British Columbia</td><td>Completed</td><td>Feb 2005</td><td>Nov 2005</td><td>Interventional</td><td>Sep 2005</td><td>Keratosis</td><td>Imiquimod</td></tr><tr><td>NCT00172913</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jul 2008</td><td>Observational</td><td>Sep 2005</td><td>Myopia</td><td>null</td></tr><tr><td>NCT00173628</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 1990</td><td>Dec 2006</td><td>Observational</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00172757</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2002</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Colorectal Neoplasms,Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00174512</td><td>Pfizer</td><td>Completed</td><td>Mar 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Heart Diseases,Myocardial Ischemia,Coronary Artery Disease</td><td>Moxifloxacin</td></tr><tr><td>NCT00172939</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jan 2008</td><td>Interventional</td><td>Sep 2005</td><td>Vitiligo</td><td>null</td></tr><tr><td>NCT00176995</td><td>Hordinsky, Maria K., MD</td><td>Completed</td><td>Mar 1999</td><td>Oct 2000</td><td>Interventional</td><td>Sep 2005</td><td>Hair Diseases</td><td>Eflornithine</td></tr></tbody></table>Showing the first 1000 rows.</div>"]}}],"execution_count":0},{"cell_type":"code","source":["# File location and type\nfile_location = \"/FileStore/tables/clinicaltrial_2020.csv/clinicaltrial_2020.csv\"\nfile_type = \"csv\"\n\n# CSV options\ninfer_schema = \"true\"\nfirst_row_is_header = \"true\"\ndelimiter = \"|\"\n\n# The applied options are for CSV files. For other file types, these will be ignored.\ndf = spark.read.format(file_type) \\\n  .option(\"inferSchema\", infer_schema) \\\n  .option(\"header\", first_row_is_header) \\\n  .option(\"sep\", delimiter) \\\n  .load(file_location)\n\ndisplay(df)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"35be0efe-958c-4d66-9393-c1ecb7a69ceb"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"overflow":true,"datasetInfos":[],"data":[["NCT02758028","The University of Hong Kong","Recruiting","Aug 2005","Nov 2021","Interventional","Apr 2016",null,null],["NCT02751957","Duke University","Completed","Jul 2016","Jul 2020","Interventional","Apr 2016","Autistic Disorder,Autism Spectrum Disorder",null],["NCT02758483","Universidade Federal do Rio de Janeiro","Completed","Mar 2017","Jan 2018","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02759848","Istanbul Medeniyet University","Completed","Jan 2012","Dec 2014","Observational","May 2016","Tuberculosis,Lung Diseases,Pulmonary Disease",null],["NCT02758860","University of Roma La Sapienza","Active, not recruiting","Jun 2016","Sep 2020","Observational [Patient Registry]","Apr 2016","Diverticular Diseases,Diverticulum,Diverticulosis",null],["NCT02757209","Consorzio Futuro in Ricerca","Completed","Apr 2016","Jan 2018","Interventional","Apr 2016","Asthma","Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate"],["NCT02752438","Ankara University","Unknown status","May 2016","Jul 2017","Observational [Patient Registry]","Apr 2016","Hypoventilation",null],["NCT02753543","Ruijin Hospital","Unknown status","Nov 2015","Nov 2019","Interventional","Apr 2016","Lymphoma",null],["NCT02757508","Washington University School of Medicine","Completed","Mar 2016","Jul 2017","Interventional","Apr 2016",null,"Vitamins"],["NCT02753530","Orphazyme","Completed","Aug 2017","Jan 2021","Interventional","Apr 2016","Myositis",null],["NCT02754817","Novo Nordisk A/S","Completed","Apr 2016","Oct 2016","Observational","Apr 2016","Diabetes Mellitus","Liraglutide,Xultophy"],["NCT02759276","Daniel Alexandre Bottino","Completed","May 2015","Dec 2015","Observational","Apr 2016","Hypertension",null],["NCT02750956","Bulent Ecevit University","Completed","Jun 2015","Mar 2016","Observational","Apr 2016","Periodontal Diseases",null],["NCT02752113","Institut für Pharmakologie und Präventive Medizin","Completed","Apr 2016","May 2019","Interventional","Apr 2016","Diabetes Mellitus","Metformin,Empagliflozin,Linagliptin"],["NCT02752698","The Third Xiangya Hospital of Central South University","Active, not recruiting","Jan 2015","Dec 2021","Interventional","Jun 2015","Appendicitis,Stomach Ulcer,Cholecystolithiasis,Cholelithiasis,Gallstones",null],["NCT02755779","Tel Aviv Medical Center","Unknown status","Jun 2016","Jun 2017","Observational","Apr 2016",null,null],["NCT02750384","Medicines for Malaria Venture","Terminated","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02754609","James Cook University, Queensland, Australia","Completed","Sep 2016","Oct 2019","Interventional","Apr 2016","Hookworm Infections,Celiac Disease",null],["NCT02755701","Soonchunhyang University Hospital","Unknown status","Jul 2016","Dec 2018","Interventional","Apr 2016","Ascites",null],["NCT02751762","Member Companies of the Opioid PMR Consortium","Recruiting","Nov 2017","Oct 2022","Observational","Apr 2016","Chronic Pain,Substance-Related Disorders,Opioid-Related Disorders,Narcotic-Related Disorders,Behavior",null],["NCT02756299","Marmara University","Completed","Jun 2014","Apr 2015","Interventional","Apr 2016","Sleep Apnea Syndromes,Sleep Apnea",null],["NCT02750709","Cycle Pharmaceuticals Ltd.","Completed","Oct 2015","Jan 2016","Interventional","Apr 2016","Tyrosinemias","Nitisinone"],["NCT02753907","Yonsei University","Completed","Jun 2015",null,"Interventional","Apr 2016",null,null],["NCT02755467","Cutera Inc.","Completed","May 2016","Apr 2017","Interventional","Apr 2016","Hemangioma",null],["NCT02755298","University of Zurich","Completed","Oct 2016","Nov 2020","Interventional","Mar 2016","Hypertension","Acetazolamide"],["NCT02759614","Guangdong Association of Clinical Trials","Unknown status","Apr 2016","Jun 2019","Interventional","Mar 2016","Carcinoma","Bevacizumab,Erlotinib Hydrochloride"],["NCT02752815","Ruijin Hospital","Unknown status","Apr 2016","Jun 2020","Interventional","Apr 2016","Lymphoma","Prednisone,Cyclophosphamide,Rituximab,Vincristine,Epirubicin"],["NCT02757131","The Cleveland Clinic","Completed","Jul 2016","Jul 2017","Interventional","Apr 2016","Iatrogenic Disease",null],["NCT02758704","St. Justine's Hospital","Completed","Oct 2015","Jun 2021","Interventional","Apr 2016",null,null],["NCT02750501","Alcresta Therapeutics, Inc.","Completed","Jul 2016","Mar 2017","Interventional","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02759913","Iron Horse Diagnostics, Inc.","Unknown status","Jan 2015","Dec 2016","Observational","Apr 2016","Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis",null],["NCT02752724","VA Puget Sound Health Care System","Completed","Mar 2016","Apr 2018","Interventional","Mar 2016","Depressive Disorder,Depression","Ketamine,Methohexital"],["NCT02758444","University of Colorado, Denver","Completed","Nov 2015","Feb 2019","Interventional","Apr 2016",null,"Micronutrients,Trace Elements"],["NCT02758067","H. Lundbeck A/S","Withdrawn","Jun 2016",null,"Interventional","Apr 2016","Schizophrenia","Risperidone,Brexpiprazole"],["NCT02759341","Ospedale San Giovanni Bellinzona","Completed","Feb 2016","Nov 2017","Interventional","Apr 2016","Myocardial Infarction,Cardiomyopathies,Microvascular Angina,Takotsubo Cardiomyopathy,Syndrome,Infarction",null],["NCT02753803","Dong-A ST Co., Ltd.","Completed","Jul 2016","Mar 2017","Interventional","Apr 2016",null,"Pioglitazone"],["NCT02752490","The University of Texas Health Science Center, Houston","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02759562","Gilead Sciences","Terminated","Nov 2016","Jul 2017","Interventional","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02758262","Laval University","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016","Hyperphagia",null],["NCT02754258","Children's Hospital of Eastern Ontario","Unknown status","Jan 2017","Dec 2018","Interventional","Apr 2016",null,"Methylphenidate"],["NCT02755207","Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","Unknown status","Apr 2016","Dec 2020","Observational","Mar 2016","Acute Coronary Syndrome,Syndrome",null],["NCT02759900","The Skin Center Dermatology Group","Recruiting","Jan 2016","Jan 2023","Interventional","Apr 2016","Molluscum Contagiosum,Keratosis,Bowens Disease,Rosacea,Skin Diseases",null],["NCT02752581","Mert Özcan","Completed","Jan 2009","Apr 2013","Interventional","Apr 2016","Hemarthrosis",null],["NCT02759796","Instituto de Investigación Hospital Universitario La Paz","Completed","Nov 2015","Apr 2017","Interventional","Apr 2016","Necrosis,Neovascularization,Fat Necrosis",null],["NCT02754063","University Hospital, Grenoble","Active, not recruiting","Jun 2016","Apr 2022","Interventional","Apr 2016","Brain Injuries,Wounds and Injuries","3"],["NCT02750917","Foisor Orthopedics Clinical Hospital","Completed","Sep 2014","Mar 2015","Interventional","Feb 2016","Pain","Etoricoxib,Lornoxicam"],["NCT02753569","Institute of Cancer Research, United Kingdom","Completed","May 2016","May 2020","Observational","Apr 2016",null,null],["NCT02751255","VU University Medical Center","Active, not recruiting","Jul 2016","Mar 2022","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Tretinoin"],["NCT02751528","NantBioScience, Inc.","Unknown status","Dec 2016","Dec 2020","Interventional","Apr 2016","Breast Neoplasms","Vaccines"],["NCT02751619","University of Campania Luigi Vanvitelli","Completed","Jan 2013","Dec 2015","Interventional","Apr 2016","Pain","Lidocaine"],["NCT02757833","Lawson Health Research Institute","Withdrawn","Feb 2019","Feb 2019","Interventional","Apr 2016","Depression,Depressive Disorder",null],["NCT02750761","Merck Sharp & Dohme Corp.","Completed","May 2016","Dec 2018","Interventional","Apr 2016","Infections,Bacterial Infections,Gram-Positive Bacterial Infections","Tedizolid phosphate,Tedizolid,Oxazolidinones"],["NCT02752594","Sharda University","Completed","Apr 2015","Apr 2015","Interventional","Apr 2016","Dental Caries",null],["NCT02753452","Holland Bloorview Kids Rehabilitation Hospital","Unknown status","May 2015","Mar 2020","Interventional","Apr 2016",null,null],["NCT02752763","Niğde State Hospital","Completed","Oct 2015","Mar 2016","Interventional","Mar 2016","Dry Eye Syndromes,Keratoconjunctivitis Sicca","Dextrans,Povidone,Ophthalmic Solutions,Lubricant Eye Drops"],["NCT02753816","Spectrum Health Hospitals","Terminated","Apr 2016","Dec 2019","Interventional","Apr 2016","Burns","Tranexamic Acid"],["NCT02751294","GlaxoSmithKline","Completed","May 2016","Aug 2016","Interventional","Apr 2016","Malaria","Tafenoquine"],["NCT02756429","Hospices Civils de Lyon","Completed","Feb 2014","Jan 2018","Interventional","Apr 2016","Atrial Fibrillation",null],["NCT02750163","Università Politecnica delle Marche","Completed","Jul 2017","Jun 2019","Observational","Apr 2016","Shock","Acetaminophen"],["NCT02751905","Biogen","Completed","Apr 2016","May 2016","Interventional","Apr 2016","Neuralgia",null],["NCT02753153","University of Liege","Completed","May 2011","May 2015","Interventional","Apr 2016","Tooth Loss",null],["NCT02750891","Sumitomo Dainippon Pharma Co., Ltd.","Completed","Apr 2016","Jan 2020","Interventional","Apr 2016","Glioblastoma,Glioma,Diffuse Intrinsic Pontine Glioma",null],["NCT02751073","Mayo Clinic","Completed","Feb 2016","Jul 2018","Observational","Feb 2016","Infections,Communicable Diseases,Urinary Tract Infections,Prolapse,Pelvic Organ Prolapse",null],["NCT02753114","University of British Columbia","Completed","Nov 2017","May 2018","Interventional","Apr 2016","Acute Pain","Ketamine"],["NCT02752516","Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016",null,null],["NCT02752269","Medical University of Graz","Completed","Oct 2014","Jun 2019","Observational","Nov 2015","Sjogrens Syndrome,Hypertension,Vascular Diseases,Syndrome",null],["NCT02754713","Hippocration General Hospital","Recruiting","Sep 2009","Dec 2025","Observational","Apr 2016","Pericarditis",null],["NCT02759770","Beijing Anzhen Hospital","Completed","Jul 2017","Sep 2017","Observational","Apr 2016","Respiratory Distress Syndrome,Acute Lung Injury",null],["NCT02755129","Medtronic BRC","Completed","Sep 2016","Jul 2017","Interventional","Mar 2016","Frailty",null],["NCT02754674","Samsung Medical Center","Completed","May 2014","Dec 2017","Interventional","Feb 2015","Rupture",null],["NCT02757521","Washington University School of Medicine","Terminated","Mar 2016","Dec 2016","Interventional","Apr 2016","Disease,Depression,Depressive Disorder,Bipolar Disorder","Nitrous Oxide"],["NCT02750774","University of Modena and Reggio Emilia","Unknown status","Dec 2015","Dec 2016","Interventional","Apr 2016","Diabetes,Obesity,Pregnancy Complications,Fetal Macrosomia,Overweight,Birth Weight",null],["NCT02754739","Samsung Medical Center","Completed","Apr 2014","Aug 2017","Interventional","Apr 2016","Diabetes Mellitus,Prediabetic State","Pravastatin"],["NCT02758808","University of Michigan","Recruiting","Mar 2016","Oct 2023","Observational [Patient Registry]","Apr 2016","Lung Diseases,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis",null],["NCT02751840","Tel Hai College","Completed","Oct 2014","Apr 2016","Interventional","Apr 2016","Asymptomatic Diseases","Caffeine"],["NCT02752451","University of Arizona","Completed","Mar 2015","Apr 2015","Interventional","Apr 2016",null,null],["NCT02757599","Rigshospitalet, Denmark","Completed","Aug 2016","Jun 2017","Interventional","Apr 2016",null,null],["NCT02753894","Astellas Pharma Inc","Completed","Jan 2008","Jun 2008","Interventional","Mar 2016","Kidney Diseases,Renal Insufficiency,Hyperphosphatemia",null],["NCT02757638","Texas A&M University","Active, not recruiting","Oct 2015","Oct 2021","Interventional","Feb 2016","Weight Loss",null],["NCT02757378","Kevin Farrell","Completed","May 2015","Sep 2015","Interventional","Apr 2016","Back Pain,Low Back Pain",null],["NCT02751489","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02759315","Merck Sharp & Dohme Corp.","Terminated","May 2016","Nov 2017","Interventional","Apr 2016","Hepatitis A,Hepatitis C,Hepatitis","Uprifosbuvir,Ruzasvir"],["NCT02754895","Massachusetts General Hospital","Completed","Oct 2014","May 2017","Interventional","Apr 2016","Acute Coronary Syndrome,Syndrome",null],["NCT02750475","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis","Sunscreening Agents"],["NCT02755064","Adil Bharucha","Completed","Jun 2010","Nov 2013","Interventional","Apr 2016","Diabetes Mellitus","Erythromycin,Erythromycin Estolate,Erythromycin Ethylsuccinate,Erythromycin stearate,Erythromycin lactobionate"],["NCT02758002","University of California, San Diego","Withdrawn","Jan 2016","Dec 2018","Interventional","Apr 2016","Atrial Fibrillation",null],["NCT02755142","medac GmbH","Completed","Feb 2000","Jun 2001","Interventional","Apr 2016","Glioma,Brain Neoplasms","Aminolevulinic Acid"],["NCT02756364","Millennium Pharmaceuticals, Inc.","Completed","Jul 2016","Nov 2019","Interventional","Apr 2016","Breast Neoplasms","Fulvestrant"],["NCT02759484","Rush University Medical Center","Unknown status","Mar 2015","Mar 2019","Interventional","Dec 2015","Hypertension,Diabetes Mellitus,Hyperglycemia",null],["NCT02752061","Harvard School of Public Health (HSPH)","Completed","May 2016","Jul 2020","Interventional","Apr 2016",null,null],["NCT02756598","Aarhus University Hospital","Completed","Jan 2015","Jun 2018","Interventional","Dec 2015",null,"Sufentanil,Dsuvia,Propofol"],["NCT02755727","Royal Devon and Exeter NHS Foundation Trust","Completed","Mar 2016","Sep 2017","Interventional","Apr 2016","Tennis Elbow",null],["NCT02754882","Samsung Bioepis Co., Ltd.","Completed","Jul 2016","Oct 2018","Interventional","Mar 2016","Lung Neoplasms,Carcinoma","Paclitaxel,Bevacizumab,Carboplatin"],["NCT02754778","Martin-Luther-Universität Halle-Wittenberg","Completed","Apr 2016","Mar 2021","Interventional","Apr 2016","Pre-Eclampsia,HELLP Syndrome,Syndrome",null],["NCT02758171","Boehringer Ingelheim","Completed","May 2016","Aug 2016","Interventional","Apr 2016",null,"Empagliflozin,Linagliptin"],["NCT02755376","Samsung Medical Center","Completed","Jan 2014","Dec 2018","Interventional","Feb 2015",null,"Hyaluronic Acid"],["NCT02759016","Boehringer Ingelheim","Completed","Jun 2016","Jul 2019","Interventional","Apr 2016","Leukemia","BI 836826"],["NCT02758457","University of Bologna","Completed","Jan 2008","Apr 2015","Interventional","Apr 2016",null,null],["NCT02755519","Chongqing Medical University","Completed","May 2014","Oct 2016","Observational","Apr 2016","Hyperaldosteronism",null],["NCT02758782","Charite University, Berlin, Germany","Completed","Sep 2016","Jan 2021","Interventional","Apr 2016","Spondylitis","Celecoxib,Golimumab"],["NCT02756806","Cutera Inc.","Completed","Apr 2016","Sep 2016","Interventional","Apr 2016",null,null],["NCT02756156","Kahramanmaras Sutcu Imam University","Unknown status","Apr 2016","Aug 2016","Observational","Mar 2016","Humeral Fractures",null],["NCT02759458","Rush University Medical Center","Completed","Nov 2013","Jan 2017","Interventional","Apr 2016","Rotator Cuff Injuries",null],["NCT02750982","Brown, Theodore R., M.D., MPH","Completed","Jul 2016","Aug 2018","Interventional","Apr 2016","Parkinson Disease,Multiple Sclerosis,Alzheimer Disease,Brain Injuries,Spinal Cord Injuries,Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Huntington Disease,Sclerosis,Wounds and Injuries",null],["NCT02751502","NYU Langone Health","Terminated","Jan 2017","Feb 2021","Interventional","Apr 2016","Hemiplegia",null],["NCT02752087","Eli Lilly and Company","Completed","Apr 2016","May 2016","Interventional","Apr 2016",null,null],["NCT02756858","Anavex Life Sciences Corp.","Completed","Mar 2016","Nov 2020","Interventional","Mar 2016","Alzheimer Disease",null],["NCT02758249","Konkuk University Medical Center","Completed","Jan 2016","Jan 2016","Interventional","Feb 2016",null,"Propofol,Sevoflurane"],["NCT02754570","University of Colorado, Denver","Completed","Jul 2016","Feb 2018","Interventional","Apr 2016","Glaucoma,Ocular Hypertension,Hypertension","Pilocarpine"],["NCT02754102","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis","Sunscreening Agents"],["NCT02751593","Peking University People's Hospital","Unknown status","Jan 2016","Dec 2017","Interventional","Apr 2016","Thrombocytopenia,Purpura","Dexamethasone"],["NCT02757014","Bayer","Completed","Oct 2015","Oct 2015","Interventional","Apr 2016",null,null],["NCT02753062","Asan Medical Center","Recruiting","Aug 2015","Aug 2023","Interventional","Apr 2016","Lymphoma","Rituximab,Bendamustine Hydrochloride"],["NCT02752425","Hospices Civils de Lyon","Completed","May 2016","May 2018","Interventional","Apr 2016","Speech Disorders",null],["NCT02757300","Marienhospital Osnabrück","Unknown status","May 2016","Jul 2017","Interventional","Apr 2016","Pharyngitis",null],["NCT02754180","Peking Union Medical College Hospital","Unknown status","Mar 2016","Mar 2021","Interventional","Apr 2016","Adenocarcinoma,Pancreatic Neoplasms","Gemcitabine"],["NCT02752321","Northwell Health","Terminated","Aug 2016","Dec 2017","Interventional","Apr 2016",null,null],["NCT02753595","Eisai Inc.","Terminated","Jul 2016","Aug 2019","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02755246","Charite University, Berlin, Germany","Completed","Apr 2016","Sep 2016","Interventional","Apr 2016","Cognitive Dysfunction",null],["NCT02754115","Tata Memorial Centre","Recruiting","Apr 2016","Jan 2022","Observational","Mar 2016","Peritoneal Diseases",null],["NCT02756897","M.D. Anderson Cancer Center","Active, not recruiting","Jul 2016","Jul 2024","Interventional","Apr 2016","Lymphoma,Leukemia","Venetoclax"],["NCT02752334","Magrabi Eye & Ear Hospital","Completed","Sep 2015","Mar 2019","Interventional","Mar 2016",null,"Magnesium Sulfate,Bupivacaine"],["NCT02754791","Shaare Zedek Medical Center","Unknown status","May 2016","May 2017","Interventional","Apr 2016",null,null],["NCT02754128","Holland Bloorview Kids Rehabilitation Hospital","Completed","Jun 2016","Oct 2017","Interventional","Apr 2016","Cerebral Palsy",null],["NCT02751190","Umeå University","Completed","Sep 2013","Feb 2017","Observational [Patient Registry]","Apr 2016","Chronic Pain,Hernia",null],["NCT02751645","Oregon Health and Science University","Unknown status","Jun 2016","May 2020","Interventional","Apr 2016",null,null],["NCT02758184","Duke University","Terminated","Jun 2016","May 2018","Interventional","Apr 2016",null,null],["NCT02751892","University of East Anglia","Completed","Oct 2013","Sep 2014","Interventional","Apr 2016","Colorectal Neoplasms",null],["NCT02755324","Leiden University","Completed","Oct 2016","Jan 2019","Interventional","Apr 2016","Schistosomiasis",null],["NCT02758886","Washington State University","Completed","Apr 2014",null,"Interventional","Apr 2016","Stress",null],["NCT02750072","Fraser Orthopaedic Research Society","Active, not recruiting","Sep 2016","Apr 2023","Interventional","Apr 2016","Patellofemoral Pain Syndrome,Fractures,Tibial Fractures",null],["NCT02750332","Cycle Pharmaceuticals Ltd.","Completed","Nov 2015","Jan 2016","Interventional","Apr 2016","Tyrosinemias","Nitisinone"],["NCT02752529","Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","Unknown status","Mar 2016",null,"Interventional","Mar 2016","Liver Cirrhosis","Tacrolimus"],["NCT02759939","Dartmouth-Hitchcock Medical Center","Completed","Jul 2016","Jul 2017","Interventional","Feb 2016",null,null],["NCT02757157","European Respiratory Society","Terminated","Oct 2016","Jan 2020","Interventional","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02759627","Istanbul University","Completed","Nov 2014","Mar 2016","Interventional","Apr 2016","Stroke",null],["NCT02752412","Sanofi","Completed","May 2016","Oct 2018","Interventional","Apr 2016","Diabetes Mellitus","Insulin,Metformin,Insulin Glargine,Lixisenatide"],["NCT02756988","Bayer","Completed","Oct 2015","Oct 2015","Interventional","Apr 2016",null,null],["NCT02751203","Lara McKenzie","Completed","Apr 2016","Dec 2017","Interventional","Mar 2016",null,null],["NCT02753946","Nabriva Therapeutics AG","Completed","Apr 2016","May 2017","Interventional","Apr 2016","Infections,Communicable Diseases,Urinary Tract Infections,Pyelonephritis","Tazobactam,Piperacillin,Fosfomycin"],["NCT02755480","University Health Network, Toronto","Terminated","Feb 2015","Feb 2017","Interventional","Mar 2015",null,null],["NCT02753257","Valtari Bio","Unknown status","Sep 2016","Dec 2019","Observational","Apr 2016","Stroke",null],["NCT02758691","Virginia Polytechnic Institute and State University","Completed","Dec 2015","May 2017","Interventional","Apr 2016",null,"Insulin"],["NCT02755623","Centre hospitalier de Ville-Evrard, France","Unknown status","May 2015","Dec 2018","Interventional","Apr 2016","Hallucinations,Schizophrenia",null],["NCT02756234","Lancaster General Hospital","Completed","May 2016","Aug 2018","Observational","Apr 2016","Coronary Artery Disease",null],["NCT02756091","University Hospital Inselspital, Berne","Recruiting","Aug 2016","May 2022","Observational [Patient Registry]","Apr 2016","Cerebrovascular Disorders",null],["NCT02753491","Marmara University","Completed","Oct 2015","Mar 2016","Interventional","Apr 2016",null,null],["NCT02752737","Medtronic Cardiac Rhythm and Heart Failure","Recruiting","May 2016","Dec 2024","Observational [Patient Registry]","Apr 2016","Atrial Fibrillation",null],["NCT02758925","University Hospital, Caen","Unknown status","Jun 2016","Dec 2018","Interventional","Apr 2016","Lymphoma","Cytarabine,Rituximab,Bendamustine Hydrochloride"],["NCT02751723","Florian Lordick, MD","Unknown status","Sep 2014","Oct 2019","Observational","Apr 2016",null,null],["NCT02751931","Astellas Pharma Europe B.V.","Completed","Jun 2016","May 2019","Interventional","Apr 2016","Urinary Bladder","Mirabegron"],["NCT02758847","Rabih A. Chaer","Recruiting","Sep 2016","Dec 2022","Interventional","Apr 2016","Ischemia","Paclitaxel,Albumin-Bound Paclitaxel"],["NCT02757807","Eco Fusion","Unknown status","Jul 2016","Dec 2016","Interventional","Apr 2016","Erectile Dysfunction",null],["NCT02755220","Shanghai Cingularbio Co. Ltd","Completed","Jan 2016","Apr 2019","Interventional","Apr 2016",null,null],["NCT02758548","Novartis Pharmaceuticals","Completed","Mar 2016","May 2016","Interventional","Mar 2016",null,null],["NCT02756845","Amgen","Recruiting","Aug 2017","Jun 2024","Interventional","Dec 2015","Neoplasms","Talimogene laherparepvec"],["NCT02750605","Skane University Hospital","Active, not recruiting","Feb 2016","Dec 2021","Interventional","Jan 2016","Vascular Diseases,Peripheral Vascular Diseases,Peripheral Arterial Disease,Ischemia",null],["NCT02756702","Aesculap AG","Active, not recruiting","Mar 2016","Dec 2022","Observational","Apr 2016","Osteoarthritis",null],["NCT02752945","King's College London","Completed","Apr 2016","Dec 2016","Interventional","Apr 2016","Depression,Depressive Disorder,Anxiety Disorders",null],["NCT02759952","STZ eyetrial","Enrolling by invitation","Jan 2013","Dec 2025","Observational","Apr 2016","Retinitis,Retinitis Pigmentosa",null],["NCT02754661","Medtronic - MITG","Completed","Sep 2016","Aug 2018","Interventional","Apr 2016","Colorectal Neoplasms",null],["NCT02755441","Nils Hoyer","Recruiting","Apr 2016","Dec 2024","Observational","Apr 2016","Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis",null],["NCT02750098","Sheba Medical Center","Unknown status","May 2016","Mar 2018","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02753179","Hospices Civils de Lyon","Completed","May 2016","Jan 2017","Interventional","Apr 2016","Vestibular Diseases",null],["NCT02758509","Parc de Salut Mar","Completed","Jan 2010","Oct 2017","Observational","Apr 2016","Hepatitis C,Hepatitis","Interferons,Ritonavir,Ribavirin,Interferon-alpha,Interferon alpha-2,Sofosbuvir,Peginterferon alfa-2a,Ledipasvir,Simeprevir"],["NCT02751970","Universidad de Valparaiso","Unknown status","Apr 2014","Apr 2018","Interventional","Apr 2016","Dental Caries",null],["NCT02753712","Mundipharma Research Limited","Completed","Jun 2016","Aug 2017","Interventional","Apr 2016","Asthma","Fluticasone,Xhance,Formoterol Fumarate"],["NCT02751151","Inova Health Care Services","Completed","Feb 2016","May 2021","Interventional","Mar 2016","Skin Neoplasms","Aminolevulinic Acid"],["NCT02757716","Sana Klinikum Offenbach","Completed","Apr 2016","Jan 2019","Interventional","Apr 2016","Behavior",null],["NCT02758652","Tampere University Hospital","Active, not recruiting","May 2016","May 2026","Observational","Apr 2016","Ovarian Neoplasms,Carcinoma",null],["NCT02754206","Southern Methodist University","Terminated","Jan 2016","Sep 2021","Observational","Apr 2016","Post-Concussion Syndrome,Brain Concussion",null],["NCT02752243","Peter Bader","Active, not recruiting","Mar 2016","Mar 2022","Interventional","Mar 2016","Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome,Acute Disease",null],["NCT02754856","M.D. Anderson Cancer Center","Active, not recruiting","Jul 2016","Jul 2021","Interventional","Apr 2016","Colorectal Neoplasms","Durvalumab,Ipilimumab,Tremelimumab,Immunoglobulins,Antibodies,Immunoglobulin G"],["NCT02759861","University of Nebraska","Active, not recruiting","Aug 2016","Aug 2020","Interventional","Apr 2016","Hepatitis A,Hepatitis C,Hepatitis","Sofosbuvir,Ledipasvir"],["NCT02759679","Haukeland University Hospital","Unknown status","May 2016","Dec 2019","Interventional","Mar 2016","Lung Neoplasms",null],["NCT02752932","Lawson Health Research Institute","Completed","Nov 2015","Oct 2017","Interventional","Feb 2016","Carcinoma,Squamous Cell Carcinoma of Head and Neck,Neoplasms",null],["NCT02759445","RWTH Aachen University","Unknown status","Apr 2016","Oct 2016","Observational","Nov 2015",null,null],["NCT02754622","Guy's and St Thomas' NHS Foundation Trust","Completed","Jul 2016","Dec 2016","Observational","Apr 2016","Critical Illness",null],["NCT02756611","AbbVie","Active, not recruiting","Jun 2016","Sep 2022","Interventional","Apr 2016","Leukemia","Venetoclax"],["NCT02758223","Wuerzburg University Hospital","Active, not recruiting","Apr 2016","Jun 2021","Interventional","Feb 2016","Leukemia,Myelodysplastic Syndromes",null],["NCT02757079","Nobelpharma","Completed","Jun 2016","Jul 2018","Interventional","Apr 2016","Sleep Wake Disorders,Parasomnias,Disease,Neurodevelopmental Disorders","Melatonin"],["NCT02754219","Dong-A ST Co., Ltd.","Completed","Sep 2016","Jan 2018","Interventional","Apr 2016","Liver Diseases",null],["NCT02753101","Stanford University","Completed","Feb 2016","Feb 2017","Interventional","Apr 2016","Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Sciatica",null],["NCT02759003","Fondazione Salvatore Maugeri","Completed","Mar 2011","Mar 2014","Interventional","Apr 2016","Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis",null],["NCT02752659","University of British Columbia","Completed","Jun 2016","Jun 2017","Interventional","Apr 2016","Breast Neoplasms,Lymphedema",null],["NCT02758912","Burnasyan Federal Medical Biophysical Center","Completed","Nov 2016","Oct 2019","Interventional","Apr 2016","Stroke,Angina Pectoris,Infarction,Hemorrhage",null],["NCT02754388","National Taiwan University Hospital","Completed","Feb 2016","Dec 2019","Observational [Patient Registry]","Apr 2016","Lung Neoplasms",null],["NCT02759666","Atridia Pty Ltd.","Completed","Jun 2016","Apr 2019","Interventional","Apr 2016","Neoplasms",null],["NCT02750241","The University of Texas Medical Branch, Galveston","Completed","Apr 2016","Jan 2019","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02752568","Kasr El Aini Hospital","Unknown status","May 2016","Dec 2016","Interventional","Apr 2016",null,null],["NCT02758015","University of California, San Francisco","Completed","Jun 2016","Mar 2018","Interventional","Apr 2016",null,"Betaine"],["NCT02756884","Arkansas Heart Hospital","Completed","Jun 2015","Jan 2019","Interventional","Apr 2016","Peripheral Arterial Disease,Peripheral Vascular Diseases",null],["NCT02758353","JSI Research & Training Institute, Inc.","Completed","Apr 2015","Nov 2015","Interventional","Apr 2016","Malaria,Stillbirth",null],["NCT02753751","Yale University","Completed","Mar 2018","Jan 2020","Interventional","Apr 2016","Acute Kidney Injury,Wounds and Injuries",null],["NCT02757170","All India Institute of Medical Sciences, New Delhi","Unknown status","Jul 2015","Jul 2016","Interventional","Apr 2016","Liver Failure,Hepatic Insufficiency,End Stage Liver Disease,Acute-On-Chronic Liver Failure",null],["NCT02757625","Pfizer","Completed","Jul 2016","May 2017","Interventional","Apr 2016",null,"Dexmedetomidine"],["NCT02752347","Riyadh Colleges of Dentistry and Pharmacy","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016","Malocclusion",null],["NCT02756468","University of Roma La Sapienza","Unknown status","Jan 2015","Dec 2016","Observational [Patient Registry]","Apr 2016","Pancreatic Neoplasms",null],["NCT02750410","Eli Lilly and Company","Completed","Aug 2016","Jun 2018","Interventional","Apr 2016","Diabetes Mellitus","Dulaglutide"],["NCT02755389","Nova Scotia Health Authority","Completed","Sep 2016","Jun 2018","Interventional","Apr 2016","Apnea",null],["NCT02755168","Assiut University","Unknown status","May 2017","May 2018","Interventional","Apr 2016",null,null],["NCT02751567","Bayer","Withdrawn","May 2016","Jun 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02755558","Penn State University","Completed","Sep 2014","May 2015","Interventional","Apr 2016",null,null],["NCT02757547","Electrical Geodesics, Inc.","Terminated","Sep 2015","Nov 2017","Interventional","Apr 2016","Epilepsy",null],["NCT02752828","Sanofi","Completed","May 2016","Mar 2018","Interventional","Apr 2016","Diabetes Mellitus","Insulin,Insulin Glargine,Lixisenatide,Hypoglycemic Agents"],["NCT02756715","Konkuk University Medical Center","Completed","May 2016","Feb 2020","Interventional","Apr 2016","Vascular System Injuries,Ischemia","Propofol,Desflurane"],["NCT02756117","Vanderbilt University","Completed","May 2016","Oct 2016","Interventional","Apr 2016","Prediabetic State",null],["NCT02753205","Gachon University Gil Medical Center","Withdrawn","Apr 2016","Apr 2018","Interventional","Apr 2016","Intracranial Hypertension","Dexmedetomidine"],["NCT02756221","Tel Hai College","Completed","Mar 2016","Apr 2018","Interventional","Apr 2016","Respiratory Tract Infections,Gastroenteritis",null],["NCT02755675","Rigshospitalet, Denmark","Recruiting","Apr 2016","Oct 2023","Interventional","Apr 2016","Carcinoma,Lung Neoplasms,Mesothelioma",null],["NCT02754037","University of California, Davis","Recruiting","Apr 2016","Jun 2024","Observational","Apr 2016","Liver Diseases,Fatty Liver,Non-alcoholic Fatty Liver Disease,Inflammation","Fluorodeoxyglucose F18"],["NCT02750306","Merck Sharp & Dohme Corp.","Completed","May 2016","Sep 2018","Interventional","Apr 2016","Alzheimer Disease,Sleep Initiation and Maintenance Disorders","Suvorexant"],["NCT02756403","Medstar Health Research Institute","Completed","Mar 2016","Jul 2017","Interventional","Mar 2016",null,"Azithromycin,Metronidazole,Doxycycline"],["NCT02759653","Haukeland University Hospital","Completed","May 2016","Dec 2018","Observational","Apr 2016","Stroke,Ischemic Stroke,Carotid Artery Diseases,Embolic Stroke",null],["NCT02753920","Northwell Health","Completed","Mar 2016","Jul 2018","Interventional","Apr 2016","Prolapse",null],["NCT02759367","Samuel Lunenfeld Research Institute, Mount Sinai Hospital","Completed","Mar 2008","Jun 2015","Interventional","Dec 2015","Hypertension",null],["NCT02752997","Mayo Clinic","Completed","Dec 2015","Mar 2016","Interventional","Apr 2016","Heart Failure",null],["NCT02750059","South East Asia Research Collaboration with Hawaii","Completed","Jan 2015","Feb 2018","Interventional","May 2015","Infections,Communicable Diseases,HIV Infections,Acquired Immunodeficiency Syndrome","Tenofovir,Lamivudine,Efavirenz,Telmisartan"],["NCT02754505","Danube Hospital","Completed","Feb 2008","Dec 2011","Interventional","Mar 2016","Critical Illness",null],["NCT02751736","Seoul National University Hospital","Unknown status","Apr 2016","Dec 2017","Interventional","Apr 2016","Rectal Neoplasms",null],["NCT02750930","GlaxoSmithKline","Terminated","Oct 2016","Mar 2017","Interventional","Apr 2016","Diabetes Mellitus","rGLP-1 protein"],["NCT02753582","Indonesia University","Unknown status","Apr 2016","Apr 2017","Interventional","Apr 2016","Frailty",null],["NCT02750722","University of Zurich","Completed","May 2016","Jan 2017","Interventional","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02756793","Lawson Health Research Institute","Active, not recruiting","Oct 2016","Jun 2026","Interventional","Apr 2016","Neoplasm Metastasis,Neoplasms",null],["NCT02750436","Montreal General Hospital","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Back Pain",null],["NCT02755922","Instituto Mexicano del Seguro Social","Completed","Apr 2010","Dec 2010","Interventional","Apr 2016","Mandibular Fractures",null],["NCT02755493","Brigham and Women's Hospital","Completed","Apr 2016","May 2018","Interventional","Apr 2016","Sleep Deprivation",null],["NCT02750397","Massachusetts General Hospital","Active, not recruiting","Aug 2016","Dec 2024","Observational","Apr 2016",null,null],["NCT02753621","Johns Hopkins University","Completed","Dec 2015","Dec 2016","Interventional","Apr 2016","Parkinson Disease",null],["NCT02754154","Bristol-Myers Squibb","Unknown status","Dec 2014","Feb 2019","Observational","Apr 2016","Atrial Fibrillation","Warfarin,Rivaroxaban,Dabigatran,Apixaban"],["NCT02753049","New York University","Unknown status","Nov 2016","Aug 2018","Interventional","Apr 2016","HIV Infections,Acquired Immunodeficiency Syndrome",null],["NCT02750813","Alcon, a Novartis Company","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016","Refractive Errors",null],["NCT02756975","Modarres Hospital","Completed","Dec 2014","Dec 2015","Interventional","Apr 2016",null,null],["NCT02759601","Queen Mary University of London","Unknown status","Jan 2013","Dec 2018","Interventional","Oct 2014","Carcinoma",null],["NCT02757326","RedHill Biopharma Limited","Terminated","Dec 2016","May 2019","Interventional","Mar 2016","Multiple Myeloma,Neoplasms",null],["NCT02758236","Ina-Respond","Active, not recruiting","Feb 2017","Dec 2021","Observational","Apr 2016","Tuberculosis",null],["NCT02754804","University Hospital, Angers","Completed","Jul 2016","Mar 2020","Observational","Apr 2016","Peripheral Arterial Disease",null],["NCT02756065","Washington University Early Recognition Center","Completed","Sep 2014","Aug 2019","Observational","Jun 2015","Schizophrenia,Bipolar Disorder",null],["NCT02756247","Memorial Sloan Kettering Cancer Center","Active, not recruiting","May 2016","May 2022","Interventional","Apr 2016","Lymphoma",null],["NCT02755857","Mayne Pharma International Pty Ltd","Completed","Jul 2016","Jan 2017","Interventional","Apr 2016","Neutropenia","Itraconazole"],["NCT02750111","Dr. Orit Hamiel","Unknown status","May 2016","May 2018","Observational","Apr 2016","Diabetes Mellitus",null],["NCT02755948","Imperial College London","Recruiting","Apr 2012","Mar 2023","Interventional","Apr 2016","Influenza,Virus Diseases,Respiratory Syncytial Virus Infections",null],["NCT02754089","Shiraz University of Medical Sciences","Completed","May 2016","Sep 2016","Interventional","Apr 2016","Body Weight",null],["NCT02756169","Universidad Iberoamericana A.C., Mexico","Completed","Jul 2016","Feb 2018","Interventional","Apr 2016","Obesity",null],["NCT02757664","Federal University of São Paulo","Completed","Feb 2017","Jun 2020","Interventional","Apr 2016","Tendinopathy",null],["NCT02757989","Groupe Francophone des Myelodysplasies","Active, not recruiting","May 2016","Jun 2024","Interventional","Mar 2016","Preleukemia,Myelodysplastic Syndromes",null],["NCT02755038","Bnai Zion Medical Center","Unknown status","Mar 2016","Mar 2017","Observational","Apr 2016",null,null],["NCT02759354","MCM Vaccines B.V.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016","Hepatitis A,Hepatitis B,Whooping Cough,Hepatitis",null],["NCT02750254","Washington University School of Medicine","Terminated","Jun 2016","Oct 2020","Interventional","Apr 2016","Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Myelodysplastic Syndromes","Plerixafor,Cyclophosphamide,Melphalan,Busulfan,Fludarabine,Azacitidine,Lenograstim,Sargramostim"],["NCT02755025","Mayo Clinic","Completed","Jul 2016","Aug 2016","Observational","Mar 2016","Sepsis",null],["NCT02757703","Kaohsiung Veterans General Hospital.","Completed","May 2010","Jan 2015","Interventional","Apr 2016","Hemorrhage","Terlipressin,Pantoprazole,Somatostatin"],["NCT02758899","Washington University School of Medicine","Terminated","Mar 2014","Aug 2016","Observational","Apr 2016","Spondylosis,Spinal Cord Diseases,Diabetes Mellitus",null],["NCT02751450","GlaxoSmithKline","Completed","Feb 2016","Jun 2016","Interventional","Apr 2016","Dentin Sensitivity,Hypersensitivity","Fluorides,Tin Fluorides,Fluorophosphate"],["NCT02759497","Tanta University","Unknown status","Mar 2016","Nov 2020","Observational","May 2016","Peritonitis",null],["NCT02750826","Alliance for Clinical Trials in Oncology","Active, not recruiting","Aug 2016",null,"Interventional","Apr 2016","Breast Neoplasms,Weight Loss",null],["NCT02750631","New York State Psychiatric Institute","Completed","Apr 2014","Jul 2017","Interventional","Apr 2016","Depression,Depressive Disorder",null],["NCT02756182","Laborie Medical Technologies Inc.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016",null,null],["NCT02754583","University of California, San Francisco","Recruiting","Dec 2015","Aug 2024","Interventional","Oct 2015","Trachoma","Azithromycin,Tetracycline"],["NCT02750020","The University of Hong Kong","Completed","Feb 2016","Sep 2016","Observational","Apr 2016",null,null],["NCT02759978","University Medical Center Groningen","Recruiting","May 2016","May 2023","Observational [Patient Registry]","Apr 2016","Endocarditis",null],["NCT02759575","Vinita Takiar","Completed","Apr 2016","Feb 2021","Interventional","Apr 2016","Carcinoma,Squamous Cell Carcinoma of Head and Neck","Pembrolizumab"],["NCT02750878","Boston Urogynecology Associates","Unknown status","Nov 2015","Jul 2020","Interventional","Apr 2016","Urinary Incontinence,Enuresis",null],["NCT02758600","Federal University of São Paulo","Unknown status","Mar 2016","Dec 2017","Interventional","Apr 2016","Myocardial Infarction,Infarction",null],["NCT02750657","University Health Network, Toronto","Active, not recruiting","Dec 2015","Dec 2021","Observational","Jan 2016","Carcinoma",null],["NCT02750007","Jiangsu Hansoh Pharmaceutical Co., Ltd.","Unknown status","Dec 2015",null,"Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02750462","University Hospital Schleswig-Holstein","Completed","Nov 2016","Sep 2019","Interventional","Apr 2016","Heart Arrest,Out-of-Hospital Cardiac Arrest",null],["NCT02755597","AbbVie","Suspended","Jul 2016","Feb 2022","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Dexamethasone,Bortezomib,Venetoclax"],["NCT02754232","Odense University Hospital","Withdrawn","Aug 2016","Aug 2016","Interventional","Apr 2016","Pulmonary Disease,Chronic Disease",null],["NCT02751515","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02758080","Seoul National University Hospital","Unknown status","Jan 2016","Jun 2019","Interventional","Apr 2016","Neoplasms,Hematologic Neoplasms",null],["NCT02756312","Beijing Tiantan Hospital","Not yet recruiting","Oct 2020","Dec 2022","Interventional","Apr 2016","Glioma","Anesthetics"],["NCT02759107","Eli Lilly and Company","Completed","May 2016","Jun 2017","Interventional","Apr 2016","Diabetes Mellitus","Dulaglutide,Tirzepatide"],["NCT02758795","University of Limerick","Completed","Feb 2016","Apr 2017","Interventional","Feb 2016","Inflammation",null],["NCT02757859","Sidney Kimmel Cancer Center at Thomas Jefferson University","Recruiting","Apr 2016","Jan 2022","Interventional","Apr 2016","Adenocarcinoma,Cholangiocarcinoma,Carcinoma,Pancreatic Intraductal Neoplasms","Pancrelipase,Pancreatin"],["NCT02750800","AbbVie","Completed","Apr 2016","Apr 2018","Observational","Apr 2016","Spondylitis,Arthritis,Crohn Disease,Colitis,Inflammatory Bowel Diseases,Psoriasis","Adalimumab"],["NCT02754167","Pieris Pharmaceuticals GmbH","Unknown status","Jun 2016","Dec 2017","Interventional","Apr 2016","Kidney Diseases,Renal Insufficiency",null],["NCT02758379","Shockwave Medical, Inc.","Completed","Jul 2014","Mar 2016","Interventional","Jan 2015","Coronary Stenosis",null],["NCT02755740","The University of Hong Kong","Completed","Jul 2015","Aug 2017","Interventional","Apr 2016",null,null],["NCT02751008","Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","Completed","Apr 2016","Jun 2018","Observational","Apr 2016","Osteoporosis",null],["NCT02756390","Dana-Farber Cancer Institute","Completed","Dec 2015","May 2018","Interventional","Apr 2016","Sleep Initiation and Maintenance Disorders",null],["NCT02753075","GlaxoSmithKline","Completed","Sep 2015","Dec 2015","Interventional","Apr 2016","Dentin Sensitivity,Hypersensitivity","Fluorides"],["NCT02753465","Fudan University","Unknown status","Apr 2016","Dec 2019","Interventional","Apr 2016","Rectal Neoplasms",null],["NCT02750852","Azienda Ospedaliera Bolognini di Seriate Bergamo","Unknown status","Apr 2016","May 2016","Observational","Apr 2016","Hemorrhage",null],["NCT02753088","Biocad","Completed","Oct 2013","Nov 2015","Interventional","Apr 2016","Multiple Sclerosis,Sclerosis","Glatiramer Acetate,Mannitol,(T"],["NCT02758626","NYU Langone Health","Completed","Nov 2016","Feb 2021","Interventional","Apr 2016","Epilepsy,Epilepsies",null],["NCT02757222","Tata Medical Center","Recruiting","Jan 2016","Dec 2022","Interventional","Mar 2016","Neoplasms,Oropharyngeal Neoplasms,Hypopharyngeal Neoplasms,Laryngeal Neoplasms,Laryngeal Diseases",null],["NCT02750150","University Hospital, Lille","Completed","Jul 2013","Jan 2016","Interventional","Apr 2016","Hemostatic Disorders,Blood Coagulation Disorders,Wounds and Injuries",null],["NCT02752776","Novartis Pharmaceuticals","Completed","Mar 2016","Mar 2018","Interventional","Feb 2016","Psoriasis",null],["NCT02752984","IRCCS Policlinico S. Matteo","Unknown status","Apr 2016","Jun 2018","Observational","Apr 2016","Thrombosis,Venous Thrombosis",null],["NCT02755272","Fox Chase Cancer Center","Recruiting","May 2016","Apr 2024","Interventional","Apr 2016","Breast Neoplasms,Triple Negative Breast Neoplasms","Gemcitabine,Carboplatin,Pembrolizumab"],["NCT02753192","Centre National de la Recherche Scientifique, France","Unknown status","Jan 2014","Jul 2017","Interventional","Apr 2016","Parkinson Disease,Dysarthria,Disease Progression",null],["NCT02750189","Konkuk University Medical Center","Completed","Sep 2015","Jan 2017","Observational","Mar 2016","Lung Diseases,Pulmonary Disease",null],["NCT02756338","Biotronik, Inc.","Completed","Jun 2016","Jul 2017","Observational","Apr 2016",null,null],["NCT02759809","The Hospital for Sick Children","Completed","Jun 2016","Jul 2018","Observational","Apr 2016","Birth Weight",null],["NCT02758431","University of Colorado, Denver","Recruiting","Feb 2016","Nov 2022","Interventional","Apr 2016","Hypogonadism","Methyltestosterone,Anastrozole,Testosterone,Testosterone undecanoate,Testosterone enanthate,Testosterone 17 beta-cypionate,Aromatase Inhibitors,Acyline,Hormone Antagonists"],["NCT02756962","Washington University School of Medicine","Recruiting","Jul 2016","Jul 2024","Interventional","Apr 2016",null,"Cytarabine"],["NCT02752919","Eli Lilly and Company","Completed","Apr 2016","Jun 2016","Interventional","Apr 2016",null,null],["NCT02759705","Hospices Civils de Lyon","Withdrawn","Sep 2017","May 2018","Observational","Apr 2016","Bladder Exstrophy",null],["NCT02753478","Catharina Ziekenhuis Eindhoven","Completed","Jun 2016","Nov 2016","Interventional","Apr 2016","Myocardial Infarction,Infarction,Hypothermia",null],["NCT02753413","GlaxoSmithKline","Completed","Apr 2016","Jun 2016","Interventional","Apr 2016","Respiratory Syncytial Virus Infections",null],["NCT02759510","RenJi Hospital","Unknown status","Jun 2016","Jun 2017","Interventional","Apr 2016","Cardiac Output","Phenylephrine,Oxymetazoline,Norepinephrine"],["NCT02756130","Jonsson Comprehensive Cancer Center","Withdrawn","Aug 2018","Feb 2021","Interventional","Apr 2016","Carcinoma,Adenocarcinoma,Ovarian Neoplasms,Cystadenocarcinoma","Carboplatin"],["NCT02750124","Karolinska Institutet","Active, not recruiting","Mar 2016","Dec 2021","Interventional","Mar 2016","Uterine Cervical Neoplasms",null],["NCT02755610","Chulalongkorn University","Unknown status","May 2016","Apr 2019","Interventional","Feb 2016","Peritonitis,Kidney Diseases,Kidney Failure",null],["NCT02759328","Ankara University","Completed","Dec 2012","Mar 2014","Interventional","Apr 2016","Stroke",null],["NCT02753608","Jena University Hospital","Completed","Jun 2016","Mar 2018","Interventional","Mar 2016","Pneumonia",null],["NCT02751944","ESM Technologies, LLC","Completed","Dec 2015","Jan 2016","Interventional","Apr 2016","Arthralgia",null],["NCT02750748","National Institute on Drug Abuse (NIDA)","Completed","Jul 2016","Sep 2016","Interventional","Apr 2016","Opioid-Related Disorders","Naltrexone"],["NCT02758405","Samuel Lunenfeld Research Institute, Mount Sinai Hospital","Completed","May 2016","Feb 2017","Interventional","Apr 2016","Labor Pain","Fentanyl,Bupivacaine"],["NCT02753829","Ágata Sofia da Silva Vieira","Completed","Sep 2013","Jul 2015","Interventional","Apr 2016","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Heart Diseases,Infarction",null],["NCT02751788","Pennington Biomedical Research Center","Completed","Apr 2016","Jun 2018","Observational","Apr 2016","Pediatric Obesity",null],["NCT02753010","Uppsala University","Completed","Mar 2011","Mar 2016","Observational","Apr 2016","Gastroparesis,Fractures,Hip Fractures",null],["NCT02750969","HaEmek Medical Center, Israel","Unknown status","Apr 2016","Feb 2019","Interventional","Mar 2016","Tinnitus","Lidocaine"],["NCT02755831","United States Naval Medical Center, San Diego","Completed","Feb 2017","Oct 2019","Interventional","Mar 2016","Apnea,Sleep Apnea Syndromes,Sleep Apnea",null],["NCT02752009","Dana-Farber Cancer Institute","Withdrawn","Apr 2016","Dec 2016","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02758990","Verifomics LLC","Terminated","Mar 2016","Nov 2016","Interventional","Apr 2016","Rhinitis,Arthralgia,Dyspnea,Sleep Deprivation,Migraine Disorders,Sleep Initiation and Maintenance Disorders,Disease,Headache,Respiratory Sounds","Vitamin D,Cholecalciferol,Vitamins,Ascorbic Acid,Vitamin E,Tocopherols,Vitamin A,Niacinamide,Niacin,Nicotinic Acids,Pyridoxine,Pyridoxal,Vitamin B 6,Caffeine"],["NCT02754193","Central Hospital, Nancy, France","Completed","Oct 2016","Nov 2019","Interventional","Apr 2016","Shock,Hypothermia",null],["NCT02758613","Eli Lilly and Company","Completed","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02751047","Seoul National University Hospital","Completed","May 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02758197","Ottawa Hospital Research Institute","Completed","Jul 2016","Oct 2020","Interventional","Apr 2016","Neuralgia,Chronic Pain",null],["NCT02753270","University of Sao Paulo","Completed","Dec 2014","Apr 2017","Interventional","Apr 2016","Varicose Veins",null],["NCT02750839","Azienda Ospedaliera Bolognini di Seriate Bergamo","Unknown status","Apr 2016","Apr 2016","Observational","Apr 2016","Osteoporosis,Fractures,Humeral Fractures",null],["NCT02750488","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02752958","GlaxoSmithKline","Completed","May 2016","Feb 2017","Interventional","Apr 2016","Dentin Sensitivity,Hypersensitivity","Fluorides,Tin Fluorides"],["NCT02753322","The Queen Elizabeth Hospital","Unknown status","Apr 2016","Mar 2018","Interventional","Apr 2016","Stroke",null],["NCT02757261","University of Nove de Julho","Unknown status","Jun 2016","Mar 2017","Interventional","Apr 2016","Bruxism,Sleep Bruxism","Salicylic Acid"],["NCT02754427","University of British Columbia","Completed","Feb 2013","Aug 2015","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02758366","Meyer Children's Hospital","Terminated","Feb 2016","Jan 2020","Interventional","Apr 2016","Glioblastoma,Glioma,Astrocytoma,Diffuse Intrinsic Pontine Glioma,Neoplasms","Doxorubicin"],["NCT02755402","Centre hospitalier de l'Université de Montréal (CHUM)","Completed","Jan 2017","May 2021","Interventional","Apr 2016","Hepatitis C",null],["NCT02754453","The Cleveland Clinic","Withdrawn","Jul 2013","Oct 2015","Interventional","Sep 2013","Body Weight,Weight Loss",null],["NCT02755103","Medical University of South Carolina","Active, not recruiting","Jun 2016","Oct 2021","Interventional","Apr 2016","Disease,Substance-Related Disorders,Stress Disorders",null],["NCT02758834","Università Politecnica delle Marche","Completed","Jan 2014","Apr 2016","Observational","Apr 2016","Liver Diseases",null],["NCT02759146","Michigan State University","Completed","May 2016","Nov 2019","Interventional","Apr 2016",null,null],["NCT02754414","Bloodworks","Unknown status","Apr 2016","Jan 2019","Interventional","Apr 2016",null,null],["NCT02759783","Royal Marsden NHS Foundation Trust","Active, not recruiting","Nov 2016","Oct 2024","Interventional","Apr 2016","Carcinoma",null],["NCT02756923","Weill Medical College of Cornell University","Suspended","Apr 2012","Dec 2025","Observational","Apr 2016","Infertility",null],["NCT02759237","Medtronic Cardiovascular","Terminated","Feb 2016","May 2017","Observational","Apr 2016","Aortic Valve Stenosis",null],["NCT02757391","M.D. Anderson Cancer Center","Terminated","Aug 2019","Oct 2020","Interventional","Apr 2016","Carcinoma,Colorectal Neoplasms,Adenocarcinoma,Stomach Neoplasms,Esophageal Neoplasms,Cholangiocarcinoma","Aldesleukin,Cyclophosphamide,Pembrolizumab,Interleukin-2,Immunologic Factors"],["NCT02750904","Fred Hutchinson Cancer Research Center","Completed","Apr 2017","May 2019","Interventional","Mar 2016","Disease,Bipolar Disorder","Nicotine"],["NCT02758418","Universitat Jaume I","Unknown status","Apr 2016","Jul 2019","Interventional","Apr 2016","Adjustment Disorders",null],["NCT02756039","AstraZeneca","Completed","May 2016","Aug 2018","Observational","Apr 2016",null,null],["NCT02755077","Massachusetts General Hospital","Completed","Jul 2014","Jan 2016","Interventional","Apr 2016",null,null],["NCT02751801","Sheffield Teaching Hospitals NHS Foundation Trust","Completed","Nov 2016","Dec 2017","Observational","Apr 2016","Hypophosphatasia",null],["NCT02751177","Institut de Cancérologie de Lorraine","Completed","Mar 2016","May 2017","Interventional","Mar 2016","Colorectal Neoplasms",null],["NCT02758574","University of Pittsburgh","Completed","May 2016","Aug 2021","Interventional","Mar 2016","Pulmonary Embolism,Embolism",null],["NCT02758587","NHS Greater Glasgow and Clyde","Recruiting","Jul 2017","Dec 2021","Interventional","Apr 2016","Mesothelioma,Carcinoma,Pancreatic Neoplasms","Pembrolizumab"],["NCT02752100","Third Military Medical University","Unknown status","Mar 2016","May 2020","Interventional","Mar 2016","Arterial Occlusive Diseases",null],["NCT02755818","University of California, Davis","Terminated","Oct 2008","Feb 2019","Observational","Mar 2016","Insulin Resistance","Heparin,Calcium heparin"],["NCT02752906","Sanofi Pasteur, a Sanofi Company","Completed","Apr 2016","Dec 2016","Interventional","Apr 2016","Meningococcal Infections,Meningitis","Vaccines"],["NCT02750371","University Hospital, Bordeaux","Active, not recruiting","Jul 2016","Oct 2021","Interventional","Apr 2016","Adenoma,Meningioma,Pituitary Neoplasms,Pituitary Diseases",null],["NCT02751125","University of Bergen","Completed","Jun 2014","Mar 2020","Interventional","Mar 2016","Atrophy",null],["NCT02754700","High Point University","Completed","Apr 2016","Feb 2019","Interventional","Apr 2016","Knee Injuries",null],["NCT02756442","Assistance Publique Hopitaux De Marseille","Unknown status","Apr 2016","Apr 2019","Interventional","Apr 2016","Respiration Disorders,Respiratory Tract Diseases,Diabetes",null],["NCT02756637","Abramson Cancer Center of the University of Pennsylvania","Completed","Apr 2016","Nov 2016","Observational","Apr 2016","Urinary Bladder Neoplasms",null],["NCT02755688","Royal Brompton & Harefield NHS Foundation Trust","Unknown status","Jun 2015","Mar 2020","Interventional","Apr 2016","Atrial Fibrillation",null],["NCT02753387","Rennes University Hospital","Completed","May 2016","Sep 2018","Interventional","Apr 2016","Bacterial Infections,Head and Neck Neoplasms","Chlorhexidine"],["NCT02758470","University of British Columbia","Completed","Nov 2016","Jun 2017","Interventional","Apr 2016","Fatigue,Hypoxia","Acetazolamide,Methazolamide"],["NCT02754375","Centre Hospitalier Universitaire de Nice","Unknown status","May 2016","May 2019","Interventional","Apr 2016","Depression,Depressive Disorder",null],["NCT02758756","University of Rochester","Completed","Jun 2016","May 2019","Interventional","Apr 2016","Fatigue",null],["NCT02750787","Abbott Nutrition","Completed","Aug 2016","Jul 2017","Interventional","Apr 2016","Malabsorption Syndromes",null],["NCT02757339","Mclean Hospital","Enrolling by invitation","Jun 2015","May 2022","Observational","Mar 2016","Disease,Stress Disorders,Dissociative Disorders,Dissociative Identity Disorder",null],["NCT02753959","Guy's and St Thomas' NHS Foundation Trust","Completed","Aug 2016","Sep 2019","Interventional","Apr 2016","Neuromuscular Diseases",null],["NCT02753426","University of California, San Francisco","Completed","Apr 2016","Jan 2018","Interventional","Apr 2016","Kidney Diseases,Renal Insufficiency,Cardio-Renal Syndrome","Doxycycline"],["NCT02757183","AnalyticsPlus, Inc.","Unknown status","Apr 2016","Mar 2017","Observational","Apr 2016",null,null],["NCT02750293","University of Tromso","Completed","Jun 2015","Sep 2017","Interventional","Apr 2016","Vitamin D Deficiency","Cholecalciferol"],["NCT02757274","European Association of Urology Research Foundation","Recruiting","Feb 2017","Jul 2027","Observational [Patient Registry]","Apr 2016","Urinary Incontinence,Enuresis",null],["NCT02756741","All India Institute of Medical Sciences, New Delhi","Completed","Apr 2014","Jul 2015","Interventional","Apr 2016","Peritonitis,Fibrosis",null],["NCT02758964","Charite University, Berlin, Germany","Completed","Sep 2016","Jan 2019","Observational","Apr 2016","Intracranial Embolism,Embolism,Aortic Valve Stenosis",null],["NCT02753439","The Baruch Padeh Medical Center, Poriya","Unknown status","Feb 2017","Feb 2019","Interventional","Mar 2016","Tooth",null],["NCT02751281","Isfahan University of Medical Sciences","Completed","Dec 2014","Apr 2016","Interventional","Apr 2016","Kidney Calculi,Nephrolithiasis",null],["NCT02756676","Ospedale Generale Di Zona Moriggia-Pelascini","Completed","Apr 2015","Dec 2016","Interventional","Apr 2016","Parkinson Disease",null],["NCT02750215","Massachusetts General Hospital","Completed","May 2016","May 2021","Interventional","Apr 2016","Lung Neoplasms",null],["NCT02755935","Cochlear","Completed","May 2016","Sep 2017","Interventional","Apr 2016","Hearing Loss",null],["NCT02759523","Penn State University","Completed","Jul 2013","Dec 2015","Observational","Apr 2016","Pediatric Obesity",null],["NCT02756533","University Hospital, Grenoble","Recruiting","Aug 2016","Aug 2021","Interventional","Mar 2016","Lung Diseases,Pulmonary Disease,Signs and Symptoms",null],["NCT02752841","Brown University","Terminated","May 2016","May 2019","Interventional","Apr 2016","Kidney Calculi,Calculi","Vitamin D"],["NCT02758392","Janssen Research & Development, LLC","Completed","Apr 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02755870","Clene Nanomedicine","Completed","Apr 2015","Oct 2016","Interventional","Apr 2016",null,null],["NCT02752464","Boston Medical Center","Completed","Sep 2016","Jun 2018","Interventional","Apr 2016",null,null],["NCT02756780","Royal Marsden NHS Foundation Trust","Unknown status","Apr 2016","Apr 2018","Interventional","Apr 2016",null,null],["NCT02753998","Assistance Publique - Hôpitaux de Paris","Active, not recruiting","Dec 2016","Sep 2021","Interventional","Apr 2016","Arteriovenous Fistula,Constriction,Fistula","Paclitaxel"],["NCT02751307","Taipei Medical University WanFang Hospital","Completed","May 2013","Jan 2015","Interventional","Apr 2016","Congenital Abnormalities,Metabolic Syndrome,Schizophrenia","Metformin,Clozapine"],["NCT02757755","Armata Pharmaceuticals, Inc.","Completed","May 2016","Aug 2016","Interventional","Apr 2016",null,null],["NCT02753972","University of New Mexico","Completed","Aug 2006","Jan 2008","Interventional","Apr 2016",null,null],["NCT02751853","University of Luebeck","Unknown status","Dec 2016","Aug 2020","Interventional","Apr 2016","Heart Failure",null],["NCT02752971","Hospital Central Dr. Luis Ortega","Completed","Feb 2015",null,"Interventional","Mar 2016","Pain","Diclofenac,Bupivacaine"],["NCT02755012","McGill University","Completed","Jun 2012","Nov 2013","Observational","Apr 2016","Infections,Mastitis,Malnutrition,Infant Nutrition Disorders,Growth Disorders,Stress",null],["NCT02751996","F-star Therapeutics, Inc.","Completed","May 2016","Feb 2020","Interventional","Apr 2016","Hepatitis A,Hepatitis B,Hepatitis","Tenofovir"],["NCT02752893","Dartmouth-Hitchcock Medical Center","Completed","Jan 2017","Apr 2019","Observational","Apr 2016","Breast Neoplasms",null],["NCT02753842","Global Protection Corp.","Completed","May 2016","Jul 2017","Interventional","Apr 2016",null,null],["NCT02757040","Peking University People's Hospital","Unknown status","Dec 2016","Dec 2018","Interventional","Apr 2016","Leukemia","Arsenic Trioxide"],["NCT02751606","Radboud University","Unknown status","Jun 2015","Nov 2019","Interventional","Nov 2014","Neoplasms,Breast Neoplasms,Rectal Neoplasms",null],["NCT02751372","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016",null,null],["NCT02753764","National Jewish Health","Completed","Jan 2017","Feb 2019","Interventional","Apr 2016","Asthma","Prednisone,AZD7624"],["NCT02758938","University of Wisconsin, Madison","Completed","Jun 2016","Sep 2018","Interventional","Dec 2015","Lower Urinary Tract Symptoms",null],["NCT02752399","Federal University of São Paulo","Unknown status","Apr 2016","Jun 2017","Observational","Apr 2016","Hypertension,Heart Defects,Eisenmenger Complex",null],["NCT02753296","University of Sheffield","Unknown status","May 2016","Jun 2018","Observational","Apr 2016",null,null],["NCT02759432","Teesside University","Completed","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02750137","KK Women's and Children's Hospital","Completed","Aug 2014","May 2015","Observational","Apr 2016","Drug-Related Side Effects and Adverse Reactions","Tetracaine"],["NCT02754466","University of Brasilia","Terminated","May 2017","Sep 2021","Interventional","Apr 2016","Dental Caries",null],["NCT02752191","Paul Finn","Recruiting","Apr 2016","Apr 2021","Interventional","Apr 2016","Heart Diseases,Heart Defects","Ferrosoferric Oxide"],["NCT02753517","University Hospital, Lille","Recruiting","Dec 2015","Nov 2023","Interventional","Apr 2016","Liver Failure,Hepatic Insufficiency",null],["NCT02758054","University of Texas Southwestern Medical Center","Active, not recruiting","Jun 2017","Mar 2023","Interventional","Apr 2016","Carcinoma",null],["NCT02757573","Tampere University Hospital","Active, not recruiting","Apr 2016","Dec 2022","Interventional","Apr 2016","Hypercapnia",null],["NCT02752789","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Jul 2014","Nov 2019","Observational","Apr 2016",null,null],["NCT02756416","University of Nottingham","Unknown status","Jul 2016","May 2017","Interventional","Mar 2016","Syndrome",null],["NCT02758106","Chung Shan Medical University","Completed","Feb 2014","Nov 2015","Interventional","Apr 2016","Respiratory Insufficiency",null],["NCT02759159","Xuanwu Hospital, Beijing","Unknown status","Jun 2016","Dec 2018","Interventional","Apr 2016","Alzheimer Disease",null],["NCT02753777","University of Pennsylvania","Recruiting","Apr 2016","Dec 2025","Observational [Patient Registry]","Apr 2016","Pemphigoid,Pemphigus",null],["NCT02754245","Baylor Research Institute","Unknown status","Nov 2016","Jul 2017","Observational","Apr 2016","Emergencies",null],["NCT02754687","Health Decisions","Unknown status","Apr 2016","Jan 2020","Interventional","Mar 2016",null,"Nandrolone Decanoate,Nandrolone,Nandrolone phenpropionate"],["NCT02755337","Dr. Soetomo General Hospital","Unknown status","Jan 2016","Dec 2016","Observational","Apr 2016","Lung Neoplasms",null],["NCT02755090","University of New Mexico","Completed","Jul 2016","May 2017","Interventional","Apr 2016",null,"Nitrous Oxide"],["NCT02751437","Liverpool Women's NHS Foundation Trust","Completed","Aug 2016","Mar 2018","Interventional","Mar 2016","Premature Birth",null],["NCT02757950","GlaxoSmithKline","Completed","Jul 2016","May 2017","Observational","Apr 2016","Diphtheria",null],["NCT02756754","University Hospital, Toulouse","Completed","Nov 2016","May 2019","Interventional","Apr 2016","Adenoma,Adrenocortical Adenoma,Hyperaldosteronism",null],["NCT02754726","HonorHealth Research Institute","Active, not recruiting","Apr 2016","Jun 2022","Interventional","Apr 2016","Adenocarcinoma","Gemcitabine,Paclitaxel,Nivolumab,Albumin-Bound Paclitaxel"],["NCT02759549","Emory University","Withdrawn","Sep 2015",null,"Interventional","Apr 2016","Breast Neoplasms",null],["NCT02755714","Haukeland University Hospital","Completed","Jun 2016","Oct 2020","Interventional","Apr 2016",null,"Bromides,Ipratropium"],["NCT02750358","Memorial Sloan Kettering Cancer Center","Active, not recruiting","May 2016","May 2022","Interventional","Apr 2016","Breast Neoplasms,Triple Negative Breast Neoplasms",null],["NCT02754921","Mohamed Sayed Mohamed Abbas","Completed","Jan 2013",null,"Interventional","Apr 2016",null,null],["NCT02755259","University of Zurich","Completed","Jan 2017","Apr 2019","Interventional","Mar 2016","Hypertension","Acetazolamide"],["NCT02759081","Dalin Tzu Chi General Hospital","Completed","Jan 2015",null,"Interventional","Apr 2016",null,null],["NCT02755155","University Hospital, Strasbourg, France","Terminated","Sep 2016","Aug 2019","Interventional","Apr 2016","Hypoalbuminemia,Syndrome,Systemic Inflammatory Response Syndrome",null],["NCT02758119","Ilumens","Completed","Jun 2016","Oct 2016","Interventional","Apr 2016","Heart Arrest,Out-of-Hospital Cardiac Arrest",null],["NCT02755415","China Medical University Hospital","Unknown status","May 2016","Dec 2017","Interventional","Apr 2016","Stroke",null],["NCT02751268","Armed Forces Hampyeong Hospital","Unknown status","Apr 2016","Mar 2017","Interventional","Apr 2016","Psychomotor Agitation,Emergence Delirium","Ropivacaine"],["NCT02756572","University of Washington","Completed","Sep 2016","Jul 2020","Interventional","Apr 2016","Leukemia,Neoplasms,Preleukemia,Myelodysplastic Syndromes,Anemia,Syndrome","Cytarabine,Cyclosporine,Mycophenolic Acid,Sirolimus,Fludarabine,Fludarabine phosphate,Melphalan,Mechlorethamine,Mitoxantrone,Nitrogen Mustard Compounds,Cladribine,2-chloro-3-deoxyadenosine,Cyclosporins,Lenograstim"],["NCT02756871","Institute of Child Health","Completed","Jul 2015","Feb 2017","Interventional","Apr 2016",null,null],["NCT02750618","Ultragenyx Pharmaceutical Inc","Completed","May 2016","Sep 2019","Interventional","Dec 2015","Familial Hypophosphatemic Rickets,Hypophosphatemia",null],["NCT02757196","Peking University People's Hospital","Unknown status","May 2016","Dec 2018","Interventional","Apr 2016","Thrombocytopenia,Purpura","Methylprednisolone,Methylprednisolone Acetate,Methylprednisolone Hemisuccinate,Prednisolone,Prednisolone acetate,Rituximab,Prednisolone hemisuccinate,Prednisolone phosphate"],["NCT02758093","University of Alabama at Birmingham","Completed","Sep 2016","Mar 2020","Interventional","Mar 2016",null,null],["NCT02750943","GlaxoSmithKline","Completed","Nov 2015","Mar 2016","Interventional","Nov 2015","Gingivitis","Fluorides,Tin Fluorides,Fluorophosphate"],["NCT02754908","The University of Hong Kong","Completed","Jan 2016","Jun 2018","Interventional","Apr 2016","Brain Neoplasms",null],["NCT02750514","Bristol-Myers Squibb","Terminated","May 2016","Jan 2020","Interventional","Apr 2016","Carcinoma","Nivolumab,Ipilimumab,Dasatinib,Linrodostat"],["NCT02755350","LVCT Health","Unknown status","Aug 2015","Apr 2017","Interventional","Nov 2015",null,"Emtricitabine"],["NCT02753374","Beijing Children's Hospital","Not yet recruiting","May 2016","Jul 2030","Observational","Apr 2016","Cystic Fibrosis,Fibrosis",null],["NCT02759419","Bayer","Recruiting","Jun 2016","Dec 2023","Interventional","Apr 2016","Pulmonary Arterial Hypertension,Hypertension","Riociguat"],["NCT02757612","Universidad de Murcia","Completed","Jun 2015","Jul 2016","Interventional","Apr 2016","Burning Mouth Syndrome,Syndrome,Burns",null],["NCT02754297","CHU de Quebec-Universite Laval","Recruiting","Apr 2016","Dec 2026","Interventional","Mar 2016","Neoplasms,Neuroendocrine Tumors,Carcinoid Tumor,Carcinoma","Lutetium Lu 177 dotatate"],["NCT02758665","University of Ulm","Active, not recruiting","Sep 2016","Mar 2022","Interventional","Apr 2016","Leukemia","Venetoclax,Obinutuzumab"],["NCT02755285","Fujifilm Medical Systems USA, Inc.","Completed","Aug 2016","Oct 2016","Interventional","Apr 2016",null,null],["NCT02757690","Asan Medical Center","Completed","Jan 2015","Feb 2016","Interventional","Apr 2016","Neoplasms,Brain Neoplasms",null],["NCT02753218","LEO Pharma","Terminated","Apr 2016","May 2016","Interventional","Apr 2016","Psoriasis","Midazolam"],["NCT02754986","University of Hyogo","Completed","Mar 2015",null,"Interventional","Mar 2016","Kidney Diseases,Renal Insufficiency",null],["NCT02752048","Taiho Pharmaceutical Co., Ltd.","Completed","May 2016","Oct 2017","Interventional","Apr 2016","Muscular Dystrophies,Muscular Dystrophy",null],["NCT02752256","University of Iowa","Completed","Oct 2015","Oct 2017","Observational","Apr 2016",null,"Plasminogen,Tissue Plasminogen Activator"],["NCT02756936","Genuine Research Center, Egypt","Completed","Feb 2016","Mar 2016","Interventional","Apr 2016",null,null],["NCT02756000","Clinical Hospital Center Zemun","Unknown status","Jan 2016","Jul 2018","Interventional","Apr 2016","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Infarction","Dobutamine"],["NCT02754492","Terumo BCT","Completed","Apr 2016","Feb 2017","Interventional","Apr 2016",null,null],["NCT02757677","Swiss Vision Network","Unknown status","Dec 2015","Dec 2019","Observational","Apr 2016","Glaucoma",null],["NCT02752373","Brain Sentinel","Terminated","May 2016","Feb 2017","Observational","Mar 2016","Epilepsy,Seizures",null],["NCT02752230","Kettering Health Network","Withdrawn","Nov 2016","Jun 2021","Interventional","Mar 2016","Pain",null],["NCT02756728","BioInvent International AB","Terminated","May 2016","Dec 2016","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Melphalan"],["NCT02751658","University Hospital, Montpellier","Completed","Nov 2016","Jul 2019","Interventional","Mar 2016","Otorhinolaryngologic Diseases",null],["NCT02754518","University of Chicago","Completed","Apr 2016","Apr 2019","Interventional","Apr 2016","Heart Failure","Valsartan,Sacubitril and valsartan sodium hydrate drug combination"],["NCT02759380","Sahlgrenska University Hospital, Sweden","Recruiting","Mar 2016","Oct 2022","Interventional","Apr 2016","Prostatic Neoplasms","Phytoestrogens"],["NCT02755649","Regeneron Pharmaceuticals","Completed","Jan 2016","Mar 2017","Interventional","Mar 2016","Dermatitis,Eczema",null],["NCT02751827","Institut Bergonié","Completed","Feb 2016","Nov 2019","Observational","Apr 2016",null,null],["NCT02755545","Galderma Laboratories, L.P.","Completed","May 2016","Apr 2017","Interventional","Apr 2016","Acne Vulgaris","Salicylic Acid,Adapalene,Salicylates"],["NCT02750345","Cycle Pharmaceuticals Ltd.","Completed","Mar 2016","May 2016","Interventional","Apr 2016","Tyrosinemias","Nitisinone"],["NCT02755532","Federal University of São Paulo","Completed","Jan 2014","Oct 2015","Interventional","Apr 2016",null,"Bupivacaine"],["NCT02758743","Biohit Oyj","Completed","Apr 2016","May 2017","Interventional","Apr 2016",null,null],["NCT02754947","Nationwide Children's Hospital","Completed","Feb 2015","Mar 2016","Observational","Apr 2016","Respiration Disorders,Respiratory Tract Diseases,Nervous System Diseases,Cardiovascular Diseases",null],["NCT02750280","Calvary Hospital, Bronx, NY","Completed","Jun 2015","Dec 2015","Interventional","Apr 2016","Diabetic Foot,Foot Ulcer,Ulcer",null],["NCT02756325","NYU Langone Health","Withdrawn","Jun 2016","Jan 2019","Interventional","Apr 2016","Infertility",null],["NCT02758717","Academic and Community Cancer Research United","Active, not recruiting","May 2016","May 2024","Interventional","Apr 2016","Lymphoma,Hodgkin Disease","Antineoplastic Agents,Nivolumab,Brentuximab Vedotin,Antibodies,Immunoglobulins,Immunoconjugates"],["NCT02751034","Medy-Tox","Completed","Jun 2013","Jan 2014","Interventional","Apr 2015",null,"Lidocaine"],["NCT02751476","Action Contre la Faim","Unknown status","Apr 2016","Mar 2017","Interventional","Apr 2016","Malnutrition,Severe Acute Malnutrition,Protein-Energy Malnutrition","Disinfectants"],["NCT02755454","University Health Network, Toronto","Completed","Oct 2013","Nov 2018","Interventional","Mar 2016","Lung Neoplasms",null],["NCT02752867","Dongfang Hospital Beijing University of Chinese Medicine","Unknown status","Dec 2016","Nov 2019","Interventional","Mar 2016","Cerebral Infarction,Infarction,Cognitive Dysfunction",null],["NCT02754830","Eli Lilly and Company","Completed","Apr 2016","Jul 2018","Interventional","Apr 2016","Alzheimer Disease",null],["NCT02753738","Medical University of Vienna","Unknown status","Aug 2016",null,"Interventional","Apr 2016",null,"Citalopram"],["NCT02750267","University of Virginia","Completed","May 2016","May 2016","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02754999","Prolong Pharmaceuticals","Completed","Mar 2016","May 2017","Interventional","Apr 2016","Anemia",null],["NCT02754843","Sonova AG","Completed","Oct 2015",null,"Interventional","Oct 2015","Hearing Loss",null],["NCT02759055","HealthPartners Institute","Completed","Oct 2016","Dec 2019","Interventional","Apr 2016","Prediabetic State,Glucose Intolerance",null],["NCT02753673","Memorial Sloan Kettering Cancer Center","Completed","Apr 2016","Apr 2020","Observational","Apr 2016",null,null],["NCT02754531","Indonesia University","Completed","May 2016","Jul 2016","Interventional","Apr 2016",null,null],["NCT02750033","Seton Healthcare Family","Withdrawn","Oct 2016","Mar 2017","Observational","Apr 2016","Carcinoma",null],["NCT02759133","Centre Antoine Lacassagne","Recruiting","Jun 2016","Nov 2022","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02756650","Novartis Pharmaceuticals","Completed","Jun 2016","Jan 2019","Interventional","Mar 2016","Behcet Syndrome",null],["NCT02752152","Institut de Recherche pour le Developpement","Completed","Dec 2015","Oct 2020","Interventional","Apr 2016","Hepatitis A,Hepatitis C,Hepatitis B,Syphilis,Hepatitis",null],["NCT02751385","Boehringer Ingelheim","Terminated","May 2016","Nov 2017","Interventional","Apr 2016","Carcinoma","Nintedanib,Ethinyl estradiol,Ethinyl Estradiol-Norgestrel Combination"],["NCT02751879","Boehringer Ingelheim","Completed","Nov 2016","Sep 2017","Observational","Apr 2016","Carcinoma",null],["NCT02756663","Novartis Pharmaceuticals","Withdrawn","Dec 2016","Feb 2021","Interventional","Apr 2016","Multiple Myeloma,Neoplasms","Dexamethasone,Panobinostat"],["NCT02756273","Centre Hospitalier Universitaire, Amiens","Recruiting","May 2016","May 2022","Interventional","Apr 2016",null,null],["NCT02755974","Imperial College London","Unknown status","Jan 2009","Apr 2021","Observational","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02756507","Babes-Bolyai University","Completed","Jun 2016","Jun 2018","Interventional","Apr 2016","Disease,Depression,Anxiety Disorders,Panic Disorder",null],["NCT02750553","Jiangsu HengRui Medicine Co., Ltd.","Completed","Jan 2015",null,"Interventional","Apr 2016",null,null],["NCT02750228","Mednax Center for Research, Education, Quality and Safety","Completed","May 2016","Jun 2020","Observational","Mar 2016","Ductus Arteriosus",null],["NCT02751710","Ontario Clinical Oncology Group (OCOG)","Recruiting","Dec 2016","Dec 2022","Interventional","Apr 2016","Breast Neoplasms",null],["NCT02753361","Suez Canal University","Completed","May 2016","Dec 2016","Interventional","Apr 2016","Lipoma",null],["NCT02753634","Lawson Health Research Institute","Completed","Apr 2015","Jun 2016","Interventional","Mar 2016","Osteoarthritis",null],["NCT02759250","argenx","Completed","Feb 2015","Jun 2018","Interventional","Apr 2016","Nasopharyngeal Carcinoma",null],["NCT02757482","Celal Bayar University","Completed","Sep 2014","Jun 2015","Interventional","Apr 2016",null,null],["NCT02757105","RedHill Biopharma Limited","Completed","May 2016","Jul 2017","Interventional","Apr 2016","Irritable Bowel Syndrome,Syndrome,Diarrhea","Ondansetron"],["NCT02756520","Fresenius Kabi","Completed","Sep 2016","Oct 2018","Observational","Apr 2016","Kidney Diseases,Renal Insufficiency",null],["NCT02753309","The University of Texas Health Science Center at San Antonio","Completed","Jun 2016","Mar 2021","Interventional","Apr 2016","Urinary Bladder Neoplasms","Sirolimus"],["NCT02756832","Takeda","Completed","Sep 2016","Apr 2018","Observational","Apr 2016","Diabetes Mellitus","Alogliptin"],["NCT02758158","University Health Network, Toronto","Completed","Jan 2016","Feb 2017","Interventional","Mar 2016","Thyroid Neoplasms,Thyroid Nodule,Thyroid Diseases",null],["NCT02752360","Beijing Friendship Hospital","Unknown status","Apr 2016","Dec 2018","Interventional","Apr 2016","Colonic Neoplasms,Crohn Disease,Diverticulum,Diverticular Diseases,Diverticulosis",null],["NCT02757794","Assistance Publique Hopitaux De Marseille","Recruiting","Nov 2016","Jun 2022","Interventional","Apr 2016","Memory Disorders",null],["NCT02751346","Washington University School of Medicine","Completed","Jan 2016","Feb 2017","Observational","Apr 2016","Pain",null],["NCT02757027","Konkuk University Medical Center","Unknown status","May 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02756689","University of Alabama at Birmingham","Completed","Mar 2016","Oct 2017","Interventional","Apr 2016",null,null],["NCT02751164","Intensive Care National Audit & Research Centre","Completed","Apr 2013","May 2016","Observational","Apr 2016","Critical Illness",null],["NCT02754765","Médecins Sans Frontières, France","Recruiting","Dec 2016","Aug 2023","Interventional","Apr 2016","Tuberculosis,Bacterial Infections","Moxifloxacin,Levofloxacin,Ofloxacin,Linezolid,Pyrazinamide,Bedaquiline,Clofazimine"],["NCT02757729","Amorepacific Corporation","Completed","Oct 2015",null,"Interventional","Apr 2016","Dermatitis,Eczema",null],["NCT02751866","University of Cincinnati","Recruiting","Jan 2016","Jul 2023","Interventional","Apr 2016","Overweight,Hyperphagia",null],["NCT02759068","Hospices Civils de Lyon","Completed","Nov 2014","May 2017","Interventional","Apr 2016","Consciousness Disorders",null],["NCT02752503","Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","Unknown status","Mar 2015",null,"Interventional","Apr 2016","Disease,Alcoholism,Alcohol Drinking,Personality Disorders,Borderline Personality Disorder","Nalmefene"],["NCT02750592","Novartis Pharmaceuticals","Completed","Mar 2016","May 2018","Interventional","Apr 2016","Spondylitis",null],["NCT02754440","Terumo BCT","Completed","Apr 2016","Jul 2017","Interventional","Apr 2016",null,null],["NCT02750670","University Health Network, Toronto","Completed","Mar 2017","Feb 2021","Interventional","Apr 2016","Lymphoma","Gemcitabine,Dexamethasone,Obinutuzumab"],["NCT02753400","Kubota Vision Inc.","Completed","May 2016","Dec 2017","Interventional","Apr 2016","Retinal Diseases,Diabetic Retinopathy",null],["NCT02754310","Ilumens","Completed","May 2016","Oct 2016","Interventional","Apr 2016",null,null],["NCT02758275","Universidad Industrial de Santander","Completed","Apr 2016","Sep 2017","Interventional","Apr 2016","Hypertension,Diabetes Mellitus",null],["NCT02757417","University Hospitals Cleveland Medical Center","Unknown status","Jul 2016","Dec 2019","Interventional","Apr 2016",null,null],["NCT02753725","University of Nairobi","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Delirium,Emergence Delirium","Fentanyl"],["NCT02752646","MDbackline, LLC","Completed","Apr 2016","Mar 2017","Interventional","Apr 2016","Cataract","Ketorolac,Nepafenac"],["NCT02750566","New York Institute of Technology","Recruiting","Nov 2015","Dec 2021","Interventional","Dec 2015","Post-Concussion Syndrome",null],["NCT02753335","University of Tromso","Recruiting","Sep 2016","Dec 2022","Interventional","Mar 2016","Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Syndrome",null],["NCT02754544","M.D. Anderson Cancer Center","Recruiting","Jul 2016","Aug 2020","Interventional","Apr 2016","Neoplasms,Brain Neoplasms",null],["NCT02751112","Imagine Institute","Terminated","Nov 2015","Aug 2017","Interventional","Apr 2016","Graft vs Host Disease",null],["NCT02751320","GlaxoSmithKline","Completed","Feb 2016","Aug 2016","Interventional","Apr 2016","Dental Caries","Citric Acid,Sodium Citrate"],["NCT02753036","Charite University, Berlin, Germany","Active, not recruiting","Jan 2016","Jun 2023","Observational","Apr 2016","Polyneuropathies,Cognition Disorders",null],["NCT02759198","Yuhan Corporation","Completed","May 2016","Sep 2017","Interventional","Apr 2016","Osteoarthritis","Celecoxib"],["NCT02752802","Osprey Medical, Inc","Completed","Apr 2016","May 2016","Interventional","Apr 2016",null,null],["NCT02757586","Peking University People's Hospital","Unknown status","Dec 2016","Dec 2019","Observational","Apr 2016","Leukemia",null],["NCT02755961","Ajou University School of Medicine","Completed","Jul 2015","Oct 2015","Interventional","Apr 2016","Kidney Diseases,Kidney Failure,Hyperphosphatemia",null],["NCT02759263","Boston Children's Hospital","Completed","Jun 2016","Oct 2018","Interventional","Apr 2016","Heart Diseases,Heart Defects",null],["NCT02754271","Toronto Rehabilitation Institute","Unknown status","Apr 2014","Mar 2017","Interventional","Apr 2016","Kidney Failure",null],["NCT02756195","Vanderbilt University","Recruiting","Nov 2016","Jan 2022","Observational [Patient Registry]","Apr 2016",null,null],["NCT02754336","Helse Stavanger HF","Completed","Oct 2014","Jun 2015","Interventional","Nov 2015",null,null],["NCT02758639","University of Texas at Austin","Completed","Sep 2015","Aug 2018","Interventional","Apr 2016",null,null],["NCT02759185","Multidisciplinary Association for Psychedelic Studies","Completed","Jan 2017","Jan 2019","Interventional","Apr 2016","Marijuana Abuse,Stress Disorders","Dronabinol,Cannabidiol"],["NCT02758145","Service de Médecine Préventive Hospitalière","Completed","Apr 2016","Apr 2018","Interventional","Apr 2016","Influenza","Vaccines"],["NCT02756455","University of Roma La Sapienza","Unknown status","Jan 2015","Dec 2016","Observational [Patient Registry]","Apr 2016","Stomach Neoplasms",null],["NCT02757118","Konkuk University Medical Center","Unknown status","May 2016","Jan 2017","Interventional","Apr 2016",null,null],["NCT02756819","Takeda","Completed","Jul 2016","May 2018","Observational","Apr 2016","Hypertension,Overweight","Azilsartan medoxomil"],["NCT02754362","NYU Langone Health","Withdrawn","Nov 2016","Jun 2019","Interventional","Apr 2016","Glioblastoma","Bevacizumab,Poly ICLC,Keyhole-limpet hemocyanin,Adjuvants"],["NCT02752711","Nantes University Hospital","Completed","May 2013","Dec 2015","Observational","Apr 2016","Craniocerebral Trauma",null],["NCT02756494","Beijing Chao Yang Hospital","Unknown status","Apr 2016","Dec 2018","Observational","Apr 2016","Stroke,Ischemic Stroke,Cerebral Infarction,Ischemia",null],["NCT02753855","University of Illinois at Chicago","Completed","Apr 2016","Oct 2016","Interventional","Apr 2016",null,"Telavancin"],["NCT02756013","Case Comprehensive Cancer Center","Terminated","Apr 2016","Jan 2019","Interventional","Apr 2016","Overweight","Paclitaxel,Carboplatin"],["NCT02756949","World Bank","Completed","Oct 2015","Jun 2017","Interventional","Apr 2016","HIV Infections",null],["NCT02757885","Emory University","Recruiting","Apr 2016","Jul 2023","Interventional","Apr 2016","Anemia","Cyclophosphamide,Thiotepa,Fludarabine,Fludarabine phosphate,Hydroxyurea,Antilymphocyte Serum,Thymoglobulin"],["NCT02758340","Karachi Medical and Dental College","Completed","Apr 2016","Nov 2016","Interventional","Apr 2016","Labor Pain","Misoprostol"],["NCT02753933","Guy's and St Thomas' NHS Foundation Trust","Unknown status","Apr 2016","Dec 2018","Observational","Apr 2016","Headache Disorders,Headache",null],["NCT02756624","Nicox Ophthalmics, Inc.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016",null,"Cetirizine"],["NCT02759393","National Cheng-Kung University Hospital","Unknown status","Oct 2015","Sep 2017","Interventional","Apr 2016","Gastroesophageal Reflux,Esophagitis","Lansoprazole,Dexlansoprazole"],["NCT02757820","Assiut University","Completed","Jun 2016","Apr 2018","Interventional","Apr 2016",null,null],["NCT02754141","Bristol-Myers Squibb","Active, not recruiting","Jun 2016","Feb 2023","Interventional","Apr 2016",null,"Nivolumab"],["NCT02753985","Abramson Cancer Center of the University of Pennsylvania","Completed","Jul 2014","Apr 2016","Observational","Apr 2016",null,null],["NCT02757768","Astellas Pharma Global Development, Inc.","Completed","Jun 2016","Sep 2018","Interventional","Apr 2016","Urinary Bladder,Prostatic Hyperplasia,Hyperplasia,Lower Urinary Tract Symptoms","Tamsulosin,Mirabegron"],["NCT02753348","Henning Bundgaard","Completed","Apr 2016","Nov 2018","Observational","Apr 2016","Heart Diseases,Heart Defects",null],["NCT02759718","Asan Medical Center","Unknown status","Jun 2012","May 2017","Interventional","Apr 2016","Neuroendocrine Tumors,Endocrine Gland Neoplasms,Adenoma",null],["NCT02755181","Boehringer Ingelheim","Completed","Jul 2016","May 2018","Observational","Apr 2016","Disease,Personality Disorders,Borderline Personality Disorder,Impulsive Behavior,Disruptive",null],["NCT02759926","Universitaire Ziekenhuizen Leuven","Unknown status","Aug 2011",null,"Interventional","Apr 2016","Obesity","Quinine,Denatonium"],["NCT02756286","Think Now Incorporated","Completed","Jan 2017","Jul 2018","Observational","Nov 2015","Attention Deficit Disorder with Hyperactivity",null],["NCT02752126","Lawson Health Research Institute","Completed","Jun 2016","Sep 2020","Interventional","Apr 2016","Carcinoma",null],["NCT02752035","Astellas Pharma Global Development, Inc.","Active, not recruiting","Aug 2016","Aug 2023","Interventional","Apr 2016","Leukemia","Azacitidine"],["NCT02750865","Boston Medical Center","Recruiting","Aug 2017","Dec 2022","Interventional","Mar 2016",null,null],["NCT02752165","University of Rochester","Recruiting","Aug 2016","Feb 2023","Interventional","Mar 2016","Asthma,Emergencies",null],["NCT02755792","The Hong Kong Polytechnic University","Completed","Jul 2012","Apr 2016","Interventional","Apr 2016","Cognitive Dysfunction",null],["NCT02757898","Emory University","Recruiting","Jan 2017","Dec 2021","Interventional","Apr 2016",null,"Biotin"],["NCT02758678","Science and Technology Park, Center of Innovation Technologies for Human Health","Completed","Nov 2015","Oct 2016","Observational","Apr 2016","Lung Neoplasms",null],["NCT02751424","GlaxoSmithKline","Terminated","Jun 2016","Feb 2017","Interventional","Apr 2016","Bacterial Infections",null],["NCT02750319","Memorial Sloan Kettering Cancer Center","Active, not recruiting","Apr 2016","Apr 2022","Interventional","Apr 2016","Atrial Fibrillation","Acetylcysteine,Amiodarone,N-monoacetylcystine"],["NCT02757495","Suez Canal University","Completed","Apr 2016","May 2017","Interventional","Apr 2016","Psychomotor Agitation,Emergence Delirium,Delayed Emergence from Anesthesia","Dexmedetomidine"],["NCT02752607","Dr. Vicky Tagalakis","Terminated","May 2016","Nov 2018","Observational","Apr 2016","Thrombosis,Venous Thrombosis",null],["NCT02757911","Genethon","Active, not recruiting","Mar 2016","Jun 2024","Interventional","Apr 2016","Granuloma,Granulomatous Disease",null],["NCT02759224","Boryung Pharmaceutical Co., Ltd","Completed","Apr 2016","Dec 2016","Interventional","Apr 2016","Stomach Ulcer","Irsogladine,Lafutidine"],["NCT02756351","CytaCoat AB","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Cross Infection,Pneumonia",null],["NCT02751359","University of California, Los Angeles","Completed","Jul 2016","Apr 2020","Interventional","Apr 2016",null,"Cannabidiol"],["NCT02756585","Nova Scotia Health Authority","Unknown status","Sep 2016","Dec 2018","Interventional","Apr 2016","Brain Injuries,Craniocerebral Trauma,Wounds and Injuries",null],["NCT02751411","Aboca Spa Societa' Agricola","Completed","Apr 2016","Mar 2020","Interventional","Apr 2016","Constipation",null],["NCT02750735","University of Palermo","Completed","Jan 2001","Mar 2016","Observational","Apr 2016","Hypersensitivity",null],["NCT02753868","University of Illinois at Urbana-Champaign","Completed","Feb 2016","Feb 2017","Interventional","Feb 2016","Renal Insufficiency",null],["NCT02755844","Hospices Civils de Lyon","Active, not recruiting","Sep 2016","Apr 2022","Interventional","Apr 2016","Endometrial Neoplasms","Metformin,Cyclophosphamide,Olaparib"],["NCT02758301","Medtronic Cardiac Rhythm and Heart Failure","Completed","Jun 2016","Dec 2018","Observational","Apr 2016","Heart Failure",null],["NCT02751463","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02752633","Landspitali University Hospital","Completed","May 2013","May 2015","Interventional","Apr 2016",null,"Allopurinol,Febuxostat"],["NCT02755909","Indonesia University","Completed","Dec 2015","Mar 2016","Interventional","Apr 2016","Anxiety Disorders","Anesthetics"],["NCT02752620","Rio de Janeiro State University","Completed","May 2016","Oct 2016","Interventional","Apr 2016","Back Pain,Low Back Pain",null],["NCT02759965","Karolinska University Hospital","Completed","Sep 2014","Dec 2018","Observational","Nov 2014","Acute-Phase Reaction,Cognitive Dysfunction",null],["NCT02754752","M.D. Anderson Cancer Center","Recruiting","Sep 2016","Sep 2023","Interventional","Apr 2016","Breast Neoplasms,Chronic Pain",null],["NCT02754349","Onze Lieve Vrouw Hospital","Completed","Feb 2015","May 2016","Interventional","Mar 2016","Atrial Fibrillation",null],["NCT02754479","Cutera Inc.","Completed","Apr 2016","Mar 2017","Interventional","Apr 2016","Telangiectasis",null],["NCT02753790","New Mexico Cancer Care Alliance","Active, not recruiting","Feb 2016","Mar 2023","Interventional","Apr 2016","Neoplasm Metastasis,Neoplasms,Brain Neoplasms",null],["NCT02757248","Anne Beaven, MD","Withdrawn","Nov 2016","Nov 2016","Interventional","Mar 2016",null,"Romidepsin"],["NCT02759991","Norwegian Institute of Public Health","Completed","Oct 2017","Sep 2019","Interventional","Mar 2016","Infections,Hepatitis A,Hepatitis E,Hepatitis","Vaccines"],["NCT02758561","Ottawa Hospital Research Institute","Completed","May 2016","Nov 2017","Interventional","Dec 2015","Urinary Incontinence,Enuresis,Pelvic Floor Disorders,Prolapse",null],["NCT02753504","Chong Kun Dang Pharmaceutical","Completed","Apr 2016","Jul 2016","Interventional","Apr 2016","Dyslipidemias",null],["NCT02758821","University of Oxford","Completed","Jun 2016","Sep 2017","Interventional","Mar 2016",null,null],["NCT02757430","Abbott Medical Devices","Completed","Aug 2016","Jul 2017","Observational [Patient Registry]","Apr 2016","Arrhythmias",null],["NCT02754024","Werner Anderl","Active, not recruiting","Sep 2005","Sep 2025","Observational","Apr 2016","Osteoarthritis,Necrosis",null],["NCT02757651","Institute of Cancer Research, United Kingdom","Completed","Jan 2017","Nov 2020","Interventional","Apr 2016","Breast Neoplasms","Hydrogen Peroxide"],["NCT02758769","Bristol-Myers Squibb","Active, not recruiting","Jun 2016","Oct 2023","Observational","Apr 2016","Arthritis","Abatacept"],["NCT02755896","Weill Medical College of Cornell University","Recruiting","Jul 2015","Jul 2024","Interventional","Aug 2015","Neoplasms,Breast Neoplasms,Radiation Pneumonitis",null],["NCT02753699","Debiopharm International SA","Completed","Dec 2011","May 2015","Interventional","Mar 2016","Hepatitis A,Hepatitis C,Hepatitis",null],["NCT02754323","Centre Hospitalier Universitaire de Nice","Unknown status","May 2016","Dec 2016","Interventional","Apr 2016",null,null],["NCT02753881","Yale University","Completed","Nov 2015","Dec 2019","Interventional","Mar 2016","Liver Neoplasms","Doxorubicin,Liposomal doxorubicin"],["NCT02752074","Incyte Corporation","Completed","Jun 2016","Aug 2019","Interventional","Apr 2016","Melanoma","Pembrolizumab"],["NCT02753244","Intendu Ltd.","Unknown status","Apr 2015",null,"Interventional","Apr 2016","Brain Injuries,Wounds and Injuries",null],["NCT02752672","Medical University of Graz","Completed","Mar 2016","Nov 2016","Observational","Apr 2016","Psoriasis",null],["NCT02759029","Gangnam Severance Hospital","Unknown status","Mar 2016","Feb 2018","Interventional","Apr 2016","Disease Susceptibility",null],["NCT02750202","University of Pretoria","Recruiting","Jul 2018","Jul 2023","Interventional","Apr 2016","Warts,Condylomata Acuminata,Recurrence","Vaccines"],["NCT02753686","Novartis Pharmaceuticals","Active, not recruiting","Mar 2016","Aug 2022","Observational [Patient Registry]","Apr 2016","Breast Neoplasms","Tamoxifen,Everolimus,Letrozole,Fulvestrant,Anastrozole,Exemestane"],["NCT02752217","Khon Kaen University","Unknown status","Mar 2016","Sep 2018","Interventional","Apr 2016","Hypertension",null],["NCT02755662","ResMed","Completed","May 2016","Jul 2017","Interventional","Apr 2016","Apnea,Sleep Apnea Syndromes,Sleep Apnea,Syndrome",null],["NCT02751671","St. Justine's Hospital","Completed","Aug 2016","Jun 2017","Interventional","Apr 2016",null,null],["NCT02752880","Chang Gung Memorial Hospital","Completed","Jun 2016","Feb 2018","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02751632","Orygen","Active, not recruiting","Apr 2016","May 2021","Interventional","Apr 2016","Disease,Psychotic Disorders,Mental Disorders,Personality Disorders","Fluoxetine"],["NCT02750527","Kinderkrankenhaus auf der Bult","Completed","Sep 2016","Dec 2020","Observational","Apr 2016","Hyperlipoproteinemia Type II,Diabetes Mellitus,Hypercholesterolemia",null],["NCT02751242","Vanderbilt University","Completed","Aug 2016","Jul 2017","Observational","Apr 2016","Heart Failure",null],["NCT02755363","Medical University of Warsaw","Unknown status","Apr 2016","Jul 2016","Interventional","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02751775","Pennington Biomedical Research Center","Completed","Jun 2016","Jun 2017","Observational","Apr 2016","Pediatric Obesity",null],["NCT02757976","Lawson Health Research Institute","Terminated","Mar 2018","Jun 2019","Interventional","Apr 2016","Heart Failure,Ventricular Dysfunction",null],["NCT02752386","University of Tulsa","Completed","Feb 2016","Jul 2018","Interventional","Apr 2016",null,null],["NCT02756143","University Hospital of Torrejon","Completed","Nov 2014","Feb 2017","Interventional","Apr 2016",null,null],["NCT02754648","Ain Shams University","Unknown status","Sep 2015","Sep 2016","Interventional","Mar 2016","Endometriosis",null],["NCT02751138","University of Ulm","Recruiting","Mar 2016","Sep 2024","Observational [Patient Registry]","Apr 2016","Glioblastoma",null],["NCT02753231","Universidad Santo Tomas","Completed","Jan 2017","Dec 2017","Interventional","Apr 2016","Metabolic Syndrome,Metabolic Diseases,Lipid Metabolism Disorders,Overweight",null],["NCT02759588","Genelux Corporation","Active, not recruiting","May 2016","May 2022","Interventional","Apr 2016","Ovarian Neoplasms,Carcinoma,Fallopian Tube Neoplasms,Peritoneal Neoplasms","Bevacizumab"],["NCT02757352","Eli Lilly and Company","Completed","Aug 2016","May 2019","Interventional","Apr 2016","Spondylarthritis","Ixekizumab"],["NCT02752022","St George's, University of London","Unknown status","Sep 2016","Apr 2019","Observational","Apr 2016",null,null],["NCT02754973","The University of Hong Kong","Completed","May 2015","Nov 2017","Interventional","Apr 2016",null,null],["NCT02755506","Chinese PLA General Hospital","Unknown status","Oct 2015","Oct 2016","Interventional","Apr 2016","Aneurysm",null],["NCT02751216","Moens Maarten","Completed","May 2016","Jan 2018","Interventional","Apr 2016","Syndrome,Failed Back Surgery Syndrome",null],["NCT02756559","Lixin Xie","Unknown status","Jan 2014","Dec 2017","Observational","Apr 2016",null,null],["NCT02754557","Emory University","Recruiting","Mar 2016","Dec 2021","Interventional","Apr 2016","Stress Disorders",null],["NCT02758496","Wave Neuroscience","Completed","Apr 2016","Apr 2017","Observational","Apr 2016","Autistic Disorder",null],["NCT02757066","Nobelpharma","Completed","Jun 2016","Sep 2018","Interventional","Apr 2016","Sleep Wake Disorders,Parasomnias,Disease,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders","Melatonin"],["NCT02756104","University Hospital, Montpellier","Completed","Jun 2016","May 2020","Interventional","Apr 2016",null,"Vitamin D"],["NCT02751814","Pennington Biomedical Research Center","Completed","Apr 2016","Jun 2018","Observational","Apr 2016","Pediatric Obesity",null],["NCT02751749","Örebro University, Sweden","Completed","Dec 2015","Sep 2016","Interventional","Apr 2016","Chronic Pain",null],["NCT02756052","University of Calgary","Completed","Mar 2016","Aug 2016","Interventional","Mar 2016",null,null],["NCT02753647","Ruijin Hospital","Unknown status","Apr 2016","Apr 2019","Interventional","Apr 2016","Lymphoma","Prednisone,Cyclophosphamide,Rituximab,Doxorubicin,Vincristine"],["NCT02756910","Peking Union Medical College Hospital","Completed","May 2016","Sep 2016","Observational","Apr 2016",null,null],["NCT02756208","University of Maryland, College Park","Completed","Nov 2015","Jul 2018","Interventional","Apr 2016","HIV Infections","Vaccines"],["NCT02757443","Meshalkin Research Institute of Pathology of Circulation","Completed","Jun 2016","May 2021","Interventional","Apr 2016",null,"Phosphocreatine,Anesthetics"],["NCT02759744","National Institutes of Health Clinical Center (CC)","Enrolling by invitation","Oct 2017","Jan 2026","Interventional","Apr 2016","Prostatic Neoplasms",null],["NCT02753140","Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","Unknown status","Apr 2016","Sep 2018","Interventional","Apr 2016","Carcinoma,Squamous Cell Carcinoma of Head and Neck","Docetaxel,Cetuximab"],["NCT02759536","The Third Xiangya Hospital of Central South University","Unknown status","Jul 2013",null,"Interventional","Apr 2016","Melanoma",null],["NCT02750449","Bayer","Completed","May 2016","Jul 2016","Interventional","Apr 2016","Dermatitis",null],["NCT02759211","Mount Sinai Rehabilitation Hospital","Unknown status","Apr 2016","Feb 2018","Interventional","Mar 2016","Multiple Sclerosis,Sclerosis",null],["NCT02752477","Ben Lim","Active, not recruiting","Aug 2016","Sep 2020","Interventional","Mar 2016","Pain,Chronic Pain","Anesthetics"],["NCT02759835","National Cancer Institute (NCI)","Active, not recruiting","Apr 2016","Sep 2022","Interventional","Apr 2016","Lung Neoplasms,Adenocarcinoma of Lung","Osimertinib"],["NCT02754596","Glaukos Corporation","Active, not recruiting","Mar 2016","Dec 2021","Interventional","Mar 2016","Glaucoma","Timolol,Travoprost,Ophthalmic Solutions"],["NCT02757846","Chinese Academy of Sciences","Enrolling by invitation","Apr 2017","Mar 2022","Observational","Apr 2016","Carcinoma",null],["NCT02750085","Victor Blanchette","Active, not recruiting","Apr 2016","Dec 2020","Observational","Apr 2016","Hemophilia A",null],["NCT02759692","Johnson & Johnson Vision Care, Inc.","Completed","Apr 2016","Jun 2016","Interventional","Apr 2016",null,null],["NCT02752750","Medical University of Graz","Enrolling by invitation","May 2016","May 2022","Observational","Apr 2016","Alzheimer Disease",null],["NCT02757781","Avedis Donabedian Research Institute","Unknown status","Jul 2016","Dec 2018","Interventional","Apr 2016","Chronic Disease",null],["NCT02757924","Abbott Nutrition","Completed","May 2016","May 2017","Interventional","Apr 2016",null,null],["NCT02759887","St. Joseph's Hospital and Medical Center, Phoenix","Completed","Nov 2016","Dec 2018","Interventional","Apr 2016","Dementia,Down Syndrome,Alzheimer Disease,Syndrome","Fluorodeoxyglucose F18"],["NCT02758977","University of Zurich","Unknown status","May 2016",null,"Interventional","Apr 2016","Neoplasms,Neoplasm Metastasis,Liver Neoplasms,Colorectal Neoplasms,Liver Diseases",null],["NCT02751580","Sidney Kimmel Cancer Center at Thomas Jefferson University","Completed","Mar 2016","Aug 2018","Interventional","Apr 2016","Neoplasms",null],["NCT02751333","Johns Hopkins University","Withdrawn","Mar 2016","Feb 2017","Interventional","Apr 2016","Esophageal Stenosis,Esophageal Fistula,Esophageal Perforation,Fistula,Constriction",null],["NCT02759731","National Cancer Institute (NCI)","Recruiting","Nov 2016","Jun 2022","Interventional","Apr 2016","Graft vs Host Disease",null],["NCT02758288","Loma Linda University","Withdrawn","Sep 2015","Jul 2022","Observational","Mar 2016","Virus Diseases,Kidney Diseases",null],["NCT02756546","Cairo University","Completed","Sep 2014","Dec 2015","Interventional","Apr 2016","Lupus Erythematosus","Hydroxychloroquine,Hydrocortisone,Cyclophosphamide"],["NCT02759094","Implantica CE & Production Ltd","Unknown status","Dec 2016","Feb 2018","Interventional","Apr 2016","Gastroesophageal Reflux",null],["NCT02757313","Yale University","Completed","Oct 2016","May 2021","Interventional","Apr 2016","Marijuana Abuse","Dronabinol"],["NCT02754011","UNICANCER","Recruiting","Jan 2017","Dec 2021","Interventional","Feb 2016","Breast Neoplasms","Capecitabine"],["NCT02755805","University of Pittsburgh","Completed","Jul 2009","Dec 2012","Interventional","Apr 2016","Stroke",null],["NCT02755428","Chinese Academy of Sciences","Unknown status","Jan 2018","Dec 2020","Interventional","Mar 2016","Macular Degeneration",null],["NCT02752555","Benha University","Unknown status","Apr 2016",null,"Interventional","Apr 2016","Oligospermia","Antioxidants"],["NCT02751398","Yonsei University","Completed","Aug 2016","Jun 2020","Interventional","Apr 2016","Diabetes Mellitus","Dapagliflozin"],["NCT02758951","Koen Rovers","Recruiting","Jun 2017","Aug 2026","Interventional","Apr 2016","Neoplasms,Colorectal Neoplasms,Neoplasm Metastasis,Carcinoma,Peritoneal Neoplasms","Bevacizumab"],["NCT02750176","University of Southern California","Completed","Apr 2016","Jul 2018","Interventional","Apr 2016","Rotator Cuff Injuries",null],["NCT02750696","Federal University of Rio Grande do Sul","Completed","Apr 2013","Apr 2015","Interventional","Apr 2016","Abscess,Periapical Abscess","Acetaminophen,Tramadol,Codeine"],["NCT02757963","GlaxoSmithKline","Completed","May 2016","Feb 2017","Interventional","Apr 2016","Prostatic Hyperplasia,Hyperplasia",null],["NCT02756026","USDA, Western Human Nutrition Research Center","Completed","Sep 2013","Feb 2014","Interventional","Apr 2016",null,"Micronutrients,Trace Elements"],["NCT02756481","Bristol-Myers Squibb","Completed","Oct 2013","Nov 2014","Observational","Oct 2015","Atrial Fibrillation",null],["NCT02751060","Tongji Hospital","Enrolling by invitation","Apr 2016","Dec 2022","Observational [Patient Registry]","Apr 2016","Heart Diseases,Coronary Disease,Coronary Artery Disease,Myocardial Ischemia",null],["NCT02753127","Sumitomo Dainippon Pharma Oncology, Inc","Completed","Jun 2016","May 2021","Interventional","Apr 2016","Colorectal Neoplasms","Leucovorin,Bevacizumab,Fluorouracil,Irinotecan"],["NCT02755051","University of Missouri-Columbia","Completed","Jul 2016","Mar 2018","Interventional","Mar 2016","Sleep Initiation and Maintenance Disorders,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders",null],["NCT02757560","Phoenix VA Health Care System","Unknown status","Feb 2012","Dec 2020","Interventional","Aug 2015","Insulin Resistance",null],["NCT02754076","Allievex Corporation","Completed","Apr 2016","Jul 2020","Interventional","Feb 2016","Mucopolysaccharidoses,Mucopolysaccharidosis III",null],["NCT02752282","University of Washington","Unknown status","Mar 2016","Dec 2019","Interventional","Apr 2016","Uterine Hemorrhage",null],["NCT02751021","University Hospital, Caen","Completed","Jun 2016","Jun 2019","Interventional","Apr 2016","Apnea,Sleep Apnea Syndromes,Arrhythmias,Hyperaldosteronism",null],["NCT02759471","Coopervision, Inc.","Completed","Apr 2016","Aug 2016","Interventional","Apr 2016","Myopia",null],["NCT02752854","Taif University","Unknown status","Apr 2015","May 2016","Observational","Apr 2016",null,null],["NCT02759822","Leonardo Javier Arcuri","Unknown status","Apr 2016",null,"Observational","Apr 2016","Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma",null],["NCT02752139","Yi Yang","Completed","May 2016","Oct 2018","Observational [Patient Registry]","Mar 2016","Sleep Wake Disorders,Parasomnias,Sleep Disorders,Disease",null],["NCT02752295","Medical University of Vienna","Completed","May 2015","Jul 2016","Interventional","Apr 2016","Disease,Inflammation,Anxiety Disorders,Mood Disorders,Stress",null],["NCT02753023","University of Sao Paulo General Hospital","Unknown status","May 2015","May 2020","Observational [Patient Registry]","Apr 2016","Pulmonary Embolism,Pulmonary Edema,Syncope,Aneurysm,Acute Coronary Syndrome,Embolism,Aortic Aneurysm,Emergencies,Chest Pain",null],["NCT02757365","West China Hospital","Unknown status","Apr 2014","Apr 2019","Interventional","Apr 2016","Prostatic Neoplasms","Aspirin,Levofloxacin,Ofloxacin"],["NCT02757092","Chang Gung Memorial Hospital","Completed","Mar 2016","May 2017","Interventional","Apr 2016","Lung Neoplasms",null],["NCT02758327","Koffler Vision Group","Completed","Oct 2015","Mar 2016","Interventional","Apr 2016","Dry Eye Syndromes","Carboxymethylcellulose Sodium,Ophthalmic Solutions,Lubricant Eye Drops"],["NCT02757404","Medy-Tox","Completed","May 2016","Aug 2016","Interventional","Apr 2016","Muscle Spasticity","Botulinum Toxins"],["NCT02757469","Navy General Hospital, Beijing","Unknown status","May 2016","May 2021","Interventional","Apr 2016","Premature Birth,Infertility,Primary Ovarian Insufficiency,Menopause","Drospirenone,Ethinyl Estradiol,Drospirenone and ethinyl estradiol combination,Estradiol"],["NCT02759172","Michigan State University","Unknown status","Apr 2016",null,"Interventional","Apr 2016","Suicide",null],["NCT02758041","Sebacia, Inc.","Completed","Feb 2016","Feb 2017","Interventional","Apr 2016","Acne Vulgaris",null],["NCT02755116","Jaime B Hyman","Completed","Apr 2016","Sep 2019","Interventional","Apr 2016","Nausea,Vomiting,Postoperative Nausea and Vomiting","Olanzapine"],["NCT02755584","National Institute on Aging (NIA)","Completed","Jun 2016","Apr 2021","Observational","Apr 2016",null,null],["NCT02750540","Johns Hopkins University","Completed","Oct 2016","May 2019","Interventional","Apr 2016",null,"Tenofovir"],["NCT02751918","Bayer","Completed","Jun 2016","Oct 2019","Interventional","Apr 2016","Ovarian Neoplasms","Doxorubicin,Liposomal doxorubicin,Maytansine"],["NCT02751541","Bayer","Completed","May 2016","May 2016","Interventional","Apr 2016","Dermatitis","Sunscreening Agents"],["NCT02755883","Weill Medical College of Cornell University","Completed","Apr 2016","Oct 2017","Interventional","Apr 2016","Lung Neoplasms",null],["NCT02751229","University of Ulm","Completed","May 2016","May 2017","Interventional","Mar 2016","Mental Disorders",null],["NCT02759640","Atridia Pty Ltd.","Completed","Sep 2016","May 2018","Interventional","Apr 2016","Neoplasms",null],["NCT02750683","Hopital Antoine Beclere","Completed","Oct 2014","Jan 2016","Observational","Apr 2016","Shock",null],["NCT02758132","University of Hawaii","Terminated","Mar 2016","Sep 2016","Interventional","Apr 2016","Prostatic Neoplasms,Neoplasm Metastasis","Denosumab,Prednisone"],["NCT02757001","Group of Research in Minimally Invasive Techniques","Completed","Jun 2016","Jul 2019","Observational [Patient Registry]","Apr 2016",null,null],["NCT02757235","Sahlgrenska University Hospital, Sweden","Unknown status","Mar 2016","Jun 2020","Interventional","Apr 2016","Hematoma",null],["NCT02754869","University College, London","Unknown status","Feb 2011","Aug 2018","Observational","Feb 2016","Intestinal Diseases",null],["NCT02759406","Palmaz Scientific","Completed","Sep 2013","Jun 2015","Interventional","Apr 2016","Heart Diseases,Myocardial Ischemia,Coronary Artery Disease,Ischemia",null],["NCT02758522","Hospital Universitario Dr. Jose E. Gonzalez","Completed","Oct 2013","Oct 2015","Interventional","Apr 2016","Diabetes Mellitus,Hyperglycemia","Insulin"],["NCT02750046","Second Affiliated Hospital of Soochow University","Unknown status","Mar 2016","Feb 2018","Interventional","Mar 2016","Fractures,Femoral Neck Fractures",null],["NCT02755233","University of Zurich","Completed","Jan 2014","Mar 2016","Observational","Apr 2016","Melanoma",null],["NCT02750423","Emory University","Completed","Apr 2016","Dec 2017","Interventional","Apr 2016",null,null],["NCT02754050","Tandem Technologies LTD","Unknown status","Sep 2016","Oct 2018","Interventional","Apr 2016",null,null],["NCT02754284","Chinese Academy of Sciences","Completed","Dec 2015","Jun 2020","Interventional","Apr 2016","Vocal Cord Dysfunction",null],["NCT02756078","Johnson & Johnson Vision Care, Inc.","Completed","Apr 2016","Oct 2017","Interventional","Apr 2016",null,null],["NCT02750995","Daniel El Fassi","Completed","Apr 2016","Jun 2019","Interventional","Apr 2016","Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome","Azacitidine"],["NCT02759302","Rigshospitalet, Denmark","Completed","Apr 2016","Apr 2017","Observational","Apr 2016","Muscular Dystrophies",null],["NCT02759874","Institute of Health Economics, Canada","Unknown status","Nov 2015","Nov 2018","Interventional","Apr 2016","Fetal Alcohol Spectrum Disorders,Alcoholism",null],["NCT02758535","Modarres Hospital","Completed","Mar 2015","Mar 2016","Interventional","Apr 2016",null,null],["NCT02755636","Pro-Change Behavior Systems","Unknown status","May 2016","Jul 2017","Interventional","Mar 2016",null,null],["NCT02758873","University of Sussex","Completed","Feb 2016","Jul 2019","Interventional","Apr 2016","Asthma","Salmeterol Xinafoate,Montelukast"],["NCT02753166","NYU Langone Health","Withdrawn","Jan 2017","Dec 2017","Interventional","Apr 2016",null,"Dexamethasone"],["NCT02755766","Shriners Hospitals for Children","Completed","May 2015","Jul 2019","Observational","Mar 2016","Scoliosis,Clubfoot,Talipes,Equinus Deformity",null],["NCT02751983","VA Office of Research and Development","Completed","Nov 2016","Dec 2018","Interventional","Apr 2016","Suicide",null],["NCT02754960","Shanghai Jiao Tong University School of Medicine","Withdrawn","Mar 2010","Sep 2014","Interventional","Apr 2016","Gastrointestinal Hemorrhage,Vascular Malformations,Congenital Abnormalities,Hemorrhage","Thalidomide"],["NCT02751086","International Study Group on Minimally Invasive Surgery for Gastric Cancer","Recruiting","Apr 2016","Dec 2024","Observational","Apr 2016","Stomach Neoplasms",null],["NCT02755753","YongChan Lee","Completed","Jan 2014","Apr 2016","Interventional","Sep 2015","Gastroesophageal Reflux,Esophagitis","Lansoprazole,Dexlansoprazole,Rebamipide"],["NCT02757872","Albert Einstein College of Medicine","Active, not recruiting","Apr 2016","Nov 2021","Interventional","Apr 2016","Kidney Diseases,Hypertension","Vitamin D,Ergocalciferols,Cholecalciferol,Vitamins"],["NCT02756767","Abramson Cancer Center of the University of Pennsylvania","Completed","Apr 2016","Apr 2021","Observational","Apr 2016","Neoplasms",null],["NCT02757937","Children's Hospital of Philadelphia","Completed","May 2016","Dec 2017","Interventional","Apr 2016","Diabetes Mellitus",null],["NCT02753660","Indonesia University","Completed","Aug 2014","Oct 2014","Interventional","Apr 2016",null,null],["NCT02751684","Universitätsklinikum Köln","Completed","Mar 2017","May 2017","Observational","Apr 2016",null,null],["NCT02753556","Dimagi Inc.","Completed","Sep 2015","Jun 2016","Observational","Apr 2016","Lung Diseases,Pulmonary Disease",null],["NCT02757287","Institut Universitari Dexeus","Withdrawn","May 2016","Dec 2018","Interventional","Apr 2016","Infertility","Desogestrel"],["NCT02752308","Isfahan University of Medical Sciences","Completed","Sep 2014","Mar 2015","Interventional","Apr 2016","Hypospadias","Atropine,Epinephrine,Fentanyl,Bupivacaine,Neostigmine"],["NCT02758314","Instituto Nacional de Cancerologia de Mexico","Unknown status","Mar 2017","Dec 2018","Observational","Apr 2016","Lung Neoplasms,Carcinoma",null],["NCT02752685","NYU Langone Health","Recruiting","Jun 2016","Dec 2021","Observational","Apr 2016","Breast Neoplasms","Paclitaxel,Pembrolizumab"],["NCT02759289","NYU Langone Health","Completed","Nov 2015","Sep 2020","Observational","Apr 2016","Atherosclerosis",null],["NCT02759120","Weill Medical College of Cornell University","Terminated","Mar 2017","Mar 2020","Interventional","Apr 2016","Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis","Doxycycline,Anti-Bacterial Agents,Trimethoprim,Anti-Infective Agents"],["NCT02754401","Renatus, Antonio Renatus, Dent., M.Sc","Completed","Jan 2014","Jul 2014","Interventional","Apr 2016","Periodontitis",null],["NCT02759757","Leandro Pires","Unknown status","May 2016","Feb 2017","Interventional","Apr 2016","Back Pain,Low Back Pain",null],["NCT02750579","Assistance Publique Hopitaux De Marseille","Completed","Sep 2016","Apr 2018","Interventional","Apr 2016","Acute Coronary Syndrome,Syndrome",null],["NCT02752204","University of Birmingham","Completed","Oct 2015","Feb 2020","Interventional","Apr 2016","Lymphoma","Rituximab"],["NCT02757053","Mosaic Life Care","Terminated","Apr 2016","Jun 2016","Interventional","Apr 2016","Brain Injuries,Brain Concussion,Diffuse Axonal Injury,Wounds and Injuries,Athletic Injuries",null],["NCT02752542","Nova Scotia Health Authority","Unknown status","Oct 2016","May 2021","Interventional","Apr 2016","Disease,Depressive Disorder,Depression",null],["NCT02753283","Susan L. Greenspan","Active, not recruiting","Jun 2016","Sep 2023","Interventional","Apr 2016","Osteoporosis,Osteoporotic Fractures","Vitamin D,Zoledronic Acid,Denosumab,Calcium"],["NCT02754934","Balgrist University Hospital","Completed","Nov 2014","Nov 2016","Observational","Apr 2016","Neck Pain",null],["NCT02755194","The Hospital for Sick Children","Terminated","Sep 2014","Sep 2019","Observational","Apr 2016",null,null],["NCT02758210","Emory University","Completed","Apr 2016","Oct 2016","Interventional","Apr 2016","Bradycardia,Tachycardia",null],["NCT02757456","Sameena Iqbal","Completed","Feb 2015","Feb 2016","Interventional","Nov 2012","Cardiovascular Diseases",null],["NCT02756377","Islamic Azad University, Tehran","Completed","May 2014","Jun 2015","Interventional","Apr 2016","Periodontal Diseases","Chlorhexidine,Chlorhexidine gluconate,Cetylpyridinium"],["NCT02751099","Centro Hospitalar de Lisboa Central","Unknown status","Nov 2015","Dec 2018","Observational","Apr 2016","Bone Diseases,Renal Insufficiency,Vascular Diseases",null],["NCT02752178","University of Cambridge","Completed","Jun 2015","Sep 2018","Observational","Mar 2016","Depressive Disorder,Depression",null],["NCT02757144","Daewoong Pharmaceutical Co. LTD.","Completed","Mar 2016","Feb 2017","Interventional","Mar 2016",null,"Esomeprazole"],["NCT02757742","Fu Wai Hospital, Beijing, China","Completed","Dec 2010","Aug 2016","Observational","Apr 2016","Cardiomyopathies",null],["NCT02750644","Joaquin de Haro, M.D.","Completed","Jan 2005","Apr 2016","Observational","Apr 2016","Carotid Artery Diseases",null],["NCT02754635","HaEmek Medical Center, Israel","Unknown status","Mar 2016","Jul 2018","Interventional","Feb 2016",null,null],["NCT02755311","Sun Yat-sen University","Unknown status","Mar 2014","Jun 2016","Interventional","Apr 2016","Carcinoma","Cisplatin,Carboplatin,Fluorouracil,Epirubicin,Ethiodized Oil,Pirarubicin,Doxorubicin,Gelatin Sponge"],["NCT00170053","Mayo Clinic","Completed","Jun 2005","Sep 2008","Interventional","Sep 2005","Kidney Diseases","Sirolimus"],["NCT00175396","University of British Columbia","Unknown status","May 2004","Jun 2014","Interventional","Sep 2005","Prostatic Neoplasms","Ascorbic Acid,Leuprolide,Methyltestosterone,Flutamide,Bicalutamide,Nilutamide,Buserelin,Androgens,Estrogens"],["NCT00179647","Celgene Corporation","Completed","Sep 2005","Apr 2009","Interventional","Sep 2005","Multiple Myeloma,Neoplasms","Dexamethasone,Lenalidomide"],["NCT00172523","National Taiwan University Hospital","Unknown status","Oct 2004","Aug 2005","Observational","Sep 2005","Polycystic Ovary Syndrome,Syndrome",null],["NCT00174785","Sanofi","Completed","Jun 2005","Mar 2008","Interventional","Sep 2005","Atrial Fibrillation,Atrial Flutter","Dronedarone"],["NCT00175058","TherOx","Completed","Aug 2005","May 2008","Interventional","Sep 2005","Myocardial Infarction,Infarction",null],["NCT00177541","University of Pittsburgh","Completed","Feb 2004","Sep 2016","Interventional","Sep 2005","Urinary Incontinence",null],["NCT00176215","Heidelberg University","Unknown status","May 2003",null,"Interventional","Sep 2005","Tooth Abrasion",null],["NCT00178529","The University of Texas Health Science Center, Houston","Completed","Jul 2001","Sep 2005","Interventional","Sep 2005","Stroke",null],["NCT00172367","National Taiwan University Hospital","Withdrawn","Jan 2006",null,"Interventional","Sep 2005","Carcinoma","Lycopene"],["NCT00173875","National Taiwan University Hospital","Completed","Mar 2005","Jul 2007","Interventional","Sep 2005","Lung Neoplasms,Carcinoma","Gefitinib"],["NCT00174668","Sanofi","Completed","Nov 2004",null,"Interventional","Sep 2005","Diabetes Mellitus","Insulin,Insulin Glargine,Insulin glulisine"],["NCT00173927","National Taiwan University Hospital","Unknown status","Mar 2004",null,"Observational","Sep 2005","Atherosclerosis",null],["NCT00179933","Ann & Robert H Lurie Children's Hospital of Chicago","Terminated","Sep 2005","Feb 2007","Interventional","Sep 2005",null,null],["NCT00176878","Masonic Cancer Center, University of Minnesota","Completed","Jun 2000","Mar 2009","Interventional","Sep 2005","Shwachman-Diamond Syndrome,Neutropenia,Bone Marrow Failure Disorders,Pancytopenia,Anemia,Syndrome","Fludarabine,Fludarabine phosphate,Busulfan,Antilymphocyte Serum"],["NCT00172653","National Taiwan University Hospital","Unknown status","Aug 2005","Jul 2006","Observational","Sep 2005",null,null],["NCT00177645","University of Pittsburgh","Completed","Mar 2002","Dec 2006","Interventional","Sep 2005","Cystic Fibrosis,Fibrosis",null],["NCT00176475","University of Medicine and Dentistry of New Jersey","Terminated","Jan 2005","Feb 2008","Interventional","Sep 2005","Lymphoma,Leukemia,Multiple Myeloma,Neoplasms,Plasmacytoma","Rituximab"],["NCT00178087","University of Pittsburgh","Completed","Aug 2005","Aug 2011","Observational","Sep 2005","Depression,Depressive Disorder",null],["NCT00178854","Vanderbilt University Medical Center","Withdrawn","May 2004","Mar 2006","Interventional","Sep 2005","Depressive Disorder","Risperidone"],["NCT00178503","The University of Texas Health Science Center, Houston","Completed","Sep 2005","May 2011","Interventional","Sep 2005","Hyperkinesis,Autistic Disorder,Attention Deficit Disorder with Hyperactivity","Methylphenidate"],["NCT00176410","University of Leipzig","Unknown status","Jan 2003","Dec 2009","Interventional","Sep 2005","Aortic Valve Stenosis,Constriction",null],["NCT00179166","Vanderbilt University","Terminated","Jun 2004","Jul 2005","Interventional","Sep 2005","Renal Insufficiency,Acute Kidney Injury",null],["NCT00171054","Novartis","Completed","Sep 2003","Oct 2007","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan,Hydrochlorothiazide"],["NCT00170300","Medtronic Bakken Research Center","Completed","Jan 2001","May 2005","Interventional","Sep 2005","Heart Failure",null],["NCT00177619","University of Pittsburgh","Completed","May 2002","Dec 2005","Interventional","Sep 2005","Prostatic Neoplasms,Osteoporosis","Alendronate"],["NCT00178139","University of Rochester","Completed","Apr 2004","Jul 2006","Interventional","Sep 2005","Respiratory Insufficiency,Pulmonary Valve Insufficiency",null],["NCT00175799","University of British Columbia","Completed","Sep 2007","Jul 2013","Observational","Sep 2005",null,null],["NCT00172874","National Taiwan University Hospital","Completed","Jan 1998","Dec 2008","Observational","Sep 2005","Feeding and Eating Disorders",null],["NCT00179985","Ann & Robert H Lurie Children's Hospital of Chicago","Completed","Dec 2004","Jul 2011","Observational","Sep 2005","Hypersensitivity",null],["NCT00176384","University of Leipzig","Completed","Mar 2003","Dec 2006","Interventional","Sep 2005","Heart Failure",null],["NCT00176644","University of Medicine and Dentistry of New Jersey","Terminated","May 2005","Dec 2008","Interventional","Sep 2005","Prostatic Neoplasms","Estradiol"],["NCT00174070","National Taiwan University Hospital","Unknown status","Aug 2005","Feb 2006","Observational","Sep 2005","Respiratory Insufficiency",null],["NCT00173472","National Taiwan University Hospital","Unknown status","Jul 2002","Jul 2005","Observational","Sep 2005","Colorectal Neoplasms",null],["NCT00172640","National Taiwan University Hospital","Unknown status","Jan 2005",null,"Observational","Sep 2005","Carcinoma",null],["NCT00174967","Takeda","Completed","Jan 2001","Jul 2001","Interventional","Sep 2005","Gout","Febuxostat"],["NCT00171028","Novartis","Completed","Dec 2003","Nov 2006","Interventional","Sep 2005","Hypertension","Valsartan"],["NCT00175344","University of British Columbia","Completed","Feb 2004","Apr 2006","Interventional","Sep 2005","Breast Neoplasms,Pain",null],["NCT00173368","National Taiwan University Hospital","Completed","Jan 2003","Mar 2005","Observational","Sep 2005","Choledocholithiasis",null],["NCT00174629","Sanofi","Completed","Jun 2001",null,"Interventional","Sep 2005","Lung Neoplasms","Gemcitabine,Docetaxel"],["NCT00179231","Vanderbilt University","Completed","May 2000","Feb 2004","Interventional","Sep 2005","Schizophrenia,Psychotic Disorders","Olanzapine,Clozapine"],["NCT00173693","National Taiwan University Hospital","Withdrawn","Jan 2006","Dec 2010","Interventional","Sep 2005","Osteoporosis,Bone Diseases",null],["NCT00171093","Novartis","Completed","Sep 2004",null,"Interventional","Sep 2005","Hypertension,Hypercholesterolemia","Valsartan,Simvastatin"],["NCT00179348","Albert Einstein College of Medicine","Completed","Feb 2001","Jul 2016","Interventional","Sep 2005","Carcinoma,Breast Neoplasms,Colorectal Neoplasms,Sleep Wake Disorders,Alopecia,Vomiting",null],["NCT00172133","Shire","Completed","Oct 2001","Apr 2005","Interventional","Sep 2005","Osteoporosis",null],["NCT00170508","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Jun 2005","Aug 2005","Interventional","Sep 2005","Influenza",null],["NCT00179543","Beth Israel Deaconess Medical Center","Completed","Aug 2001",null,"Interventional","Sep 2005","Hypertension",null],["NCT00177216","University of Pittsburgh","Completed","Feb 2002","May 2008","Interventional","Sep 2005","Sleep Initiation and Maintenance Disorders,Sleep Wake Disorders","Zolpidem,Citalopram"],["NCT00176813","University of Michigan Rogel Cancer Center","Completed","Mar 2003","Nov 2006","Interventional","Sep 2005","Pancreatic Neoplasms","Gemcitabine,Celecoxib"],["NCT00170131","Mayo Clinic","Completed","Sep 2002","Jul 2007","Observational","Sep 2005","Infections,Hepatitis C",null],["NCT00174551","Rainier Associates","Unknown status","Nov 2003","Nov 2005","Interventional","Sep 2005","Stress Disorders","Prazosin"],["NCT00170755","Novartis","Completed","Apr 2002","Jan 2005","Interventional","Sep 2005","Urinary Bladder","Darifenacin"],["NCT00174200","Pfizer","Completed","Dec 2004","May 2006","Interventional","Sep 2005","Schizophrenia,Mental Disorders,Psychotic Disorders","Risperidone"],["NCT00178698","The University of Texas Health Science Center, Houston","Unknown status","Jul 2002","Jun 2014","Interventional","Sep 2005","Lung Neoplasms,Stomach Neoplasms,Small Cell Lung Carcinoma,Carcinoma","Gemcitabine,Interferons"],["NCT00178516","University of Rochester","Completed","Jun 2004","Dec 2005","Observational","Sep 2005","Infertility",null],["NCT00172289","National Taiwan University Hospital","Unknown status","Aug 2004","Dec 2006","Observational","Sep 2005","Spinal Cord Injuries,Stroke,Wounds and Injuries",null],["NCT00172718","National Taiwan University Hospital","Unknown status","Mar 2005",null,"Observational","Sep 2005","Jaw,Mouth",null],["NCT00174239","Pfizer","Terminated","Jul 2004","Sep 2005","Interventional","Sep 2005","Parkinson Disease","Levodopa,Carbidopa,Cabergoline"],["NCT00178620","The University of Texas Health Science Center, Houston","Completed","Nov 2003","Mar 2014","Interventional","Sep 2005","Myocardial Infarction,Heart Diseases,Infarction","Reteplase"],["NCT00177112","University of Minnesota","Completed","Jun 2005","Oct 2007","Interventional","Sep 2005","Infections,Communicable Diseases,Urinary Tract Infections",null],["NCT00173108","National Taiwan University Hospital","Completed","Jan 2006","Oct 2010","Interventional","Sep 2005","Premature Birth",null],["NCT00170404","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Jun 2000","Oct 2005","Interventional","Sep 2005","Tuberculosis","Vitamins,Folic Acid,Vitamin A,Thiamine,Selenium,Micronutrients,Trace Elements"],["NCT00176280","University of Kentucky","Withdrawn","Sep 2005",null,"Interventional","Sep 2005","Carcinoma","Dexamethasone,Sargramostim"],["NCT00175123","University of Aarhus","Unknown status","May 2005","Jun 2008","Interventional","Sep 2005","Urinary Bladder,Meningomyelocele,Spina Bifida Cystica","Botulinum Toxins,abobotulinumtoxinA"],["NCT00170924","Novartis","Completed","Aug 2004","Jun 2006","Interventional","Sep 2005","Hypertension","Valsartan"],["NCT00170222","Medical Center Alkmaar","Completed","Jul 2002","Aug 2008","Interventional","Sep 2005","Lung Diseases,Pulmonary Disease","Doxycycline"],["NCT00172042","Novartis Pharmaceuticals","Completed","Mar 2005","Jun 2010","Interventional","Sep 2005","Lung Neoplasms,Carcinoma,Neoplasm Metastasis","Zoledronic Acid"],["NCT00170690","North Eastern German Society of Gynaecological Oncology","Completed","Aug 2004","Apr 2012","Interventional","Sep 2005","Ovarian Neoplasms,Carcinoma","Treosulfan,Busulfan"],["NCT00176904","Masonic Cancer Center, University of Minnesota","Completed","Jan 1995","Jun 2010","Interventional","Sep 2005","Gaucher Disease,Adrenoleukodystrophy,Pick Disease of the Brain,Gangliosidoses,Leukodystrophy,Niemann-Pick Diseases,Niemann-Pick Disease,Neuronal Ceroid-Lipofuscinoses,Tay-Sachs Disease,Gangliosidosis,Sandhoff Disease,Fucosidosis,Metabolism,Wolman Disease","Cyclophosphamide,Busulfan,Antilymphocyte Serum"],["NCT00178204","University of Rochester","Completed","Nov 2004","Dec 2011","Observational","Sep 2005","Fatigue",null],["NCT00176345","University of Leipzig","Unknown status","Jan 2001",null,"Interventional","Sep 2005","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease",null],["NCT00178711","The University of Texas Health Science Center, Houston","Terminated","Nov 2005","Dec 2009","Interventional","Sep 2005","Brain Injuries,Hypothermia,Wounds and Injuries",null],["NCT00173680","National Taiwan University Hospital","Unknown status","Aug 2005",null,"Observational","Sep 2005","Lung Neoplasms",null],["NCT00170417","NHS Greater Glasgow and Clyde","Completed","Dec 2000","May 2003","Interventional","Sep 2005","Sleep Initiation and Maintenance Disorders",null],["NCT00173485","National Taiwan University Hospital","Unknown status","Jun 2005","Jun 2009","Observational","Sep 2005","Peritonitis,Renal Insufficiency",null],["NCT00178269","University of Rochester","Completed","Jan 2005",null,"Interventional","Sep 2005","Uterine Cervical Neoplasms","Docetaxel"],["NCT00171301","Novartis Pharmaceuticals","Completed","Jun 2005","May 2008","Interventional","Sep 2005","Thalassemia,beta-Thalassemia,Iron Overload,Hemosiderosis","Deferasirox"],["NCT00171782","Novartis","Completed","Feb 2004","Dec 2004","Interventional","Sep 2005","Hypertension","Valsartan,Hydrochlorothiazide"],["NCT00176566","University of Medicine and Dentistry of New Jersey","Terminated","Sep 2003","Nov 2006","Interventional","Sep 2005","Leukoplakia",null],["NCT00170846","Novartis Pharmaceuticals","Completed","Feb 2005","Oct 2009","Interventional","Sep 2005",null,"Everolimus,Azathioprine,Calcineurin Inhibitors"],["NCT00173836","National Taiwan University Hospital","Completed","Aug 2003","Aug 2006","Observational","Sep 2005","Nasopharyngeal Carcinoma,Nasopharyngeal Neoplasms",null],["NCT00174005","National Taiwan University Hospital","Unknown status","Dec 1994",null,"Observational","Sep 2005",null,null],["NCT00176527","University of Medicine and Dentistry of New Jersey","Terminated","Nov 2002","Aug 2007","Interventional","Sep 2005","Prostatic Neoplasms","Interferons,Interferon-alpha,Interferon alpha-2,Docetaxel,Estramustine,Isotretinoin"],["NCT00171314","Novartis Pharmaceuticals","Completed","Mar 2004",null,"Interventional","Sep 2005","Breast Neoplasms","Zoledronic Acid,Letrozole"],["NCT00175409","University of British Columbia","Completed","Jan 2008","Jun 2010","Interventional","Sep 2005",null,null],["NCT00177190","University of Pittsburgh","Completed","Jun 2002","Jan 2006","Observational","Sep 2005","Mycoses,Lymphoma,Mycosis Fungoides,Sezary Syndrome",null],["NCT00179101","Vanderbilt University","Completed","Apr 2004","Nov 2005","Observational","Sep 2005","Parkinson Disease,Depression",null],["NCT00175526","University of British Columbia","Completed","Sep 2005","Dec 2010","Observational","Sep 2005","Toxemia,Sepsis",null],["NCT00176293","University of Kentucky","Terminated","Oct 2005","Feb 2007","Interventional","Sep 2005","Prostatic Neoplasms","Dexamethasone,Doxorubicin"],["NCT00178347","University of Rochester","Terminated","Dec 2004",null,"Observational","Sep 2005",null,null],["NCT00171964","Novartis Pharmaceuticals","Completed","May 2002","Dec 2008","Interventional","Sep 2005","Neoplasm Metastasis","Zoledronic Acid"],["NCT00178945","Vanderbilt University","Completed","Mar 2004","Mar 2006","Interventional","Sep 2005","Myofascial Pain Syndromes,Fibromyalgia,Dystonia,Dystonic Disorders,Syndrome,Torticollis","Botulinum Toxins,abobotulinumtoxinA"],["NCT00172965","National Taiwan University Hospital","Unknown status","Aug 2004","Jun 2005","Observational","Sep 2005","Mouth Neoplasms",null],["NCT00179764","Ann & Robert H Lurie Children's Hospital of Chicago","Completed","Mar 2000","Jan 2014","Interventional","Sep 2005","Leukemia,Melanoma,Neoplasms,Hematologic Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma","Busulfan"],["NCT00170612","University of Melbourne","Completed","Nov 2005","Aug 2008","Interventional","Sep 2005","Pneumococcal Infections","Heptavalent Pneumococcal Conjugate Vaccine"],["NCT00172627","National Taiwan University Hospital","Unknown status","Jan 2005",null,"Observational","Sep 2005","Stomach Neoplasms",null],["NCT00170872","Novartis","Completed","Nov 2004",null,"Interventional","Sep 2005","Arthritis,Osteoarthritis","Lumiracoxib"],["NCT00172770","National Taiwan University Hospital","Unknown status","Aug 2004","Jul 2006","Observational","Sep 2005","Schizophrenia",null],["NCT00173849","National Taiwan University Hospital","Unknown status","Jan 2006","Jul 2006","Observational","Sep 2005","Mouth Neoplasms",null],["NCT00175682","University of British Columbia","Completed","Dec 2004","Jul 2011","Interventional","Sep 2005","Spinal Cord Injuries,Autonomic Dysreflexia","Prazosin"],["NCT00179127","Vanderbilt University Medical Center","Completed","Aug 2004","Sep 2012","Interventional","Sep 2005","Ketosis,Acidosis,Diabetic Ketoacidosis","Insulin Glargine"],["NCT00178113","University of Pittsburgh","Completed","Jul 2003","Jul 2004","Interventional","Sep 2005","Neoplasms,Carcinoma in Situ,Prostatic Intraepithelial Neoplasia","Lycopene"],["NCT00170560","National Institute of Allergy and Infectious Diseases (NIAID)","Completed","Oct 2001",null,"Observational","Sep 2005","Infections",null],["NCT00178022","University of Pittsburgh","Completed","Feb 2005","Sep 2006","Interventional","Sep 2005","Brain Injuries,Wounds and Injuries,Depression,Anxiety Disorders",null],["NCT00178425","University of Rochester","Completed","Jan 2005","Jun 2006","Interventional","Sep 2005",null,null],["NCT00178438","University of Rochester","Withdrawn","Jun 2005","Jun 2006","Interventional","Sep 2005","Crohn Disease",null],["NCT00173173","National Taiwan University Hospital","Completed","Aug 2003","Jul 2004","Observational","Sep 2005","Disease,Feeding and Eating Disorders",null],["NCT00177294","University of Pittsburgh","Completed","Apr 2004","Aug 2009","Interventional","Sep 2005","Depression,Depressive Disorder","Citalopram"],["NCT00175461","University of British Columbia","Completed","Sep 2005","Aug 2011","Interventional","Sep 2005","Osteoarthritis",null],["NCT00179062","Vanderbilt University","Completed","Feb 2000","Jun 2007","Interventional","Sep 2005","Disease,Schizophrenia,Depressive Disorder,Bipolar Disorder,Psychotic Disorders","Olanzapine,Risperidone"],["NCT00173550","National Taiwan University Hospital","Unknown status","Aug 2004",null,"Observational","Sep 2005","Premature Birth,Menopause,Primary Ovarian Insufficiency",null],["NCT00177385","University of Pittsburgh","Completed","Jun 2003","Sep 2011","Interventional","Sep 2005",null,null],["NCT00171002","Novartis","Completed","Nov 2004","Jun 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00177125","University of Minnesota","Completed","Jan 2004","Jan 2004","Interventional","Sep 2005","Prostatic Neoplasms",null],["NCT00172861","National Taiwan University Hospital","Unknown status","Jan 2005",null,"Observational","Sep 2005","Stomach Neoplasms",null],["NCT00174798","Sanofi","Completed","May 2005","May 2006","Interventional","Sep 2005","Urinary Incontinence,Enuresis,Urinary Bladder","Tolterodine Tartrate"],["NCT00177892","National Institute on Aging (NIA)","Unknown status","Sep 2003","Aug 2008","Interventional","Sep 2005","Apnea,Sleep Apnea Syndromes,Sleep Apnea,Metabolic Syndrome,Syndrome",null],["NCT00176761","University of Michigan Rogel Cancer Center","Terminated","Mar 2000","May 2006","Interventional","Sep 2005","Colorectal Neoplasms","Interleukin-2"],["NCT00176319","University of Leipzig","Completed","May 2005",null,"Interventional","Sep 2005","Heart Failure",null],["NCT00177203","University of Pittsburgh","Completed","Jun 2003","Jan 2009","Interventional","Sep 2005","Sleep Initiation and Maintenance Disorders",null],["NCT00174993","Takeda","Completed","May 2001","Jan 2005","Interventional","Sep 2005","Diabetes Mellitus","Pioglitazone"],["NCT00177658","University of Pittsburgh","Completed","Mar 2006","Jun 2017","Observational","Sep 2005","Salmonella Infections",null],["NCT00174928","Takeda","Completed","May 2005","Aug 2005","Interventional","Sep 2005","Gastroesophageal Reflux,Esophagitis","Lansoprazole,Dexlansoprazole"],["NCT00170677","North Eastern German Society of Gynaecological Oncology","Completed","Sep 2005","Jan 2013","Interventional","Sep 2005","Ovarian Neoplasms,Carcinoma","Topotecan"],["NCT00178295","University of Rochester","Completed","Nov 1999",null,"Observational","Sep 2005","Brain Neoplasms,Trauma",null],["NCT00176449","University of Maryland, Baltimore","Completed","Apr 2001","Dec 2005","Interventional","Sep 2005","Tobacco Use Disorder","Bupropion"],["NCT00179751","Celgene Corporation","Terminated","Apr 2005","Aug 2006","Interventional","Sep 2005","Pancreatic Neoplasms","Gemcitabine,Lenalidomide"],["NCT00172744","National Taiwan University Hospital","Unknown status","Apr 2005","Jul 2006","Observational","Sep 2005",null,null],["NCT00177255","University of Pittsburgh","Terminated","Apr 2005","Dec 2008","Interventional","Sep 2005",null,"Docetaxel,Capecitabine"],["NCT00171925","Novartis Pharmaceuticals","Terminated","Aug 2000","Nov 2008","Interventional","Sep 2005","Multiple Myeloma,Neoplasms","Vitamin D,Zoledronic Acid,Calcium"],["NCT00177307","University of Pittsburgh","Completed","Jan 2005","Feb 2012","Interventional","Sep 2005","Colorectal Neoplasms","Bevacizumab,Capecitabine,Oxaliplatin"],["NCT00173862","National Taiwan University Hospital","Completed","May 2000","Jun 2006","Interventional","Jun 2005","Carcinoma","Gemcitabine,Ifosfamide"],["NCT00171990","Novartis","Completed","Jan 2003","Feb 2006","Interventional","Sep 2005","Herpes Genitalis","Famciclovir"],["NCT00177060","Hordinsky, Maria K., MD","Terminated","Oct 2003","May 2007","Interventional","Sep 2005","Wounds and Injuries","Hydromorphone"],["NCT00173043","National Taiwan University Hospital","Unknown status","Oct 2004","Aug 2005","Observational","Sep 2005","Polycystic Ovary Syndrome,Insulin Resistance,Syndrome",null],["NCT00171769","Novartis","Completed","Apr 2005",null,"Interventional","Sep 2005","Atrial Fibrillation","Certoparin"],["NCT00171951","Novartis Pharmaceuticals","Completed","Aug 2004","Jul 2013","Interventional","Sep 2005","ACTH-Secreting Pituitary Adenoma,Pituitary ACTH Hypersecretion","Pasireotide"],["NCT00174850","State University of New York - Upstate Medical University","Completed","Jul 2004","May 2005","Interventional","Sep 2005","Anxiety Disorders",null],["NCT00177970","University of Pittsburgh","Terminated","Oct 2003","Apr 2008","Interventional","Sep 2005","Diarrhea","Immunoglobulins,Antibodies,Immunoglobulin G,gamma-Globulins,Rho(D) Immune Globulin"],["NCT00171834","Novartis Pharmaceuticals","Completed","Aug 2003","Sep 2008","Interventional","Sep 2005","Lung Neoplasms,Carcinoma","Epothilones,Epothilone B"],["NCT00172601","National Taiwan University Hospital","Unknown status","Aug 2005",null,"Interventional","Sep 2005","Bursitis",null],["NCT00176254","Susanne Arnold","Completed","May 2000","Oct 2012","Interventional","Sep 2005","Carcinoma,Head and Neck Neoplasms","Paclitaxel,Carboplatin"],["NCT00176553","University of Medicine and Dentistry of New Jersey","Terminated","Mar 2003","May 2007","Interventional","Sep 2005","Neurotoxicity Syndromes","Dextromethorphan"],["NCT00171405","Novartis","Completed","Jun 2005","Feb 2006","Interventional","Aug 2005","Hypertension",null],["NCT00177814","University of Pittsburgh","Completed","Sep 2005","Jun 2017","Observational","Sep 2005","Bacterial Infections,Gram-Negative Bacterial Infections",null],["NCT00174122","National Taiwan University Hospital","Unknown status","Jul 2005","Jun 2006","Observational","Sep 2005",null,null],["NCT00179608","Celgene","Completed","Sep 2005","Jun 2007","Interventional","Sep 2005","Melanoma","Lenalidomide"],["NCT00173394","National Taiwan University Hospital","Unknown status","Aug 2005","Dec 2008","Observational","Sep 2005","Ovarian Neoplasms,Carcinoma",null],["NCT00170001","Mayo Clinic","Completed","Apr 2005","Aug 2006","Interventional","Sep 2005","Gastroesophageal Reflux","Esomeprazole"],["NCT00170963","Novartis","Completed","Oct 2004","Jun 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00170365","Hennepin Healthcare Research Institute","Completed","Jul 2004","Mar 2005","Interventional","Sep 2005",null,null],["NCT00173810","National Taiwan University Hospital","Unknown status","Aug 2005","Apr 2007","Observational","Sep 2005","Stroke",null],["NCT00179335","Albert Einstein College of Medicine","Completed","Aug 2003","Sep 2006","Observational","Sep 2005","HIV Infections",null],["NCT00178256","University of Rochester","Completed","Jun 1998","Dec 2012","Interventional","Sep 2005","Carcinoma","Paclitaxel"],["NCT00178035","University of Pittsburgh","Completed","Dec 1999","Aug 2003","Interventional","Sep 2005","Depression,Depressive Disorder","Paroxetine"],["NCT00177567","University of Pittsburgh","Completed","Jul 2001","Jan 2004","Interventional","Sep 2005","Disease,Bipolar Disorder,Mood Disorders","Lamotrigine,Valproic Acid,Olanzapine,Risperidone,Lithium Carbonate,Mirtazapine,Tranylcypromine,Bupropion,Paroxetine,Venlafaxine Hydrochloride"],["NCT00172666","National Taiwan University Hospital","Unknown status","Aug 2005","Jul 2006","Observational","Sep 2005","Arthritis,Lupus Erythematosus",null],["NCT00172731","National Taiwan University Hospital","Completed","Mar 2005","Jun 2005","Observational","Sep 2005","Schizophrenia",null],["NCT00171873","Carmen Schade-Brittinger","Completed","Sep 2001","Dec 2013","Interventional","Sep 2005","Neuroendocrine Tumors,Neoplasm Metastasis","Octreotide"],["NCT00173355","National Taiwan University Hospital","Unknown status","Jun 2005","Aug 2005","Observational","Sep 2005","Dermatofibrosarcoma,Soft Tissue Neoplasms",null],["NCT00176111","Heidelberg University","Terminated","Jan 2004","Jan 2005","Interventional","Sep 2005",null,null],["NCT00170274","Medtronic Bakken Research Center","Completed","Aug 2000","Oct 2014","Interventional","Sep 2005","Arrhythmias,Tachycardia",null],["NCT00172250","National Taiwan University Hospital","Completed","Sep 2003",null,"Observational","Sep 2005","Coronary Artery Disease",null],["NCT00174356","Pfizer","Completed","Dec 2002","Oct 2005","Interventional","Sep 2005","Carcinoma","Paclitaxel,Carboplatin"],["NCT00170989","Novartis","Completed","Sep 2004","Jul 2005","Interventional","Sep 2005","Hypertension","Valsartan,Hydrochlorothiazide"],["NCT00179569","Beth Israel Deaconess Medical Center","Completed","Aug 2005","Sep 2007","Interventional","Sep 2005",null,null],["NCT00172796","National Taiwan University Hospital","Unknown status","Apr 2005",null,"Observational","Sep 2005","Metabolic Syndrome,Prediabetic State",null],["NCT00178126","University of Pittsburgh","Completed","Mar 2004","Oct 2008","Interventional","Sep 2005","Pressure Ulcer,Ulcer",null],["NCT00172029","Novartis","Completed","Apr 2003",null,"Interventional","Sep 2005","Breast Neoplasms,Bone Diseases","Zoledronic Acid"],["NCT00176696","University of Medicine and Dentistry of New Jersey","Terminated","Aug 2005","Apr 2007","Observational","Sep 2005","Pain","Anesthetics"],["NCT00177788","University of Pittsburgh","Completed","Sep 2005","Aug 2012","Observational","Sep 2005","Mycoses,Fungemia",null],["NCT00171938","Novartis","Terminated","Apr 2004","Jun 2006","Interventional","Sep 2005","Glioblastoma","Imatinib Mesylate"],["NCT00177359","University of Pittsburgh","Completed","Nov 2005","Jun 2007","Interventional","Sep 2005","Mobility Limitation",null],["NCT00171860","Novartis Pharmaceuticals","Terminated","Sep 2002",null,"Interventional","Sep 2005","Hypereosinophilic Syndrome,Syndrome","Imatinib Mesylate"],["NCT00171717","Novartis","Completed","Feb 2004","Dec 2005","Interventional","Sep 2005","Diabetes Mellitus","Cyclosporine,Cyclosporins"],["NCT00176748","University of Michigan Rogel Cancer Center","Completed","Jul 2005","Jun 2009","Interventional","Sep 2005","Thyroid Neoplasms,Thyroid Diseases",null],["NCT00175084","Tufts University","Completed","Oct 2004","Dec 2012","Interventional","Sep 2005","Cardiovascular Diseases,Metabolic Syndrome,Hyperlipidemias",null],["NCT00178334","University of Rochester","Completed","Mar 2006","Jul 2006","Observational","Sep 2005","Urinary Incontinence,Enuresis",null],["NCT00172822","National Taiwan University Hospital","Unknown status","Jan 2003","Jun 2005","Observational","Sep 2005","Appendicitis",null],["NCT00170885","Novartis","Completed","May 2005","Jul 2007","Interventional","Sep 2005",null,"Everolimus"],["NCT00177684","University of Pittsburgh","Completed","Sep 2004","Sep 2005","Interventional","Sep 2005","Mycoses","Amphotericin B,Liposomal amphotericin B"],["NCT00178672","The University of Texas Health Science Center, Houston","Completed","Nov 2002","Aug 2007","Interventional","Sep 2005","Carotid Stenosis,Carotid Artery Diseases,Stroke,Heart Diseases",null],["NCT00171080","Novartis","Completed","Apr 2004","Mar 2006","Interventional","Sep 2005","Hypertension","Valsartan,Irbesartan"],["NCT00176891","Masonic Cancer Center, University of Minnesota","Completed","Mar 2004","Nov 2012","Interventional","Sep 2005","Mucopolysaccharidoses,Mucopolysaccharidosis I,Syndrome",null],["NCT00172107","Shire","Completed","May 1995","Mar 1997","Interventional","Sep 2005","Osteoporosis","Parathyroid Hormone"],["NCT00177827","University of Pittsburgh","Completed","Mar 2004","Mar 2006","Observational","Sep 2005","Aspergillosis",null],["NCT00177502","University of Pittsburgh","Completed","Jan 2003","Dec 2006","Interventional","Sep 2005","Body Weight,Weight Loss,Weight Gain",null],["NCT00175045","Takeda","Completed","Jun 2003","Oct 2003","Interventional","Sep 2005","Esophagitis","Lansoprazole,Dexlansoprazole"],["NCT00175981","Heidelberg University","Completed","Feb 2003","Nov 2004","Interventional","Sep 2005",null,"Sildenafil Citrate,Fluvoxamine"],["NCT00177983","University of Pittsburgh","Completed","Jan 2003","Jan 2005","Interventional","Sep 2005","Recurrence",null],["NCT00179699","Celgene Corporation","Terminated","Sep 2005","Nov 2006","Interventional","Sep 2005","Lung Neoplasms,Carcinoma","Pemetrexed,Lenalidomide"],["NCT00175383","University of British Columbia","Unknown status","Jun 2004","Dec 2013","Interventional","Sep 2005","Prostatic Neoplasms","Hormones,Prolactin Release-Inhibiting Factors"],["NCT00178230","University of Rochester","Completed","Mar 1996","Nov 2013","Observational","Sep 2005","Lung Neoplasms",null],["NCT00170859","Novartis Pharmaceuticals","Completed","Aug 2004","Dec 2006","Interventional","Sep 2005",null,"Everolimus"],["NCT00179465","Beth Israel Deaconess Medical Center","Active, not recruiting","Nov 2003","Sep 2022","Interventional","Sep 2005","Schizophrenia","Tiagabine,Antipsychotic Agents"],["NCT00173732","National Taiwan University Hospital","Unknown status","Sep 2005",null,"Observational","Sep 2005",null,null],["NCT00170976","Novartis","Completed","Apr 2004","Jun 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00173641","National Taiwan University Hospital","Unknown status","Sep 2005","Aug 2006","Observational","Sep 2005","Diabetes Mellitus",null],["NCT00173342","National Taiwan University Hospital","Unknown status","Jun 2005",null,"Observational","Sep 2005","Bundle-Branch Block,Heart Block",null],["NCT00174148","National Taiwan University Hospital","Unknown status","Jul 2005","Jul 2006","Observational","Sep 2005","Neck Pain",null],["NCT00170144","Mayo Clinic","Completed","Sep 2005","Jun 2007","Interventional","Sep 2005",null,null],["NCT00170469","PharmAthene UK Limited","Completed","Mar 2005","Feb 2007","Interventional","Sep 2005","Anthrax","Aluminum Hydroxide"],["NCT00179634","Beth Israel Deaconess Medical Center","Terminated","Mar 2005","Mar 2008","Interventional","Sep 2005","Breast Neoplasms",null],["NCT00175318","University of British Columbia","Completed","Apr 2005","Feb 2011","Interventional","Sep 2005","Dental Caries",null],["NCT00175812","University of Bergen","Completed","Nov 2004","Nov 2009","Interventional","Sep 2005","Leukemia","Tretinoin,Theophylline,Valproic Acid"],["NCT00178906","Vanderbilt University","Completed","Dec 1999","Apr 2008","Observational","Sep 2005","Depression",null],["NCT00175448","University of British Columbia","Completed","Sep 2005","Dec 2007","Interventional","Sep 2005","Arthritis",null],["NCT00173069","National Taiwan University Hospital","Unknown status","Jan 2006","Dec 2010","Observational","Sep 2005","Schizophrenia",null],["NCT00176956","Hordinsky, Maria K., MD","Terminated","Nov 2002","Jan 2007","Interventional","Sep 2005","Dermatitis,Skin Diseases",null],["NCT00173095","National Taiwan University Hospital","Unknown status","Jan 2005","Jan 2008","Observational","Sep 2005","Subarachnoid Hemorrhage,Hemorrhage",null],["NCT00177424","University of Pittsburgh","Terminated","Jul 2004","Oct 2007","Interventional","Sep 2005","Stroke,Depression,Depressive Disorder","Sertraline"],["NCT00172783","National Taiwan University Hospital","Unknown status","Jun 2005","Dec 2005","Observational","Sep 2005","Tuberculosis",null],["NCT00176917","Masonic Cancer Center, University of Minnesota","Completed","May 1999","May 2010","Interventional","Sep 2005","Mucolipidoses,Mucopolysaccharidoses,Mucopolysaccharidosis I,Mannosidase Deficiency Diseases,alpha-Mannosidosis,Mucopolysaccharidosis VI","Cyclophosphamide,Busulfan,Thymoglobulin"],["NCT00176839","Masonic Cancer Center, University of Minnesota","Terminated","Jun 2000","Feb 2012","Interventional","Sep 2005","Neoplasms,Hematologic Neoplasms,Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma","Cyclophosphamide,Melphalan,Busulfan,Antilymphocyte Serum,Lenograstim,Sargramostim"],["NCT00179322","National Institute on Deafness and Other Communication Disorders (NIDCD)","Completed","Sep 2005","Sep 2016","Observational","Sep 2005","Sleep Deprivation",null],["NCT00170664","North Eastern German Society of Gynaecological Oncology","Completed","Jan 1999","Sep 2004","Interventional","Sep 2005","Ovarian Neoplasms,Carcinoma","Paclitaxel,Carboplatin"],["NCT00172003","Novartis Pharmaceuticals","Completed","Sep 2004","Jul 2009","Interventional","Sep 2005","Neoplasm Metastasis,Neoplasms,Carcinoma","Zoledronic Acid"],["NCT00170261","Medtronic Bakken Research Center","Completed","Apr 2002","Sep 2006","Interventional","Sep 2005","Syncope",null],["NCT00179075","Vanderbilt University","Completed","Apr 2003","Apr 2008","Observational","Sep 2005","Graft vs Host Disease",null],["NCT00179777","University of Helsinki","Completed","May 2002","Sep 2017","Interventional","Sep 2005","Diabetes Mellitus",null],["NCT00174018","National Taiwan University Hospital","Completed","Sep 1993",null,"Observational","Sep 2005","Shoulder Impingement Syndrome",null],["NCT00171535","Novartis","Completed","Oct 2004","Apr 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Valsartan"],["NCT00173914","National Taiwan University Hospital","Unknown status","Mar 2003",null,"Observational","Sep 2005",null,null],["NCT00175825","UCB Pharma","Completed","Nov 2005","Jun 2006","Interventional","Sep 2005","Epilepsy,Seizures","Brivaracetam"],["NCT00172198","National Taiwan University Hospital","Unknown status","Mar 2005","Mar 2007","Interventional","Sep 2005",null,null],["NCT00171366","Novartis","Completed","Jul 2004","Jul 2005","Interventional","Sep 2005","Hypertension","Amlodipine,Benazepril"],["NCT00170287","Medtronic Bakken Research Center","Completed","May 2002","Aug 2011","Interventional","Sep 2005","Tachycardia",null],["NCT00170729","Novartis","Completed","Aug 2004","Feb 2005","Interventional","Sep 2005","Cataract,Capsule Opacification,Uveitis,Inflammation","Prednisolone,Methylprednisolone Acetate,Methylprednisolone,Methylprednisolone Hemisuccinate,Prednisolone acetate,Prednisolone hemisuccinate,Prednisolone phosphate"],["NCT00173225","National Taiwan University Hospital","Unknown status","Jun 2005","Jun 2005","Observational","Sep 2005","Asthma,Cough",null],["NCT00178100","University of Pittsburgh","Completed","Mar 1999","Aug 2005","Interventional","Sep 2005","Depression,Depressive Disorder","Paroxetine"],["NCT00176397","University of Leipzig","Unknown status","Aug 2003",null,"Interventional","Sep 2005","Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Coronary Stenosis,Constriction",null],["NCT00177333","University of Pittsburgh","Completed","Sep 2005","May 2006","Interventional","Sep 2005","Vomiting","Doxycycline"],["NCT00175643","University of British Columbia","Completed","Feb 2005","Nov 2005","Interventional","Sep 2005","Keratosis","Imiquimod"],["NCT00172913","National Taiwan University Hospital","Unknown status","Jun 2005","Jul 2008","Observational","Sep 2005","Myopia",null],["NCT00173628","National Taiwan University Hospital","Unknown status","Jan 1990","Dec 2006","Observational","Sep 2005","Diabetes Mellitus",null],["NCT00172757","National Taiwan University Hospital","Unknown status","Jan 2002","Jun 2005","Observational","Sep 2005","Colorectal Neoplasms,Diabetes Mellitus",null],["NCT00174512","Pfizer","Completed","Mar 2005","Jun 2006","Interventional","Sep 2005","Heart Diseases,Myocardial Ischemia,Coronary Artery Disease","Moxifloxacin"],["NCT00172939","National Taiwan University Hospital","Unknown status","Jun 2005","Jan 2008","Interventional","Sep 2005","Vitiligo",null],["NCT00176995","Hordinsky, Maria K., MD","Completed","Mar 1999","Oct 2000","Interventional","Sep 2005","Hair Diseases","Eflornithine"]],"plotOptions":{"displayType":"table","customPlotOptions":{},"pivotColumns":null,"pivotAggregation":null,"xColumns":null,"yColumns":null},"columnCustomDisplayInfos":{},"aggType":"","isJsonSchema":true,"removedWidgets":[],"aggSchema":[],"schema":[{"name":"Id","type":"\"string\"","metadata":"{}"},{"name":"Sponsor","type":"\"string\"","metadata":"{}"},{"name":"Status","type":"\"string\"","metadata":"{}"},{"name":"Start","type":"\"string\"","metadata":"{}"},{"name":"Completion","type":"\"string\"","metadata":"{}"},{"name":"Type","type":"\"string\"","metadata":"{}"},{"name":"Submission","type":"\"string\"","metadata":"{}"},{"name":"Conditions","type":"\"string\"","metadata":"{}"},{"name":"Interventions","type":"\"string\"","metadata":"{}"}],"aggError":"","aggData":[],"addedWidgets":{},"metadata":{},"dbfsResultPath":null,"type":"table","aggOverflow":false,"aggSeriesLimitReached":false,"arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .table-result-container {\n    max-height: 300px;\n    overflow: auto;\n  }\n  table, th, td {\n    border: 1px solid black;\n    border-collapse: collapse;\n  }\n  th, td {\n    padding: 5px;\n  }\n  th {\n    text-align: left;\n  }\n</style><div class='table-result-container'><table class='table-result'><thead style='background-color: white'><tr><th>Id</th><th>Sponsor</th><th>Status</th><th>Start</th><th>Completion</th><th>Type</th><th>Submission</th><th>Conditions</th><th>Interventions</th></tr></thead><tbody><tr><td>NCT02758028</td><td>The University of Hong Kong</td><td>Recruiting</td><td>Aug 2005</td><td>Nov 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751957</td><td>Duke University</td><td>Completed</td><td>Jul 2016</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>Autistic Disorder,Autism Spectrum Disorder</td><td>null</td></tr><tr><td>NCT02758483</td><td>Universidade Federal do Rio de Janeiro</td><td>Completed</td><td>Mar 2017</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02759848</td><td>Istanbul Medeniyet University</td><td>Completed</td><td>Jan 2012</td><td>Dec 2014</td><td>Observational</td><td>May 2016</td><td>Tuberculosis,Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02758860</td><td>University of Roma La Sapienza</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Sep 2020</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Diverticular Diseases,Diverticulum,Diverticulosis</td><td>null</td></tr><tr><td>NCT02757209</td><td>Consorzio Futuro in Ricerca</td><td>Completed</td><td>Apr 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate</td></tr><tr><td>NCT02752438</td><td>Ankara University</td><td>Unknown status</td><td>May 2016</td><td>Jul 2017</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Hypoventilation</td><td>null</td></tr><tr><td>NCT02753543</td><td>Ruijin Hospital</td><td>Unknown status</td><td>Nov 2015</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>null</td></tr><tr><td>NCT02757508</td><td>Washington University School of Medicine</td><td>Completed</td><td>Mar 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Vitamins</td></tr><tr><td>NCT02753530</td><td>Orphazyme</td><td>Completed</td><td>Aug 2017</td><td>Jan 2021</td><td>Interventional</td><td>Apr 2016</td><td>Myositis</td><td>null</td></tr><tr><td>NCT02754817</td><td>Novo Nordisk A/S</td><td>Completed</td><td>Apr 2016</td><td>Oct 2016</td><td>Observational</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Liraglutide,Xultophy</td></tr><tr><td>NCT02759276</td><td>Daniel Alexandre Bottino</td><td>Completed</td><td>May 2015</td><td>Dec 2015</td><td>Observational</td><td>Apr 2016</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT02750956</td><td>Bulent Ecevit University</td><td>Completed</td><td>Jun 2015</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Periodontal Diseases</td><td>null</td></tr><tr><td>NCT02752113</td><td>Institut für Pharmakologie und Präventive Medizin</td><td>Completed</td><td>Apr 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Metformin,Empagliflozin,Linagliptin</td></tr><tr><td>NCT02752698</td><td>The Third Xiangya Hospital of Central South University</td><td>Active, not recruiting</td><td>Jan 2015</td><td>Dec 2021</td><td>Interventional</td><td>Jun 2015</td><td>Appendicitis,Stomach Ulcer,Cholecystolithiasis,Cholelithiasis,Gallstones</td><td>null</td></tr><tr><td>NCT02755779</td><td>Tel Aviv Medical Center</td><td>Unknown status</td><td>Jun 2016</td><td>Jun 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750384</td><td>Medicines for Malaria Venture</td><td>Terminated</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754609</td><td>James Cook University, Queensland, Australia</td><td>Completed</td><td>Sep 2016</td><td>Oct 2019</td><td>Interventional</td><td>Apr 2016</td><td>Hookworm Infections,Celiac Disease</td><td>null</td></tr><tr><td>NCT02755701</td><td>Soonchunhyang University Hospital</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Ascites</td><td>null</td></tr><tr><td>NCT02751762</td><td>Member Companies of the Opioid PMR Consortium</td><td>Recruiting</td><td>Nov 2017</td><td>Oct 2022</td><td>Observational</td><td>Apr 2016</td><td>Chronic Pain,Substance-Related Disorders,Opioid-Related Disorders,Narcotic-Related Disorders,Behavior</td><td>null</td></tr><tr><td>NCT02756299</td><td>Marmara University</td><td>Completed</td><td>Jun 2014</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Apnea Syndromes,Sleep Apnea</td><td>null</td></tr><tr><td>NCT02750709</td><td>Cycle Pharmaceuticals Ltd.</td><td>Completed</td><td>Oct 2015</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Tyrosinemias</td><td>Nitisinone</td></tr><tr><td>NCT02753907</td><td>Yonsei University</td><td>Completed</td><td>Jun 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755467</td><td>Cutera Inc.</td><td>Completed</td><td>May 2016</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hemangioma</td><td>null</td></tr><tr><td>NCT02755298</td><td>University of Zurich</td><td>Completed</td><td>Oct 2016</td><td>Nov 2020</td><td>Interventional</td><td>Mar 2016</td><td>Hypertension</td><td>Acetazolamide</td></tr><tr><td>NCT02759614</td><td>Guangdong Association of Clinical Trials</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2019</td><td>Interventional</td><td>Mar 2016</td><td>Carcinoma</td><td>Bevacizumab,Erlotinib Hydrochloride</td></tr><tr><td>NCT02752815</td><td>Ruijin Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Prednisone,Cyclophosphamide,Rituximab,Vincristine,Epirubicin</td></tr><tr><td>NCT02757131</td><td>The Cleveland Clinic</td><td>Completed</td><td>Jul 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Iatrogenic Disease</td><td>null</td></tr><tr><td>NCT02758704</td><td>St. Justine's Hospital</td><td>Completed</td><td>Oct 2015</td><td>Jun 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750501</td><td>Alcresta Therapeutics, Inc.</td><td>Completed</td><td>Jul 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02759913</td><td>Iron Horse Diagnostics, Inc.</td><td>Unknown status</td><td>Jan 2015</td><td>Dec 2016</td><td>Observational</td><td>Apr 2016</td><td>Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis</td><td>null</td></tr><tr><td>NCT02752724</td><td>VA Puget Sound Health Care System</td><td>Completed</td><td>Mar 2016</td><td>Apr 2018</td><td>Interventional</td><td>Mar 2016</td><td>Depressive Disorder,Depression</td><td>Ketamine,Methohexital</td></tr><tr><td>NCT02758444</td><td>University of Colorado, Denver</td><td>Completed</td><td>Nov 2015</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Micronutrients,Trace Elements</td></tr><tr><td>NCT02758067</td><td>H. Lundbeck A/S</td><td>Withdrawn</td><td>Jun 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Schizophrenia</td><td>Risperidone,Brexpiprazole</td></tr><tr><td>NCT02759341</td><td>Ospedale San Giovanni Bellinzona</td><td>Completed</td><td>Feb 2016</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Myocardial Infarction,Cardiomyopathies,Microvascular Angina,Takotsubo Cardiomyopathy,Syndrome,Infarction</td><td>null</td></tr><tr><td>NCT02753803</td><td>Dong-A ST Co., Ltd.</td><td>Completed</td><td>Jul 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Pioglitazone</td></tr><tr><td>NCT02752490</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759562</td><td>Gilead Sciences</td><td>Terminated</td><td>Nov 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02758262</td><td>Laval University</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hyperphagia</td><td>null</td></tr><tr><td>NCT02754258</td><td>Children's Hospital of Eastern Ontario</td><td>Unknown status</td><td>Jan 2017</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Methylphenidate</td></tr><tr><td>NCT02755207</td><td>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2020</td><td>Observational</td><td>Mar 2016</td><td>Acute Coronary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02759900</td><td>The Skin Center Dermatology Group</td><td>Recruiting</td><td>Jan 2016</td><td>Jan 2023</td><td>Interventional</td><td>Apr 2016</td><td>Molluscum Contagiosum,Keratosis,Bowens Disease,Rosacea,Skin Diseases</td><td>null</td></tr><tr><td>NCT02752581</td><td>Mert Özcan</td><td>Completed</td><td>Jan 2009</td><td>Apr 2013</td><td>Interventional</td><td>Apr 2016</td><td>Hemarthrosis</td><td>null</td></tr><tr><td>NCT02759796</td><td>Instituto de Investigación Hospital Universitario La Paz</td><td>Completed</td><td>Nov 2015</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Necrosis,Neovascularization,Fat Necrosis</td><td>null</td></tr><tr><td>NCT02754063</td><td>University Hospital, Grenoble</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Apr 2022</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Wounds and Injuries</td><td>3</td></tr><tr><td>NCT02750917</td><td>Foisor Orthopedics Clinical Hospital</td><td>Completed</td><td>Sep 2014</td><td>Mar 2015</td><td>Interventional</td><td>Feb 2016</td><td>Pain</td><td>Etoricoxib,Lornoxicam</td></tr><tr><td>NCT02753569</td><td>Institute of Cancer Research, United Kingdom</td><td>Completed</td><td>May 2016</td><td>May 2020</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751255</td><td>VU University Medical Center</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Mar 2022</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Tretinoin</td></tr><tr><td>NCT02751528</td><td>NantBioScience, Inc.</td><td>Unknown status</td><td>Dec 2016</td><td>Dec 2020</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Vaccines</td></tr><tr><td>NCT02751619</td><td>University of Campania Luigi Vanvitelli</td><td>Completed</td><td>Jan 2013</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Pain</td><td>Lidocaine</td></tr><tr><td>NCT02757833</td><td>Lawson Health Research Institute</td><td>Withdrawn</td><td>Feb 2019</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT02750761</td><td>Merck Sharp & Dohme Corp.</td><td>Completed</td><td>May 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Infections,Bacterial Infections,Gram-Positive Bacterial Infections</td><td>Tedizolid phosphate,Tedizolid,Oxazolidinones</td></tr><tr><td>NCT02752594</td><td>Sharda University</td><td>Completed</td><td>Apr 2015</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT02753452</td><td>Holland Bloorview Kids Rehabilitation Hospital</td><td>Unknown status</td><td>May 2015</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752763</td><td>Niğde State Hospital</td><td>Completed</td><td>Oct 2015</td><td>Mar 2016</td><td>Interventional</td><td>Mar 2016</td><td>Dry Eye Syndromes,Keratoconjunctivitis Sicca</td><td>Dextrans,Povidone,Ophthalmic Solutions,Lubricant Eye Drops</td></tr><tr><td>NCT02753816</td><td>Spectrum Health Hospitals</td><td>Terminated</td><td>Apr 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Burns</td><td>Tranexamic Acid</td></tr><tr><td>NCT02751294</td><td>GlaxoSmithKline</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Malaria</td><td>Tafenoquine</td></tr><tr><td>NCT02756429</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>Feb 2014</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02750163</td><td>Università Politecnica delle Marche</td><td>Completed</td><td>Jul 2017</td><td>Jun 2019</td><td>Observational</td><td>Apr 2016</td><td>Shock</td><td>Acetaminophen</td></tr><tr><td>NCT02751905</td><td>Biogen</td><td>Completed</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Neuralgia</td><td>null</td></tr><tr><td>NCT02753153</td><td>University of Liege</td><td>Completed</td><td>May 2011</td><td>May 2015</td><td>Interventional</td><td>Apr 2016</td><td>Tooth Loss</td><td>null</td></tr><tr><td>NCT02750891</td><td>Sumitomo Dainippon Pharma Co., Ltd.</td><td>Completed</td><td>Apr 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Glioblastoma,Glioma,Diffuse Intrinsic Pontine Glioma</td><td>null</td></tr><tr><td>NCT02751073</td><td>Mayo Clinic</td><td>Completed</td><td>Feb 2016</td><td>Jul 2018</td><td>Observational</td><td>Feb 2016</td><td>Infections,Communicable Diseases,Urinary Tract Infections,Prolapse,Pelvic Organ Prolapse</td><td>null</td></tr><tr><td>NCT02753114</td><td>University of British Columbia</td><td>Completed</td><td>Nov 2017</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Acute Pain</td><td>Ketamine</td></tr><tr><td>NCT02752516</td><td>Chia Tai Tianqing Pharmaceutical Group Co., Ltd.</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752269</td><td>Medical University of Graz</td><td>Completed</td><td>Oct 2014</td><td>Jun 2019</td><td>Observational</td><td>Nov 2015</td><td>Sjogrens Syndrome,Hypertension,Vascular Diseases,Syndrome</td><td>null</td></tr><tr><td>NCT02754713</td><td>Hippocration General Hospital</td><td>Recruiting</td><td>Sep 2009</td><td>Dec 2025</td><td>Observational</td><td>Apr 2016</td><td>Pericarditis</td><td>null</td></tr><tr><td>NCT02759770</td><td>Beijing Anzhen Hospital</td><td>Completed</td><td>Jul 2017</td><td>Sep 2017</td><td>Observational</td><td>Apr 2016</td><td>Respiratory Distress Syndrome,Acute Lung Injury</td><td>null</td></tr><tr><td>NCT02755129</td><td>Medtronic BRC</td><td>Completed</td><td>Sep 2016</td><td>Jul 2017</td><td>Interventional</td><td>Mar 2016</td><td>Frailty</td><td>null</td></tr><tr><td>NCT02754674</td><td>Samsung Medical Center</td><td>Completed</td><td>May 2014</td><td>Dec 2017</td><td>Interventional</td><td>Feb 2015</td><td>Rupture</td><td>null</td></tr><tr><td>NCT02757521</td><td>Washington University School of Medicine</td><td>Terminated</td><td>Mar 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Depression,Depressive Disorder,Bipolar Disorder</td><td>Nitrous Oxide</td></tr><tr><td>NCT02750774</td><td>University of Modena and Reggio Emilia</td><td>Unknown status</td><td>Dec 2015</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes,Obesity,Pregnancy Complications,Fetal Macrosomia,Overweight,Birth Weight</td><td>null</td></tr><tr><td>NCT02754739</td><td>Samsung Medical Center</td><td>Completed</td><td>Apr 2014</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus,Prediabetic State</td><td>Pravastatin</td></tr><tr><td>NCT02758808</td><td>University of Michigan</td><td>Recruiting</td><td>Mar 2016</td><td>Oct 2023</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02751840</td><td>Tel Hai College</td><td>Completed</td><td>Oct 2014</td><td>Apr 2016</td><td>Interventional</td><td>Apr 2016</td><td>Asymptomatic Diseases</td><td>Caffeine</td></tr><tr><td>NCT02752451</td><td>University of Arizona</td><td>Completed</td><td>Mar 2015</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757599</td><td>Rigshospitalet, Denmark</td><td>Completed</td><td>Aug 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753894</td><td>Astellas Pharma Inc</td><td>Completed</td><td>Jan 2008</td><td>Jun 2008</td><td>Interventional</td><td>Mar 2016</td><td>Kidney Diseases,Renal Insufficiency,Hyperphosphatemia</td><td>null</td></tr><tr><td>NCT02757638</td><td>Texas A&M University</td><td>Active, not recruiting</td><td>Oct 2015</td><td>Oct 2021</td><td>Interventional</td><td>Feb 2016</td><td>Weight Loss</td><td>null</td></tr><tr><td>NCT02757378</td><td>Kevin Farrell</td><td>Completed</td><td>May 2015</td><td>Sep 2015</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain,Low Back Pain</td><td>null</td></tr><tr><td>NCT02751489</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02759315</td><td>Merck Sharp & Dohme Corp.</td><td>Terminated</td><td>May 2016</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis</td><td>Uprifosbuvir,Ruzasvir</td></tr><tr><td>NCT02754895</td><td>Massachusetts General Hospital</td><td>Completed</td><td>Oct 2014</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Acute Coronary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02750475</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>Sunscreening Agents</td></tr><tr><td>NCT02755064</td><td>Adil Bharucha</td><td>Completed</td><td>Jun 2010</td><td>Nov 2013</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Erythromycin,Erythromycin Estolate,Erythromycin Ethylsuccinate,Erythromycin stearate,Erythromycin lactobionate</td></tr><tr><td>NCT02758002</td><td>University of California, San Diego</td><td>Withdrawn</td><td>Jan 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02755142</td><td>medac GmbH</td><td>Completed</td><td>Feb 2000</td><td>Jun 2001</td><td>Interventional</td><td>Apr 2016</td><td>Glioma,Brain Neoplasms</td><td>Aminolevulinic Acid</td></tr><tr><td>NCT02756364</td><td>Millennium Pharmaceuticals, Inc.</td><td>Completed</td><td>Jul 2016</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Fulvestrant</td></tr><tr><td>NCT02759484</td><td>Rush University Medical Center</td><td>Unknown status</td><td>Mar 2015</td><td>Mar 2019</td><td>Interventional</td><td>Dec 2015</td><td>Hypertension,Diabetes Mellitus,Hyperglycemia</td><td>null</td></tr><tr><td>NCT02752061</td><td>Harvard School of Public Health (HSPH)</td><td>Completed</td><td>May 2016</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756598</td><td>Aarhus University Hospital</td><td>Completed</td><td>Jan 2015</td><td>Jun 2018</td><td>Interventional</td><td>Dec 2015</td><td>null</td><td>Sufentanil,Dsuvia,Propofol</td></tr><tr><td>NCT02755727</td><td>Royal Devon and Exeter NHS Foundation Trust</td><td>Completed</td><td>Mar 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Tennis Elbow</td><td>null</td></tr><tr><td>NCT02754882</td><td>Samsung Bioepis Co., Ltd.</td><td>Completed</td><td>Jul 2016</td><td>Oct 2018</td><td>Interventional</td><td>Mar 2016</td><td>Lung Neoplasms,Carcinoma</td><td>Paclitaxel,Bevacizumab,Carboplatin</td></tr><tr><td>NCT02754778</td><td>Martin-Luther-Universität Halle-Wittenberg</td><td>Completed</td><td>Apr 2016</td><td>Mar 2021</td><td>Interventional</td><td>Apr 2016</td><td>Pre-Eclampsia,HELLP Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02758171</td><td>Boehringer Ingelheim</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Empagliflozin,Linagliptin</td></tr><tr><td>NCT02755376</td><td>Samsung Medical Center</td><td>Completed</td><td>Jan 2014</td><td>Dec 2018</td><td>Interventional</td><td>Feb 2015</td><td>null</td><td>Hyaluronic Acid</td></tr><tr><td>NCT02759016</td><td>Boehringer Ingelheim</td><td>Completed</td><td>Jun 2016</td><td>Jul 2019</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>BI 836826</td></tr><tr><td>NCT02758457</td><td>University of Bologna</td><td>Completed</td><td>Jan 2008</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755519</td><td>Chongqing Medical University</td><td>Completed</td><td>May 2014</td><td>Oct 2016</td><td>Observational</td><td>Apr 2016</td><td>Hyperaldosteronism</td><td>null</td></tr><tr><td>NCT02758782</td><td>Charite University, Berlin, Germany</td><td>Completed</td><td>Sep 2016</td><td>Jan 2021</td><td>Interventional</td><td>Apr 2016</td><td>Spondylitis</td><td>Celecoxib,Golimumab</td></tr><tr><td>NCT02756806</td><td>Cutera Inc.</td><td>Completed</td><td>Apr 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756156</td><td>Kahramanmaras Sutcu Imam University</td><td>Unknown status</td><td>Apr 2016</td><td>Aug 2016</td><td>Observational</td><td>Mar 2016</td><td>Humeral Fractures</td><td>null</td></tr><tr><td>NCT02759458</td><td>Rush University Medical Center</td><td>Completed</td><td>Nov 2013</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Rotator Cuff Injuries</td><td>null</td></tr><tr><td>NCT02750982</td><td>Brown, Theodore R., M.D., MPH</td><td>Completed</td><td>Jul 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease,Multiple Sclerosis,Alzheimer Disease,Brain Injuries,Spinal Cord Injuries,Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Huntington Disease,Sclerosis,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02751502</td><td>NYU Langone Health</td><td>Terminated</td><td>Jan 2017</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Hemiplegia</td><td>null</td></tr><tr><td>NCT02752087</td><td>Eli Lilly and Company</td><td>Completed</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756858</td><td>Anavex Life Sciences Corp.</td><td>Completed</td><td>Mar 2016</td><td>Nov 2020</td><td>Interventional</td><td>Mar 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02758249</td><td>Konkuk University Medical Center</td><td>Completed</td><td>Jan 2016</td><td>Jan 2016</td><td>Interventional</td><td>Feb 2016</td><td>null</td><td>Propofol,Sevoflurane</td></tr><tr><td>NCT02754570</td><td>University of Colorado, Denver</td><td>Completed</td><td>Jul 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Glaucoma,Ocular Hypertension,Hypertension</td><td>Pilocarpine</td></tr><tr><td>NCT02754102</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>Sunscreening Agents</td></tr><tr><td>NCT02751593</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>Jan 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Thrombocytopenia,Purpura</td><td>Dexamethasone</td></tr><tr><td>NCT02757014</td><td>Bayer</td><td>Completed</td><td>Oct 2015</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753062</td><td>Asan Medical Center</td><td>Recruiting</td><td>Aug 2015</td><td>Aug 2023</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Rituximab,Bendamustine Hydrochloride</td></tr><tr><td>NCT02752425</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>May 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Speech Disorders</td><td>null</td></tr><tr><td>NCT02757300</td><td>Marienhospital Osnabrück</td><td>Unknown status</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Pharyngitis</td><td>null</td></tr><tr><td>NCT02754180</td><td>Peking Union Medical College Hospital</td><td>Unknown status</td><td>Mar 2016</td><td>Mar 2021</td><td>Interventional</td><td>Apr 2016</td><td>Adenocarcinoma,Pancreatic Neoplasms</td><td>Gemcitabine</td></tr><tr><td>NCT02752321</td><td>Northwell Health</td><td>Terminated</td><td>Aug 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753595</td><td>Eisai Inc.</td><td>Terminated</td><td>Jul 2016</td><td>Aug 2019</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02755246</td><td>Charite University, Berlin, Germany</td><td>Completed</td><td>Apr 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02754115</td><td>Tata Memorial Centre</td><td>Recruiting</td><td>Apr 2016</td><td>Jan 2022</td><td>Observational</td><td>Mar 2016</td><td>Peritoneal Diseases</td><td>null</td></tr><tr><td>NCT02756897</td><td>M.D. Anderson Cancer Center</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Jul 2024</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma,Leukemia</td><td>Venetoclax</td></tr><tr><td>NCT02752334</td><td>Magrabi Eye & Ear Hospital</td><td>Completed</td><td>Sep 2015</td><td>Mar 2019</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Magnesium Sulfate,Bupivacaine</td></tr><tr><td>NCT02754791</td><td>Shaare Zedek Medical Center</td><td>Unknown status</td><td>May 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754128</td><td>Holland Bloorview Kids Rehabilitation Hospital</td><td>Completed</td><td>Jun 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cerebral Palsy</td><td>null</td></tr><tr><td>NCT02751190</td><td>Umeå University</td><td>Completed</td><td>Sep 2013</td><td>Feb 2017</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Chronic Pain,Hernia</td><td>null</td></tr><tr><td>NCT02751645</td><td>Oregon Health and Science University</td><td>Unknown status</td><td>Jun 2016</td><td>May 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758184</td><td>Duke University</td><td>Terminated</td><td>Jun 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751892</td><td>University of East Anglia</td><td>Completed</td><td>Oct 2013</td><td>Sep 2014</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT02755324</td><td>Leiden University</td><td>Completed</td><td>Oct 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Schistosomiasis</td><td>null</td></tr><tr><td>NCT02758886</td><td>Washington State University</td><td>Completed</td><td>Apr 2014</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Stress</td><td>null</td></tr><tr><td>NCT02750072</td><td>Fraser Orthopaedic Research Society</td><td>Active, not recruiting</td><td>Sep 2016</td><td>Apr 2023</td><td>Interventional</td><td>Apr 2016</td><td>Patellofemoral Pain Syndrome,Fractures,Tibial Fractures</td><td>null</td></tr><tr><td>NCT02750332</td><td>Cycle Pharmaceuticals Ltd.</td><td>Completed</td><td>Nov 2015</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Tyrosinemias</td><td>Nitisinone</td></tr><tr><td>NCT02752529</td><td>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</td><td>Unknown status</td><td>Mar 2016</td><td>null</td><td>Interventional</td><td>Mar 2016</td><td>Liver Cirrhosis</td><td>Tacrolimus</td></tr><tr><td>NCT02759939</td><td>Dartmouth-Hitchcock Medical Center</td><td>Completed</td><td>Jul 2016</td><td>Jul 2017</td><td>Interventional</td><td>Feb 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757157</td><td>European Respiratory Society</td><td>Terminated</td><td>Oct 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02759627</td><td>Istanbul University</td><td>Completed</td><td>Nov 2014</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02752412</td><td>Sanofi</td><td>Completed</td><td>May 2016</td><td>Oct 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Insulin,Metformin,Insulin Glargine,Lixisenatide</td></tr><tr><td>NCT02756988</td><td>Bayer</td><td>Completed</td><td>Oct 2015</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751203</td><td>Lara McKenzie</td><td>Completed</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753946</td><td>Nabriva Therapeutics AG</td><td>Completed</td><td>Apr 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Infections,Communicable Diseases,Urinary Tract Infections,Pyelonephritis</td><td>Tazobactam,Piperacillin,Fosfomycin</td></tr><tr><td>NCT02755480</td><td>University Health Network, Toronto</td><td>Terminated</td><td>Feb 2015</td><td>Feb 2017</td><td>Interventional</td><td>Mar 2015</td><td>null</td><td>null</td></tr><tr><td>NCT02753257</td><td>Valtari Bio</td><td>Unknown status</td><td>Sep 2016</td><td>Dec 2019</td><td>Observational</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02758691</td><td>Virginia Polytechnic Institute and State University</td><td>Completed</td><td>Dec 2015</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Insulin</td></tr><tr><td>NCT02755623</td><td>Centre hospitalier de Ville-Evrard, France</td><td>Unknown status</td><td>May 2015</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Hallucinations,Schizophrenia</td><td>null</td></tr><tr><td>NCT02756234</td><td>Lancaster General Hospital</td><td>Completed</td><td>May 2016</td><td>Aug 2018</td><td>Observational</td><td>Apr 2016</td><td>Coronary Artery Disease</td><td>null</td></tr><tr><td>NCT02756091</td><td>University Hospital Inselspital, Berne</td><td>Recruiting</td><td>Aug 2016</td><td>May 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Cerebrovascular Disorders</td><td>null</td></tr><tr><td>NCT02753491</td><td>Marmara University</td><td>Completed</td><td>Oct 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752737</td><td>Medtronic Cardiac Rhythm and Heart Failure</td><td>Recruiting</td><td>May 2016</td><td>Dec 2024</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02758925</td><td>University Hospital, Caen</td><td>Unknown status</td><td>Jun 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Cytarabine,Rituximab,Bendamustine Hydrochloride</td></tr><tr><td>NCT02751723</td><td>Florian Lordick, MD</td><td>Unknown status</td><td>Sep 2014</td><td>Oct 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751931</td><td>Astellas Pharma Europe B.V.</td><td>Completed</td><td>Jun 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Bladder</td><td>Mirabegron</td></tr><tr><td>NCT02758847</td><td>Rabih A. Chaer</td><td>Recruiting</td><td>Sep 2016</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Ischemia</td><td>Paclitaxel,Albumin-Bound Paclitaxel</td></tr><tr><td>NCT02757807</td><td>Eco Fusion</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Erectile Dysfunction</td><td>null</td></tr><tr><td>NCT02755220</td><td>Shanghai Cingularbio Co. Ltd</td><td>Completed</td><td>Jan 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758548</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>May 2016</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756845</td><td>Amgen</td><td>Recruiting</td><td>Aug 2017</td><td>Jun 2024</td><td>Interventional</td><td>Dec 2015</td><td>Neoplasms</td><td>Talimogene laherparepvec</td></tr><tr><td>NCT02750605</td><td>Skane University Hospital</td><td>Active, not recruiting</td><td>Feb 2016</td><td>Dec 2021</td><td>Interventional</td><td>Jan 2016</td><td>Vascular Diseases,Peripheral Vascular Diseases,Peripheral Arterial Disease,Ischemia</td><td>null</td></tr><tr><td>NCT02756702</td><td>Aesculap AG</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Dec 2022</td><td>Observational</td><td>Apr 2016</td><td>Osteoarthritis</td><td>null</td></tr><tr><td>NCT02752945</td><td>King's College London</td><td>Completed</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder,Anxiety Disorders</td><td>null</td></tr><tr><td>NCT02759952</td><td>STZ eyetrial</td><td>Enrolling by invitation</td><td>Jan 2013</td><td>Dec 2025</td><td>Observational</td><td>Apr 2016</td><td>Retinitis,Retinitis Pigmentosa</td><td>null</td></tr><tr><td>NCT02754661</td><td>Medtronic - MITG</td><td>Completed</td><td>Sep 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT02755441</td><td>Nils Hoyer</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2024</td><td>Observational</td><td>Apr 2016</td><td>Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02750098</td><td>Sheba Medical Center</td><td>Unknown status</td><td>May 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02753179</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Vestibular Diseases</td><td>null</td></tr><tr><td>NCT02758509</td><td>Parc de Salut Mar</td><td>Completed</td><td>Jan 2010</td><td>Oct 2017</td><td>Observational</td><td>Apr 2016</td><td>Hepatitis C,Hepatitis</td><td>Interferons,Ritonavir,Ribavirin,Interferon-alpha,Interferon alpha-2,Sofosbuvir,Peginterferon alfa-2a,Ledipasvir,Simeprevir</td></tr><tr><td>NCT02751970</td><td>Universidad de Valparaiso</td><td>Unknown status</td><td>Apr 2014</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT02753712</td><td>Mundipharma Research Limited</td><td>Completed</td><td>Jun 2016</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Fluticasone,Xhance,Formoterol Fumarate</td></tr><tr><td>NCT02751151</td><td>Inova Health Care Services</td><td>Completed</td><td>Feb 2016</td><td>May 2021</td><td>Interventional</td><td>Mar 2016</td><td>Skin Neoplasms</td><td>Aminolevulinic Acid</td></tr><tr><td>NCT02757716</td><td>Sana Klinikum Offenbach</td><td>Completed</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Behavior</td><td>null</td></tr><tr><td>NCT02758652</td><td>Tampere University Hospital</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2026</td><td>Observational</td><td>Apr 2016</td><td>Ovarian Neoplasms,Carcinoma</td><td>null</td></tr><tr><td>NCT02754206</td><td>Southern Methodist University</td><td>Terminated</td><td>Jan 2016</td><td>Sep 2021</td><td>Observational</td><td>Apr 2016</td><td>Post-Concussion Syndrome,Brain Concussion</td><td>null</td></tr><tr><td>NCT02752243</td><td>Peter Bader</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Mar 2022</td><td>Interventional</td><td>Mar 2016</td><td>Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome,Acute Disease</td><td>null</td></tr><tr><td>NCT02754856</td><td>M.D. Anderson Cancer Center</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Jul 2021</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>Durvalumab,Ipilimumab,Tremelimumab,Immunoglobulins,Antibodies,Immunoglobulin G</td></tr><tr><td>NCT02759861</td><td>University of Nebraska</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Aug 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis</td><td>Sofosbuvir,Ledipasvir</td></tr><tr><td>NCT02759679</td><td>Haukeland University Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2019</td><td>Interventional</td><td>Mar 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02752932</td><td>Lawson Health Research Institute</td><td>Completed</td><td>Nov 2015</td><td>Oct 2017</td><td>Interventional</td><td>Feb 2016</td><td>Carcinoma,Squamous Cell Carcinoma of Head and Neck,Neoplasms</td><td>null</td></tr><tr><td>NCT02759445</td><td>RWTH Aachen University</td><td>Unknown status</td><td>Apr 2016</td><td>Oct 2016</td><td>Observational</td><td>Nov 2015</td><td>null</td><td>null</td></tr><tr><td>NCT02754622</td><td>Guy's and St Thomas' NHS Foundation Trust</td><td>Completed</td><td>Jul 2016</td><td>Dec 2016</td><td>Observational</td><td>Apr 2016</td><td>Critical Illness</td><td>null</td></tr><tr><td>NCT02756611</td><td>AbbVie</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Sep 2022</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Venetoclax</td></tr><tr><td>NCT02758223</td><td>Wuerzburg University Hospital</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Jun 2021</td><td>Interventional</td><td>Feb 2016</td><td>Leukemia,Myelodysplastic Syndromes</td><td>null</td></tr><tr><td>NCT02757079</td><td>Nobelpharma</td><td>Completed</td><td>Jun 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Wake Disorders,Parasomnias,Disease,Neurodevelopmental Disorders</td><td>Melatonin</td></tr><tr><td>NCT02754219</td><td>Dong-A ST Co., Ltd.</td><td>Completed</td><td>Sep 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Liver Diseases</td><td>null</td></tr><tr><td>NCT02753101</td><td>Stanford University</td><td>Completed</td><td>Feb 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Sciatica</td><td>null</td></tr><tr><td>NCT02759003</td><td>Fondazione Salvatore Maugeri</td><td>Completed</td><td>Mar 2011</td><td>Mar 2014</td><td>Interventional</td><td>Apr 2016</td><td>Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis</td><td>null</td></tr><tr><td>NCT02752659</td><td>University of British Columbia</td><td>Completed</td><td>Jun 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Lymphedema</td><td>null</td></tr><tr><td>NCT02758912</td><td>Burnasyan Federal Medical Biophysical Center</td><td>Completed</td><td>Nov 2016</td><td>Oct 2019</td><td>Interventional</td><td>Apr 2016</td><td>Stroke,Angina Pectoris,Infarction,Hemorrhage</td><td>null</td></tr><tr><td>NCT02754388</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Feb 2016</td><td>Dec 2019</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02759666</td><td>Atridia Pty Ltd.</td><td>Completed</td><td>Jun 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02750241</td><td>The University of Texas Medical Branch, Galveston</td><td>Completed</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02752568</td><td>Kasr El Aini Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758015</td><td>University of California, San Francisco</td><td>Completed</td><td>Jun 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Betaine</td></tr><tr><td>NCT02756884</td><td>Arkansas Heart Hospital</td><td>Completed</td><td>Jun 2015</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Peripheral Arterial Disease,Peripheral Vascular Diseases</td><td>null</td></tr><tr><td>NCT02758353</td><td>JSI Research & Training Institute, Inc.</td><td>Completed</td><td>Apr 2015</td><td>Nov 2015</td><td>Interventional</td><td>Apr 2016</td><td>Malaria,Stillbirth</td><td>null</td></tr><tr><td>NCT02753751</td><td>Yale University</td><td>Completed</td><td>Mar 2018</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Acute Kidney Injury,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02757170</td><td>All India Institute of Medical Sciences, New Delhi</td><td>Unknown status</td><td>Jul 2015</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Liver Failure,Hepatic Insufficiency,End Stage Liver Disease,Acute-On-Chronic Liver Failure</td><td>null</td></tr><tr><td>NCT02757625</td><td>Pfizer</td><td>Completed</td><td>Jul 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Dexmedetomidine</td></tr><tr><td>NCT02752347</td><td>Riyadh Colleges of Dentistry and Pharmacy</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Malocclusion</td><td>null</td></tr><tr><td>NCT02756468</td><td>University of Roma La Sapienza</td><td>Unknown status</td><td>Jan 2015</td><td>Dec 2016</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Pancreatic Neoplasms</td><td>null</td></tr><tr><td>NCT02750410</td><td>Eli Lilly and Company</td><td>Completed</td><td>Aug 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Dulaglutide</td></tr><tr><td>NCT02755389</td><td>Nova Scotia Health Authority</td><td>Completed</td><td>Sep 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Apnea</td><td>null</td></tr><tr><td>NCT02755168</td><td>Assiut University</td><td>Unknown status</td><td>May 2017</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751567</td><td>Bayer</td><td>Withdrawn</td><td>May 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02755558</td><td>Penn State University</td><td>Completed</td><td>Sep 2014</td><td>May 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757547</td><td>Electrical Geodesics, Inc.</td><td>Terminated</td><td>Sep 2015</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Epilepsy</td><td>null</td></tr><tr><td>NCT02752828</td><td>Sanofi</td><td>Completed</td><td>May 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Insulin,Insulin Glargine,Lixisenatide,Hypoglycemic Agents</td></tr><tr><td>NCT02756715</td><td>Konkuk University Medical Center</td><td>Completed</td><td>May 2016</td><td>Feb 2020</td><td>Interventional</td><td>Apr 2016</td><td>Vascular System Injuries,Ischemia</td><td>Propofol,Desflurane</td></tr><tr><td>NCT02756117</td><td>Vanderbilt University</td><td>Completed</td><td>May 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Prediabetic State</td><td>null</td></tr><tr><td>NCT02753205</td><td>Gachon University Gil Medical Center</td><td>Withdrawn</td><td>Apr 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Intracranial Hypertension</td><td>Dexmedetomidine</td></tr><tr><td>NCT02756221</td><td>Tel Hai College</td><td>Completed</td><td>Mar 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Respiratory Tract Infections,Gastroenteritis</td><td>null</td></tr><tr><td>NCT02755675</td><td>Rigshospitalet, Denmark</td><td>Recruiting</td><td>Apr 2016</td><td>Oct 2023</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Lung Neoplasms,Mesothelioma</td><td>null</td></tr><tr><td>NCT02754037</td><td>University of California, Davis</td><td>Recruiting</td><td>Apr 2016</td><td>Jun 2024</td><td>Observational</td><td>Apr 2016</td><td>Liver Diseases,Fatty Liver,Non-alcoholic Fatty Liver Disease,Inflammation</td><td>Fluorodeoxyglucose F18</td></tr><tr><td>NCT02750306</td><td>Merck Sharp & Dohme Corp.</td><td>Completed</td><td>May 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Alzheimer Disease,Sleep Initiation and Maintenance Disorders</td><td>Suvorexant</td></tr><tr><td>NCT02756403</td><td>Medstar Health Research Institute</td><td>Completed</td><td>Mar 2016</td><td>Jul 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Azithromycin,Metronidazole,Doxycycline</td></tr><tr><td>NCT02759653</td><td>Haukeland University Hospital</td><td>Completed</td><td>May 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Stroke,Ischemic Stroke,Carotid Artery Diseases,Embolic Stroke</td><td>null</td></tr><tr><td>NCT02753920</td><td>Northwell Health</td><td>Completed</td><td>Mar 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Prolapse</td><td>null</td></tr><tr><td>NCT02759367</td><td>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</td><td>Completed</td><td>Mar 2008</td><td>Jun 2015</td><td>Interventional</td><td>Dec 2015</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT02752997</td><td>Mayo Clinic</td><td>Completed</td><td>Dec 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02750059</td><td>South East Asia Research Collaboration with Hawaii</td><td>Completed</td><td>Jan 2015</td><td>Feb 2018</td><td>Interventional</td><td>May 2015</td><td>Infections,Communicable Diseases,HIV Infections,Acquired Immunodeficiency Syndrome</td><td>Tenofovir,Lamivudine,Efavirenz,Telmisartan</td></tr><tr><td>NCT02754505</td><td>Danube Hospital</td><td>Completed</td><td>Feb 2008</td><td>Dec 2011</td><td>Interventional</td><td>Mar 2016</td><td>Critical Illness</td><td>null</td></tr><tr><td>NCT02751736</td><td>Seoul National University Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Rectal Neoplasms</td><td>null</td></tr><tr><td>NCT02750930</td><td>GlaxoSmithKline</td><td>Terminated</td><td>Oct 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>rGLP-1 protein</td></tr><tr><td>NCT02753582</td><td>Indonesia University</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Frailty</td><td>null</td></tr><tr><td>NCT02750722</td><td>University of Zurich</td><td>Completed</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02756793</td><td>Lawson Health Research Institute</td><td>Active, not recruiting</td><td>Oct 2016</td><td>Jun 2026</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasm Metastasis,Neoplasms</td><td>null</td></tr><tr><td>NCT02750436</td><td>Montreal General Hospital</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain</td><td>null</td></tr><tr><td>NCT02755922</td><td>Instituto Mexicano del Seguro Social</td><td>Completed</td><td>Apr 2010</td><td>Dec 2010</td><td>Interventional</td><td>Apr 2016</td><td>Mandibular Fractures</td><td>null</td></tr><tr><td>NCT02755493</td><td>Brigham and Women's Hospital</td><td>Completed</td><td>Apr 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Deprivation</td><td>null</td></tr><tr><td>NCT02750397</td><td>Massachusetts General Hospital</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Dec 2024</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753621</td><td>Johns Hopkins University</td><td>Completed</td><td>Dec 2015</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease</td><td>null</td></tr><tr><td>NCT02754154</td><td>Bristol-Myers Squibb</td><td>Unknown status</td><td>Dec 2014</td><td>Feb 2019</td><td>Observational</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>Warfarin,Rivaroxaban,Dabigatran,Apixaban</td></tr><tr><td>NCT02753049</td><td>New York University</td><td>Unknown status</td><td>Nov 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>HIV Infections,Acquired Immunodeficiency Syndrome</td><td>null</td></tr><tr><td>NCT02750813</td><td>Alcon, a Novartis Company</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Refractive Errors</td><td>null</td></tr><tr><td>NCT02756975</td><td>Modarres Hospital</td><td>Completed</td><td>Dec 2014</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759601</td><td>Queen Mary University of London</td><td>Unknown status</td><td>Jan 2013</td><td>Dec 2018</td><td>Interventional</td><td>Oct 2014</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02757326</td><td>RedHill Biopharma Limited</td><td>Terminated</td><td>Dec 2016</td><td>May 2019</td><td>Interventional</td><td>Mar 2016</td><td>Multiple Myeloma,Neoplasms</td><td>null</td></tr><tr><td>NCT02758236</td><td>Ina-Respond</td><td>Active, not recruiting</td><td>Feb 2017</td><td>Dec 2021</td><td>Observational</td><td>Apr 2016</td><td>Tuberculosis</td><td>null</td></tr><tr><td>NCT02754804</td><td>University Hospital, Angers</td><td>Completed</td><td>Jul 2016</td><td>Mar 2020</td><td>Observational</td><td>Apr 2016</td><td>Peripheral Arterial Disease</td><td>null</td></tr><tr><td>NCT02756065</td><td>Washington University Early Recognition Center</td><td>Completed</td><td>Sep 2014</td><td>Aug 2019</td><td>Observational</td><td>Jun 2015</td><td>Schizophrenia,Bipolar Disorder</td><td>null</td></tr><tr><td>NCT02756247</td><td>Memorial Sloan Kettering Cancer Center</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>null</td></tr><tr><td>NCT02755857</td><td>Mayne Pharma International Pty Ltd</td><td>Completed</td><td>Jul 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>Neutropenia</td><td>Itraconazole</td></tr><tr><td>NCT02750111</td><td>Dr. Orit Hamiel</td><td>Unknown status</td><td>May 2016</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02755948</td><td>Imperial College London</td><td>Recruiting</td><td>Apr 2012</td><td>Mar 2023</td><td>Interventional</td><td>Apr 2016</td><td>Influenza,Virus Diseases,Respiratory Syncytial Virus Infections</td><td>null</td></tr><tr><td>NCT02754089</td><td>Shiraz University of Medical Sciences</td><td>Completed</td><td>May 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Body Weight</td><td>null</td></tr><tr><td>NCT02756169</td><td>Universidad Iberoamericana A.C., Mexico</td><td>Completed</td><td>Jul 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Obesity</td><td>null</td></tr><tr><td>NCT02757664</td><td>Federal University of São Paulo</td><td>Completed</td><td>Feb 2017</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Tendinopathy</td><td>null</td></tr><tr><td>NCT02757989</td><td>Groupe Francophone des Myelodysplasies</td><td>Active, not recruiting</td><td>May 2016</td><td>Jun 2024</td><td>Interventional</td><td>Mar 2016</td><td>Preleukemia,Myelodysplastic Syndromes</td><td>null</td></tr><tr><td>NCT02755038</td><td>Bnai Zion Medical Center</td><td>Unknown status</td><td>Mar 2016</td><td>Mar 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759354</td><td>MCM Vaccines B.V.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis B,Whooping Cough,Hepatitis</td><td>null</td></tr><tr><td>NCT02750254</td><td>Washington University School of Medicine</td><td>Terminated</td><td>Jun 2016</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Myelodysplastic Syndromes</td><td>Plerixafor,Cyclophosphamide,Melphalan,Busulfan,Fludarabine,Azacitidine,Lenograstim,Sargramostim</td></tr><tr><td>NCT02755025</td><td>Mayo Clinic</td><td>Completed</td><td>Jul 2016</td><td>Aug 2016</td><td>Observational</td><td>Mar 2016</td><td>Sepsis</td><td>null</td></tr><tr><td>NCT02757703</td><td>Kaohsiung Veterans General Hospital.</td><td>Completed</td><td>May 2010</td><td>Jan 2015</td><td>Interventional</td><td>Apr 2016</td><td>Hemorrhage</td><td>Terlipressin,Pantoprazole,Somatostatin</td></tr><tr><td>NCT02758899</td><td>Washington University School of Medicine</td><td>Terminated</td><td>Mar 2014</td><td>Aug 2016</td><td>Observational</td><td>Apr 2016</td><td>Spondylosis,Spinal Cord Diseases,Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02751450</td><td>GlaxoSmithKline</td><td>Completed</td><td>Feb 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dentin Sensitivity,Hypersensitivity</td><td>Fluorides,Tin Fluorides,Fluorophosphate</td></tr><tr><td>NCT02759497</td><td>Tanta University</td><td>Unknown status</td><td>Mar 2016</td><td>Nov 2020</td><td>Observational</td><td>May 2016</td><td>Peritonitis</td><td>null</td></tr><tr><td>NCT02750826</td><td>Alliance for Clinical Trials in Oncology</td><td>Active, not recruiting</td><td>Aug 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Weight Loss</td><td>null</td></tr><tr><td>NCT02750631</td><td>New York State Psychiatric Institute</td><td>Completed</td><td>Apr 2014</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT02756182</td><td>Laborie Medical Technologies Inc.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754583</td><td>University of California, San Francisco</td><td>Recruiting</td><td>Dec 2015</td><td>Aug 2024</td><td>Interventional</td><td>Oct 2015</td><td>Trachoma</td><td>Azithromycin,Tetracycline</td></tr><tr><td>NCT02750020</td><td>The University of Hong Kong</td><td>Completed</td><td>Feb 2016</td><td>Sep 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759978</td><td>University Medical Center Groningen</td><td>Recruiting</td><td>May 2016</td><td>May 2023</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Endocarditis</td><td>null</td></tr><tr><td>NCT02759575</td><td>Vinita Takiar</td><td>Completed</td><td>Apr 2016</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Squamous Cell Carcinoma of Head and Neck</td><td>Pembrolizumab</td></tr><tr><td>NCT02750878</td><td>Boston Urogynecology Associates</td><td>Unknown status</td><td>Nov 2015</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Incontinence,Enuresis</td><td>null</td></tr><tr><td>NCT02758600</td><td>Federal University of São Paulo</td><td>Unknown status</td><td>Mar 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Myocardial Infarction,Infarction</td><td>null</td></tr><tr><td>NCT02750657</td><td>University Health Network, Toronto</td><td>Active, not recruiting</td><td>Dec 2015</td><td>Dec 2021</td><td>Observational</td><td>Jan 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02750007</td><td>Jiangsu Hansoh Pharmaceutical Co., Ltd.</td><td>Unknown status</td><td>Dec 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02750462</td><td>University Hospital Schleswig-Holstein</td><td>Completed</td><td>Nov 2016</td><td>Sep 2019</td><td>Interventional</td><td>Apr 2016</td><td>Heart Arrest,Out-of-Hospital Cardiac Arrest</td><td>null</td></tr><tr><td>NCT02755597</td><td>AbbVie</td><td>Suspended</td><td>Jul 2016</td><td>Feb 2022</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Dexamethasone,Bortezomib,Venetoclax</td></tr><tr><td>NCT02754232</td><td>Odense University Hospital</td><td>Withdrawn</td><td>Aug 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Pulmonary Disease,Chronic Disease</td><td>null</td></tr><tr><td>NCT02751515</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02758080</td><td>Seoul National University Hospital</td><td>Unknown status</td><td>Jan 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Hematologic Neoplasms</td><td>null</td></tr><tr><td>NCT02756312</td><td>Beijing Tiantan Hospital</td><td>Not yet recruiting</td><td>Oct 2020</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Glioma</td><td>Anesthetics</td></tr><tr><td>NCT02759107</td><td>Eli Lilly and Company</td><td>Completed</td><td>May 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Dulaglutide,Tirzepatide</td></tr><tr><td>NCT02758795</td><td>University of Limerick</td><td>Completed</td><td>Feb 2016</td><td>Apr 2017</td><td>Interventional</td><td>Feb 2016</td><td>Inflammation</td><td>null</td></tr><tr><td>NCT02757859</td><td>Sidney Kimmel Cancer Center at Thomas Jefferson University</td><td>Recruiting</td><td>Apr 2016</td><td>Jan 2022</td><td>Interventional</td><td>Apr 2016</td><td>Adenocarcinoma,Cholangiocarcinoma,Carcinoma,Pancreatic Intraductal Neoplasms</td><td>Pancrelipase,Pancreatin</td></tr><tr><td>NCT02750800</td><td>AbbVie</td><td>Completed</td><td>Apr 2016</td><td>Apr 2018</td><td>Observational</td><td>Apr 2016</td><td>Spondylitis,Arthritis,Crohn Disease,Colitis,Inflammatory Bowel Diseases,Psoriasis</td><td>Adalimumab</td></tr><tr><td>NCT02754167</td><td>Pieris Pharmaceuticals GmbH</td><td>Unknown status</td><td>Jun 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02758379</td><td>Shockwave Medical, Inc.</td><td>Completed</td><td>Jul 2014</td><td>Mar 2016</td><td>Interventional</td><td>Jan 2015</td><td>Coronary Stenosis</td><td>null</td></tr><tr><td>NCT02755740</td><td>The University of Hong Kong</td><td>Completed</td><td>Jul 2015</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751008</td><td>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</td><td>Completed</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Osteoporosis</td><td>null</td></tr><tr><td>NCT02756390</td><td>Dana-Farber Cancer Institute</td><td>Completed</td><td>Dec 2015</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Initiation and Maintenance Disorders</td><td>null</td></tr><tr><td>NCT02753075</td><td>GlaxoSmithKline</td><td>Completed</td><td>Sep 2015</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Dentin Sensitivity,Hypersensitivity</td><td>Fluorides</td></tr><tr><td>NCT02753465</td><td>Fudan University</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Rectal Neoplasms</td><td>null</td></tr><tr><td>NCT02750852</td><td>Azienda Ospedaliera Bolognini di Seriate Bergamo</td><td>Unknown status</td><td>Apr 2016</td><td>May 2016</td><td>Observational</td><td>Apr 2016</td><td>Hemorrhage</td><td>null</td></tr><tr><td>NCT02753088</td><td>Biocad</td><td>Completed</td><td>Oct 2013</td><td>Nov 2015</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Sclerosis,Sclerosis</td><td>Glatiramer Acetate,Mannitol,(T</td></tr><tr><td>NCT02758626</td><td>NYU Langone Health</td><td>Completed</td><td>Nov 2016</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Epilepsy,Epilepsies</td><td>null</td></tr><tr><td>NCT02757222</td><td>Tata Medical Center</td><td>Recruiting</td><td>Jan 2016</td><td>Dec 2022</td><td>Interventional</td><td>Mar 2016</td><td>Neoplasms,Oropharyngeal Neoplasms,Hypopharyngeal Neoplasms,Laryngeal Neoplasms,Laryngeal Diseases</td><td>null</td></tr><tr><td>NCT02750150</td><td>University Hospital, Lille</td><td>Completed</td><td>Jul 2013</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Hemostatic Disorders,Blood Coagulation Disorders,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02752776</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>Mar 2018</td><td>Interventional</td><td>Feb 2016</td><td>Psoriasis</td><td>null</td></tr><tr><td>NCT02752984</td><td>IRCCS Policlinico S. Matteo</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Thrombosis,Venous Thrombosis</td><td>null</td></tr><tr><td>NCT02755272</td><td>Fox Chase Cancer Center</td><td>Recruiting</td><td>May 2016</td><td>Apr 2024</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Triple Negative Breast Neoplasms</td><td>Gemcitabine,Carboplatin,Pembrolizumab</td></tr><tr><td>NCT02753192</td><td>Centre National de la Recherche Scientifique, France</td><td>Unknown status</td><td>Jan 2014</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease,Dysarthria,Disease Progression</td><td>null</td></tr><tr><td>NCT02750189</td><td>Konkuk University Medical Center</td><td>Completed</td><td>Sep 2015</td><td>Jan 2017</td><td>Observational</td><td>Mar 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02756338</td><td>Biotronik, Inc.</td><td>Completed</td><td>Jun 2016</td><td>Jul 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759809</td><td>The Hospital for Sick Children</td><td>Completed</td><td>Jun 2016</td><td>Jul 2018</td><td>Observational</td><td>Apr 2016</td><td>Birth Weight</td><td>null</td></tr><tr><td>NCT02758431</td><td>University of Colorado, Denver</td><td>Recruiting</td><td>Feb 2016</td><td>Nov 2022</td><td>Interventional</td><td>Apr 2016</td><td>Hypogonadism</td><td>Methyltestosterone,Anastrozole,Testosterone,Testosterone undecanoate,Testosterone enanthate,Testosterone 17 beta-cypionate,Aromatase Inhibitors,Acyline,Hormone Antagonists</td></tr><tr><td>NCT02756962</td><td>Washington University School of Medicine</td><td>Recruiting</td><td>Jul 2016</td><td>Jul 2024</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Cytarabine</td></tr><tr><td>NCT02752919</td><td>Eli Lilly and Company</td><td>Completed</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759705</td><td>Hospices Civils de Lyon</td><td>Withdrawn</td><td>Sep 2017</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Bladder Exstrophy</td><td>null</td></tr><tr><td>NCT02753478</td><td>Catharina Ziekenhuis Eindhoven</td><td>Completed</td><td>Jun 2016</td><td>Nov 2016</td><td>Interventional</td><td>Apr 2016</td><td>Myocardial Infarction,Infarction,Hypothermia</td><td>null</td></tr><tr><td>NCT02753413</td><td>GlaxoSmithKline</td><td>Completed</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Respiratory Syncytial Virus Infections</td><td>null</td></tr><tr><td>NCT02759510</td><td>RenJi Hospital</td><td>Unknown status</td><td>Jun 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cardiac Output</td><td>Phenylephrine,Oxymetazoline,Norepinephrine</td></tr><tr><td>NCT02756130</td><td>Jonsson Comprehensive Cancer Center</td><td>Withdrawn</td><td>Aug 2018</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Adenocarcinoma,Ovarian Neoplasms,Cystadenocarcinoma</td><td>Carboplatin</td></tr><tr><td>NCT02750124</td><td>Karolinska Institutet</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Dec 2021</td><td>Interventional</td><td>Mar 2016</td><td>Uterine Cervical Neoplasms</td><td>null</td></tr><tr><td>NCT02755610</td><td>Chulalongkorn University</td><td>Unknown status</td><td>May 2016</td><td>Apr 2019</td><td>Interventional</td><td>Feb 2016</td><td>Peritonitis,Kidney Diseases,Kidney Failure</td><td>null</td></tr><tr><td>NCT02759328</td><td>Ankara University</td><td>Completed</td><td>Dec 2012</td><td>Mar 2014</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02753608</td><td>Jena University Hospital</td><td>Completed</td><td>Jun 2016</td><td>Mar 2018</td><td>Interventional</td><td>Mar 2016</td><td>Pneumonia</td><td>null</td></tr><tr><td>NCT02751944</td><td>ESM Technologies, LLC</td><td>Completed</td><td>Dec 2015</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>Arthralgia</td><td>null</td></tr><tr><td>NCT02750748</td><td>National Institute on Drug Abuse (NIDA)</td><td>Completed</td><td>Jul 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Opioid-Related Disorders</td><td>Naltrexone</td></tr><tr><td>NCT02758405</td><td>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</td><td>Completed</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Labor Pain</td><td>Fentanyl,Bupivacaine</td></tr><tr><td>NCT02753829</td><td>Ágata Sofia da Silva Vieira</td><td>Completed</td><td>Sep 2013</td><td>Jul 2015</td><td>Interventional</td><td>Apr 2016</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Heart Diseases,Infarction</td><td>null</td></tr><tr><td>NCT02751788</td><td>Pennington Biomedical Research Center</td><td>Completed</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02753010</td><td>Uppsala University</td><td>Completed</td><td>Mar 2011</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Gastroparesis,Fractures,Hip Fractures</td><td>null</td></tr><tr><td>NCT02750969</td><td>HaEmek Medical Center, Israel</td><td>Unknown status</td><td>Apr 2016</td><td>Feb 2019</td><td>Interventional</td><td>Mar 2016</td><td>Tinnitus</td><td>Lidocaine</td></tr><tr><td>NCT02755831</td><td>United States Naval Medical Center, San Diego</td><td>Completed</td><td>Feb 2017</td><td>Oct 2019</td><td>Interventional</td><td>Mar 2016</td><td>Apnea,Sleep Apnea Syndromes,Sleep Apnea</td><td>null</td></tr><tr><td>NCT02752009</td><td>Dana-Farber Cancer Institute</td><td>Withdrawn</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02758990</td><td>Verifomics LLC</td><td>Terminated</td><td>Mar 2016</td><td>Nov 2016</td><td>Interventional</td><td>Apr 2016</td><td>Rhinitis,Arthralgia,Dyspnea,Sleep Deprivation,Migraine Disorders,Sleep Initiation and Maintenance Disorders,Disease,Headache,Respiratory Sounds</td><td>Vitamin D,Cholecalciferol,Vitamins,Ascorbic Acid,Vitamin E,Tocopherols,Vitamin A,Niacinamide,Niacin,Nicotinic Acids,Pyridoxine,Pyridoxal,Vitamin B 6,Caffeine</td></tr><tr><td>NCT02754193</td><td>Central Hospital, Nancy, France</td><td>Completed</td><td>Oct 2016</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>Shock,Hypothermia</td><td>null</td></tr><tr><td>NCT02758613</td><td>Eli Lilly and Company</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751047</td><td>Seoul National University Hospital</td><td>Completed</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758197</td><td>Ottawa Hospital Research Institute</td><td>Completed</td><td>Jul 2016</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Neuralgia,Chronic Pain</td><td>null</td></tr><tr><td>NCT02753270</td><td>University of Sao Paulo</td><td>Completed</td><td>Dec 2014</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Varicose Veins</td><td>null</td></tr><tr><td>NCT02750839</td><td>Azienda Ospedaliera Bolognini di Seriate Bergamo</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>Osteoporosis,Fractures,Humeral Fractures</td><td>null</td></tr><tr><td>NCT02750488</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02752958</td><td>GlaxoSmithKline</td><td>Completed</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Dentin Sensitivity,Hypersensitivity</td><td>Fluorides,Tin Fluorides</td></tr><tr><td>NCT02753322</td><td>The Queen Elizabeth Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2018</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02757261</td><td>University of Nove de Julho</td><td>Unknown status</td><td>Jun 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Bruxism,Sleep Bruxism</td><td>Salicylic Acid</td></tr><tr><td>NCT02754427</td><td>University of British Columbia</td><td>Completed</td><td>Feb 2013</td><td>Aug 2015</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02758366</td><td>Meyer Children's Hospital</td><td>Terminated</td><td>Feb 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Glioblastoma,Glioma,Astrocytoma,Diffuse Intrinsic Pontine Glioma,Neoplasms</td><td>Doxorubicin</td></tr><tr><td>NCT02755402</td><td>Centre hospitalier de l'Université de Montréal (CHUM)</td><td>Completed</td><td>Jan 2017</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis C</td><td>null</td></tr><tr><td>NCT02754453</td><td>The Cleveland Clinic</td><td>Withdrawn</td><td>Jul 2013</td><td>Oct 2015</td><td>Interventional</td><td>Sep 2013</td><td>Body Weight,Weight Loss</td><td>null</td></tr><tr><td>NCT02755103</td><td>Medical University of South Carolina</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Oct 2021</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Substance-Related Disorders,Stress Disorders</td><td>null</td></tr><tr><td>NCT02758834</td><td>Università Politecnica delle Marche</td><td>Completed</td><td>Jan 2014</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>Liver Diseases</td><td>null</td></tr><tr><td>NCT02759146</td><td>Michigan State University</td><td>Completed</td><td>May 2016</td><td>Nov 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754414</td><td>Bloodworks</td><td>Unknown status</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759783</td><td>Royal Marsden NHS Foundation Trust</td><td>Active, not recruiting</td><td>Nov 2016</td><td>Oct 2024</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02756923</td><td>Weill Medical College of Cornell University</td><td>Suspended</td><td>Apr 2012</td><td>Dec 2025</td><td>Observational</td><td>Apr 2016</td><td>Infertility</td><td>null</td></tr><tr><td>NCT02759237</td><td>Medtronic Cardiovascular</td><td>Terminated</td><td>Feb 2016</td><td>May 2017</td><td>Observational</td><td>Apr 2016</td><td>Aortic Valve Stenosis</td><td>null</td></tr><tr><td>NCT02757391</td><td>M.D. Anderson Cancer Center</td><td>Terminated</td><td>Aug 2019</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Colorectal Neoplasms,Adenocarcinoma,Stomach Neoplasms,Esophageal Neoplasms,Cholangiocarcinoma</td><td>Aldesleukin,Cyclophosphamide,Pembrolizumab,Interleukin-2,Immunologic Factors</td></tr><tr><td>NCT02750904</td><td>Fred Hutchinson Cancer Research Center</td><td>Completed</td><td>Apr 2017</td><td>May 2019</td><td>Interventional</td><td>Mar 2016</td><td>Disease,Bipolar Disorder</td><td>Nicotine</td></tr><tr><td>NCT02758418</td><td>Universitat Jaume I</td><td>Unknown status</td><td>Apr 2016</td><td>Jul 2019</td><td>Interventional</td><td>Apr 2016</td><td>Adjustment Disorders</td><td>null</td></tr><tr><td>NCT02756039</td><td>AstraZeneca</td><td>Completed</td><td>May 2016</td><td>Aug 2018</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755077</td><td>Massachusetts General Hospital</td><td>Completed</td><td>Jul 2014</td><td>Jan 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751801</td><td>Sheffield Teaching Hospitals NHS Foundation Trust</td><td>Completed</td><td>Nov 2016</td><td>Dec 2017</td><td>Observational</td><td>Apr 2016</td><td>Hypophosphatasia</td><td>null</td></tr><tr><td>NCT02751177</td><td>Institut de Cancérologie de Lorraine</td><td>Completed</td><td>Mar 2016</td><td>May 2017</td><td>Interventional</td><td>Mar 2016</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT02758574</td><td>University of Pittsburgh</td><td>Completed</td><td>May 2016</td><td>Aug 2021</td><td>Interventional</td><td>Mar 2016</td><td>Pulmonary Embolism,Embolism</td><td>null</td></tr><tr><td>NCT02758587</td><td>NHS Greater Glasgow and Clyde</td><td>Recruiting</td><td>Jul 2017</td><td>Dec 2021</td><td>Interventional</td><td>Apr 2016</td><td>Mesothelioma,Carcinoma,Pancreatic Neoplasms</td><td>Pembrolizumab</td></tr><tr><td>NCT02752100</td><td>Third Military Medical University</td><td>Unknown status</td><td>Mar 2016</td><td>May 2020</td><td>Interventional</td><td>Mar 2016</td><td>Arterial Occlusive Diseases</td><td>null</td></tr><tr><td>NCT02755818</td><td>University of California, Davis</td><td>Terminated</td><td>Oct 2008</td><td>Feb 2019</td><td>Observational</td><td>Mar 2016</td><td>Insulin Resistance</td><td>Heparin,Calcium heparin</td></tr><tr><td>NCT02752906</td><td>Sanofi Pasteur, a Sanofi Company</td><td>Completed</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Meningococcal Infections,Meningitis</td><td>Vaccines</td></tr><tr><td>NCT02750371</td><td>University Hospital, Bordeaux</td><td>Active, not recruiting</td><td>Jul 2016</td><td>Oct 2021</td><td>Interventional</td><td>Apr 2016</td><td>Adenoma,Meningioma,Pituitary Neoplasms,Pituitary Diseases</td><td>null</td></tr><tr><td>NCT02751125</td><td>University of Bergen</td><td>Completed</td><td>Jun 2014</td><td>Mar 2020</td><td>Interventional</td><td>Mar 2016</td><td>Atrophy</td><td>null</td></tr><tr><td>NCT02754700</td><td>High Point University</td><td>Completed</td><td>Apr 2016</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>Knee Injuries</td><td>null</td></tr><tr><td>NCT02756442</td><td>Assistance Publique Hopitaux De Marseille</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Respiration Disorders,Respiratory Tract Diseases,Diabetes</td><td>null</td></tr><tr><td>NCT02756637</td><td>Abramson Cancer Center of the University of Pennsylvania</td><td>Completed</td><td>Apr 2016</td><td>Nov 2016</td><td>Observational</td><td>Apr 2016</td><td>Urinary Bladder Neoplasms</td><td>null</td></tr><tr><td>NCT02755688</td><td>Royal Brompton & Harefield NHS Foundation Trust</td><td>Unknown status</td><td>Jun 2015</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02753387</td><td>Rennes University Hospital</td><td>Completed</td><td>May 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Bacterial Infections,Head and Neck Neoplasms</td><td>Chlorhexidine</td></tr><tr><td>NCT02758470</td><td>University of British Columbia</td><td>Completed</td><td>Nov 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>Fatigue,Hypoxia</td><td>Acetazolamide,Methazolamide</td></tr><tr><td>NCT02754375</td><td>Centre Hospitalier Universitaire de Nice</td><td>Unknown status</td><td>May 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT02758756</td><td>University of Rochester</td><td>Completed</td><td>Jun 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Fatigue</td><td>null</td></tr><tr><td>NCT02750787</td><td>Abbott Nutrition</td><td>Completed</td><td>Aug 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Malabsorption Syndromes</td><td>null</td></tr><tr><td>NCT02757339</td><td>Mclean Hospital</td><td>Enrolling by invitation</td><td>Jun 2015</td><td>May 2022</td><td>Observational</td><td>Mar 2016</td><td>Disease,Stress Disorders,Dissociative Disorders,Dissociative Identity Disorder</td><td>null</td></tr><tr><td>NCT02753959</td><td>Guy's and St Thomas' NHS Foundation Trust</td><td>Completed</td><td>Aug 2016</td><td>Sep 2019</td><td>Interventional</td><td>Apr 2016</td><td>Neuromuscular Diseases</td><td>null</td></tr><tr><td>NCT02753426</td><td>University of California, San Francisco</td><td>Completed</td><td>Apr 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Renal Insufficiency,Cardio-Renal Syndrome</td><td>Doxycycline</td></tr><tr><td>NCT02757183</td><td>AnalyticsPlus, Inc.</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750293</td><td>University of Tromso</td><td>Completed</td><td>Jun 2015</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Vitamin D Deficiency</td><td>Cholecalciferol</td></tr><tr><td>NCT02757274</td><td>European Association of Urology Research Foundation</td><td>Recruiting</td><td>Feb 2017</td><td>Jul 2027</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Urinary Incontinence,Enuresis</td><td>null</td></tr><tr><td>NCT02756741</td><td>All India Institute of Medical Sciences, New Delhi</td><td>Completed</td><td>Apr 2014</td><td>Jul 2015</td><td>Interventional</td><td>Apr 2016</td><td>Peritonitis,Fibrosis</td><td>null</td></tr><tr><td>NCT02758964</td><td>Charite University, Berlin, Germany</td><td>Completed</td><td>Sep 2016</td><td>Jan 2019</td><td>Observational</td><td>Apr 2016</td><td>Intracranial Embolism,Embolism,Aortic Valve Stenosis</td><td>null</td></tr><tr><td>NCT02753439</td><td>The Baruch Padeh Medical Center, Poriya</td><td>Unknown status</td><td>Feb 2017</td><td>Feb 2019</td><td>Interventional</td><td>Mar 2016</td><td>Tooth</td><td>null</td></tr><tr><td>NCT02751281</td><td>Isfahan University of Medical Sciences</td><td>Completed</td><td>Dec 2014</td><td>Apr 2016</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Calculi,Nephrolithiasis</td><td>null</td></tr><tr><td>NCT02756676</td><td>Ospedale Generale Di Zona Moriggia-Pelascini</td><td>Completed</td><td>Apr 2015</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Parkinson Disease</td><td>null</td></tr><tr><td>NCT02750215</td><td>Massachusetts General Hospital</td><td>Completed</td><td>May 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02755935</td><td>Cochlear</td><td>Completed</td><td>May 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hearing Loss</td><td>null</td></tr><tr><td>NCT02759523</td><td>Penn State University</td><td>Completed</td><td>Jul 2013</td><td>Dec 2015</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02756533</td><td>University Hospital, Grenoble</td><td>Recruiting</td><td>Aug 2016</td><td>Aug 2021</td><td>Interventional</td><td>Mar 2016</td><td>Lung Diseases,Pulmonary Disease,Signs and Symptoms</td><td>null</td></tr><tr><td>NCT02752841</td><td>Brown University</td><td>Terminated</td><td>May 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Calculi,Calculi</td><td>Vitamin D</td></tr><tr><td>NCT02758392</td><td>Janssen Research & Development, LLC</td><td>Completed</td><td>Apr 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755870</td><td>Clene Nanomedicine</td><td>Completed</td><td>Apr 2015</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752464</td><td>Boston Medical Center</td><td>Completed</td><td>Sep 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756780</td><td>Royal Marsden NHS Foundation Trust</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753998</td><td>Assistance Publique - Hôpitaux de Paris</td><td>Active, not recruiting</td><td>Dec 2016</td><td>Sep 2021</td><td>Interventional</td><td>Apr 2016</td><td>Arteriovenous Fistula,Constriction,Fistula</td><td>Paclitaxel</td></tr><tr><td>NCT02751307</td><td>Taipei Medical University WanFang Hospital</td><td>Completed</td><td>May 2013</td><td>Jan 2015</td><td>Interventional</td><td>Apr 2016</td><td>Congenital Abnormalities,Metabolic Syndrome,Schizophrenia</td><td>Metformin,Clozapine</td></tr><tr><td>NCT02757755</td><td>Armata Pharmaceuticals, Inc.</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753972</td><td>University of New Mexico</td><td>Completed</td><td>Aug 2006</td><td>Jan 2008</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751853</td><td>University of Luebeck</td><td>Unknown status</td><td>Dec 2016</td><td>Aug 2020</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02752971</td><td>Hospital Central Dr. Luis Ortega</td><td>Completed</td><td>Feb 2015</td><td>null</td><td>Interventional</td><td>Mar 2016</td><td>Pain</td><td>Diclofenac,Bupivacaine</td></tr><tr><td>NCT02755012</td><td>McGill University</td><td>Completed</td><td>Jun 2012</td><td>Nov 2013</td><td>Observational</td><td>Apr 2016</td><td>Infections,Mastitis,Malnutrition,Infant Nutrition Disorders,Growth Disorders,Stress</td><td>null</td></tr><tr><td>NCT02751996</td><td>F-star Therapeutics, Inc.</td><td>Completed</td><td>May 2016</td><td>Feb 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis B,Hepatitis</td><td>Tenofovir</td></tr><tr><td>NCT02752893</td><td>Dartmouth-Hitchcock Medical Center</td><td>Completed</td><td>Jan 2017</td><td>Apr 2019</td><td>Observational</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02753842</td><td>Global Protection Corp.</td><td>Completed</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757040</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>Dec 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Arsenic Trioxide</td></tr><tr><td>NCT02751606</td><td>Radboud University</td><td>Unknown status</td><td>Jun 2015</td><td>Nov 2019</td><td>Interventional</td><td>Nov 2014</td><td>Neoplasms,Breast Neoplasms,Rectal Neoplasms</td><td>null</td></tr><tr><td>NCT02751372</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753764</td><td>National Jewish Health</td><td>Completed</td><td>Jan 2017</td><td>Feb 2019</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Prednisone,AZD7624</td></tr><tr><td>NCT02758938</td><td>University of Wisconsin, Madison</td><td>Completed</td><td>Jun 2016</td><td>Sep 2018</td><td>Interventional</td><td>Dec 2015</td><td>Lower Urinary Tract Symptoms</td><td>null</td></tr><tr><td>NCT02752399</td><td>Federal University of São Paulo</td><td>Unknown status</td><td>Apr 2016</td><td>Jun 2017</td><td>Observational</td><td>Apr 2016</td><td>Hypertension,Heart Defects,Eisenmenger Complex</td><td>null</td></tr><tr><td>NCT02753296</td><td>University of Sheffield</td><td>Unknown status</td><td>May 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759432</td><td>Teesside University</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750137</td><td>KK Women's and Children's Hospital</td><td>Completed</td><td>Aug 2014</td><td>May 2015</td><td>Observational</td><td>Apr 2016</td><td>Drug-Related Side Effects and Adverse Reactions</td><td>Tetracaine</td></tr><tr><td>NCT02754466</td><td>University of Brasilia</td><td>Terminated</td><td>May 2017</td><td>Sep 2021</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT02752191</td><td>Paul Finn</td><td>Recruiting</td><td>Apr 2016</td><td>Apr 2021</td><td>Interventional</td><td>Apr 2016</td><td>Heart Diseases,Heart Defects</td><td>Ferrosoferric Oxide</td></tr><tr><td>NCT02753517</td><td>University Hospital, Lille</td><td>Recruiting</td><td>Dec 2015</td><td>Nov 2023</td><td>Interventional</td><td>Apr 2016</td><td>Liver Failure,Hepatic Insufficiency</td><td>null</td></tr><tr><td>NCT02758054</td><td>University of Texas Southwestern Medical Center</td><td>Active, not recruiting</td><td>Jun 2017</td><td>Mar 2023</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02757573</td><td>Tampere University Hospital</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Hypercapnia</td><td>null</td></tr><tr><td>NCT02752789</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Jul 2014</td><td>Nov 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756416</td><td>University of Nottingham</td><td>Unknown status</td><td>Jul 2016</td><td>May 2017</td><td>Interventional</td><td>Mar 2016</td><td>Syndrome</td><td>null</td></tr><tr><td>NCT02758106</td><td>Chung Shan Medical University</td><td>Completed</td><td>Feb 2014</td><td>Nov 2015</td><td>Interventional</td><td>Apr 2016</td><td>Respiratory Insufficiency</td><td>null</td></tr><tr><td>NCT02759159</td><td>Xuanwu Hospital, Beijing</td><td>Unknown status</td><td>Jun 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02753777</td><td>University of Pennsylvania</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2025</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Pemphigoid,Pemphigus</td><td>null</td></tr><tr><td>NCT02754245</td><td>Baylor Research Institute</td><td>Unknown status</td><td>Nov 2016</td><td>Jul 2017</td><td>Observational</td><td>Apr 2016</td><td>Emergencies</td><td>null</td></tr><tr><td>NCT02754687</td><td>Health Decisions</td><td>Unknown status</td><td>Apr 2016</td><td>Jan 2020</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Nandrolone Decanoate,Nandrolone,Nandrolone phenpropionate</td></tr><tr><td>NCT02755337</td><td>Dr. Soetomo General Hospital</td><td>Unknown status</td><td>Jan 2016</td><td>Dec 2016</td><td>Observational</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02755090</td><td>University of New Mexico</td><td>Completed</td><td>Jul 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Nitrous Oxide</td></tr><tr><td>NCT02751437</td><td>Liverpool Women's NHS Foundation Trust</td><td>Completed</td><td>Aug 2016</td><td>Mar 2018</td><td>Interventional</td><td>Mar 2016</td><td>Premature Birth</td><td>null</td></tr><tr><td>NCT02757950</td><td>GlaxoSmithKline</td><td>Completed</td><td>Jul 2016</td><td>May 2017</td><td>Observational</td><td>Apr 2016</td><td>Diphtheria</td><td>null</td></tr><tr><td>NCT02756754</td><td>University Hospital, Toulouse</td><td>Completed</td><td>Nov 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Adenoma,Adrenocortical Adenoma,Hyperaldosteronism</td><td>null</td></tr><tr><td>NCT02754726</td><td>HonorHealth Research Institute</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Jun 2022</td><td>Interventional</td><td>Apr 2016</td><td>Adenocarcinoma</td><td>Gemcitabine,Paclitaxel,Nivolumab,Albumin-Bound Paclitaxel</td></tr><tr><td>NCT02759549</td><td>Emory University</td><td>Withdrawn</td><td>Sep 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02755714</td><td>Haukeland University Hospital</td><td>Completed</td><td>Jun 2016</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Bromides,Ipratropium</td></tr><tr><td>NCT02750358</td><td>Memorial Sloan Kettering Cancer Center</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Triple Negative Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02754921</td><td>Mohamed Sayed Mohamed Abbas</td><td>Completed</td><td>Jan 2013</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755259</td><td>University of Zurich</td><td>Completed</td><td>Jan 2017</td><td>Apr 2019</td><td>Interventional</td><td>Mar 2016</td><td>Hypertension</td><td>Acetazolamide</td></tr><tr><td>NCT02759081</td><td>Dalin Tzu Chi General Hospital</td><td>Completed</td><td>Jan 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755155</td><td>University Hospital, Strasbourg, France</td><td>Terminated</td><td>Sep 2016</td><td>Aug 2019</td><td>Interventional</td><td>Apr 2016</td><td>Hypoalbuminemia,Syndrome,Systemic Inflammatory Response Syndrome</td><td>null</td></tr><tr><td>NCT02758119</td><td>Ilumens</td><td>Completed</td><td>Jun 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Heart Arrest,Out-of-Hospital Cardiac Arrest</td><td>null</td></tr><tr><td>NCT02755415</td><td>China Medical University Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02751268</td><td>Armed Forces Hampyeong Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Psychomotor Agitation,Emergence Delirium</td><td>Ropivacaine</td></tr><tr><td>NCT02756572</td><td>University of Washington</td><td>Completed</td><td>Sep 2016</td><td>Jul 2020</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia,Neoplasms,Preleukemia,Myelodysplastic Syndromes,Anemia,Syndrome</td><td>Cytarabine,Cyclosporine,Mycophenolic Acid,Sirolimus,Fludarabine,Fludarabine phosphate,Melphalan,Mechlorethamine,Mitoxantrone,Nitrogen Mustard Compounds,Cladribine,2-chloro-3-deoxyadenosine,Cyclosporins,Lenograstim</td></tr><tr><td>NCT02756871</td><td>Institute of Child Health</td><td>Completed</td><td>Jul 2015</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750618</td><td>Ultragenyx Pharmaceutical Inc</td><td>Completed</td><td>May 2016</td><td>Sep 2019</td><td>Interventional</td><td>Dec 2015</td><td>Familial Hypophosphatemic Rickets,Hypophosphatemia</td><td>null</td></tr><tr><td>NCT02757196</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>May 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Thrombocytopenia,Purpura</td><td>Methylprednisolone,Methylprednisolone Acetate,Methylprednisolone Hemisuccinate,Prednisolone,Prednisolone acetate,Rituximab,Prednisolone hemisuccinate,Prednisolone phosphate</td></tr><tr><td>NCT02758093</td><td>University of Alabama at Birmingham</td><td>Completed</td><td>Sep 2016</td><td>Mar 2020</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750943</td><td>GlaxoSmithKline</td><td>Completed</td><td>Nov 2015</td><td>Mar 2016</td><td>Interventional</td><td>Nov 2015</td><td>Gingivitis</td><td>Fluorides,Tin Fluorides,Fluorophosphate</td></tr><tr><td>NCT02754908</td><td>The University of Hong Kong</td><td>Completed</td><td>Jan 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02750514</td><td>Bristol-Myers Squibb</td><td>Terminated</td><td>May 2016</td><td>Jan 2020</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>Nivolumab,Ipilimumab,Dasatinib,Linrodostat</td></tr><tr><td>NCT02755350</td><td>LVCT Health</td><td>Unknown status</td><td>Aug 2015</td><td>Apr 2017</td><td>Interventional</td><td>Nov 2015</td><td>null</td><td>Emtricitabine</td></tr><tr><td>NCT02753374</td><td>Beijing Children's Hospital</td><td>Not yet recruiting</td><td>May 2016</td><td>Jul 2030</td><td>Observational</td><td>Apr 2016</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT02759419</td><td>Bayer</td><td>Recruiting</td><td>Jun 2016</td><td>Dec 2023</td><td>Interventional</td><td>Apr 2016</td><td>Pulmonary Arterial Hypertension,Hypertension</td><td>Riociguat</td></tr><tr><td>NCT02757612</td><td>Universidad de Murcia</td><td>Completed</td><td>Jun 2015</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Burning Mouth Syndrome,Syndrome,Burns</td><td>null</td></tr><tr><td>NCT02754297</td><td>CHU de Quebec-Universite Laval</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2026</td><td>Interventional</td><td>Mar 2016</td><td>Neoplasms,Neuroendocrine Tumors,Carcinoid Tumor,Carcinoma</td><td>Lutetium Lu 177 dotatate</td></tr><tr><td>NCT02758665</td><td>University of Ulm</td><td>Active, not recruiting</td><td>Sep 2016</td><td>Mar 2022</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Venetoclax,Obinutuzumab</td></tr><tr><td>NCT02755285</td><td>Fujifilm Medical Systems USA, Inc.</td><td>Completed</td><td>Aug 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757690</td><td>Asan Medical Center</td><td>Completed</td><td>Jan 2015</td><td>Feb 2016</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02753218</td><td>LEO Pharma</td><td>Terminated</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Psoriasis</td><td>Midazolam</td></tr><tr><td>NCT02754986</td><td>University of Hyogo</td><td>Completed</td><td>Mar 2015</td><td>null</td><td>Interventional</td><td>Mar 2016</td><td>Kidney Diseases,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02752048</td><td>Taiho Pharmaceutical Co., Ltd.</td><td>Completed</td><td>May 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>Muscular Dystrophies,Muscular Dystrophy</td><td>null</td></tr><tr><td>NCT02752256</td><td>University of Iowa</td><td>Completed</td><td>Oct 2015</td><td>Oct 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>Plasminogen,Tissue Plasminogen Activator</td></tr><tr><td>NCT02756936</td><td>Genuine Research Center, Egypt</td><td>Completed</td><td>Feb 2016</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756000</td><td>Clinical Hospital Center Zemun</td><td>Unknown status</td><td>Jan 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Infarction</td><td>Dobutamine</td></tr><tr><td>NCT02754492</td><td>Terumo BCT</td><td>Completed</td><td>Apr 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757677</td><td>Swiss Vision Network</td><td>Unknown status</td><td>Dec 2015</td><td>Dec 2019</td><td>Observational</td><td>Apr 2016</td><td>Glaucoma</td><td>null</td></tr><tr><td>NCT02752373</td><td>Brain Sentinel</td><td>Terminated</td><td>May 2016</td><td>Feb 2017</td><td>Observational</td><td>Mar 2016</td><td>Epilepsy,Seizures</td><td>null</td></tr><tr><td>NCT02752230</td><td>Kettering Health Network</td><td>Withdrawn</td><td>Nov 2016</td><td>Jun 2021</td><td>Interventional</td><td>Mar 2016</td><td>Pain</td><td>null</td></tr><tr><td>NCT02756728</td><td>BioInvent International AB</td><td>Terminated</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Melphalan</td></tr><tr><td>NCT02751658</td><td>University Hospital, Montpellier</td><td>Completed</td><td>Nov 2016</td><td>Jul 2019</td><td>Interventional</td><td>Mar 2016</td><td>Otorhinolaryngologic Diseases</td><td>null</td></tr><tr><td>NCT02754518</td><td>University of Chicago</td><td>Completed</td><td>Apr 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure</td><td>Valsartan,Sacubitril and valsartan sodium hydrate drug combination</td></tr><tr><td>NCT02759380</td><td>Sahlgrenska University Hospital, Sweden</td><td>Recruiting</td><td>Mar 2016</td><td>Oct 2022</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms</td><td>Phytoestrogens</td></tr><tr><td>NCT02755649</td><td>Regeneron Pharmaceuticals</td><td>Completed</td><td>Jan 2016</td><td>Mar 2017</td><td>Interventional</td><td>Mar 2016</td><td>Dermatitis,Eczema</td><td>null</td></tr><tr><td>NCT02751827</td><td>Institut Bergonié</td><td>Completed</td><td>Feb 2016</td><td>Nov 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755545</td><td>Galderma Laboratories, L.P.</td><td>Completed</td><td>May 2016</td><td>Apr 2017</td><td>Interventional</td><td>Apr 2016</td><td>Acne Vulgaris</td><td>Salicylic Acid,Adapalene,Salicylates</td></tr><tr><td>NCT02750345</td><td>Cycle Pharmaceuticals Ltd.</td><td>Completed</td><td>Mar 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Tyrosinemias</td><td>Nitisinone</td></tr><tr><td>NCT02755532</td><td>Federal University of São Paulo</td><td>Completed</td><td>Jan 2014</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Bupivacaine</td></tr><tr><td>NCT02758743</td><td>Biohit Oyj</td><td>Completed</td><td>Apr 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754947</td><td>Nationwide Children's Hospital</td><td>Completed</td><td>Feb 2015</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Respiration Disorders,Respiratory Tract Diseases,Nervous System Diseases,Cardiovascular Diseases</td><td>null</td></tr><tr><td>NCT02750280</td><td>Calvary Hospital, Bronx, NY</td><td>Completed</td><td>Jun 2015</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Diabetic Foot,Foot Ulcer,Ulcer</td><td>null</td></tr><tr><td>NCT02756325</td><td>NYU Langone Health</td><td>Withdrawn</td><td>Jun 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Infertility</td><td>null</td></tr><tr><td>NCT02758717</td><td>Academic and Community Cancer Research United</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2024</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma,Hodgkin Disease</td><td>Antineoplastic Agents,Nivolumab,Brentuximab Vedotin,Antibodies,Immunoglobulins,Immunoconjugates</td></tr><tr><td>NCT02751034</td><td>Medy-Tox</td><td>Completed</td><td>Jun 2013</td><td>Jan 2014</td><td>Interventional</td><td>Apr 2015</td><td>null</td><td>Lidocaine</td></tr><tr><td>NCT02751476</td><td>Action Contre la Faim</td><td>Unknown status</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Malnutrition,Severe Acute Malnutrition,Protein-Energy Malnutrition</td><td>Disinfectants</td></tr><tr><td>NCT02755454</td><td>University Health Network, Toronto</td><td>Completed</td><td>Oct 2013</td><td>Nov 2018</td><td>Interventional</td><td>Mar 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02752867</td><td>Dongfang Hospital Beijing University of Chinese Medicine</td><td>Unknown status</td><td>Dec 2016</td><td>Nov 2019</td><td>Interventional</td><td>Mar 2016</td><td>Cerebral Infarction,Infarction,Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02754830</td><td>Eli Lilly and Company</td><td>Completed</td><td>Apr 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02753738</td><td>Medical University of Vienna</td><td>Unknown status</td><td>Aug 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Citalopram</td></tr><tr><td>NCT02750267</td><td>University of Virginia</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02754999</td><td>Prolong Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Anemia</td><td>null</td></tr><tr><td>NCT02754843</td><td>Sonova AG</td><td>Completed</td><td>Oct 2015</td><td>null</td><td>Interventional</td><td>Oct 2015</td><td>Hearing Loss</td><td>null</td></tr><tr><td>NCT02759055</td><td>HealthPartners Institute</td><td>Completed</td><td>Oct 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Prediabetic State,Glucose Intolerance</td><td>null</td></tr><tr><td>NCT02753673</td><td>Memorial Sloan Kettering Cancer Center</td><td>Completed</td><td>Apr 2016</td><td>Apr 2020</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754531</td><td>Indonesia University</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750033</td><td>Seton Healthcare Family</td><td>Withdrawn</td><td>Oct 2016</td><td>Mar 2017</td><td>Observational</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02759133</td><td>Centre Antoine Lacassagne</td><td>Recruiting</td><td>Jun 2016</td><td>Nov 2022</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02756650</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Jun 2016</td><td>Jan 2019</td><td>Interventional</td><td>Mar 2016</td><td>Behcet Syndrome</td><td>null</td></tr><tr><td>NCT02752152</td><td>Institut de Recherche pour le Developpement</td><td>Completed</td><td>Dec 2015</td><td>Oct 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis B,Syphilis,Hepatitis</td><td>null</td></tr><tr><td>NCT02751385</td><td>Boehringer Ingelheim</td><td>Terminated</td><td>May 2016</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>Nintedanib,Ethinyl estradiol,Ethinyl Estradiol-Norgestrel Combination</td></tr><tr><td>NCT02751879</td><td>Boehringer Ingelheim</td><td>Completed</td><td>Nov 2016</td><td>Sep 2017</td><td>Observational</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02756663</td><td>Novartis Pharmaceuticals</td><td>Withdrawn</td><td>Dec 2016</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Multiple Myeloma,Neoplasms</td><td>Dexamethasone,Panobinostat</td></tr><tr><td>NCT02756273</td><td>Centre Hospitalier Universitaire, Amiens</td><td>Recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755974</td><td>Imperial College London</td><td>Unknown status</td><td>Jan 2009</td><td>Apr 2021</td><td>Observational</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02756507</td><td>Babes-Bolyai University</td><td>Completed</td><td>Jun 2016</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Depression,Anxiety Disorders,Panic Disorder</td><td>null</td></tr><tr><td>NCT02750553</td><td>Jiangsu HengRui Medicine Co., Ltd.</td><td>Completed</td><td>Jan 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750228</td><td>Mednax Center for Research, Education, Quality and Safety</td><td>Completed</td><td>May 2016</td><td>Jun 2020</td><td>Observational</td><td>Mar 2016</td><td>Ductus Arteriosus</td><td>null</td></tr><tr><td>NCT02751710</td><td>Ontario Clinical Oncology Group (OCOG)</td><td>Recruiting</td><td>Dec 2016</td><td>Dec 2022</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT02753361</td><td>Suez Canal University</td><td>Completed</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Lipoma</td><td>null</td></tr><tr><td>NCT02753634</td><td>Lawson Health Research Institute</td><td>Completed</td><td>Apr 2015</td><td>Jun 2016</td><td>Interventional</td><td>Mar 2016</td><td>Osteoarthritis</td><td>null</td></tr><tr><td>NCT02759250</td><td>argenx</td><td>Completed</td><td>Feb 2015</td><td>Jun 2018</td><td>Interventional</td><td>Apr 2016</td><td>Nasopharyngeal Carcinoma</td><td>null</td></tr><tr><td>NCT02757482</td><td>Celal Bayar University</td><td>Completed</td><td>Sep 2014</td><td>Jun 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757105</td><td>RedHill Biopharma Limited</td><td>Completed</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Irritable Bowel Syndrome,Syndrome,Diarrhea</td><td>Ondansetron</td></tr><tr><td>NCT02756520</td><td>Fresenius Kabi</td><td>Completed</td><td>Sep 2016</td><td>Oct 2018</td><td>Observational</td><td>Apr 2016</td><td>Kidney Diseases,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02753309</td><td>The University of Texas Health Science Center at San Antonio</td><td>Completed</td><td>Jun 2016</td><td>Mar 2021</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Bladder Neoplasms</td><td>Sirolimus</td></tr><tr><td>NCT02756832</td><td>Takeda</td><td>Completed</td><td>Sep 2016</td><td>Apr 2018</td><td>Observational</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Alogliptin</td></tr><tr><td>NCT02758158</td><td>University Health Network, Toronto</td><td>Completed</td><td>Jan 2016</td><td>Feb 2017</td><td>Interventional</td><td>Mar 2016</td><td>Thyroid Neoplasms,Thyroid Nodule,Thyroid Diseases</td><td>null</td></tr><tr><td>NCT02752360</td><td>Beijing Friendship Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Colonic Neoplasms,Crohn Disease,Diverticulum,Diverticular Diseases,Diverticulosis</td><td>null</td></tr><tr><td>NCT02757794</td><td>Assistance Publique Hopitaux De Marseille</td><td>Recruiting</td><td>Nov 2016</td><td>Jun 2022</td><td>Interventional</td><td>Apr 2016</td><td>Memory Disorders</td><td>null</td></tr><tr><td>NCT02751346</td><td>Washington University School of Medicine</td><td>Completed</td><td>Jan 2016</td><td>Feb 2017</td><td>Observational</td><td>Apr 2016</td><td>Pain</td><td>null</td></tr><tr><td>NCT02757027</td><td>Konkuk University Medical Center</td><td>Unknown status</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756689</td><td>University of Alabama at Birmingham</td><td>Completed</td><td>Mar 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751164</td><td>Intensive Care National Audit & Research Centre</td><td>Completed</td><td>Apr 2013</td><td>May 2016</td><td>Observational</td><td>Apr 2016</td><td>Critical Illness</td><td>null</td></tr><tr><td>NCT02754765</td><td>Médecins Sans Frontières, France</td><td>Recruiting</td><td>Dec 2016</td><td>Aug 2023</td><td>Interventional</td><td>Apr 2016</td><td>Tuberculosis,Bacterial Infections</td><td>Moxifloxacin,Levofloxacin,Ofloxacin,Linezolid,Pyrazinamide,Bedaquiline,Clofazimine</td></tr><tr><td>NCT02757729</td><td>Amorepacific Corporation</td><td>Completed</td><td>Oct 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis,Eczema</td><td>null</td></tr><tr><td>NCT02751866</td><td>University of Cincinnati</td><td>Recruiting</td><td>Jan 2016</td><td>Jul 2023</td><td>Interventional</td><td>Apr 2016</td><td>Overweight,Hyperphagia</td><td>null</td></tr><tr><td>NCT02759068</td><td>Hospices Civils de Lyon</td><td>Completed</td><td>Nov 2014</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Consciousness Disorders</td><td>null</td></tr><tr><td>NCT02752503</td><td>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</td><td>Unknown status</td><td>Mar 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Alcoholism,Alcohol Drinking,Personality Disorders,Borderline Personality Disorder</td><td>Nalmefene</td></tr><tr><td>NCT02750592</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Spondylitis</td><td>null</td></tr><tr><td>NCT02754440</td><td>Terumo BCT</td><td>Completed</td><td>Apr 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750670</td><td>University Health Network, Toronto</td><td>Completed</td><td>Mar 2017</td><td>Feb 2021</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Gemcitabine,Dexamethasone,Obinutuzumab</td></tr><tr><td>NCT02753400</td><td>Kubota Vision Inc.</td><td>Completed</td><td>May 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Retinal Diseases,Diabetic Retinopathy</td><td>null</td></tr><tr><td>NCT02754310</td><td>Ilumens</td><td>Completed</td><td>May 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758275</td><td>Universidad Industrial de Santander</td><td>Completed</td><td>Apr 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Hypertension,Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02757417</td><td>University Hospitals Cleveland Medical Center</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753725</td><td>University of Nairobi</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Delirium,Emergence Delirium</td><td>Fentanyl</td></tr><tr><td>NCT02752646</td><td>MDbackline, LLC</td><td>Completed</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Cataract</td><td>Ketorolac,Nepafenac</td></tr><tr><td>NCT02750566</td><td>New York Institute of Technology</td><td>Recruiting</td><td>Nov 2015</td><td>Dec 2021</td><td>Interventional</td><td>Dec 2015</td><td>Post-Concussion Syndrome</td><td>null</td></tr><tr><td>NCT02753335</td><td>University of Tromso</td><td>Recruiting</td><td>Sep 2016</td><td>Dec 2022</td><td>Interventional</td><td>Mar 2016</td><td>Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Syndrome</td><td>null</td></tr><tr><td>NCT02754544</td><td>M.D. Anderson Cancer Center</td><td>Recruiting</td><td>Jul 2016</td><td>Aug 2020</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02751112</td><td>Imagine Institute</td><td>Terminated</td><td>Nov 2015</td><td>Aug 2017</td><td>Interventional</td><td>Apr 2016</td><td>Graft vs Host Disease</td><td>null</td></tr><tr><td>NCT02751320</td><td>GlaxoSmithKline</td><td>Completed</td><td>Feb 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dental Caries</td><td>Citric Acid,Sodium Citrate</td></tr><tr><td>NCT02753036</td><td>Charite University, Berlin, Germany</td><td>Active, not recruiting</td><td>Jan 2016</td><td>Jun 2023</td><td>Observational</td><td>Apr 2016</td><td>Polyneuropathies,Cognition Disorders</td><td>null</td></tr><tr><td>NCT02759198</td><td>Yuhan Corporation</td><td>Completed</td><td>May 2016</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Osteoarthritis</td><td>Celecoxib</td></tr><tr><td>NCT02752802</td><td>Osprey Medical, Inc</td><td>Completed</td><td>Apr 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757586</td><td>Peking University People's Hospital</td><td>Unknown status</td><td>Dec 2016</td><td>Dec 2019</td><td>Observational</td><td>Apr 2016</td><td>Leukemia</td><td>null</td></tr><tr><td>NCT02755961</td><td>Ajou University School of Medicine</td><td>Completed</td><td>Jul 2015</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Kidney Failure,Hyperphosphatemia</td><td>null</td></tr><tr><td>NCT02759263</td><td>Boston Children's Hospital</td><td>Completed</td><td>Jun 2016</td><td>Oct 2018</td><td>Interventional</td><td>Apr 2016</td><td>Heart Diseases,Heart Defects</td><td>null</td></tr><tr><td>NCT02754271</td><td>Toronto Rehabilitation Institute</td><td>Unknown status</td><td>Apr 2014</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Failure</td><td>null</td></tr><tr><td>NCT02756195</td><td>Vanderbilt University</td><td>Recruiting</td><td>Nov 2016</td><td>Jan 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754336</td><td>Helse Stavanger HF</td><td>Completed</td><td>Oct 2014</td><td>Jun 2015</td><td>Interventional</td><td>Nov 2015</td><td>null</td><td>null</td></tr><tr><td>NCT02758639</td><td>University of Texas at Austin</td><td>Completed</td><td>Sep 2015</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759185</td><td>Multidisciplinary Association for Psychedelic Studies</td><td>Completed</td><td>Jan 2017</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Marijuana Abuse,Stress Disorders</td><td>Dronabinol,Cannabidiol</td></tr><tr><td>NCT02758145</td><td>Service de Médecine Préventive Hospitalière</td><td>Completed</td><td>Apr 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Influenza</td><td>Vaccines</td></tr><tr><td>NCT02756455</td><td>University of Roma La Sapienza</td><td>Unknown status</td><td>Jan 2015</td><td>Dec 2016</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT02757118</td><td>Konkuk University Medical Center</td><td>Unknown status</td><td>May 2016</td><td>Jan 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756819</td><td>Takeda</td><td>Completed</td><td>Jul 2016</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Hypertension,Overweight</td><td>Azilsartan medoxomil</td></tr><tr><td>NCT02754362</td><td>NYU Langone Health</td><td>Withdrawn</td><td>Nov 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Glioblastoma</td><td>Bevacizumab,Poly ICLC,Keyhole-limpet hemocyanin,Adjuvants</td></tr><tr><td>NCT02752711</td><td>Nantes University Hospital</td><td>Completed</td><td>May 2013</td><td>Dec 2015</td><td>Observational</td><td>Apr 2016</td><td>Craniocerebral Trauma</td><td>null</td></tr><tr><td>NCT02756494</td><td>Beijing Chao Yang Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Stroke,Ischemic Stroke,Cerebral Infarction,Ischemia</td><td>null</td></tr><tr><td>NCT02753855</td><td>University of Illinois at Chicago</td><td>Completed</td><td>Apr 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Telavancin</td></tr><tr><td>NCT02756013</td><td>Case Comprehensive Cancer Center</td><td>Terminated</td><td>Apr 2016</td><td>Jan 2019</td><td>Interventional</td><td>Apr 2016</td><td>Overweight</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT02756949</td><td>World Bank</td><td>Completed</td><td>Oct 2015</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>HIV Infections</td><td>null</td></tr><tr><td>NCT02757885</td><td>Emory University</td><td>Recruiting</td><td>Apr 2016</td><td>Jul 2023</td><td>Interventional</td><td>Apr 2016</td><td>Anemia</td><td>Cyclophosphamide,Thiotepa,Fludarabine,Fludarabine phosphate,Hydroxyurea,Antilymphocyte Serum,Thymoglobulin</td></tr><tr><td>NCT02758340</td><td>Karachi Medical and Dental College</td><td>Completed</td><td>Apr 2016</td><td>Nov 2016</td><td>Interventional</td><td>Apr 2016</td><td>Labor Pain</td><td>Misoprostol</td></tr><tr><td>NCT02753933</td><td>Guy's and St Thomas' NHS Foundation Trust</td><td>Unknown status</td><td>Apr 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Headache Disorders,Headache</td><td>null</td></tr><tr><td>NCT02756624</td><td>Nicox Ophthalmics, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Cetirizine</td></tr><tr><td>NCT02759393</td><td>National Cheng-Kung University Hospital</td><td>Unknown status</td><td>Oct 2015</td><td>Sep 2017</td><td>Interventional</td><td>Apr 2016</td><td>Gastroesophageal Reflux,Esophagitis</td><td>Lansoprazole,Dexlansoprazole</td></tr><tr><td>NCT02757820</td><td>Assiut University</td><td>Completed</td><td>Jun 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754141</td><td>Bristol-Myers Squibb</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Feb 2023</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Nivolumab</td></tr><tr><td>NCT02753985</td><td>Abramson Cancer Center of the University of Pennsylvania</td><td>Completed</td><td>Jul 2014</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757768</td><td>Astellas Pharma Global Development, Inc.</td><td>Completed</td><td>Jun 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Urinary Bladder,Prostatic Hyperplasia,Hyperplasia,Lower Urinary Tract Symptoms</td><td>Tamsulosin,Mirabegron</td></tr><tr><td>NCT02753348</td><td>Henning Bundgaard</td><td>Completed</td><td>Apr 2016</td><td>Nov 2018</td><td>Observational</td><td>Apr 2016</td><td>Heart Diseases,Heart Defects</td><td>null</td></tr><tr><td>NCT02759718</td><td>Asan Medical Center</td><td>Unknown status</td><td>Jun 2012</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Neuroendocrine Tumors,Endocrine Gland Neoplasms,Adenoma</td><td>null</td></tr><tr><td>NCT02755181</td><td>Boehringer Ingelheim</td><td>Completed</td><td>Jul 2016</td><td>May 2018</td><td>Observational</td><td>Apr 2016</td><td>Disease,Personality Disorders,Borderline Personality Disorder,Impulsive Behavior,Disruptive</td><td>null</td></tr><tr><td>NCT02759926</td><td>Universitaire Ziekenhuizen Leuven</td><td>Unknown status</td><td>Aug 2011</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Obesity</td><td>Quinine,Denatonium</td></tr><tr><td>NCT02756286</td><td>Think Now Incorporated</td><td>Completed</td><td>Jan 2017</td><td>Jul 2018</td><td>Observational</td><td>Nov 2015</td><td>Attention Deficit Disorder with Hyperactivity</td><td>null</td></tr><tr><td>NCT02752126</td><td>Lawson Health Research Institute</td><td>Completed</td><td>Jun 2016</td><td>Sep 2020</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02752035</td><td>Astellas Pharma Global Development, Inc.</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Aug 2023</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia</td><td>Azacitidine</td></tr><tr><td>NCT02750865</td><td>Boston Medical Center</td><td>Recruiting</td><td>Aug 2017</td><td>Dec 2022</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752165</td><td>University of Rochester</td><td>Recruiting</td><td>Aug 2016</td><td>Feb 2023</td><td>Interventional</td><td>Mar 2016</td><td>Asthma,Emergencies</td><td>null</td></tr><tr><td>NCT02755792</td><td>The Hong Kong Polytechnic University</td><td>Completed</td><td>Jul 2012</td><td>Apr 2016</td><td>Interventional</td><td>Apr 2016</td><td>Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02757898</td><td>Emory University</td><td>Recruiting</td><td>Jan 2017</td><td>Dec 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Biotin</td></tr><tr><td>NCT02758678</td><td>Science and Technology Park, Center of Innovation Technologies for Human Health</td><td>Completed</td><td>Nov 2015</td><td>Oct 2016</td><td>Observational</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02751424</td><td>GlaxoSmithKline</td><td>Terminated</td><td>Jun 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Bacterial Infections</td><td>null</td></tr><tr><td>NCT02750319</td><td>Memorial Sloan Kettering Cancer Center</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Apr 2022</td><td>Interventional</td><td>Apr 2016</td><td>Atrial Fibrillation</td><td>Acetylcysteine,Amiodarone,N-monoacetylcystine</td></tr><tr><td>NCT02757495</td><td>Suez Canal University</td><td>Completed</td><td>Apr 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Psychomotor Agitation,Emergence Delirium,Delayed Emergence from Anesthesia</td><td>Dexmedetomidine</td></tr><tr><td>NCT02752607</td><td>Dr. Vicky Tagalakis</td><td>Terminated</td><td>May 2016</td><td>Nov 2018</td><td>Observational</td><td>Apr 2016</td><td>Thrombosis,Venous Thrombosis</td><td>null</td></tr><tr><td>NCT02757911</td><td>Genethon</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Jun 2024</td><td>Interventional</td><td>Apr 2016</td><td>Granuloma,Granulomatous Disease</td><td>null</td></tr><tr><td>NCT02759224</td><td>Boryung Pharmaceutical Co., Ltd</td><td>Completed</td><td>Apr 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>Stomach Ulcer</td><td>Irsogladine,Lafutidine</td></tr><tr><td>NCT02756351</td><td>CytaCoat AB</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Cross Infection,Pneumonia</td><td>null</td></tr><tr><td>NCT02751359</td><td>University of California, Los Angeles</td><td>Completed</td><td>Jul 2016</td><td>Apr 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Cannabidiol</td></tr><tr><td>NCT02756585</td><td>Nova Scotia Health Authority</td><td>Unknown status</td><td>Sep 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Craniocerebral Trauma,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02751411</td><td>Aboca Spa Societa' Agricola</td><td>Completed</td><td>Apr 2016</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>Constipation</td><td>null</td></tr><tr><td>NCT02750735</td><td>University of Palermo</td><td>Completed</td><td>Jan 2001</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Hypersensitivity</td><td>null</td></tr><tr><td>NCT02753868</td><td>University of Illinois at Urbana-Champaign</td><td>Completed</td><td>Feb 2016</td><td>Feb 2017</td><td>Interventional</td><td>Feb 2016</td><td>Renal Insufficiency</td><td>null</td></tr><tr><td>NCT02755844</td><td>Hospices Civils de Lyon</td><td>Active, not recruiting</td><td>Sep 2016</td><td>Apr 2022</td><td>Interventional</td><td>Apr 2016</td><td>Endometrial Neoplasms</td><td>Metformin,Cyclophosphamide,Olaparib</td></tr><tr><td>NCT02758301</td><td>Medtronic Cardiac Rhythm and Heart Failure</td><td>Completed</td><td>Jun 2016</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02751463</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02752633</td><td>Landspitali University Hospital</td><td>Completed</td><td>May 2013</td><td>May 2015</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Allopurinol,Febuxostat</td></tr><tr><td>NCT02755909</td><td>Indonesia University</td><td>Completed</td><td>Dec 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Anxiety Disorders</td><td>Anesthetics</td></tr><tr><td>NCT02752620</td><td>Rio de Janeiro State University</td><td>Completed</td><td>May 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain,Low Back Pain</td><td>null</td></tr><tr><td>NCT02759965</td><td>Karolinska University Hospital</td><td>Completed</td><td>Sep 2014</td><td>Dec 2018</td><td>Observational</td><td>Nov 2014</td><td>Acute-Phase Reaction,Cognitive Dysfunction</td><td>null</td></tr><tr><td>NCT02754752</td><td>M.D. Anderson Cancer Center</td><td>Recruiting</td><td>Sep 2016</td><td>Sep 2023</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms,Chronic Pain</td><td>null</td></tr><tr><td>NCT02754349</td><td>Onze Lieve Vrouw Hospital</td><td>Completed</td><td>Feb 2015</td><td>May 2016</td><td>Interventional</td><td>Mar 2016</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02754479</td><td>Cutera Inc.</td><td>Completed</td><td>Apr 2016</td><td>Mar 2017</td><td>Interventional</td><td>Apr 2016</td><td>Telangiectasis</td><td>null</td></tr><tr><td>NCT02753790</td><td>New Mexico Cancer Care Alliance</td><td>Active, not recruiting</td><td>Feb 2016</td><td>Mar 2023</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasm Metastasis,Neoplasms,Brain Neoplasms</td><td>null</td></tr><tr><td>NCT02757248</td><td>Anne Beaven, MD</td><td>Withdrawn</td><td>Nov 2016</td><td>Nov 2016</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Romidepsin</td></tr><tr><td>NCT02759991</td><td>Norwegian Institute of Public Health</td><td>Completed</td><td>Oct 2017</td><td>Sep 2019</td><td>Interventional</td><td>Mar 2016</td><td>Infections,Hepatitis A,Hepatitis E,Hepatitis</td><td>Vaccines</td></tr><tr><td>NCT02758561</td><td>Ottawa Hospital Research Institute</td><td>Completed</td><td>May 2016</td><td>Nov 2017</td><td>Interventional</td><td>Dec 2015</td><td>Urinary Incontinence,Enuresis,Pelvic Floor Disorders,Prolapse</td><td>null</td></tr><tr><td>NCT02753504</td><td>Chong Kun Dang Pharmaceutical</td><td>Completed</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dyslipidemias</td><td>null</td></tr><tr><td>NCT02758821</td><td>University of Oxford</td><td>Completed</td><td>Jun 2016</td><td>Sep 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757430</td><td>Abbott Medical Devices</td><td>Completed</td><td>Aug 2016</td><td>Jul 2017</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Arrhythmias</td><td>null</td></tr><tr><td>NCT02754024</td><td>Werner Anderl</td><td>Active, not recruiting</td><td>Sep 2005</td><td>Sep 2025</td><td>Observational</td><td>Apr 2016</td><td>Osteoarthritis,Necrosis</td><td>null</td></tr><tr><td>NCT02757651</td><td>Institute of Cancer Research, United Kingdom</td><td>Completed</td><td>Jan 2017</td><td>Nov 2020</td><td>Interventional</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Hydrogen Peroxide</td></tr><tr><td>NCT02758769</td><td>Bristol-Myers Squibb</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Oct 2023</td><td>Observational</td><td>Apr 2016</td><td>Arthritis</td><td>Abatacept</td></tr><tr><td>NCT02755896</td><td>Weill Medical College of Cornell University</td><td>Recruiting</td><td>Jul 2015</td><td>Jul 2024</td><td>Interventional</td><td>Aug 2015</td><td>Neoplasms,Breast Neoplasms,Radiation Pneumonitis</td><td>null</td></tr><tr><td>NCT02753699</td><td>Debiopharm International SA</td><td>Completed</td><td>Dec 2011</td><td>May 2015</td><td>Interventional</td><td>Mar 2016</td><td>Hepatitis A,Hepatitis C,Hepatitis</td><td>null</td></tr><tr><td>NCT02754323</td><td>Centre Hospitalier Universitaire de Nice</td><td>Unknown status</td><td>May 2016</td><td>Dec 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753881</td><td>Yale University</td><td>Completed</td><td>Nov 2015</td><td>Dec 2019</td><td>Interventional</td><td>Mar 2016</td><td>Liver Neoplasms</td><td>Doxorubicin,Liposomal doxorubicin</td></tr><tr><td>NCT02752074</td><td>Incyte Corporation</td><td>Completed</td><td>Jun 2016</td><td>Aug 2019</td><td>Interventional</td><td>Apr 2016</td><td>Melanoma</td><td>Pembrolizumab</td></tr><tr><td>NCT02753244</td><td>Intendu Ltd.</td><td>Unknown status</td><td>Apr 2015</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT02752672</td><td>Medical University of Graz</td><td>Completed</td><td>Mar 2016</td><td>Nov 2016</td><td>Observational</td><td>Apr 2016</td><td>Psoriasis</td><td>null</td></tr><tr><td>NCT02759029</td><td>Gangnam Severance Hospital</td><td>Unknown status</td><td>Mar 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Disease Susceptibility</td><td>null</td></tr><tr><td>NCT02750202</td><td>University of Pretoria</td><td>Recruiting</td><td>Jul 2018</td><td>Jul 2023</td><td>Interventional</td><td>Apr 2016</td><td>Warts,Condylomata Acuminata,Recurrence</td><td>Vaccines</td></tr><tr><td>NCT02753686</td><td>Novartis Pharmaceuticals</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Aug 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Tamoxifen,Everolimus,Letrozole,Fulvestrant,Anastrozole,Exemestane</td></tr><tr><td>NCT02752217</td><td>Khon Kaen University</td><td>Unknown status</td><td>Mar 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT02755662</td><td>ResMed</td><td>Completed</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Apr 2016</td><td>Apnea,Sleep Apnea Syndromes,Sleep Apnea,Syndrome</td><td>null</td></tr><tr><td>NCT02751671</td><td>St. Justine's Hospital</td><td>Completed</td><td>Aug 2016</td><td>Jun 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752880</td><td>Chang Gung Memorial Hospital</td><td>Completed</td><td>Jun 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02751632</td><td>Orygen</td><td>Active, not recruiting</td><td>Apr 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Psychotic Disorders,Mental Disorders,Personality Disorders</td><td>Fluoxetine</td></tr><tr><td>NCT02750527</td><td>Kinderkrankenhaus auf der Bult</td><td>Completed</td><td>Sep 2016</td><td>Dec 2020</td><td>Observational</td><td>Apr 2016</td><td>Hyperlipoproteinemia Type II,Diabetes Mellitus,Hypercholesterolemia</td><td>null</td></tr><tr><td>NCT02751242</td><td>Vanderbilt University</td><td>Completed</td><td>Aug 2016</td><td>Jul 2017</td><td>Observational</td><td>Apr 2016</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT02755363</td><td>Medical University of Warsaw</td><td>Unknown status</td><td>Apr 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02751775</td><td>Pennington Biomedical Research Center</td><td>Completed</td><td>Jun 2016</td><td>Jun 2017</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02757976</td><td>Lawson Health Research Institute</td><td>Terminated</td><td>Mar 2018</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Heart Failure,Ventricular Dysfunction</td><td>null</td></tr><tr><td>NCT02752386</td><td>University of Tulsa</td><td>Completed</td><td>Feb 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756143</td><td>University Hospital of Torrejon</td><td>Completed</td><td>Nov 2014</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754648</td><td>Ain Shams University</td><td>Unknown status</td><td>Sep 2015</td><td>Sep 2016</td><td>Interventional</td><td>Mar 2016</td><td>Endometriosis</td><td>null</td></tr><tr><td>NCT02751138</td><td>University of Ulm</td><td>Recruiting</td><td>Mar 2016</td><td>Sep 2024</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Glioblastoma</td><td>null</td></tr><tr><td>NCT02753231</td><td>Universidad Santo Tomas</td><td>Completed</td><td>Jan 2017</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Metabolic Syndrome,Metabolic Diseases,Lipid Metabolism Disorders,Overweight</td><td>null</td></tr><tr><td>NCT02759588</td><td>Genelux Corporation</td><td>Active, not recruiting</td><td>May 2016</td><td>May 2022</td><td>Interventional</td><td>Apr 2016</td><td>Ovarian Neoplasms,Carcinoma,Fallopian Tube Neoplasms,Peritoneal Neoplasms</td><td>Bevacizumab</td></tr><tr><td>NCT02757352</td><td>Eli Lilly and Company</td><td>Completed</td><td>Aug 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>Spondylarthritis</td><td>Ixekizumab</td></tr><tr><td>NCT02752022</td><td>St George's, University of London</td><td>Unknown status</td><td>Sep 2016</td><td>Apr 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754973</td><td>The University of Hong Kong</td><td>Completed</td><td>May 2015</td><td>Nov 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755506</td><td>Chinese PLA General Hospital</td><td>Unknown status</td><td>Oct 2015</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Aneurysm</td><td>null</td></tr><tr><td>NCT02751216</td><td>Moens Maarten</td><td>Completed</td><td>May 2016</td><td>Jan 2018</td><td>Interventional</td><td>Apr 2016</td><td>Syndrome,Failed Back Surgery Syndrome</td><td>null</td></tr><tr><td>NCT02756559</td><td>Lixin Xie</td><td>Unknown status</td><td>Jan 2014</td><td>Dec 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754557</td><td>Emory University</td><td>Recruiting</td><td>Mar 2016</td><td>Dec 2021</td><td>Interventional</td><td>Apr 2016</td><td>Stress Disorders</td><td>null</td></tr><tr><td>NCT02758496</td><td>Wave Neuroscience</td><td>Completed</td><td>Apr 2016</td><td>Apr 2017</td><td>Observational</td><td>Apr 2016</td><td>Autistic Disorder</td><td>null</td></tr><tr><td>NCT02757066</td><td>Nobelpharma</td><td>Completed</td><td>Jun 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Sleep Wake Disorders,Parasomnias,Disease,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders</td><td>Melatonin</td></tr><tr><td>NCT02756104</td><td>University Hospital, Montpellier</td><td>Completed</td><td>Jun 2016</td><td>May 2020</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Vitamin D</td></tr><tr><td>NCT02751814</td><td>Pennington Biomedical Research Center</td><td>Completed</td><td>Apr 2016</td><td>Jun 2018</td><td>Observational</td><td>Apr 2016</td><td>Pediatric Obesity</td><td>null</td></tr><tr><td>NCT02751749</td><td>Örebro University, Sweden</td><td>Completed</td><td>Dec 2015</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Chronic Pain</td><td>null</td></tr><tr><td>NCT02756052</td><td>University of Calgary</td><td>Completed</td><td>Mar 2016</td><td>Aug 2016</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753647</td><td>Ruijin Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Prednisone,Cyclophosphamide,Rituximab,Doxorubicin,Vincristine</td></tr><tr><td>NCT02756910</td><td>Peking Union Medical College Hospital</td><td>Completed</td><td>May 2016</td><td>Sep 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02756208</td><td>University of Maryland, College Park</td><td>Completed</td><td>Nov 2015</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>HIV Infections</td><td>Vaccines</td></tr><tr><td>NCT02757443</td><td>Meshalkin Research Institute of Pathology of Circulation</td><td>Completed</td><td>Jun 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Phosphocreatine,Anesthetics</td></tr><tr><td>NCT02759744</td><td>National Institutes of Health Clinical Center (CC)</td><td>Enrolling by invitation</td><td>Oct 2017</td><td>Jan 2026</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms</td><td>null</td></tr><tr><td>NCT02753140</td><td>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</td><td>Unknown status</td><td>Apr 2016</td><td>Sep 2018</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma,Squamous Cell Carcinoma of Head and Neck</td><td>Docetaxel,Cetuximab</td></tr><tr><td>NCT02759536</td><td>The Third Xiangya Hospital of Central South University</td><td>Unknown status</td><td>Jul 2013</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Melanoma</td><td>null</td></tr><tr><td>NCT02750449</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>null</td></tr><tr><td>NCT02759211</td><td>Mount Sinai Rehabilitation Hospital</td><td>Unknown status</td><td>Apr 2016</td><td>Feb 2018</td><td>Interventional</td><td>Mar 2016</td><td>Multiple Sclerosis,Sclerosis</td><td>null</td></tr><tr><td>NCT02752477</td><td>Ben Lim</td><td>Active, not recruiting</td><td>Aug 2016</td><td>Sep 2020</td><td>Interventional</td><td>Mar 2016</td><td>Pain,Chronic Pain</td><td>Anesthetics</td></tr><tr><td>NCT02759835</td><td>National Cancer Institute (NCI)</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Sep 2022</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms,Adenocarcinoma of Lung</td><td>Osimertinib</td></tr><tr><td>NCT02754596</td><td>Glaukos Corporation</td><td>Active, not recruiting</td><td>Mar 2016</td><td>Dec 2021</td><td>Interventional</td><td>Mar 2016</td><td>Glaucoma</td><td>Timolol,Travoprost,Ophthalmic Solutions</td></tr><tr><td>NCT02757846</td><td>Chinese Academy of Sciences</td><td>Enrolling by invitation</td><td>Apr 2017</td><td>Mar 2022</td><td>Observational</td><td>Apr 2016</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT02750085</td><td>Victor Blanchette</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Dec 2020</td><td>Observational</td><td>Apr 2016</td><td>Hemophilia A</td><td>null</td></tr><tr><td>NCT02759692</td><td>Johnson & Johnson Vision Care, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02752750</td><td>Medical University of Graz</td><td>Enrolling by invitation</td><td>May 2016</td><td>May 2022</td><td>Observational</td><td>Apr 2016</td><td>Alzheimer Disease</td><td>null</td></tr><tr><td>NCT02757781</td><td>Avedis Donabedian Research Institute</td><td>Unknown status</td><td>Jul 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Chronic Disease</td><td>null</td></tr><tr><td>NCT02757924</td><td>Abbott Nutrition</td><td>Completed</td><td>May 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759887</td><td>St. Joseph's Hospital and Medical Center, Phoenix</td><td>Completed</td><td>Nov 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Dementia,Down Syndrome,Alzheimer Disease,Syndrome</td><td>Fluorodeoxyglucose F18</td></tr><tr><td>NCT02758977</td><td>University of Zurich</td><td>Unknown status</td><td>May 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Neoplasm Metastasis,Liver Neoplasms,Colorectal Neoplasms,Liver Diseases</td><td>null</td></tr><tr><td>NCT02751580</td><td>Sidney Kimmel Cancer Center at Thomas Jefferson University</td><td>Completed</td><td>Mar 2016</td><td>Aug 2018</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02751333</td><td>Johns Hopkins University</td><td>Withdrawn</td><td>Mar 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Esophageal Stenosis,Esophageal Fistula,Esophageal Perforation,Fistula,Constriction</td><td>null</td></tr><tr><td>NCT02759731</td><td>National Cancer Institute (NCI)</td><td>Recruiting</td><td>Nov 2016</td><td>Jun 2022</td><td>Interventional</td><td>Apr 2016</td><td>Graft vs Host Disease</td><td>null</td></tr><tr><td>NCT02758288</td><td>Loma Linda University</td><td>Withdrawn</td><td>Sep 2015</td><td>Jul 2022</td><td>Observational</td><td>Mar 2016</td><td>Virus Diseases,Kidney Diseases</td><td>null</td></tr><tr><td>NCT02756546</td><td>Cairo University</td><td>Completed</td><td>Sep 2014</td><td>Dec 2015</td><td>Interventional</td><td>Apr 2016</td><td>Lupus Erythematosus</td><td>Hydroxychloroquine,Hydrocortisone,Cyclophosphamide</td></tr><tr><td>NCT02759094</td><td>Implantica CE & Production Ltd</td><td>Unknown status</td><td>Dec 2016</td><td>Feb 2018</td><td>Interventional</td><td>Apr 2016</td><td>Gastroesophageal Reflux</td><td>null</td></tr><tr><td>NCT02757313</td><td>Yale University</td><td>Completed</td><td>Oct 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Marijuana Abuse</td><td>Dronabinol</td></tr><tr><td>NCT02754011</td><td>UNICANCER</td><td>Recruiting</td><td>Jan 2017</td><td>Dec 2021</td><td>Interventional</td><td>Feb 2016</td><td>Breast Neoplasms</td><td>Capecitabine</td></tr><tr><td>NCT02755805</td><td>University of Pittsburgh</td><td>Completed</td><td>Jul 2009</td><td>Dec 2012</td><td>Interventional</td><td>Apr 2016</td><td>Stroke</td><td>null</td></tr><tr><td>NCT02755428</td><td>Chinese Academy of Sciences</td><td>Unknown status</td><td>Jan 2018</td><td>Dec 2020</td><td>Interventional</td><td>Mar 2016</td><td>Macular Degeneration</td><td>null</td></tr><tr><td>NCT02752555</td><td>Benha University</td><td>Unknown status</td><td>Apr 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Oligospermia</td><td>Antioxidants</td></tr><tr><td>NCT02751398</td><td>Yonsei University</td><td>Completed</td><td>Aug 2016</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>Dapagliflozin</td></tr><tr><td>NCT02758951</td><td>Koen Rovers</td><td>Recruiting</td><td>Jun 2017</td><td>Aug 2026</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms,Colorectal Neoplasms,Neoplasm Metastasis,Carcinoma,Peritoneal Neoplasms</td><td>Bevacizumab</td></tr><tr><td>NCT02750176</td><td>University of Southern California</td><td>Completed</td><td>Apr 2016</td><td>Jul 2018</td><td>Interventional</td><td>Apr 2016</td><td>Rotator Cuff Injuries</td><td>null</td></tr><tr><td>NCT02750696</td><td>Federal University of Rio Grande do Sul</td><td>Completed</td><td>Apr 2013</td><td>Apr 2015</td><td>Interventional</td><td>Apr 2016</td><td>Abscess,Periapical Abscess</td><td>Acetaminophen,Tramadol,Codeine</td></tr><tr><td>NCT02757963</td><td>GlaxoSmithKline</td><td>Completed</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Hyperplasia,Hyperplasia</td><td>null</td></tr><tr><td>NCT02756026</td><td>USDA, Western Human Nutrition Research Center</td><td>Completed</td><td>Sep 2013</td><td>Feb 2014</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Micronutrients,Trace Elements</td></tr><tr><td>NCT02756481</td><td>Bristol-Myers Squibb</td><td>Completed</td><td>Oct 2013</td><td>Nov 2014</td><td>Observational</td><td>Oct 2015</td><td>Atrial Fibrillation</td><td>null</td></tr><tr><td>NCT02751060</td><td>Tongji Hospital</td><td>Enrolling by invitation</td><td>Apr 2016</td><td>Dec 2022</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Heart Diseases,Coronary Disease,Coronary Artery Disease,Myocardial Ischemia</td><td>null</td></tr><tr><td>NCT02753127</td><td>Sumitomo Dainippon Pharma Oncology, Inc</td><td>Completed</td><td>Jun 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Colorectal Neoplasms</td><td>Leucovorin,Bevacizumab,Fluorouracil,Irinotecan</td></tr><tr><td>NCT02755051</td><td>University of Missouri-Columbia</td><td>Completed</td><td>Jul 2016</td><td>Mar 2018</td><td>Interventional</td><td>Mar 2016</td><td>Sleep Initiation and Maintenance Disorders,Autistic Disorder,Autism Spectrum Disorder,Child Development Disorders</td><td>null</td></tr><tr><td>NCT02757560</td><td>Phoenix VA Health Care System</td><td>Unknown status</td><td>Feb 2012</td><td>Dec 2020</td><td>Interventional</td><td>Aug 2015</td><td>Insulin Resistance</td><td>null</td></tr><tr><td>NCT02754076</td><td>Allievex Corporation</td><td>Completed</td><td>Apr 2016</td><td>Jul 2020</td><td>Interventional</td><td>Feb 2016</td><td>Mucopolysaccharidoses,Mucopolysaccharidosis III</td><td>null</td></tr><tr><td>NCT02752282</td><td>University of Washington</td><td>Unknown status</td><td>Mar 2016</td><td>Dec 2019</td><td>Interventional</td><td>Apr 2016</td><td>Uterine Hemorrhage</td><td>null</td></tr><tr><td>NCT02751021</td><td>University Hospital, Caen</td><td>Completed</td><td>Jun 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Apnea,Sleep Apnea Syndromes,Arrhythmias,Hyperaldosteronism</td><td>null</td></tr><tr><td>NCT02759471</td><td>Coopervision, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Myopia</td><td>null</td></tr><tr><td>NCT02752854</td><td>Taif University</td><td>Unknown status</td><td>Apr 2015</td><td>May 2016</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02759822</td><td>Leonardo Javier Arcuri</td><td>Unknown status</td><td>Apr 2016</td><td>null</td><td>Observational</td><td>Apr 2016</td><td>Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma</td><td>null</td></tr><tr><td>NCT02752139</td><td>Yi Yang</td><td>Completed</td><td>May 2016</td><td>Oct 2018</td><td>Observational [Patient Registry]</td><td>Mar 2016</td><td>Sleep Wake Disorders,Parasomnias,Sleep Disorders,Disease</td><td>null</td></tr><tr><td>NCT02752295</td><td>Medical University of Vienna</td><td>Completed</td><td>May 2015</td><td>Jul 2016</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Inflammation,Anxiety Disorders,Mood Disorders,Stress</td><td>null</td></tr><tr><td>NCT02753023</td><td>University of Sao Paulo General Hospital</td><td>Unknown status</td><td>May 2015</td><td>May 2020</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>Pulmonary Embolism,Pulmonary Edema,Syncope,Aneurysm,Acute Coronary Syndrome,Embolism,Aortic Aneurysm,Emergencies,Chest Pain</td><td>null</td></tr><tr><td>NCT02757365</td><td>West China Hospital</td><td>Unknown status</td><td>Apr 2014</td><td>Apr 2019</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms</td><td>Aspirin,Levofloxacin,Ofloxacin</td></tr><tr><td>NCT02757092</td><td>Chang Gung Memorial Hospital</td><td>Completed</td><td>Mar 2016</td><td>May 2017</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02758327</td><td>Koffler Vision Group</td><td>Completed</td><td>Oct 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dry Eye Syndromes</td><td>Carboxymethylcellulose Sodium,Ophthalmic Solutions,Lubricant Eye Drops</td></tr><tr><td>NCT02757404</td><td>Medy-Tox</td><td>Completed</td><td>May 2016</td><td>Aug 2016</td><td>Interventional</td><td>Apr 2016</td><td>Muscle Spasticity</td><td>Botulinum Toxins</td></tr><tr><td>NCT02757469</td><td>Navy General Hospital, Beijing</td><td>Unknown status</td><td>May 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Premature Birth,Infertility,Primary Ovarian Insufficiency,Menopause</td><td>Drospirenone,Ethinyl Estradiol,Drospirenone and ethinyl estradiol combination,Estradiol</td></tr><tr><td>NCT02759172</td><td>Michigan State University</td><td>Unknown status</td><td>Apr 2016</td><td>null</td><td>Interventional</td><td>Apr 2016</td><td>Suicide</td><td>null</td></tr><tr><td>NCT02758041</td><td>Sebacia, Inc.</td><td>Completed</td><td>Feb 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Acne Vulgaris</td><td>null</td></tr><tr><td>NCT02755116</td><td>Jaime B Hyman</td><td>Completed</td><td>Apr 2016</td><td>Sep 2019</td><td>Interventional</td><td>Apr 2016</td><td>Nausea,Vomiting,Postoperative Nausea and Vomiting</td><td>Olanzapine</td></tr><tr><td>NCT02755584</td><td>National Institute on Aging (NIA)</td><td>Completed</td><td>Jun 2016</td><td>Apr 2021</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750540</td><td>Johns Hopkins University</td><td>Completed</td><td>Oct 2016</td><td>May 2019</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Tenofovir</td></tr><tr><td>NCT02751918</td><td>Bayer</td><td>Completed</td><td>Jun 2016</td><td>Oct 2019</td><td>Interventional</td><td>Apr 2016</td><td>Ovarian Neoplasms</td><td>Doxorubicin,Liposomal doxorubicin,Maytansine</td></tr><tr><td>NCT02751541</td><td>Bayer</td><td>Completed</td><td>May 2016</td><td>May 2016</td><td>Interventional</td><td>Apr 2016</td><td>Dermatitis</td><td>Sunscreening Agents</td></tr><tr><td>NCT02755883</td><td>Weill Medical College of Cornell University</td><td>Completed</td><td>Apr 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT02751229</td><td>University of Ulm</td><td>Completed</td><td>May 2016</td><td>May 2017</td><td>Interventional</td><td>Mar 2016</td><td>Mental Disorders</td><td>null</td></tr><tr><td>NCT02759640</td><td>Atridia Pty Ltd.</td><td>Completed</td><td>Sep 2016</td><td>May 2018</td><td>Interventional</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02750683</td><td>Hopital Antoine Beclere</td><td>Completed</td><td>Oct 2014</td><td>Jan 2016</td><td>Observational</td><td>Apr 2016</td><td>Shock</td><td>null</td></tr><tr><td>NCT02758132</td><td>University of Hawaii</td><td>Terminated</td><td>Mar 2016</td><td>Sep 2016</td><td>Interventional</td><td>Apr 2016</td><td>Prostatic Neoplasms,Neoplasm Metastasis</td><td>Denosumab,Prednisone</td></tr><tr><td>NCT02757001</td><td>Group of Research in Minimally Invasive Techniques</td><td>Completed</td><td>Jun 2016</td><td>Jul 2019</td><td>Observational [Patient Registry]</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02757235</td><td>Sahlgrenska University Hospital, Sweden</td><td>Unknown status</td><td>Mar 2016</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Hematoma</td><td>null</td></tr><tr><td>NCT02754869</td><td>University College, London</td><td>Unknown status</td><td>Feb 2011</td><td>Aug 2018</td><td>Observational</td><td>Feb 2016</td><td>Intestinal Diseases</td><td>null</td></tr><tr><td>NCT02759406</td><td>Palmaz Scientific</td><td>Completed</td><td>Sep 2013</td><td>Jun 2015</td><td>Interventional</td><td>Apr 2016</td><td>Heart Diseases,Myocardial Ischemia,Coronary Artery Disease,Ischemia</td><td>null</td></tr><tr><td>NCT02758522</td><td>Hospital Universitario Dr. Jose E. Gonzalez</td><td>Completed</td><td>Oct 2013</td><td>Oct 2015</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus,Hyperglycemia</td><td>Insulin</td></tr><tr><td>NCT02750046</td><td>Second Affiliated Hospital of Soochow University</td><td>Unknown status</td><td>Mar 2016</td><td>Feb 2018</td><td>Interventional</td><td>Mar 2016</td><td>Fractures,Femoral Neck Fractures</td><td>null</td></tr><tr><td>NCT02755233</td><td>University of Zurich</td><td>Completed</td><td>Jan 2014</td><td>Mar 2016</td><td>Observational</td><td>Apr 2016</td><td>Melanoma</td><td>null</td></tr><tr><td>NCT02750423</td><td>Emory University</td><td>Completed</td><td>Apr 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754050</td><td>Tandem Technologies LTD</td><td>Unknown status</td><td>Sep 2016</td><td>Oct 2018</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02754284</td><td>Chinese Academy of Sciences</td><td>Completed</td><td>Dec 2015</td><td>Jun 2020</td><td>Interventional</td><td>Apr 2016</td><td>Vocal Cord Dysfunction</td><td>null</td></tr><tr><td>NCT02756078</td><td>Johnson & Johnson Vision Care, Inc.</td><td>Completed</td><td>Apr 2016</td><td>Oct 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02750995</td><td>Daniel El Fassi</td><td>Completed</td><td>Apr 2016</td><td>Jun 2019</td><td>Interventional</td><td>Apr 2016</td><td>Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome</td><td>Azacitidine</td></tr><tr><td>NCT02759302</td><td>Rigshospitalet, Denmark</td><td>Completed</td><td>Apr 2016</td><td>Apr 2017</td><td>Observational</td><td>Apr 2016</td><td>Muscular Dystrophies</td><td>null</td></tr><tr><td>NCT02759874</td><td>Institute of Health Economics, Canada</td><td>Unknown status</td><td>Nov 2015</td><td>Nov 2018</td><td>Interventional</td><td>Apr 2016</td><td>Fetal Alcohol Spectrum Disorders,Alcoholism</td><td>null</td></tr><tr><td>NCT02758535</td><td>Modarres Hospital</td><td>Completed</td><td>Mar 2015</td><td>Mar 2016</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755636</td><td>Pro-Change Behavior Systems</td><td>Unknown status</td><td>May 2016</td><td>Jul 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758873</td><td>University of Sussex</td><td>Completed</td><td>Feb 2016</td><td>Jul 2019</td><td>Interventional</td><td>Apr 2016</td><td>Asthma</td><td>Salmeterol Xinafoate,Montelukast</td></tr><tr><td>NCT02753166</td><td>NYU Langone Health</td><td>Withdrawn</td><td>Jan 2017</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>Dexamethasone</td></tr><tr><td>NCT02755766</td><td>Shriners Hospitals for Children</td><td>Completed</td><td>May 2015</td><td>Jul 2019</td><td>Observational</td><td>Mar 2016</td><td>Scoliosis,Clubfoot,Talipes,Equinus Deformity</td><td>null</td></tr><tr><td>NCT02751983</td><td>VA Office of Research and Development</td><td>Completed</td><td>Nov 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Suicide</td><td>null</td></tr><tr><td>NCT02754960</td><td>Shanghai Jiao Tong University School of Medicine</td><td>Withdrawn</td><td>Mar 2010</td><td>Sep 2014</td><td>Interventional</td><td>Apr 2016</td><td>Gastrointestinal Hemorrhage,Vascular Malformations,Congenital Abnormalities,Hemorrhage</td><td>Thalidomide</td></tr><tr><td>NCT02751086</td><td>International Study Group on Minimally Invasive Surgery for Gastric Cancer</td><td>Recruiting</td><td>Apr 2016</td><td>Dec 2024</td><td>Observational</td><td>Apr 2016</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT02755753</td><td>YongChan Lee</td><td>Completed</td><td>Jan 2014</td><td>Apr 2016</td><td>Interventional</td><td>Sep 2015</td><td>Gastroesophageal Reflux,Esophagitis</td><td>Lansoprazole,Dexlansoprazole,Rebamipide</td></tr><tr><td>NCT02757872</td><td>Albert Einstein College of Medicine</td><td>Active, not recruiting</td><td>Apr 2016</td><td>Nov 2021</td><td>Interventional</td><td>Apr 2016</td><td>Kidney Diseases,Hypertension</td><td>Vitamin D,Ergocalciferols,Cholecalciferol,Vitamins</td></tr><tr><td>NCT02756767</td><td>Abramson Cancer Center of the University of Pennsylvania</td><td>Completed</td><td>Apr 2016</td><td>Apr 2021</td><td>Observational</td><td>Apr 2016</td><td>Neoplasms</td><td>null</td></tr><tr><td>NCT02757937</td><td>Children's Hospital of Philadelphia</td><td>Completed</td><td>May 2016</td><td>Dec 2017</td><td>Interventional</td><td>Apr 2016</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT02753660</td><td>Indonesia University</td><td>Completed</td><td>Aug 2014</td><td>Oct 2014</td><td>Interventional</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02751684</td><td>Universitätsklinikum Köln</td><td>Completed</td><td>Mar 2017</td><td>May 2017</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02753556</td><td>Dimagi Inc.</td><td>Completed</td><td>Sep 2015</td><td>Jun 2016</td><td>Observational</td><td>Apr 2016</td><td>Lung Diseases,Pulmonary Disease</td><td>null</td></tr><tr><td>NCT02757287</td><td>Institut Universitari Dexeus</td><td>Withdrawn</td><td>May 2016</td><td>Dec 2018</td><td>Interventional</td><td>Apr 2016</td><td>Infertility</td><td>Desogestrel</td></tr><tr><td>NCT02752308</td><td>Isfahan University of Medical Sciences</td><td>Completed</td><td>Sep 2014</td><td>Mar 2015</td><td>Interventional</td><td>Apr 2016</td><td>Hypospadias</td><td>Atropine,Epinephrine,Fentanyl,Bupivacaine,Neostigmine</td></tr><tr><td>NCT02758314</td><td>Instituto Nacional de Cancerologia de Mexico</td><td>Unknown status</td><td>Mar 2017</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Lung Neoplasms,Carcinoma</td><td>null</td></tr><tr><td>NCT02752685</td><td>NYU Langone Health</td><td>Recruiting</td><td>Jun 2016</td><td>Dec 2021</td><td>Observational</td><td>Apr 2016</td><td>Breast Neoplasms</td><td>Paclitaxel,Pembrolizumab</td></tr><tr><td>NCT02759289</td><td>NYU Langone Health</td><td>Completed</td><td>Nov 2015</td><td>Sep 2020</td><td>Observational</td><td>Apr 2016</td><td>Atherosclerosis</td><td>null</td></tr><tr><td>NCT02759120</td><td>Weill Medical College of Cornell University</td><td>Terminated</td><td>Mar 2017</td><td>Mar 2020</td><td>Interventional</td><td>Apr 2016</td><td>Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis</td><td>Doxycycline,Anti-Bacterial Agents,Trimethoprim,Anti-Infective Agents</td></tr><tr><td>NCT02754401</td><td>Renatus, Antonio Renatus, Dent., M.Sc</td><td>Completed</td><td>Jan 2014</td><td>Jul 2014</td><td>Interventional</td><td>Apr 2016</td><td>Periodontitis</td><td>null</td></tr><tr><td>NCT02759757</td><td>Leandro Pires</td><td>Unknown status</td><td>May 2016</td><td>Feb 2017</td><td>Interventional</td><td>Apr 2016</td><td>Back Pain,Low Back Pain</td><td>null</td></tr><tr><td>NCT02750579</td><td>Assistance Publique Hopitaux De Marseille</td><td>Completed</td><td>Sep 2016</td><td>Apr 2018</td><td>Interventional</td><td>Apr 2016</td><td>Acute Coronary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT02752204</td><td>University of Birmingham</td><td>Completed</td><td>Oct 2015</td><td>Feb 2020</td><td>Interventional</td><td>Apr 2016</td><td>Lymphoma</td><td>Rituximab</td></tr><tr><td>NCT02757053</td><td>Mosaic Life Care</td><td>Terminated</td><td>Apr 2016</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Brain Injuries,Brain Concussion,Diffuse Axonal Injury,Wounds and Injuries,Athletic Injuries</td><td>null</td></tr><tr><td>NCT02752542</td><td>Nova Scotia Health Authority</td><td>Unknown status</td><td>Oct 2016</td><td>May 2021</td><td>Interventional</td><td>Apr 2016</td><td>Disease,Depressive Disorder,Depression</td><td>null</td></tr><tr><td>NCT02753283</td><td>Susan L. Greenspan</td><td>Active, not recruiting</td><td>Jun 2016</td><td>Sep 2023</td><td>Interventional</td><td>Apr 2016</td><td>Osteoporosis,Osteoporotic Fractures</td><td>Vitamin D,Zoledronic Acid,Denosumab,Calcium</td></tr><tr><td>NCT02754934</td><td>Balgrist University Hospital</td><td>Completed</td><td>Nov 2014</td><td>Nov 2016</td><td>Observational</td><td>Apr 2016</td><td>Neck Pain</td><td>null</td></tr><tr><td>NCT02755194</td><td>The Hospital for Sick Children</td><td>Terminated</td><td>Sep 2014</td><td>Sep 2019</td><td>Observational</td><td>Apr 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02758210</td><td>Emory University</td><td>Completed</td><td>Apr 2016</td><td>Oct 2016</td><td>Interventional</td><td>Apr 2016</td><td>Bradycardia,Tachycardia</td><td>null</td></tr><tr><td>NCT02757456</td><td>Sameena Iqbal</td><td>Completed</td><td>Feb 2015</td><td>Feb 2016</td><td>Interventional</td><td>Nov 2012</td><td>Cardiovascular Diseases</td><td>null</td></tr><tr><td>NCT02756377</td><td>Islamic Azad University, Tehran</td><td>Completed</td><td>May 2014</td><td>Jun 2015</td><td>Interventional</td><td>Apr 2016</td><td>Periodontal Diseases</td><td>Chlorhexidine,Chlorhexidine gluconate,Cetylpyridinium</td></tr><tr><td>NCT02751099</td><td>Centro Hospitalar de Lisboa Central</td><td>Unknown status</td><td>Nov 2015</td><td>Dec 2018</td><td>Observational</td><td>Apr 2016</td><td>Bone Diseases,Renal Insufficiency,Vascular Diseases</td><td>null</td></tr><tr><td>NCT02752178</td><td>University of Cambridge</td><td>Completed</td><td>Jun 2015</td><td>Sep 2018</td><td>Observational</td><td>Mar 2016</td><td>Depressive Disorder,Depression</td><td>null</td></tr><tr><td>NCT02757144</td><td>Daewoong Pharmaceutical Co. LTD.</td><td>Completed</td><td>Mar 2016</td><td>Feb 2017</td><td>Interventional</td><td>Mar 2016</td><td>null</td><td>Esomeprazole</td></tr><tr><td>NCT02757742</td><td>Fu Wai Hospital, Beijing, China</td><td>Completed</td><td>Dec 2010</td><td>Aug 2016</td><td>Observational</td><td>Apr 2016</td><td>Cardiomyopathies</td><td>null</td></tr><tr><td>NCT02750644</td><td>Joaquin de Haro, M.D.</td><td>Completed</td><td>Jan 2005</td><td>Apr 2016</td><td>Observational</td><td>Apr 2016</td><td>Carotid Artery Diseases</td><td>null</td></tr><tr><td>NCT02754635</td><td>HaEmek Medical Center, Israel</td><td>Unknown status</td><td>Mar 2016</td><td>Jul 2018</td><td>Interventional</td><td>Feb 2016</td><td>null</td><td>null</td></tr><tr><td>NCT02755311</td><td>Sun Yat-sen University</td><td>Unknown status</td><td>Mar 2014</td><td>Jun 2016</td><td>Interventional</td><td>Apr 2016</td><td>Carcinoma</td><td>Cisplatin,Carboplatin,Fluorouracil,Epirubicin,Ethiodized Oil,Pirarubicin,Doxorubicin,Gelatin Sponge</td></tr><tr><td>NCT00170053</td><td>Mayo Clinic</td><td>Completed</td><td>Jun 2005</td><td>Sep 2008</td><td>Interventional</td><td>Sep 2005</td><td>Kidney Diseases</td><td>Sirolimus</td></tr><tr><td>NCT00175396</td><td>University of British Columbia</td><td>Unknown status</td><td>May 2004</td><td>Jun 2014</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Ascorbic Acid,Leuprolide,Methyltestosterone,Flutamide,Bicalutamide,Nilutamide,Buserelin,Androgens,Estrogens</td></tr><tr><td>NCT00179647</td><td>Celgene Corporation</td><td>Completed</td><td>Sep 2005</td><td>Apr 2009</td><td>Interventional</td><td>Sep 2005</td><td>Multiple Myeloma,Neoplasms</td><td>Dexamethasone,Lenalidomide</td></tr><tr><td>NCT00172523</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Oct 2004</td><td>Aug 2005</td><td>Observational</td><td>Sep 2005</td><td>Polycystic Ovary Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT00174785</td><td>Sanofi</td><td>Completed</td><td>Jun 2005</td><td>Mar 2008</td><td>Interventional</td><td>Sep 2005</td><td>Atrial Fibrillation,Atrial Flutter</td><td>Dronedarone</td></tr><tr><td>NCT00175058</td><td>TherOx</td><td>Completed</td><td>Aug 2005</td><td>May 2008</td><td>Interventional</td><td>Sep 2005</td><td>Myocardial Infarction,Infarction</td><td>null</td></tr><tr><td>NCT00177541</td><td>University of Pittsburgh</td><td>Completed</td><td>Feb 2004</td><td>Sep 2016</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Incontinence</td><td>null</td></tr><tr><td>NCT00176215</td><td>Heidelberg University</td><td>Unknown status</td><td>May 2003</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Tooth Abrasion</td><td>null</td></tr><tr><td>NCT00178529</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Jul 2001</td><td>Sep 2005</td><td>Interventional</td><td>Sep 2005</td><td>Stroke</td><td>null</td></tr><tr><td>NCT00172367</td><td>National Taiwan University Hospital</td><td>Withdrawn</td><td>Jan 2006</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Lycopene</td></tr><tr><td>NCT00173875</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Mar 2005</td><td>Jul 2007</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma</td><td>Gefitinib</td></tr><tr><td>NCT00174668</td><td>Sanofi</td><td>Completed</td><td>Nov 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>Insulin,Insulin Glargine,Insulin glulisine</td></tr><tr><td>NCT00173927</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2004</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Atherosclerosis</td><td>null</td></tr><tr><td>NCT00179933</td><td>Ann & Robert H Lurie Children's Hospital of Chicago</td><td>Terminated</td><td>Sep 2005</td><td>Feb 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00176878</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>Jun 2000</td><td>Mar 2009</td><td>Interventional</td><td>Sep 2005</td><td>Shwachman-Diamond Syndrome,Neutropenia,Bone Marrow Failure Disorders,Pancytopenia,Anemia,Syndrome</td><td>Fludarabine,Fludarabine phosphate,Busulfan,Antilymphocyte Serum</td></tr><tr><td>NCT00172653</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00177645</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2002</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>Cystic Fibrosis,Fibrosis</td><td>null</td></tr><tr><td>NCT00176475</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Jan 2005</td><td>Feb 2008</td><td>Interventional</td><td>Sep 2005</td><td>Lymphoma,Leukemia,Multiple Myeloma,Neoplasms,Plasmacytoma</td><td>Rituximab</td></tr><tr><td>NCT00178087</td><td>University of Pittsburgh</td><td>Completed</td><td>Aug 2005</td><td>Aug 2011</td><td>Observational</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>null</td></tr><tr><td>NCT00178854</td><td>Vanderbilt University Medical Center</td><td>Withdrawn</td><td>May 2004</td><td>Mar 2006</td><td>Interventional</td><td>Sep 2005</td><td>Depressive Disorder</td><td>Risperidone</td></tr><tr><td>NCT00178503</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Sep 2005</td><td>May 2011</td><td>Interventional</td><td>Sep 2005</td><td>Hyperkinesis,Autistic Disorder,Attention Deficit Disorder with Hyperactivity</td><td>Methylphenidate</td></tr><tr><td>NCT00176410</td><td>University of Leipzig</td><td>Unknown status</td><td>Jan 2003</td><td>Dec 2009</td><td>Interventional</td><td>Sep 2005</td><td>Aortic Valve Stenosis,Constriction</td><td>null</td></tr><tr><td>NCT00179166</td><td>Vanderbilt University</td><td>Terminated</td><td>Jun 2004</td><td>Jul 2005</td><td>Interventional</td><td>Sep 2005</td><td>Renal Insufficiency,Acute Kidney Injury</td><td>null</td></tr><tr><td>NCT00171054</td><td>Novartis</td><td>Completed</td><td>Sep 2003</td><td>Oct 2007</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan,Hydrochlorothiazide</td></tr><tr><td>NCT00170300</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>Jan 2001</td><td>May 2005</td><td>Interventional</td><td>Sep 2005</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT00177619</td><td>University of Pittsburgh</td><td>Completed</td><td>May 2002</td><td>Dec 2005</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms,Osteoporosis</td><td>Alendronate</td></tr><tr><td>NCT00178139</td><td>University of Rochester</td><td>Completed</td><td>Apr 2004</td><td>Jul 2006</td><td>Interventional</td><td>Sep 2005</td><td>Respiratory Insufficiency,Pulmonary Valve Insufficiency</td><td>null</td></tr><tr><td>NCT00175799</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2007</td><td>Jul 2013</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00172874</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Jan 1998</td><td>Dec 2008</td><td>Observational</td><td>Sep 2005</td><td>Feeding and Eating Disorders</td><td>null</td></tr><tr><td>NCT00179985</td><td>Ann & Robert H Lurie Children's Hospital of Chicago</td><td>Completed</td><td>Dec 2004</td><td>Jul 2011</td><td>Observational</td><td>Sep 2005</td><td>Hypersensitivity</td><td>null</td></tr><tr><td>NCT00176384</td><td>University of Leipzig</td><td>Completed</td><td>Mar 2003</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT00176644</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>May 2005</td><td>Dec 2008</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Estradiol</td></tr><tr><td>NCT00174070</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Feb 2006</td><td>Observational</td><td>Sep 2005</td><td>Respiratory Insufficiency</td><td>null</td></tr><tr><td>NCT00173472</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jul 2002</td><td>Jul 2005</td><td>Observational</td><td>Sep 2005</td><td>Colorectal Neoplasms</td><td>null</td></tr><tr><td>NCT00172640</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Carcinoma</td><td>null</td></tr><tr><td>NCT00174967</td><td>Takeda</td><td>Completed</td><td>Jan 2001</td><td>Jul 2001</td><td>Interventional</td><td>Sep 2005</td><td>Gout</td><td>Febuxostat</td></tr><tr><td>NCT00171028</td><td>Novartis</td><td>Completed</td><td>Dec 2003</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan</td></tr><tr><td>NCT00175344</td><td>University of British Columbia</td><td>Completed</td><td>Feb 2004</td><td>Apr 2006</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms,Pain</td><td>null</td></tr><tr><td>NCT00173368</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Jan 2003</td><td>Mar 2005</td><td>Observational</td><td>Sep 2005</td><td>Choledocholithiasis</td><td>null</td></tr><tr><td>NCT00174629</td><td>Sanofi</td><td>Completed</td><td>Jun 2001</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms</td><td>Gemcitabine,Docetaxel</td></tr><tr><td>NCT00179231</td><td>Vanderbilt University</td><td>Completed</td><td>May 2000</td><td>Feb 2004</td><td>Interventional</td><td>Sep 2005</td><td>Schizophrenia,Psychotic Disorders</td><td>Olanzapine,Clozapine</td></tr><tr><td>NCT00173693</td><td>National Taiwan University Hospital</td><td>Withdrawn</td><td>Jan 2006</td><td>Dec 2010</td><td>Interventional</td><td>Sep 2005</td><td>Osteoporosis,Bone Diseases</td><td>null</td></tr><tr><td>NCT00171093</td><td>Novartis</td><td>Completed</td><td>Sep 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension,Hypercholesterolemia</td><td>Valsartan,Simvastatin</td></tr><tr><td>NCT00179348</td><td>Albert Einstein College of Medicine</td><td>Completed</td><td>Feb 2001</td><td>Jul 2016</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma,Breast Neoplasms,Colorectal Neoplasms,Sleep Wake Disorders,Alopecia,Vomiting</td><td>null</td></tr><tr><td>NCT00172133</td><td>Shire</td><td>Completed</td><td>Oct 2001</td><td>Apr 2005</td><td>Interventional</td><td>Sep 2005</td><td>Osteoporosis</td><td>null</td></tr><tr><td>NCT00170508</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Jun 2005</td><td>Aug 2005</td><td>Interventional</td><td>Sep 2005</td><td>Influenza</td><td>null</td></tr><tr><td>NCT00179543</td><td>Beth Israel Deaconess Medical Center</td><td>Completed</td><td>Aug 2001</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT00177216</td><td>University of Pittsburgh</td><td>Completed</td><td>Feb 2002</td><td>May 2008</td><td>Interventional</td><td>Sep 2005</td><td>Sleep Initiation and Maintenance Disorders,Sleep Wake Disorders</td><td>Zolpidem,Citalopram</td></tr><tr><td>NCT00176813</td><td>University of Michigan Rogel Cancer Center</td><td>Completed</td><td>Mar 2003</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Pancreatic Neoplasms</td><td>Gemcitabine,Celecoxib</td></tr><tr><td>NCT00170131</td><td>Mayo Clinic</td><td>Completed</td><td>Sep 2002</td><td>Jul 2007</td><td>Observational</td><td>Sep 2005</td><td>Infections,Hepatitis C</td><td>null</td></tr><tr><td>NCT00174551</td><td>Rainier Associates</td><td>Unknown status</td><td>Nov 2003</td><td>Nov 2005</td><td>Interventional</td><td>Sep 2005</td><td>Stress Disorders</td><td>Prazosin</td></tr><tr><td>NCT00170755</td><td>Novartis</td><td>Completed</td><td>Apr 2002</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Bladder</td><td>Darifenacin</td></tr><tr><td>NCT00174200</td><td>Pfizer</td><td>Completed</td><td>Dec 2004</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Schizophrenia,Mental Disorders,Psychotic Disorders</td><td>Risperidone</td></tr><tr><td>NCT00178698</td><td>The University of Texas Health Science Center, Houston</td><td>Unknown status</td><td>Jul 2002</td><td>Jun 2014</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Stomach Neoplasms,Small Cell Lung Carcinoma,Carcinoma</td><td>Gemcitabine,Interferons</td></tr><tr><td>NCT00178516</td><td>University of Rochester</td><td>Completed</td><td>Jun 2004</td><td>Dec 2005</td><td>Observational</td><td>Sep 2005</td><td>Infertility</td><td>null</td></tr><tr><td>NCT00172289</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>Dec 2006</td><td>Observational</td><td>Sep 2005</td><td>Spinal Cord Injuries,Stroke,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT00172718</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Jaw,Mouth</td><td>null</td></tr><tr><td>NCT00174239</td><td>Pfizer</td><td>Terminated</td><td>Jul 2004</td><td>Sep 2005</td><td>Interventional</td><td>Sep 2005</td><td>Parkinson Disease</td><td>Levodopa,Carbidopa,Cabergoline</td></tr><tr><td>NCT00178620</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Nov 2003</td><td>Mar 2014</td><td>Interventional</td><td>Sep 2005</td><td>Myocardial Infarction,Heart Diseases,Infarction</td><td>Reteplase</td></tr><tr><td>NCT00177112</td><td>University of Minnesota</td><td>Completed</td><td>Jun 2005</td><td>Oct 2007</td><td>Interventional</td><td>Sep 2005</td><td>Infections,Communicable Diseases,Urinary Tract Infections</td><td>null</td></tr><tr><td>NCT00173108</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Jan 2006</td><td>Oct 2010</td><td>Interventional</td><td>Sep 2005</td><td>Premature Birth</td><td>null</td></tr><tr><td>NCT00170404</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Jun 2000</td><td>Oct 2005</td><td>Interventional</td><td>Sep 2005</td><td>Tuberculosis</td><td>Vitamins,Folic Acid,Vitamin A,Thiamine,Selenium,Micronutrients,Trace Elements</td></tr><tr><td>NCT00176280</td><td>University of Kentucky</td><td>Withdrawn</td><td>Sep 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Dexamethasone,Sargramostim</td></tr><tr><td>NCT00175123</td><td>University of Aarhus</td><td>Unknown status</td><td>May 2005</td><td>Jun 2008</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Bladder,Meningomyelocele,Spina Bifida Cystica</td><td>Botulinum Toxins,abobotulinumtoxinA</td></tr><tr><td>NCT00170924</td><td>Novartis</td><td>Completed</td><td>Aug 2004</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan</td></tr><tr><td>NCT00170222</td><td>Medical Center Alkmaar</td><td>Completed</td><td>Jul 2002</td><td>Aug 2008</td><td>Interventional</td><td>Sep 2005</td><td>Lung Diseases,Pulmonary Disease</td><td>Doxycycline</td></tr><tr><td>NCT00172042</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2005</td><td>Jun 2010</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma,Neoplasm Metastasis</td><td>Zoledronic Acid</td></tr><tr><td>NCT00170690</td><td>North Eastern German Society of Gynaecological Oncology</td><td>Completed</td><td>Aug 2004</td><td>Apr 2012</td><td>Interventional</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>Treosulfan,Busulfan</td></tr><tr><td>NCT00176904</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>Jan 1995</td><td>Jun 2010</td><td>Interventional</td><td>Sep 2005</td><td>Gaucher Disease,Adrenoleukodystrophy,Pick Disease of the Brain,Gangliosidoses,Leukodystrophy,Niemann-Pick Diseases,Niemann-Pick Disease,Neuronal Ceroid-Lipofuscinoses,Tay-Sachs Disease,Gangliosidosis,Sandhoff Disease,Fucosidosis,Metabolism,Wolman Disease</td><td>Cyclophosphamide,Busulfan,Antilymphocyte Serum</td></tr><tr><td>NCT00178204</td><td>University of Rochester</td><td>Completed</td><td>Nov 2004</td><td>Dec 2011</td><td>Observational</td><td>Sep 2005</td><td>Fatigue</td><td>null</td></tr><tr><td>NCT00176345</td><td>University of Leipzig</td><td>Unknown status</td><td>Jan 2001</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease</td><td>null</td></tr><tr><td>NCT00178711</td><td>The University of Texas Health Science Center, Houston</td><td>Terminated</td><td>Nov 2005</td><td>Dec 2009</td><td>Interventional</td><td>Sep 2005</td><td>Brain Injuries,Hypothermia,Wounds and Injuries</td><td>null</td></tr><tr><td>NCT00173680</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT00170417</td><td>NHS Greater Glasgow and Clyde</td><td>Completed</td><td>Dec 2000</td><td>May 2003</td><td>Interventional</td><td>Sep 2005</td><td>Sleep Initiation and Maintenance Disorders</td><td>null</td></tr><tr><td>NCT00173485</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jun 2009</td><td>Observational</td><td>Sep 2005</td><td>Peritonitis,Renal Insufficiency</td><td>null</td></tr><tr><td>NCT00178269</td><td>University of Rochester</td><td>Completed</td><td>Jan 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Uterine Cervical Neoplasms</td><td>Docetaxel</td></tr><tr><td>NCT00171301</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Jun 2005</td><td>May 2008</td><td>Interventional</td><td>Sep 2005</td><td>Thalassemia,beta-Thalassemia,Iron Overload,Hemosiderosis</td><td>Deferasirox</td></tr><tr><td>NCT00171782</td><td>Novartis</td><td>Completed</td><td>Feb 2004</td><td>Dec 2004</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan,Hydrochlorothiazide</td></tr><tr><td>NCT00176566</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Sep 2003</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Leukoplakia</td><td>null</td></tr><tr><td>NCT00170846</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Feb 2005</td><td>Oct 2009</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Everolimus,Azathioprine,Calcineurin Inhibitors</td></tr><tr><td>NCT00173836</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Aug 2003</td><td>Aug 2006</td><td>Observational</td><td>Sep 2005</td><td>Nasopharyngeal Carcinoma,Nasopharyngeal Neoplasms</td><td>null</td></tr><tr><td>NCT00174005</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Dec 1994</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00176527</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Nov 2002</td><td>Aug 2007</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Interferons,Interferon-alpha,Interferon alpha-2,Docetaxel,Estramustine,Isotretinoin</td></tr><tr><td>NCT00171314</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Mar 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms</td><td>Zoledronic Acid,Letrozole</td></tr><tr><td>NCT00175409</td><td>University of British Columbia</td><td>Completed</td><td>Jan 2008</td><td>Jun 2010</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00177190</td><td>University of Pittsburgh</td><td>Completed</td><td>Jun 2002</td><td>Jan 2006</td><td>Observational</td><td>Sep 2005</td><td>Mycoses,Lymphoma,Mycosis Fungoides,Sezary Syndrome</td><td>null</td></tr><tr><td>NCT00179101</td><td>Vanderbilt University</td><td>Completed</td><td>Apr 2004</td><td>Nov 2005</td><td>Observational</td><td>Sep 2005</td><td>Parkinson Disease,Depression</td><td>null</td></tr><tr><td>NCT00175526</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2005</td><td>Dec 2010</td><td>Observational</td><td>Sep 2005</td><td>Toxemia,Sepsis</td><td>null</td></tr><tr><td>NCT00176293</td><td>University of Kentucky</td><td>Terminated</td><td>Oct 2005</td><td>Feb 2007</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Dexamethasone,Doxorubicin</td></tr><tr><td>NCT00178347</td><td>University of Rochester</td><td>Terminated</td><td>Dec 2004</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00171964</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>May 2002</td><td>Dec 2008</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasm Metastasis</td><td>Zoledronic Acid</td></tr><tr><td>NCT00178945</td><td>Vanderbilt University</td><td>Completed</td><td>Mar 2004</td><td>Mar 2006</td><td>Interventional</td><td>Sep 2005</td><td>Myofascial Pain Syndromes,Fibromyalgia,Dystonia,Dystonic Disorders,Syndrome,Torticollis</td><td>Botulinum Toxins,abobotulinumtoxinA</td></tr><tr><td>NCT00172965</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Mouth Neoplasms</td><td>null</td></tr><tr><td>NCT00179764</td><td>Ann & Robert H Lurie Children's Hospital of Chicago</td><td>Completed</td><td>Mar 2000</td><td>Jan 2014</td><td>Interventional</td><td>Sep 2005</td><td>Leukemia,Melanoma,Neoplasms,Hematologic Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma</td><td>Busulfan</td></tr><tr><td>NCT00170612</td><td>University of Melbourne</td><td>Completed</td><td>Nov 2005</td><td>Aug 2008</td><td>Interventional</td><td>Sep 2005</td><td>Pneumococcal Infections</td><td>Heptavalent Pneumococcal Conjugate Vaccine</td></tr><tr><td>NCT00172627</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT00170872</td><td>Novartis</td><td>Completed</td><td>Nov 2004</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Arthritis,Osteoarthritis</td><td>Lumiracoxib</td></tr><tr><td>NCT00172770</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Schizophrenia</td><td>null</td></tr><tr><td>NCT00173849</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2006</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Mouth Neoplasms</td><td>null</td></tr><tr><td>NCT00175682</td><td>University of British Columbia</td><td>Completed</td><td>Dec 2004</td><td>Jul 2011</td><td>Interventional</td><td>Sep 2005</td><td>Spinal Cord Injuries,Autonomic Dysreflexia</td><td>Prazosin</td></tr><tr><td>NCT00179127</td><td>Vanderbilt University Medical Center</td><td>Completed</td><td>Aug 2004</td><td>Sep 2012</td><td>Interventional</td><td>Sep 2005</td><td>Ketosis,Acidosis,Diabetic Ketoacidosis</td><td>Insulin Glargine</td></tr><tr><td>NCT00178113</td><td>University of Pittsburgh</td><td>Completed</td><td>Jul 2003</td><td>Jul 2004</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasms,Carcinoma in Situ,Prostatic Intraepithelial Neoplasia</td><td>Lycopene</td></tr><tr><td>NCT00170560</td><td>National Institute of Allergy and Infectious Diseases (NIAID)</td><td>Completed</td><td>Oct 2001</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Infections</td><td>null</td></tr><tr><td>NCT00178022</td><td>University of Pittsburgh</td><td>Completed</td><td>Feb 2005</td><td>Sep 2006</td><td>Interventional</td><td>Sep 2005</td><td>Brain Injuries,Wounds and Injuries,Depression,Anxiety Disorders</td><td>null</td></tr><tr><td>NCT00178425</td><td>University of Rochester</td><td>Completed</td><td>Jan 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00178438</td><td>University of Rochester</td><td>Withdrawn</td><td>Jun 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Crohn Disease</td><td>null</td></tr><tr><td>NCT00173173</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Aug 2003</td><td>Jul 2004</td><td>Observational</td><td>Sep 2005</td><td>Disease,Feeding and Eating Disorders</td><td>null</td></tr><tr><td>NCT00177294</td><td>University of Pittsburgh</td><td>Completed</td><td>Apr 2004</td><td>Aug 2009</td><td>Interventional</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>Citalopram</td></tr><tr><td>NCT00175461</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2005</td><td>Aug 2011</td><td>Interventional</td><td>Sep 2005</td><td>Osteoarthritis</td><td>null</td></tr><tr><td>NCT00179062</td><td>Vanderbilt University</td><td>Completed</td><td>Feb 2000</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>Disease,Schizophrenia,Depressive Disorder,Bipolar Disorder,Psychotic Disorders</td><td>Olanzapine,Risperidone</td></tr><tr><td>NCT00173550</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2004</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Premature Birth,Menopause,Primary Ovarian Insufficiency</td><td>null</td></tr><tr><td>NCT00177385</td><td>University of Pittsburgh</td><td>Completed</td><td>Jun 2003</td><td>Sep 2011</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00171002</td><td>Novartis</td><td>Completed</td><td>Nov 2004</td><td>Jun 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00177125</td><td>University of Minnesota</td><td>Completed</td><td>Jan 2004</td><td>Jan 2004</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>null</td></tr><tr><td>NCT00172861</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Stomach Neoplasms</td><td>null</td></tr><tr><td>NCT00174798</td><td>Sanofi</td><td>Completed</td><td>May 2005</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Urinary Incontinence,Enuresis,Urinary Bladder</td><td>Tolterodine Tartrate</td></tr><tr><td>NCT00177892</td><td>National Institute on Aging (NIA)</td><td>Unknown status</td><td>Sep 2003</td><td>Aug 2008</td><td>Interventional</td><td>Sep 2005</td><td>Apnea,Sleep Apnea Syndromes,Sleep Apnea,Metabolic Syndrome,Syndrome</td><td>null</td></tr><tr><td>NCT00176761</td><td>University of Michigan Rogel Cancer Center</td><td>Terminated</td><td>Mar 2000</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Colorectal Neoplasms</td><td>Interleukin-2</td></tr><tr><td>NCT00176319</td><td>University of Leipzig</td><td>Completed</td><td>May 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Heart Failure</td><td>null</td></tr><tr><td>NCT00177203</td><td>University of Pittsburgh</td><td>Completed</td><td>Jun 2003</td><td>Jan 2009</td><td>Interventional</td><td>Sep 2005</td><td>Sleep Initiation and Maintenance Disorders</td><td>null</td></tr><tr><td>NCT00174993</td><td>Takeda</td><td>Completed</td><td>May 2001</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>Pioglitazone</td></tr><tr><td>NCT00177658</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2006</td><td>Jun 2017</td><td>Observational</td><td>Sep 2005</td><td>Salmonella Infections</td><td>null</td></tr><tr><td>NCT00174928</td><td>Takeda</td><td>Completed</td><td>May 2005</td><td>Aug 2005</td><td>Interventional</td><td>Sep 2005</td><td>Gastroesophageal Reflux,Esophagitis</td><td>Lansoprazole,Dexlansoprazole</td></tr><tr><td>NCT00170677</td><td>North Eastern German Society of Gynaecological Oncology</td><td>Completed</td><td>Sep 2005</td><td>Jan 2013</td><td>Interventional</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>Topotecan</td></tr><tr><td>NCT00178295</td><td>University of Rochester</td><td>Completed</td><td>Nov 1999</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Brain Neoplasms,Trauma</td><td>null</td></tr><tr><td>NCT00176449</td><td>University of Maryland, Baltimore</td><td>Completed</td><td>Apr 2001</td><td>Dec 2005</td><td>Interventional</td><td>Sep 2005</td><td>Tobacco Use Disorder</td><td>Bupropion</td></tr><tr><td>NCT00179751</td><td>Celgene Corporation</td><td>Terminated</td><td>Apr 2005</td><td>Aug 2006</td><td>Interventional</td><td>Sep 2005</td><td>Pancreatic Neoplasms</td><td>Gemcitabine,Lenalidomide</td></tr><tr><td>NCT00172744</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Apr 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00177255</td><td>University of Pittsburgh</td><td>Terminated</td><td>Apr 2005</td><td>Dec 2008</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Docetaxel,Capecitabine</td></tr><tr><td>NCT00171925</td><td>Novartis Pharmaceuticals</td><td>Terminated</td><td>Aug 2000</td><td>Nov 2008</td><td>Interventional</td><td>Sep 2005</td><td>Multiple Myeloma,Neoplasms</td><td>Vitamin D,Zoledronic Acid,Calcium</td></tr><tr><td>NCT00177307</td><td>University of Pittsburgh</td><td>Completed</td><td>Jan 2005</td><td>Feb 2012</td><td>Interventional</td><td>Sep 2005</td><td>Colorectal Neoplasms</td><td>Bevacizumab,Capecitabine,Oxaliplatin</td></tr><tr><td>NCT00173862</td><td>National Taiwan University Hospital</td><td>Completed</td><td>May 2000</td><td>Jun 2006</td><td>Interventional</td><td>Jun 2005</td><td>Carcinoma</td><td>Gemcitabine,Ifosfamide</td></tr><tr><td>NCT00171990</td><td>Novartis</td><td>Completed</td><td>Jan 2003</td><td>Feb 2006</td><td>Interventional</td><td>Sep 2005</td><td>Herpes Genitalis</td><td>Famciclovir</td></tr><tr><td>NCT00177060</td><td>Hordinsky, Maria K., MD</td><td>Terminated</td><td>Oct 2003</td><td>May 2007</td><td>Interventional</td><td>Sep 2005</td><td>Wounds and Injuries</td><td>Hydromorphone</td></tr><tr><td>NCT00173043</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Oct 2004</td><td>Aug 2005</td><td>Observational</td><td>Sep 2005</td><td>Polycystic Ovary Syndrome,Insulin Resistance,Syndrome</td><td>null</td></tr><tr><td>NCT00171769</td><td>Novartis</td><td>Completed</td><td>Apr 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Atrial Fibrillation</td><td>Certoparin</td></tr><tr><td>NCT00171951</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Aug 2004</td><td>Jul 2013</td><td>Interventional</td><td>Sep 2005</td><td>ACTH-Secreting Pituitary Adenoma,Pituitary ACTH Hypersecretion</td><td>Pasireotide</td></tr><tr><td>NCT00174850</td><td>State University of New York - Upstate Medical University</td><td>Completed</td><td>Jul 2004</td><td>May 2005</td><td>Interventional</td><td>Sep 2005</td><td>Anxiety Disorders</td><td>null</td></tr><tr><td>NCT00177970</td><td>University of Pittsburgh</td><td>Terminated</td><td>Oct 2003</td><td>Apr 2008</td><td>Interventional</td><td>Sep 2005</td><td>Diarrhea</td><td>Immunoglobulins,Antibodies,Immunoglobulin G,gamma-Globulins,Rho(D) Immune Globulin</td></tr><tr><td>NCT00171834</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Aug 2003</td><td>Sep 2008</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma</td><td>Epothilones,Epothilone B</td></tr><tr><td>NCT00172601</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Bursitis</td><td>null</td></tr><tr><td>NCT00176254</td><td>Susanne Arnold</td><td>Completed</td><td>May 2000</td><td>Oct 2012</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma,Head and Neck Neoplasms</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT00176553</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Mar 2003</td><td>May 2007</td><td>Interventional</td><td>Sep 2005</td><td>Neurotoxicity Syndromes</td><td>Dextromethorphan</td></tr><tr><td>NCT00171405</td><td>Novartis</td><td>Completed</td><td>Jun 2005</td><td>Feb 2006</td><td>Interventional</td><td>Aug 2005</td><td>Hypertension</td><td>null</td></tr><tr><td>NCT00177814</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2005</td><td>Jun 2017</td><td>Observational</td><td>Sep 2005</td><td>Bacterial Infections,Gram-Negative Bacterial Infections</td><td>null</td></tr><tr><td>NCT00174122</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jul 2005</td><td>Jun 2006</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00179608</td><td>Celgene</td><td>Completed</td><td>Sep 2005</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>Melanoma</td><td>Lenalidomide</td></tr><tr><td>NCT00173394</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Dec 2008</td><td>Observational</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>null</td></tr><tr><td>NCT00170001</td><td>Mayo Clinic</td><td>Completed</td><td>Apr 2005</td><td>Aug 2006</td><td>Interventional</td><td>Sep 2005</td><td>Gastroesophageal Reflux</td><td>Esomeprazole</td></tr><tr><td>NCT00170963</td><td>Novartis</td><td>Completed</td><td>Oct 2004</td><td>Jun 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00170365</td><td>Hennepin Healthcare Research Institute</td><td>Completed</td><td>Jul 2004</td><td>Mar 2005</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00173810</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Apr 2007</td><td>Observational</td><td>Sep 2005</td><td>Stroke</td><td>null</td></tr><tr><td>NCT00179335</td><td>Albert Einstein College of Medicine</td><td>Completed</td><td>Aug 2003</td><td>Sep 2006</td><td>Observational</td><td>Sep 2005</td><td>HIV Infections</td><td>null</td></tr><tr><td>NCT00178256</td><td>University of Rochester</td><td>Completed</td><td>Jun 1998</td><td>Dec 2012</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Paclitaxel</td></tr><tr><td>NCT00178035</td><td>University of Pittsburgh</td><td>Completed</td><td>Dec 1999</td><td>Aug 2003</td><td>Interventional</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>Paroxetine</td></tr><tr><td>NCT00177567</td><td>University of Pittsburgh</td><td>Completed</td><td>Jul 2001</td><td>Jan 2004</td><td>Interventional</td><td>Sep 2005</td><td>Disease,Bipolar Disorder,Mood Disorders</td><td>Lamotrigine,Valproic Acid,Olanzapine,Risperidone,Lithium Carbonate,Mirtazapine,Tranylcypromine,Bupropion,Paroxetine,Venlafaxine Hydrochloride</td></tr><tr><td>NCT00172666</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Aug 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Arthritis,Lupus Erythematosus</td><td>null</td></tr><tr><td>NCT00172731</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Mar 2005</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Schizophrenia</td><td>null</td></tr><tr><td>NCT00171873</td><td>Carmen Schade-Brittinger</td><td>Completed</td><td>Sep 2001</td><td>Dec 2013</td><td>Interventional</td><td>Sep 2005</td><td>Neuroendocrine Tumors,Neoplasm Metastasis</td><td>Octreotide</td></tr><tr><td>NCT00173355</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Aug 2005</td><td>Observational</td><td>Sep 2005</td><td>Dermatofibrosarcoma,Soft Tissue Neoplasms</td><td>null</td></tr><tr><td>NCT00176111</td><td>Heidelberg University</td><td>Terminated</td><td>Jan 2004</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00170274</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>Aug 2000</td><td>Oct 2014</td><td>Interventional</td><td>Sep 2005</td><td>Arrhythmias,Tachycardia</td><td>null</td></tr><tr><td>NCT00172250</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Sep 2003</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Coronary Artery Disease</td><td>null</td></tr><tr><td>NCT00174356</td><td>Pfizer</td><td>Completed</td><td>Dec 2002</td><td>Oct 2005</td><td>Interventional</td><td>Sep 2005</td><td>Carcinoma</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT00170989</td><td>Novartis</td><td>Completed</td><td>Sep 2004</td><td>Jul 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan,Hydrochlorothiazide</td></tr><tr><td>NCT00179569</td><td>Beth Israel Deaconess Medical Center</td><td>Completed</td><td>Aug 2005</td><td>Sep 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00172796</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Apr 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Metabolic Syndrome,Prediabetic State</td><td>null</td></tr><tr><td>NCT00178126</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2004</td><td>Oct 2008</td><td>Interventional</td><td>Sep 2005</td><td>Pressure Ulcer,Ulcer</td><td>null</td></tr><tr><td>NCT00172029</td><td>Novartis</td><td>Completed</td><td>Apr 2003</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms,Bone Diseases</td><td>Zoledronic Acid</td></tr><tr><td>NCT00176696</td><td>University of Medicine and Dentistry of New Jersey</td><td>Terminated</td><td>Aug 2005</td><td>Apr 2007</td><td>Observational</td><td>Sep 2005</td><td>Pain</td><td>Anesthetics</td></tr><tr><td>NCT00177788</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2005</td><td>Aug 2012</td><td>Observational</td><td>Sep 2005</td><td>Mycoses,Fungemia</td><td>null</td></tr><tr><td>NCT00171938</td><td>Novartis</td><td>Terminated</td><td>Apr 2004</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Glioblastoma</td><td>Imatinib Mesylate</td></tr><tr><td>NCT00177359</td><td>University of Pittsburgh</td><td>Completed</td><td>Nov 2005</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>Mobility Limitation</td><td>null</td></tr><tr><td>NCT00171860</td><td>Novartis Pharmaceuticals</td><td>Terminated</td><td>Sep 2002</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Hypereosinophilic Syndrome,Syndrome</td><td>Imatinib Mesylate</td></tr><tr><td>NCT00171717</td><td>Novartis</td><td>Completed</td><td>Feb 2004</td><td>Dec 2005</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>Cyclosporine,Cyclosporins</td></tr><tr><td>NCT00176748</td><td>University of Michigan Rogel Cancer Center</td><td>Completed</td><td>Jul 2005</td><td>Jun 2009</td><td>Interventional</td><td>Sep 2005</td><td>Thyroid Neoplasms,Thyroid Diseases</td><td>null</td></tr><tr><td>NCT00175084</td><td>Tufts University</td><td>Completed</td><td>Oct 2004</td><td>Dec 2012</td><td>Interventional</td><td>Sep 2005</td><td>Cardiovascular Diseases,Metabolic Syndrome,Hyperlipidemias</td><td>null</td></tr><tr><td>NCT00178334</td><td>University of Rochester</td><td>Completed</td><td>Mar 2006</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Urinary Incontinence,Enuresis</td><td>null</td></tr><tr><td>NCT00172822</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2003</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Appendicitis</td><td>null</td></tr><tr><td>NCT00170885</td><td>Novartis</td><td>Completed</td><td>May 2005</td><td>Jul 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Everolimus</td></tr><tr><td>NCT00177684</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2004</td><td>Sep 2005</td><td>Interventional</td><td>Sep 2005</td><td>Mycoses</td><td>Amphotericin B,Liposomal amphotericin B</td></tr><tr><td>NCT00178672</td><td>The University of Texas Health Science Center, Houston</td><td>Completed</td><td>Nov 2002</td><td>Aug 2007</td><td>Interventional</td><td>Sep 2005</td><td>Carotid Stenosis,Carotid Artery Diseases,Stroke,Heart Diseases</td><td>null</td></tr><tr><td>NCT00171080</td><td>Novartis</td><td>Completed</td><td>Apr 2004</td><td>Mar 2006</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Valsartan,Irbesartan</td></tr><tr><td>NCT00176891</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>Mar 2004</td><td>Nov 2012</td><td>Interventional</td><td>Sep 2005</td><td>Mucopolysaccharidoses,Mucopolysaccharidosis I,Syndrome</td><td>null</td></tr><tr><td>NCT00172107</td><td>Shire</td><td>Completed</td><td>May 1995</td><td>Mar 1997</td><td>Interventional</td><td>Sep 2005</td><td>Osteoporosis</td><td>Parathyroid Hormone</td></tr><tr><td>NCT00177827</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 2004</td><td>Mar 2006</td><td>Observational</td><td>Sep 2005</td><td>Aspergillosis</td><td>null</td></tr><tr><td>NCT00177502</td><td>University of Pittsburgh</td><td>Completed</td><td>Jan 2003</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>Body Weight,Weight Loss,Weight Gain</td><td>null</td></tr><tr><td>NCT00175045</td><td>Takeda</td><td>Completed</td><td>Jun 2003</td><td>Oct 2003</td><td>Interventional</td><td>Sep 2005</td><td>Esophagitis</td><td>Lansoprazole,Dexlansoprazole</td></tr><tr><td>NCT00175981</td><td>Heidelberg University</td><td>Completed</td><td>Feb 2003</td><td>Nov 2004</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Sildenafil Citrate,Fluvoxamine</td></tr><tr><td>NCT00177983</td><td>University of Pittsburgh</td><td>Completed</td><td>Jan 2003</td><td>Jan 2005</td><td>Interventional</td><td>Sep 2005</td><td>Recurrence</td><td>null</td></tr><tr><td>NCT00179699</td><td>Celgene Corporation</td><td>Terminated</td><td>Sep 2005</td><td>Nov 2006</td><td>Interventional</td><td>Sep 2005</td><td>Lung Neoplasms,Carcinoma</td><td>Pemetrexed,Lenalidomide</td></tr><tr><td>NCT00175383</td><td>University of British Columbia</td><td>Unknown status</td><td>Jun 2004</td><td>Dec 2013</td><td>Interventional</td><td>Sep 2005</td><td>Prostatic Neoplasms</td><td>Hormones,Prolactin Release-Inhibiting Factors</td></tr><tr><td>NCT00178230</td><td>University of Rochester</td><td>Completed</td><td>Mar 1996</td><td>Nov 2013</td><td>Observational</td><td>Sep 2005</td><td>Lung Neoplasms</td><td>null</td></tr><tr><td>NCT00170859</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Aug 2004</td><td>Dec 2006</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>Everolimus</td></tr><tr><td>NCT00179465</td><td>Beth Israel Deaconess Medical Center</td><td>Active, not recruiting</td><td>Nov 2003</td><td>Sep 2022</td><td>Interventional</td><td>Sep 2005</td><td>Schizophrenia</td><td>Tiagabine,Antipsychotic Agents</td></tr><tr><td>NCT00173732</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Sep 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00170976</td><td>Novartis</td><td>Completed</td><td>Apr 2004</td><td>Jun 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00173641</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Sep 2005</td><td>Aug 2006</td><td>Observational</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00173342</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Bundle-Branch Block,Heart Block</td><td>null</td></tr><tr><td>NCT00174148</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jul 2005</td><td>Jul 2006</td><td>Observational</td><td>Sep 2005</td><td>Neck Pain</td><td>null</td></tr><tr><td>NCT00170144</td><td>Mayo Clinic</td><td>Completed</td><td>Sep 2005</td><td>Jun 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00170469</td><td>PharmAthene UK Limited</td><td>Completed</td><td>Mar 2005</td><td>Feb 2007</td><td>Interventional</td><td>Sep 2005</td><td>Anthrax</td><td>Aluminum Hydroxide</td></tr><tr><td>NCT00179634</td><td>Beth Israel Deaconess Medical Center</td><td>Terminated</td><td>Mar 2005</td><td>Mar 2008</td><td>Interventional</td><td>Sep 2005</td><td>Breast Neoplasms</td><td>null</td></tr><tr><td>NCT00175318</td><td>University of British Columbia</td><td>Completed</td><td>Apr 2005</td><td>Feb 2011</td><td>Interventional</td><td>Sep 2005</td><td>Dental Caries</td><td>null</td></tr><tr><td>NCT00175812</td><td>University of Bergen</td><td>Completed</td><td>Nov 2004</td><td>Nov 2009</td><td>Interventional</td><td>Sep 2005</td><td>Leukemia</td><td>Tretinoin,Theophylline,Valproic Acid</td></tr><tr><td>NCT00178906</td><td>Vanderbilt University</td><td>Completed</td><td>Dec 1999</td><td>Apr 2008</td><td>Observational</td><td>Sep 2005</td><td>Depression</td><td>null</td></tr><tr><td>NCT00175448</td><td>University of British Columbia</td><td>Completed</td><td>Sep 2005</td><td>Dec 2007</td><td>Interventional</td><td>Sep 2005</td><td>Arthritis</td><td>null</td></tr><tr><td>NCT00173069</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2006</td><td>Dec 2010</td><td>Observational</td><td>Sep 2005</td><td>Schizophrenia</td><td>null</td></tr><tr><td>NCT00176956</td><td>Hordinsky, Maria K., MD</td><td>Terminated</td><td>Nov 2002</td><td>Jan 2007</td><td>Interventional</td><td>Sep 2005</td><td>Dermatitis,Skin Diseases</td><td>null</td></tr><tr><td>NCT00173095</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2005</td><td>Jan 2008</td><td>Observational</td><td>Sep 2005</td><td>Subarachnoid Hemorrhage,Hemorrhage</td><td>null</td></tr><tr><td>NCT00177424</td><td>University of Pittsburgh</td><td>Terminated</td><td>Jul 2004</td><td>Oct 2007</td><td>Interventional</td><td>Sep 2005</td><td>Stroke,Depression,Depressive Disorder</td><td>Sertraline</td></tr><tr><td>NCT00172783</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Dec 2005</td><td>Observational</td><td>Sep 2005</td><td>Tuberculosis</td><td>null</td></tr><tr><td>NCT00176917</td><td>Masonic Cancer Center, University of Minnesota</td><td>Completed</td><td>May 1999</td><td>May 2010</td><td>Interventional</td><td>Sep 2005</td><td>Mucolipidoses,Mucopolysaccharidoses,Mucopolysaccharidosis I,Mannosidase Deficiency Diseases,alpha-Mannosidosis,Mucopolysaccharidosis VI</td><td>Cyclophosphamide,Busulfan,Thymoglobulin</td></tr><tr><td>NCT00176839</td><td>Masonic Cancer Center, University of Minnesota</td><td>Terminated</td><td>Jun 2000</td><td>Feb 2012</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasms,Hematologic Neoplasms,Leukemia,Precursor Cell Lymphoblastic Leukemia-Lymphoma</td><td>Cyclophosphamide,Melphalan,Busulfan,Antilymphocyte Serum,Lenograstim,Sargramostim</td></tr><tr><td>NCT00179322</td><td>National Institute on Deafness and Other Communication Disorders (NIDCD)</td><td>Completed</td><td>Sep 2005</td><td>Sep 2016</td><td>Observational</td><td>Sep 2005</td><td>Sleep Deprivation</td><td>null</td></tr><tr><td>NCT00170664</td><td>North Eastern German Society of Gynaecological Oncology</td><td>Completed</td><td>Jan 1999</td><td>Sep 2004</td><td>Interventional</td><td>Sep 2005</td><td>Ovarian Neoplasms,Carcinoma</td><td>Paclitaxel,Carboplatin</td></tr><tr><td>NCT00172003</td><td>Novartis Pharmaceuticals</td><td>Completed</td><td>Sep 2004</td><td>Jul 2009</td><td>Interventional</td><td>Sep 2005</td><td>Neoplasm Metastasis,Neoplasms,Carcinoma</td><td>Zoledronic Acid</td></tr><tr><td>NCT00170261</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>Apr 2002</td><td>Sep 2006</td><td>Interventional</td><td>Sep 2005</td><td>Syncope</td><td>null</td></tr><tr><td>NCT00179075</td><td>Vanderbilt University</td><td>Completed</td><td>Apr 2003</td><td>Apr 2008</td><td>Observational</td><td>Sep 2005</td><td>Graft vs Host Disease</td><td>null</td></tr><tr><td>NCT00179777</td><td>University of Helsinki</td><td>Completed</td><td>May 2002</td><td>Sep 2017</td><td>Interventional</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00174018</td><td>National Taiwan University Hospital</td><td>Completed</td><td>Sep 1993</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>Shoulder Impingement Syndrome</td><td>null</td></tr><tr><td>NCT00171535</td><td>Novartis</td><td>Completed</td><td>Oct 2004</td><td>Apr 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Valsartan</td></tr><tr><td>NCT00173914</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2003</td><td>null</td><td>Observational</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00175825</td><td>UCB Pharma</td><td>Completed</td><td>Nov 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Epilepsy,Seizures</td><td>Brivaracetam</td></tr><tr><td>NCT00172198</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Mar 2005</td><td>Mar 2007</td><td>Interventional</td><td>Sep 2005</td><td>null</td><td>null</td></tr><tr><td>NCT00171366</td><td>Novartis</td><td>Completed</td><td>Jul 2004</td><td>Jul 2005</td><td>Interventional</td><td>Sep 2005</td><td>Hypertension</td><td>Amlodipine,Benazepril</td></tr><tr><td>NCT00170287</td><td>Medtronic Bakken Research Center</td><td>Completed</td><td>May 2002</td><td>Aug 2011</td><td>Interventional</td><td>Sep 2005</td><td>Tachycardia</td><td>null</td></tr><tr><td>NCT00170729</td><td>Novartis</td><td>Completed</td><td>Aug 2004</td><td>Feb 2005</td><td>Interventional</td><td>Sep 2005</td><td>Cataract,Capsule Opacification,Uveitis,Inflammation</td><td>Prednisolone,Methylprednisolone Acetate,Methylprednisolone,Methylprednisolone Hemisuccinate,Prednisolone acetate,Prednisolone hemisuccinate,Prednisolone phosphate</td></tr><tr><td>NCT00173225</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Asthma,Cough</td><td>null</td></tr><tr><td>NCT00178100</td><td>University of Pittsburgh</td><td>Completed</td><td>Mar 1999</td><td>Aug 2005</td><td>Interventional</td><td>Sep 2005</td><td>Depression,Depressive Disorder</td><td>Paroxetine</td></tr><tr><td>NCT00176397</td><td>University of Leipzig</td><td>Unknown status</td><td>Aug 2003</td><td>null</td><td>Interventional</td><td>Sep 2005</td><td>Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Coronary Stenosis,Constriction</td><td>null</td></tr><tr><td>NCT00177333</td><td>University of Pittsburgh</td><td>Completed</td><td>Sep 2005</td><td>May 2006</td><td>Interventional</td><td>Sep 2005</td><td>Vomiting</td><td>Doxycycline</td></tr><tr><td>NCT00175643</td><td>University of British Columbia</td><td>Completed</td><td>Feb 2005</td><td>Nov 2005</td><td>Interventional</td><td>Sep 2005</td><td>Keratosis</td><td>Imiquimod</td></tr><tr><td>NCT00172913</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jul 2008</td><td>Observational</td><td>Sep 2005</td><td>Myopia</td><td>null</td></tr><tr><td>NCT00173628</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 1990</td><td>Dec 2006</td><td>Observational</td><td>Sep 2005</td><td>Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00172757</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jan 2002</td><td>Jun 2005</td><td>Observational</td><td>Sep 2005</td><td>Colorectal Neoplasms,Diabetes Mellitus</td><td>null</td></tr><tr><td>NCT00174512</td><td>Pfizer</td><td>Completed</td><td>Mar 2005</td><td>Jun 2006</td><td>Interventional</td><td>Sep 2005</td><td>Heart Diseases,Myocardial Ischemia,Coronary Artery Disease</td><td>Moxifloxacin</td></tr><tr><td>NCT00172939</td><td>National Taiwan University Hospital</td><td>Unknown status</td><td>Jun 2005</td><td>Jan 2008</td><td>Interventional</td><td>Sep 2005</td><td>Vitiligo</td><td>null</td></tr><tr><td>NCT00176995</td><td>Hordinsky, Maria K., MD</td><td>Completed</td><td>Mar 1999</td><td>Oct 2000</td><td>Interventional</td><td>Sep 2005</td><td>Hair Diseases</td><td>Eflornithine</td></tr></tbody></table>Showing the first 1000 rows.</div>"]}}],"execution_count":0},{"cell_type":"code","source":["file_location = \"/FileStore/tables/pharma.csv/pharma.csv\"\nfile_type = \"csv\"\n\n# CSV options\ninfer_schema = \"true\"\nfirst_row_is_header = \"true\"\ndelimiter = \",\"\n\n# The applied options are for CSV files. For other file types, these will be ignored.\npharma = spark.read.format(file_type) \\\n  .option(\"inferSchema\", infer_schema) \\\n  .option(\"header\", first_row_is_header) \\\n  .option(\"sep\", delimiter) \\\n  .load(file_location)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4d561092-79fe-4528-a226-165d9fd7792d"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["# File location and type\nfile_location = \"/FileStore/tables/mesh.csv/mesh.csv\"\nfile_type = \"csv\"\n\n# CSV options\ninfer_schema = \"true\"\nfirst_row_is_header = \"true\"\ndelimiter = \",\"\n\n# The applied options are for CSV files. For other file types, these will be ignored.\nmesh = spark.read.format(file_type) \\\n  .option(\"inferSchema\", infer_schema) \\\n  .option(\"header\", first_row_is_header) \\\n  .option(\"sep\", delimiter) \\\n  .load(file_location)\n"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"03b1f3b4-ad17-4ca4-9a4b-21d79d178d41"}},"outputs":[],"execution_count":0},{"cell_type":"markdown","source":["## 1. The number of studies in the dataset"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8b1af0f5-a225-4efa-9810-4d259b244dc2"}}},{"cell_type":"code","source":["total_studies = df.distinct().count()\n# distinct count of studies in dataset\nprint(total_studies)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"23b845a1-8dac-4079-949e-c6b841bc25ef"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"356466\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["356466\n"]}}],"execution_count":0},{"cell_type":"code","source":["print(total_studies)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"92e18576-f02e-4c63-884f-1b83e19d0b55"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"356466\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["356466\n"]}}],"execution_count":0},{"cell_type":"markdown","source":["#### There are total 356466 Studies in 2020"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"df42dd4c-5165-48ed-9e0b-f4023cea5b72"}}},{"cell_type":"markdown","source":["# 2. Type of Studies \n\n  listed most frequent to least frequent"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"43c66121-cbb5-43be-aab4-5df9cd7b1225"}}},{"cell_type":"code","source":["df.groupby(\"Type\").count().sort(\"count\",ascending=False).show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"63d33815-0519-405e-90c4-ef61c5f49bab"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+------+\n|                Type| count|\n+--------------------+------+\n|      Interventional|277631|\n|       Observational| 71434|\n|Observational [Pa...|  7332|\n|     Expanded Access|    69|\n+--------------------+------+\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+------+\n|                Type| count|\n+--------------------+------+\n|      Interventional|277631|\n|       Observational| 71434|\n|Observational [Pa...|  7332|\n|     Expanded Access|    69|\n+--------------------+------+\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["type_of_study = df.groupby(\"Type\").count().sort(\"count\",ascending=False).toPandas()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fa2911b4-12fb-45b6-8e9a-d6c3ab4b91b2"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["# importing plotting libraries\nimport matplotlib.pyplot as plt\nimport seaborn as sns\nplt.rcParams['figure.figsize'] = 12, 6\nplt.rcParams['xtick.major.pad'] = 5\nplt.rcParams['xtick.major.pad'] = 5\nplt.rcParams['ytick.major.pad'] = 5\nplt.rcParams['ytick.major.pad'] = 5\nplt.rcParams['axes.labelcolor'] = 'red'\nplt.rcParams['axes.labelsize'] = 10\nplt.rcParams['xtick.labelsize'] = 10\nplt.rcParams['ytick.labelsize'] = 10\nplt.rcParams['legend.fontsize'] = 10\n"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"024e1dbc-11fb-40c9-80f6-839c7095c050"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["plt.figure(dpi=200)\nsns.barplot(y=type_of_study['Type'], x=type_of_study['count'],palette=\"YlOrBr\", orient=\"h\")\nax = plt.gca()\nplt.grid(alpha=0.2)\nfor patch, lb in zip(ax.patches, ax.get_yticklabels()):\n    x  = patch.get_y() + 0.5\n    h = patch.get_width()\n    y = h \n    text = int(h)\n    \n    ax.text(y, x, text, fontsize=20, color='red')\n    lb.set_color(\"red\")\nplt.title(\"Type of Studies\", color='red')\nplt.ylabel(\"Frequency\")\n#plt.xticks(range(int(max(type_of_study['count'])+max(type_of_study['count'])*.2)), 2500)\nplt.gca().spines['top'].set_visible(False)\nplt.gca().spines['right'].set_visible(False)\nplt.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"f7eb3429-4559-4b8b-812b-fb225c2c4987"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"data:image/png;base64,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\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"image","arguments":{}}},"output_type":"display_data","data":{"image/png":"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\n"}}],"execution_count":0},{"cell_type":"code","source":["plt.figure(dpi=200)\nplt.pie(type_of_study['count'], labels=type_of_study['Type'], autopct=\"%.2f%%\", pctdistance=0.75, explode=[0, 0, 0.2, 0])\nax = plt.gca()\nplt.grid(alpha=0.2)\nmy_circle=plt.Circle( (0,0), 0.5, color='white')\nax.add_artist(my_circle)\nplt.title(\"Type of Studies\", color='red')\nplt.ylabel(\"Frequency\")\nplt.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6d1b228a-41ce-4513-9cc1-17a120ce162c"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"data:image/png;base64,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\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"image","arguments":{}}},"output_type":"display_data","data":{"image/png":"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\n"}}],"execution_count":0},{"cell_type":"markdown","source":["# 3. Top 5 Conditions"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"d9e16061-9817-4663-b4b1-020dbef6bdbd"}}},{"cell_type":"code","source":["import pyspark.sql.functions as f"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"021915c2-7c32-4d90-9c60-f9838d792bc9"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["df.select( f.explode(f.split('Conditions', ',')).alias('Conditions')).groupby('Conditions').count().sort(\"count\", ascending=False).show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"9fa2a964-9e78-46c8-9943-b88558722081"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------------+-----+\n|       Conditions|count|\n+-----------------+-----+\n|        Carcinoma|12245|\n|Diabetes Mellitus|10425|\n|        Neoplasms| 8534|\n| Breast Neoplasms| 8009|\n|         Syndrome| 7419|\n+-----------------+-----+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------------+-----+\n|       Conditions|count|\n+-----------------+-----+\n|        Carcinoma|12245|\n|Diabetes Mellitus|10425|\n|        Neoplasms| 8534|\n| Breast Neoplasms| 8009|\n|         Syndrome| 7419|\n+-----------------+-----+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"markdown","source":["# 4. Most Frequent roots"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a368964b-fae2-4fe4-a9f1-8945d4641789"}}},{"cell_type":"code","source":["mesh.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2b966dfd-eb53-4b75-8232-d257ff63daf8"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----------+-------------------+\n|      term|               tree|\n+----------+-------------------+\n|Calcimycin|D03.633.100.221.173|\n|   A-23187|D03.633.100.221.173|\n|   Temefos|D02.705.400.625.800|\n|   Temefos|D02.705.539.345.800|\n|   Temefos|D02.886.300.692.800|\n+----------+-------------------+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----------+-------------------+\n|      term|               tree|\n+----------+-------------------+\n|Calcimycin|D03.633.100.221.173|\n|   A-23187|D03.633.100.221.173|\n|   Temefos|D02.705.400.625.800|\n|   Temefos|D02.705.539.345.800|\n|   Temefos|D02.886.300.692.800|\n+----------+-------------------+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["mesh = mesh.withColumn(\"root\", f.split(mesh.tree, '\\.').getItem(0))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"52195537-b5fb-4492-82b0-3f274749a5cf"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["mesh.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"169bd464-fdac-410d-8a25-43ceae374395"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----------+-------------------+----+\n|      term|               tree|root|\n+----------+-------------------+----+\n|Calcimycin|D03.633.100.221.173| D03|\n|   A-23187|D03.633.100.221.173| D03|\n|   Temefos|D02.705.400.625.800| D02|\n|   Temefos|D02.705.539.345.800| D02|\n|   Temefos|D02.886.300.692.800| D02|\n+----------+-------------------+----+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----------+-------------------+----+\n|      term|               tree|root|\n+----------+-------------------+----+\n|Calcimycin|D03.633.100.221.173| D03|\n|   A-23187|D03.633.100.221.173| D03|\n|   Temefos|D02.705.400.625.800| D02|\n|   Temefos|D02.705.539.345.800| D02|\n|   Temefos|D02.886.300.692.800| D02|\n+----------+-------------------+----+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["df.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fb351912-a721-43b8-a3fb-c100c27d8b9a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\n|         Id|             Sponsor|              Status|   Start|Completion|                Type|Submission|          Conditions|Interventions|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\n|NCT02758028|The University of...|          Recruiting|Aug 2005|  Nov 2021|      Interventional|  Apr 2016|                null|         null|\n|NCT02751957|     Duke University|           Completed|Jul 2016|  Jul 2020|      Interventional|  Apr 2016|Autistic Disorder...|         null|\n|NCT02758483|Universidade Fede...|           Completed|Mar 2017|  Jan 2018|      Interventional|  Apr 2016|   Diabetes Mellitus|         null|\n|NCT02759848|Istanbul Medeniye...|           Completed|Jan 2012|  Dec 2014|       Observational|  May 2016|Tuberculosis,Lung...|         null|\n|NCT02758860|University of Rom...|Active, not recru...|Jun 2016|  Sep 2020|Observational [Pa...|  Apr 2016|Diverticular Dise...|         null|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\n|         Id|             Sponsor|              Status|   Start|Completion|                Type|Submission|          Conditions|Interventions|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\n|NCT02758028|The University of...|          Recruiting|Aug 2005|  Nov 2021|      Interventional|  Apr 2016|                null|         null|\n|NCT02751957|     Duke University|           Completed|Jul 2016|  Jul 2020|      Interventional|  Apr 2016|Autistic Disorder...|         null|\n|NCT02758483|Universidade Fede...|           Completed|Mar 2017|  Jan 2018|      Interventional|  Apr 2016|   Diabetes Mellitus|         null|\n|NCT02759848|Istanbul Medeniye...|           Completed|Jan 2012|  Dec 2014|       Observational|  May 2016|Tuberculosis,Lung...|         null|\n|NCT02758860|University of Rom...|Active, not recru...|Jun 2016|  Sep 2020|Observational [Pa...|  Apr 2016|Diverticular Dise...|         null|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["common_sponsors = df.join(pharma, df.Sponsor == pharma.Parent_Company, 'leftanti').groupby('Sponsor').count().sort('count', ascending=False).limit(10).toPandas()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4f15f114-1933-40ab-9360-6777b9cce783"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["condition_df = df.select(df.Id, f.explode(f.split(df.Conditions, \",\")).alias('Condition'))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"f5d775f8-32c9-4586-9978-409c0b1efc12"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["condition_df.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cef1741e-d184-4795-9ba7-85d68969cce6"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------+--------------------+\n|         Id|           Condition|\n+-----------+--------------------+\n|NCT02751957|   Autistic Disorder|\n|NCT02751957|Autism Spectrum D...|\n|NCT02758483|   Diabetes Mellitus|\n|NCT02759848|        Tuberculosis|\n|NCT02759848|       Lung Diseases|\n+-----------+--------------------+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------+--------------------+\n|         Id|           Condition|\n+-----------+--------------------+\n|NCT02751957|   Autistic Disorder|\n|NCT02751957|Autism Spectrum D...|\n|NCT02758483|   Diabetes Mellitus|\n|NCT02759848|        Tuberculosis|\n|NCT02759848|       Lung Diseases|\n+-----------+--------------------+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["condition_df.join(mesh, condition_df.Condition == mesh.term, 'left').groupby(\"root\").count().sort('count', ascending=False ).show(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"48b41dfa-dc22-49ac-8698-b9241b4c48cd"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----+------+\n|root| count|\n+----+------+\n| C04|133091|\n| C23|124589|\n| C01| 94293|\n| C14| 88065|\n| C10| 83894|\n| C06| 79382|\n| C08| 61138|\n| C13| 39316|\n| C18| 38439|\n| C12| 37294|\n+----+------+\nonly showing top 10 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----+------+\n|root| count|\n+----+------+\n| C04|133091|\n| C23|124589|\n| C01| 94293|\n| C14| 88065|\n| C10| 83894|\n| C06| 79382|\n| C08| 61138|\n| C13| 39316|\n| C18| 38439|\n| C12| 37294|\n+----+------+\nonly showing top 10 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["condition = condition_df.join(mesh, condition_df.Condition == mesh.term, 'left').groupby(\"root\").count().sort('count', ascending=False ).limit(10).toPandas()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fccf9dcf-5101-497e-aee4-516247dedc6a"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["condition"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"340ef600-8ee9-4c80-9bfb-09442e9bd69c"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>root</th>\n      <th>count</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>C04</td>\n      <td>133091</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>C23</td>\n      <td>124589</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>C01</td>\n      <td>94293</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>C14</td>\n      <td>88065</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>C10</td>\n      <td>83894</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>C06</td>\n      <td>79382</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>C08</td>\n      <td>61138</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>C13</td>\n      <td>39316</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>C18</td>\n      <td>38439</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>C12</td>\n      <td>37294</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>root</th>\n      <th>count</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>C04</td>\n      <td>133091</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>C23</td>\n      <td>124589</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>C01</td>\n      <td>94293</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>C14</td>\n      <td>88065</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>C10</td>\n      <td>83894</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>C06</td>\n      <td>79382</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>C08</td>\n      <td>61138</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>C13</td>\n      <td>39316</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>C18</td>\n      <td>38439</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>C12</td>\n      <td>37294</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["plt.figure(dpi=200)\nsns.barplot(y=condition['root'], x=condition['count'],palette=\"cubehelix\", orient=\"h\")\nax = plt.gca()\nplt.grid(alpha=0.2)\nfor patch, lb in zip(ax.patches, ax.get_yticklabels()):\n    x  = patch.get_y() + 0.6\n    h = patch.get_width()\n    y = h \n    text = int(h)\n    ax.text(y, x, text, fontsize=10, color='#770000')\n    lb.set_color(\"#ff7062\")\nplt.title(\"Most Frequent Roots\", color='#7a637f')\nplt.ylabel(\"Root\")\nplt.xlabel(\"Frequency\")\nplt.gca().spines['top'].set_visible(False)\nplt.gca().spines['right'].set_visible(False)\nplt.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b56337b8-87c6-4d20-88d8-fa02dd48c86d"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"data:image/png;base64,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\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"image","arguments":{}}},"output_type":"display_data","data":{"image/png":"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\n"}}],"execution_count":0},{"cell_type":"markdown","source":["# 5. Most Common sponsors that are not pharmaceutical companies, with clinical trials they have sponsored"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b8ef9c2a-810b-40b6-a49d-93ce649e5636"}}},{"cell_type":"code","source":["pharma.select(\"Parent_Company\")"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"536a5d4e-be63-425c-8def-2bfd0452a6b5"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[109]: DataFrame[Parent_Company: string]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[109]: DataFrame[Parent_Company: string]"]}}],"execution_count":0},{"cell_type":"code","source":["df.join(pharma, df.Sponsor == pharma.Parent_Company, 'leftanti').groupby('Sponsor').count().sort('count', ascending=False).show(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"266d7b2a-7cab-46bc-9dfe-98777500c1d8"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|National Cancer I...| 3100|\n|M.D. Anderson Can...| 2238|\n|Merck Sharp & Doh...| 2184|\n|         Mayo Clinic| 2097|\n|Assistance Publiq...| 2043|\n|Novartis Pharmace...| 1962|\n|Massachusetts Gen...| 1823|\n|   Assiut University| 1806|\n|   Hoffmann-La Roche| 1761|\n|National Taiwan U...| 1720|\n+--------------------+-----+\nonly showing top 10 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|National Cancer I...| 3100|\n|M.D. Anderson Can...| 2238|\n|Merck Sharp & Doh...| 2184|\n|         Mayo Clinic| 2097|\n|Assistance Publiq...| 2043|\n|Novartis Pharmace...| 1962|\n|Massachusetts Gen...| 1823|\n|   Assiut University| 1806|\n|   Hoffmann-La Roche| 1761|\n|National Taiwan U...| 1720|\n+--------------------+-----+\nonly showing top 10 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["common_sponsors = df.join(pharma, df.Sponsor == pharma.Parent_Company, 'leftanti').groupby('Sponsor').count().sort('count', ascending=False).limit(10).toPandas()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"d49ac459-0e7a-4365-be0b-d2d74b7606cd"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["common_sponsors"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"32d2837a-eeb7-442c-a20e-c4fef9dd1025"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Sponsor</th>\n      <th>count</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>National Cancer Institute (NCI)</td>\n      <td>3100</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>M.D. Anderson Cancer Center</td>\n      <td>2238</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Merck Sharp &amp; Dohme Corp.</td>\n      <td>2184</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Mayo Clinic</td>\n      <td>2097</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>Assistance Publique - Hôpitaux de Paris</td>\n      <td>2043</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Novartis Pharmaceuticals</td>\n      <td>1962</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Massachusetts General Hospital</td>\n      <td>1823</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Assiut University</td>\n      <td>1806</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Hoffmann-La Roche</td>\n      <td>1761</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>National Taiwan University Hospital</td>\n      <td>1720</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Sponsor</th>\n      <th>count</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>National Cancer Institute (NCI)</td>\n      <td>3100</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>M.D. Anderson Cancer Center</td>\n      <td>2238</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Merck Sharp &amp; Dohme Corp.</td>\n      <td>2184</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Mayo Clinic</td>\n      <td>2097</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>Assistance Publique - Hôpitaux de Paris</td>\n      <td>2043</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Novartis Pharmaceuticals</td>\n      <td>1962</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Massachusetts General Hospital</td>\n      <td>1823</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Assiut University</td>\n      <td>1806</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Hoffmann-La Roche</td>\n      <td>1761</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>National Taiwan University Hospital</td>\n      <td>1720</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["plt.figure(dpi=200)\nsns.barplot(y=common_sponsors['Sponsor'], x=common_sponsors['count'],palette=\"rainbow\", orient=\"h\")\nax = plt.gca()\nplt.grid(alpha=0.2)\nfor patch, lb in zip(ax.patches, ax.get_yticklabels()):\n    x  = patch.get_y() + 0.5\n    h = patch.get_width()\n    y = h \n    text = int(h)\n    \n    ax.text(y, x, text, fontsize=20, color='#6768ab')\n    lb.set_color(\"#ff7062\")\nplt.title(\"Common Sponsors which are not pharamaceutical companies\", color='#7a637f')\nplt.ylabel(\"Sponsors\")\nplt.xlabel(\"Frequency\")\n#plt.xticks(range(int(max(type_of_study['count'])+max(type_of_study['count'])*.2)), 2500)\nplt.gca().spines['top'].set_visible(False)\nplt.gca().spines['right'].set_visible(False)\nplt.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"9f408eb2-f6e3-43a5-8e02-8f7b40ae8404"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"data:image/png;base64,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\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"image","arguments":{}}},"output_type":"display_data","data":{"image/png":"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\n"}}],"execution_count":0},{"cell_type":"markdown","source":["# 6. Completed Case Studies in 2021"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2fba6848-c64b-4689-94ac-9b8305afb4a3"}}},{"cell_type":"code","source":["from pyspark.sql.types import StructType,StructField, StringType"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fd8eabb3-56ca-44ca-9a97-b6744b5b2aef"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":[""],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7349be26-4b4c-4caa-96bc-b419aba15c1f"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["completed = spark.createDataFrame(data =  spark.sparkContext.emptyRDD(),\n                             schema = StructType([]))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b4209699-94af-4109-8698-1a80f5983539"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["split_col_1 = f.split(df['Completion'], \" \").getItem(0)\nsplit_col_2 = f.split(df['Completion'], \" \").getItem(1)\ncompletion = df.withColumn(\"month\", split_col_1)\ncompletion = completion.withColumn(\"year\", split_col_2)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"d54bdd9c-a16c-4ed4-8f71-1846e59f44e4"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["completion.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"da7e1baa-4d00-4e11-a4c8-f6a419c88859"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+-----+----+\n|         Id|             Sponsor|              Status|   Start|Completion|                Type|Submission|          Conditions|Interventions|month|year|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+-----+----+\n|NCT02758028|The University of...|          Recruiting|Aug 2005|  Nov 2021|      Interventional|  Apr 2016|                null|         null|  Nov|2021|\n|NCT02751957|     Duke University|           Completed|Jul 2016|  Jul 2020|      Interventional|  Apr 2016|Autistic Disorder...|         null|  Jul|2020|\n|NCT02758483|Universidade Fede...|           Completed|Mar 2017|  Jan 2018|      Interventional|  Apr 2016|   Diabetes Mellitus|         null|  Jan|2018|\n|NCT02759848|Istanbul Medeniye...|           Completed|Jan 2012|  Dec 2014|       Observational|  May 2016|Tuberculosis,Lung...|         null|  Dec|2014|\n|NCT02758860|University of Rom...|Active, not recru...|Jun 2016|  Sep 2020|Observational [Pa...|  Apr 2016|Diverticular Dise...|         null|  Sep|2020|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+-----+----+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+-----+----+\n|         Id|             Sponsor|              Status|   Start|Completion|                Type|Submission|          Conditions|Interventions|month|year|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+-----+----+\n|NCT02758028|The University of...|          Recruiting|Aug 2005|  Nov 2021|      Interventional|  Apr 2016|                null|         null|  Nov|2021|\n|NCT02751957|     Duke University|           Completed|Jul 2016|  Jul 2020|      Interventional|  Apr 2016|Autistic Disorder...|         null|  Jul|2020|\n|NCT02758483|Universidade Fede...|           Completed|Mar 2017|  Jan 2018|      Interventional|  Apr 2016|   Diabetes Mellitus|         null|  Jan|2018|\n|NCT02759848|Istanbul Medeniye...|           Completed|Jan 2012|  Dec 2014|       Observational|  May 2016|Tuberculosis,Lung...|         null|  Dec|2014|\n|NCT02758860|University of Rom...|Active, not recru...|Jun 2016|  Sep 2020|Observational [Pa...|  Apr 2016|Diverticular Dise...|         null|  Sep|2020|\n+-----------+--------------------+--------------------+--------+----------+--------------------+----------+--------------------+-------------+-----+----+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["year = \"2020\"\ncompletion.filter( (completion['year']== year) & (completion[\"Status\"]==\"Completed\")).groupby(\"month\").count().show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"ceea453c-ff24-4e67-9517-89eba3840e6d"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----+-----+\n|month|count|\n+-----+-----+\n|  Oct| 1176|\n|  Sep| 1167|\n|  Dec| 2084|\n|  Aug| 1126|\n|  May| 1176|\n|  Jun| 1424|\n|  Feb| 1286|\n|  Nov| 1078|\n|  Mar| 1740|\n|  Jan| 1544|\n|  Apr| 1080|\n|  Jul| 1237|\n+-----+-----+\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----+-----+\n|month|count|\n+-----+-----+\n|  Oct| 1176|\n|  Sep| 1167|\n|  Dec| 2084|\n|  Aug| 1126|\n|  May| 1176|\n|  Jun| 1424|\n|  Feb| 1286|\n|  Nov| 1078|\n|  Mar| 1740|\n|  Jan| 1544|\n|  Apr| 1080|\n|  Jul| 1237|\n+-----+-----+\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["months =  [\"Jan\", \"Feb\", \"Mar\", \"Apr\", \"May\", \"Jun\", \"Jul\", \"Aug\", \"Sep\", \"Oct\", \"Nov\", \"Dec\"]\nstudy_completed_2020 = completion.filter( (completion['year']== year) & (completion[\"Status\"]==\"Completed\")).groupby(\"month\").count().toPandas().set_index('month').loc[months]\n"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"96e07313-0b56-4a4b-a295-1cc86f855f25"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["study_completed_2020.reset_index(inplace=True)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"1db511d8-6b3e-454e-93c4-d8c48643491b"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["study_completed_2020"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"95d719b0-3160-4950-a121-c9c32f729199"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>month</th>\n      <th>count</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Jan</td>\n      <td>1544</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Feb</td>\n      <td>1286</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Mar</td>\n      <td>1740</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Apr</td>\n      <td>1080</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>May</td>\n      <td>1176</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Jun</td>\n      <td>1424</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Jul</td>\n      <td>1237</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Aug</td>\n      <td>1126</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Sep</td>\n      <td>1167</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>Oct</td>\n      <td>1176</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Nov</td>\n      <td>1078</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>Dec</td>\n      <td>2084</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>month</th>\n      <th>count</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Jan</td>\n      <td>1544</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Feb</td>\n      <td>1286</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Mar</td>\n      <td>1740</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Apr</td>\n      <td>1080</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>May</td>\n      <td>1176</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Jun</td>\n      <td>1424</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Jul</td>\n      <td>1237</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Aug</td>\n      <td>1126</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Sep</td>\n      <td>1167</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>Oct</td>\n      <td>1176</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Nov</td>\n      <td>1078</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>Dec</td>\n      <td>2084</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["plt.figure(dpi=200)\nsns.barplot(x=study_completed_2020['month'],y=study_completed_2020['count'],palette=\"icefire\")\n\nax = plt.gca()\n\nfor patch, lb in zip(ax.patches, ax.get_xticklabels()):\n    x  = patch.get_x() + 0.2\n    h = patch.get_height()\n    y = patch.get_height() + 50\n    text = int(h)\n    ax.text(x, y, text, fontsize=10, color='#6768ab')\n    lb.set_color(\"#ff7062\")\nplt.title(f\"Completed Studies in Year {year}\", color='#7a637f')\nplt.ylabel(\"Frequency\")\nplt.grid(alpha=0.2)\nplt.gca().spines['top'].set_visible(False)\nplt.gca().spines['right'].set_visible(False)\nplt.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2b34c83b-e83e-4ed1-b6af-c5909a91679a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAB/EAAAQ3CAYAAAAADp0wAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjQuMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8rg+JYAAAACXBIWXMAAB7CAAAewgFu0HU+AAEAAElEQVR4nOzdd5gdV2E/7s+suizJlizbcpXcu7GNbWxswDRTTA0QAiTYwCUhISRA8iUkS8INYUmB/CiBAGEJJTTTO9jgArhi3G3cbclyV7V63fn9MXe1V6ttkla7V9b7Ps8+PjNz5sy5V+fetfSZc6YoyzIAAAAAAAAAwOhrG+0OAAAAAAAAAAAVIT4AAAAAAAAAtAghPgAAAAAAAAC0CCE+AAAAAAAAALQIIT4AAAAAAAAAtAghPgAAAAAAAAC0CCE+AAAAAAAAALQIIT4AAAAAAAAAtAghPgAAAAAAAAC0CCE+AAAAAAAAALQIIT4AAAAAAAAAtAghPgAAAAAAAAC0CCE+AAAAAAAAALQIIT4AAAAAAAAAtAghPgAAAAAAAAC0CCE+AAAAAAAAALQIIT4AAAAAAAAAtAghPgAAAAAAAAC0CCE+AAAAAAAAALSIsaPdAQAAAHZO7bX62UkubWz+qqOzfvbo9ab1tdfqc5PMbmwe3NFZnzt6vXlyaa/Vv5jkvMbmmzo661/so049yfsbm//c0Vmvj0TfRlp7rX5Zkmc1Np/d0Vm/bPR6AwAAwLYQ4gMAAE8a7bX6tCQvSvL8JKck2SvJzCTrkixJcleSa5P8sKOzftVo9ROGU3utPiHJHyR5SZKTk8xKMjXJmlTjfl6S21KN/Us6Ouv3jVJX2YW11+rfSPLaxubdSZ7S0VlfvRXnvyVJZ2NzfZKndnTWbxneXu5c2mv16Umel+TZSU5McliSPVJ99hek+sz/KMk3Ozrr67eh/YOSvDnJS5MclGRKkoeT3JDkq0m+39FZL4fY1tGpfjefleS4JPsnmZzkiSRzk1yR5IsdnfUbtrafjfafm+pGntMbba9N8mCSC5N8vqOzfse2tAsAAKNFiA8AAOz02mv1yUnemeRvk0zvo8r4VOHDgUmem+S97bX6XUnqSb4x1BCC1rCrzKgeivZa/SVJPpMqtOptt8bPAUnOTPKnjXM+2dFZf0c/7c2N1QLYMd6R6vt3ZpLDk/xzkvcM5cT2Wn3fJB9p2tWxKwf47bX6lCRfT3JOqt9vvY1LdSPPIalunPhge61+Xkdn/ddbcY23JPl4qu+QZoc0fl6V5JfttfqfdHTWHx2gnecn+WiSY/upsmfj56lJ/qq9Vv9Wkrd1dNYXD7Gf05L8T3puEOk2OdX/Dxyf5K/ba/X3d3TW/3UobQIAQCtoG+0OAAAAbI/GTMGrknRk8wD/gSQ/TvKFJF9OclGSx5qOH5Hka0n+38j0FIZXe63+piQ/zOYB/t1JvpMq1PpSkp8leaTXqX3d6AI7VEdnfUGqIL/bu9tr9VOGePqnUs0wT5Kbk3xoGLu2M5qSauWN5gD/sSQ/SfL5VL/zbm46NifJxY2bfgbVXqu/OdWqB90B/tIk3031+/TapqrPS3Jh46aC/jw1mwf4ZZKbknwr1ffU91KtGtDtNUl+3V6r7zmEfo5rnN8c4N+a6vV/Mz3ffeOSfKi9Vv+nwdoEAIBWYSY+AACw02qv1eekCvBnNXaVqWYnfqijs35bH/WLVMvsvyPJG1Ld2Dx5RDoLw6i9Vj8syaeTFI1dVyV5e39LUbfX6kekWnL/LSPTw9bTWLGhPsrd2OE6Outnj3Yf+tPRWf9Ge63+2iSvSDImyf+21+pPHWip9/Za/dVJXtnY3JDkTduyNPyT1JJUgfUXOjrrN/U+2F6rn9U4fnCqfwP8anutfkRHZ/2x3nWbzjky1eoe3b6a5M86Ousrm+o8J8m3U90QdEKST6Radn8gNyb5XJILOjrri3pdc3ySd6W6GW9MqtD/v7Pl7Pre/jHJcxrlNanGxjd6tfvB9NysV2+v1X/V0Vn/1SDtAgDAqDMTHwAA2Ck1/nH+W+kJ8Nck+YOOzvob+grwk6Sjs152dNav7eisvzHJU1LN2IOd0buSTGiUb0vynIGeJd3RWb+ro7P+b6lWoDAbldH056nC56Ra6ry9v4qNZ75/smnXhzs669fvwL7tLNYl+UCSOR2d9Xf2FeAnSUdn/fJUIfeyxq5pqR49M5B/STVzPameU//G5gC/0e4lqW6E6/bGxjPv+3JXkld0dNZP6uis/3fvAL/R3rqOzvq/Z/OVcf6wvVY/qr9Ottfqeyd5d9OudzYH+E3tvifJBY1dRRJL6gMAsFMQ4gMAADur96SaVd/tvI7O+veHenJHZ/3WJKcn+cUw9wtGwjlN5f/q6KyvGcpJjRtZ7ttBfYJBNZ6f/q6mXf/QXqsf30/1jybZp1G+Pck/78i+7Sw6OuuLOzrr7+/orC8bQt252Xxm/bn91W2v1fdJ9az7bu/p6Kx39dPuz5L8srE5Jsnb+qn33Y7O+g8G62fDJ5I83LT94gHqnpee5f7vSrU0f3/ek6T7dZzRXqufNMT+AADAqLGcPgAAsNNpr9UnJfmrpl3f7eisf3Nr22nMLrxikGvNTrUE+TmpliSenmoW6f1JLkzS2dFZnz9IG2cnubSx+avu5a4bzyd+c5KTU60osDLJb1OFsj/t1UZbkpcmeWuqpYb3bfTj8iT/2dFZv3qQPnwxVeiRVEsOf7HxzOFaqtDm4FTPWX44ycVJPj3QzO5t1V6rH5jk/FTv56FJ9kz1uuc1rvs/HZ31u/o597Ikz+q1+/3ttfr7+6j+pY7O+vn9tFOkWs77FUnOSBUSTkj1XObrUj1j+asdnfUNQ3xNE5L8aZI/THJUet7Ha5J8rqOzfukAp2+r/ZvK87anocZjKe7v49D97bV6X6c8u6Ozflkf587r6KzPGcL15iaZ3dg8uBEyDlT/FUnelOqmnZmp/pxuT7VM+Ne34s+pnqR7rPxzY3n9wc45Ncnrkzw71Xu+e5LFSe5M8tNU43VJ/y1samdmqnH/wiTHJJmRKvhcmeShxuu5Msn3Ojrrff1ZDFmvz8mmP6tedb6YLb8PJjf6+Pokh6d6Bv3jqb5jPtnRWR/wu3JrdHTWv9RYVv9FqWZ9/297rX56R2d9Y1Mfz2nqY1eSN3d01tf28Vr2TM97e1SSvVKtzPJwqu/dL3R01n83WJ8az1d/TpLnJjk1yZGp/pzKJIuS3JKe7/wVg7Q1J318LhrL25+f5KxU3+HTkny8o7P+zsH6t52a/+zmDFDvZemZ8HNXR2f9ykHa/WKS5zXKr0jy19vQt006Ousb22v1a9Lz+IQ5A1R/RXM/Ojrr5QDtPtBeq1+Snr6+Msmw/34DAIDhZCY+AACwM3p1qqCm2/+3Iy7SXqu3J7kj1XN3n5Zk71SB096N7X9Kcld7rf53W9nu5PZa/etJfpQqTJidKkSekSqI+kkjcOyuv1eS3yT5fqpZlHMa9Welei+ubK/V/3Ir+3BGkpuT/FuqwGpmkolJDkl1o8C1zX3YXu21elt7rf6BVDMmP5CeEGt8qhsjTkzyN0lua6/VOxpB+7Brr9VPSHJ9ku8meWOqsHJaqvfzgCQvTxVM3dpeqx8zhPaOTnJTqhmkZ2Xz9/F1SS5pr9U/3QgIh1Pz7NiDh7ntltBeq09pr9V/kuqmipcl2S/VeNk/VRj35SSXttfqs/pvZZuvPb29Vv92qptq3pnq8RszU33+90nyzFSfnfsaz2wfqK2Xpxr3H04VEO+baryNTXVTwDGpbqT5z1Sf8xHXGOu/S/KpJGem+o4bn+oz8UdJLm+v1Yd7FvyfpmeZ91NSff67+7Nbks821f1YXzcqtdfqb09yb5KPpBoTB6R6b3dPcnSSv0jy2/Za/fONR7D0qXFz0SNJfp5qSfez0/PnNDHVmHthqpUB5rbX6s/fmhfaXquPb6/VP5Pqz/ctqW4QmLY1bWyn5oB7zAD1nt1UvmwI7TbfoHRQe61+2NZ0qh+D9rW9Vp+YaiWdbpcNod3mvj5n67sFAAAjS4gPAADsjJr/Af6B4Zwh2q29Vv9kkg+mCnCSZEWq0P1zjf92z8ScmOTf2mv1j25F859PFYxtSPKrxvbXkzzWVOf97bX66xqrDlyU5OmpZpdelKQzybfT81zpIsknGsH8UMxO8pNUoeiKJD9svK6fJFnVqDOm0YcPbMXr6lN7rT4myTdT3QzR/X4+lCqc/Z8kX0sVxCVVsPkP2TzA6/a9VCHjtU37rm3s6/3zy94nt9fqz0wVop3Y2LU+1eznL6V6T3+Z6j1OqpDtygGe89y9SsPFjbrdbkvyf6kC5lsb+96WKvAdTvc2ld/RmEW9rZal531b3rT/y+n7vX1oO641JI2bHn6SzZfTfjTVOPp8qs/NxlQ3TnwvPc/wHo5rz0o1c7l5WfHbUo3T/0l1M033c733SPLN9lq9+fngzW2dkuqzOr2xa3Uas8NTLXH+tVQrNqzq6/wRsl+qsX90kqXp+Z77XpInmur9U2P2/LDo6Kw/mM2fgf7P7bX6EY3yh9IzC/ueJO/rfX57rf6xJJ9MFdgnycKmvv9fej5/RaoVT37QWNGkL7ulWhUk6Vnh5Kupvoe+kCok7v5u2DPJT9tr9acP/io3+WiSP2uUb0nylUa7V2TzG3J2lObHFQy0ckzz9931gzXa0Vl/OJv/3ur3+3IrDKWvR6bn3zTLDG1WffPrGY5+AgDADmU5fQAAYGf0jKbyNcPdeHut/odJ3t6064tJ/rr5+cPttfq0VIHmHzd2vbO9Vv9NR2f9u4M0f3qq2Z1XJvmT5ueTNwL7LyV5TWPXP6da7v3EVIHa2zo664831Z+eKlB8ZqqgqiNDm2H4D6lm2X41yV/0el3TUwXaf9C9q71W//kQllUeyPvTE4g+muq9/V7v5Y/ba/XXpArgdk/y1vZa/ZfNj0no6Kx/vFGvnmr1gCT56RCXRZ+V5Fvpmf365STv7eisP9Kr3j5JPp1qhYTdk1zQXquf1LzMd5PPp5qtm1Rh5x93dNZ/3Ku9F6V6n9+d6qaB4fL9JCc0ykcnuaa9Vv+3JD/s6Kwv7/esPnR01hcn+ctk0yMepjYOvX+wpe53oPemGtdJFdK9L8m/91pu/YhUof7pqR5Jsd0aIe/X0hPy/TbV5+6GXvUmJvm7VGO7SPLZ9lr9yj6Wwm9Pz7+9fCfJW/tafr/R3nNSrTgw0v4p1XfSvyf5QEdnfdMNBe21+oxUn5vu75UPtdfq3xxo6fKt0dFZ/5/G9+1zU93g09leq783jfGY6s/+LR2d9dXN57XX6m9Oz9Lty1LN4v9SR2d9fa96z04V6HfPpP/bJP/RR1dWJ/mvVOH67/p6DnzjO/+fGtcam+QL7bX60f09M77JAalWBJif5A0dnfXNVltoPI5jh2mM6T9p2rXFDU5Nmm9IGupjOh5ItTpFUj3O4EdD793mGjdGHN60q7++Nvfz8Y7O+pp+6jV7oKk8o71W36ujs75ga/sIAAAjxUx8AABgZzS7qXzbcDbcCDyaZ01/K9WzmJc112tsvzHJD5p2/8cAMz27TUj1PO1zmgP8RpurUy21vLix6/Ak70hySZJXNwf4jfpLGn3oDjbPHuLS4uNTPc/7jX28riVJXpue5Yl7vx9bpfFs6H9obC5OclZHZ/27fYWAHZ31b6XnWchJUh/GZfU7Ui0RniSf6Oisn9c7wG/04bFUN1Fc0th1fKpHFmymsZz2cxubZZJX9g7wG+39LNUS/WWGcbZ4ko9l85DtuFQB5KL2Wv237bX6p9pr9Te11+pH9nl2C2uv1XdPFeJ3++eOzvqHet9I0dFZvyvJ81Mtg97vUulb6Q3pWVL86iRn9w7wG9de09FZ/+dUj4ZIqpnc7+mjve4bjtYmOb+vAL+pvZ92dNbftl293zYTkvxrR2f9vc0BfqNfi5O8PsnKxq5Dkpw2zNevNbX/jFRL2nd/j/53R2f9182V22v1qakePZAk61J9l3b2DvCTpKOzfmmqMdId8r6nr1UrOjrr8zo663/V0Vn/bX+hfEdnfVlHZ/1vU62gkCRHJHnBEF7fmFQrLTyvd4DfaHftENrYHn+RKlxPqln/n+6rUuMmsklNux7rq14fHm0qz9jq3vVcvy3V91q3azo667/rp/qeTeVt6WeyHX0FAICRIMQHAAB2Ko3ZkM2rii0d5kuck55njK9L8lf9zTpt7H97emZYH5oqMBrMezs66yv7OtCYRf2TXrvfPUCwNC/VrP6kmhF8yhCuX6Z6Xf21uSHJXzXtesZ2hMF/nZ7nGn+go7N+70CVG6HbhY3No5OctI3X3aS9Vt8rPSsmPJpqBvVAfdiYagZ1t76WSq81lb/d6Hd/7f0m1eMShk0jDD4nW97EMi7VKgV/keR/k9zRXqs/0l6rf6y9Vj88O4fXJ+kOWh9M8q/9VWzMpH3/MF773U3lt/WeAd6Hf0vPd9Dr+riJp3vlh1UdnfUVaU0L0nMzwhYaN7Y0fycNa4jfWO3h75t2da8EMTeb38zR7c2pHmOQVCH/gKuxdHTWb0+1wklShb8v3MaudvtCU/l5Qzznk42bTkZUe61+bDb//Hy+o7Pe341vU3ptDzb2+6rXu42t8Y/pWWGlK9WqCf1pvs629LN3GwAA0HKE+AAAwM5maq/t4Q7Gmpej/2lHZ7337L3NdHTWH0o1c7Tbs/ur27A6W4b0vd3SVL6no7N+0yD1b20qH9xvrR5XDiFMvyWbP2d4sNfVn+Znmn9tiOdc0lQ+axuv2+x56Zmp/d0hLr18TXpmB/fVh+b348tDaO9Lg1fZOo1Q8ORUgf0tA1Sdlepmitvaa/UPDWG1iNHW/N5e0NFZXzdI/W+kuuFmu7TX6vumenRFkvx+CJ+7NMbSVY3N3VOtiNCs+5ne04fzefLD7EdD+Ew0fxfM2QF9+GSS3rPU39rPjQ879DulvVYf116rn9Veq7+9vVb/l8YNMJ/s/snmj1o5cYjX/8YQ6w2b9lp9j1SP3egOq+/O5jep9Dax1/ZQP1PNKwlM6rfWANpr9Zdm85tx/r2js375AKc093Vb+plsY18BAGCkjB28CgAAQEvp/bzv4Z5N1zzze6jPgb8iyUsb5cGezX1XX8s+99K85PZQHhewuKk8rd9aPa4avMqmet3vx1bPiG+v1fdMteR0UgUt72+v1Ydy6jFN5QO39rp9OKOpfEIjiNsa09tr9d26V09or9X3T7JX0/Grh9DG1alWQBiuxwMkSRoB96eTfLox0/5ZqV7vSakeBdD89/5xqWY875/kvOHsxzBrHmuDjtWOzvry9lr91gz+2RtM8ziZtBXj5NCm8oFJbm7a/mZ6ZpN/vRHkX5Dk0t6PxxhFA90A0m1RU3ko3zFbpaOzXrbX6v+bnscPzOvorPf3PPTmP6c/ba/VhzKWD2gq9/md0lhO/h+SvC3JzCG0mSHWW5+hvcfDpr1Wn5jqUS+HNXYtS/VIloFueut9I8dQH1Exoak81Fnxm7TX6qemWqmk+7vxl0n+aZDTmvu6Lf1MtqGvAAAwkoT4AADATqWjs76svVbfkJ6/z+wxzJdoDmfn9Vtrc3ObyoOFOk8Mob0N21F/KM9df2AIdXrX26vfWv3bt6k8PpvPYB2q6dtwTm/7NZXPyrbN7p+enpn5ze/Fqo7O+sLBTm6M2ycy/OO1+Rp3p5pt25kk7bX6lFSPd/iLbL7s9xvba/UfdHTWv7uj+rKdmt/frRmr2xviN4+TgzM84/WDSc5OcnqqkPKVjZ+01+p3p5p9fnGq2fC9b1AaKUP5jmm+8Wgo3zE7RGNMN6/GUuuv7gC2+E5pr9Wnp5qtf+JWttV7ZZi+LGk8omREtNfqY1PdKPLMxq41SV7W0Vm/uf+zkmy5qs1QZ6o319uqlXHaa/VjkvwsyW6NXdcmeeUQ3q/m62xLP3u3AQAALafVl9ADAADoS3O4fky/tbZN88z+Pp9b34fmeoOFOuXWdWer6w/FqiHW25rX1Zfdt+Gc3obj5vPh7kfzGBnqe5kMfTwNi47O+oqOzvr3Ojrrz0+1nH6z3tutZFve3+F4b4d9vDZWb3hWkv+XzW/2SZLDUz3f/atJHm2v1f+jMRt8pO2I75gdZUd9p3wqPQH+ulQ3wrw81UoiU5OM7eisFx2d9SKbP7JkKP+uNmIzvhuPyvhikpc1dm1I8pqOzvqvBju3o7O+Opv3dZ8hXnZWU3lxv7V6aa/VD07yiyR7NnbdluSFg6wW0K15ZYht6WeyFX0FAIDRYCY+AACwM7o8PUtYP22Y224OEHbrt9bmmuuN1mzarTF5iPW293U1B6vLOjrrwxHAbYvmfry7o7P+0e1sr3mMDPW9TIY+noZdR2f9E+21+rlJzmnsOqO9Vh87kjOEmwwWfK5IT1i7LWN1WzWPkx92dNZfPgxtdj/y4CPttfp/Jjkh1Qzpp6daOn7/RrXJqYL+Z7bX6s9uBKpsqffNGjM6OutL+qw5RI3HY/xRY7MrVZB86QCnbMsNTSPlM0ne0Ch3JXljR2f9x1tx/p3puZlh9hDPOaipfMdQTmi85xenZ/WLe5M8v6OzPtRg/c6m8t7ttfrEjs5678cBDNTPxR2d9QVDvBYAAIwKM/EBAICd0SVN5dnttfrTh7Ht5n/YP6jfWpub01QedGn1FjDU19X87OhteV2PNZWntdfqWxN4D6fmfvSejbktmsfI5PZafc9+aza01+pTMzyziLfHz5vK49IzA3Z7NC+zPtSJAoO9D9vyGezzOedbabjHyWY6OutlR2f9po7O+n91dNZf19FZPyDVIwC+0FTtadm2Zfx3CR2d9aVJ1jbtGo4/p+ek53nsPxskwE+GHm6PqPZa/aNJ3tq06886Outf38pmbm8qnzSEa+6XzWfC395f3aZz9kkV4HevaPBgkud1dNYf2Yp+3pnqJoWk+rM7cQjnND9uY9B+AgDAaBPiAwAAO6NvZfNQ+d3D2PYNTeWh3hzQXO/6YezLjnL6EOud0VTe6tfVCGXmN+0arpsttnb572uaymdu78U7OusPZfOgeSjvZ/cz0UdT75mqa/uos7Xv7bKm8vT2Wn3A19heqx+UZNogbTZ/Bgd9bxvPST9usHpD0DxOTmyv1Xf4ygkdnfUbOjrrb061fHu3l/VXnyTJb5vK2/15Ts9s8CS5ZQj1nzl4lZHVXqt3JHln0653dXTWO/upPpDmGxjOHkL9ZzWVH+jorN8zUOXGDU+/SHJkY9fjqQL8uVvRxzRm3V/dtOvsIZzW3NdL+q0FAAAtQogPAADsdBpLTX+iader2mv1V21tO+21+m59zOJv/sf9F7fX6nsP0sZ+SV7Uz/mt6szG84j71V6rH5vNZy5eto3Xal7K+S+2sY3emsPocUOof2GqZ0MnydPba/WnDEMfmsOuPxlC/TcOwzW3V/PrXt6Y1dzbVr23HZ315el5tvTkVM8QH8gfDtZmNn9vX9teqw/Wj9cmmTCEdgfU0Vm/Lz0zdMcnecv2trkVfthUHuozvndVzd8pfz7YjSND0NVUHnC1kMZqIq3wWd6kvVZvT/IPTbv+qaOz/rFtbO6H6Xk/jmyv1Qe7ieb8pvIPBqrYXqtPS/VdfHxj15JUS+jf2f9ZA/p+P/3o69oHJnluP+cCAEBLEuIDAAA7q//I5rPD/6+9Vn/pUE9ur9WPSzWT75xehy5Kcn+jPCHJxwZoo0jyX+kJO+9N8suh9mEUFUk+3l/41V6rj8nmN0lc3tFZH9Kzjvvwn0k2NsqvbK/Vzx/qie21en9LZS9qKu/fT51NGjPnv9LYLJJ8uREoDaUPbe21+l59HGqe5fqH7bV6v7Nz22v1M5O8fijXG6r2Wv2j7bX6kYPX3FT/yGx+s8HP+6m6Ve9tQ/MM9vMH6MMBSf5+CO19LcmqRvnAJH83QJt7JvnAENocqn9vKn+wvVY/vt+aW/ZlVq/tCY1VAoai+XEAjw/1mruozyZZ2iifnOT9Qz2xvVaf2fh+a3ZfU/nFfRxv9p9poZss2mv1v07ywaZd/9HRWf+XbW2vo7P+WJLvNrc3wO+Jc9Lz+3Njks8M0M/JSX6S5KmNXcuTvLCjs37ztvY1yZeSrGyUj2yv1WsD1P33JN1/rld1dNZ3hhVzAADYxQnxAQCAnVJHZ31tktekJ/CalOT77bX6l9tr9aP7Oqe9Vi/aa/VT22v1LyW5KX0swd3RWe9K8t6mXa9rr9U/1zuMazzj/AtJ/qBp93sa57e6dUlemuSLjdexSXutPj3J11M9JzqpllcfSvDap47O+r3ZPGT63/Za/SPttfrMvuq31+pj22v1c9pr9f/L5suqN7u1qXxOe60+lGfNtyfpfubyCUl+2wih+q5cqx/QXqu/K9Wzl1/b+3hHZ/0X6ZkxXqQaey/uo51zUs1ubcvmz4/fXq9Lclt7rf6D9lr9Vf0t/d54P/8wya/SM8u4K5uH1c2a39vXDLEvX2sqv7uvVTEaM3p/lWR6qvHXr47O+hOpbtLp9oH2Wv3veoer7bX64amW5t5vsDa3wlfSs5rG1CSXt9fqf9Zeq4/vq3J7rT6tvVZ/Q3utflmqG3qa7ZtkfmO8n9LfBdtr9ecn+eemXT/b5t7vAhrj411Nu97fXqt/qfGohi00vvfPbK/V/zvJA6l+VzS7JD03jRyW5EvttfoevdqY1l6r/0+St6UnOB5V7bX6m5N8tGnXpzo66/3e8LIV/jE931XPSPV+bPb90l6rPzubf+6/3NFZ/30//ZyQaub7WY1dq5O8pKOz/tu+6g9VR2f98ST/X9OuTzS+65qvPa69Vv+3VN+X3bb59xkAAIyksaPdAQAAgG3V0Vm/r71Wf1qSH6UK5NtSzTb+k/ZafW6Sm5MsTDUDb1aSE7PlLMrlfbT7zcbM6rc3dtVSLet9aZLHkuydamne5mD/Yx2d9e9m5/CvSf461bLQr2yv1S9JdTPErFThfXNg868dnfXLt/N6/5xkTpLzUgXef5PkHe21+u9SrV6wKtVz0uekCti7r7+od0MNv00yP9Xs5X2T3NFeq1+U6s+6+5nu13Z01i/oPqGjs/5we63+8iQ/TTIz1TOZL2yv1R9qtLcg1YoKM1ONpQEfN9DwliRXpRpT05P8pL1WvzXVChFlkpMaryepwqZXJZk9hHaHakyq56e/LMnG9lr95lSzihel+vv+fklOTbJnr/Pe09FZv66fNr+T5M8a5b9or9Wfmur1rGqq8+nGzRndvpHkb1Mt1z8+ybfba/Xrk9zY6OMJqd6LJKkneVMGfx/+NcnzUz3zvEjyb0n+ur1W/1WSFanC1mc02r8m1Tja7tUOOjrrGxtB4C8afZ6Waobxf7TX6lcleSjVrOPpqcbQ0en5t5Xv9NHkHqnG+9+01+qLU92Y8lCqxxbsneq9OaSp/l1JPr69r+PJrqOz/sX2Wv2QVIFzUn2XvaG9Vr8xyR2pxsiUJAek+t7v90afjs76kvZa/SNJ/qmx6w1JXtReq1+T6s9q31TPXN8t1WM5/iLVLPBR01gh4nOpPhtJdWNB0V6rf3KITXy8o7N+d18HOjrrd7TX6n+entVG/iTJSxq/J5YlOSbJ05pOuTnV75P+/Euqz3K321OtXjKUR2ss6uisD7TSwr+k+o54TqqbMy5or9Xfl+o7a2KSZ6b68+v2/o7O+q+GcF0AABh1QnwAAGCn1tFZn9teq5+Rambmu1OFZkkVCM8Z4NSbktQ7Ouvf76fdv2yv1R9N8r5Uy+pPTRWW9rYmyQc6Ouv/ug3dHy1zk5yb5NupAo6X91FnY5J/6+isv297L9bRWS+TnN9eq1+XKtCfnirsfXrjpy9lkiv6aa+rvVb/i1Sh6fhUNx/0fk71l5Jc0Ou8axszoj+fnucj75/klQN0/7Ek/YVd97fX6s9N8r0khzd2H5ctV3j4XKrVHbaYob4dvpNqdun0xvaYVKHzSf2eUQWS7+zorH+7vwodnfVftNfqX0/PzNWnZfPALqmeSX5v0zkb2mv1V6Z6lER3IH1y46dbmeRDqZa+f9MAfexuc11jZYMLkrywsXvfJH/Uq+qVSV6dKvQfFh2d9UWNRyD8f6lu4BmbKsx/wQCnrU7S+8aI9UnWpvr+SJIZ2fy53L1dluR1HZ31lpjp3eo6Ouv/1Lhp5qOpblgZk2q59qcOcNpv0/eKGB9I9fui+3tkRpIX9aqzNNXYvXFb+zyM9szmq2vulurmgqH6dvr5XkuSjs765xvL6H+s0fb09P39dXGSP+norG9xM1yTvXtt9/5uGMi8DPC4hI7O+vr2Wv0PkvxPku6bAo5v/DRbn+r3/YeGeF0AABh1ltMHAAB2eh2d9RWN5wDPSTUb9wupZgc+mmqZ7RWpllG+KNXMvad2dNZP7C/Ab2r3g6lm234wybWpZnpvaPz3t422jtzJAvwkSUdn/cpUM6fflyp8XJQqcLw/Vch92nAE+L2u+V+pZmC/PdXyyven+rPZkGRJkltSzep+W5LZHZ31vm4u6G7rx0lOSfV87NtSrahQ9le/6bx5HZ3156W6eeCjqV7746lCntVJHky1TP6HU80ePaCjs37hAO3dlmo29V+nCpQXp7qx4/4k30xyTkdn/U87OuvDuZR+Ojrrb08Vjj0z1aMCvpfk96nexw2NPjyeatx2prpR4ZCBAvwmb2j8/DjV+7FmCP25P9X78PeNaz7ROO++VDdUnNHRWX9f44aOob7GZR2d9RelCg9/lJ7P88OpwsM3Jzm7o7P+SP+tbJuOzvrqjs76n6e6OeMfU42J7hn061Kt3HBNqvDwtUlm9f4e6OisP5QqbH1ZqvF0SarvodWpbpJZmupmos4kz+/orD+7o7P+6HC/liezjs76N1PdOHJ+qseA3JNq7G1MNWv89lTPeH9Xqu/qpzUexdK7nY0dnfXzUj1m5Efp+U54PMnvUo2BYwf7nfFk0tFZ70w16/4DqVaQ6P4dMTfVe/oHqcbtsH/+tkZHZ/2Jjs76a1N9X38lPau7PJHq8SD/meQpAnwAAHY2RVkO+e/PAAAA7KTaa/UvplrOPkne1NFZ/+Lo9QYAAACA/piJDwAAAAAAAAAtQogPAAAAAAAAAC1CiA8AAAAAAAAALUKIDwAAAAAAAAAtQogPAAAAAAAAAC1CiA8AAAAAAAAALaIoy3K0+wAAAAAAAAAAxEx8AAAAAAAAAGgZQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEWNHuwM8uRVFMTbJrMbmo2VZbhjN/gAAAAAAAAC0MjPx2dFmJZnf+Jk1SF0AAAAAAACAXZqZ+IyY+fPnzx/tPuwMurq6smzZsiTJtGnT0tbmXht2DGONkWKsMVKMNUaKscZIMdYYKcYaI8VYY6QYa4wUY42RYqwxUoy17VYMV0PeeQAAAAAAAABoEWbiAwAAAAAAALSoefMW59ZbH8099y7MI48sz4oVazNmTJHdd5+UQw/dM2c+/eAcdtjMIbd3662P5DeX359585ZkxYq1mTJlQmbPnp6zzpyTAw+cPKQ27rtvUS6//P7ce+/CLH1idTZuLDN58vgcsP/uOenk/XPG6XMyduzWzyf/7vduzkUX3bVp+13vemaOPGLvrW5nZyfEBwAAAAAAAGhBH/nPy3LPPQu32L9hQ/L44yvy+OMrctVV83L602bnj//4qQMG511dZb761etyxZVzN9u/dOnqLF26Ojfd9HBOPXW/vPIVR/fbRlmW+eY3b8qll92zxbFly9bk98vW5Pe3P5ZLL7knf/mXZ2XGjKHdFJAk8+cvzS9/efeQ6z+ZCfEBAAAAAAAAWtATT6xOkuy++8Q89eQDcthhMzNjxuR0dZW57/5F+eUv787Spatz9TXzsnFjV97ylqf129YPfnjrpgD/wAP3yDnPPzJ77bVbFixYmYt+cWfmz1+aa699OLvtNj5/+JqT+2zjwgvv3BTgT5w4Ns997uE59NCZmThhbB59bHl++cu78vDDy/LwI8vyyU9dnvZ/eF7GjBl8Rn5XV5mvfPW6dHWVmTp1QpYvX7uV79STixAfAAAAAAAAoAXN2mdqXv7y43LySQekra3Y7Nghh+yZ0582Ox/+8KV57PEVufZ38/PMZx6Sww/fa4t2HntseX7xi2qZ+tmzp+dv3n12xo8fkySZM2dGnvKUffOR/7wsDzywNL/+9byc/awjMmvWtM3a2LixKxdddGeSZOzYtvzNu8/OgQfusVl/nnbaQfnIRy7L/XMX5+GHl+XGmx7OU08+YNDXeeml92TevCWZNWtqTnzKfvn5hXdu1fv0ZLP1DyIAAAAAAAAAYId7+9vPyilPPXCLAL/blCkT8qpXn7Bp+/rrH+qz3sWX3J2urjJJ8to/PHFTgN9t/Pixee0fnpikmhV/yaVbLpf/yCPLsmr1+iTJ8cftu1mA323MmLa88IVHbdq+/75F/b+4hsWLV+WHP7otSfL6152cMQM8EmBX4R0AAAAAAAAA2EkdecTem8oLFq7Y4nhZlrnppoeTJLNmTc0hh+zZZzsHHzwje+1VPcP+5psfTlmWmx3fuLFrU3nmzN367c9ee/Uc29B0Tn++/o0bsnbthpx++uwcccSWqwjsioT4AAAAAAAAADupDRt6gvK2YssZ+wsXrswTT6xJkj6X2m928MHTkyRLl67JokWrNju2995T0938woUr+21jwYKeY/vsM3XA6/3uuvm55ZZHsttu4/PqV50wYN1diRAfAAAAAAAAYCd1190LNpVn7btlaP7Io8t6jg8SqnfPxO99XpJMmjQup5xyYJLkllsfyYMPLt3i/I0bu/LzC+/YVP/URv2+rFq1Lt/85k1Jkle+4vhMmTJhwL7tSsaOdgcAAAAAAAAA2HpdXWUubITmSfLUk7cMzZcuWb2pvMf0SQO2t8fuEzeVlzSd1+01r35KHnt0eR6YvzQf+c/L8vznHZFDDtkzEyaMzWOPLc/Fl9ydBx98IuPHj8n55506YDD/3e/dkmXL1uTQQ/fMmWfOGbBfuxohPgAAAAAAAMBO6OJL7s7cuUuSJCeduH9mz56+RZ01azZsKk+cMHA8PH78mE3ltWs3bHF82rSJ+du/PTu/ufz+XHjhHfnRj3+/2fGiSM488+A8/3mHZ9asaf1e5+67F+SKK+5PW1uR17/u5BR9PAZgV2Y5fQAAAAAAAICdzF13Lcj3vndLkmTq1Al53etO6rPe+g0bN5XHjBk4Hh4ztuf4+nUb+6xzx52P57e/fSDLlq3d4lhZJjff9HCuumpeNmzo6vP8DRu68tWvXZ+yTJ773MOz//67D9inXZGZ+AAAAAAAAAA7kYcffiKf+eyV6eoqM25cW/70radn2rSJfdYdN7Zndv3GjX0H65uONwXv45pm5Xe7+JK78+1v35SyTA4/fGZe/KKjM2fOjIwbNyYLFqzIlVfOzcWX3J0LL7oz99y7MO/4y2dk4sTNI+mf/fz2PPro8syYMTkvOfeYrXnZuwwz8QEAAAAAAAB2EgsXrszHP/GbrFq1Pm1tRd7yltNz+OF79Vu/OURf08cS+c3WNc2+n9Br6f0HH1y6KcA/6qi98653PitHH71PJk0al7Fj27LvvtPyqledkDe84eQkyb33LsqPf3zbZm08+uiyXHjhnUmS1/7hiVtcg4p3BQAAAAAAAGAnsHTp6nzs47/OE0+sSVEkb/yTU3LiU/Yb8Jw9pk/qOX/J6oHbf2LNpvL0pvOS5Mqr5qYsq/JLX3JM2tr6fo79mU8/OBdeeGcef3xFrrp6Xl71qhM2PfP+4ovvzoYNXZk5c7esW7cx1147f4vzH3542abynXcuyLInqmX7Tzhh310m9N81XiUAAAAAAADATmzFirX5+Cd+k4ULVyapZrKffvrsQc/bd9a0TeVHH1s+YN0FC1b1eV6SPPpoz7kHHTR9wHYOOnCPPP74iqxcuS7Ll6/dtNT/+sZy/QsXrszn//eaQfv+05/evqn8wQ++aJcJ8S2nDwAAAAAAANDCVq9en0984jd55JFqlvorX3Fczj77sCGdO3Pmbtl99ypEv/vuBQPWvf/+JUmSPfaYmD33nLzZsTFNM+83biwHbKf5eH8z9unfrnGrAgAAAAAAAMBOaN26Dfnkpy7PA/OXJkle9MKj8oIXHDXk84uiyFOesl9+/ev78uijy3PffYtyyCF7blHv/vsXb5qJf8IJ+21aAr/bnjN321S+554FOe64ffu83saNXbnv/kVJkkmTxmW33cZvOnb+eafm/PNOHbC/P/rxbfnJT6oZ+O961zNz5BF7D+FVPrmYiQ8AAAAAAADQgjZs6MpnPnNV7r23CsWf8+zD8vKXH7fV7Tz3OYdvmhF/wTdvzLp1Gzc7vm7dxlzwzRuTVDPnn/PsLWf5n3B8T2j/ve/fmtWr1/d5rR/96LY88cSaJMlxx87a4mYABmcmPgAAAAAAAEAL+vznr8nvb38sSXLkkXvlzDMPzkMPPdFv/bFj27LPPlO32L/PPlPz/OcfkQsvvDPz5i3Jhz9yaV5wzpHZa6/dsmDBylx40Z2Z35jp/8xnzs7ee0/Zoo1jjpmVI4/cK3feuSAPPfREOjp+mWc/57AcPGdGxo5ry4LHV+bKK+/Pbb+v+jthwpice+4xw/Au7HqE+AAAAAAAAAAt6IYbH9pUvvPOBfmXD/5iwPozZkzOhzpe3Oexl7/suCxfvjZXXjk38+cvTefnr9mizimn7Jdznn9ov+3/6VvPyP/8z1W5864FWbhoZb71rZv6rDd1yoS8+c2nZdasLW8oYHBCfAAAAAAAAIAnuba2Im/8k1Ny0kn75/LL78/cuYuzcuW67Lbb+MyZMyNnnTknBx44ecA2dtttfN75zmfmppsfybXXPpB5c5fkiWVr0tXVlcmTxmff/abl2GNn5awzD85uu40foVf25CPEBwAAAAAAAGhBn/n0q4e9zeOP2zfHH7fvFvu7urqybNmyQc8viiInPmW/nPiU/Ya9b0ny0pccm5e+5Ngd0vbOom20OwAAAAAAAAAAVIT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIsaOdgcAAAAAAAAAWs2DX/n70e7CiOpKkdVtk5Mky7pWpS3lKPdoZB3wx/862l3YxEx8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRQnwAAAAAAAAAaBFCfAAAAAAAAABoEUJ8AAAAAAAAAGgRu2yIXxTFKUVR/FNRFBcVRfFgURRri6JYURTFXUVRfKEoirO2sr0XFUXxvaa2Hmxsv2gr2hhbFMXbiqL4TVEUC4qiWF0Uxb1FUXy2KIpjt6KdmUVRfKAoipuLoljW+Lm5sW/PrXldAAAAAAAAAIycsaPdgdFQFMWvkzyjj0Pjkxze+Dm/KIovJ3lrWZbrBmirLcn/JHlLr0P7N35eURRFZ5I/K8uya4B2Zib5aZJTex06JMmfJjmvKIq/LMuyc5DX9rQk308yq9eh4xs/taIoXlGW5W8HagcAAAAAAACAkberzsTfr/Hfh5N8PMmrk5yW5Iwk707yUOP4G5N8cZC2OtIT4N+Q5HWNtl7X2E6SWpIP9tdAURRjknwvPQH+d5O8KMnTkvxVkseTTEjy2YFm9hdFcWCSH6UK8Dck+Y8kz2z8/Edj375JflQUxQGDvC4AAAAAAAAARtguORM/yR1J/iHJd8qy3Njr2NVFUfxfkiuSHJHkdUVRfKYsy1/3bqQoiiOS/G1j83dJnlmW5erG9rVFUfwwya+SnJLk/xVF8b9lWd7TR3/OS9K9fP9/l2X59qZjvy2K4mdJrksyLckniqI4uizLDX2005Fkr0b59WVZfqvp2G+KorguyQVJ9k51U8H5fbQBAAAAAAAAwCjZJWfil2X5krIsv9lHgN99fGGSv2na9ep+mnpnem6EeEdTgN/dzqok72hsjk3yrn7a6b4RYHGS/9dHf+5J8q+NzcOSvLJ3naIoZiV5Q2Pzwl4Bfnc730xyYWPzTxrnAAAAAAAAANAidskQf4gubSof2vtgURRFkpc3Nu8oy/Lqvhpp7L+zsfnyxnnN7RyR5OjG5jcbwX9fvthU3iLET/Ky9Px5fqGfNprbaWucAwAAAAAAAECLEOL3b0JTua8Z+wcn2a9R/tUgbXUf3z/JnF7Hzuqj3hbKsnw0yV2NzTP7qDKkdnod66sdAAAAAAAAAEbJ2MGr7LKe1VS+vY/jxzSV7xikrebjRye5fzvaOSLJgUVR7FaW5co+2nmiEfj3qSzLR4qiWJZkWnpWANhmRVEcMEiVTUv2d3V1paura3sv+aTX/D55v9iRjDVGirHGSDHWGCnGGiPFWGOkGGuMFGONkWKsMVKMNUaKsTZ6ulIMXulJpCtFysZr3tVee7L9n6+2tuGbPy/E70NRFG1J3tu065t9VGsOrx8cpMn5TeUDh6GdonHenU3HutsZrI3udo7toy/bYv7gVSrLly/PsmXLhuGST25dXV1ZubLn/ozh/MBDM2ONkWKsMVKMNUaKscZIMdYYKcYaI8VYY6QYa4wUY42RYqyNntVtk0e7CyOqTLK2bcKmrV0txt/eHHOPPfYYno7Ecvr9eVeS0xrl75ZleV0fdaY2lVcM0l7zjPkpO7idwdpobqd3GwAAAAAAAACMIjPxeymK4llJ/q2x+XiSP++n6sSm8rpBml3bVJ60g9sZrI3mdnq3sS0Gm80/K8m1STJ16tRMmzZtGC755Na8VMe0adPcUccOY6wxUow1Roqxxkgx1hgpxhojxVhjpBhrjBRjjZFirDFSjLXRs6xr1Wh3YURVS+hX8+8ndq1OW8rR7dAIa6UcU4jfpCiKY5N8L9X7sibJa8qyfLyf6muayuMHaXpCU3n1IO2sSf8Ga2fyEPrS3E7vNrZaWZYDLt9fFD0LbbS1tfnFMkTd75P3jB3NWGOkGGuMFGONkWKsMVKMNUaKscZIMdYYKcYaI8VYY6QYa6NjVwuxk6RovOa2lLvc62+lz1br9GSUFUVxcJKLkkxPsjHJH5Vl+esBTlneVB5sWfrdmsq9l7sf7naGskR+dztDWXofAAAAAAAAgBEixE9SFMV+SX6ZZL8kZZI3l2X5g0FOa56BfsAgdZuXnJ8/DO2Uvc5rbmewNprb6d0XAAAAAAAAAEbRLh/iF0UxM8kvkhzS2PWOsiy/PIRTf99UPmqQus3Hbx+GduaXZbmyn3Z2L4piVn8NFEWxb5LuBzr07gsAAAAAAAAAo2iXDvGLotg9yYVJjmnsem9Zlp8a4un3J3m4UX7WIHWf2fjvQ0nm9jp2eVO533YawfwRjc0r+qgypHZ6HeurHQAAAAAAAABGyS4b4hdFMTnJT5Kc3NjVUZblvw/1/LIsyyTdS+4fVRTF6f1c5/T0zKD/QeO85nbuSs+M+D9s9Ksv5zeVv9fH8R8m6WqU3zRA17vb6WqcAwAAAAAAAECL2CVD/KIoxqcKws9s7Pp4WZbv24amPpZkY6P8X0VRTOp1nUlJ/quxuaFRvy8fafx3RpL/6KO/hyb5+8bmPekjxC/L8tEkX21svqAoilf30c5rkrygsfl/jXMAAAAAAAAAaBFjR7sDo+TrSc5plC9J8vmiKI4boP66xoz5zZRleVdRFB9O8t4kpyS5oiiKf09yb5JDk/xdkpMa1T9cluXd/bT/pSRvTnVTwdsbS+d/LsmSJKcl+cdUz7HvSvJXZVlu6Ked9iQvTLJXkq8XRXFKkh83jr0kyd80yguSbMtNCwAAAAAAAADsQLtqiP8HTeXnJLl5kPrzkszp51h7kr1ThfAnJflGH3U+nwFC87IsNxZF8YokP01yapJXNX6arU3yl2VZ/myAduYXRfHSJN9PMivVTQR/16vao0leUZblg/21AwAAAAAAAMDo2CWX0x9OZVl2lWX5liTnJvlBkoeTrGv89wdJXlyWZa0sy64BmklZlguTPD3JXyS5PMmiJGuS3JdqVv5Ty7LsHEJ/rklyfJIPJrk1yYrGzy2Nfcc16gAAAAAAAADQYnbJmfhlWRY7oM2fpppJvz1tbEjy6cbP9rSzMNUS/P+4Pe0AAAAAAAAAMLLMxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYxdrQ7AACMjmXL1mTuvMWZO3dJ5s1dnLnzlmTlynVJktNPn53zzzt1wPMXLlqZ973vZ1t1zRkzJudDHS8ecv1bb30kn/zUFZu2zz336Lz0JccOet5DDz2Ryy67J7ff8XieeGJ1JkwYm1n7TM1ppx2UM888OGPGuI8RAAAAAIDWJMQHgF3Ue/7uxyN+zX32mTLkumvXbsjXvn7DVl/jN5fflwsuuDEbNnRt2rd+/brcs2JR7rl3Ua68am7+8u1nZcqUCVvdNgAAAAAA7GhCfAAgM2ZMzqx9pub3tz825HOm7zEp//i+5w9a7+c/vyPX/m5+kuT0p80ecvs//NFtWbx4VaZOnZDly9cO6Zxbbn0kX/va9SnLZNq0CXnRC4/OnINnZNXKdbn88vtzw40PZe7cJfnMZ67Mu999dtraiiH3BwAAAAAARoIQHwB2Uee++OjMnjM9c2bPyLRpE7d6efwxY9qy//67D1inq6vMXXcvSJJMmDAmT3nKfkNqe968Jbn00nsydmxbXv6y4/KVr1436DkbN3blggtuTFkmEyeOzf/722dnr716Zv4fe+ysfP3rN+RXv74399y7KFdfMy9PP2POkPoDAAAAAAAjxQNhAWAX9dKXHpsTjt8v06ZN3GHXuP2Ox/LEE2uSJMcdt3fGjx8z6DldXWW+8tXr0tVV5kUvPCp77b3bkK51w40PZeHClUmSF77wqM0C/G6vetXxmTx5XJLkF7+4a6gvAwAAAAAARowQHwDYYa6+et6m8lNPHtos/F9efFfmz1+affaeknPOOXLI17rpxoc3lc84fU6fdcaPH5unPvXAJMkjjyzLY48tH3L7AAAAAAAwEoT4AMAOsWbN+tx0UxWsT58+MQcfvMeg5yxctDI//vHvkySve93JGTdu8Jn73e65d2GSZJ99pmb33ftfXeCIw2duKt9776Ihtw8AAAAAACNBiA8A7BDXX/9Q1q3bmCQ56aR9UxTFoOd8/WvXZ926jTnttINy1FF7D/laa9ZsyJIlq5Mks2ZNHbDuPk3HH3l02ZCvAQAAAAAAI0GIDwDsEFdf07OU/skn7Tto/d/+9oHc9vvHMnnSuLz6VSds1bWWLl21qbzHHpMGrDtj+uRN5e7gHwAAAAAAWoUQHwAYdosXr8rddy9IkhxyyIzMnDl5wPorV67Lt759U5LkFa84LtOm9b8cfl/WrNmwqTxxwtgB644f33N87doNA9QEAAAAAICRJ8QHAIbdNdfMS1lW5aeddtCg9b/znZuzfPnaHDxnRs4665Ctvt769Rs3lceMHfh/b8Y2HV+/buMANQEAAAAAYOQJ8QGAYXfNbx9IUgXmT33qAQPWvfOux3PlVXPT1lbk9a8/OW1txVZfb9y4MZvKGzd0DVh3Q9PxcePHDFATAAAAAABGnhAfABhW989dnEcfXZ4kOeGE/TJ58vh+665fvzFf++r1SZJnP/uwHHjgHtt0zYkTe5bIXzPIEvnr1vUcnzDI0vsAAAAAADDS/Ms1ADCsrr563qby6acPvJT+jTc+lMceX5ExY4rsO2tarr12/hZ1Hnl02abyww8v21Tn4INnZObM3ZIke+wxaVOdpUtXD3jNxUtWbSpPnz5pgJoAAAAAADDyhPgAwLDZuLErv/tdFbJPnTohxx4za8D66xtL22/cWOYrX71u0PZvuOGh3HDDQ0mSN77xlE0h/sSJ4zJ9+qQsWbJ60yoA/Xms6fi+s6YNek0AAAAAABhJltMHAIbNLbc8kpUr1yVJTj31wIwZM3L/q3HYoTOTJI89tjxPPLGm33p33b1wU/nQQ/fc4f0CAAAAAICtYSY+ADBsrr6mZyn9M06fM2j9p58xJ08/Y+B6d971eD760V8nSc499+i89CXH9lnvKSful2sbqwBcdfXcvPAFR21RZ926DbnuuqrOvvtOyz77TB20jwAAAAAAMJLMxAcAhsXKlety662PJkn233/3HHjgHiN6/ZNO3H/T8vo///kdWbBgxRZ1vvOdW7Jq1fokyfOff8SI9g8AAAAAAIbCTHwA2EXdc8/CPN4UdK9YsXZTecGCFbnyqrmb1R9sxvy1v5ufDY1n3J9++uxh6+dQjRnTlte+9sT8939fkTVrNuTDH7k0L3rR0ZkzZ0ZWrVqXyy+/Pzfc8FCS5LBD98zpTxv5PgIAAAAAwGCE+ACwi7r8ivtz9dXz+jx2772Lcu+9izbbN1iIf02jrba2IqedetCw9HFrHX/cvnn960/OBRfcmGXL1uaCC27cos6cOdPztrc9PW1txch3EAAAAAAABiHEBwC222OPL8/9cxcnSY4+au/svvvEUevLM846JIccvGcuveye3HHH43niidUZP35s9p01NaeddlDOPPPgjBnjiUIAAAAAALQmIT4A7KLOP+/UnH/eqcPS1j57T81nPv3qYWmrtyOP2Hur295//93zx2946g7pDwAAAAAA7EimoQEAAAAAAABAixDiAwAAAAAAAECLEOIDAAAAAAAAQIsQ4gMAAAAAAABAixDiAwAAAAAAAECL2GVD/KIo9i6K4iVFUXygKIqfFUWxsCiKsvHzxSGcP6ep/lB/5vbT1mVDbWOIr+24oig+WxTFvUVRrC6KYkFRFL8piuJtRVGM3bp3CgAAAAAAAICRsisHuo+NwjXv3NEXKIrirUk+mWR80+6JSc5q/LypKIpzy7JcuKP7AgAAAAAAAMDW2ZVD/GYPJLkjyTlbcc5DSY4fQr2/T/L6RvlLg9T9XZI3bUUfNlMUxYuTfCbVCguPJelIck2SGUnemuQPkpyW5HtFUZxdluXGbb0WAAAAAAAAAMNvVw7xP5Dk2iTXlmX5WFEUc5LcP9STy7Jcn+TWgeoURTEmydmNzeVJvjdIsyvLshywzQGuNS7Jf6UK8JclObMsy3ubqvy8KIpPJfmLVDPy/yTJF7flWgAAAAAAAADsGG2j3YHRUpbl+8uy/HFZljtyWf3nJdmvUf52WZard+C1XpnkkEb5X3sF+N3+X5IlTWUAAAAAAAAAWsguG+KPkDc2lQdbSn97vaKp/MW+KpRluSrJNxubxxRFccQO7hMAAAAAAAAAW0GIv4MURTE1PcH63CS/3sGXPKvx3zvLsnx0gHq/aiqfuQP7AwAAAAAAAMBWEuLvOK9OMrlR/r+yLMshnHNUURTXFEWxtCiKNUVRPFgUxQ+Konhj45n3fSqKYkqSAxubdwxyjebjRw+hTwAAAAAAAACMkLGj3YEnseal9L88xHP2afx027/x87Ikf1cUxavLsry9j/MOaCo/OMg15jeVD+y31hAVRXHAIFVmdRe6urrS1dW1vZd80mt+n7xf7EjGGiPFWGOkGGuMFGONkWKsMVKMNUaKscZIMdYYKcYaI8VYGz1dKUa7CyOqK0XKxmve1V57sv2fr7a24Zs/L8TfAYqiOCjJsxqbV5Zlec8gp3QluTjJT5PclGRRkqlJTk7yZ6lmzB+T5NKiKE4ry/KBXudPbSqvGORaK5vKUwapOxTzB69SWb58eZYtWzYMl3xy6+rqysqVPX9Mw/mBh2bGGiPFWGOkGGuMFGONkWKsMVKMNUaKscZIMdYYKcYaI8VYGz2r2yYPXulJpEyytm3Cpq1dLcbf3hxzjz32GJ6ORIi/o/xxsmlcD2UW/h+UZbm0j/2/KYriv5N8Lsl5qWbpfyzJH/SqN7GpvG6Qa61tKk8aQt8AAAAAAAAAGCFC/B3jTxr/XZvkgsEq9xPgdx9bXxRFLcnpSY5M8sqiKPYvy/KhpmprmsrjB7nchKby6sH6NgSDLck/K8m1STJ16tRMmzZtGC755Na8VMe0adPcUccOY6wxUow1Roqxxkgx1hgpxhojxVhjpBhrjBRjjZFirDFSjLXRs6xr1Wh3YURVS+hX85Qndq1OW8rR7dAIa6UcU4g/zIqiOC3JUY3NHw4U0A9VWZYbiqL4fJL/aOx6VpKvNVVZ3lQebIn83ZrKgy29P5S+PTjQ8aLoWWijra3NL5Yh6n6fvGfsaMYaI8VYY6QYa4wUY42RYqwxUow1Roqxxkgx1hgpxhojxVgbHbtaiJ0kReM1t6Xc5V5/K322WqcnTx5vbCoPZSn9ofp9U3n/XseaZ+UfMEg7zTPnh/w8ewAAAAAAAAB2PDPxh1FRFOOS/FFj8/EkPx/G5vu91aUsy+VFUcxPFdAf1V+9hubjtw9HxwDYOi9978Wj3YUR1VaUmT65WvJryaq2dJXFIGc8ufzo35472l0AAAAAAGAnYib+8Do3yZ6N8tfKstwwjG0f01R+uI/jlzf+e2RRFLMGaOdZTeUrtrtXAAAAAAAAAAwbIf7wal5K/0vD1WhRFGOTvLlp16/7qPb9pvL5/bQzOckfNjZ/X5blXcPRPwAAAAAAAACGhxB/mBRFMSPVTPwkuaUsyxuHeN6zi6LYY4Dj45J0Jjm6setHZVn29Sz77yW5r1H++6IoDu2jzoeTTG8qAwAAAAAAANBCxo52B0ZLURRnJTmsadfMpvJhRVGc31y/LMsvDtLkHyUZ3yhvzSz885L8sCiKHya5LMmdSZYlmZLkqUn+ND1L6T+e5K/7aqQsy/VFUbwjyY+STEtyRVEUH0zy21TB/VuTvKpR/fIk/7cVfQQAAAAAAABgBOyyIX6SWqoAvS9nNn6afXGQ9rqX0t+Y5Ktb2ZcpSV7f+OnPLUn+qCzL+/urUJblT4uieFuSTybZJ8l/9VHtt0leWZblxq3sIwAAAAAAAAA72K4c4g+boigOT/K0xuYvyrJ8dCtO//ckNyY5I9WM+72SzEiyNsljSX6X5NtJvjeU4L0sy88VRXFVkr9K8twk+yVZmeT2VDcXdJZluWEr+gcAAAAAAADACNllQ/yyLM9Pcv4wtXV3kmIbz709VcD+seHoS6PNW1Mtww8AAAAAAADATqRttDsAAAAAAAAAAFSE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIoT4AAAAAAAAANAihPgAAAAAAAAA0CKE+AAAAAAAAADQIsaOdgdgZ7Fs2ZrMnbc4c+cuyby5izN33pKsXLkuSXL66bNz/nmnDtrGlVfNzZe//LshXe/Vrz4mz3n2tK3q4623PpJPfuqKTdvnnnt0XvqSY7eqjST5XOfVue66Bzdtf/CDL8rMPXfb6nYAAAAAAACArSPEhyF6z9/9eLS7MKC1azfka1+/YbvbufmWhzcL8AEAAAAAAICRI8SHbTBjxuTM2mdqfn/7Y9vcxl+946zsvvukLfaXZVdWrFiZ3XefsFXt/fBHt2Xx4lWZOnVCli9fu019WrNmQ77xjRuTZLvaAQAAAAAAALaNEB+G6NwXH53Zc6ZnzuwZmTZtYhYuWpn3ve9n29ze3vtM7XOJ+q6urixbVmxVW/PmLcmll96TsWPb8vKXHZevfPW6berTD394axYvXpWjjtw7e0yflKuvnrdN7QAAAAAAAADbpm20OwA7i5e+9NiccPx+mTZt4mh3ZTNdXWW+8tXr0tVV5kUvPCp77b1tz66fN29xLr2suhHgda87aZh7CQAAAAAAAAyFEB92cr+8+K7Mn780++w9Jeecc+Q2tbFxY1e+8pXrU5bJC15wZPbZZ+ow9xIAAAAAAAAYCiE+7MQWLlqZH//490mS173u5IwbN2ab2vnlxXdn/oNLs/feU/LCFxw1nF0EAAAAAAAAtsLY0e4A7Kq+/OXf5bHHlmfFirWZOHFc9t5rSo46au884xkHp22It9d8/WvXZ926jTnttINy1FF7b1M/Fi5cmZ/8pHEjwB+dtM03AgAAAAAAAADbT4gPo+SuuxZsKq9cuS73r1yc++cuzi8vvisvOfeIPO1pBwx4/m9/+0Bu+/1jmTxpXF79qhO2uR9fa9wIcOopB+boo/fZ5nYAAAAAAACA7SfEhxE2c+ZuOenE/XPIIXtm+vRJSarZ8Nff8FBuuOHBrF/fle99/46kSJ7/vGP6bGPlynX51rdvSpK84hXHZdq0idvUl2uumZff3/5YJk0al9e85inb9oIAAAAAAACAYSPEhxF00on754zTZ6cois32z5kzI6eccmBuvuXhfPazV2XjxjI//vFdOe3UQzJ9+uQt2vnOd27O8uVrc/CcGTnrrEO2qS8rVqzNt799c5Lk5S/f9hsBAAAAAAAAgOEzxCdvA8Nh0qRxWwT4zU44fr+8+EVHJ0nWr+/KlVfN3aLOnXc9niuvmpu2tiKvf/3JaWvrv72BfPs7N2f5irWZM2d6nvmMbbsRAAAAAAAAABheQnxoMWedNSfdOf/ddy/c7Nj69Rvzta9enyR59rMPy4EH7rFN17jjjsdz9dXztvtGAAAAAAAAAGB4WU4fWszUqRMzefK4rFy5Pk8sXb3ZsRtvfCiPPb4iY8YU2XfWtFx77fwtzn/k0WWbyg8/vGxTnYMPnpGZM3dLklx00Z1JktkHTc9jj67IY4+u2KKdRYtWbirfcvMjmTJlQpLk1FMP3M5XCAAAAAAAAPRHiA87kfUbupIkGzeW+cpXrxu0/g03PJQbbngoSfLGN56yKcRfv2FjkuT+uYvz+f+9ZtB2LvjmjZvKQnwAAAAAAADYcSynDy1m+fK1WbVqfZJk9z0mjXJvAAAAAAAAgJFkJj60mMuvuD9lWZUPP2zmZseefsacPP2MOQOef+ddj+ejH/11kuTcc4/OS19y7BZ1/ubdZw/ajy9+6dpcffW8JMkHP/iizNxzt8E7DwAAAAAAAGwXM/FhhCxctDIPzF8yYJ2bb3k4P/vZHUmScePacsYZs0eiawAAAAAAAECLMBMfhuieexbm8QUrNm2vWLF2U3nBghW58qq5m9XvPWN+0aKV+ehHf51DDpmRE47fL/sfsHumTZ1Qnb9wZa6//qHccMODm2bhv/hFh2cPy+kDAAAAAADALkWID0N0+RX3b1pevrd7712Ue+9dtNm+/pa9v+++xbnvvsX9Xmf8+DE599zD87TTDtjmvgIAAAAAAAA7JyE+jJDZB03Pm950Wu67b1EemLckTyxbkxUr1qarq8zkyeOy777TctSRe+fpT5+dslw32t0FAAAAAAAARoEQH4bo/PNOzfnnnbrN50+cOC5PO+2gPO20gwas19XVlWXLtj3EP/KIvfOZT796m8/vtr2vFwAAAAAAANh6baPdAQAAAAAAAACgIsQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWIcQHAAAAAAAAgBYhxAcAAAAAAACAFiHEBwAAAAAAAIAWMXa0OwCD+fglV412F0ZWWWZ814Ykybq2sUlRjHKHRtZfP+eM0e4CAAAAAAAAjBoz8QEAAAAAAACgRQjxAQAAAAAAAKBFCPEBAAAAAAAAoEUI8QEAAAAAAACgRQjxAQAAAAAAAKBFCPEBAAAAAAAAoEUI8QEAAAAAAACgRYwd7Q4AAADAzmTZsjWZO29x5s5dknlzF2fuvCVZuXJdkuT002fn/PNO3ea2163bkA984BdZuGhlkmSPPSbmvX93Vr/1Fy5amVtufiR33bUgDz70RJYuXZ2yLDNlyoTMnj09pzz1wJx88v4ZM2bb7uH/XOfVue66Bzdtf/CDL8rMPXfbprYAAACAodllQ/yiKPZOclrj59TGz56Nw18qy/L8IbRxfpIvDPGSbyrL8ouDtDc5yV8meU2SQ5NMSDI/yU+SfKIsy3lDuVBRFLOT/FWSc5McmGRtknuTfDPJp8qyXDXEPgMAANDLe/7uxzus7R/+6LZNAf6gdX94a3728ztSllseW7p0dZYuXZ2bbno4v7x4ev7sT8/IjBmTt6ovN9/y8GYBPgAAADAydtkQP8ljo92BZkVRHJbkp0kO73XoyMZPrSiKN5RlOeC/FhVF8dIkX0kyrWn35CSnNH5qRVGcW5blPcPWeQAAgF3UjBmTM2ufqfn97dv/V8wH5i/JJZfck3Hj2jJmTFvWrNkwYP0nnliTskwmTBiTE5+yf448au/svfeUjBs7Jo8+uiyXXHpP5s1bknnzluRjH/91/uHvn5eJE4f2zwBr1mzIN75xY5Jk6tQJWb587fa+PAAAAGCIduUQv9kDSe5Ics52tPGCJA8PcLzf6QtFUUxNNdu+O8D/XJJvJFmd5NlJ/j5VKH9BURRnlmV5Yz/tnJTkgiSTkqxI8q9JLm1s/1GStyY5IslPiqI4pSzL5UN9cQAAAFTOffHRmT1neubMnpFp0yZm4aKVed/7frZdbXZ1lfnKV65PV1eZc889OldcMXfQEH+3KePzylcen2c985BMnDhus2OzZ0/PqacelM//7zW57roH8/jjK3LxxXfl3HOPGVJ/fvjDW7N48aocdeTe2WP6pFx99ZAWhgMAAACGwa4c4n8gybVJri3L8rGiKOYkuX872rurLMu523ju/0sVrifJe8qy/HDTsauKorgsya9Szaj/WJKz+2nn46kC+w1JzinL8qqmY5cURXF3kv9oXOtvktS3sb8AAAC7rJe+9Nhhb/OSS+7OAw8syT77TM0LzjkqV1wxd9Bz/uCVJwx4vK2tyOv+6KTcdNPD2bChK9ff8NCQQvx58xbn0svuydixbXnd607Kz35+x1BfBgAAADAM2ka7A6OlLMv3l2X547IsR3VZ/aIoxqV6fn2S3J7kP3vXKcvyyiSfb2w+qyiKU/to57Qkz2hsfr5XgN/tPxvXSJK/blwbAACAUbRo0cr86Me3JUle//qTMnbs8P1VfcqUCdl//92TJAsWrBi0/saNXfnKV65PWSYveMGR2WefqcPWFwAAAGBodtkQv4U8O8nujfKXyrLs6qfeF5vKr+zj+Cuayl/oq4FG219ubO7RuDYAAACj6OvfuCFr127M0552UI48Yu9hb3/DhuqvmW1txaB1f3nx3Zn/4NLsvfeUvPAFRw17XwAAAIDBCfFH31lN5V8NUO93SVY1ymcO0M7KJNcN0E7zNfpqBwAAgBFy7bXzc+utj2by5HF59aueMuztL1u2Jo88sixJMmvWwLPqFy5cmZ/85PdJktf90UkZN27MsPcHAAAAGNzY0e7Ak8gXiqI4MsnMJMuS3JPkl0k+XZblQwOc1/xAwn4fNFiW5YaiKO5JckKSo/uo0r3vnrIsNwxwveZr9NXOVimK4oBBqszqLnR1daWrq7+FBgZQllt/zs6sLHte86722pNtGyNsk+bPpPd9ZLUVu9Znu60oUzRe86722hOfr5Hke42RYqzRW9k8DspyyONi1ap1+da3bkySvOLlx2W33cb1ee42/10qyUUX3Zmurur378knHTBgO1/92nVZt25jTjnlgBx55F49dZv+XlJuR19oXb7XGCnGGiPFWGOkGGuMFGNt9HRl8BXNnky6UqRsvOZd7bUn2//5amsbvvnzQvzhc3ZTec/Gz9OS/E1RFO8sy/Kz/ZzXHYKvLMty6SDXmJ8qxN+rKIoJZVmuTZKiKCamunkgSR4cqIGyLJcURbEyyW5JDhzkekMxf6gVly9fnmXLlm31BcZ3DXRPwpNQWWZcubEqdyUpdq0vyW0ZI2ybrq6urFy5ctP2cP5yYWDTJ+9a/6PdVpSZNrH6x/8iXekqfa+xY/heY6QYa/S2fMXqTeV169cP+bv/29/5fZYtX5uDDto9xx8/Y7Pzuv/hoCx7xtvWjrUHHngil1x6T5Jk990n5MQTZ/bbtxtueCS33/54Jk4cmxecc/Bm9datX7+pvHzFiowbt3Gr+kHr873GSDHWGCnGGiPFWGOkGGujZ3Xb5NHuwogqk6xtm7Bpa9f6l9zt/7fcPfbYY3g6EiH+cLgvyXeTXJWeQPuQJK9K8uokE5N8piiKsizL/+nj/O71DFcM4Vorm8pTkqzt1cbWtLNbow0AAABG2H33L8l11z2ctrYir3zFUSmG+ebd5cvX5qtfuzldXWWKInnNa47N+PF9L4+/cuW6/PgndyVJXnDOoZk6dUKf9QAAAICRIcTfPt9L8qWy3GLN82uTXFAUxUtSBfzjkny0KIoflmX5aK+6Exv/XTeE661tKk/qo42tbWfSgLWGZrDZ/LNSvR+ZOnVqpk2bttUXWNe2iw3Tsqxm4Kfx2nexmfjbMkbYNs3LwkybNs3dmyNoyapd671uK8qUjS+2pavadrmZ+L7XRo7vNUaKsUZv69f3hOPjx40b9Lt//fqN+cEPrk5ZJs95zmE58sj9t6jTPa6Koi277bbbVo21NWvW5/++8rs88UT1V7+Xv/y4nHzSnH7rf//7v8vKleszZ/b0PP/5x6StbfPf1ePHjdtUnjplSqZN221I/WDn4XuNkWKsMVKMNUaKscZIMdZGz7KuVaPdhRFVLaFf/Z1wYtfqtGXXejxqK/1b7i6Wjg6vsiyfGOT4j4ui+ECSf0kyOclbknT0qram8d/xQ7hk83SI1U3lNU3lrWln9YC1hqAsywGX72+eTdLW1rZtv1h2sRA7Sc9rLopd7vX7n4+R1f1+b/Pnk22yq4XYSVI2XnNXWexyr99na2T5XmOkGGs0K5rHQFEMOiYuvOj2PPbYikyfPikve+mxg9bvHmdDGWvr12/MZz97dR54YGmS5PnPOyIvfMFR/da/447Hc/U1D6Strcjr33Byxo7tY7Z+099JCmP+Scv3GiPFWGOkGGuMFGONkWKsjY5dLcROkqLxmttS7nKvv5U+W0L8He9/knwg1W0rz8qWIf7yxn+HsrR983SH5mXzlzeVt6adoSy9DwAAwDC66KI7kyRHH7VPbr75kT7rrFu3IUkVyt9006OZNOmJTJs2KUcdtXe/7W7c2JXPfe7q3HnXgiTJmWcenFe96oQh9WX2QdPz2KMr8tijW/41cdGinie73XLzI5kypbov/NRTB1uYDQAAANgWQvwdrCzLx4uiWJRkZpIt10hMHkzytCS7FUWxR1mWSwdorvtfSBaUZblpaf2yLNc0rrFnkgMG6k9RFNPTE+LPH9qrAAAAYLhs2FAthXnlVXNz5VVzB6y7cuX6fP0btyZJDj98Zr8hfldXmS988drcfEt1U8ApTz0gb3j9yYP2Zf2GjUmS++cuzuf/95pB61/wzRs3lYX4AAAAsGO0zpoAT24DrTXx+6Zyv2scFkUxNsmhjc3bB2jnsEbd/jRfo692AAAA2Ml89WvX53e/q+7TPuH4ffOmN522xbPtAQAAgJ2Dmfg7WFEUe6WahZ8kD/dR5fKm8rOSXN1PU6ekZwb9Ff2084xGnacm6W8KxbOayn21AwAAwA70mU+/etA6/9D+0yxevCp77DEx7/27szJt2rR+n833rW/flCuuuD9JctSRe+etbz09Y8YM7Z79v3n32YPW+eKXrs3VV89Lknzwgy/KzD13G+QMAAAAYHuYib/j/WmS7ukPv+rj+GVJnmiUzyuKor+pEuc3lb/Xx/HvN5Xf1FcDRVG0JXljY3Npkkv7uRYAAAA7gR/9+LZcfPHdSZJDDtkzf/7nT8+4cWNGuVcAAADA9jATfxsVRTEnyfSyLG8YoM5LkvxTY3N1ki/0rlOW5bqiKD6R5B+THJ3kb5N8uFc7ZyR5S2PzV2VZXttHO78tiuI3qWbjv6Uoii+VZXlVr2p/07hGkny8LMv1A79KAAAAervnnoV5fMGKTdsrVqzdVF6wYMUWz7l/+hlzdkg/Lr30nvzkJ9VT0vbYY1L+4A+Oz8KFKwc8Z9asqUOepQ8AAACMjl02xC+K4qwkhzXtmtlUPqwoivOb65dl+cVeTcxJcmlRFFcl+VGSm5I83jh2SJJXN366Z9b/bVmWD/XTnQ8neW2SI5L8R1EUhyX5Rqrg/9lJ/iHVn9XqJO8c4GX9daol8icluagoig+lmm0/KckfpVoVIEnuSvKfA7QDAABAPy6/4v5Ny8v3du+9i3LvvYs227ejQvzrb3hwU3np0tX5yEcuG/Qcy+EDAABA69tlQ/wktSTn9XPszMZPsy/2U/eMxk9/ViV5V1mW/9NfhbIslxdFcW6SnyY5PFXY/qe9qi1L8oayLG8coJ0biqJ4bZKvJJmW5EN9VLsrybllWS4foM8AAAAAAAAAjIJdOcTfXtcl+eNUAf4pSfZNNZt/bJIlSW5LcnGSzrIsH++vkW5lWd5TFMVJSd6e5DWpVgkYn2R+qnD/42VZ9j3VY/N2flQUxQmpZuWfm+SAJOuS3JPkW0k+WZblqq17qQAAAHQ7/7xTc/55p+7Qa3yo48Xp6urKsmXL+q3zN+8+e4f2odtIvF4AAACgxy4b4pdleX6S87fj/OVJvtr4GRZlWa5M8h+Nn+1pZ16Sdzd+AAAAAAAAANhJtI12BwAAAAAAAACAihAfAAAAAAAAAFqEEB8AAAAAAAAAWoQQHwAAAAAAAABahBAfAAAAAAAAAFqEEB8AAAAAAAAAWoQQHwAAAAAAAABahBAfAAAAAAAAAFqEEB8AAAAAAAAAWoQQHwAAAAAAAABahBAfAAAAAAAAAFqEEB8AAAAAAAAAWoQQHwAAAAAAAABahBAfAAAAAAAAAFqEEB8AAAAAAAAAWoQQHwAAAAAAAABahBAfAAAAAAAAAFqEEB8AAAAAAAAAWoQQHwAAAAAAAABaxNjR7gAAAAAMxaGHHDXaXRhRY8aMyb77zkqSPPLIo9m4ceMo92hk3XvfHaPdBQAAABgVZuIDAAAAAAAAQIsQ4gMAAAAAAABAixDiAwAAAAAAAECLEOIDAAAAAAAAQIsQ4gMAAAAAAABAixDiAwAAAAAAAECLEOIDAAAAAAAAQIsQ4gMAAAAAAABAixDiAwAAAAAAAECLEOIDAAAAAAAAQIsQ4gMAAAAAAABAixDiAwAAAAAAAECLEOIDAAAAAAAAQIsQ4gMAAAAAAABAixDiAwAAAAAAAECLGDvaHQBgc8uWrcnceYszd+6SzJu7OHPnLcnKleuSJKefPjvnn3fqoG2sW7cht932WG6//bHMe2BJFjy+ImvWbsikSeOy995Tcswx++SsMw9OUQytT7fd9miuumpu5s5dkieWrUlZlpk6dUIOPHCPnHbqQTn55APS1ja0xh55ZFmuvHJufn/7Y1myeFXWb9iYqVMnZu+9puTII/fKqacdlJl77ja0jgEAAAAAADzJCPEBWsx7/u7H23X+gw8uzYc/clnWrt2wxbGVK9fl/vsX5/77F+fii+/OK195VJ5ywqx+21q/fmP+9wu/zQ03PLTFsSVLVmfJktW5+eZHctiv7s1f/PnTM3ny+H7bKssyP/jhbbnoojvT1VVudmzx4lVZvHhV7rjz8YwfPzbPfe7hW/GKAQAAAAAAnjyE+AAtbMaMyZm1z9T8/vbHhnzOmjUbNgX4hx66Z44/ft/MPmh6dpsyPiuWr80NNz6cyy+/L2vWbMgFF9yWiRPG5tRTp/XZ1je/eeOmAH/q1Ak555wjc9CBe2TMmLY89NATufCiO7N48arcc8/CdH7+mvzVO57Rb7++8tXrc8UV9ydJDjpoep7+9DnZf79pmTBxbJYvX5u5cxdX1xri6gAAAAAAAABPRkJ8gBZz7ouPzuw50zNn9oxMmzYxCxetzPve97Mhn18UyVOfekDOPfeY7LfvluH8McfMyrHHzspnP3tlurrK/PCHd+aUUw7eot6yZWtyeSN0nzx5XP7h75+b6dMnbzp+2GEzc9ppB+WDHb/IokWr8vvfP5Z58xZn9uwZW7R1xZX3bwrwX/jCo/Lylx2botda/sceMyvnvviYbNjQNeTXCgAAAAAA8GTTNtodAGBzL33psTnh+P0ybdrEbTr/0ENn5q210/sM8Lud+JT9cuJT9kuSLFq8OvPnL92izv33L07ZWPX+6WfM2SzA7zZp0rg89zk9S9/fd9/iLeqsWbM+3/nOzUmS44+blVe8/LgtAvxmY8f61QQAAAAAAOy6JCUAu6gjjthrU3nhwpVbHN+wsWdG/MyZu/Xbzl57TenznG6//e0DWbVqfZLkRS86epv6CgAAAAAAsKuwnD7ALqp52fqibcuZ8bP2mbqp3FfI323BghWbyvvsM2WL49dd/2CSZMqU8TnkkD037V+2bE3WrNmQqVMnZNKkcVvXeQAAAAAAgCcpIT7ALuruuxduKs+aNXWL4/vvv3sOOWTP3Hffolx19bw873lHZI89Jm1WZ82a9bnkknuSVLP1jzl61mbHu7rKzJu3pGpvv91TlmUuu+zeXHzx3Vm4qOfGgAMO2D3PPvuwnHHGnLT1cUMBAAAAAADArkKID7ALevDBpbn1tkeTJLNmTcm+s6b1We+8N56S//qvy7Nw0cp86F9/mXOef2QOPGiPjGlry8MPP5GLLrorCxetzJQp4/PmN522xfPslyxZlTVrNiRJJu82Pp/9n6ty440P99GfJ/J/X7kuN9/ySN5aO32LdgAAAAAAAHYVQnyAXcz69Rvzf1+5Ll1dZZLknHMO7bfuPvtMzXvf+5z8+tf35cKL7sy3v3PzZsfHjCny/Ocdkec857BMnz55i/NXrlq3qXzrrY9k/fqu7LP3lLzqVSfkiCP2SlLk7rsX5DvfvTmPPro8N930cL73/Vvymlc/ZXheLAAAAAAAwE7GVEeAXcw3Lrhx0xL3J5+8b445eq8B6998yyP57bUPZO3aDVsc27ixzHXXP5jfXjs/ZVlucXzd2o2byuvXd2XatIn52799dk44Yb9MnDguEyeOzfHH75u//Zuzs/vuE5Mkl112T5YsWbU9LxEAAAAAAGCnZSY+wC7k5z+/I1dccX+SZPbs6XnFy48asP63v31Tfnnx3UmSpzxlv5zz/CNywAF7pK2tyCOPLstll96bK6+am+9975bMvX9x3vrW0zd7pv24cZvfK3bOOUdk6tQJW1xnypQJedELj8o3LrgxGzeWueGGh/Kc5xy+vS8XAAAAAABgp2MmPsAu4te/uS/f/8GtSZJZs6bm7X/x9IwfP6bf+rfc8simAP+MM2bnz9/29Bx66MxMmDA248aNyUEHTs8b33hKXvzio5MkN9z4UH71q3s3a2PChHGbbR9z9D79Xu+YY2ZtKnevFAAAAAAAALCrEeID7AKuvfaBfP3r1ydJZsyYnL/+q2dkypQtZ8Q3u7wxY78okpe97Lh+673ohUdlwoRqYZcrr5y72bHp0yelKJq3J/fbzvTpkzaVl69YO2DfAAAAAAAAnqyE+ABPcjfd9HC+8MVrU5bJ7rtPzLve+cwBw/Rujz66PEkydeqETN9jUr/1xo0bk/32nVad89iyzY5NmDA2M2b0XKurq+y3nbLsOTamaUl+AAAAAACAXYkQH+BJ7I47HsvnOq9OV1eZ3XYbn7/+q2dkr72mDOnc7iB948b+g/duGzd2JUna2rb8tXL4YXttKi9cuLLfNhYs6Dm2xwA3DQAAAAAAADyZCfEBnqTuvXdhPv2ZK7NhQ1cmTRqXv3rHM7LffrsP+fw9Z+6WJFm5cl0eeWRZv/VWrlyXhxvHZzbOaXbSSftvKt9440P9tnPDDT3HDjts5pD7CQAAAAAA8GQixAd4Epo/f2k+9akrsnbtxkyYMCZvf/uZmT17+la1ccLx+24qf+tbN2XDhq4t6nR1lbngmzduOnb8cbO2qHP88ftmv/2q5fYvufTuPPzwE1vUeeSRZfnFL+9KkkydMmGz4B8AAAAAAGBXMna0OwDA5u65Z2EeX7Bi0/aKFWs3lRcsWJErr5q7Wf2nnzFns+0FC1bkE//1m6xavT5J8rKXHpdJE8floYc2D8/LsisrVlRL2BfF+Oy+++TNjp9xxpxcfMndefTR5fn97Y/lX//t4px99qE54IA90lYUeeTRZfn1r+/NffctTpJMmzYhz3veEVu8nra2Iq9/3cn52Md/nbVrN+YjH7ks55xzZI44olpm/+57FubCC+/I2rUbkiSvfe2JGT/erycAAAAAAGDXJCUBaDGXX3F/rr56Xp/H7r13Ue69d9Fm+3qH+HffszDLl/cE/9/69k2DXvPFLz4qL3vpcZvtGzu2Le/4y7Py6c9cmQcffCIPPfREvvrV6/s8f+aeu+XP/uyMTJkyoc/jhx02M29+02n58v/9LqtWr8/3f3DrFnXGjCny2j88MaeccuCg/QUAAAAAAHiyEuID0K8999wtf//e5+ba383P9dc/mPnzl266QWDy5PE5YP/d85Sn7JfTT5+dCRMG/pVy8skHZM6cGbn00ntyy62PZMmS1SnLMtOnT85RR+2d5z7n8Oy995SReFkAALBTWLZsTebOW5y5c5dk3tzFmTtvSVauXJckOf302Tn/vFMHbWPdug257bbHcvvtj2XeA0uy4PEVWbN2QyZNGpe9956SY47ZJ2edeXCKYuB2brnlkcydtzjz5i3JwoUrs3z52qxevT4TJ4zNzJm75Ygj9spZZx2SWbOm9tvGf/5/l+Xuuxdu1Xvwrnc9M0cesfdWnQMAALCzE+IDtJjzzzt1SP8Y15+nnzFni9n5fenq6sqyZcuSJNOmTeu33pgxbTn9abNz+tNmb3Ofus2YMTmvetUJedWrTtjutgAA4MnuPX/34+06/8EHl+bDH7ls06Ormq1cuS73378499+/OBdffHde+cqj8pQTZvXZzsaNXfnUf1/R57FVq9fngflL88D8/5+9+w6z6yrshf1bZ9SsLlmSJTe5V2xjsLGNTe8YU2JKyg04CaRcQhJCypeEm3tvbnJzv4R8lxSSUJIAqZDQW+imuBuwjTEuMpZcJFmS1bs0Z39/nDOjkTRVGs0+1nnf55nnrD177bXXHq3RnHN+Z629MV+/flmuueb8vPQl5xxWv/uUkixaNPSHAgAAAI5WQnwAAACADjd//vQsPm5W7vnh46M+ZufOvf0B/umnH5sLLliSpSfPy4yZU7J1y658746V+fa3f5SdO/fmIx/5QaZNnZRLLx38A77HHDM5Z521MKeeMj8LFszInDnTMmVKTzZu3Jn7H1ibG29cnh079uSTn7w704+ZnGc/+/SD2njTGy8d9AMFA61avTkf+MAtSZJzzlmUeXOPGfX1AgAAHC2E+AAAAAAd6OqXn5ulp8zLKUvnZ/bsaVn3xLa8851fGPXxpSRPf/qJufrq83L8koPD+fPOW5zzz1+c9773xjSbVT796ftyySWnHlSvp6eRP3vXK9NoHLzm/tKlyUUXHZ/nPfeM/O8//kq2b9+Tz3zmnlx11WkH1V+wYMaIfb7l1hX95fFYDQwAAODJqFF3BwAAAAA42DXXnJ8LLzg+s2dPO6TjTz99Qd7y5ssHDfD7PPWi4/PUi45PkjyxfkceeWTjoPUGC/AHWrBgRp7+9JOSJFu27srq1ZvH3N9ms8qttz6SJJk6dVIuvviEMbcBAABwNBDiAwAAAHSxs85a2F9et27bIbczbeq+BR/37GmO+fh771uTjRt3JEme9rQTMmWKBSQBAIDuJMQHAAAA6GJ79+4L3MsIM+6Hsnt3b+68a2WrjZIcd9zMMbdxy82W0gcAAEgSH2kGAAAA6GIPPLCuv7x48axRH9fb28ymTTvz4INP5Etfui9r1mxNkjzzmadm2rTJY+rDzp17c8edjyVJ5s+fvt/qAAAAAN1GiA8AAADQpR59dGPu/sHqJMnixTOzZPHsYeuve2Jb3vnOLwy5/7zzjstrr71wzP343vceza5dvUmSy55xcko5tBUBAAAAjgZCfAAAAIAutGdPb/7xn76TZrNKkrz4xacfclszZ07Jj//4xXnaxSemcQhL8t98y4Cl9C+3lD4AANDdhPgAAAAAXejfPnJHVqzYkCR52tOW5LxzR17Cft7cY/Lf3vmiJEmzWWXjxh35wT2rc8MNy/Mv//LdrFu7LS996Tlj6seGDdtz//1rkySnnjo/xx03+iX9AQAAjkZCfAAAAIAu85//eW9uuOGhJMnSpfPy6leNLnjv6WnkhBPm9G+fdNLcXHDBklx15an5v+/+Zj75qbuzZs3WvPGNl4y6L7fc+nCq1mIAucIsfAAAgDTq7gAAAAAAE+eb3/pRPvmpu5MkixfPylv/6zMzZUrPYbV54olz88przk+S3HjT8txzz+pRH3vLLQ8nSSZNauTpTz/psPoBAABwNBDiAwAAAHSJ2257OP/6r99NksyfPz2/+ivPysyZU8el7YsuOr6//N3vPTaqY1asWJ9VqzYnSS64YElmzJgyLn0BAAB4MhPiAwAAAHSBO+9cmX/44G2pqmTOnGl5+689O/PmTR+39mfN2vdhgPVPbB/VMTff/HB/2VL6AAAALUJ8AAAAgKPcvfc+nvd/4OY0m1VmzJiSX/2VZ2Xhwpnjeo4NG3f0l6dOnTRi/d7eZm6//ZEkyayZU3P++YvHtT8AAABPVkJ8AAAAgKPYgw+uy9/87Y3Zu7eZY46ZnF9527Ny/PFzxv083/3Oo/3l40+YPWL9u+9enS1bdyVJLr30pPT0eJsKAAAgEeIDAAAAHLUeeWRj3vOeG7JrV2+mTu3JW996ZZYunTemNu6447Fs2rRj2DoPPLA2n/v8D5MkjUbJpZecPGK7N9+yor98uaX0AQAA+o28thkAAAAAE27ZsnVZs3Zr//bW9qz1JFm7dmtuvGn5fvWfecUp+22vXbs1f/GX38r2HXuSJK+85ik5ZtrkPPbYpv3qVVUzW7duS5KUMiVz5kzfb/8dd67MB/7uljzlKYtzztmLsuT42Zl+zJTs3dubtWu35a7vr8p3vvNIqqpV/+qrz83ixbOGvbZt23bn+99flSQ5/vjZOfnksX2wAAAA4GgmxAcAAADoQN++4aHcfPOKQfc9+OATefDBJ/b73oEh/gPL1mXLln3B/7//x50jnvPlLz8nr7zmKQd9f+/eZu64Y2XuuGPlkMdOntyTV73y/LzwhWeNeJ7vfOeR7N3bTJJcfplZ+AAAAAMJ8QEAAAAY0o+95oKcdebCPLBsbVau3JzNm3dmy5ZdKaVkxowpOX7J7Jx99sJcfvnSzJlzzKjavPmWh5O0lt5/xjNGXnofAACgmwjxAdre9P6v1d2FCVVSZc6k1syXTXsbqVJq7tHE+tBbnl93FwAAYFjXvenSXPemSw/5+GdeccpBs/MH02w2s3nz5iTJ7NmzD9o/e/a0PPOZp+SZzxy5rdH6rd983ri1BQAAcLRp1N0BAAAAAAAAAKBFiA8AAAAAAAAAHUKIDwAAAAAAAAAdYlLdHQAAABgPmzfvzPIV67N8+YasWL4+y1dsyLZtu5Mkl1++dFT3lW42q6x+fEuWL1+f5cvXZ8WKDXnssU3Zu7eZJHn725+dM89YMGwbn/nsD/K5z/1wTH2/+upzc80rzh+2zqpVm3Pjjctzzw8fz4b127Nnb29mzZqWRQtn5uyzF+bSZ5ycBcfOGNN5AQDgaOS1gdcGAE92XRvil1IWJXlG++vS9tex7d0fqqrqulG0MT3JS5O8KMklSc5IMjPJ5iT3J/likr+tqmr1CO1cn+Q5o+l3VVVlFP16SpK3JXlhkuOTbE1yb5J/TvKBqqr2juZcAADwZPJbv/3Zw27jlltW5EMfvn0cejM2i4+bNeS+qqryqU//IF/60n1pNqv99q1fvz3r12/PvfetyZQpk/KCF5x5pLsKAAAdz2sDrw0Anuy6NsRP8vjhHFxKuTDJDWmF9gean+Ty9tfbSyk/X1XVRw7nfGPo11uS/FWSKQO+PS3JVe2vnymlXF1V1bqJ6A8AANRh/vzpWXzcrNzzw7E97R/4NlhPT8kJx89Jb7PKY49tGnUbz3n26XnaxScOf56qyrv+7Prs3Lk306ZNykUXnTBk3X/65+/mhhseSpKcfPK8PPOZp+SE42dn6rRJ2bJlV5YvX5/vfe+xZMSP+wIAQPfx2gCAJ6NuDvEHejitmeovHsMxs7MvwL8hyWeT3J7kiSQLk/xYkre06/1zKWVzVVVfGKHN25P8zBj6sJ9SysuT/G2SRlofUvijJLek9aGCt7T79IwknyilPLeqqt5DPRcAAHSaq19+bpaeMi+nLJ2f2bOnZd0T2/LOd470FHx/S5bMzhte/9QsXTovJ500N5Mn9+Qzn/3BmN6omz17WmbPnjZsnbvvXpWdO1sLZD39aSdmypSeQevdcOND/W/SvfSl5+RVrzw/pez/jtz55y3O1S8/r39ZTwAA6HZeG3htAPBk180h/h8kuS3JbVVVPV5KOSXJQ2M4vpnko0n+Z1VV9wyy/0ullC8k+USSniR/WUo5s6qqapC6fbZVVXX3GPrQr5QyOclfphXgb05yZVVVDw6o8p+llPck+a9pzcj/6SQfPJRzAQBAJ7rmmuHvGzkap54yP6eeMn8cejO8m295uL98+eVLB62zc+eefOxjdyVJLnjK4rz6VU8Zts1Jkxrj10EAgCOgU+5TfqBdu/bmppuW53t3PJbVq7dk27bdOeaYyZk795icfvqxufCCJTnvvMUHHfe7v/f5rF+/fUzn+sM/fJl7lU8Arw28NgB4suvaEL+qqv9+mMffmOTGEep8qpTy8STXJjk9ycVJvns45x3Ga5Kc1i7/8QEBfp/fTPITSea1yx88Qn0BAACGsGPHntx558okyYJjZ+SMId5kvvXWh7N9+54kyctedu6E9Q8A4EjpxPuU33ffmnzow7cfFMZv2bIrW7bsyiOPbMyyZesGDfHH6phjJmfOCLOy6S5eGwAwlK4N8SfQ19MK8ZNWkH+kQvxXDyh/cLAKVVVtL6V8NMkvJDmvlHJWVVX3H6H+AAAAg/judx/Nnj2tO1tddtnJBy2B2ec73300STJz5pScdtqx/d/fvHlndu7cm1mzpuaYYyYf+Q4DABwBdd6nvM8Pf/h4/vpvbsiePc1MP2ZynvXs03LWWQsza9bU7N7dm9WrtuT7d6/K5s07Bz3+V3/lWSMuW37vvWvy7/9xZ5Lk6U8/MZMnD75UOt3JawMAhiLEP/KmDigfyXvQX9V+vK+qqtXD1PtGWiF+klyZRIgPAAAT6OZbVvSXh1ous9mssmLFhiTJCcfPSVVVuf76B/PVrz6QdU9s66934olz8rznnpErrjgljcbgb/gBAHSKTrlPedKaaf+Bv7sle/Y0c9KJc/O2t1110L3Lzzh9Qa666tQhg/rjjps14nk+/4Uf9pcvv2zw5350L68NABjKxIf4pfxGkg+nqtZM+Lnr8ZwB5R8OWavlnFLKLUnOTjItybok30nysST/WlXVnsEOKqXMTHJSe/PeEc4xcL91dwAAYAKte2Jbli1blyQ5/fRjs3DhzEHrbdiwPTt37k2STJ8xJe993025446VB9V79NFN+cd/+k7u+v6qvOXNl7v3JQDQ0TrpPuWf/OT3s23b7kyZ0pNf/MUrDgrwBzrU51g7duzJXXe1l0pfMPRS6XQnrw0AGE4dM/H/JMkfpZTPJ/n7JJ9LVQ2/5tCTVCnloiRXtze/X1XVSCH+ce2vPie0v16Z5LdLKa8doo0TB5QfHeEcjwwonzRkrVEqpZw4QpX+m0U1m800m4fwT11VI9c5mlTVvmvutmtPDm2MjJOS7vp5l1T919xt157UO9Yapbt+3o1SpbSvuduuPal3rHWbgc81/NxJkmrgOKiqQx4X1YDnZFWzOqyxdvPNy/uf4l122clDHr91667+8t13r8qePc0sWjQzP/ZjF+SsMxckKXlg2dp8/ON35/HHt+TOO1fm45+4K6+99sKxXdyTTE9Pdy0/29PTk0aj0V/uNv4vnzj+hjJRjDUOVNfzte3bd+fW21pvkz7j0pMyb94xR2RM3nb7w9mzp9XuZc8Y+rkfR57XBjzZ+Rtan2a6a2WLZjs56Ct3m8P9/ep7DT8e6lpOf3JawfQrk6xJKR9O8g+pqpFmkT9plFKmJvlAkr53Wn5vmOrNJF9N8vkkdyZ5IsmsJE9La+n7c5Ocl+TrpZRnVFX18AHHD1y3aesIXds2oDz4R/vG5pGRq7Rs2bIlmzdvHvMJpjT3jvmYJ7WqyuSqfeeFZpIh7oN0tDqUMTJe5kzqric/JVVm9vS98Gj2/2HuFnWOtXnTu2usNUqV2dP6PjDSTLMy1jgyms1mtm3b91RnPJ808+S0ZeuO/vLuPXsO+fdx1659b5pt274tmzdPPuSxdvPNreUyJ01q5Kwz5wzZpw0b9n1/z55mZs2akp9/y9Myc+aU7N7duq6lJ8/Iz7/l4vz5X9ySzZt35RvfeDCXPWNx5swZehbZk92SJYtHrnQUaTQaWbBg3z1Pu+3NOn9DJ46/oUwUY40D1fV87bvfXdV/H/Izzpjbf97du3uzefOuTJ3ak5kzpwx5f/LRuvHGh5K03t477/x5/rbVyGsDnuz8Da3Pjsb0urswoaokuxpT+7e6653cw38dOnfu3PHpSOoJ8S9I8nNJfirJwrRmnv9Gkt9Iayn5v0vykVTVSGF0p/urJJe0yx+qquozw9T9saqqNg7y/W+VUv46yfuTvCmtn9W7k/zYAfUG/iXePUK/dg0oHzNCXQAAYJw8/PCmrFu3PUly3nkLM23a0C/HDlz68tnPXpqZM6ccVG/GjCl53nNPyac+fV96e6vcffeaXHnlyePbcQCAo8zDj2zqLy9ePDOPPLIpX/rSg1n24Pr+mdEzZkzOhRccl+c//9TMmjV1iJaGtn79jqxYsTFJsnTp3Bw7v7tCIIbntQEAI5n4EL+qfpDk11PKbyV5RZKfSfKydl8ua3+9O6X8R1qz87854X08TKWU30ny5vbmbUneOlz9IQL8vn17SilvTnJ5krOTvKaUckJVVY8NqLZzQPngv977G/iMc8eQtUZvpCX5F6f1M8isWbMye/bsMZ9gd6OuBSNqUlWtGfhpX3uXzcQ/lDEyXjbt7a5PL7aW0G8Ntk17G133mbo6x9qG7d011hqlStUeaxu3N7puJn6dY63bDJyhOnv2bJ9KJ3v27Ft+fMrkyYf8+zh16r6n0DOmz9ivnbGMte/f/WB/+aorTx+2P8ceu///lRc/demQ9S++eGk+9en7kiSPP77jqP5/Z9Wq1XV3YUINXEJ/9erH09vbW2NvJt7RPJY7jb+hTBRjjQPV9XztiSf2vZ26cuWO/NM/fzfN5v63f9u2bU9uuvnR/OCetfnlt16ZE0+cO6Y+fetbj/V/IODKZ57q71rNvDbgyc7f0Ppsbm6vuwsTqrWEfuv/nWnNHWl02a14O+n/zfrS0aram+STST6ZUhYleWOS69JaNn5Ge/uNKeXBJP+Q5EOpqpX1dHb0Sim/kOR/tzfvTfLyqqq2DXPIiKqq2ltK+bskf9L+1nOS/MuAKlsGlEdaIn/GgPJhr3ZQVdWjw+0fuORUo9E4tD8sXRZiJ9l3zaV03fXX+eSj20LsZN81VwPuc9Mt6hxr3RZiJ0nVvuZmVbru+r2omlh9P+9Dft7BUaUMHAOlHPKYGPictjTKfuNrtGNt795mvvvd1udwZ8+emqc8ZUkajaH/P5w/f0ZKSf8bv8ceO2PI8xx77L6n+Fu37T6qx363hdjJvjfrent7u+76j+ax3In8DWWiGGsMVNfzte3b9/SX//XfvpdSkle+8vxcftnSzJ49LWvWbs2Xv3xfbrppRTZv3pX3vu/mvPP3XpRjjpk86j7delvrjqiTJ/fkkktONt5r5rUBRwN/Q+vRbSF20jcBsHXt3Xb9nfS71Rk9qao1qap3paqektaM8/cl2ZzWRz3OSPKHSVaklM+nlGtTyuifLU2gUspPJPnr9uaKJC+qqmrdODV/z4DyCQfsGzgr/8QR2hk4c37U97MHAAAO3fe/vyrbtrXufPWMS08e9k26JJk6dVLmD1hy9cCZYQNV1b59PSO0CwBAsnv33v7ynj3N/PRPX5KXv+zczJ8/PZMmNXL8ktl50xsvzbOuOjVJ8sQT2/PNbz44VHMHefDBdVm7tjWv66KLjh9T+M/Rz2sDAEajM0L8garq1lTVLyZZktZs/NVphfk9SV6S5KNJHksp/yelLK6vo/srpbwyyYfT+pmuSvKCkWapj9GQf5mrqtqSfYH8OSO0M3D/Dw+3UwAAwMhuvmVFf/nyy5eO6pgzz1jYX163bujFvfreIE6SuXOPOYTeAQB0l8mT9i2tfsIJc3L5ZYM/P3vVq57Sfz/y278z+rd6b77l4f7yFaN87kf38NoAgNHozJuNl7I0raX135TkuLQC7H03YUgWJPnNJG9LKe9MVf3fOrrZp5TygrQ+XDApyRNpzcAf/UczR+e8AeXBbivw7SQ/keTsUsriqqqGulnkcwaUbxivzgEAAIPbunVX7r57VZLkxBPnjPp+qhdffEL/G3x33PFYli6dN2i9731v38JcZ5yx4PA6CyRJzjv1tLq7MKF6enpy3JIlSZLHV63quls33PPQj+ruAjDBpk7b97b4eeceN2S9mTOnZunSeXnwwSfy6KMbs3dvsz/UH8qePb35znda863mzJmWc4dpn+7jtQEAo9U5M/FLmZZS/ktK+WqSB5P8fpJT0gruH0jy20mOT/LiJB9J0pvkmCTvSin/pZY+JymlPDPJp5JMTbIpyUuqqvrBOJ9jUpKfHfCtbw5S7ZMDytcN0c70JK9vb95TVdX949E/AABgaLfd/kh6e1sLaw01y2swF1ywJMcfPztJ8rWvP5CVKzcdVGfVqs358ldaT+tnzZyaiy8+8M5bAAAcaN686QPKw89W7qtbVelfAn04d31/VbZv35MkufTSk0ZcKp3u4rUBAKNV/0z8Uq5I8jNphcuz+r6bZEeS/0jygVTVtwYcsTrJV1LK6e39FyV5e5J/mrA+93WylKcm+VySGUm2Jbm6qqrvjLGN5yX5XlVVG4fYPznJ+5Oc2/7WZ6qqGuxe9p9I8qMkpyX5nVLKvw+yGsCfJpk3oAwAAEeNZcvWZc3arf3bW7fu6i+vXbs1N960fL/6z7zilEHbObDeo4/ue4Psnh88nnVrt2XHzh1JkpNP2p2zzlo0bL9uvrk1Y6bRKHnGM04e6TL6NRolP/kTT8u7//yb2bWrN+961/V58YvPzllntZbSfGDZunzxi/dm167WPV3f8IanZsqU+l/iAQB0uuOXzM532+VmNfT9xZP97z/e0zNyIH/LzfuWSr/i8lMOpXuMA68NvDYAeLKr53/xUvrud39dkrP6vtt+/F6SDyT551TV5iHbqKoHU8pvJ/nPAW2MoQvlqiRnDPjWwLVlziilXLf/6aoPHnD86Um+mGRu+1vvTLKplPKUYU67pqqqNQd8701JPl1K+XSS65Pcl2RzkplJnp7k57NvKf01SX51sIarqtpTSnlbks8kmZ3khlLKHya5Na3g/i1Jrm1X/3aSfxymnwAA8KTz7Rse6n9T7EAPPvhEHnzwif2+N9QbdR/+8O1DnuOLX7pvv+3LLzt52DfqVq/enBUrNiRJzjvvuMyePW3IuoM544wF+dmfeUY+/I+3Z/uOPfnkp+4+qE5PT8kbXv/UXHLJSWNqGwCgW5155r63goe7v3iSrGsHwZMnNzJ9+pRh627Zsis/uKd1l9OTTpybE06Yc5g95VB5beC1AcCT3cSH+KV8PsmL0lrKvy+435TkX9Kadf+9MbTWd9Oy6cPWGtyb0wrQB3Nl+2ugDx6w/awkA/8i/99RnPN/Jvkfg3x/ZpKfbH8N5ftJfryqqoeGqlBV1edLKb+Y5K+SHJfkLwepdmuS11RV1V03uAMAgBrcfMvD/eWxLJc50NOedmJOOWV+vv71Zfn+3auyYcOOVFWVefOm55xzFuUFzz8zixbNHK8uAwAc9c48c2FmzZyaLVt35a67VuX1r3vqoMver1u3LY88ujFJcvppC0ZcGv+22x7et1T65Yf23I+jl9cGAIxFHTPxXzqg/K20Zt3/e6pq5yG0tT2t+8MPv+ZRZ/t/k9yR5Iq0ZtwvTDI/ya4kjye5Pa3bBnxiNMF7VVXvL6XclORXkrwgyfFpLfX/wyT/nOQDVVXtHf/LAACAel33pktz3ZsuPex2/vZvXjvs/mazmc2bW4uGzZ49e9i6r37VU/LqVw23WNfozJ8/Pddee2GuvfbCw24LAA60efPOLF+xPsuXb8iK5euzfMWG/nt/X3750lH9fW02q6x+fEuWL1+f5cvXZ8WKDXnssU3Zu7eZJHn725+dM89YMEIrybontuX7d63K/fevzaOPbcrGja2AaubMqVm6dF4uefpJedrTTkhPT2PU17dq1ebceOPy3PPDx7Nh/fbs2dubWbOmZdHCmTn77IW59BknZ8GxM0bdHk9+jUbJC190Vj7xie9n/frt+dzn78k1rzh/vzq9vc38679+N32r7T/r2aeN2G5fSNtolFx6qZnQdfLaAIAnuzpC/DVJPpTWrPsHDqulqlqZ5LmHdmh1XVrL+R/iqasP5uDZ+YfSzg/TCtjffbhtDWjz7rSW4QcAAACAYf3Wb3/2sNu45ZYV+dAwy06Pxqc/fXe+8J/3ZrBblG/cuCMbN+7InXeuzFe+Oi+/8PNXZP784RfnrKoqn/r0D/KlL923333Nk2T9+u1Zv3577r1vTaZMmZQXvODMw+o7o9NJ9yl//vPOyHdufyQPP7Ixn/vcD/P441tzxeVLM2vW1Kxduy1f/dr9+dGP1idJnvKUxXnaxScMe20rV23Oww+3lko///zFY14qHQBgoDpC/BNjJjgAAAAAdJz586dn8XGzcs8PHx/TcQMj8p6ekhOOn5PeZpXHHts05DEH2rRpZ6oqmTq1J0+96IScfc6iLFo0M5Mn9WT16s352teXZcWKDVmxYkPe/effzO/+zgszbdrQb2/+0z9/Nzfc0Loz5cknz8szn3lKTjh+dqZOm5QtW3Zl+fL1+d73Htt3w0+OuE66T/nkyT1561uvzHv++sY8/PCG3H77I7n99kcOqveUpyzOm3/uspQy/EC5ZcB1HepS6QAAfSY+xBfgAwAAAEDHuPrl52bpKfNyytL5mT17WtY9sS3vfOcXxtTGkiWz84bXPzVLl87LSSfNzeTJPfnMZ38wphB/xswpec1rLshznn1apk2bvN++pUvn5dJLT87f/f0t+c53Hs2aNVvz1a/en6uvPm/Qtm648aH+AP+lLz0nr3rl+QeFsOeftzhXv/y8/iX/6T5z5hyT3/6t5+WGG5fnttsezupVW7J9x+7MmDE1p5wyL1dccUoufurwM/CT1u0kbr2ttZT+9GMm58ILlxzprgMAR7mJD/FLmZTkme2tO1NVwz+TL2Vukr6bu3wr1WALagEAAAAAh+Kaa84fudIITj1lfk49Zf5htfFjrxn+/s6NRslP/PjFufPOldm7t5nvfu+xQUP8nTv35GMfuytJcsFTFo94D+pJkxqH3mnGpBPvU97T08izn3Vanv2ske95P5RGo+SP//fVh3w8AMCB6niG+qok1yf5WJI9o6i/O8nHk3w9iWdCAAAAANClZs6cmhNOmJOkdQ/1wdx668PZvr31tuPLXnbuhPUNAADGSx0h/mvaj/+eqto+Yu1WnY+kdXeqa49gvwAAAACADte3/H2jMfg9yr/z3UeTJDNnTslppx3b//3Nm3dmzZqt2bFjNPOKAACgPhO/nH5yaZIqydfGcMzXkvxSksuPSI8AAAAAgI63efPOrFrVWiZ98eJZB+1vNqusWLEhSXLC8XNSVVWuv/7BfPWrD2TdE9v665144pw877ln5IorThnywwAAAFCXOkL8k9qPD43hmOUHHAsAAAAAdJkvf/n+NJtVkuTpTz/4rcING7Zn5869SZLpM6bkve+7KXfcsfKgeo8+uin/+E/fyV3fX5W3vPnyTJpUx4KlAAAwuDpC/D5j+YhrX906+wsAAAAA1OShh57IV7/2QJJk3rxj8pxnn3ZQnW3bd/eX7757Vfbsaea4RTNz7bUX5qyzFiYpeeCBtfnYx+/K6tVbcuedK/OJT34/r3vtRRN1GQAAMKI6PmK6tv14zhiO6au7bpz7AgAAAAB0uM2bd+Z97785zWaVUpI3vfHSTJly8Hyf3bt6+8t79jQze/a0/MZvPC8XXnh8pk2bnGnTJuWCC5bkN97x3MyZMy1Jcv31y7Jhw/YJuxYAABhJHSH+bWnNrH/jGI65LkmV5LtHokMAAAAAQGfauXNP/uo9N2TDhh1Jkle/+oKcc86iQetOnrz/250vfvFZmTVr6kH1Zs6cmpe9tDVvqLe3yve+99g49xoAAA5dHSH+f7QfX5BS3jFi7Vad57e3/v1IdQoAAAAA6Cx79vTmb/7mxjz88IYkyYteeFZe8uKzh6w/derk/bbPO/e4Ieued97i/vKKFRsOs6cAADB+6gjxP5LkzrRm4/9JSvmPlHJVStm3/lUpk1LKs1LKx5L8SVqz8O9O8k819BcAAAAAmGC9vc28//035777W3fnvPLKU3PttRcOe8y8eceklIHb04et22fL1l2H11kAABhHB9846kirqiqlvCbJDUmWJHlN+2tPSlnfrjU/Sd/HZkuSlUlelaqqJrq7AAAAAMDEajar/MMHb8td31+VJLnk6Sfmp37yaSMeN3XqpMyfPz1PPLG9v52hDHyrsadRhqwHAAATrY6Z+ElVLU9ycZJPtr9TkkxJsrj9NaX9vST5eJKntY8BAAAAAI5y//wv383ttz+SJLnwgiX5mZ95RhqjDNrPPGNhf3ndum1D1lu7dt++uXOPGbIeAABMtImfid+nqtYk+bGUclaSq9MK9Re0965L8t0kn0tVPVBTDwEAAACACfbv/3FnbrjhoSTJOWcvylvecnl6ekY/F+nii0/IzbesSJLcccdjWbp03qD1vve9x/rLZ5yxYNA6AABQh/pC/D5VdX+S++vuBgAAAABQr8989gf56ldbc3pOO+3Y/NIvPTOTJ/eMqY0LLliS44+fnZUrN+drX38gl156Uo4/fs5+dVat2pwvf6X1luSsmVNz8cUnjM8FAADAOKg/xAcAAAAAarNs2bqsWbu1f3vr1l395bVrt+bGm5bvV/+ZV5wyaDsH1nv00U395Xt+8HjWrd2WHTt3JElOPml3zjpr0X71v/71Zfnc536YpLW8/Y/92AXDLoefJIsXzzpoln6jUfKTP/G0vPvPv5ldu3rzrnddnxe/+OycdVZrmf0Hlq3LF794b3bt2pskecMbnpopU7xNCgBA5/DsFACAI2rz5p1ZvmJ9li/fkBXL12f5ig3Ztm13kuTyy5fmujddOqb27r57Vb717YeyYsWGbN26KzNnTs3SpfNy1ZWn5KSTpo+qjR/96Il8+9sP5cEH12Xjph3p7a0yffqUnHjCnFz8tBNyxeWnZNKkkZdsfeKJbfn615fl+3evzoYN2zNpUiMLF87M0592Yp773NO9GQwAPCl8+4aHcvPNKwbd9+CDT+TBB5/Y73tDhfgf/vDtQ57ji1+6b7/tyy87+aAQ/7vfe7S/vHHjjrzrXdcP0+uWP/zDl2XBsTMO+v4ZZyzIz/7MM/Lhf7w923fsySc/dfdBdXp6St7w+qfmkktOGvE8AAAwkep9V7GURpLzkpyWZFaSkdfGqqoPH+FeAQAwjn7rtz87Lu00m1X++Z+/kxtuXL7f9zdu3JGNG3fkzjtX5tJLj89rXn3ukG1UVZWPfvTOfP36ZQft27x5Z+7ZvDP3/PDxfP1ry/LLv3xV5s8f+kMBd921Mn//D7dm5869/d/bvbs3K1ZsyIoVG3LDDQ/lrW+9KosWzRz7xT7JXHH5tXV3YUI1Go0sXDQ3SbJ2zcY0m816OzTBbrr5Y3V3AQBG5WlPOzGnnDK//aHLVdmwYUeqqsq8edNzzjmL8oLnn9kVz9VgIn3mFa+suwsTqmo0kvnzWhvrN6R02WuDaz776bq7ULtOmbhw403Lh/0w3WCG69/evc3cfPOKfPe7j+bRxzZl+/bd6ekpmTvnmJx2+rG56spTc/rpC8Z0PmBs6gnxSzkmyTuTvCXJsWM4skoixAcAeJKaP396Fh83K/f88PExH/upT9/dH+CfdNLcvPhFZ2fhwhlZu3ZbvvTl+/LIIxtz220rM2PGlLz+dU8btI0vfvG+/gB/2rRJecELzszppy/ItKmTsvrxLfnKV+7PypWbs3LV5vzVe76d3/vdFx60PGuSPPzIhrz/A7dkz57eTJ06KS99ydk5++xF2b27N7d/55F8+9sP5fE1W/Oe93w7v/M7L8i0aZPHfL0AABPlujddOuaQYTB/+zevHXZ/s9nM5s2bkySzZ88+aP87fv25h92HA82fPz3XXnthrr32wnFvGwA6aeLCWC0+btag33/iiW15z3tuyMpVm/f7/t69yeNrtubxNVtz000r8rznnpHXv/6ilFLGrU/APhMf4rcC/K8leUYSv9kAAEe5q19+bpaeMi+nLJ2f2bOnZd0T2/LOd35hTG08/viWfPnL9ydJli6dl3f8+nMzZUprEadTTpmfiy5aknf92fV5+OGN+eY3V+S5zzkrixfv/8Zwb28zX2ov4zppUiPv+PXn5qST5vbvP+20Y3PZM07Ou951fR5avj4rV27OHXeuzNOfduJB/fnoR+/Mnj29aTRKfvVXnpXTTtv3udRzzlmURQtn5uOf+H4eX7M1X/7K/bnmFeeP6XoBAACAJ5c6Jy489aLjs/SdLxrxPO99301Zs2ZrSkkuu+zkg/b39jb3C/BPOGFOXviCM3PccbOyc9fePLhsXb7y1fuza1dvvn79ssyZOy0vfck5Y75eYGR1zMR/e5LL2uW7k/xVku8kWZ+ku9aaAQDoAtdcc/gB9le/9kCazSpJ8obXP7U/wO8zZcqkvOH1T82fvuv6NJtVvvb1ZfnJn9j/Re2qVZuzfceeJMkFT1myX4Dfp6enkZe+9Jz8zd/emCR56EdPHBTiP7R8fZYtW5ckufLKU/cL8Pu88IVn5cablmf16i35+teW5eUvO3fQGf0AAADAk1enTFyYPn1Kpk+fMux5Vq3anDVrtiZJzj5rUebNO3h5/jvuXNkf4J922vz8xjuel0Zj33zc8849LhdeeHz+5E+/lt7eKl/64n150QvP8p4HHAF1hPhvaD/emOT5qardNfQBAIAniaqqcuedK5MkixfPGjQ0T5JTT52fhQunZ+3a7bnrrpX5iR+/eL8l3Xp7931edMGCGUOeb+HCffv29h78GdM773isv/zMK5YO2kajUXL55UvzyU/ene079uS++9bkvPMWD3lOAAA4kv7gyqvr7sKEKo1Gpi2cnyTZuXZ9qi67T/nv3/C5ursAXaNTJi6Mxs23rOgvX3754O9n/OhHT/SXX/qSc/YL8PssXTovF1ywJHfcsTLbd+zJ6tVbcsIJc8bcH2B4dXw05vS07m3/JwJ8AABGsm7dtmzatDNJcuaZC4ete+qp85IkGzfuzBNPbN9v36JFs9KX6a9bt23INtau3bfvuEHuD7fswdYL2qlTe3LyyfOGbOesAX198MEnhqwHAAAAdKexTlxIkrvuWpmqqsZ0nmazyq23PpwkmTp1Ui6++IRB6+3dO8oJEAtmDnoMMH7qCPH7gvuHazg3AABPMqtWb+4vLx4kVB+o7wXtgcclyTHHTM4ll5yUJPn+3avy6KMbDzq+t7eZ//zivf31L23XH2h1u92FC2cOu1zcwA8ArFq9Zdh+AwAAAN1nvCYujOT++9dkw4YdSZKLn3pCpk4dfKHuge+7DDsBYl1rWf5SkkWLZg5ZDzh0dYT497YfrScKAMCINrZfZCbJ3HnHDFt37pxp/eUNA47r87rXXpSTT5qbvXubedefXZ/Pfe6e/PCHj+dHP3oiN920PH/8f76ahx5anylTenLdmy7NzJlT9zt+z57ebN3a+kzqvLnD92XGjCmZOrWn3ZexvbgGAAAAjn7jNXFhJDffvG9e7VBL6SfJpZeelGnTWgH/F790X/8y/wM9/MiG3H336nb9k3PMMZPH1BdgdAb/qM2R9cEklyd5XZL/rOH8AAA8iezcube/PG2IT4r3GXjfuF279h60f/bsafmN33huvvXth/LFL96bz3z2nv32l5JceeWpedELz8zixbOH7ctQn1rfvz+TsmtX76B9AQAAALrbeE5cGMquXXvzvTseS5LMm3dMzj576Bn/M2dOzc9c94z83d/fkgcffCJ//H++mhc8/8wsWjQzu3btzYMPPpGvfPX+7N3bzMknzc1rr71w1P0AxqaOEP/9SV6f5I0p5Supqn+toQ8AADxJ7Nnb218ebvn6JOmZtG//nt29g9a59741ufXWh7N5866D9lVVctedKzNzxpRcc835mTRp//Pt2TOgL5NGXtSq7/iBxwEAAAAk4ztxYSjfu+Ox/vqXXbY0pZRh61900fH53d95Qb78lQdy440P5YMfum2//bNnT80115yfZ111aqZMqSNmhO5Qx2/XSUnellaY/08p5TVJ/iWtZfZHXme0qh4esQ4AAEeNyZP2vUjt7W0OW7d37779kwe8uO3z1a89kP/4jztTVcmZZy7Iy192bk45ZX4mT+7J2rVbc+ONy/PVrz2QL37pvix7cF3e9svP6l9GLkkmTx7Ql73D9yVJ9rbrDDwOAAAAIBn/iQuDueWWFf3lyy8bein9Pnv3NnPzzSty150rUx28mn42b96VW299OAuOnZGLLjp+1P0AxqaOEH95kr5f+5Lk2vbXaFSpp88AANRkYIi+c4RPmu8e8CL2wOXuH310Y3+Af845i/Irb3tWGo19nz5fsmR2rr32wixeMiv/+I/fyYMPPpHPfvYHee1rLxq0L6P51Pvu3XsH7QsAAADAeE5cGMzGjTty771rkiSnnjI/ixfPGrb+rl1785d/9e0sW7YujUbJi198Vp55xSlZsGBm9uzpzUPL1+fzn7snyx58In/73htz7Y9dmBe+8KxR9QUYm5HXAD0ySvtrYHm0XwAAdJGB94TbOMI93zZu2tlfnnfAveRuvGl5/yfIr3nFefsF+ANd+cxTs2jRzCTJTTevSDXgY+eTJ/dkxowpSZING4fvy7Ztu7NrV2+7L9OHrQsAAAB0n/GauDCUW259uP+9kMsuH3kW/mc/e0+WLVuXJPnp//L0/NhrLszixbMzaVIjxxwzOeede1ze/vbn5OyzFqaqko99/K48+ujGUfUFGJs6pgT9TA3nBADgSWrJ4tn95dWPbxm27tq1++7ONPC4JFm9et+xJ588b9h2Tj5pbtas2Zpt23Zny5ZdmT172r52l8zOsmXrsnbt1vT2Nodc7u7xAX1dMsIn3QEAAIDuM14TF4bSt5T+pEmNXHrJScPWraoqN960PEly3KKZueKKUwat19PTyDWvPD/3vev6VFVr0sTrX/fUUfUHGL2JD/Gr6kMTfk4AAJ60FiyYkTlzpmXTpp154IG1w9Z96KENSZK5c6fl2GP3n/3eM2DmfW9vlcmTh26nt3ff7PsDZ+yfcfqxWbZsXXbt6s3DD2/IqaceO2gb9w/o6+mnD14HAAAA6F7jNXFhMA8/vCErV25OklzwlCX9KwsOZfPmXdm2bXeS5KST5g5bd+mAyRGPrx6+38ChqWs5fQAAGJVSSi666Pgkrdn0P/rRE4PWe+ih9f0vaC+88PiUsn/4fuyCGf3lZcuG/jBAb28zP3qodY5jjpl80Ivci556Qn/5xptWDNpGs1nl5ptb+6YfMzlnn71oyPMBAAAA3alv4kKSw5q4MJi+9yWS0S2l39MzYPJDsxqmZuu9kz6NIVYoBA6P3ywAADreC55/Zv+M+I989I797gOXtO4L95GP3pGkNXP++c8746A2LrxgSX/5E5+8Ozt27Bn0XJ/5zA+yqb1E3VPOX3zQhwFOPWV+zjhjQZLkhhseGvRDBV/5yv39y/c/7/lnDLnkPgAAANC9xmviwoF6e5u57fZHkiQzZ07JBU9ZPGJfpk+fkmnTWgt4/+hHT+wX1B9o4OqDC46dMWQ94NBN/HL6A5XSSPK8JFckWZxkepLfS1WtGlBnSlr97E1V7aqjmwAAHLply9Zlzdqt/dtbt+57Srd27db++631eeYg91w77rhZedGLzsoXv3hfVqzYkD9919fzkhefnYULZ2Tt2m354pfuyyOPbEySPPvZS7No0cyD2jjvvMU5++yFue++tXnssU35oz/6Sp73/DNy6inzM2lyI2vXbMuNNz6UH9zzeJJk6tSeXH31eYNe0+tff1H+9E+vz549vfnzv/hWXvbSc3LWWQuzZ09vbr/9kXzr2w+1+r1oZl70wrPG8uMCAAAAusgLnn9mvv3th9JsVvnIR+/IO379uZkypad//2gmLhzoB/eszpYtrfdfLr3k5FFNLmg0Si54ypLcdvsj2bRpZ77whXvzilcc/L7Itm2784lP3N2/fcEFI39AABi7+kL8Ul6R5C+SHLiGx7uSrBqw/eYkf5lka0o5PlW1bYJ6CADAOPj2DQ/tt4TbQA8++EQefHD/T5kPFuInyate+ZRs2bIrN964PI88sjEf+LtbDqpzySXH58UvOn3Ivvz8W67I+953U+67f23WPbEt//7vdw5ab9bMqfnZn31GFi+eNej+k0+al7e8+bL8/T/cmp079+aTn7r7oDrHLZqZt771qkybNnnI/gAAAABPXp0yceFAN9/8cH/58lEspd/n6qvPzZ13rczu3b357OfuycMPb8jlly/NgoUzsndP6/aDX/vasqxf31oV4JyzF+W884T4cCTUE+KX8pYkf5ukb72PdUkWJBnsJhsfSPKHSeYkeU2Sf5qILgIA0FkajZI3/vQlufjiE/Ltbz+U5cvXZ9u23ZkxY0pOOWV+rrrylJx00vD3hJsxY0p+7deenTvvWpXbbns4K5ZvyKbNO9NsNjP9mClZcvzsnH/+4lx15amZMWPKsG1deOHx+W/vfFG+9vVlufv7q7Jh445M6mlk4aKZedrTTszznnt6pkypd+ErAAAA4MjppIkLfbZv353vf39lkuT4JbOzdOm8EY/ps3jx7PzSLz4zf/f3t2Tr1t256/urctf3Vw1a9+yzF+Ytb7l81G0DYzPx7yqWcmaS97S3vpbkl1NV96aUwW+uUVW7U8rHkvxckhdHiA8A8KRy3ZsuzXVvunTc2rvgKUtywVOWHPT9ZrOZzZs3j3h8KSVPvej4PLV9z7nDceyxM/K6116U1732osNuCwAAAOhO4zFxoc93vvto9uxpRW6XXXbymPty7rnH5X/895fkhhuX5wc/WJ1VKzdn+47daTQamTN7WpaeMi+XXnpyLrpwSUopIzcIHJI6pga9vX3eu5O8PFW1exTHfCutEP/iI9kxAAAAAJgor77wGXV3YUI1ehqZd9yiJMmGx9ek2Tv4nJ6j1SfvurXuLgAwzjpt4kKSPOuq0/Ksq047rH7MnDk1L3nx2XnJi88+rHaAQ9eo4ZzPT2vZ/HePMsBPkmXtx5OOTJcAAAAAAAAAoH51hPgnth/vHMMx29qPo1srBAAAAAAAAACehOoI8av241gC+WPbj5vGuS8AAAAAAAAA0DHqCPEfaz+O5YYcV7UffzTOfQEAAAAAAACAjlFHiH99kpLkTaOqXcqcJL+Y1gz+rx2xXgEAAAAAAABAzeoI8d+bViD/nJRy3bA1Szk2ySeTLE6yN8nfHuG+AQAAAAAAAEBtJj7Er6rvJfnztGbj/11K+UhKef2AGs9MKT+ZUt6TZFmSZ6cV+v+vVNWKCe8vAAAAAAAAAEyQSTWd9x1Jpib5pSSvbX9V7X3vHVCvtB/fnar6w4nrHgAAAAAAAABMvDqW00+qqkpVvTXJS5Jcn1aAXw74SpKbklydqvr1OroJAAAAAAAAABOprpn4LVX15SRfTimzklycZFGSniRPJLkjVbWuzu4BAAAAAAAAwESqN8TvU1Vbknyz7m4AAAAAAAAAQJ3qWU4fAAAAAAAAADiIEB8AAAAAAAAAOsTEL6dfyt8fxtFVqurnxq0vAAAAAAAAANBBJj7ET65LUh3CcaV9nBAfAAAAAAAAgKNSHSH+wxk5xJ+R5NjsC+7XJdl+hPsFAAAAAAAAALWa+BC/qk4ZVb1S5iX5iSR/kGRjklemqu47Yv0CAAAAAAAAgJo16u7AkKpqQ6rqr5NcmWRRki+0g30AAAAAAAAAOCrVsZz+2FTVfSnlL5L8tyTvSPLOmnsEAPCk8Lo3/FXdXZhQjUYyd87kJMnGTXvSbNbcoQn27x/55bq7AAAAAACMg84P8Vu+klaI/2MR4gMAAAAAAHStO99+dd1dmFBVaWT3jPlJkinb1qdU3TVz4aL/+7m6uwATrnOX09/f1vbjybX2AgAAAAAAAACOoCdLiH9x+3FPrb0AAAAAAAAAgCOo80P8Uk5N8j+SVEnuqLUvAAAAAAAAAHAETZrwM5byxlHUaiSZl+SSJK9KMj2tEP9vj2DPAAAAAAAAAKBWEx/iJx9MK5AfrdJ+/ItU1UfGvzsAAAAAAAAA0BnqCPGTfcH8SDYm+WaSv05VfenIdQcAAAAAAAAA6ldHiH/qKOo0k2xJVW08wn0BAAAAAAAAgI4x8SF+Va2Y8HMCAAAAAAAAwJNAo+4OAAAAAAAAAAAtQnwAAAAAAAAA6BBCfAAAAAAAAADoEJMm/Iyl9B6BVqtU1cRfCwAAAAAAAACMozqC71LDOQEAAAAAAACg49UR4v/P9uPVSS5pl3+Q5NYkj7e3j0tyaZKnJKmS3J7k8xPYRwAAAAAAAACYcBMf4lfV/0wpv59WgH9nkp9PVd02aN1SLk3y3nbdz6Wq/mDC+gkAAAAAAAAAE6wx4Wcs5QVJ/keS+5NcNWSAn6S971lJliX57ynlhRPRRQAAAAAAAACow8SH+MmvpLVE/v9JVW0bsXarzv9JUpK87ch2DQAAAAAAAADqU0eIf0n78a4xHHNn+/HSce4LAAAAAAAAAHSMOkL8+e3HOWM4Znb7cd449wUAAAAAAAAAOkYdIf7K9uO1Yzjmte3HVePcFwAAAAAAAADoGHWE+P+Z1v3tfyGlvH7E2qW8NskvJKmSfP7Idg0AAAAAAAAA6lNHiP+/k2xun/tfU8onU8qrU8oJKWVySpnULr86pXwiyUeS9CTZkuSPa+gvAAAAAAAAAEyIiQ/xq+qxJNekFcqXdvljSR5OsjPJrnb5Y0le2a6zJcmr2seOi1LKolLKK0opf1BK+UIpZV0ppWp/ffAQ2ntZKeUTpZRHSym72o+fKKW8bAxtTCql/GIp5VullLWllB2llAdLKe8tpZw/hnYWtK/rrlLK5vbXXe3vHTvWawMAAAAAAABgYkyq5axV9a2UckGS/y/Jq9OaaT+Y3iSfSvKOVNWKce7F4+PRSCmlkeR9SX7ugF0ntL9eXUr5QJJfqKqqOUw7C9K6XcClB+w6LcnPJ3lTKeWXq6r6wAj9uSzJJ5MsPmDXBe2vN5dSXl1V1a3DXhgAAAAAAAAAE66eED9JquqRJK9LKccleV5aAfP89t4NSb6f5OupqtUT0JuHk9yb5MWHcOwfZV+A/70kf5LkwSSnJ/mtJBcneXOStUl+d7AGSik9ST6RfQH+x5O8P8n6JJcleWeSRUneW0p5rKqqLwzRzklJPpNkYZK9aX1I4rPt3a9I8utJliT5TCnl6VVVPXoI1wsAAAAAAADAEVJfiN+nqh5P8m/tr4n0B0luS3JbVVWPl1JOSfLQWBoopZyV5Dfam7cneXZVVTva27eVUj6d5BtJLknym6WUv6+qatkgTb0pyVXt8l9XVfXWAftuLaV8Icl3ksxO8hellHOrqto7SDt/lFaAnyQ/WVXVvw/Y961SyneSfCStDwT8YZLrxnC5AAAAAAAAABxhjbo7UJeqqv57VVWfrVofIjhUv5Z9H4R424AAv+8c25O8rb05Kcnbh2in74MA65P85iB9XZbkj9ubZyR5zYF1SimLk/xUe/OLBwT4fe18NMkX25s/3T4GAAAAAAAAgA5Rf4hfyjEp5aqU8tqU8saUMrvuLo1GKaUkeVV7896qqm4erF77+/e1N1/VPm5gO2clObe9+dF28D+YDw4oHxTiJ3ll9v17/sMwXe9rp9E+BgAAAAAAAIAOUV+IX8pJKeUfk2xIa8n5j6QVPp94QL2fSym3ppQv54AAvGanJjm+Xf7GCHX79p+Q5JQD9l01SL2DVFW1Osn97c0rB6kyqnYO2DdYOwAAAAAAAADUZNLIVY6AUi5L8rkk85IMDOarQWp/Jsl7kkxO8uLsWw6+bucNKN87Qt2B+89N8tBhtHNWkpNKKTOqqto2SDub2oH/oKqqWlVK2ZxkdvatAHDISiknjlClf8n+ZrOZZrM59pNUgw2Lo1hV7bvmbrv25NDGyDgpg/4XdPQqqfqvuduuPal3rDVKd/28G6VKaV9zt117UvNYq3/NpQnVaCR9H/nstmtP6h5r3fUDbzQaaTRKf7nb1DnWenp6ajt3HXp6evrHWLdde2KsTSRjrca/oT3d9Xek0dNIaY+1brv2pOb3PLrsOUtpNJL287Vuu/ak3rFWddnPu+ryF6K1jrXSXT/vqjRStcdat117Uu9Ya6aT5hcfec12ctBX7jaHO9bG832iiQ/xS5mb5FNJ5idZleR/JflWku8PWr+q1qSUL6S19PvV6ZwQf2B4/egIdR8ZUD5pHNop7ePuG7Cvr52R2uhr5/xB+nIoHhm5SsuWLVuyefPmMZ9gSnPvmI95UquqTK56W+Vm9j0J7BKHMkbGy5xJ9T0RqENJlZk9fYFqs/8Pc7eoc6zNm95dY61Rqsye1veBkWaalbE2UebOmVzbuetQGsmsme2ntyWpuutXrdaxtnDR3NrOXYdGaWTevFmtjaqk2WWDrc6xtmTJ4pErHUUajUYWLDi2f7vON67qUOdYO27JktrOXYeenkbmL1iQpPUStLfXWJso845bVNu561AajcyeP69/u/L/2oSZtnB+beeuQ2mUTJk7p1VOUjW76wPldY61DPgd7wqlkcyZ1bfRdS9E6xxru2d01/9rVSnZe8yc/u3SZRMA6xxrOxrTazt3HaokuxpT+7e6653cwx9rc+fOHZ+OpJ6Z+L+SZFGSdUmuSFU9nGSkoPIrad1//hlHunNjMGtAeesIdQfOmJ95hNsZqY2B7RzYBgAAAAAAAAA1qiPEvyatD3L8f/0B/sh+0H48/ch06ZBMG1DePULdXQPKxxzhdkZqY2A7B7ZxKEaazb84yW1JMmvWrMyePXvMJ9jdqOeuD7WpqtYM/LSvvctm4h/KGBkvm/Z21zJErSX0W4Nt095G132mrs6xtmF7d421RqlStcfaxu2NrpuJX+dY27hpT23nrkOjkf6bM23avCddNrGr1rG2ds3G2s5dh0ajkbRvD7J27aaumx1d51hbtWrIO4cdlQYua7569ePp7e2tsTcTr86x9viqVbWduw49PT39d3Nbs3q1sTaBNjy+prZz12HgEvob16xJs8tWfahzrO1cu762c9ehNBr9Nw7ctXZD1636UOdYy/oN9Z27DgNfiG7YmG57IVrnWJuyrbv+Xxu4hP6UbRtSumzVhzrH2ubm9trOXYfWEvqt92+nNXek0WW34q31b+gB6khHz2g/fnMMx/T95e+cn1yyc0B5ygh1pw4o7xihnZ0Z2kjtTB9FXwa2c2AbY1ZV1bDL95cBAXTr3qGHEFx1WYidZN81l9J111/nfWW7LcRO9l1zNeA+N92izrHWbSF2klTta25Wpeuuv9ax1l2v55KkP4BoNrvv+usda132w07SbC/J2mw2u+766xxr3RYsJvt+v3p7e7vu+o21iWWs1aPbQuxk3xL6zd5m111/re95dNnzlSRJ+/la1Wx23fXXOdZKl/2sk+z3QrTbrr/WsdZlIXaybwn9UjW77vrrHGvdFmInfRMAW9febddf51g7UB096ZsxPpapYTPaj4cdOo+jLQPKIy1LP2NA+cDl7se7ndEskd/XzmiW3gcAAAAAAABggtQR4vetE3bqGI55avtx5fh25bAMnIF+4gh1By45/8g4tFMdcNzAdkZqY2A7B/YFAAAAAAAAgBrVEeLf0n582ahqt9Zjf0tawfW3jlCfDsU9A8rnjFB34P4fjkM7j1RVtW2IduaUUhYP1UApZUn23ZbgwL4AAAAAAAAAUKM6Qvx/TlKS/FRKeeoo6v9Zkova5Q8dqU4dgoeyb2WA54xQ99ntx8eSLD9g37cHlIdspx3Mn9XevGGQKqNq54B9g7UDAAAAAAAAQE0mPsSvqk8l+XqSSUm+mlJ+KaUsGlBjUko5PqW8LqV8K8mvpjUL/+OpqhsnvL9DqKqqSvKp9uY5pZTLB6vX/n7fDPpPtY8b2M792Tcj/vWllOlDnPK6AeVPDLL/00ma7fLPDNP1vnaa7WMAAAAAAAAA6BB1zMRPkmuTfC/JvCR/lWRVWkF92t9/JMm/JXlmWrP2b8n+IXaneHeS3nb5L0spxwzc2d7+y/bm3nb9wbyr/Tg/yZ8cuLOUcnqS32lvLssgIX5VVavTWuUgSV5SSnntIO28LslL2pv/2D4GAAAAAAAAgA4xqZazVtXGlHJFkv+e5L8mmTNEze1phfy/n6raPZ5dKKVcleSMAd9aMKB8RinluoH1q6r64IFtVFV1fynlT5P8P0kuSXJDKeX/TfJgktOT/HaSi9vV/7SqqgeG6M6HkvxskiuTvLW9dP77k2xI8owk/y2t+9g3k/xKVVV7h2jn95K8NMnCJP9aSrkkyWfb+16R5B3t8tok7xyiDQAAAAAAAABqUk+In6Qdyv9eSvnfad2n/ZIki5L0JHkirRn5X0lVbTpCPXhzkjcNse/K9tdAHxyi7u+l1e+fTSuw/7dB6vxdhgnNq6rqLaW8Osnnk1ya1koF1x5QbVeSX66q6gvDtPNIKeWaJJ9MsjitDxH89gHVVid5dVVVjw7VDgAAAAAAAAD1mPgQv5Q3tkv3papuSVVtSyu8/vyE92UcVFXVTPJzpZSPJfn5tEL4BUnWJbktyXuHC94HtLOulPLMJG9J8pNJzk0yI8nKJF9N8udVVf1gFO3cUkq5IMmvJnl1klPaux5K8qkk766q6omxXCMAAAAAAAAAE6OOmfgfTFIl+Ym07nVfi6qqrkty3Ti2d9gfRGgvk/837a/DaWddWkvw/7fDaQcAAAAAAACAidWo4Zx9y+MPdX94AAAAAAAAAOhKdYT4D7Uf59VwbgAAAAAAAADoWHWE+J9IUpJcU8O5AQAAAAAAAKBj1RHi/3mSFUl+KaW8oIbzAwAAAAAAAEBHmvgQv6o2J3lRknuT/GdKeV9KeW5KmZ9SyoT3BwAAAAAAAAA6xKQJP2MpvQO3kvxc+6tv/3BHV6mqie8zAAAAAAAAAEyAOgLxA1N6s+8BAAAAAAAAIPWE+P+zhnMCAAAAAAAAQMc7siF+KW9slz6ZqtqcJKkqIT4AAAAAAAAADOJIz8T/YJIqye1J7jlobykLk/xSWve6/19HuC8AAAAAAAAA0NHqWE5/oEVJ/kdaQb8QHwAAAAAAAICu1qi7AwAAAAAAAABAixAfAAAAAAAAADqEEB8AAAAAAAAAOoQQHwAAAAAAAAA6hBAfAAAAAAAAADqEEB8AAAAAAAAAOsSkCTrPf00pawb5/qL+Uim/P6qWquoPxqlPAAAAAAAAANBRJirE/6Vh9lXtx/8+yraE+AAAAAAAAAAclSYixC/j2FY1chUAAAAAAAAAeHI60iH+845w+wAAAAAAAABw1DiyIX5VfeOItg8AAAAAAAAAR5FG3R0AAAAAAAAAAFqE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4AAAAAAAAANAhhPgAAAAAAAAA0CGE+AAAAAAAAADQIYT4h6GUcn0ppRrj13MPaOO6MRx73Sj6NL2U8lullNtKKetLKdtKKfeWUv6slLL0CP0oAAAAAAAAABgHk+ruQJdpJnngSDVeSjkjyeeTnHnArrPbX28upfxUVVWfPVJ9AAAAAAAAAODQCfEPz88kmTFCnfOSfKRd/mpVVY8NU/clSVYOs//RoXaUUmYl+Vz2BfjvT/JvSXYkeV6S30kyO8lHSilXVlV1xwj9BgAAAAAAAGCCCfEPQ1VVD41Up5Ty0wM2PzxC9furqlp+iN35zSRntcu/VVXVnw7Yd1Mp5fok30gyPcm7kzz3EM8DAAAAAAAAwBHSqLsDR7NSSiPJT7U3tyb5+BE6z+Qkv9Le/GGSPzuwTlVVNyb5u/bmc0oplx6JvgAAAAAAAABw6IT4R9YLkpzQLv9HVVXbj9B5npdkTrv8oaqqmkPU++CA8muOUF8AAAAAAAAAOERC/CPrjQPKIy2lfziuGlD+xjD1bk/S90GCK49cdwAAAAAAAAA4FEL8I6SUMjP7ZruvSHL9KA77h1LKylLK7lLKulLKzaWUPyylnDDCcecNKN87VKWqqvYmWdbePHcU/QEAAAAAAABgAk2quwNHsWuTzGiX/6mqqmoUxzx3QPnY9tdlSd5RSvm1qqreO8RxJ7Yft1VVtXGEczyS5MIkC0spU6uq2jWKfg2plHLiCFUW9xWazWaazaFW+h/GqH50R5Gq2nfN3XbtyaGNkXFS0l0/75Kq/5q77dqTesdao3TXz7tRqpT2NXfbtSc1j7Uu+7hmo5GUsq/cbeoda931A280Gmk0Sn+529Q51np6emo7dx16enr6x1i3XXtirE0kY63Gv6E93fV3pNHTSGmPtW679qTm9zy67DlLaTSS9vO1brv2pN6xVnXZz7vq8heitY610l0/76o0UrXHWrdde1LvWGum1HbuOjTbyUFfudsc7lgbz/eJhPhHzliW0v9Rko8nuSmtkD1JTkvrgwCvTTItyd+WUqqqqt43yPGz2o9bR9GvbQPKM5McVoifff0d0ZYtW7J58+Yxn2BKc++Yj3lSq6pMrnpb5Wb2PQnsEocyRsbLnEn1PRGoQ0mVmT19gWqz/w9zt6hzrM2b3l1jrVGqzJ7W94GRZpqVsTZR5s6ZXNu561AayayZ7ae3Jam661et1rG2cNHc2s5dh0ZpZN689lPwqqTZZYOtzrG2ZMnikSsdRRqNRhYsOLZ/u843rupQ51g7bsmS2s5dh56eRuYvWJCk9RK0t9dYmyjzjltU27nrUBqNzJ4/r3+78v/ahJm2cH5t565DaZRMmTunVU5SNbvrA+V1jrUM+B3vCqWRzOl7e777XojWOdZ2z+iu/9eqUrL3mDn926XLJgDWOdZ2NKbXdu46VEl2Nab2b3XXO7mHP9bmzp07Ph2JEP+IaM9Of2578+aqqu4fpvonknxokJn6tyX5SCnlFWkF/JOT/N9Syqerqlp9QN1p7cfdo+jewND+mFHUBwAAAAAAAGCCCPGPjP+SpG+9hA8NV7Gqqk0j7P9sKeUPkvyvJNOT/FySPzqg2s7245RR9G3qgPKOUdQfyUkj7F+c1gcSMmvWrMyePXvMJ9jd6LJhWlWtGfhpX3uXzcQ/lDEyXjbt7a5liFpL6LcG26a9ja77TF2dY23D9u4aa41SpWqPtY3bG103E7/OsbZx057azl2HRiPpuzvIps170mUTu2oda2vXbKzt3HVoNBpJ+/Yga9du6rrZ0XWOtVWrDvw889Ft4LLmq1c/nt7e3hp7M/HqHGuPr1pV27nr0NPT0383tzWrVxtrE2jD42tqO3cdBi6hv3HNmjS7bNWHOsfazrXrazt3HUqj0X/jwF1rN3Tdqg91jrWs31Dfuesw8IXoho3ptheidY61Kdu66/+1gUvoT9m2IaXLVn2oc6xtbm6v7dx1aC2h33r/dlpzRxpddiveWv+GHqDL0tEJ89Ptx11JPjIO7b0vyR+k9VvznBwc4m9pP84cRVszBpRHs/z+sKqqenS4/WVAAN26d+ghBFddFmIn2XfNpXTd9dd5X9luC7GTfddcDbjPTbeoc6x1W4idJFX7mptV6brrr3WsddfruSTpDyCaze67/nrHWpf9sJM020uyNpvNrrv+OsdatwWLyb7fr97e3q67fmNtYhlr9ei2EDvZt4R+s7fZdddf63seXfZ8JUnSfr5WNZtdd/11jrXSZT/rJPu9EO226691rHVZiJ3sW0K/VM2uu/46x1q3hdhJ3wTA1rV32/XXOdYO1Dk9OUqUUi5Jcl5787NVVR32Rw+rqlqT5In25gmDVOkL0meUUuaO0FzfzPm1VVXtGrYmAAAAAAAAABNKiD/+3jigPOxS+mM03Edd7hlQPmeoSqWUSUlOb2/+cDw6BQAAAAAAAMD4EeKPo1LK5CQ/3t5cm+QL49TuwiQL2psrB6ny7QHl5wzT1CXZt5z+DePQNQAAAAAAAADGkRB/fL0sycJ2+V+qqto7Tu3+fNJ/s+pvDLL/+iSb2uU3lTLkTdSvG1D+xLj0DAAAAAAAAIBxI8QfXwOX0v/wSJVLKaeUUi4eoc4rkvx+e3NHkn84sE5VVbuT/EV789wkvzFIO1ck+bn25jeqqrptpP4BAAAAAAAAMLEm1d2Bo0UpZV6SV7Q3766q6rujOOyUJF8vpdyU5DNJ7kyypr3vtCSvbX/1zaz/jaqqHhuirT9N8oYkZyX5k1LKGUn+La3g/3lJfjetf+8dSX5t1BcGAAAAAAAAwIQR4o+fNySZ2i6POAv/AFe0v4ayPcnbq6p631AVqqraUkq5Osnnk5yZ1hL8P39Atc1JfqqqqjvG2D8AAAAAAAAAJoAQf/z8dPuxN8k/j/KY7yT5L2kF+JckWZJkQVr/LhuS/CDJV5N8oKqqNUM10qeqqmXt5fnfmuR1Sc5IMiXJI2mF+39eVdWK0V4QAAAAAAAAABNLiD9Oqqq68hCO2ZJW4D/a0H80bW5L8iftLwAAAAAAAACeRBp1dwAAAAAAAAAAaBHiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiAwAAAAAAAECHEOIDAAAAAAAAQIcQ4gMAAAAAAABAhxDiH6ZSSjXKr+tH0dbLSimfKKU8WkrZ1X78RCnlZWPoz6RSyi+WUr5VSllbStlRSnmwlPLeUsr5h3WxAAAAAAAAABxRk+ruAEkppZHkfUl+7oBdJ7S/Xl1K+UCSX6iqqjlMOwuSfD7JpQfsOi3Jzyd5Uynll6uq+sC4dR4AAAAAAACAcSPEHz9/k+Svh9m/bZh9f5R9Af73kvxJkgeTnJ7kt5JcnOTNSdYm+d3BGiil9CT5RPYF+B9P8v4k65NcluSdSRYleW8p5bGqqr4w8iUBAAAAAAAAMJGE+ONnTVVVd4/1oFLKWUl+o715e5JnV1W1o719Wynl00m+keSSJL9ZSvn7qqqWDdLUm5Jc1S7/dVVVbx2w79ZSyheSfCfJ7CR/UUo5t6qqvWPtLwAAAAAAAABHTqPuDpBfy74PU7xtQICfJKmqanuSt7U3JyV5+xDt9H0QYH2S3zxwZzv4/+P25hlJXnPoXQYAAAAAAADgSBDi16iUUpK8qr15b1VVNw9Wr/39+9qbr2ofN7Cds5Kc2978aDv4H8wHB5SF+AAAAAAAAAAdRohfr1OTHN8uf2OEun37T0hyygH7rhqk3kGqqlqd5P725pWj6yIAAAAAAAAAE2XSyFUYpdeVUl6fVsDem2R1khuTfLCqqq8Pccx5A8r3jtD+wP3nJnnoMNo5K8lJpZQZVVVtG6H+sEopJ45QZXFfodlsptlsjv0kVTX2Y57MqmrfNXfbtSeHNkbGSUl3/bxLqv5r7rZrT+oda43SXT/vRqlS2tfcbdee1DzWuuzjmo1G0rdeUbdde1L3WOuuH3ij0UijUfrL3abOsdbT01PbuevQ09PTP8a67doTY20iGWs1/g3t6a6/I42eRkp7rHXbtSc1v+fRZc9ZSqORtJ+vddu1J/WOtarLft5Vl78QrXWsle76eVelkao91rrt2pN6x1ozZeRKR5FmOznoK3ebwx1r4/k+kRB//Jx3wPYZ7a83llI+meS6qqo2HVBnYAD+6AjtPzKgfNI4tFPax903TN3ReGTkKi1btmzJ5s2bx3yCKc29Yz7mSa2qMrnqbZWb2fcksEscyhgZL3Mm1fdEoA4lVWb29AWqzf4/zN2izrE2b3p3jbVGqTJ7Wt8HRpppVsbaRJk7Z3Jt565DaSSzZraf3pak6q5ftVrH2sJFc2s7dx0apZF582a1NqqSZpcNtjrH2pIli0eudBRpNBpZsODY/u0637iqQ51j7bglS2o7dx16ehqZv2BBktZL0N5eY22izDtuUW3nrkNpNDJ7/rz+7cr/axNm2sL5tZ27DqVRMmXunFY5SdXsrg+U1znWMuB3vCuURjJnVt9G170QrXOs7Z7RXf+vVaVk7zFz+rdLl00ArHOs7WhMr+3cdaiS7GpM7d/qrndyD3+szZ07d3w6EiH+eNie5NNJvprWLPetSRYmeU6SX0xybJJXJ/lUKeVFVVXtGXDsrAHlrSOcZ+CM+ZkH7BuvdgAAAAAAAACokRD/8J1QVdXGQb7/5VLKXyb5QpKL0wr1fynJXwyoM21AefcI59k1oHzMAfvGq51DceCqAAdanOS2JJk1a1Zmz5495hPsbnTZMK2q1gz8tK+9y2biH8oYGS+b9nbXMkStJfRbg23T3kbXfaauzrG2YXt3jbVGqVK1x9rG7Y2um4lf51jbuGnPyJWOIo1G0nd3kE2b96TLJnbVOtbWrtlY27nr0Gg0kvbtQdau3dR1s6PrHGurVq2u7dx1GLis+erVj6e3t7fG3ky8Osfa46tW1XbuOvT09PTfzW3N6tXG2gTa8Pia2s5dh4FL6G9csybNLlv1oc6xtnPt+trOXYfSaPTfOHDX2g1dt+pDnWMt6zfUd+46DHwhumFjuu2FaJ1jbcq27vp/beAS+lO2bUjpslUf6hxrm5vbazt3HVpL6Lfev53W3JFGl92Kt9a/oQfosnR0/A0R4Pfte7yU8tq0ZuhPTvK27B/i7xxQnjLCqaYOKO84YN+B7ezM0IZrZ8yqqhp2+f4yIIBu3Tv0EIKrLguxk+y75lK67vrrvK9st4XYyb5rrgbc56Zb1DnWui3ETpKqfc3NqnTd9dc61rrr9VyS9AcQzWb3XX+9Y63LfthJmu0lWZvNZtddf51jrduCxWTf71dvb2/XXb+xNrGMtXp0W4id7FtCv9nb7Lrrr/U9jy57vpIkaT9fq5rNrrv+Osda6bKfdZL9Xoh22/XXOta6LMRO9i2hX6pm111/nWOt20LspG8CYOvau+366xxrB+qcnhylqqr6UZIvtzfPKKUcP2D3lgHlkZa2nzGgfOCS+ePVDgAAAAAAAAA1EuJPjHsGlE8YUB44i/3EEdoYuGz9IwfsO5R2qgOOAwAAAAAAAKBmQvyJMdRaEwPD/XNGaGPg/h+OQzuPVFW1bYS6AAAAAAAAAEwgIf7EOG9AeeWA8kMDtp8zQhvPbj8+lmT5Afu+PaA8ZDullMVJzmpv3jDC+QAAAAAAAACYYEL8I6yUcmqSF7U3H6yq6rG+fVVVVUk+1d48p5Ry+RBtXJ59M+g/1T6uX1VV92ff7PzXl1KmD9Gd6waUPzHqiwAAAAAAAABgQgjxD0Mp5ZpSyqRh9h+X5GNJprS/9deDVHt3kt52+S9LKccc0MYxSf6yvbm3XX8w72o/zk/yJ4P05fQkv9PeXBYhPgAAAAAAAEDHGTKAZlT+MsnkUsrHktyU1jL3O5IsSPLcJL/QLietJe/fc2ADVVXdX0r50yT/T5JLktxQSvl/kzyY5PQkv53k4nb1P62q6oEh+vKhJD+b5Mokb20vnf/+JBuSPCPJf0syO0kzya9UVbX3kK8aAAAAAAAAgCNCiH/4jk/ytvbXUD6W5M1VVe0aYv/vJVmUVgh/cZJ/G6TO3yV551AnqKqqt5Ty6iSfT3JpkmvbXwPtSvLLVVV9YZi+AgAAAAAAAFATIf7heVOS5yS5Islpac26n51ka5JHktyY5ENVVd00XCNVVTWT/Fx7Rv/PpxXCL0iyLsltSd47muC9qqp1pZRnJnlLkp9Mcm6SGUlWJvlqkj+vquoHh3CdAAAAAAAAAEwAIf5hqKrqG0m+MY7tfT6tmfSH08beJH/T/gIAAAAAAADgSaRRdwcAAAAAAAAAgBYhPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIT4AAAAAAAAAdAghPgAAAAAAAAB0CCE+AAAAAAAAAHQIIf5hKqVcUkr5/VLKl0opj5ZSdpVStpZS7i+l/EMp5apRtHFdKaUa5dd1o2hveinlt0opt5VS1pdStpVS7i2l/FkpZem4XDgAAAAAAAAA425S3R14MiulfDPJswbZNSXJme2v60opH07ylqqqdk9An85I8vn2uQc6u/315lLKT1VV9dkj3RcAAAAAAAAAxkaIf3iObz+uTPLvSb6V5OEkPUmuSPKOJCckeWOSyUl+chRtvqTd3lAeHWpHKWVWks9lX4D//iT/lmRHkucl+Z0ks5N8pJRyZVVVd4yiPwAAAAAAAABMECH+4bk3ye8m+VhVVb0H7Lu5lPKPSW5IclaSnyil/G1VVd8coc37q6pafoj9+c32uZLkt6qq+tMB+24qpVyf5BtJpid5d5LnHuJ5AAAAAAAAADgCGnV34MmsqqpXVFX10UEC/L7969Kajd/ntUeqL6WUyUl+pb35wyR/Nkh/bkzyd+3N55RSLj1S/QEAAAAAAABg7IT4R97XB5RPP4LneV6SOe3yh6qqag5R74MDyq85gv0BAAAAAAAAYIyE+Efe1AHlQWfsj5OrBpS/MUy925Nsb5evPHLdAQAAAAAAAGCshPhH3nMGlH84ivr/UEpZWUrZXUpZV0q5uZTyh6WUE0Y47rwB5XuHqlRV1d4ky9qb546iPwAAAAAAAABMkEl1d+BoVkppJPl/Bnzro6M47LkDyse2vy5L8o5Syq9VVfXeIY47sf24raqqjSOc45EkFyZZWEqZWlXVrlH0a1CllBNHqLK4r9BsNtNsDrXK/zCqauzHPJlV1b5r7rZrTw5tjIyTku76eZdU/dfcbdee1DvWGqW7ft6NUqW0r7nbrj2peax12cc1G42klH3lblPvWOuuH3ij0UijUfrL3abOsdbT01PbuevQ09PTP8a67doTY20iGWs1/g3t6a6/I42eRkp7rHXbtSc1v+fRZc9ZSqORtJ+vddu1J/WOtarLft5Vl78QrXWsle76eVelkao91rrt2pN6x1ozpbZz16HZTg76yt3mcMfaeL5PJMQ/st6e5Bnt8serqvrOMHV/lOTjSW5KK2RPktOSXJvktUmmJfnbUkpVVdX7Bjl+Vvtx6yj6tW1AeWaSQw7xs6+vI9qyZUs2b9485hNMae4d8zFPalWVyVX7zgvN7HsS2CUOZYyMlzmT6nsiUIeSKjN7+gLVZv8f5m5R51ibN727xlqjVJk9re8DI800K2NtosydM7m2c9ehNJJZM9tPb0tSddevWq1jbeGiubWduw6N0si8ee2n31VJs8sGW51jbcmSxSNXOoo0Go0sWHBs/3adb1zVoc6xdtySJbWduw49PY3MX7AgSeslaG+vsTZR5h23qLZz16E0Gpk9f17/duX/tQkzbeH82s5dh9IomTJ3TqucpGp21wfK6xxrGfA73hVKI5nT99Z8970QrXOs7Z7RXf+vVaVk7zFz+rdLl00ArHOs7WhMr+3cdaiS7GpM7d/qrndyD3+szZ07d3w6EiH+EVNKeU6S/9PeXJPkl4ap/okkH6qqg/7XvS3JR0opr0gr4J+c5P+WUj5dVdXqA+pOaz/uHkX3Bob2x4yiPgAAAAAAAAATQIh/BJRSzk8rmJ+UZGeS11VVtWao+lVVbRquvaqqPltK+YMk/yvJ9CQ/l+SPDqi2s/04ZRRdnDqgvGMU9Ydz0gj7F6f1YYTMmjUrs2fPHvMJdje6bJhWVWsGftrX3mUz8Q9ljIyXTXu7axmi1hL6rcG2aW+j6z5TV+dY27C9u8Zao1Sp2mNt4/ZG183Er3Osbdy0p7Zz16HRSPruDrJp85502cSuWsfa2jUbazt3HRqNRtK+PcjatZu6bnZ0nWNt1aoDP8t8dBu4rPnq1Y+nt7e3xt5MvDrH2uOrVtV27jr09PT0381tzerVxtoE2vD4kG8XHZUGLqG/cc2aNLts1Yc6x9rOtetrO3cdSqPRf+PAXWs3dN2qD3WOtazfUN+56zDwheiGjem2F6J1jrUp27rr/7WBS+hP2bYhpctWfahzrG1ubq/t3HVoLaHfev92WnNHGl12K95a/4YeoMvS0SOvlHJqki8lmZekN8mPV1X1zXFo+n1J/iCt35zn5OAQf0v7ceYo2poxoDya5feHVFXVo8PtLwMC6Na9Qw8huOqyEDvJvmsupeuuv877ynZbiJ3su+ZqwH1uukWdY63bQuwkqdrX3KxK111/rWOtu17PJUl/ANFsdt/11zvWuuyHnaTZXpK12Wx23fXXOda6LVhM9v1+9fb2dt31G2sTy1irR7eF2Mm+JfSbvc2uu/5a3/PosucrSZL287Wq2ey6669zrJUu+1kn2e+FaLddf61jrctC7GTfEvqlanbd9dc51rotxE76JgC2rr3brr/OsXagzunJUaCU8v+3d99hslR1/vjfdUkioogiBlyRNYsBCYqoGFEXcQ3IKoqiteZYq/50V10x7uq6tvHrGmpBAbMr5qwoKkpQ1rAiYkBEEQQD6V4u3P79caqdvnNnembundAz83o9Tz9d1X2q6gz3cLrqfE64cZIvJ7lxSve7J/X7/U/Mx7m7kfwXdbs3mSLJIJi+Q1VVO81wusHo+Qv7/f66kSkBAAAAAAAAWDSC+POkqqrrJ/lSkj26j57d7/ffN8+XGdXd5f+Gtm8zXaKqqrZO8rfd7k/mI1MAAAAAAAAAzA9B/HlQVdV1knwhye26j17c7/ffPs/X2CXJ9bvd306R5JtD2weOONU+mZhO/1vzkDUAAAAAAAAA5okg/haqquqaST6T5C7dR6/p9/uvW4BLPSX564LVX5/i+xOT/LnbfkJVTbuQ+pFD2x+fl5wBAAAAAAAAMC8E8bdAVVXbpgTCD+g+enO/33/pHM+xe1VVe82Q5iFJ/rXbvSLJ0ZPT9Pv9K5O8pdu9bZIXTHGe/ZPU3e7X+/3+qXPJKwAAAAAAAAALa+ulzsAy94EkB3XbX03SVlW154j0V/b7/bMmfbZ7kq9VVXVykk8l+d8kF3Tf7ZHk0O41GFn/gn6/f9405/+PJP+Q5FZJXl9V1S2SfDAl8H+fJP+S8m9+RZLnzeLvAwAAAAAAAGARCeJvmUcMbd83yQ9mSH9OStB+Kvt3r+lcnqTp9/vvmi5Bv9+/pKqqg5N8NsktU6bgf8qkZH9J8th+v3/GDHkFAAAAAAAAYJEJ4i+905M8LiWAv0+SGyW5fsq/zR+T/DjJV5K8p9/vXzDdSQb6/f7Z3fT8z0zyqCS3SLJtknNTgvtv7vf75yzA3wEAAAAAAADAFhLE3wL9fr+aOdWM57gkyfHda170+/3Lkry+ewEAAAAAAACwTKxZ6gwAAAAAAAAAAIUgPgAAAAAAAACMCUF8AAAAAAAAABgTgvgAAAAAAAAAMCYE8QEAAAAAAABgTAjiAwAAAAAAAMCYEMQHAAAAAAAAgDEhiA8AAAAAAAAAY0IQHwAAAAAAAADGhCA+AAAAAAAAAIwJQXwAAAAAAAAAGBOC+AAAAAAAAAAwJgTxAQAAAAAAAGBMCOIDAAAAAAAAwJgQxAcAAAAAAACAMSGIDwAAAAAAAABjQhAfAAAAAAAAAMaEID4AAAAAAAAAjAlBfAAAAAAAAAAYE4L4AAAAAAAAADAmBPEBAAAAAAAAYEwI4gMAAAAAAADAmBDEBwAAAAAAAIAxIYgPAAAAAAAAAGNCEB8AAAAAAAAAxoQgPgAAAAAAAACMCUF8AAAAAAAAABgTgvgAAAAAAAAAMCYE8QEAAAAAAABgTAjiAwAAAAAAAMCYEMQHAAAAAAAAgDEhiA8AAAAAAAAAY0IQHwAAAAAAAADGhCA+AAAAAAAAAIwJQXwAAAAAAAAAGBOC+AAAAAAAAAAwJgTxAQAAAAAAAGBMCOIDAAAAAAAAwJgQxAcAAAAAAACAMSGIDwAAAAAAAABjQhAfAAAAAAAAAMaEID4AAAAAAAAAjAlBfAAAAAAAAAAYE4L4AAAAAAAAADAmBPEBAAAAAAAAYEwI4gMAAAAAAADAmBDEBwAAAAAAAIAxIYgPAAAAAAAAAGNCEB8AAAAAAAAAxoQgPgAAAAAAAACMCUF8AAAAAAAAABgTgvgAAAAAAAAAMCYE8QEAAAAAAABgTAjiAwAAAAAAAMCYEMQHAAAAAAAAgDEhiA8AAAAAAAAAY0IQHwAAAAAAAADGhCA+AAAAAAAAAIwJQXwAAAAAAAAAGBOC+AAAAAAAAAAwJgTxAQAAAAAAAGBMCOIDAAAAAAAAwJgQxAcAAAAAAACAMSGIDwAAAAAAAABjQhAfAAAAAAAAAMaEID4AAAAAAAAAjAlBfAAAAAAAAAAYE4L4AAAAAAAAADAmBPEBAAAAAAAAYEwI4gMAAAAAAADAmBDEBwAAAAAAAIAxIYgPAAAAAAAAAGNCEB8AAAAAAAAAxoQgPgAAAAAAAACMCUF8AAAAAAAAABgTgvgAAAAAAAAAMCYE8QEAAAAAAABgTAjiAwAAAAAAAMCYEMQHAAAAAAAAgDEhiA8AAAAAAAAAY0IQHwAAAAAAAADGhCA+AAAAAAAAAIwJQfwVqqqqm1VV9Z9VVZ1ZVdVlVVVdXFXVqVVVvbCqqmsudf4AAAAAAAAA2NTWS50B5l9VVYckOS7JtYc+vmaSfbrXP1ZVdXC/3z97KfIHAAAAAAAAwNSMxF9hqqraK8mHUgL4lyZ5SZK7J7lfknd3yW6V5DNVVe24JJkEAAAAAAAAYEpG4q88b06yfZKrkhzU7/dPHvruq1VV/SzJ61MC+c9PctSi5xAAAAAAAACAKRmJv4JUVbVfknt2u+2kAP7Afyb5Sbf93KqqtlmUzAEAAAAAAAAwI0H8leVhQ9tHT5Wg3+9vSPK+bnenJPdZ2CwBAAAAAAAAMFuC+CvLPbr3y5KcPiLd14e2D1i47AAAAAAAAAAwF1svdQaYV7ft3s/u9/tXjUh35hTHbJaqqnabIclNBhvnnXdeNmzYMOdr/OmC38/5mGWt3882G8o/3/o1WydVtcQZWly//vWvl+zal//xgiW79lKo0s9WW5X/Jy+/ek36UdYWy7pLVldZW1P1c/lVpaytu2JNNvSVtcWydu0fl+zaS2HNmuSyrctKQWvXrs9m3HYsa0tZ1tavX7tk114Ka9asybp1lyUpf/vm3OMuZ0tZ1jb0V9d/62pDlSvXX5kk2bBhw6r7+5e2rPWX7NpLYsOGXLl+fZLk6g0bVt3fv6TPBlevX7JrL4Uqa3L5unVJkrVXr0//avXaYvnL+nVLdu2lUK1Zk7VrL0+SXLl+Xfru1xbNhetWV1nrr1mTXF7KWtatS6WsLZrzL11lZa1ak/UbSlnb5vJ1qVbZs8F1l7Cs/e7iS5bs2kthQ6qsq0qMarv+FVmT1fVssGELy9rNbnaz3ZKcP0Ocdlaq/ip7MFupqqq6RpIrut3P9Pv9h8yQ/tIkOyT5Tr/f338LrqsAAQAAAAAAACQ37ff7v9nSk5hOf+XYcWj70lmkv6x7v9YC5AUAAAAAAACAzWA6/ZXjGkPbV84i/WCume238Lo3neH7bZPcJskFSS5McvUWXm81uGGSU7vtfZOcv4R5YWVT1lgsyhqLRVljsShrLBZljcWirLFYlDUWi7LGYlHWWCzKGotFWdty8/LfTBB/5RheiHTbWaTfrnu/YmSqGcxyOohfbMk1Vpuq2mit6PPnY8oNmIqyxmJR1lgsyhqLRVljsShrLBZljcWirLFYlDUWi7LGYlHWWCzK2vgwnf7KccnQ9mymyN+he5/N1PsAAAAAAAAALAJB/BWi3++vTXJRt7vbqLRVVV03E0H8cxcyXwAAAAAAAADMniD+yvJ/3fstqqoatVTCbYa2f7KA+QEAAAAAAABgDgTxV5Zvdu87JNl7RLoDh7a/tXDZAQAAAAAAAGAuBPFXlhOGtp84VYKqqtYkeXy3+6ckX1vYLAEAAAAAAAAwW4L4K0i/3z8lyUndbl1V1f5TJHt+ktt222/u9/vrFyVzAAAAAAAAAMxo1LrpLE/PTZkif/skX6yq6rUpo+23T/LoJE/p0p2V5D+XJIcAAAAAAAAATKnq9/tLnQfmWVVVhyQ5Lsm1p0lyVpKD+/3+2YuXKwAAAAAAAABmIoi/QlVVdbOUUfkHJ9ktyZVJzk7ykSRv6/f7ly9h9gAAAAAAAACYgiA+AAAAAAAAAIyJNUudAQAAAAAAAACgEMQHAAAAAAAAgDEhiA8AAAAAAAAAY0IQHwAAAAAAAADGhCA+AAAAAAAAAIwJQXwAAAAAAAAAGBOC+AAAAAAAAAAwJgTxAQAAAAAAAGBMCOIDAAAAAAAAwJgQxAcAAAAAAACAMSGIDwAAAAAAAABjYuulzgAAy0BT97utV6TXHrWUWQEAAMZAUx+V5OVJkl5bLWleAAAAVhhBfJhPTX3vJF/r9gQ7mV8bl6/ZeGJ67TELkxlWrE3L2aVJdk2vvXyG47ZPcn6Saw99ep/02hPnOYesdE19YJIThz45IL3220uUG5YrdRnjwLMBS0n5Y765R2MxNPUOSY5I8tAkd0pyvSRVkr8k+VWSHyY5Ocnn02vPXaJcshI19XWSPC7JwUlul+QGSdYn+X2SU5N8MslH02uvXrI8snxs+jz64fTaf5jhmGOSPCGJzpHM3vTxgqtTfjv/nOTcJKcn+WaST6XXXrlo+WOLmU4fABjlWkkeNot0f5+Ng16wuZ4waf/xS5ILVhp1GQBsGfdoLKym3j/J/yV5R5IHJ7lxku2SbJvk+kn2SfLEJO9KCarC/GjqJyf5eZK3pZS9myXZPuW54JZJDk/ywSQ/SFPfY4HycGSaut+9dl+Qa7CUHpWmvsNSZ4JVZask102ye5J7Jnleko8m+U2a+qVpagO8lwlBfIDl6R1J7jDD64Slyhwrxtru/YhZpB2kWTsyFYxSRkEf2u1d2r0flqbebolyxMqgLgOALeEejYXW1LdK8oUkf9N98smUjiJ3S3KXJAcleWGSL6aMjob50dRvSOkYcr0kVyU5LslhSe6aEvj6xyRf7VLfLsmX09SHTnEmGKVK8oqlzgQr3uR4wf5J/i7Ji5N8KUk/yS5JXpXkW2nqXZYon8yB3hYAy9MF6bU/WupMsOJ9MuXh9QFp6hum154/ZaqmvkFKo0qSfCLJ6CnCYHoPT7Jjt/2cJP+d0nP4kJQew7A51GUAsGXco7HQXpOJMjbd0oBfSvKGLuhw2GJljBWsqZ+R5Pnd3m+SHJJee8akVN9M0qapD09ydMrsEMelqc+eIi1M5Q8ps4k8PE29V3rt95c6Q6xY08ULPpfkdWnq26V0VNoryX5JPp6mvq/p9cebkfgAwHS+mLI29FZJHjMi3WNSOgaen9KwAptrMC3rD9Jrj07y00mfw+ZQlwHAlnGPxsJp6q1S1iFPktOmCeBP6LUXpte+faGzxQrX1DdL8p/d3mVJ7jcyKN9r35/kSd3edkmOTVNbt5zZeEuSdd32K5cyI6xyvfb/khyQZNCR5IAkz1y6DDEbRuLDYmrqG6X0YL9vkjulrO+1dUqPvNOSvD/JR9JrN0xz/L2TfK3bu0967Ylp6sOSPDXJHVPWe/11yuixf0+vvXjB/haWn6a+TpJnJHlIklsluU6Si1LK3nuTfCy9tj/Lc90/ZQTGvikjMH6b5LNJ/i299rx5zztL5eokH0jSpEwx3Zsm3aDx7v3dMdNr6j1T1qW+Z5Lbp0zjtD7J75J8O8k70mu/M+L4o5K8PEnSa6uuXD8nySOS3DylXE83coNxVn4j79/tHTf0/qokD0pT75Jee+E0xx6VjcvFTinl9tCU9QyvTPK/Sd6VXvuBEXn4VZf+vem1R6ap907y7CQHpvxmb5teq6Fm+Rmfuqypt0lybpJdk3whvfZBs7jOD7u9F6XXvn5kepaPpj4yZTRXktw8vfZX06TbPckvu71Nf9+a+piUdarPSa/dvav//inJI1PWP1yf5AdJ3plee/y85Z/lbb7KH6vDlt2jHZPhOmr6axyZ2ZXJe6T8nh+QZKeU59AvJnlDeu3ZaeoTU+7bvp5ee++Z/jTGxi4p648nydlbfLamvkbKFOgPT7lP2znJn1J+Dz+Qcq9/1TTH/iobPw/sm/K7eo8unxcm+XKS16XXnrnFeWUpPS/JNbrtV6bXnjXjEb32+DT145I8KMmeKe1rn9okXVOvSZnV69CUdrPBlNXnJjk1yceTfCK9dv2ktt6BX6apJ5+1tAOzHJ2bsmTDs5M8JE29X3rtKZt1pjITyXNTOj7dPKUMn5/kpJT7/W9OcczjU9p9k+Sg9NrRHdab+p1JnpLSjnLD9No/blZeGU+99oo09REp7QxVkhekqd+WXrvpUjVNfcOUcvvAJHsk2SHJBUlOTmlf+/KM1ytl9undOW6ZEke4NMlZSb6e5Lj02h9s+R+2chmJD4ul9Cz+TZK3pzSq3SLJNZNsmxIYeGiSDyb5fJr6WrM445o09bFJPpTSKeD6KT/ct0pZJ+y7XUULSVPfL8nPk7w2yd1Tyss2SW6Y8tDxkSSfnlXZa+qXp4xQPKQ7fruUG8dnJvlxmvqeC/AXsHSO7d73SlPffpNvy1RMd5mUdmrl4fSHKQ1+ByW5SUoduENKnfj4JCenqf9tVjlr6lsmOSOlJ/OdUwL4LF+PTRkpvSEliJokx6es2bVNRo+gntDUN0/pnPSvKWsW7pDykHDvJO9PU38oTT1zR9amflqS76Q0PO+eUlZZvsajLisPxu/r9h6Qpr7JDPkejPa5aug4mFpT3zplVMXLUuq/a6b8Nt4zZdrXty1h7oDla37u0bZUU78oyTdSOu/umonn0Kcm+V6a+qARRzPehqfxve0Wnamp75TkzCRvTWkr2zWlnO6S5H5J3pPk22nqXWdxrieldM58dJLdUsrcbkmOTHJGmvpRW5RXlk4ZQT/owHtFknfO4eg3DW0/cYpz757k9JT68hFJbprSXnuNlADW4SltcAfMLdMsc/+WUtaS8hw5d+V37uwkL8lEG9h2KR2PHpfkpDT127pOJMM+PnTtw2e4xjYpnU+S5LMC+CtUr/1xJmYfvHFKZ6ONNfVjU8rbvyTZO6VdbduU38FHJflSmvo9I9vXyjl+meQVKfGIXVIGtO6UMp3/C1OWP2QEQXxYPIORe19NqaAelFIB3julgfbk7vsHpAT6Z/KqlB/oE1JuCvdO8ndJPtN9f4tMP9KM1aSpD0hZ++Z6SX6f5KUpAfi9u/fBaIq/y0TPzOkcnOSolOkT65Qf+funPPBsSLmB/HSa+qbz+jewdMpaXT/u9o6YIsXgsx/NYj24rVOmqftwkqel1H93SakPn5/knC7di9PUmz4Mb+qjKcGzt6bUnfukNCL+dNRBjK1BWTrxrzN69NpfpjScJbOfrvVDKQ26/5VSP+2bUl8NRlYcluQ/ZjjHvkneltL57llJ7pYy+uafZ5kHxs141WXv6d7XZFS5Lg0oj+v2Ppdee/4M+WJ1u2bKSLDrJXl1SrncJ8mTU+qyJHlmmvqBS5I7YDmbr3u0zVdmIPz3lHaVi5O8KKUx+O7d9lUpgyJutOB5Yf6VWSQH9093SlO/aIog1Mya+hYpo/puluQvKUGzh6f8Hj4wpa3tqpR7/U9091rTuXPK88QFKaMQ75oyy8PrUqbF3i7J8WnqfeacT8bBYIaGJDkpvfbPczj2y5kIiN5jo29K55BvpZSfpLQBPyGl/OyXMjr/nSn12MCpSe6Q0lY38MDus+HXqXPII+Om1/4uyTu6vYO6mWVmr6nvnHKvf+2UmbZ6Se6TUq6emomZk56ZUvcNX/uSTARKH9HNVjKdB2fi/w2zeK1sw6PoNx6QV+67jk0ZqPCLlBlpBrGsR6bMxpuUtrapZwsso/2P686xNqXt9u9S2k7uldLW9sWUeAIjmE4fFs/VSW6dXjvV1GBfT3J0mvoVKSMHj0hTvzq99mcjznf3JC9Nr33NRp829eeTfD5lZNihaernTDu1HcvZDbopdqdzQXrtBd1D6XEpPc8/n+SR6bWXD6X7XkrQ/RspUzs9Ik39gBFTK+3THXNgeu2lQ59/JU39rZRRgtdOWVfssM36yxhH70tprDg8Tf3Pf112ofRef+xQmpmckWS39No/TfHdF7oRgp9OCci/PE39vvTaUVNa75nkwem1Xxz67PRZ5INxUx5I79jtHTfp2+NSRinsnaa+XbeG1yj7Jjl80rT5p6WpP5IyxdydkjwnTd2m1/5omnPcLmWk9b0mlddvzfi3MM7Goy7rtWelqU9KeVA+MpMbWSY8JBNTb/73LPLF6rZLysiI/buRFQOnd9NL/zBlBNgzknxh0XMHLE/ze4+2uXnYLmU94aQsRbj/pHaVk9PUJ6QMjLjVguSBxfDWJG/otv89ydPS1J9M6SxyStdxZCbvTRlY8P2UKaP/MOn7L6apP50y+OWuKfdh757mXHdK6Vhwt0kdKb+Rpv5CSuBhmyT/LyWIxvJyp6Ht783pyF57dZr6f1M6eu+Spr5xeu1vu2/fkTKqNZl6KaxTk3w4Tf2ClPKT9NrLkvxoUoeQs6ZdVoTl7HUpAfcdUmaUvO8cjn1Xyr3+1UkeMqkd7NSuveObKW0ZL+ieQYefCY5P6URy7ZTnzI9Oc53BSP2/pDzTsnIN130T909Nff2U8laltEM8ddISNN9L8j9p6tekjNJ/bpr6nem1Px06x41SOsIlpTPc/aZofzspydsNBJyZkfiwWHptf5oA/rBXpjyUVinT649yesrU6JteJ3ljt7d1kv3nllGWiaenNMZO93pGl+7RKdNAr03y+EkB/Am99t1JBusxHTnDtZ8yKYA/OMexKSP+k+ThlnNYUY5P6Rl505SRfQP37j4bnlpzer32D9MEvQbfX5kyU0lSRk/ceYYzHjPpwYXla3gqw49N+u7DmZhiczYjvT495br3pff5U7q9NSkjqEd55sjyynI0TnXZYDT+rboZc6YyGMV/QTSgMDsvm9RYV5RnkBO6vbmN+gFWu/m8R9tcD0uZEj1JjpqyXaWsZf2KBcwDC6+XjTst7p7kOSkzLPwiTX1+mvqDaepDug6YGyvL+t2923vCFAH87irt5zMRvDpyhjw9f8qZkHrt1zIR/N/XaPxl6fpD25sz29Xvh7avl2SwrNHDus9OmCKAP6HXXmqa8lWo116QMuNfktwnTX2fWR3X1PtlYrrzd0/ZDlbK03B7xzMmpfh8kou67cdmKmWJ1UE84mPptWtnlT+Wq4uGtq87tP30lA5x5yV5xqQA/rCXd2mmmmHw2SkzxSUljjDdAJqk1547hzyvSoL4sFSaek2a+sZp6lunqffsRlXfNhPTXd5pxNFJ8v6/jiDb1PBI1D22NKssa4Obr6/PYkaGb3Tvozp+/DC9dtRI58FD99bZOEDCclamzfxatzc8DfVg+6t/nVpzLpp6uzT136SpbzdUDw43yMxUD5raayUo62cNent/Kr32Lxt9X6bXHEzV9dhZTK159LTf9NpTMjGl+v1HnOPc9NqTZrgOy8141WUfSTKYtnOqtTR3TZnKMEmOHfHgDAP9jO6EMrh/2zlNvdPCZwdY9ub/Hm1zDe7ZNmT0/f9xKXUhy1Gv3ZBeW6fMKvn5lGnvh+2aMor0k0lOSVP/7aTvB20fP02v/eEMVxu0few7Yi3fPyb5xIhzDHc4GPVcwXjacWh700EqMxs+5trd+8GZeAawvCnT+Y8kl3Tbr5rlMcN1TDttql77rSQ/meKYpNeuT3kGTZIHT/M88PAk23fb2ttWvuF6bLhOHPyefjq9dt20R5c2isHy0JNjCQ/p3n8Ra95vMdPpw2KamK61Tpm6a/sRqa8/4rskOXPEd8NrK+04bSqWs1ek1x41i3SDHuEPTFPPtkFj1Aj6mdbgOmVo+w4pveZZGd6X5H5JHpmmfmb32aFD381OU++QMqLi0Snr0G01IvVM9eAPZn1dxtkDMzG6avI0rRn6/GFJdktZ9+0rI843m3rq9ikjoLftRk1PpmytXONRl/XaK9LU70/p5X5Yt/zR8Gw5R2TiWc1U+szGH9JrLxrx/eTngz8tbHaAFWC+79E212AZuV/MMBPOxWnqXySZHNxlOSlL+30pTX3tlOUa9k1p17hXysjAdPsnpan37taZHnyWJLeeQ9vHNilrP18wxXffn6ET5RkpM1Fsm9L2wfJyydD2tTbj+OFjBh2c9ure1yf5zuZkilWg116Upn5TkpclOSBN/cD02pmWuhr8Dl6ZUveM8t2UQYK3nKK94/iUGQm3S3kGfs+kYwcd936bic7vrFzDMaNSjzX1VpmYSfCpaeqnzvJcE7GEsrTvoMx+c8QgVGbJSHxYLE19jZR1t45NGaE8KoCfWXw/9bToSenBPGFUozIr3w0245hRZW+qh9thw1OK7bwZ12Z8/U9KvXPtJH+f0li3Y5LLuu9m1tS7pyz38NqUtTVnqp9mqgdNP7cyDKbduihl1M1UPp2JgNNM07XOtp6qsvGUYcOUrZVrnOqyQaPJjpnoSDAwGJ3/3QVbY5iVZvpng8LzATBX832PtrkG92szzSw32zQsB732L+m1n0uvfWV67UNTOpQ8KRP36TfKxqNYN6ftI5mY7ney0c8UJcA/6CCn7WP5GV5uYXOWgtx1aHvQiXLQcffiaTqKw8AbM/HbOZulYAZ1zMWzmKFtsDzEVO0d30pyTre98ZT6TX2DTIze/+Ck2AIr0/Bgg+Hfs80Z+D38W7pzJmYl+d0UaZkjQXxYPC/JxLSoX09yWJJbpPTe3Cq9tkqvrZIMpu/ddI0vmLtBI+3nUnqHz/Y1Hb3nVqtee2mSj3d7R2Ri+umPp9deNsuzHJvk5inl6L9Tpkq8aZJrJFnT1YHDgYXR9WCvvXqW12VcNfV1MjFV1/WSXJmm7m/yStYm2alL94huFPR05qOeUrZWqnGqy3rt95J8v9ubmFK/qe+a5HbdnlH4ACy+hblHg83Xa9el1x6d5DFDnz5iaBmHwb3X/2ZubR/TLaWk7WNlG555ba9pU02ljFS9Y7d3YXrtb+crU6wSZVaZN3Z7d01TP2RE6mFbVi+VEdGD5bfulaa+ydC3h2UieGsq/dVhuO77afc+3I7xnsz+t/Sghc7samY6fVgMZRr9f+z2Tkpy3xE92vTgZT5dlOTGSbZNr/3RPJxv1zl8f/G0qViu3pfSW/egSZ/NrKlvk+Qe3d5r02tfOk1KdeDqclhK4HMurpXkESmB1KnsmuTcEccP6ql+jLhfrcapLntPkrcnOTBNffP02l9mIqB/eSxLs5INPwuM6lwvIMZCUP6YyXzdow3K2kyDiEaVtcH92i6zyMNs0rCc9dovpKnPTelAed2UTiYXZmI09LUWpe2jqbfO8OhYlpsfpfy77ZwSzLxOeu2fZ3ns/TMx6vSkoc8Ho/t3HrFsGwy8KclzU+qwV6TMbDOdQR1zvTT11jOMxh/MLDFde8fxSf455Xf5MUne0H0+mEr/zK6zOSvfA4a2v9m9D/+eVZv5e3pxyv3fmpRZc9hCRuLD4tg5Ez+iH5k2gN/U10py68XKFKvCYITfPmnqbefhfPvO4fv5eHBmvHwlZSqkrbvXbzP7dS9vP7T9oRHp9hnxHSvPYNrV36U8QM70+s2k46Yy23rqZxpWVq1xqsuOT3JFymj9I9PU2yd5dPfdx9Jr/zLtkSx3w2uxTre0R5LcaqEzwqqk/DGT+bpHG5S1nWa43qiy9uPufY809fTltal3TrLHDNdhZRge+TwYmTpo+9gjTb0506NPducuUD+dOyUZtLFo+1huyojkQSfe7ZM8eQ5HP3to+5ih7UHgc5sk+29Grsz+sJr02kuS/Ee3d5c09cNHpB7UMdtmYr3y6ezXvU/d3tFrf5wyY0kyCNw39c0zUWaNwl8NmnrPJPfr9s5NclqSdGVmcN91wGadu9euz0SZvWc3uJUtYCQ+LI7h/9dG9TD/x/j/kvn1ySQHJ7lOysi+d27h+e6Qpt4rvfb703z/pO796iQnbuG1GDe99uo09bEpvYWT5Ng5rJM123rwaZuVN5af8qA4eCj4WHrtzCOOm/puKeXvvmnqm6TXTjX95RMy3drmTb1vkj27vS/PNcusEONUl/XaP6epP5oyrf8Tkpyd8pudmEp/pfvl0PY+SU6fJt1jpvkctoTyx/Tm9x5tUNZ2TFPfOr32p1Mcu22SR444+1eS1CkDkQ5PmcFmKo+LZQlXvqa+ZiaWHfpLJkbgfzLJM1PKwHNTRppuiZ2THJKJZZgme9LQtueK5enNSZ6eZLskL09Tn5Bee/bII5r60SltbEkJUg2Pnv5Mkv9MKYPPS1lKdS7WDm1vN8djWZ7eluSfktwgZTT+dG2tX07ymm77SRkEXCdr6v0zUT+OqpeOT+mItFea+rYps+gMvH/qQ1gxysCB92XinukNk2Z3+GTK4IXbpKkfmF77hc24yqdSlh25eZK/T3LC5mcYI/FhcVyY5E/d9mPS1JvejJXAwqsWMU+sDu/NxLTSb0hT32tk6qa+R5r6wBnO+a4p1zps6sOT/F23d0J67e/mmFeWg177ovTaa3SvF8/hyJ8NbR85ZYqmfnrKzR2rw+Mz8dDw0VkeM0i3JqWhdioPTVMftsmnOkzygwAAEItJREFUZbabQUemDdnyTk0sZ+NVl72ne79Zktd32z/P3Bv+WF4G07gmybOmeT44LMmjFjNTrBrKH6PM5z3a8G/Z86c59o1JbjLNd0kJol7QbR+Vpv7bTVI09S2TvHxWOWX8NPW10tTfTVM/ZGiN+6nSrUny1iQ7dp98shtRnfTaLyY5pfv8hVM+D2x8rjukqQ+ZIWdvTFNvOq1+aTN5Srd3enrtqTOch3HUa3+V5IXd3rWSfCVNfadp05cy9d5u78okR/y1/JXznZWJTh8PS1O/MNNp6h2mmFlkuA1t03qOlafXXpbkdd3eHTLRpjo53SmZCNw/OU19v03SNPV1snF7xztGXPkDmZj54bGZ6LR5cnrtL2aZe5ajpr5dytT5e3WffD2blpU3J7m02z46TX37jNLUB6ep7zjp07cluazbfmc38n+643ebOeOrmxG/sBh67YY09fEpvYLvmOSbaeo3pjQEXyflR/oZKRXkb2PaQuZLr13XPWicmPJQ8tU09QdTesD9MhPr0+yd5OEpN43PzvSBg9NSRuuclqZ+XZIfppThQ5M8tUtzSZIXLMBfw/L2/ZQG4z2TPLV7YD025UF1t5TGvkOTfCubO2UTy80R3fsF2XgtwVG+nVJmbtQd/7op0pyW5P1d49pHU0bo3DHJizKxZM3b02t/sJn5ZnWb/7qs134jTX1Wyv3fYPrXYzZqFGTl6bVXpanfmTJScM+Ue7TXJ/l1yjq8j0rpKPLtJHdfqmyyQil/jDZ/92i99vtp6pNTpul9cjfq/r1J/pzklimB0PtmVFnrtWvT1M9LGR14/STf7Z5FB3m7V8p93pqUNpZbxrTUy9F+KSP3zktTn5Dk5CTnpLQv7JQScHhSSptFUsrQyyad4/CUQP7OST6Upn5cyvJHP0uZLfAG3XkOSXK3lFHTn5omP/+bMqL19DT1v3Xn3S6l/a5JaVO/KqWdj+Wq17616xj03CR/k9LW9YGUkajnpEyNf5uUsjUInK5L8rj02jOmOOMzUsrWjZO8Pk39oJQp989MqZd2T3KflOWzHpmNZ7D8fspo/GskeVWaen2Xh8GMYeel116xpX8yY+cdKW2oN0r5jZvOk5N8N2VK/c+mqd+aUn9dllKvvTgTS8q8YeRa5r32N2nqrye5d0odtlP3jan0l78bTAqY75CydNYdU+qwB2Sio+Z3khzaTX8/odf+Pk39hJT2tBul1IvHJPlcyvJJ26S0feyX0vaxR8rv6g+GznF+N7jhfSm/vaekqd/dneP8lBjFnkkemtJOp+PSCEbiw8KZ/ND4kiRndNv7pDyAnpoyvc0/Jbk85QbO6GXmV6/9TsqN2blJtkrpZfmRlEDXKUk+keRfM/EwPGr93c+kTPF0myRHd+f4SsoUZGu6Yw/pejTDhBKMOiLJH7tPDkt54DgtpVPJoSmdQoz4Wg2a+oBM3KR/fNZTmZd0g9ENt09T7z1FqsNSghDPSPLVlDL235kI4H8s5XcX5m7h6rJ2aHtDNl5fk5VhqoDSq1MaT5ISvDohZT3Vz6UEKr6RiZF+sCWUP2ZnYe7RnpSJkfRPSLk/Oz3JB1MC+G9I8u4Zzv+BJC9NKcvXS5m55uTu9bqUoNdjUxqGk42npWb8XZWJf7ubpASVjkvpqHFGSqCzl4k2i58lud8m7Q699ucpHUYGwatDuvN8N+Ve7bMpU1Lfrft+VNvHGSnPE7umjCg8pcvPP6eUt8FI7O/O5Q9lDPXa56W0aV2c0jnjiJQ2s1NSOua2mQjg/yTJA9Jrp56lpNf+Psk9M1EG75sSxDolpQ34Iynlaucpjr0kyVu6vbsk+WKSn6aU958luevm/omMsdIx47WzSHdGSp32l5RA/vNT6sZTk7wrEwH8t2d2y4kMAvY7de9XJfnwrPLMOHt6SnvE4PWdlHv71yU5KCWAf2FKnOqe6bV/mPIsvfZ/UmYXvDjlN+9pKfGD07tzfjTJ/5dS7jZkYtT98DmOTekUfEWS7ZM8p8vL91N+T9+R5MEpsQpGEMSH+bXt0PblG33Ta/+cMiLrZSmV6NqUkfc/SXlovVN67TcWJ5usOiWQf8uUH93PpMz4cGVKOTw35eHgJUluk177vhnOdVSSB3Xn+X13nl8l+X9Jbp9ea/pfplYeOu6c5L9SepSvT7khPCWl5/F+lmFYNR4/tP2xOR47nP7xm3zba3+ZMrvIa1N+Yy9PGanzjZQRE4dOWu8L5mZh6rJjh7a/lF77my3PKGNg+meDJOm1l6c07r4k5fngipSGuVOTPCvJ/TNVgwjMjvLH5pj/e7Ree2ZKQOodKb+bV6Y0IH8+ycHptdNPOT2s174myYEpHU4uSBkNe05KZ8190ms/m+TaXeo/zzHvLKVeuzYleH9AyrIIn0vyi5Q66OqUuunMlFH1hyfZM7329GnOdVbKfdrhKWXy1yn125Upg2ZOTOnEtHd67StnyNd7UgKyH85EG8p5KUHZvdJrP7hZfy/jp9f+V0oHpmen1E3nZqLd9ucpnY4ek+QO6bWjZygp05HfOSV49ZmUcrc+pRyelVJ+/j5Tz3Ty4pQR1yelPF9cvSV/FsvGuzOxFOr0yrIht0hp6zgjpW5cl1LPHZ8SlH3WLDvgfbQ7duCL6bUXzi3bjLkNKfdDv06pU96UMoB0t/Ta187YLtZrP5Wypv0LUjpg/j4Tddkvk3w6ZYDM7um1X5vmHO9NqVtfk9IB4E8p9dofUzoDvDYlxsAIVb9vhimYN039Dyk3dkny5O6GHwBYSE19VAbroPbaamRaGEdN/YCUDnVJ8g/ptUZBrASeDVhKyh+rTVNvk9JYvX2SV6fXTp5qHWbW1L9KcrMk702vPXJpMwMArHZG4sP8uv3Q9plLlgsAAJaTJ3XvF6VMU8fK4NmApaT8sdo8LCWAn0wsFQEAAMuWID7Ml6beLmVqpaRMZ3PaEuYGAIDloKn/Nsmh3d7R6bXrRiVnmfBswFJS/liJmvoWI77bPckbu73fJ/nCIuQIAAAW1NZLnQFY1pr6ekl2S7J7yvogg4fK93RregEAwMaa+iZJrplkjySvS3kuW5ukt5TZYgt5NmApKX+sfGemqT+bsgbrj1PWS79BkvskeVqSnbp0L5hxnVcAAFgGBPFhyxyRTRtbv5PBurwAALCp45McOOmzl6XX/nYpMsO88WzAUlL+WOm2SnJI95rKhiQvTa89bvGyBAAAC0cQH7ZcP8mfk/wkyYeTvMM0qAAAzMLlSc5K8qb02vcudWaYF54NWErKHyvZIUkenOTuSXZNcr0k65Kcl+TEJG9Pr/3RkuUOAADmWdXv95c6DwAAAAAAAABAkjVLnQEAAAAAAAAAoBDEBwAAAAAAAIAxIYgPAAAAAAAAAGNCEB8AAAAAAAAAxoQgPgAAAAAAAACMCUF8AAAAAAAAABgTgvgAAAAAAAAAMCYE8QEAAAAAAABgTAjiAwAAAAAAAMCYEMQHAAAAAAAAgDEhiA8AAAAwH6qq372OWuqsAAAAsHwJ4gMAAAAAAADAmBDEBwAAAJhOVZ3Yja4/camzAgAAwOogiA8AAAAAAAAAY0IQHwAAAAAAAADGhCA+AAAAAAAAAIwJQXwAAABgdqrqqG59+H63f+3usx+mqi5NVV2Qqvpsquruk467Qarq1amqH6eqLktVXZSq+kSqaq8ZrrcmVfW47pznp6quTFVdmKr6WqrqGamqbeeQ12ukql6YqvpequqS7nVKqupZqaqtpzj+mO7YA7tPDvzr+SZev5oh//umqj6QqvpNqmpdquq8VNWxqarbjjwOAACAVa3q9/tLnQcAAABgOaiqo5K8vNv7myRfTnKrKVJeneQx6fc/kqq6Y5LPJrnJFOnWJXlw+v2vTXGtnZN8MskBI3L0k+74c2bI6w2TfD7Jnac5z6eSPCz9/oah449J8oQR106Sc9Lv7z50zKCR5RVJLkjy5iSbdhBILu/y/Y0Zzg8AAMAqZCQ+AAAAsDk+kmS3JP+WMlp93yRNkr8k2SpJm6q6eZJPJ9k+yUuS3CPJXVOC61cm2S7JMZuMqK+qrbrjBgH8ryd5VJJ9kjw0yQnd57dN8pVU1bVmyOv/JLldkrckeUCSvZMcntIJIEkOSfLkSce8JMkdkpzW7Z/W7Q+/Dprmeg9M8tYkP07ypJT/NvdK0kuyIck1kxw7ciYBAAAAVq2peoMDAAAAzOTOSQ5Mv//doc9OS1X9LCUAv2OS7yapkuyXfv/nQ+lOSVX9IcnbU0b0H5zk40PfPy3J/t32+5IcmYmpBE9P8qlU1WuS/EuSv03ysiQvGpHXfZMclH7/xKHPvpeq+kKS/0uya5JnJHnnX7/t989Lcl6q6rLuk8vS7/9oxDWG3S1l9oGHp9+/cujzk1JVFyV5dab+uwEAAMBIfAAAAGCzvGlSAL/o9z+TZDC9/S5JXjYpgD9wdJK13fY9J333zO79wiTPytRrAb48yZnd9pNTVduNyOtbJwXwB3m9uMtHktwhVXWdEeeYi7VJnjgpgD/wlpRZCJJN/24AAAAQxAcAAAA2ywdHfPeD7r2f5ENTpuj3r0jys25vj79+XlU3TpkmP0k+nH7/kmmOvyoTAfjrJrnLiPwcP+K70wdXTnLzEenm4kvp9y+Y8pvy92z6dwMAAEBHEB8AAADYHGeN+O5P3fsf0u//cRbpdhz6bM+h7U1H+m9s+Ps9p001MWJ/KhcPbe84baq5GXW94WvO1/UAAABYQQTxAQAAgLnr9y8f8e2G7n1UmuF0Ww19tvPQ9tSj2SecP81xG5tdXifnY0tszt8NAAAASQTxAQAAgPHVX+oMAAAAwGITxAcAAADGyfD09rvOkPaG0xwHAAAAy5YgPgAAADBOfjS0fdcZ0u43zXHzyWwAAAAALCpBfAAAAGB89Pu/TfKTbu+wVNW1pkxXVVslObLb+2OS7y1QjtZ279st0PkBAABgI4L4AAAAwLh5e/e+S5K3TJPm5Ulu122/O/3+ugXKy++69z1SVdUCXQMAAAD+ShAfAAAAGDf/leTkbvuJqaqvpKoemaq6S6rq4FTVx5K8rPv+50letYB5+Xb3foMkb0xV7Z2qukX3utkCXhcAAIBVauulzgAAAADARvr9q1NVD0nyySQHJLlv95rsJ0kenH7/0gXMzQeT/HOSPZI8r3sNnJNk9wW8NgAAAKuQkfgAAADA+On3L05yrySPT/L5JL9Psj7JRUlOTPKsJHdOv3/OAufj0iR3T/LmlE4Dly/o9QAAAFj1qn6/v9R5AAAAAAAAAABiJD4AAAAAAAAAjA1BfAAAAAAAAAAYE4L4AAAAAAAAADAmBPEBAAAAAAAAYEwI4gMAAAAAAADAmBDEBwAAAAAAAIAxIYgPAAAAAAAAAGNCEB8AAAAAAAAAxoQgPgAAAAAAAACMCUF8AAAAAAAAABgTgvgAAAAAAAAAMCYE8QEAAAAAAABgTAjiAwAAAAAAAMCYEMQHAAAAAAAAgDEhiA8AAAAAAAAAY0IQHwAAAAAAAADGhCA+AAAAAAAAAIwJQXwAAAAAAAAAGBOC+AAAAAAAAAAwJgTxAQAAAAAAAGBMCOIDAAAAAAAAwJgQxAcAAAAAAACAMSGIDwAAAAAAAABjQhAfAAAAAAAAAMaEID4AAAAAAAAAjIn/HznZdisn8FybAAAAAElFTkSuQmCC\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"image","arguments":{}}},"output_type":"display_data","data":{"image/png":"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\n"}}],"execution_count":0},{"cell_type":"code","source":[""],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"51fba8e7-6386-49b6-bcf1-d4d380c89c8b"}},"outputs":[],"execution_count":0}],"metadata":{"application/vnd.databricks.v1+notebook":{"notebookName":"clinicaltrial_2020_analysis","dashboards":[],"notebookMetadata":{"pythonIndentUnit":4},"language":"python","widgets":{},"notebookOrigID":3469311754156786}},"nbformat":4,"nbformat_minor":0}
